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 Preface 
The main task of the Nordic Expert Group for Criteria Documentation of Health 
Risks from Chemicals (NEG) is to produce criteria documents to be used by the 
regulatory authorities as the scientific basis for setting occupational exposure limits 
for chemical substances. For each document, NEG appoints one or several authors. 
An evaluation is made of all relevant published, peer-reviewed original literature 
found. Whereas NEG adopts the document by consensus procedures, thereby 
granting the quality and conclusions, the authors are responsible for the factual 
content of the document. 
The evaluation of the literature and the drafting of this document on Occupational 
chemical exposures and cardiovascular disease were done by Dr Bengt Sjögren, 
Dr Carolina Bigert and Prof. Per Gustavsson at the Institute of Environmental 
Medicine, Karolinska Institutet, Sweden.  
The draft versions were discussed within NEG and the final version was adopted 
at the NEG meeting on 9 May 2019. Editorial work and technical editing were 
performed by the NEG secretariat. The following experts participated in the 
elaboration of the document: 
 
NEG experts  
Gunnar Johanson Institute of Environmental Medicine, Karolinska Institutet, Sweden 
Merete Drevvatne Bugge  National Institute of Occupational Health, Norway 
Helge Johnsen National Institute of Occupational Health, Norway 
Anne Thoustrup Saber  National Research Centre for the Working Environment, Denmark 
Piia Taxell  Finnish Institute of Occupational Health, Finland 
Mattias Öberg  Institute of Environmental Medicine, Karolinska Institutet, Sweden 
Former NEG experts  
Nina Landvik National Institute of Occupational Health, Norway 
Tiina Santonen  Finnish Institute of Occupational Health, Finland 
Vidar Skaug  National Institute of Occupational Health, Norway  
Helene Stockmann-
Juvala  
Finnish Institute of Occupational Health, Finland 
NEG secretariat  
Anna-Karin Alexandrie  Swedish Work Environment Authority, Sweden 
Jill Järnberg Swedish Work Environment Authority, Sweden 
 
The NEG secretariat is financially supported by the Swedish Work Environment 
Authority and the Norwegian Ministry of Labour and Social Affairs. 
All criteria documents produced by NEG may be downloaded from 
www.nordicexpertgroup.org. 
 
Gunnar Johanson, Chairman of NEG  
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1. Introduction 
This document reviews occupational chemical exposures in relation to 
cardiovascular disease (CVD). The scientific data used for the evaluations are 
primarily epidemiological studies, supplemented with experimental human and 
animal data. Some chemical air pollutants are widely distributed and with exposure 
including the general population. When appropriate, such exposures have been 
included in this presentation. Occupational air pollutant exposures are often 
mixtures of many different chemicals, e.g. welding fumes and farming dust,  
which complicates exposure-effect analyses. Even individuals with their main 
occupational exposure restricted to one chemical (e.g. tetrachloroethylene in dry 
cleaning) may have a complex lifetime history of occupational exposures. 
CVD includes several diseases, the main categories being heart and cerebro-
vascular diseases (CeVD), respectively. 
The main group of the former is ischaemic heart disease (IHD) or myocardial 
ischaemia which is characterised by reduced blood flow (ischaemia) to the heart 
muscle. The most common cause of this condition is atherosclerosis in the coronary 
arteries and consequently IHD is often called coronary heart disease (CHD). The 
most common vascular disease is high blood pressure (hypertension). 
The main CeVD is stroke, which signifies the abrupt impairment of brain 
function caused by a variety of changes involving one or several cerebral blood 
vessels. Approximately 85% of all strokes are caused by diminished blood flow 
(ischaemic stroke) and the remaining 15% comprise haemorrhage in the brain tissue 
and the surrounding subarachnoid space (1056). 
Some reviews have been presented regarding occupational chemical exposures 
and CVD. In 1989, Kristensen presented well-documented relationships between 
exposures to carbon disulphide and nitroglycerine/nitroglycol, respectively, and 
CVD. Causal relationships between lead and second-hand smoke (passive smoking) 
and CVD were considered less likely at the time (518). Attributable fractions for 
the occupational burden of deaths in Finland and Sweden due to circulatory disease 
and IHD have been estimated for some chemical and non-chemical agents (473, 
719). 
Fang and coworkers reviewed studies on occupational particulate exposures and 
found a possible association with IHD (279). In another review, exposure to some 
metals (e.g. arsenic and lead) was found to be associated with CVD (881). In 2013, 
Jakobsson and Gustavsson evaluated the evidence of relationships between 
occupational exposures and stroke. They found limited evidence for a relationship 
between exposure to carbon disulphide and stroke and insufficient evidence for 
relationships between dynamite and combustion products and stroke (451). 
In 2017, the Swedish Agency for Health Technology Assessment and Assess-
ment of Social Services presented a review on chemical exposures and CVD. The 
review included occupational epidemiological studies but excluded environmental 
epidemiological, and experimental human and animal studies. The conclusion was 
that there is evidence that workplace exposure to crystalline silica dust, engine 
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exhaust and welding fumes is associated with IHD. An association with IHD was 
also seen for workplace exposure to arsenic, asbestos, benzo(a)pyrene (BaP), lead, 
dynamite, carbon disulphide, carbon monoxide, metalworking fluids and tobacco 
smoke. Associations were also found between IHD and work with electrolytic 
production of aluminium and exposure to compounds which are banned in  
many countries, such as asbestos and phenoxy acids containing dioxins. There was 
further evidence that workplace exposure to crystalline silica dust and asbestos, 
respectively, is associated with pulmonary heart disease (cor pulmonale) and that 
workplace exposure to lead, carbon disulphide, phenoxy acids containing dioxin, as 
well as working in an environment where aluminium is being electrolytically 
produced, is associated with stroke (835). 
Some of the agents included in the present review have recently been evaluated 
by the Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals (NEG), in documentations covering also cardiovascular effects, e.g. 
carbon nanotubes (395), diesel engine exhaust (941) and carbon monoxide (918).  
2. Definitions 
In 1899, Jacques Bertillon presented a report at the meeting of the International 
Statistical Institute at Christiania. The report contained the progress of the Bertillon 
Classification of Causes of Death and included a recommendation from the 
American Public Health for decennial revisions. This was the start of the generally 
accepted International Classification of Diseases (ICD). Diagnoses have changed 
and developed during the years and the coding of diseases in effect at present is 
ICD-10 (1014). Chapter IX in the 10th revision (ICD-10) comprises diseases of the 
circulatory system (ICD-code I00–I99).  
By the authors of the present document, cardiovascular disease (CVD) comprises 
heart and vascular diseases and covers the diseases listed in Table 1. Consequently, 
CVD is equivalent to diseases of the circulatory system. In the conclusions for each 
chemical agent, the term CVD is generally used, but more specific diagnoses are 
given when appropriate, e.g. IHD (ICD-10, I20–I25), CeVD (ICD-10, I60–I69), 
pulmonary heart disease including cor pulmonale (ICD-10, I27.9), and cardio-
myopathy (ICD-10, I42). 
In the description of individual epidemiological studies, the diagnoses used in the 
publications were kept, e.g. sometimes CVD comprised fewer diagnoses and 
excluded CeVD (242, 867). No attempt was made to translate previous ICD-codes 
to current ICD-10 codes. 
The concept coronary heart disease (CHD) appears in the literature. According 
to ICD-8 or -9 (codes 410–414), CHD is equal to IHD. According to ICD-7 (code 
420), CHD means arteriosclerotic heart disease (1014). Arteriosclerosis literally 
means “hardening of the arteries” and refers to a group of processes which have in 
common thickening and loss of elasticity of arterial walls. At least two morpho-
logical variants are included in the term: atherosclerosis and arteriolosclerosis. 
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Atherosclerosis is an extremely common arterial disease characterised by the 
deposition of elevated focal, fatty-fibrous plaques, known as atheromas, within the 
intima and inner media of the walls of arteries. Arteriolosclerosis is characterised 
by proliferative fibromuscular or endothelial thickening of the walls of small 
arteries and arterioles (780). Although atherosclerosis is a specific type of 
arteriosclerosis, the terms are sometimes used interchangeably in the literature. 
 
 
Table 1. Diseases of the circulatory system falling under the category cardiovascular 
disease (CVD) according to the definition in the present document. ICD-10 codes are 
according to WHO (1014). 
ICD-10 
code 
Diagnosis 
I10–I15 Hypertensive diseases 
I20–I25 
I20 
I21 
I25 
Ischaemic heart diseases 
Angina pectoris 
Acute myocardial infarction 
Chronic ischaemic heart disease (atherosclerotic heart disease) 
I26–I28 
I26 
127.2 
I27.9 
Pulmonary heart disease and diseases of pulmonary circulation 
Pulmonary embolism 
Secondary pulmonary hypertension 
Pulmonary heart disease, unspecified (chronic cor pulmonale) a 
I30–I52 
I30–I31 
I33 
I40–I41 
I42 
I46 
I48 
I49 
I50 
Other forms of heart disease 
Pericarditis 
Endocarditis 
Myocarditis 
Cardiomyopathy 
Cardiac arrest 
Atrial fibrillation and flutter 
Other cardiac arrhythmias  
Heart failure 
I60–I69 
I60 
I61 
I63 
Cerebrovascular diseases 
Subarachnoid haemorrhage 
Intracerebral haemorrhage 
Cerebral infarction 
I70–I79 
I70 
I71 
Diseases of arteries, arterioles and capillaries 
Atherosclerosis 
Aortic aneurysm and dissection  
I80–I89 
I80 
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified 
Phlebitis and thrombophlebitis 
I95–I99 
I95 
Other and unspecified disorders of the circulatory system 
Hypotension 
a For a description of cor pulmonale, see Section 4.4. 
ICD-10: The 10th revision of the International Classification of Diseases, WHO: World Health 
Organization. 
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3. Occurrence 
CVD is the number one cause of death in the developed as well as in the developing 
world. In 2010, there were 52.8 million deaths globally of which CVD contributed 
to 15.6 million, i.e. 30%. The most common CVD was IHD (7.0 million) and CeVD 
(5.9 million). The annual CVD mortality has increased dramatically from 11.9 
million in 1990 to 15.6 million in 2010 (578) and is expected to reach 23.6 million 
by 2030 (17). However, the age-standardised death rates from CVD decreased from 
298 to 235 per 100 000 persons in the period 1990–2010, thus the increase in total 
CVD mortality is driven by population growth and ageing (578). 
The World Health Organization (WHO) has launched the project Monitoring 
Trends and Determinants in Cardiovascular Disease (MONICA), which during the 
mid-1980s until the mid-1990s revealed substantial differences in coronary event 
rates [myocardial infarction (MI) and coronary deaths] across countries. Thus, the 
coronary event rate (per 100 000) in men varied 10-fold, being highest in Finland 
(835 in North Karelia) and lowest in China (81 in Beijing). Among women, an  
8-fold variation was observed with the highest coronary event rate observed in 
Scotland (265 in Glasgow), and the lowest rates of 35 in Spain and China (321). 
During the same period (mid-1980s to mid-1990s) the average coronary event 
rates decreased by 23% among women and by 25% among men and the mortality 
of CHD decreased even more; 34% among women and 42% among men. The 
greatest decline in coronary event rates in men occurred in north European 
populations (Finland and Northern Sweden). Populations experiencing notable 
increases in coronary event rates were predominantly from Asia and the central and 
eastern parts of Europe, although the general pattern of increases and decreases 
appeared to be less consistent in women (321). 
Reliable and comparable occupational disease statistics based on compensated 
cases are not available at the global level. This lack has been compensated for by 
calculations of the population attributable fractions for work-related illnesses found 
in different studies. These attributable fractions are commonly used to measure the 
fraction of illnesses and deaths that are related to work. The International Labour 
Organization (ILO) has used the attributable fraction 12.4% (14.4% for males and 
6.7% for females) to estimate the global burden of work-related diseases regarding 
the circulatory system (936). 
In 2001, Nurminen and Karjalainen estimated the attributable fraction for the 
occupational burden of deaths due to circulatory disease to 12%, with shift work, 
work strain and second-hand smoke as the most important agents (719). In 2013, 
Järvholm and coworkers estimated the attributable fraction for work-related IHD 
from motor exhaust to 3.5% and that from other combustion products to 4.4% 
among Swedish males (473). 
  
5 
4. Mechanisms for development of cardiovascular disease  
The main hypothesis for the association between inhalation of air pollutants and 
development of CVD is that of a general inflammatory process. Other hypothetical 
pathways include disturbances of the autonomic nervous system and systemic 
uptake of particles from the lungs to the cardiovascular system (126). 
The potential health risk from inhalation of chemical agents depends on mass 
concentration as well as particle or droplet size. The conventional particle fractions 
of total airborne particles are the inhalable, thoracic and respiratory fractions. The 
inhalable fraction consists of all particles inhaled through the mouth and nose. The 
thoracic fraction consists of particles reaching beyond the larynx. The respirable 
particle fraction reaches the alveolar region (1027). In the European Standard  
EN 481:1993 defining sampling conventions for particle size fractions (target 
specifications for sampling instruments), it is stated that the collection efficiency 
should be 50% of particles with aerodynamic diameters of 100, 10 and 4 µm for the 
inhalable, thoracic and respirable fractions, respectively (265). Other frequently 
used and generally accepted particle-size selective criteria for aerosol sampling are 
PM2.5 and PM10 (particulate matter with maximal aerodynamic diameter of 2.5 and 
10 µm, respectively). PM2.5 is not related to particle-size deposition within the 
respiratory tract, but rather to the source-related properties from atmospheric 
combustion processes. The thoracic and the PM10 criteria represent basically the 
same fraction, but the thoracic fraction allows for sampling up to 25 µm, whereas 
the PM10 collection efficiency has a cut off around 15 µm (1027). Particles may 
also be divided in coarse (2.5–10 µm), fine (≤ 2.5 µm) and ultrafine (≤ 0.1 µm) 
(126). 
Mouse models have been useful for studying development and progression of 
atherosclerotic lesions. Current mouse models are based on genetic modifications 
of lipoprotein metabolism. Low-density lipoprotein receptor-deficient mice 
(LDLR-/-) and apolipoprotein E-deficient (atherosclerosis prone) mice (ApoE-/-) 
are the most widely used (380). Overexpression of serum amyloid A (SAA) 
increases plaque progression in the arteries, and inhibition of SAA synthesis lowers 
plaque progression, in mouse models of CVD (958). 
4.1 Inflammation originating from the airways 
Already in the 1840s, the inflammatory nature of atherosclerosis was described by 
the Austrian pathologist Carl von Rokitansky and by Rudolf Virchow. Virchow 
considered atherosclerosis to be a primary inflammatory disease while Rokitansky 
viewed atherosclerotic inflammation as secondary to other disease processes (318, 
613). The “response to injury hypothesis” was summarised by Ross in 1993 (802). 
This theory postulated an alteration of the endothelium and smooth muscle of the 
artery wall, due to e.g. mechanical injury, toxins and oxygen radicals, as the 
initiating event leading to endothelial dysfunction. During the last two decades 
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more data have linked inflammation to the occurrence of atherosclerosis and 
thrombosis (261, 563, 778, 803).  
In the mid-1990s, the observed association between environmental as well as 
occupational air pollutants and IHD was proposed to occur via a low-grade 
inflammation (850, 878). 
Several markers of inflammation such as interleukin-6 (IL-6), fibrinogen and 
leukocyte cell count are established markers for an increased risk of IHD (209-211, 
288). 
Acute respiratory tract infections were associated with increases of inflammatory 
markers and a raised risk of MI the following 10 days (629). Influenza was followed 
by increased risk of MI within 7 days (523). Likewise, short-term (days) elevations 
of urban particulate air pollution are associated with an increased daily CVD 
mortality. It is assumed that endothelial cell activation and blood coagulation are 
engaged in the rapid response leading to thrombosis in the coronary arteries (126).  
Long-term exposure to airborne particles is capable of augmenting the develop-
ment and progression of atherosclerosis (126). Thus, long-term inflammatory 
responses after exposure to particles may have similarities with several chronic 
inflammatory diseases which are associated with an increased risk of IHD. 
Examples of such diseases are chronic bronchitis (371, 465), periodontitis (108), 
systemic lupus erythematosus (373), rheumatoid arthritis (792) and psoriasis (516). 
Reduced forced expiratory volume in the first second (FEV1) may be an expression 
of inflammatory lung disease, and is associated with CVD mortality (872). Certain 
occupational exposures have been associated with some of the diseases mentioned 
above. For example, exposure to dusts, gases and fumes has been related to an 
increased incidence of chronic bronchitis (925) and silica exposure has been 
associated with the development of rheumatoid arthritis (919).  
Cigarette smoke is an example of an air pollutant containing both particles and 
gases. Smoking and second-hand smoke are established risk factors for CHD. It has 
also been suggested that the risk of CHD from smoking is higher in women than in 
men (433). Smoking and second-hand smoke are also major causative factors for 
stroke (743).  
When rats were exposed by inhalation to titanium dioxide particles of equal 
gravimetrical dose (mg/m3) but different sizes, ultrafine particles (20 nm) induced 
more inflammation in the lungs than larger particles (250 nm) (721). For a given 
particle mass concentration, a 100-fold decrease in diameter (e.g. from 2 to 0.02 
µm) corresponds to a million-fold increase in particle count and a 100-fold increase 
in total surface area (239). Some characteristics of the ultrafine particles, such as 
high particle number and large surface area, suggest that they may pose a 
particularly high cardiovascular risk after inhalation (126, 814).  
Volunteers exposed to zinc oxide or swine dust reacted with a stronger 
inflammatory response after the first exposure than after repeated exposures (290, 
731). These reactions indicate an adaptation process and may be one explanation of 
the increased CVD mortality on Mondays (1032).  
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In 2010, the American Heart Association (AHA) reviewed the literature and 
presented a statement regarding particulate matter air pollution and CVD. They 
summarised the epidemiological evidence of the cardiovascular effects of PM2.5 
(traffic-related and combustion-related air pollution exposure at ambient levels); 
there was strong overall epidemiological evidence for an association between both 
short-term exposure (days) and long-term exposure (months to years) and IHD. 
AHA also evaluated the biological pathways leading to effects on the cardio-
vascular system. There was strong overall mechanistic evidence of a relation 
between a systemic proinflammatory response and CVD in humans as well as in 
animals (126). In more recent reviews, the weight of evidence further suggests that 
acute exposure to PM2.5 induces a shift in the haemostatic balance towards a pro-
thrombotic or pro-coagulative state (781) and also a causal link between pulmonary 
acute phase response, induced by inhalation of nanoparticles, and CVD (814). 
4.2 Systemic uptake of inhalable particles 
Inhaled particles may be translocated from the lungs to the blood and further to 
other organs in the body. When volunteers inhaled radioactive 35-nm carbon 
particles for 6 minutes, 1% of the initially deposited activity was detected in blood 
80 minutes after exposure (1017). Inhalation of slightly bigger carbon particles (84 
nm) resulted in a lower translocation to blood (0.3%) (500). 
Several animal studies showed small but significant increases in systemic levels 
of engineered nanomaterials after inhalation exposure, suggesting that these 
materials are absorbed to a low but measurable degree via the respiratory route. The 
systemic uptake of gold nanomaterials is less than 1% of the inhaled dose in animal 
experiments. Small engineered nanomaterials tend to be taken up to a greater extent 
than large nanomaterials. The uptake of molecules from soluble or degradable 
engineered nanomaterials, e.g. silver and zinc oxide, can be much higher (457, 488). 
Inhaled asbestos fibres entrapped in the lungs may become coated by proteins 
and form ferrugineous bodies which in general consist of a fibrous core coated by 
protein and haemosiderin, a result from oxidation of ferritin (333). These coated 
fibres have a unique appearance under the microscope and are usually called 
asbestos bodies. Electron microscopic studies have shown that only a tiny 
proportion of the asbestos fibres present in the lungs of asbestos workers become 
coated. Asbestos bodies have been detected in many organs including the heart (53), 
which indicates translocation of fibres from the lungs. 
A case of epicardial anthracosis in a coal miner emphasises extrapulmonary 
dissemination of inorganic carbon particles (23). 
Generally, particles in the heart and blood vessels may disturb function in these 
organs, but the relationship with CVD is unclear. 
4.3 Disturbances of the autonomic nervous system 
The heart rate is regulated by the autonomic nervous system. Stimulation of the 
sympathetic system will increase the heart rate while parasympathetic stimulation 
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will decrease it. Heart rate variability (HRV) is a measure of the cyclic variations 
of beat-to-beat intervals that reflects cardiac autonomic function. Decreased HRV 
is associated with increased occurrence of cardiac events (972) and increased risk 
of mortality (219, 950). 
In 2010, AHA stated that there was moderate overall mechanistic evidence of a 
relation between disturbed balance in the autonomic nervous system and cardio-
vascular effects in humans (126). In addition, reduced HRV indices (indicating 
dysregulation of the autonomic nervous system) were associated with increased 
levels of an inflammatory marker (C-reactive protein, CRP) (368). It has also been 
shown that air pollution in cities can increase the incidence of ventricular 
tachyarrhythmias among patients with implantable cardioverter defibrillators (491). 
4.4 Other mechanisms 
Inhaled carbon monoxide (CO) forms a complex with haemoglobin in the erythro-
cytes. The complex, carboxyhaemoglobin (COHb), will decrease the available 
oxygen to the heart muscle and exposure to CO may consequently increase the risk 
for ischaemia (918). 
Asphyxiants such as cyanide (122), hydrogen sulphide (666) and phosphine (1) 
inhibit mitochondrial cytochrome oxidase. Cardiac arrhythmias are associated with 
these intoxications.  
Exposure to nitroglycerine and other organic nitrates is associated with cardio-
vascular symptoms which develop in three stages. The first stage is characterised 
by vasodilation. The second stage that develops after days to months includes 
compensatory responses of vasoconstriction. The third stage relates to withdrawal 
of exposure. During a period of 3–4 days vasoconstriction may overcome vaso-
dilation and this imbalance may cause coronary insufficiency or acute MI (534).  
It is well-known from animal and clinical studies that halogenated volatile 
anaesthetic hydrocarbons can sensitise the heart to the arrhythmogenic action of 
various catecholamines (e.g. adrenaline) (124, 424, 459). Several additional 
halocarbons show evidence of cardiac sensitisation to catecholamines in animal 
studies (408, 812). 
Pulmonary arterial hypertension results from diseases affecting the structure and 
function of the lungs like pneumoconiosis (e.g. silicosis and asbestosis) and 
extrinsic allergic alveolitis. Chronic obstructive pulmonary disease (COPD) is the 
leading cause of this disease. Pulmonary arterial hypertension may lead to right 
ventricular enlargement and to heart failure, a condition often called cor pulmonale 
(1002, 1003). 
Dyslipoproteinaemia is a well-known risk factor for CVD and an association 
between carbon disulphide exposure and dyslipoproteinaemia has been suggested 
(447, 588).  
When blood DNA methylation of nitric oxide synthase 3 (NOS3) and endothelin-
1 (EDN1) was studied in a group of steel workers exposed to different levels 
  
9 
of metal-rich air particles, a relationship between blood hypomethylation of these 
inflammatory genes and increased blood coagulation was found (940). 
The aryl hydrocarbon receptor (AHR) pathway is believed to play an important 
role in the development of the cardiovascular system. Ahr gene-deficient mice 
develop cardiac hypertrophy, abnormal vascular structure in multiple organs and 
altered blood pressure depending on their host environment (1052). There are two 
different potent activators of AHR signalling which exhibit strong negative 
influence on the cardiovascular system: polycyclic aromatic hydrocarbons (PAH), 
such as benzo(a)pyrene (BaP) and halogenated aromatic hydrocarbons, such as 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). AHR is an orphan receptor which 
earlier was thought primarily to function in mediating xenobiotic metabolism 
through transcriptional activation of drug-metabolising enzymes, since the most 
highly induced genes encode the cytochrome P450 (CYP1) enzymes. Today, some 
high-affinity physiological activators of AHR have been suggested (227) and it is 
established that the receptor participates in xenobiotic-independent functions and is 
a key transcription factor controlling cell physiology and organ homeostasis (682). 
In particular, one natural compound, the tryptophan-derived 6-formylindolo[3,2-
b]carbazole (FICZ), has attracted a lot of interest with regard to the physiological 
role of AHR. FICZ binds AHR with the highest affinity of all natural and xeno-
biotic ligands described and is also a perfect substrate for the induced CYP1 
enzymes (772, 1026). Therefore, this molecule causes transient AHR signalling of 
importance for normal physiology and disease prevention (452, 771). Activation of 
AHR can be an underlying mechanism of atherosclerosis mediated by certain 
environmental contaminants. This was suggested in mouse models where athero-
genic effects of e.g. dioxin-like polychlorinated biphenyls (PCBs) and BaP were 
stronger in mice with an intact AHR system (400, 487).  
Hydrogen fluoride easily penetrates the skin. An exposure area of the human skin 
of 2.5–3% is enough for the fluoride ions to reach the circulation, disturb the 
electrolytic balance and cause development of hypocalcaemia, hypomagnesaemia 
and heart arrhythmias (1038), which may be fatal (947). 
5. Measures of risk and interpretation of epidemiological studies  
The most common study designs in occupational epidemiology are cohort and case-
control studies. Both give estimates of measures of risk associated with the 
exposure, often expressed as relative risk (RR), i.e. the ratio of the disease rate 
among the exposed to the disease rate among the unexposed. Occupational cohort 
studies using the disease rate in the general population as a proxy for the disease 
rate among unexposed, report risk as a standardised mortality ratio (SMR). Studies 
based on cohort-internal comparisons of risk are often analysed by Cox regression, 
with relative risk expressed as a hazard ratio (HR). In case-control studies, the 
frequency of exposure is studied among cases of a specific disease (cases) and 
within a sample of the study base (controls). The information obtained is used to 
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estimate the odds ratio (OR), which in a well-designed study is an unbiased estimate 
of the relative risk. Sometimes there is information on exposure for dead persons 
only, e.g. in studies based on occupational titles on death certificates. In such cases, 
it is possible to compare the distribution of causes of death among those with a 
certain exposure (e.g. those in a certain occupation) to the distribution among those 
in an unexposed control population. A relative over-representation of a certain 
cause of death among the exposed may be interpreted as an effect of the exposure, 
and it is possible to calculate the proportional mortality ratio (PMR). There are 
several weaknesses associated with this method, the most obvious is that an 
apparent excess of a certain diagnosis may as well be caused by an under-
representation of the diagnoses used for comparison (804). 
In order to study the health effects of one specific chemical substance, a group of 
workers exposed to this agent is ideally compared with an identical group of 
workers without the exposure. The two groups should be similar regarding all other 
possible exposures and determinants associated with the health effects of interest, 
or the comparison may be biased. There are many determinants and risk factors 
associated with IHD. In reality, the incidence of IHD among occupationally 
exposed groups is often compared with national rates of the disease based on 
hospital registers or mortality. Such comparisons are likely to underestimate the 
true risks as the general population includes sick and disabled people unable to 
work. This underestimation is known as the healthy worker effect (61, 625).  
Lower socioeconomic classes have an increased risk of IHD compared to higher 
social classes (797). Suadicani and coworkers found an increased risk of IHD 
[RR 1.44, 95% confidence interval (CI) 1.06–1.95] among lower social classes 
compared to higher classes after adjusting for age. After further adjustment for 
smoking, alcohol, physical activity, systolic and diastolic blood pressure, hyper-
tension, body mass index (BMI), cholesterol, high-density lipoprotein (HDL) 
cholesterol, triglycerides, serum selenium levels and retirement status, the RR 
decreased to 1.38 (95% CI 1.0–1.9). After further adjusting for two significant 
occupational exposures (soldering fumes and organic solvents), the RR decreased 
to 1.24 (95% CI 0.87–1.76). Thus, exposure to particles and irritant gases might be 
one factor explaining the difference between social classes and consequently 
socioeconomic adjustments may mask possible associations between chemical 
exposures and IHD as chemical exposures are common in lower social classes but 
rare in higher social classes (923).  
In order to avoid comparisons with the general population or non-comparable 
socioeconomic classes, the occupationally exposed social class can be compared 
with the same social class without the specific occupational exposure (886, 1015). 
Another method to avoid bias is to perform internal comparisons by dividing the 
cohort of workers in different exposure categories thereby creating a possibility to 
study exposure-response relationships. Exposure categorisation can be based on 
duration or constructed as cumulative exposure. Cumulative exposure is an 
integration of air concentration of a chemical and duration of exposure. An 
exposure category as duration can bias an exposure-response relationship by the 
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healthy worker survivor effect. This effect describes a continuing selection process 
where workers who remain employed tend to be healthier than those who leave 
employment. The healthy worker survivor effect generally attenuates an adverse 
effect of exposure (49). In order to control for this effect, marginal structural models 
have been applied e.g. in an investigation of United States (US) aluminium workers 
(702) and g-estimation among autoworkers exposed to metalworking fluids (168). 
The healthy worker survivor effect can be reduced by excluding subjects who have 
been exposed prior to the first time period of follow-up (37). 
Epidemiological studies of occupational chemical exposures and CVD may be 
confounded (disturbed) by other non-chemical occupational exposures. Recently 
the Swedish Agency for Health Technology Assessment and Assessment of Social 
Services evaluated contributions of the work environment from non-chemical 
occupational exposures to IHD. There was moderately strong evidence for a 
relationship between job strain and small decision latitude on one hand and IHD 
incidence on the other hand. Limited evidence was found for a relationship between 
IHD and iso-strain, pressing work, effort-reward imbalance, low support, lack of 
justice, lack of skill discretion, insecure employment, night work, long working 
week and noise (834, 953). 
Independent epidemiological studies of the same chemical exposure may lead to 
seemingly contradictory results. Combined analysis of data from multiple studies  
is a way to resolve such ambiguities. There are two types of such analyses; a 
combination of summary statistics from individual studies (meta-analysis) and  
a combined analysis of the raw data from the individual studies (pooled analysis).  
6. Criteria for evaluation of evidence 
In general, evaluations of human health risks from chemical exposures are based on 
animal and human experimental studies, as well as mechanistic and epidemiological 
studies. Animal studies have a huge impact in the evaluation of chemical 
carcinogens, but so far only to a limited extent in the investigation of chemical 
exposures and CVD. There are animal models to study the development of athero-
sclerosis, see Chapter 4.  
The data base for each chemical agent in this document was evaluated according 
to criteria regarding strength of evidence of an association between air pollutant 
exposure and occurrence of CVD (Table 2). These criteria are mainly based on 
those presented by the Swedish Council on Health Technology Assessment (833). 
Bias and confounding in epidemiological studies are discussed in Chapter 5. 
The evaluations of chemical risks in this document are mostly based on 
epidemiological studies. Sometimes evaluations are supported by animal or human 
experimental studies, and also by investigations of markers of disease and 
inflammation. Human experimental studies may provide the key data in the 
evaluation.  
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Table 2. Criteria for evaluation of human experimental and epidemiological evidence 
for an association between chemical exposures and CVD (as used in this document). 
Evaluation Criteria 
Strong evidence Several high-quality human experimental or epidemiological 
studies including exposure-response data consistently support 
an association. Chance, bias and confounding can be 
excluded with high confidence. 
Moderately strong evidence Several human experimental or epidemiological studies 
support an association. Chance, bias and confounding can be 
reasonably excluded. 
Limited evidence Some epidemiological studies support an association. Chance, 
bias and confounding cannot be excluded. 
Insufficient evidence Studies are lacking or few epidemiological studies with 
similar quality show contradictory results. Chance, bias and 
confounding cannot be excluded. 
7. Combustion-generated air pollutants  
7.1 General background  
Combustion of organic materials such as wood, coal, coke, oil, diesel and petrol 
fuel generates a large number of air pollutants, particles and chemical substances 
such as PAH. Inhalation is the major exposure route for these agents, but also skin 
exposure may be of great importance. 
This chapter focuses on occupations and exposure circumstances involving 
exposure to high and moderate levels of combustion-generated air pollutants, and 
where important potential confounders are not present. The chapter is mainly 
organised according to occupational activities. Studies from the metal industry, 
foundry work and smelting are delimited to electrolytic aluminium smelting only, 
due to the very high levels of PAH present in this environment. Foundry work was 
excluded because of the presence of both noise and silica in the work environment, 
both being suspected risk factors for CVD. 
Epidemiological studies are generally unable to distinguish if health effects from 
combustion products are related to the particles as such, to PAH or to both since 
they typically occur together in the work environment. Animal studies may provide 
additional evidence for mechanism of action and evidence of causal associations. 
The studies reviewed in this chapter sometimes used gravimetric exposure measures 
of the particle phase (e.g. PM2.5), and sometimes PAH or BaP as indicator of 
exposure, although this approach does not imply that the health effects observed are 
related specifically to the chosen exposure indicator. A summary of estimated 
lowest observed adverse effect concentrations (LOAECs) for the different 
combustion-generated air pollutants is presented in Table 3 (Section 7.14). 
BaP is often used as an indicator of total airborne PAH exposure. Exposures to 
BaP and dust (particulate air pollution) in various industries and occupations 
involving exposure to PAH were reviewed by Armstrong et al. in 2004 (45). The 
review included 39 cohort studies of coke oven and gas production workers, 
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aluminium smelter, carbon anode plant, asphalt, tar distillation, thermoelectric 
power plant and carbon black workers, as well as chimney sweeps. Dust levels were 
classified in four categories: low (< 1 mg/m3), moderate (1–5 mg/m3), high (5–10 
mg/m3) and very high (10–25 mg/m3). Very high dust levels were found for 
Söderberg potroom workers during electrolytic aluminium smelting and for 
chimney sweeps, high levels were found for coke oven top workers, aluminium 
smelter workers (except Söderberg potroom workers) and carbon anode plant 
workers. Moderate dust levels were present among coke oven side workers, coal 
gas retort, asphalt and tar distillation workers, and low levels among coal 
gasification by-product workers and thermoelectric power plant workers. Levels of 
BaP were very high among coke oven top workers (average 20 µg/m3) and 
Söderberg potroom workers during electrolytic aluminium production (15 µg/m3). 
Intermediate levels of BaP were found e.g. among carbon plant workers in the 
aluminium industry (2 µg/m3), carbon anode plant workers (1 µg/m3) and among 
chimney sweeps (1 µg/m3). The lowest levels were found among thermoelectric 
power plant and carbon black workers (0.05 µg/m3) (45). 
7.2 Electrolytic aluminium smelting  
7.2.1 General 
Bauxite is the main raw material for aluminium production (517). Metallic 
aluminium is produced from bauxite in two stages. First, alumina (Al2O3) is 
extracted from bauxite by a chemical process (Bayer process). In the second step, 
alumina is reduced to aluminium by an electrolytic process (Hall-Héroult process). 
There are two main types of electrolytic processes used in the potrooms. The 
Söderberg type furnace consists of an anode in paste form, which is continuously 
supplied to the pots as it is consumed. In the second type of process, the prebake, 
the anode is previously manufactured and replaced periodically after consumption. 
The electrolytic smelting is associated with occupational exposure to a wide array 
of chemical pollutants such as aluminium oxide, fluorides, carbon monoxide, 
sulphur dioxide and PAH (954). The Söderberg process is usually associated with 
high exposure to PAH (45).  
Epidemiological studies and risk estimates are presented in Appendix, Table A1. 
Exposure to aluminium per se is presented in Section 9.1. 
7.2.2 Occupational epidemiological studies 
Björ et al. studied 2 264 male production workers at a Swedish primary aluminium 
smelter employed 1942–1987 and followed for mortality 1952–2004. Expected 
numbers of deaths were derived from national and local mortality rates. The overall 
SMR for MI was low, and there was no statistically significant trend with duration 
of employment. The SMR for CeVD was close to 1 and there was no positive trend 
with duration of employment (99).  
The mortality in a cohort of 1 085 male workers at a Norwegian primary 
aluminium smelter using prebaked electrodes was reported by Rønneberg (813). 
The cohort [later included in a study by Romundstad et al. (794)] comprised 
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workers employed 1922–1975 and was followed for mortality 1962–1991. The 
SMRs for IHD and CeVD were not elevated, neither among the short-term  
(< 3 years) nor among the long-term (> 3 years) employed. However, the number 
of deaths from peripheral arteriosclerotic disease was elevated in both groups, with 
statistical significance in the latter. A subgroup analysis among those employed > 3 
years subdivided by the time window of exposure as well as cumulative exposure 
showed a significantly elevated RR for all atherosclerotic diseases among those 
with a high cumulative exposure to coal-tar pitch volatiles (CTPV) more than 40 
years ago (813).  
Romundstad et al. studied 10 587 male workers at six Norwegian primary 
aluminium smelters [including the one earlier reported by Rønneberg (813)]. The 
cohort was followed 1962–1996. SMRs for IHD and CeVD were not elevated. 
There was no exposure-response relationships in terms of cumulative exposure to 
PAH or fluorides and the risk of circulatory disease (794).  
A cohort of 6 455 male aluminium smelter workers from 11 plants in France was 
followed 1950–1976. The mortality from circulatory disease was not significantly 
elevated. Analysis of SMRs in relation to length of employment and type of process 
– Söderberg or prebake process – showed no evidence of an exposure-response 
relationship (685). 
Moulin et al. reported the mortality in a cohort of 2 133 male aluminium smelter 
workers in France [earlier included in the study by Mur et al. (685)]. Follow-up was 
updated to encompass the period 1968–1994. The SMRs for circulatory diseases 
and IHD were not elevated and there was a statistically significant deficit of deaths 
from CeVD (674).  
The mortality in a cohort of 2 103 male workers in a US aluminium plant in state 
Washington was reported by Milham. The cohort was followed up to 1976. There 
was a statistically significant deficit of deaths from circulatory diseases both among 
workers classified as exposed and among those classified as unexposed. An analysis 
by duration of employment gave no firm evidence of an exposure-response relation-
ship, but analysis by latency showed a statistically significant elevated SMR for 
circulatory diseases after more than 25 years since first hire (642).  
A cohort of 21 829 workers from 11 aluminium reduction plants (smelters) in the 
US was followed up to 1977. There was a statistically significant deficit of deaths 
from CVD both among whites and non-whites. Subgroup analyses, not presented 
in detail, showed a statistically significant excess of deaths from “all other heart 
disease” among white workers in plants using the Söderberg process (789). The 
category “all other heart disease” was not defined but is likely not to include 
arteriosclerotic heart disease. It was not mentioned if the plant earlier investigated 
by Milham (642) was included in this study. 
Costello et al. performed a cohort study of 11 966 aluminium workers from eight 
plants in the US including both smelter workers and other occupational categories. 
Diagnoses 1998–2009 were obtained from health insurance claims, and smoking 
habits (not complete) were obtained from occupational health clinic records. The 
study was designed to investigate if recent exposure to particulate matter increased 
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the risk of IHD, using a job exposure matrix (JEM). Of five exposure classes, the 
risk of IHD was higher in classes 2–5 (representing > 0.05 to > 1.15 mg/m3 of PM2.5) 
than in the lowest class (≤ 0.05 mg/m3 of PM2.5), but there was no evidence of an 
exposure-response trend over classes 2–5. No relationship between cumulative 
exposure and IHD was found (199). 
The cohort study reported by Costello et al. (199) was extended and further 
analysed by Neophytou et al. Time of follow-up was extended to 2012 and Cox 
marginal structural models (MSM) were applied to adjust for the healthy worker 
survivor effect, using an index of cardiovascular risk factors as a measure of health 
status that may affect future exposure. Exposure at 0.260–1.469 mg/m3 of PM2.5 in 
smelter workers was associated with a statistically significantly increased risk of 
IHD (MSM-model, HR 2.00, 95% CI 1.16–3.45), but no further increase in risk was 
seen at higher exposure. Adjustment for the healthy worker survivor effect by Cox 
MSM-analysis indicated a stronger effect of the exposure than did regular Cox 
regression (702). A later analysis of the same cohort indicated that the risk of IHD 
was better predicted by PM2.5 than by total particle matter (703). 
A case-control study investigated sick leave or death from IHD in a cohort of 
6 000 Canadian primary aluminium smelter workers. The study identified 306 cases 
and 575 matched referents. The risk of IHD associated with work in various parts 
of the plant was estimated by conditional logistic regression, adjusted for smoking 
habits. Work in the reduction plant was associated with a statistically significantly 
increased risk of IHD (OR 1.72, 95% CI 1.09–2.97) especially among workers 
using prebaked electrodes or Söderberg electrodes. No exposure-response relation-
ship for duration of work in the reduction plant was found (954). 
Friesen et al. reported the findings of a cohort study of 6 423 male and 603 female 
Canadian aluminium smelter workers. The plant, located in Kitimat in British 
Columbia used vertical stud Söderberg electrodes. Mortality from IHD was 
followed 1954–1999. Both external and internal comparisons of mortality were 
performed. Information on tobacco smoking was available for 88% of the cohort. 
Acute and chronic exposure to CTPV and BaP was estimated by a JEM. Men with 
the highest cumulative exposure to BaP (≥ 66.7 µg/m3 BaP-years, calculated with a 
5-year lag) had a statistically significantly higher risk of death from IHD than those 
unexposed to BaP, adjusted for smoking habits. The exposure-response trend was 
of borderline statistical significance (P = 0.053). No association was seen with 
current exposure (312). According to a method used by the US Environmental 
Protection Agency (EPA), the average exposure in an open-ended upper exposure 
class can be estimated to 5/3 of the lower boundary of the upper class (982). Thus, 
the average cumulative exposure can be estimated to 66.7 × 5/3 = 111 µg/m3 BaP-
years. 
Gibbs et al. reported the mortality in male aluminium smelter workers from three 
plants in Quebec, Canada. All workers on the payroll 1 January 1950 or 1951 were 
included. Mortality was followed 1950–1999 and expected numbers of deaths were 
derived from the Quebec population. The study was focused on cancer but reported 
deaths from IHD and CeVD as well. BaP exposure measurements were structured 
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in a JEM, which was used to calculate cumulative exposure. The SMR for IHD was 
not increased in any of the three cohorts, whereas the mortality from CeVD was 
increased in all cohorts, and statistically significant in the combined cohort (SMR 
1.14, 95% CI 1.01–1.27). An exposure-response analysis using seven classes of 
cumulative exposure showed that the risk of death from CeVD was significantly 
increased among men with the highest cumulative exposure to BaP (> 320 µg/m3-
years) (SMR 2.79, 95% CI 1.34–5.13). The trend was not statistically significant 
(P = 0.16) (337). The mortality among those workers in the three cohorts that were 
hired after 1 January 1951 (with presumably lower exposure) was reported by Gibbs 
and Sevigny (339). No statistically significant excess of IHD or CeVD was found 
in any of the cohorts or in the combined cohort. An exposure-response analysis 
relating SMR for CeVD to cumulative exposure to BaP showed no statistically 
increased risks and P for trend was > 0.2 (339).  
Mortality was investigated among 4 396 male workers from two prebake 
aluminium smelters in Victoria, Australia. One of the factories started production 
in 1962 and the other in 1986. The cohort included workers employed for more than 
3 months 1983–2002 and was followed to 2002. Expected numbers of deaths were 
derived from the Australian population. Observed numbers of deaths from CVD 
and CeVD were below or close to the expected and there was no significantly 
increased risk of CVD among production or maintenance workers. The risks did not 
increase with duration of work. The authors pointed out that the cohort was 
relatively young with a limited time of follow-up (867). 
Friesen et al. further investigated mortality and cancer incidence in the cohort 
reported by Sim and coworkers (867). The cohort was limited to 4 316 men with 
full occupational histories. Mortality was investigated in relation to exposure to 
BaP, the benzene-soluble fraction, fluoride and inhalable dust. Exposure to BaP and 
the benzene-soluble fraction were used as index for exposure to CTPV. A large set 
of in-company measurements were used to develop a JEM, which was linked to the 
work histories of the subjects in the cohort. Ever exposure to CTPV or inhalable 
dust was not associated with a significantly increased mortality from CVD or 
CeVD. Contrasting high/medium to low/unexposed revealed no evidence of 
exposure-response relationships in the risk for CeVD, neither for CTPV nor for 
fluorides (310).  
7.2.3 Markers of effect 
Smelter workers at Söderberg pots exposed to high levels of air pollutants had 
slightly (non-significantly) higher levels of fibrinogen than those working with 
prebaked electrodes and exposed to lower levels of air pollutants (885). 
7.2.4 Conclusion  
There were around ten cohorts and one case-control study regarding mortality from 
CVD among electrolytic aluminium smelter workers. Findings were mixed. Three 
studies of high-exposed workers are especially informative since they used JEMs 
to estimate personal exposure. A large US study of eight plants showed an increased 
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risk of IHD (199, 702) and a Canadian study from British Columbia showed a 
smoking-adjusted increased risk of IHD in the highest class of cumulative exposure 
to BaP (312). A study from Quebec, Canada, showed an increased risk of CeVD 
but no excess of IHD (337). 
Of the remaining studies, a Canadian case-control study showed a smoking-
adjusted increased risk of IHD among workers involved in the Söderberg and 
prebake processes (954), three studies showed weak indications of an increased risk 
of circulatory diseases and five studies showed negative or inconclusive results.  
One of the studies above showed that cumulative exposure to 111 µg/m3 BaP-
years was statistically significantly associated with an elevated risk of death from 
IHD (312). A cumulative exposure of 111 µg/m3 BaP-years corresponds to an 
average exposure level of 2.78 µg/m3 of BaP over a 40-year working life. PM2.5 
exposures of 0.26–1.47 mg/m3 in US electrolytic aluminium smelter workers 
(estimated average exposure at class midpoint: 0.86 mg/m3) were associated with a 
statistically significantly increased risk of IHD, but no further increase in risk was 
seen with higher exposure (702).  
Risk estimates of CeVD were presented in seven studies of which only one 
showed an increased risk in the group with the highest cumulative exposure of BaP 
but with no significant trend (337).  
 
There is moderately strong evidence for an association between exposure in 
electrolytic aluminium smelting and IHD.  
7.3 Coke production  
7.3.1 Occupational epidemiological studies 
Bye et al. studied the mortality among 888 male Norwegian coke plant workers 
1962–1992. A JEM was developed to classify the exposure to PAH and a number 
of other exposure factors. SMRs for IHD and CeVD were not significantly elevated 
versus the general male population of Norway. There was no evidence of exposure-
response relationships in terms of cumulative exposure to PAH (P > 0.3). Group-
level data on tobacco smoking indicated that the cohort members smoked less than 
the general population (135). 
The mortality from CVD was lower than expected among 610 male coke oven 
workers in the United Kingdom (UK) followed to 1965. Death rates for England 
and Wales were used as reference. No analysis of exposure-response relationships 
was performed (213). 
Hurley et al. reported the mortality in two British companies with 2 753 (Cohort 
I) and 3 885 (Cohort II) coke workers, respectively. Expected numbers were based 
on national death rates for Scotland, England and Wales. The death rates for IHD 
and CeVD were lower than in the reference population. A subgroup of oven 
workers, with higher exposure, showed a risk for IHD that was close to significantly 
elevated (SMR 1.11, P = 0.06). There was no relationship between duration of oven 
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work and risk. The proportion of smokers in the cohort was reported to be similar 
to that of manual workers in Britain in general (429).  
Mortality was investigated in a cohort of 5 639 male Dutch coke plant workers 
employed 1945–1968 and followed until 1984. The mortality from circulatory 
diseases was not elevated, neither among the coke oven workers nor among by-
product workers. National Dutch death rates were used to derive expected numbers 
of deaths. Exposure-response relationships were not investigated (926). 
Chau et al. studied the mortality among 536 male French coke plant workers 
followed 1963–1987. There was a statistically significant excess of deaths from 
CVD in the cohort compared to the general male French population. However, a 
subdivision of the cohort with regard to proximity to the coke ovens showed no 
indication of higher risk among those working at the ovens than among the non-
exposed or those working near the ovens (152).  
The death rate from circulatory diseases among 538 male Italian coke plant 
workers followed from 1960–1990 was lower than in both the general Italian  
and local Tuscan populations (308). Exposure-response relationships were not 
investigated. 
Lloyd et al. reported the mortality in 3 530 male coke plant workers in a large 
cohort of US steel workers followed 1953–1961. Overall, SMRs for heart disease 
and vascular damage to the central nervous system (CNS) were not significantly 
elevated among the coke plant workers compared to steel workers in general. No 
excess of deaths from heart disease was noted among the oven top-side workers, a 
group that showed a high risk to develop lung cancer from the oven gases, rich in 
PAH (572). 
Epidemiological studies and risk estimates are presented in Appendix, Table A2. 
7.3.2 Conclusion  
Seven studies of coke plant workers were identified. A cohort of French workers 
showed a statistically significantly elevated risk of CVD, with no indication of an 
association between a crude dose measure (proximity to the ovens) and risk (152). 
In a study from the UK, there was an elevated risk of death from IHD of borderline 
statistical significance (P = 0.06) for the high-exposed oven workers (429). A study 
of US coke plant workers showed a very high risk of lung cancer among the oven 
workers but no excess of CVD, neither in total nor among the oven workers (572). 
Four other studies, of which one investigated exposure-response relationships, 
showed no evidence of an increased risk of CVD among coke production workers. 
 
There is insufficient evidence for an association between exposure in coke 
production and CVD. 
7.4 Coal gasification 
7.4.1 Occupational epidemiological studies 
Gustavsson and coworkers studied 295 male gas production workers in Stockholm, 
Sweden, employed 1965–1972 and followed 1966–1986. The mortality from both 
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IHD and CeVD was higher in the cohort than in the general population in the 
Stockholm County. The mortality from circulatory diseases was significantly 
elevated among those employed for more than 30 years as well as in the entire 
cohort after a long follow-up time (> 40 years). BaP was measured by area sampling 
on top of the ovens in 1964, showing an arithmetic average of 4.3 µg/m3 of BaP 
(range 0.007–33 µg/m3). Group level data on tobacco smoking habits did not 
indicate excess tobacco smoking in the cohort compared to the general male 
population (365). 
Doll et al. studied two cohorts of in all over 16 000 male gas production workers 
in the UK, which were followed from 1953 (Cohort I) and 1957 (Cohort II) to 1965. 
The analysis was focused on lung cancer mortality. The death rates from arterio-
sclerotic and degenerative heart disease in Cohort I were lower than among men in 
England and Wales in general, both among high- and low-exposed subcohorts. In 
Cohort II, the death rates from arteriosclerotic and degenerative heart disease were 
higher in a high-exposed subcohort than in the general male population, but no 
testing of statistical significance was reported. The death rates from arteriosclerotic 
and degenerative heart disease in intermittently or low-exposed workers in Cohort 
II were similar to or lower than in the general population. No adjustment for tobacco 
smoking habits was made (236, 238). 
Blot et al. reported the mortality up to 1997 among more than 50 000 male 
workers employed between 1971 and 1986 in a Californian gas and electricity 
production company. SMRs from heart disease and CeVD in the entire cohort were 
lower than in the reference population. In a subcohort of 513 generator gas workers, 
the SMR for heart diseases was lower than among the referents while the SMR for 
CeVD was close to 1 (111). 
Epidemiological studies and risk estimates are presented in Appendix, Table A3. 
7.4.2 Conclusion  
Three studies of coal gasification workers were located. A cohort of male coal gas 
production workers in Stockholm, Sweden, showed an elevated risk of both IHD 
and CeVD compared to occupationally active men in the Stockholm County. The 
risk of circulatory diseases was statistically significantly elevated among those 
employed for more than 30 years (365). A large cohort of British coal gas 
production workers showed higher death rates from arteriosclerotic and 
degenerative heart disease in a high-exposed subcohort than in other gas workers 
and the general population, but no testing of statistical significance was reported 
(236, 238). A small cohort of coal gas production workers in the US showed no 
excess of heart disease or CeVD compared to the general population. Exposure-
response relationships were not investigated (111).  
 
There is limited evidence for an association between exposure in coal gasification 
and CVD. 
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7.5 Graphite electrode production 
7.5.1 Occupational epidemiological studies 
Gustavsson et al. studied a cohort of workers at a graphite electrode manufacturing 
company in Härnösand, Sweden. The cohort comprised 807 men and 94 women, 
employed between 1968 (when the production commenced) and 1988, and was 
followed for mortality 1969–1989. Expected numbers of deaths were derived from 
local (county) death rates. The numbers of deaths from IHD and CeVD were very 
small and close to the expected. The authors pointed out that the cohort was small, 
and time of follow-up limited (360). 
The mortality in a cohort of 1 115 male workers at a French carbon electrode 
manufacturing company was reported by Moulin et al. Workers in employment 
1957–1984 were included and expected deaths were derived from national 
statistics. There was a statistically significant deficit of deaths from circulatory 
diseases. Exposure to BaP was likely to be comparatively low, 15–740 ng/m3 in 
1983–1984 (677). 
A cohort of 1 291 male workers employed 1950–1989 in a graphite electrode 
manufacturing company in Brescia, Italy, was followed for mortality 1950–1997. 
The number of deaths from circulatory diseases was lower than expected and there 
was no evidence of exposure-response relationships in terms of duration or 
association with time since first employment (635). 
Donato et al. reported the mortality in a cohort of 1 006 male workers employed 
1945–1971 in a graphite electrode manufacturing plant in Brescia, Italy. The cohort 
was followed 1955–1996. The number of deaths from circulatory diseases was 
lower than expected. Exposure-response relationships were not investigated. About 
half of the workforce was considered to be substantially exposed to PAH (240). 
Teta et al. studied the mortality 1974–1983 among 2 219 white male workers 
employed in carbon electrode and special products operations for more than 10 
years as part of a corporate wide mortality surveillance system in the US. Expected 
numbers were derived from national white male statistics. The SMRs were low for 
both circulatory diseases in general and for CeVD. In a cohort-internal analysis, the 
risk of death from circulatory diseases correlated positively and significantly with 
years of prior employment (P = 0.02), although this correlation was mainly caused 
by a low risk among those employed 10–19 years. The RR among those employed 
> 30 years was 1.1. A subdivision of the cohort in supervisory/office employees, 
crafts and operation/labourers (with assumed highest exposure) gave no evidence 
of higher risk in the highest exposed group (949). 
A cohort of 332 male workers employed 1951–1974 in a Japanese graphite 
electrode manufacturing plant was followed for mortality 1951–1988. There were 
few deaths from CVD or CeVD, neither deviated significantly from the expected 
number derived from national Japanese statistics (671). 
Epidemiological studies and risk estimates are presented in Appendix, Table A4. 
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7.5.2 Conclusion 
There were six studies of graphite electrode manufacturing workers. None of the 
studies showed any excess of circulatory diseases in comparison with the general 
population, but several of them were small with low numbers of expected deaths. 
A large study from the US showed a statistically significant positive trend in the 
risk of circulatory diseases with prior years of employment. This was caused by an 
unusually low risk in the group with lowest number of years of employment, and 
the relation to occupational exposure was uncertain (949). 
 
There is insufficient evidence for an association between exposure in graphite 
electrode production and CVD.  
7.6 Chimney sweeping 
7.6.1 Occupational epidemiological studies 
A cohort of male Swedish chimney sweeps employed 1918–2006 was followed for 
mortality 1952–2006. Expected numbers were calculated from national statistics. 
There was a statistically significant excess of deaths from IHD (SMR 1.20, 95% CI 
1.10–1.32), while the number of deaths from CeVD was lower than expected. A 
subcohort of chimney sweeps first employed after 1950 also showed a statistically 
significant excess of deaths from IHD. An analysis by duration of employment and 
time since first exposure showed no positive association with IHD or CeVD (453). 
The same cohort of 4 436 men as above was followed by Gustavsson et al. for 
incident cases (both lethal and non-lethal) of MI 1991–2005, identified from a 
national register of in-patients diagnosed with MI. Expected numbers were based 
on similarly identified cases in skilled manual workers in the service sector in 
Sweden. There was a statistically significant excess of MI among the chimney 
sweeps, but the risk did not correlate with duration of employment (362). 
Hansen et al. reported the mortality from IHD among 713 male Danish chimney 
sweeps identified from the Danish national 1970 census and followed 1970–1975. 
There were only 12 deaths from IHD, but this was statistically significantly more 
than expected, based on the reference population of Danish men identified from the 
same census (381). 
Epidemiological studies and risk estimates are presented in Appendix, Table A5. 
7.6.2 Conclusion 
There were two cohorts of chimney sweeps, both showing an excess of IHD (362, 
381, 453). 
 
There is limited evidence for an association between chimney sweeping and IHD. 
  
22 
7.7 Asphalt paving 
7.7.1 Occupational epidemiological studies 
Burstyn et al. reported the mortality from IHD and CVD in a multicentre study of 
12 367 male asphalt workers from Denmark, Finland, France, Germany, Israel, the 
Netherlands and Norway. The cohort included workers engaged in asphalt paving 
1913–1999 from 217 companies. The earliest follow-up started in 1953 and the 
latest ended in 2000. Cohort-internal analyses of risk were performed. Exposure to 
BaP was quantitatively assessed from a model based on historical measurements of 
personal exposure, production characteristics and work organisation, and was 
organised in a JEM. Exposure to coal-tar bitumen was assessed semi-quantitatively 
and was a strong predictor of exposure to BaP. The risk of death (RR) from CVD 
increased with increasing average exposure to BaP and significantly so at average 
exposure levels of 68–105 ng BaP/m3 versus the reference category of 0–68 ng/m3 
(P for trend < 0.001). In the highest exposure group (> 273 ng/m3), the risk of death 
from CVD and IHD was increased, with RRs (95% CIs) being 1.58 (1.16–2.15) and 
1.64 (1.13–2.38), respectively. There was also a positive trend in risk for both 
diagnoses with cumulative exposure, but weaker and not statistically significant. 
No individual data on tobacco smoking were available, but a sensitivity analysis 
indicated that it is not likely that the observed exposure-response associations were 
caused by confounding from tobacco smoking habits (134). 
Further details are presented in Appendix, Table A6. 
7.7.2 Conclusion 
The only retrieved publication of asphalt pavers was a well-conducted multicentre 
study. The investigation showed an excess of CVD that correlated clearly with 
average exposure levels of BaP. There was an excess of CVD at exposures of  
68–105 ng BaP/m3 or higher (134). 
 
There is limited evidence for an association between asphalt paving and CVD.  
7.8 Tar distillation work, roofing and creosote work  
7.8.1 Occupational epidemiological studies 
A cohort of 255 male British tar distillation workers at four plants was followed for 
mortality 1967–1983. Expected numbers of deaths were derived from national 
statistics for England and Wales. The numbers of deaths from circulatory diseases 
in general, IHD, CeVD and diseases in arteries and veins were not statistically 
significantly elevated. An analysis of SMR in relation to time since joining the plant 
showed no evidence of an exposure-response relationship (595). 
Swaen et al. studied 907 tar distillery workers and 866 roofers in the Netherlands. 
The cohort comprised male workers employed 1947–1980 and was followed for 
mortality 1947–1988. Expected numbers were calculated from Dutch national 
statistics. The mortality from circulatory diseases was below the expected in the tar 
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workers and equal to the expected in the roofers. Exposure-response relationships 
were not investigated (927). 
A cohort of 5 939 US male roofers and waterproofers who were members of the 
trade union in 1960 was followed for mortality 1960–1971 and expected numbers 
were derived from national statistics. The numbers of deaths from heart disease and 
cerebrovascular lesions were below the expected and the risk showed no positive 
trend with years since joining the union (378). 
Wong et al. studied 2 179 male and female workers at 11 US wood-treating plants 
using creosote. The cohort included workers employed 1979–1999 and was 
followed for mortality 1979–2001. The numbers of deaths from all heart diseases, 
IHD, endocardial disease, other heart disease and CeVD were all close to the 
expected and no statistically significant elevations were found. Increased duration 
of employment was not related to increased mortality for any of the diagnoses 
(1034). 
Epidemiological studies and risk estimates are presented in Appendix, Table A7.  
7.8.2 Conclusion 
The few studies located, representing varying occupations and exposure circum-
stances, did not indicate any excess of CVD. 
 
There is insufficient evidence for an association between tar distillation work, 
roofing or creosote work and CVD.  
7.9 Diesel engine exhaust  
7.9.1 General 
Diesel engine exhaust is a complex mixture of gases and particulates produced 
during combustion of diesel fuels. The main components of the gas phase are 
nitrogen, carbon dioxide, water vapour, nitrogen oxides (NOx) and carbon 
monoxide. These gases comprise over 99% of the mass of the whole diesel exhaust. 
Diesel exhaust particles (DEP) contain elemental carbon (EC), organic compounds, 
sulphates, nitrates, and trace amounts of metals and other elements. PAH and their 
oxygen and nitrogen derivatives comprise up to 1% of the particulate mass of 
untreated diesel exhaust. The composition of the exhaust varies, depending on the 
type, age and operational condition of the engine and on the exhaust after-treatment 
system. In comparison with pre-2005 diesel engines, exhaust from new technology 
diesel engines is characterised by a significant reduction of particle mass and EC, 
and an increased proportion of NO2 of the total NOx. EC comprises 30–90% of the 
particulate mass of pre-2000 diesel engine exhaust, with a typical proportion of 75% 
for heavy-duty diesel engines. By contrast, the average EC percentage of the 
particle mass emitted by heavy-duty diesel engines fulfilling the 2007 US emission 
standards was 13% (941). Nearly all of the mass emitted by diesel engines is in the 
fine particle range (< 2.5 µm) (495). Concentrations expressed as DEP in the 
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experimental studies below are therefore considered numerically equal to con-
centrations expressed as PM2.5.  
Some previous studies estimated the occupationally attributable mortality due to 
MI in Sweden (473) and IHD in Finland (719). Both studies included exposure to 
motor exhaust as a work-related risk factor for IHD and the attributable fraction 
was estimated to 3.5% for MI for Sweden (men and women combined) and 1.0% 
for men in Finland (based on disease risk from one US study). 
7.9.2 Animal studies 
DEP (0.5 mg) instilled intratracheally in rats induced an inflammatory response in 
the lungs, which reduced the time to thrombotic occlusion through increased 
platelet activation (935). 
In atherosclerotic ApoE-/- mice, an increase in aortic lipid peroxides and 
macrophage accumulation was observed in atherosclerotic plaques after exposure 
to diesel engine exhaust at 300 µg DEP/m3 or higher for 7 weeks (6 hours/day, 
7 days/week). No significant effects were observed at 109 µg DEP/m3 (142). In 
atherosclerotic ApoE-/- mice, oropharyngeal aspiration of DEP (35 µg of a standard 
reference material, SRM-2975, twice weekly for 4 weeks) induced pulmonary 
inflammation, increased atherosclerotic lesion size, produced more lesions per 
vessel and generated more buried fibrous connective tissue compared with controls 
(648). 
Saa3 mRNA levels were increased in the lung tissue of mice exposed to DEP by 
inhalation (20 000 µg DEP/m3, 4 days, 1.5 hours/day) (815).  
A single intratracheal instillation of DEP (18, 54 or 162 µg) induced a strong 
neutrophil influx 1 and 3 days, but not 28 days post-exposure in mice. Saa3 mRNA 
levels were increased at all time-point after the 162-µg dose (524). 
As mentioned, new technology diesel engine exhaust contains drastically reduced 
DEP concentrations. In an inhalation experiment using diesel engine exhaust 
generated from a 2007-compliant diesel engine, male and female Wistar Han rats 
were exposed to air (control) or low, mid or high levels of diesel exhaust (0.1, 0.8 
or 4.2 ppm nitrogen dioxide) for 16 hours/day, 5 days/week for 2 years. Evidence 
of exposure-induced effects was limited. Elevated plasma levels of soluble 
intercellular adhesion molecule 1 (ICAM-1) and IL-6 along with decreased plasma 
concentrations of total and non-HDL cholesterol were observed in females only 
(189). 
7.9.3 Human experimental studies 
Exposure of 6 healthy volunteers to diesel engine exhaust containing 300 µg 
DEP/m3 for 2 hours gave a reduction of baseline brachial artery diameter of border-
line statistical significance. No reductions were observed at exposures of 100 and 
214 µg DEP/m3 (965). In a double-blind crossover study, exposure of volunteers 
(10 healthy and 17 with metabolic syndrome) to diesel engine exhaust containing 
200 µg DEP/m3 for 2 hours elicited a decrease in brachial artery diameter with a 
smaller effect at 100 µg/m3. There was an increase of endothelin-1 at 200 µg/m3 but 
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not at 100 µg/m3 (736). A transient increase in arterial stiffness was detected among 
12 healthy volunteers after 1 hour of exposure to 330 µg DEP/m3 (585). 
Exposure to diesel engine exhaust containing 300 µg DEP/m3 for 1 hour was 
associated with exercise-induced ST-segment depression in electrocardiogram 
(ECG) among 20 men with stable coronary artery disease (650). 
7.9.4 Occupational epidemiological studies 
Exposure to diesel exhaust among Swedish construction workers was associated 
with an increased mortality (SMR, 95% CI) from IHD (1.18, 1.13–1.24) and 
possibly from CeVD (1.09, 0.99–1.20) (967). 
A cohort of Finnish men aged 25–64 years in 1980 was followed 1981–1994. 
Diesel exhaust exposed workers were compared with non-exposed workers.  
The RR (95% CI) for CVD mortality was 1.06 (1.00–1.14) and for CeVD mortality 
1.12 (0.97–1.29). There was no difference between low-exposed workers (1.07, 
0.95–1.20) and high-exposed workers (1.09, 0.95–1.24) regarding mortality from 
MI (1031). 
A population-based case-control study of first-time MI conducted among 
Swedish citizens in the Stockholm County included 1 643 cases and 2 235 controls 
enrolled 1992–1994 (442). Working histories and data on potential confounders 
were collected by questionnaires and telephone interviews. Exposure to EC was 
assessed through a JEM. The risk of MI increased with maximum annual average 
exposure intensity (P for trend 0.034). The OR for MI among those with the highest 
average exposure intensity (> 42 µg EC/m3, point estimate 87.5 µg/m3) during the 
work history was 1.30 (95% CI 0.99–1.71), adjusted for smoking and alcohol 
habits. A series of parallel measurements of EC and PM2.5 in motor exhaust exposed 
occupations in Stockholm (559) indicated that 87.5 µg EC/m3 corresponds to 
around 330 µg/m3 of PM2.5. The risk decreased with time since cessation of 
exposure. Cumulative exposure of 0.2–0.7 mg EC/m3-years (point estimate 
0.42 mg/m3-years) was associated with an OR of 1.25 (95% CI 0.96–1.63) for MI, 
adjusted for smoking and alcohol habits (442). 
An increased mortality from IHD was observed among US transportation 
workers exposed to diesel engine exhaust in four trucking companies (SMR 1.49, 
95% CI 1.40–1.59) (526). In an extension of this cohort, duration of employment 
correlated significantly with risk of death from IHD in long haul drivers and 
dockworkers. The trend was positive but less strong among pick-up and delivery 
drivers, mechanics, and hostlers, while it was negative among clerks (385).  
A cohort of 62 800 men with self-reported occupational exposure to diesel 
exhaust was compared with 307 143 unexposed workers, all from the prospective 
American Cancer Society study, and was followed 1982–1984. The RRs were 
standardised by age, smoking and other occupational exposures. There was no 
increased risk for IHD (RR 0.98). There was a positive correlation between duration 
of exposure and the risk of CeVD; RRs (95% CIs) were 1.43 (0.89–2.29) for 1–15 
years duration and 1.68 (1.06–2.66) for > 15 years duration (114). 
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A cohort of 12 315 workers exposed to diesel exhaust at eight US non-metal 
mining facilities was divided in 8 307 ever-underground workers and 5 848 surface-
only workers. The mean respirable dust exposure was 1.9 mg/m3 among 
underground workers and 0.7 mg/m3 among surface workers. The corresponding  
mean exposures to respirable EC were 128 and 1.7 µg/m3. State-based mortality 
rates were used for reference. The SMR (95% CI) for IHD was not increased  
among underground workers (0.97, 0.87–1.08) nor among surface workers (1.01, 
0.88–1.14). The mortality from CeVD was not elevated. Exposure-response 
relationships were investigated for lung cancer only (52).  
7.9.5 Previous evaluations 
In 2016, NEG in cooperation with the Dutch Expert Committee on Occupational 
Safety (DECOS) evaluated diesel engine exhaust. The critical health effects were 
considered to be pulmonary inflammation and lung cancer. In addition, it was noted 
that human and animal inhalation studies showed an association between exposure 
to older technology diesel engine exhaust and CVD. Subjects with chronic CVD 
were regarded to be specifically sensitive to the health impacts of diesel exhaust 
exposure. Data from animal and human studies indicated that exposure to diesel 
engine exhaust may exacerbate pre-existing CVD, especially coronary artery 
disease (941). 
The Swedish Agency for Health Technology Assessment and Assessment of 
Social Services recently reviewed the epidemiological literature on chemical 
occupational exposures and CVD (835). The reviewers concluded that there was 
moderately strong evidence for an association between occupational exposure to 
motor exhaust and development of heart disease.  
7.9.6 Conclusion 
In two controlled chamber studies, exposure for 1–2 hours to diesel engine exhaust 
containing 200–300 µg DEP/m3 elicited a decrease in brachial artery diameter in 
healthy volunteers (736, 965), and exposure for 1 hour to diesel engine exhaust with 
300 µg DEP/m3 was associated with exercise-induced ST-segment depression in 
ECG among subjects with stable coronary artery disease (650). A transient increase 
in arterial stiffness was seen in healthy volunteers after 1 hour of exposure to 330 
µg DEP/m3 (585). 
Out of five available cohort studies, four indicated an increased risk of CVD in 
association with exposure to diesel exhaust. A causal association is corroborated by 
a case-control study, showing an exposure-response association. Exposure to diesel 
exhaust of 87.5 µg EC/m3 (LOAEC) or more was associated with an increased risk 
of MI (442). Based on parallel measurements by Lewné, this corresponds to around 
330 µg/m3 of PM2.5 (LOAEC) (559). Human data are supported by animal studies 
showing that DEP exposure increases the formation of atherosclerotic plaques. 
Furthermore, DEP induce both acute phase response and pulmonary inflammation 
in mice. 
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Regarding CeVD, one study showed a significantly increased risk and two studies 
showed non-significant increased risks.  
 
There is moderately strong evidence for an association between exposure to 
diesel engine exhaust and CVD. 
7.10 Cooking fumes 
7.10.1 General  
Cooking, especially frying and grilling, generates air pollution, such as aerosol oil 
droplets, combustion products (including fine and ultrafine particles), organic 
gaseous pollutants and steam from the water contents of the food being cooked 
(165, 437, 875). A wide variety of organic compounds have been identified in 
cooking emissions, including alkanes, alkenes, acrolein, alkanoic acids, carbonyls, 
carboxylic acids, PAH and aromatic amines. Particles created during cooking may 
also have organic substances adsorbed on their surface, such as PAH (437). The 
levels and the chemical composition of cooking emissions vary depending on the 
cooking oils used, the temperature, the kind of food cooked, and the cooking 
method (228, 437, 874). Human exposure may occur by inhalation of cooking 
fumes, both in household and occupational cooking. 
This presentation contains occupational studies among cooks and other restaurant 
workers. Studies on cooking at home were not included since they mainly 
investigated exposure from biomass and coal fuels for cooking and heating, which 
were not considered relevant with respect to occupational exposure to cooking 
fumes.  
Epidemiological studies and risk estimates are presented in Appendix, Table A8. 
7.10.2 Occupational epidemiological studies 
In a Swedish cohort study (cohorts followed 1970–1995), an increased risk (SMR, 
95% CI) due to IHD mortality was observed among both male (1.33, 1.12–1.56) 
and female (1.29, 1.20–1.37) cooks and cold buffet managers. An increased risk 
was also observed among male (1.55, 1.26–1.90) and female (1.21, 1.15–1.26) 
kitchen assistants as well as among male waiters and head waiters (1.23, 1.08–1.39), 
compared to all gainfully employed men or women. Waiters were identified as a 
similar socioeconomic group exposed to low levels of kitchen-generated air 
pollutants (880).  
A case-control study in Sweden was carried out to estimate the RR (95% CI) of 
first MI in various occupational groups. Kitchen assistants were found to be one of 
ten occupations (in the 1970 and 1975 censuses) among Swedish women, but not 
men, with an increased incidence of MI (1.5, 1.0–2.1) during the period 1976–1984, 
compared to that of other employed. The excess risk did not persist after adjusting 
for socioeconomic group (1.4, 0.9–2.0). Female waitresses showed a decreased 
incidence of MI (377). 
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In a prospective cohort study of MI incidence among manual workers in the 
service sector in Sweden 1987–2005, female cooks, restaurant and kitchen 
assistants, and waiting staff all showed a statistically significant increase in risk 
(HR, 95% CI: 1.34, 1.21–1.48; 1.12, 1.03–1.21; and 1.25, 1.06–1.47, respectively). 
No increased risk was found among female cold-buffet managers. Among males, 
there was no statistically significant increase in risk for any of these occupations. 
The association was not more convincing for subjects working ≥ 5 years. Group 
level information on smoking habits showed a similar percentage of daily smokers 
among female cooks compared to female manual workers in general. The 
association with exposure to cooking fumes is uncertain because 1) no excess was 
found among male kitchen workers, and 2) female waiters showed a similar risk 
excess as female kitchen workers, although they were less exposed to cooking 
fumes (92). 
In a Finnish study, the SMR (95% CI) for fatal MI 1971–1991 was increased 
among female (1.17, 1.06–1.31) but not male kitchen assistants, compared to other 
economically active women or men. The SMR (95% CI) for other IHD was 
increased for female, but not male, cooks and other kitchen staff (1.30, 1.11–1.54), 
kitchen assistants (1.40, 1.18–1.65) and restaurant waiters (1.54, 1.19–1.98).  
The mortality from CVD was increased among female kitchen assistants (1.13, 
1.06–1.21) and female restaurant waiters (1.19, 1.07–1.33) (713). 
A study on occupational mortality of women aged 15–59 years (in the period 
1971–1981, related to their occupation as recorded in the 1971 census) in England 
and Wales showed an increased mortality of circulatory diseases among cooks 
compared to all employed women, as a result of a significant excess of mortality 
from IHD (SMR 3.60, 95% CI 1.55–7.09) (673).  
Male British retired army cooks had elevated death rates (SMR, 95% CI) from 
IHD (1.42, 1.13–1.76) and CeVD (2.05, 1.22–3.24) compared to the national 
population, as well as compared to a referent group of other men retired from the 
army and supposed to have had a similar work situation regarding physical training 
and irregular hours (1.43, 1.01–2.02 and 2.17, 0.94–4.99, respectively) (183). 
7.10.3 Conclusion 
Most occupational studies supported a relationship between working as a cook or 
other kitchen worker and CVD, including MI or other IHD, but there was no 
evidence of exposure-response relationships. For CeVD, one study supported a 
relationship with exposure to cooking fumes and another did not.  
 
There is limited evidence for an association between exposure to cooking fumes 
and CVD. 
 
  
29 
7.11 Second-hand smoke 
7.11.1 General 
Cigarette smoke contains at least 4 000 chemical compounds (890). Sidestream 
smoke may contain higher concentrations of some chemicals, e.g. aminophenyls, 
BaP and formaldehyde, than mainstream smoke (436). Exposure to second-hand 
smoke is sometimes referred to as environmental tobacco smoke (ETS) or passive 
smoking. 
Smoking was recognised as a risk factor for CVD already in the 1950s. Most 
studies report a 1.5–2.5 times greater risk of CHD and stroke for smokers than for 
non-smokers (464). 
The worldwide burden of disease from exposure to second-hand smoke was 
estimated from data from 192 countries. In 2004, 33% of male non-smokers and 
35% of female non-smokers were exposed to second-hand smoke. This exposure 
was estimated to have caused 379 000 deaths from IHD and the loss of 2 836 000 
disability-adjusted life-years in 2004 (1062).  
7.11.2 Epidemiological studies 
A US cross-sectional internet-based study (Health eHeart Study) comprised 4 976 
participants from California, 2013–2014. Second-hand smoke was assessed through 
a validated questionnaire and prevalent atrial fibrillation was self-reported by  
593 (11.9%) participants. Atrial fibrillation was validated by a subset review of 
electronic medical records. Participants who had a smoking parent during 
gestational development later showed an increased risk for atrial fibrillation 
(OR 1.37, 95% CI 1.08–1.73). Residing with a smoker during childhood was  
also associated with an increased risk of later atrial fibrillation (OR 1.40, 95% CI 
1.10–1.79). These associations were more pronounced among patients without risk 
factors for atrial fibrillation (234). 
7.11.3 Meta-analyses  
A meta-analysis comprised 10 cohort and 8 case-control studies of non-smokers. 
The RR (95% CI) of CHD was 1.25 (1.17–1.32) among non-smokers exposed to 
second-hand smoke with no difference in risk between males and females. The risk 
of CHD was slightly higher after exposure to second-hand smoke at home (1.17, 
1.11–1.24) than at work (1.11, 1.00–1.23) (392).  
In all, 28 studies were included in a meta-analysis of second-hand smoke and 
stroke. Based on 39 sex-specific estimates, the meta-analysis gave an overall fixed-
effect RR estimate of 1.23 (95% CI 1.16–1.31) with significant (P < 0.05) hetero-
geneity. There was no significant heterogeneity by sex, continent, fatality, disease 
endpoint or degree of adjustment for potential confounding factors. Risk estimates 
for stroke (RR, 95% CI) were less elevated in prospective studies (1.15, 1.06–1.24) 
than in case-control studies (1.44, 1.22–1.60) and cross-sectional studies (1.40, 
1.21–1.61). A significant increase was not seen in studies that excluded smokers of 
any tobacco (1.07, 0.97–1.17), but was seen in studies that included pipe- or cigar-
only smokers, occasional smokers or long-term former smokers. No elevation was 
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seen for haemorrhagic stroke. Eleven studies provided exposure-response 
estimates, the combined RR for the highest exposure level being 1.56 (95% CI 
1.37–1.79). Many studies have evident weaknesses, recall bias and particularly 
publication bias being major concerns (547). 
7.11.4 Previous evaluations 
In 2010, a WHO working group concluded that it is a causal relationship between 
second-hand smoke and IHD, and suggested that an RR of 1.27 (95% CI 1.19–1.36) 
could be used to estimate the burden of disease caused by second-hand smoke 
exposure at home or at work. It was considered that stroke in relation to second-
hand smoke exposure among non-smokers is biologically plausible, but that 
epidemiological evidence is currently inconsistent; the evidence of causality is less 
convincing than for IHD, but strongly suggestive (1061). 
7.11.5 Conclusion 
A large epidemiological database, including a WHO review (1061) and a meta-
analysis (392), strongly supports an association between exposure to second-hand 
smoke and IHD. Another meta-analysis (547) supports an association between 
exposure to second-hand smoke and CeVD. 
 
There is strong evidence for an association between exposure to second-hand 
smoke and CVD. 
7.12 Firefighting and smoke from fires 
7.12.1 General 
Smoke from fires is composed of suspended liquid and solid particulate matter, 
gases and vapours generated from combustion or pyrolysis of various materials. 
The particles are initially microscopic in size (0.3–1.6 µm), but coalesce rapidly 
and thereby become visible. These particles have adsorbent properties and transport 
toxic compounds generated by combustion. Most polymers in buildings will burn 
or thermally degrade to more simple monomers during a fire. These monomers 
include e.g. ethene, acrylonitrile, styrene, methyl acrylate, ethyl acrylate, propene, 
vinyl chloride, vinyl acetate, chloroprene, phenol and isoprene. Burning of plastics 
produces large amounts of soot. Plastics generate higher levels of hydrogen 
cyanide, hydrochloric acid and acrolein than wood and fossil fuels in fires (438).  
Particulate matter was generated during a peat wildfire event in eastern North 
Carolina, US. Wildland peat fires routinely produce high organic carbon levels (e.g. 
> 90% by mass of forest wildfire particulate matter). Because peat is made up of 
biologically decomposed organic materials, burning it produces organic aerosols 
that may include endotoxins and other biogenic substances (340). 
Among firefighters, the exposure may vary widely depending on type of work 
activities, time spent at fires, and use of respiratory equipment. Firefighters are 
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exposed mainly by inhalation, but for some chemicals, such as PAH and PCBs, 
exposure through dermal absorption may also be important (438).  
Carbon monoxide is a well-known constituent of smoke from fires and increased 
levels of COHb has consequently been found in the blood of non-smoking 
firefighters (574). Heart rate and COHb levels were monitored in firefighters during 
a search and rescue drill in a smoke-filled building. Carbon monoxide levels were 
200–1 000 ppm. Heart rates increased to 90% of maximum for age within minutes, 
and COHb levels increased more than 1% per minute. The results show that exertion 
levels and therefore ventilatory rates may be so great during firefighting that COHb 
can rise to dangerous levels within minutes even at moderate or low levels of 
atmospheric carbon monoxide (353). Data on carbon monoxide are presented in 
Section 15.1. 
7.12.2 Animal studies  
Naeher et al. summarised animal studies and concluded that short-term inhalation 
of wood smoke can compromise pulmonary immune defence mechanisms 
important for maintaining host resistance against pulmonary infections. Moreover, 
a likely target for wood smoke induced immunotoxicity seems to be the alveolar 
macrophages. These immune cells, which serve as the primary defence of the deep 
lung, provide a link between the non-specific and specific defence systems of the 
respiratory tract (689).  
Coarse particles obtained during the smouldering phase of a peat wildfire event 
induced strong lung inflammatory responses in mice as characterised by increases 
in bronchoalveolar lavage fluid proteins, cytokines, neutrophils and intracellular 
reactive oxygen species production. These responses were associated with organic 
coal and biological compounds [i.e. lipopolysaccharides (LPS) and endotoxins]. In 
contrast, ultrafine particles collected during the wildfire did not induce lung 
inflammation but caused cardiovascular effects in an ischaemia reperfusion injury 
model. These effects were associated with organic carbon content, because the 
ultrafine particles obtained during the smouldering, but not the glowing, phase had 
more than three times higher organic carbon content (340).  
7.12.3 Epidemiological studies of firefighters  
A cohort of 1 116 male firefighters employed for at least 1 year 1931–1983 in 
Stockholm, Sweden, was followed 1951–1986. The mortality (SMR, 95% CI)  
was lower than expected for circulatory diseases (0.84, 0.71–0.98), IHD (0.98, 
0.81–1.17) and CeVD (0.71, 0.44–1.09). There were no clear relationships between 
years of employment or number of fires and IHD mortality. The mortality showed 
a tendency to be lower among firefighters with many episodes using self-contained 
breathing apparatus (970). Some years later, Swedish male firefighters were 
compared with other manual workers and the mortality from CVD tended to be 
lower than expected (1015).  
A cohort of 11 691 male Danish firefighters was compared with a random sample 
from the employed population. The follow-up period started from the date of first 
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employment or 1 January 1977 and lasted until the end of 2014. Information on 
incidence of CVD was retrieved from the nationwide Danish National Patient 
Registry. The age- and calendar time-adjusted standardised incidence ratio (SIR, 
95% CI) for CVD was increased (1.10, 1.05–1.15). The risk was also elevated for 
the most frequent outcomes, including angina pectoris (1.16, 1.08–1.24), acute MI 
(1.16, 1.06–1.26), chronic IHD (1.15, 1.06–1.24) and atrial fibrillation/flutter  
(1.25, 1.14–1.36). No significantly increased risks were observed for cerebral 
apoplexy (0.95, 0.86–1.05), transient ischaemic attack (1.12, 0.97–1.30), arterio-
sclerosis (1.02, 0.88–1.18) and arterial embolism/thrombosis (0.83, 0.58–1.19). 
Risks were almost always higher among full-time firefighters than among part-
time/volunteer firefighters. The risks were lower during active employment as 
firefighters (733). 
Employees of the city of Buffalo formed a cohort of 1 867 white male firefighters 
who had worked for at least 1 year 1950–1979 and were followed until 1979. 
Expected deaths were calculated from US national rates for white men. The 
mortality risks (SMR, 95% CI) were somewhat lower than expected for circulatory 
diseases (0.92, 0.81–1.04), atherosclerotic heart disease (0.92, 0.79–1.07) and all 
vascular lesions of the CNS (0.92, 0.64–1.27). By years of employment, SMRs for 
circulatory disease were 0.41 (P < 0.05), 0.71, 0.84, 1.00 and 1.10 after 1–9, 10–19, 
20–29, 30–39 and ≥ 40 years of exposure, respectively. Corresponding SMRs for 
atherosclerotic heart disease were 0.51, 0.81, 0.83, 0.94 and 1.19 (1006).  
US Boston firefighters, followed 1915–1975, showed a decreased mortality from 
circulatory diseases (SMR 0.86) (688). This finding was later confirmed by the 
longitudinal Normative Aging Study from Boston. Firefighters did not differ 
significantly from non-firefighters in the incidence of CHD (230). 
US firemen, aged 25–59 years, from Connecticut, had an increased IHD mortality 
(SMR 1.52, 95% CI 1.23–1.81) (828). Also, firefighters from Philadelphia had an 
increased mortality from IHD (SMR 1.09, 95% CI 1.02–1.16) but not from CeVD. 
The IHD mortality tended to be higher among ladder company firefighters and 
among those hired before 1935 (62). Among firefighters from Florida, the mortality 
from CVD (SMR, 95% CI) was decreased in males (0.76, 0.66–0.86), but increased 
in females (3.85, 1.66–7.58) (592). 
A cohort of 2 289 male firefighters employed by the Seattle Fire Department on 
or after 1 January 1945, and who had served for at least 1 year prior to 1 January 
1980, was followed until the end of 1983. US white male rates were used for 
comparison because the large majority of the firefighters were white. There were 
172 deaths from circulatory diseases (SMR 0.78, 95% CI 0.68–0.92). Except for 
firefighters with ≥ 30 years exposure, all subgroups had lower than expected 
mortality due to circulatory diseases. However, the SMRs increased uniformly with 
both time since first exposure and duration of exposure. Duration of exposure < 15, 
15–29 and ≥ 30 years were associated with SMRs (95% CIs) of 0.63 (0.39–0.96), 
0.75 (0.62–0.91) and 1.03 (0.75–1.38), respectively. After a restriction of the cohort 
to firefighters who had survived 30 years after first exposure, the positive 
relationship between duration of exposure and mortality due to circulatory diseases 
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remained; duration of exposure < 15, 15–29 and ≥ 30 years were associated with 
SMRs (95% CIs) of 0.56 (0.21–1.22), 0.80 (0.63–1.00) and 1.03 (0.75–1.38) 
(P trend < 0.10). The trend was also calculated with the lowest duration of exposure 
as referent; exposure durations of 15–29 years and ≥ 30 years were associated with 
risks (RR, 95% CI) of 1.42 (0.69–3.36) and 1.84 (0.87–4.41), respectively (403). 
Totally 4 546 firefighters who were employed by the cities of Seattle, Tacoma, 
and Portland for at least 1 year between 1944 and 1979 were compared with US 
national rates. The mortality (SMR, 95% CI) due to IHD was less than expected 
based on US rates for white men. However, mortality due to diseases of the arteries, 
veins and pulmonary circulation was increased among firefighters who had worked 
for ≥ 30 years (1.33, 1.0–1.8) and among firefighters ≥ 65 years old (1.58, 1.1–2.1) 
(226). 
Short-term death from CHD was studied among US firefighters from 1994 to 
2004, excluding deaths associated with the terrorist attack on 11 September 2001. 
The odds of death from CHD during specific activities were compared with the 
odds during non-emergency duties. The ORs were 12.1–136 (sic) times higher 
during fire suppression, 2.8–14.1 times higher during alarm response, 2.2–10.5 
times higher during alarm return, and 2.9–6.6 times higher during physical training. 
These ORs were based on three estimates of the time that firefighters spend on their 
specific duties and were all significant (P < 0.001) (474). 
The mortality from circulatory diseases was increased among Toronto, Canada, 
firefighters aged 45–49 years (SMR 1.80, 95% CI 1.01–3.19) (69).  
Eight Australian fire agencies supplied records of male paid firefighters from 
1976 to 2003. The cohort included 17 394 full-time and 12 663 part-time fire-
fighters and was compared with the mortality of the male Australian population. 
Follow-up lasted 1980–2011. The total cohort showed decreased mortality (SMR 
95% CI) for all circulatory diseases (0.62, 0.55–0.70), IHD (0.68, 0.59–0.79) and 
CeVD (0.55, 0.39–0.77). There was no difference in mortality between full-time 
and part-time firefighters (343). 
7.12.4 Exposure-response relationships  
A cohort comprised 160 000 Australian male volunteer firefighters. Before joining 
as volunteer there was no formal fitness assessment and they were thus much less 
selected than paid firefighters. The volunteer firefighters had a reduced risk of 
mortality and cancer incidence compared with the general population, which is 
likely to be a result of a healthy-volunteer effect and, perhaps, lower smoking rates. 
However, volunteers who attended more than 576 fires had an increased relative 
mortality risk for IHD compared to volunteers who attended less than 220 fires (RR 
1.86, 95% CI 1.07–3.23). The IHD mortality was also significantly increased for 
the sub-categories structural fires, landscape fires and vehicle fires (342).  
7.12.5 Markers of effect 
In a human experimental study, inhalation of wood smoke increased the levels of 
the inflammatory marker SAA, as well as factor VIII in plasma and the factor 
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VIII/von Willebrand factor ratio, indicating a disturbed balance of coagulation 
factors (64).  
During the 1997 Southeast Asian forest fires, 30 males performing compulsory 
national service in Singapore were exposed to ~ 125 μg/m3 of PM10 for 5 weeks. 
Their IL-1β and IL-6 levels in blood were increased compared with the post-fire 
period as an expression of an inflammatory response (937, 983).  
Healthy conscripts, participating in a rescue educational course for firefighting, 
were primarily exposed to particulate matter in bystander positions. Firefighting 
training was associated with elevated urinary excretion of 1-hydroxypyrene, 
increased body temperature, decreased microvascular function and altered HRV. 
The authors concluded that altered effect markers were most likely due to complex 
effects from particle exposure, physical exhaustion and increased core body 
temperature (28). 
7.12.6 Reviews 
In 2011, the authors of a review of CVD in US firefighters concluded that CVD 
remains the leading cause of line of duty death among firefighters, 45% of on-duty 
fatalities. Firefighting activities include heavy physical exercise in combination 
with high ambient temperatures and exposure to air pollutants. Clinical epidemio-
logical investigations have proven that on-duty CVD events occur almost 
exclusively among susceptible firefighters with underlying CVD. Consequently 
firefighters with known CHD or other clinically significant atherosclerotic end-
points should be restricted from participating in strenuous emergency duties (897) 
with or without heavy fire smoke exposure.  
7.12.7 Epidemiological studies of the general population 
Daily mortality and daily hospital admissions due to CVD were monitored in the 
Helsinki metropolitan area, Finland. Days significantly affected by smoke from 
vegetation fires between 2001 and 2010 were identified using air quality measure-
ments at an urban background and a regional background monitoring station, and 
modelled data on surface concentrations of vegetation-fire smoke. Associations 
between daily PM2.5 concentration and health outcomes were analysed using 
Poisson time series regression. All statistical models were adjusted for daily 
temperature and relative humidity, influenza, pollen and public holidays. On 
smoke-affected days, a 10-µg/m3 increase in PM2.5 was associated with a borderline 
statistically significant increase in CVD mortality among the total population at  
a lag of 3 days (12.4%, 95% CI -0.2% to 26.5%). In contrast, PM2.5 on smoke-
affected days was not associated with hospital admissions due to CVD. This study 
provides suggestive evidence for an association between exposure to long-range 
transported PM2.5 from vegetation fires and CVD mortality. Hence, vegetation-fire 
originated air pollution may have adverse effects on public health over a distance 
of hundreds to thousands of kilometres from the fires (505). 
The prolonged heat wave in Moscow, Russia, during the summer of 2010 
triggered numerous wildfires leading to increased air pollution. The relative 
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increases in total mortality per 10-μg/m3 increase of PM10 were 0.43% (95% CI 
0.09–0.77%) at temperatures ≤ 18 °C, and 1.44% (95% CI 0.94–1.94%) at a 
temperature equal to 30 °C. CVD death was one of the pronounced proportions of 
total mortality (862). 
In June 2008, burning peat deposits produced haze and air pollution, encroaching 
on rural communities of eastern North Carolina, US. A population-based study used 
emergency department visits as outcome parameter. Satellite data was used to 
determine a high-exposure window and distinguish counties most impacted by the 
dense smoke plume from surrounding referent counties. Poisson log-linear 
regression with a 5-day distributed lag was used to estimate changes in the 
cumulative RR. In the exposed counties, a significant increase in cumulative RR 
was observed for visits associated with heart failure (1.37, 95% CI 1.01–1.85) 
(773). 
The relationship between particulate matter from forest fire smoke exposures, 
during a severe forest fire season in Melbourne, Victoria, Australia, and out-of-
hospital cardiac arrest was studied. Totally, 174 “fire-hours” (i.e. hours during 
which Melbourne’s air quality was affected by forest fire smoke) were identified 
during 12 days of the 2006/2007 fire season. There were 2 046 out-of-hospital 
cardiac arrests during the study period. During the fire season, men had greater 
increases in out-of-hospital cardiac arrests with interquartile range (IQR) increases 
in the 48-hour lagged PM2.5 (8.1%, 95% CI 2.3–14.1%, IQR 6.1 μg/m3) or PM10 
(11.1%, 95% CI 1.6–21.5%, IQR 13.7 μg/m3). There was no significant association 
between the rate of out-of-hospital cardiac arrests and air pollutants among women 
(229). 
In another study of the wildfires in Victoria 2006/2007, PM2.5 exposure was 
associated with increased risk of out-of-hospital cardiac arrests and IHD. After 
adjusting for temperature and relative humidity, an increase in IQR of 9.04 μg/m3 
in PM2.5 over 2 days moving average (lag 0–1) was associated with a 7.0% (95% 
CI 1.0–13.3%) increase in risk of out-of-hospital cardiac arrests, with strong 
associations shown among men (9.1%, 95% CI 1.6–17.0%) and older adults  
(aged ≥ 65 years, 7.3%, 95% CI 0.2–14.8%). The increase in risk was 2.1% (95% 
CI 0.09–4.1%) for IHD-related emergency department attendance and 1.9% (95% 
CI 0.4–3.4%) for IHD-related hospital admissions at lag 2 days, with strong 
associations shown among women (3.2%, 95% CI 0.8–5.7%) and older adults 
(2.4%, 95% CI 0.8–5.7%) (372). 
7.12.8 Conclusion  
Several studies of health effects from wood fires in the general population showed 
short-term elevated mortality from CVD, and mechanistic studies showed effects 
on early markers of CVD.  
Occupational studies of firefighters showed mixed results. The interpretation of 
occupational studies is hampered by potential confounding, both positive and 
negative. On one hand, firefighting is associated with high physical and ergonomic 
demands during rescue operations. The work can be mentally stressful and is often 
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associated with heat exposure. Many of these exposures are associated with CVD 
(358, 834). On the other hand, firefighters are often obliged to pass a regular 
physical examination test requiring a good cardiopulmonary capacity, see e.g. 
Tornling et al. (970).  
The risk of CVD in Swedish firefighters was lower than expected (970, 1015), 
whereas a study of Danish firefighters showed an increased risk (733). Studies of 
firefighters from the US, Canada and Australia did not provide consistent evidence 
for an excess of CVD; several studies showed normal or low risks of CVD while 
increased risks were reported in five studies (69, 226, 474, 592, 828 ). A possible 
interpretation of the data is that a harmful effect of exposure to smoke is counter-
balanced by a selection of physically fit individuals to the occupation.  
 
There is moderately strong evidence for an association between exposure to 
smoke from fires and CVD.  
There is limited evidence for an association between firefighting and CVD.  
7.13 Other combustion-generated air pollutants  
Estimations of quantitative data on personal exposure of combustion-generated 
respirable particles (other than motor exhaust) were used in a population-based 
case-control study of MIs 1992–1994 in Stockholm, Sweden. In total, 1 135 cases 
and 1 658 controls were identified. Lifetime history of occupations, work tasks, 
smoking and alcohol habits and several other potential confounding factors were 
obtained by questionnaire or telephone interview. Exposure to combustion-
generated particles was assessed by an industrial hygienist, based on a JEM. ORs 
were adjusted for smoking and alcohol habits, hypertension, overweight, diabetes 
mellitus and physical inactivity at leisure time. The adjusted risk of MI increased 
monotonically and statistically significantly with both maximum and cumulative 
exposure to respirable combustion-generated particles. The second highest intensity 
of exposure to respirable particles (1.0–2.4 mg/m3) during at least 1 year of work 
was associated with an increased risk (RR, 95% CI) of MI (1.42, 1.05–1.92) which 
increased further (2.11, 1.23–3.60) at the highest intensity of exposure (≥ 2.5 
mg/m3). Trend analysis of exposure-response data revealed that an increase of 
respirable particle exposure with 1 mg/m3 was associated with an increased risk  
of 1.24 (1.07–1.51). A cumulative exposure of ≥ 6.75 mg/m3-years of respirable 
particles was associated with a significantly increased risk of MI (1.35, 1.02–1.79) 
(364). 
The importance of particulate matter for CVD was demonstrated in a study 
evaluating the effect of a ban in 1990 on coal sales in Dublin, Ireland. Average 
black smoke concentrations in Dublin declined by 35.6 µg/m3 (70%) and CVD 
mortality decreased by 10.3% (8–13%, P < 0.0001) after the intervention (173). 
Exposure-response relationships for urban air pollution, second-hand smoke and 
active smoking (in terms of daily exposure of PM2.5) and relative risk of CVD was 
presented by Pope et al. in 2009. The risk of CVD in the low-exposed (urban air 
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pollution and second-hand smoke) was considerably higher than that expected from 
linear extrapolation from the high-exposed (the active smokers). A log-trans-
formation of exposure fitted the data much better. Thus, the study suggests that the 
exposure-response curve for combustion-generated particles is much steeper at low 
than at high exposures. Declining smoking-related risks among elderly participants 
were probably caused by competing risks and selection bias (756). It has been 
suggested that nicotine exposure contributes to down-regulation of inflammation 
via the cholinergic anti-inflammatory pathway (264). 
7.14 Summary of exposure-response data 
The epidemiological studies of occupational exposure to combustion-generated 
particles show partly inconsistent results.  
The inconsistent findings cannot easily be explained by differences in exposure 
circumstances, because most occupations reviewed in this document represent 
occupations known to be associated with high exposure to combustion products and 
PAH. Possibly, the proportion of PAH present in the particle phase or gas phase is 
of importance. The evidence for causality is strengthened by the fact that studies 
using more detailed exposure estimates more often showed positive findings, and 
that several of these studies adjusted for smoking. Positive exposure-response 
relationships were demonstrated in a few studies. 
An increased risk of IHD has repeatedly been reported among aluminium smelter 
workers. Positive finding were more consistently found in studies using personal 
exposure estimates, and several of the aluminium smelter studies presented 
smoking-adjusted risk estimates.  
A large multicentre study of asphalt pavers using detailed exposure data found 
an increased risk of CVD and a clear exposure-response relationship (134).  
Studies of coal gas production workers and chimney sweeps provide some 
(limited) support for an association between high exposure to PAH and IHD, while 
studies of coke plant and graphite electrode workers, roofers, tar workers or 
creosote workers do not.  
Regarding exposure to motor exhaust (mainly diesel engine exhaust), the data 
show moderately strong evidence for a casual association with CVD, while studies 
of cooking fumes and firefighting, respectively, provide limited evidence for such 
an association.  
Studies of exposure to second-hand smoke show strong evidence for an 
association with CVD.  
A population-based case-control study demonstrated exposure-response pattern 
for occupational exposure to combustion products (other than motor exhaust) and 
MI, after adjustment for several relevant confounders including smoking. A 
cumulative exposure of ≥ 6.75 mg/m3-years of respirable particles was associated 
with a significantly increased risk of MI (364). The average exposure in this 
exposure class can be estimated to 11.25 mg/m3-years of respirable particles (982), 
which corresponds to an exposure level of 0.28 mg/m3 over a 40-year working life.  
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Table 3. Summary of LOAECs from epidemiological and human experimental studies. 
Exposure/effect Estimated LOAEC Reference 
 BaP (µg/m3) PM2.5 (mg/m3) EC (µg/m3)  
Electrolytic aluminium smelting     
IHD mortality 2.78 0.86  (312, 702) 
Asphalt paving     
CVD mortality 0.068–0.105   (134) 
Diesel engine exhaust     
Decreased brachial artery 
diameter, 2-h exposure 
 0.2  (736, 965) 
Exercise-induced ST-depression 
in subjects with stable coronary 
artery disease, 1-h exposure 
 0.30 a  (650) 
Transient increase in arterial 
stiffness, 1-h exposure 
 0.33 b  (585) 
MI incidence   ~ 0.33 c 87.5 (442) 
Combustion-generated particles 
(other than motor exhaust) 
  
MI incidence   0.28 (resp.)  (364) 
a Median particle diameter 54 nm (range 20–120).  
b Same engine, fuel and rotational speed as in previous study (650). 
c Calculated based on Lewné et al. (559). 
BaP: benzo(a)pyrene, CVD: cardiovascular disease, EC: elemental carbon, IHD: ischaemic heart 
disease, LOAEC: lowest observed adverse effect concentration, MI: myocardial infarction, PM2.5: 
particulate matter with maximal aerodynamic diameter of 2.5 µm, resp.: respirable fraction.  
 
There are data on levels of combustion-generated PM2.5 from several epidemio-
logical as well as experimental studies. These data show consistent LOAEC 
estimates, regardless of exposure source and study design. The human experimental 
studies indicate negative effects on the cardiovascular system starting at 0.2–0.3 
mg/m3 (584, 649, 735, 964). Also, two of the three epidemiological studies indicate 
a LOAEC of about 0.3 mg/m3 (363, 441) while the third, addressing IHD mortality, 
indicate a LOAEC of 0.86 mg/m3 (311, 701). 
Taken together, both single human experimental exposures and epidemiological 
studies indicate that harmful effects from exposure to combustion-generated 
particles appear at 0.2–0.3 mg/m3 as PM2.5 (LOAEC). There were only two 
epidemiological studies using exposure estimates expressed as BaP (134, 311), and 
the relatively inconsistent findings allow no conclusions on LOAEC in terms of 
BaP exposure. LOAEC estimates are summarised in Table 3. 
7.15 Conclusion  
Several epidemiological and experimental studies show harmful effects on the 
cardiovascular system from exposure to combustion-generated particles (PM2.5) at 
0.2–0.3 mg/m3.  
 
There is moderately strong evidence for an association between exposure to 
combustion-generated particles and CVD.  
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8. Mineral dusts 
8.1 Asbestos 
8.1.1 General 
The term asbestos includes a number of fibrous silicates. The two main groups are 
serpentine asbestos (curved fibres) comprising chrysotile, and amphibole asbestos 
(straight fibres) comprising crocidolite, amosite, antophyllite, tremolite and 
actinolite (432). All forms of asbestos cause mesothelioma and cancer of the lung, 
larynx and ovary (439). Non-asbestiform amphibole minerals are addressed 
separately (Section 8.1.9). 
In Sweden, the import of asbestos rose sharply during the mid-1950s to a level of 
some 10 000 tonnes annually. The import continued to grow and a peak of 20 000 
tonnes was reached in the early 1970s. There was a sharp and rapid decline in 1976 
and a total ban of asbestos use was enforced in 1982 (253). All the Nordic countries 
banned asbestos before the year 2000 (475), the European Union (EU) in 2005 (19). 
In 2018, the total mining production of asbestos worldwide was around 1.1 
million tonnes. The leading producers were Russia (59%), China (9%), Brazil (9%) 
and Kazakhstan (20%) (975).  
Epidemiological studies and risk estimates are presented in Appendix, Tables 
A9–A11, for asbestos cement workers, miscellaneous asbestos exposures and 
proxies for asbestos exposure (e.g. pleural plaques), respectively. Pleural plaques 
and diffuse pleural thickening are non-neoplastic abnormalities typically caused by 
asbestos exposure. The prevalence of pleural plaques was surveyed in the male 
adult populations in the 1970s and 1980s and were higher in Finland (6.8%) (1055) 
than in Uppsala County, Sweden (2.7%) (404) and Telemark, Norway (1.8%) (405). 
8.1.2 Conversion of measurements of asbestos 
With the exception of some of the earliest studies conducted for insulators, most of 
the measurement data presented below represent concentrations reported in units of 
fibres/cm3 (ml). However, prior to around the late 1960s, the available analytical 
technologies were not capable of measuring asbestos fibres per se, but instead 
quantified total dust concentrations expressed as million particles per cubic foot 
(mppcf). These data represent collective counts of all fine, dry asbestos as well as 
non-asbestos particles such as other fibres and grains. Historical dust measurements 
were therefore likely to overestimate actual asbestos concentrations unless no other 
(non-asbestos) particles were present. Because the conversion of total dust particles 
to asbestos fibres could vary considerably, depending on the type of fibre and  
the kind of media from which the fibres were derived, no single conversion factor 
has been developed to compare these measures. In spite of this limitation, a widely 
used conversion factor when attempting to understand the significance of historical 
data is that 1 mppcf is approximately equal to 6 fibres/cm3 (1023) (1 mppcf = 106 
particles/cf = 106 particles/28 000 cm3 = 36 particles/cm3). This means that asbestos 
fibres constituted only a small fraction of the total dust. 
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Other conversion factors with ratios ranging from 1:1 to 1:10 (mppcf to fibres/ 
cm3) have been reported when working with different products or industries (1023). 
In a US study of workers manufacturing asbestos cement products from New 
Orleans, Louisiana, 1 mppcf corresponded to 1.4 fibres/cm3 (427). 
In order to study the relationship between count and mass, three industrial plants 
were investigated; an asbestos-cement sheet factory using chrysotile, an asbestos-
cement pipe factory using chrysotile and crocidolite, and a chrysotile mining and 
milling plant. The gravimetric data for asbestos appeared to be largely dependent 
on the type of plant and, when a single plant was considered, on the working process 
involved. The highest values were generally found in the mining activities, the 
lowest in the production of asbestos-cement sheets. The conversion factors varied 
widely ranging from 400 to 4 900 fibres/µg (761). 
In 1984, the US Committee on Nonoccupational Health Risks of Asbestiform 
Fibers presented relationships between different methods of measuring exposure to 
asbestos in the workplace. By light microscopy, 1 mg asbestos/m3 corresponds to 
30 fibres/cm3, which is equivalent to 30 fibres/ng. By electron microscopy, 1 mg 
asbestos/m3 corresponds to 2 000 fibres/cm3 equivalent to 2 000 fibres/ng (188). 
8.1.3 Animal studies 
Atherosclerosis-prone ApoE-/- mice who inhaled around 5 mg/m3 chrysotile 
asbestos fibres, 6 hours/day for 30 days had approximately 3-fold larger athero-
sclerotic lesions than similar asbestos-exposed ApoE-/- / CD4-/- double-knockout 
(DKO) mice. Lung inflammation and the magnitude of lung fibrosis assessed 
histologically were similar in asbestos-exposed ApoE-/- and DKO mice. Monocyte 
chemoattractant protein-1 (MCP-1) levels were increased in bronchoalveolar 
lavage fluid and plasma, and plasma concentrations correlated with lesion size 
(P < 0.04) in asbestos-exposed ApoE-/- mice. At 9 days, activator protein-1 (AP-1) 
and nuclear factor kappa B (NFκB), transcription factors linked to inflammation 
and found in the promoter region of the MCP-1 gene, were increased in aortas of 
asbestos-exposed ApoE-/- but not DKO mice. The authors concluded that the 
degree of lung inflammation and fibrosis does not correlate directly with cardio-
vascular effects of inhaled asbestos fibres and that these findings support a critical 
role of CD4+ T-cells in linking fibre-induced pulmonary signalling to consequent 
activation of NFκB- and AP-1-regulated genes in atherogenesis (320). 
Rats receiving two intratracheal instillations of 2 mg of amosite asbestos with an 
interval of 1 week showed marked perivascular and interstitial cardiac fibrosis after 
6 months (119). 
Libby amphibole asbestos (Montana, US) was intratracheally instilled in four 
strains of rats. Amphibole asbestos reduced adenosine diphosphate (ADP)-induced 
platelet aggregation and decreased circulating platelets in Wistar Kyoto (WKY) rats 
(1 mg/animal) and Fischer 344 rats (5 mg/animal) at the 3-month time-point but not 
in spontaneously hypertensive (SH) (1 mg/animal) or spontaneously hypertensive 
heart failure (SHHF) (1 mg/animal) rats. Aorta mRNA expression for biomarkers 
of oxidative stress (haem oxygenase-1 and lectin-like oxidised low-density 
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lipoprotein receptor-1), inflammation (macrophage inflammatory protein-2) and 
thrombosis (tissue plasminogen activator, plasminogen activator inhibitor-1 and 
von Willebrand factor) were increased at baseline in SHHF rats relative to WKY 
rats. The amphibole exposure upregulated several of these biomarkers and also 
those involved in aortic contractility of WKY rats at 3 months, suggesting 
thrombogenic, vasocontractile and oxidative stress-mediated impairments. The 
aorta changes in Fischer 344 rats were less remarkable than in WKY rats. The 
authors concluded that exposure to amphibole decreased circulating platelets and 
platelet coagulability while increasing the expression of oxidative stress, 
thrombosis and vasoconstriction biomarkers in the aorta of healthy rats. These 
changes were similar to those noted at baseline in SH and SHHF rats, suggesting 
that amphibole-induced pulmonary injury might increase the risk of developing 
CVD in healthy individuals (857). 
8.1.4 Occupational epidemiological studies 
8.1.4.1 Asbestos cement work  
Mortality from CVD among asbestos cement workers has been studied in Sweden 
(14, 723), Denmark (767), England (326), Poland (934), Italy (579, 632, 765), 
Greece (865), the US (427) and Canada (293). Almost all studies compared the 
mortality of asbestos-exposed workers with national or regional rates. No 
significant increased risks of CVD were observed. No increased risk of heart 
disease and no clear exposure-response relationship were observed in a Swedish 
study comparing asbestos cement workers with industrial workers (14).  
8.1.4.2 Miscellaneous asbestos exposures 
In the Great Britain Asbestos Survey, mortality was studied during 1971–2005 
among 98 117 asbestos workers undergoing regular medical examinations. The 
mortality was increased (SMR, 95% CI) due to IHD (1.40, 1.36–1.44) and CeVD 
(1.64, 1.54–1.74). The number of deaths from IHD was 4 183 (383). This cohort 
was further analysed and a significant relation was found between duration of 
exposure and IHD. The interaction between duration of exposure to asbestos and 
smoking implied that the mortality rate was positively associated with duration of 
exposure among never and former smokers, but there was a negligible increase in 
risk with duration of exposure among current smokers (382). 
Asbestos stripping and removal workers were part of the British cohort described 
above, and 52 387 workers were followed 1971–2005. A subgroup of 31 302 
stripping/removal workers completed a questionnaire and a positive exposure-
response relationship was found between the number of weekly hours spent 
stripping and mortality (RR) from circulatory disease and IHD (317). 
A cohort of 3 211 men first employed 1933–1974 at a Rochdale asbestos textile 
factory was followed until 1983. A small but not significantly increased mortality 
due to circulatory disease was observed when the cohort was compared with death 
rates for England and Wales (SMR 1.15) and for Rochdale (SMR 1.18) (744). 
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A cohort of 952 workers first employed 1930–1965 in a chrysotile asbestos mine 
in Northern Italy was followed until 1975. An increased mortality due to CVD was 
recorded (SMR 1.48, P < 0.01) when the cohort was compared with Italian national 
rates (806). 
Enterline and coworkers reported the mortality of 1 074 white men who retired 
from a US asbestos company during the period 1941–1967. The participants were 
exposed during production or maintenance and were followed until 1980. An 
increased mortality due to CHD was observed (SMR 1.12, P < 0.05) when the 
cohort was compared with US national rates (259). 
A US cohort of 1 130 former workers in Tyler, Texas, that manufactured asbestos 
pipe containing amosite insulation material was followed until 1993. An increased 
risk of CeVD mortality was found (SMR 2.21, 95% CI 1.17–3.77) (555). 
Totally 5 770 US workers, employed 1950–1973 in any of four plants in North 
Carolina that produced asbestos textile products, were followed through 2003.  
An increased mortality due to diseases of the heart was found (SMR 1.32, 95% CI 
1.22–1.42) compared to the national population (576). 
An increased mortality due to diseases of the circulatory system was found 
among white male textile workers exposed to chrysotile in the US (SMR 1.25, 
P < 0.05). Smoking habits were about the same as in the control group of US men 
(224). The cohort was expanded to contain altogether 3 072 workers and was 
followed through 2001. Increased risks (SMR, 95% CI) of IHD (1.20, 1.10–1.32) 
and CeVD (1.29, 1.08–1.53) were observed (396). 
Libby, Montana, US was the site of a vermiculite mining and processing 
operation from the 1920s to 1990. Although pure vermiculite causes no known 
adverse health effects, Libby vermiculite was contaminated with a mixture of 
amphibole fibres (mainly tremolite). By using a within-cohort comparison, a 
significantly increased CVD mortality was observed in workers exposed to levels 
≥ 44 fibres/ml-year compared with workers exposed to < 1.4 fibres/ml-year  
(RR 1.5, 95% CI 1.1–2.0). Smoking status was an unmeasured confounder, but 
adjustment for assumed differences in smoking habits had a minimal effect on the 
risk estimate (539).  
A cohort of 1 932 chrysotile asbestos miners in China who had worked at least 
1 year 1981–1988 was followed until 1 June 2010. The cohort was divided in two 
groups, exposed (miners, blasters, mechanics, maintenance and transport workers) 
and controls (not directly asbestos exposed workers; management and service 
workers). The mortality due to CVD was slightly increased among the exposed 
when compared with national rates (SMR 1.27, 95% CI 0.96–1.63) and also when 
compared with internal controls (RR 1.30, 95% CI 0.79–2.14 after adjustment for 
gender and smoking habits). The corresponding CeVD mortality was increased 
compared with national rates (SMR 1.38, 95% CI 1.03–1.79) and also when 
compared with internal controls (RR 1.75, 95% CI 1.00–3.08 after adjustment for 
gender and smoking habits). Mortality from pulmonary heart disease was also 
significantly increased (SMR 2.70) (242).  
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A cohort of 586 male and 279 female workers from a Chinese chrysotile textile 
factory was prospectively followed for 37 years, 1972–2008. Vital status was 
identified, and the date and underlying cause of death were verified from death 
registry. Cause-specific SMRs by gender were computed with nationwide gender- 
and cause-specific mortality rates as reference. There were significant increases of 
asbestosis in both genders and a significant increase of lung cancer among male 
workers. Pulmonary heart disease was increased (SMR, 95% CI) among men (13.1, 
9.5–18.1) and women (8.3, 2.3–30.4). There was no increased mortality from other 
diseases of the heart (men: 0.9, 0.5–1.4 or women: 1.0, 0.4–3.0) or from CeVD 
(men: 1.0, 0.7–1.5 or women: 0.3 based on 1 case) (987). 
A total of 1 106 crocidolite-exposed workers were selected from the workforce 
of the asbestos industry in Western Australia. Pleural thickening was a risk factor 
for death from other causes than asbestos-related diseases (RR 1.5, 95% CI  
1.3–1.8) and IHD formed the largest proportion of deaths from these other causes. 
Pleural thickening had a greater effect on mortality from diseases of other causes 
(IHD) than asbestos-related diseases (217). 
Some studies applied pleural plaque or asbestosis as proxy for asbestos exposure 
(Appendix, Table A11). Calcified pleural plaques were more common among 148 
coronary patients (35%) than among 100 lung cancer patients (19%) chosen as 
referents. The RR of calcified pleural plaques was 2.2 (95% CI 1.4–3.3) adjusted 
for age and gender (507).  
IHD was studied in a cohort of 1 725 Swedish male shipyard workers exposed  
to asbestos. Men with pleural plaques had a non-significantly increased risk (RR, 
95% CI) of IHD compared to men without pleural plaques (1.3, 0.8–2.0) after 
stratification for age and smoking habits. In addition, men with asbestosis or 
suspected asbestosis had a significantly higher risk of dying from IHD than men 
without asbestosis (3.1, 1.5–6.4), after stratification for age and smoking habits 
(825). 
A cohort of about 11 000 men born 1891–1920 and employed for at least 1 month 
in the chrysotile mines and mills of Quebec was followed until 1988 (619). One 
part of this large cohort comprising 4 559 men was followed regarding radiological 
findings, and workers with abnormal signs were compared with workers with 
normal radiological examinations. Uncalcified pleural changes were associated 
with an increased mortality risk for diseases of the heart (RR 1.54, P < 0.005). 
Pleural calcifications were also associated with a somewhat increased risk of heart 
diseases (RR 1.34, P < 0.10) (564). 
8.1.5 Case reports 
Pericardial lesions including parietal pericardial plaques (212, 971) and constrictive 
pericarditis (212, 295) have been observed 20–30 years after asbestos exposure. 
One study indicated that non-ischaemic myocardial fibrosis is more common 
among patients with asbestosis (503). 
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8.1.6 Meta-analyses 
Totally 16 studies were included in a meta-analysis of asbestos exposed cohorts 
investigating CVD. The combined result from all studies indicated an increased risk 
(SMR, 95% CI) for CVD (1.11, 1.01–1.22). The outcome varied between different 
subdiagnoses, namely pulmonary heart disease (2 studies; 4.13, 1.55–10.98), 
circulatory diseases (9 studies; 0.99, 0.88–1.11), all heart diseases (4 studies; 0.99, 
0.86–1.14) and IHD (7 studies; 1.04, 0.82–1.32). The mortality from CVD varied 
with type of asbestos exposure. The SMRs (95% CIs) were increased among 
workers exposed to chrysotile (1.23, 1.07–1.41) and amphibole (1.26, 1.02–1.56) 
except among crocidolite exposed workers (0.80, 0.74–0.86). Among chrysotile 
exposed workers, the highest risks of CVD mortality were seen in asbestos textile 
workers, whereas miners and cement production workers had lower risks. Studies 
of chrysotile exposed workers in developing countries like South Africa and China 
showed higher SMRs than studies in Europe or North America. This difference 
reflects higher fibre concentrations in the work environment in developing 
countries. Many comparisons in this meta-analysis showed significant hetero-
geneities (795). 
8.1.7 Exposure-response relationships 
In the study reported by McDonald and coworkers, IHD was more common among 
those exposed to levels ≥ 300 mppcf-years of asbestos (SMR 1.24) than among 
those exposed to < 30 mppcf-years (SMR 0.92) (619). In approximately the same 
cohort, workers exposed to levels ≥ 300 mppcf-years had an increased mortality of 
heart disease compared to unexposed workers (RR 1.57, X2 27.90, P < 0.001) (564).  
In the cohort of British asbestos workers undergoing regular medical 
examinations, a significant relationship was found between duration of exposure 
and IHD (382). In a subgroup comprising stripping and removal workers, a 
relationship was found between the number of weekly hours spent stripping and 
mortality (RR) from circulatory disease and IHD (317). 
Totally 1 862 Libby vermiculite workers were exposed to amphibole fibres, 
mainly tremolite because the vermiculite was contaminated with such fibres. By 
using a within-cohort comparison, a clear relationship was demonstrated between 
cumulative fibre exposure and CVD mortality. The mortality was significantly 
increased over the exposure groups 1.4 – < 8.6, 8.6– < 44.0 and ≥ 44 fibres/ml-year 
(P = 0.067) compared to workers exposed to < 1.4 fibres/ml-year. Risk estimates 
(RR, 95% CI) were 1.3 (1.0–1.6), 1.3 (1.0–1.6) and 1.5 (1.1–2.0) (539). 
8.1.8 Markers of effect 
Non-smoking patients with asbestosis were compared with healthy non-smoking 
controls. The asbestosis patients had significantly increased serum levels of the 
inflammatory markers CRP and IL-6 (551).  
Among 505 asbestos-exposed construction workers, a slight but significant 
relationship was found between CRP and pleural calcifications, a marker of 
asbestos exposure (995). 
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Totally 584 asbestos-exposed construction workers were screened with 
computed tomography. Paraseptal emphysema and bullae in the lungs were both 
significantly associated with CVD (997). In a similar study, 633 asbestos-exposed 
workers were investigated with high-resolution computed tomography and 
followed on average 8 years. Emphysema and visceral pleural abnormalities were 
both significantly associated with CVD (996). The relationship between pleural 
plaques and CVD was probably not possible to investigate as almost all participants 
had parietal pleural abnormalities. 
The cardiac autonomic nervous system was investigated by the time domain 
HRV and its correlation with lung function tests in patients with pleural disease 
caused by asbestos exposure. Patients with restrictive pulmonary disease had 
cardiac autonomic dysfunction, which correlated with the severity of restriction. 
This was thought to be the result of chronic hypoxia, pulmonary hypertension and 
right ventricular enlargement (734). 
Human pulmonary epithelial cells cultured in the presence of asbestos crocidolite 
produced a dose-dependent increase in the secretion of IL-6 (590). 
8.1.9 Taconite mining (non-asbestiform amphiboles) 
Mining and processing of taconite iron ore result in potential exposure to non-
asbestiform amphibole and non-amphibole elongate mineral particles (EMP), 
respirable silica (quartz) and dust. The term EMP refers to any mineral particle  
of inhalable size with a minimum aspect ratio of 3:1. Mortality was evaluated  
1960–2010 in a cohort of Minnesota taconite mining workers employed by any of 
the seven companies in operation in 1983. The cohort including 31 067 workers 
with at least 1 year of employment was compared with the Minnesota population. 
Mortality (SMR, 95% CI) from CVD (1.10, 1.06–1.14), specifically for hyper-
tensive heart disease (1.81, 1.39–2.33) and IHD (1.11, 1.07–1.16) was higher than 
expected. Also mortality from mesothelioma was found to be higher than expected 
(SMR 2.77, 95% CI 1.87–3.96) (18). Previous smaller cohort studies of Minnesota 
taconite miners and millers did not demonstrate increased risks of CVD (192). 
8.1.10 Conclusion 
Approximately ten epidemiological studies provide support for an association 
between asbestos exposure and CVD. Of these, two studies supported a relationship 
between asbestos exposure and pulmonary heart disease (cor pulmonale) (242, 987) 
and four cohorts demonstrated a relation to CeVD (223, 242, 383, 396, 555). A 
meta-analysis of 16 studies showed an increased risk of CVD (795). 
Asbestosis or pleural plaques were significantly related to heart disease in five 
studies (159, 507, 564, 825, 996).  
Two cohorts exhibited an exposure-response relationship between asbestos 
exposure and CVD (539, 564, 619) and the results from another cohort supported a 
relation between duration of exposure and IHD (382). A cumulative exposure of 
1.4–8.6 fibres/ml-year was associated with an increased mortality from CVD (539). 
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This cumulative exposure corresponds to 0.04–0.2 fibres/ml during 40 years of 
exposure. 
 
There is strong evidence for an association between exposure to asbestos and 
CVD.  
8.2 Crystalline silica  
8.2.1 General 
Crystalline silica (silicon dioxide) is an abundant mineral that makes up the earth’s 
crust. It is found in sand, rock and mineral ore. Inhalation of respirable crystalline 
silica dust such as quartz, cristobalite and tridymite can cause silicosis, a fibrotic 
lung disease. Occupational exposures to respirable-sized silica particles include 
mining, quarrying, drilling and sand-blasting activities (955).  
8.2.2 Animal studies 
Intratracheal instillation of quartz (0.125 mg) in rats induced a clear, transient 
pulmonary inflammation with a marked influx of cells. There was an increase of 
both pulmonary and plasma CRP levels and an impairment of fibrinolytic function 
(935). In hamsters, intratracheally instilled crystalline silica particles (0.02 and 0.2 
mg) triggered pulmonary inflammation, together with stimulation of peripheral 
platelet-rich thrombus formation. This activation may predispose platelets to initiate 
thrombotic events on mildly damaged blood vessels (701). 
8.2.3 Occupational epidemiological studies 
Epidemiological studies and risk estimates are presented in subgroups of miners, 
coal miners, other crystalline silica-exposed workers and silicotics (Appendix, 
Tables A12–A13). Foundry workers have been excluded due to their complex 
exposure, including PAH, silica, carbon monoxide and noise. 
Several studies of silica-exposed workers observed a decreased mortality of IHD 
(154, 177, 178, 349, 512). However, many other studies observed an increased 
mortality of IHD among miners and industrial sand workers, some of which 
compared to the general population.  
8.2.3.1 Mining 
A cohort from North Karelia in Finland comprised 597 miners employed for at least 
3 years in a copper mine or a zinc mine. The excess mortality was mainly due to 
IHD; 44 observed deaths versus 22.1 and 31.2 expected, based on the general 
Finnish and the North Karelian (P < 0.05) male population, respectively (12).  
Male miners, well borers, dressing plant workers, and other mine and stone 
workers were identified in the Swedish National Census of 1970. The cohort was 
followed from 1970 until the end of 1995 and linked to the Cause of Death Register. 
The referent group comprised all gainfully employed men identified in the same 
census. An increased IHD mortality (SMR, 95% CI) was observed among miners 
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(1.3, 1.2–1.4), well borers (1.3, 1.1–1.5), dressing plant workers (1.4, 1.2–1.7) and 
other mine and stone workers (1.4, 1.2–1.5) (1000). 
A case-control study of 22 689 male patients with first MI in former West 
Germany showed an increased risk among miners (RR 1.97, P < 0.001) (117).  
US gold miners (n = 3 328) in South Dakota who had worked underground for at 
least 1 year 1940–1965 were followed until 1990. They were exposed to silica and 
non-asbestiform amphibole minerals. Prior to 1950 the dust contained approxi-
mately 13% crystalline silica. There was a slightly decreased risk for IHD (SMR 
0.94, 95% CI 0.85–1.03) when compared with US referent rates. However, in an 
analysis based on multiple cause mortality, an increased mortality due to 
myocardial degeneration was observed among workers hired prior to 1930 (SMR 
9.2, 95% CI 5.1–15.2) (907).  
Totally 3 971 white South-African gold miners at work on 1 January 1970 were 
identified and followed until the end of 1978. At entry in the study the age of the 
workers was 39–54 years. An increased mortality of IHD was found (SMR 1.15, 
95% CI 1.00–1.32). A case-control analysis was conducted comprising the miners 
who had had at least 85% of their service in gold mines. Two referents per case 
were selected randomly from the miners born in the same year as the case and who 
survived the case. Ten years of underground mining was associated with an RR of 
1.5 (P = 0.004) for IHD after adjustment for smoking, systolic blood pressure and 
BMI (1041). This cohort was enlarged to totally 4 925 white miners and was further 
followed until the end of 1989. The SMR for IHD mortality was now 1.24 (95% CI 
1.15–1.34). However, the relationship between underground mining and IHD was 
no longer observed (776). With an increased follow-up time, the proportion of 
currently exposed miners will decrease due to retirement by age and the number of 
non-exposed will increase. This may explain the difference between short- and 
long-term follow-up. Such risk reduction would be analogues to the decreased risk 
for IHD observed among ex-smokers (237).  
A large cohort comprised 68 241 metal miners as well as pottery workers from 
south central China who were employed 1972–1974 and followed until 1989. Age-, 
sex-, and cause-specific national death rates were used to calculate the expected 
numbers of death. There was an increased mortality (SMR, 95% CI) due to IHD 
(1.25, 1.05–1.45), hypertensive heart disease (3.30, 2.68–4.02) and pulmonary heart 
disease (5.81, 5.38–6.26). Smoking habits were unlikely responsible for this risk  
as the mortality from lung cancer was lower than expected (SMR 0.8, 95% CI  
0.7–0.9) (155).  
A subgroup of this cohort comprising 7 837 workers from four tin mines were 
followed through 1994. The SMRs (95% CIs) were 0.77 (0.65–0.90) for CVD and 
1.15 (1.00–1.33) for CeVD. Cumulative dust-exposure did not show a clear 
relationship with the occurrence of CVD (164). In some mines, the dust contained 
arsenic which probably influenced the relationship between dust exposure and lung 
cancer and may also have confounded the relation with CVD.  
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8.2.3.2 Coal mining 
Coal mining generates coal-containing particles but also quartz dust and nitrogen 
oxides from blasting operations (668). Some studies showed an increased risk of 
IHD among coal miners. Enterline reviewed data for American coal miners in 1972. 
Group life insurance data showed a higher mortality among workers in the coal 
mining industry than among workers in other mining industries. In 1967, the 
Society of Actuaries published SMRs from 44 industries and the highest total 
mortality was found among coal miners. In the three cohort studies mentioning 
CHD, increased SMRs (1.09–1.44) were observed (257). Working coal miners from 
US Appalachia had a decreased risk of IHD (SMR 0.69) based on regional rates, in 
contrast to non-working coal miners (SMR 1.02). The higher SMR for the latter 
may be explained by retirement because of ill health (198). This observation was, 
however, not supported in a study of 23 000 US coal miners covered by the United 
Mine Workers Health and Retirement Funds. Time of follow-up was 1959–1971. 
Non-pensioners and pensioners had SMRs due to major CVD of 1.00 and 0.92, 
respectively (788). 
The mortality of coal miners and non-miners was studied in Rhondda Fach, 
Wales. Mortality due to IHD and other circulatory diseases was less common 
among miners with the most complicated coal workers’ pneumoconiosis (Category 
A, B or C) than among workers with less severe pneumoconiosis, no pneumo-
coniosis or non-miners (179). In contrast, Dutch coal miners had an increased 
mortality due to IHD. These workers were rather heavily exposed as most of the 
miners had radiological manifestations of coal workers’ pneumoconiosis (630). A 
later study of 17 820 coal workers from ten British collieries did not show any clear 
evidence of an association between exposure and IHD (646). 
A more recent study comprised 8 971 US coal miners from anthracite and 
bituminous regions. In the anthracite region, the IHD risk was highest in the second 
quartile of cumulative exposure while the risk decreased in the highest quartile of 
exposure. This pattern was probably due to the effect of competing risk from 
pneumoconiosis mortality, which was much higher in the anthracite region than  
in the bituminous regions. The HR regarding IHD increased with increasing 
cumulative coal dust exposure in the bituminous regions, after adjustment for age, 
BMI and smoking. Cumulative coal dust exposures of 20–63.5, 63.6–97.4 and 
> 97.4 mg/m3-years were associated with HRs (95% CIs) of 1.58 (1.09–2.30), 1.81 
(1.23–2.66) and 1.92 (1.29–2.86), respectively (529). 
8.2.3.3 Miscellaneous silica exposures 
Out of 4 626 industrial sand workers exposed to crystalline silica, 330 died due to 
IHD. The calculated SMR was 1.22 (95% CI 1.09–1.36) (910). This increase 
seemed not to be explained by smoking (879).  
A Swedish case-control study comprised 26 847 men with first MI. For each case, 
two controls were selected from the study base through random sampling, stratified 
by age, county and socioeconomic group. The occupation with the second highest 
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risk for a first MI was stonecutters and carvers (RR 1.9, 95% CI 1.1–3.4). This high 
risk could not be explained by differences in smoking habits alone (377).  
In a cohort of 17 644 porcelain production workers in Germany, there was no 
increased mortality due to diseases of the circulatory system (SMR 1.00 for men 
and 0.83 for women). However, in a Bavarian subcohort, males had an increased 
risk (SMR 1.17, 95% CI 1.05–1.31), whereas females did not (SMR 1.03, 95% CI 
0.85–1.23) (96).  
Mortality was studied among 2 924 white male and 946 white female members 
of the International Brotherhood of Potters and Allied Workers in the US who died 
1955–1977. These workers were exposed to dust particles during the production of 
ceramics. The basic raw materials used in the pottery industry contained quartz, 
silica, silicates, mica, feldspar, oxides of iron and carbonates of calcium and 
magnesium. During the latest 20–30 years the use of some fibrous materials such 
as talc increased. The PMR regarding IHD was significantly increased for both men 
(1.07, P < 0.01) and women (1.17, P < 0.01) (956).  
Swedish construction workers exposed to inorganic dust showed an increased 
risk of IHD (RR 1.07, 95% CI 1.03–1.12) after adjusting for age, smoking, hyper-
tension and BMI. However, the inorganic dust was a mixture of asbestos, cement 
dust, concrete dust, man-made mineral fibres (MMMF) and quartz (967).  
8.2.3.4 Silicotics 
An increased risk of atherosclerotic heart disease mortality was observed among 
1 130 male silicotics identified in the Swedish Hospital Discharge Register (SMR 
1.5, 95% CI 1.4–1.8) (130). Interestingly, 88% of the silicotics had the diagnosis of 
atherosclerotic heart disease prior to their first hospitalisation for silicosis. This fact 
does not immediately make this association non-causal as silicosis is a disease 
which will develop over decades of silica exposure. The disease will be manifest in 
X-ray investigations after more than 20 years of exposure (13). 
Most studies of silicotics around the world did not demonstrate an increased risk 
of IHD mortality (Appendix, Table A13). However, a case-control study among 
732 South African gold miners showed that extensive silicosis was clearly related 
to cor pulmonale (OR 4.95, 95% CI 2.92–8.38) at death, while age or smoking were 
not significant predictors of cor pulmonale (686).  
Potential years of life lost (PYLL) because of pneumoconiosis was studied using 
data from the Nationwide Epidemiological Study on Pneumoconioses in China 
1949–1986. Silicosis was the most common pneumoconiosis and comprised 44 108 
subjects. Silicosis had the greatest mean PYLL with an average of 22.1 years. 
Deaths due to circulatory diseases contributed with more PYLL (19.8 years) than 
all cancers (18.2 years) and respiratory diseases (17.2 years). Among circulatory 
diseases, cor pulmonale was responsible for the highest PYLL (20.6 years) (1054).  
Silicosis and constrictive pericarditis were observed in a male stone miner 
exposed for 10 years. An association between silica exposure and pericarditis was 
suggested as no other causing agent was identified (456). 
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8.2.3.5 Acute silicosis 
In 1929, acute silicosis was recognised as a result of comparatively short exposure 
to alkaline silica mixtures in the manufacturing of scouring soaps (150). Two 
women aged 17 and 19 years who were packing a cleaning-powder in a London 
factory developed acute silicosis after an exposure period of less than 3 years and a 
little more than 4 years, respectively. Both died from their disease and the younger 
girl had a heart with recent fibrinous pericarditis (594).  
Three men were mixing dry silica and soap at an open machine. All of them 
developed acute silicosis after 3–5 years of exposure and these were among the first 
cases identified in the US industry. One of the men developed right ventricular 
hypertrophy probably explained by the increased resistance and loss of elasticity in 
the pulmonary vessels (150).  
One case report described a 19-year-old man who had worked as a silica powder 
packer in a stone-grinding workplace in Iran. After 18 months of exposure he died 
of cardiogenic shock, and autopsy revealed advanced silicotic masses in the lungs, 
pericardial effusion, and cardiomegaly associated with irregular plaque formation 
on the visceral layer of the pericardium (657). 
8.2.4 Antineutrophil cytoplasmic antibodies associated vasculitis 
Silica exposure has also been related to the development of antineutrophil 
cytoplasmic antibodies (ANCA)-associated vasculitis (AAV). In a meta-analysis of 
six studies, silica ever-exposure was associated with development of AAV, with a 
summary OR of 2.56 (95% CI 1.51–4.36). Despite moderate heterogeneity among 
studies, the totality of the evidence after the meta-analysis pointed to an association 
between silica exposure and risk for developing AAV (347). In a previous study, 
ANCA positivity was found less frequently (7%) in a group with history of silica 
exposure without signs of pronounced silicosis, than in groups with simple (30%) 
or complicated silicosis (36%). However, no typical AAV was present among the 
participants (67). 
8.2.5 Exposure-response relationships 
Quartz-exposed quarry and shed workers employed 1950–1982 in the Vermont 
granite industry were followed until 1996. Quartz exposure decreased by 80–90% 
after 1940. Mortality (SMR, 95% CI) from silicosis was higher among workers 
exposed before 1940 (27.4, 20.3–36.1) than among workers exposed after 1940 
(3.98, 0.82–11.6). The corresponding SMR (95% CI) for circulatory disease 
decreased from 0.94 (0.86–1.03) to 0.63 (0.56–0.70) and for IHD from 0.89  
(0.81–0.97) to 0.58 (0.51–0.65). Thus, the decreased quartz exposure resulted in 
decreased mortality from silicosis, circulatory disease and IHD (349). A decreased 
mortality from circulatory disease was also observed among US goldminers. The 
SMRs before 1930 and after 1951 were 0.98 and 0.63, respectively (129). The 
estimated crystalline silica exposure decreased from 0.15 mg/m3 before 1930 to 
0.02 mg/m3 after 1950 (907). 
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The mortality of 13 621 male employees at the iron-ore mines in Malmberget and 
Kiruna, Sweden, was investigated. The cohort comprised men who had been 
employed for at least 1 year 1923–1996 and was followed 1952–2001. There were 
1 477 cases of MI, resulting in an SMR (95% CI) of 1.12 (1.07–1.18). There was a 
positive trend between number of years of underground exposure and mortality of 
MI; exposure for 0–5 years, 5–15 years and > 15 years were associated with SMRs 
(95% CIs) of 1.03 (0.92–1.16), 1.13 (1.01–1.25) and 1.20 (1.08–1.32), respectively 
(98). The content of crystalline silica in the respirable fraction of the dust was 
estimated to 2.5%. There was a positive relationship between cumulative respirable 
silica exposure and mortality (HR, 95% CI) from MI among workers ≤ 60 years of 
age; ≤ 0.9, 0.9–2.5 and > 2.5 mg/m3-years corresponded to HRs of 0.93 (0.71–1.23), 
1.36 (1.01–1.84) and 1.82 (1.33–2.49), respectively (97). In the same cohort, an 
opposite trend was found between years of underground exposure and mortality of 
stroke and CeVD. Exposure for ≥ 15 years was associated with a lower RR (95% 
CI) for both stroke (0.52, 0.29–0.90) and CeVD (0.66, 0.49–0.89) (100).  
In the large cohort comprising 68 241 metal miners as well as pottery workers 
from south central China (described in Section 8.2.3.1) (155), exposure was 
classified as high (mostly from underground open cast or separation jobs), medium, 
low or no dust-exposure. High- or medium-dust exposed workers were compared 
with low/no dust exposed workers. High-exposed workers had an increased 
mortality (RR, 95% CI) due to all heart disease (1.55, 1.3–1.8) and pulmonary heart 
disease (1.93, 1.6–2.4) with significant trends for both outcomes (P < 0.01). There 
was no significant trend regarding mortality (RR, 95% CI) due to IHD for medium 
dust-exposed workers (0.65, 0.3–1.3) and high dust-exposed workers (1.16,  
0.7–1.9) (155). 
A subcohort from the large Chinese cohort (155) consisting of 42 572 workers 
employed at 29 Chinese metal mines and pottery factories for ≥ 1 year 1960–1974 
was followed until 2003 (570). A time-specific JEM was developed using all 
available total dust concentrations to estimate individual silica dust exposure.  
Total dust concentration was converted to a respirable silica concentration by a 
conversion factor (163). Positive cumulative silica exposure-response trends were 
observed for mortality from total heart disease (HRs for increasing quartiles of 
cumulative silica exposure compared with the unexposed group were 0.89, 1.09, 
1.32, 2.10; P for trend < 0.001) and from pulmonary heart disease (0.92, 1.39, 2.47, 
5.46; P for trend < 0.001). After dividing the workers in two groups based on 
lifetime highest silica exposure (> 0.1 mg/m3 and ≤ 0.1 mg/m3, respectively), the 
positive trends remained in both groups. There was also a positive trend for IHD 
among workers with lifetime highest exposure ≤ 0.1 mg/m3 (P for trend < 0.001) 
and those with a cumulative exposure of 0.56–0.87 mg/m3-years had a significantly 
increased risk of IHD mortality (HR 1.52, 95% CI 1.02–2.27) (Table 4) (570). This 
Chinese cohort was further analysed among participants with lifetime highest 
respirable crystalline silica exposure ≤ 0.05 mg/m3. Workers with the highest 
cumulative silica exposure (> 0.67 mg/m3-years) had an increased risk of IHD (HR 
1.89, 95% CI 1.07–3.35) (Table 4) (571). 
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Table 4. Cumulative respirable crystalline silica exposure and hazard ratios (95% CI) 
for mortality from heart disease and silicosis (570, 571). 
Diagnosis Quartiles of cumulative exposure (mg/m3-years) 
 Lifetime highest silica exposure > 0.1 mg/m3 (570) 
 0.04–1.73 1.74–3.80 3.81–7.06 > 7.07 
Total heart 
disease 
0.98 (0.84–1.14) 1.15 (1.00–1.32) 1.63 (1.43–1.85) 2.14 (1.89–2.41) 
Pulmonary  
heart disease  
1.24 (0.95–1.63) 2.03 (1.61–2.55) 3.77 (3.06–4.65) 5.80 (4.75–7.07) 
IHD 1.18 (0.87–1.59) 1.05 (0.78–1.43) 0.90 (0.65–1.24) 0.61 (0.42–0.89) 
Silicosis 1.00 6.31 (4.86–8.21) 15.2 (11.8–19.5) 19.3 (14.9–25.0) 
 Lifetime highest silica exposure ≤ 0.1 mg/m3 (570) 
 0.01–0.33 0.34–0.55 0.56–0.87 > 0.87 
Total heart 
disease 
1.13 (0.85–1.49) 1.12 (0.82–1.53) 1.26 (0.97–1.62) 1.34 (1.04–1.72) 
Pulmonary 
heart disease 
1.46 (0.83–2.58) 1.51 (0.80–2.86) 1.29 (0.72–2.29) 2.40 (1.51–3.83) 
IHD 1.04 (0.63–1.72) 1.13 (0.68–1.90) 1.52 (1.02–2.27) 1.60 (1.07–2.40) 
Silicosis 1.00 0.43 (0.11–1.65) 1.12 (0.44–2.86) 1.60 (0.64–4.01) 
 Lifetime highest silica exposure ≤ 0.05 mg/m3 (571) 
 0.01–0.26 0.27–0.47 0.48–0.67 > 0.67 
Pulmonary  
heart disease  
0.71 (0.23–2.25) 1.64 (0.66–4.09) 1.17 (0.46–2.94) 1.25 (0.54–2.89) 
IHD 0.81 (0.36–1.85) 1.15 (0.55–2.41) 1.61 (0.87–2.97) 1.89 (1.07–3.35) 
CI: confidence interval, IHD: ischaemic heart disease. 
 
Another subgroup of the previous cohort comprising 7 665 workers from one iron 
mine was followed 1960–2012. A relationship was observed between cumulative 
silica exposure and IHD mortality after adjustment for gender, year and age of hire 
and smoking. Exposure to 0.49–0.84 mg/m3-years was associated with an HR for 
IHD of 1.54 (95% CI 1.06–2.23) (527). 
8.2.6 Markers of effect 
An increased plasma concentration of fibrinogen was observed among tunnel 
construction workers after a workshift with a respirable dust exposure of ≤ 2 mg/m3 
(406). Thus, signs of inflammation have been observed in relation to exposure to 
silica, however, the workers were also exposed to diesel exhaust. Furthermore, 
Spanish coal miners with pneumoconiosis had higher plasma levels of fibrinogen 
than coal miners without pneumoconiosis (284). Serum levels of CRP were also 
significantly higher among silicotics than among healthy subjects (185).  
8.2.7 Conclusion 
More than ten studies indicate a relationship between crystalline silica exposure and 
the occurrence of CVD (primarily IHD). No association between exposure and 
CeVD was observed.  
Decreasing quartz exposures resulted in decreased mortalities from silicosis, 
circulatory diseases and IHD in Vermont, Canada (349). A Swedish study showed 
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a positive relationship between cumulative respiratory crystalline silica exposure 
and mortality from MI among workers ≤ 60 years of age (97). Chinese studies 
showed relationships between cumulative crystalline silica exposure and mortality 
from pulmonary heart disease (cor pulmonale) and IHD at lifetime highest silica 
exposures ≤ 0.1 mg/m3 (570, 571). A cumulative silica exposure of 0.56–0.87 
mg/m3-years was associated with an increased IHD mortality (570). This exposure 
corresponds to 0.01–0.02 mg/m3 during a working life of 40 years.  
 
There is strong evidence for an association between exposure to crystalline silica 
and CVD.  
8.3 Man-made vitreous fibres 
8.3.1 General 
Man-made vitreous fibres (MMVF) is a generic name used to describe an inorganic 
fibrous material manufactured primarily from glass, rock, minerals, slag and 
processed inorganic oxides. The produced MMVF are non-crystalline. Other names 
for MMVF include manufactured vitreous fibres, man-made mineral fibres 
(MMMF), machine-made mineral fibres and synthetic vitreous fibres (435).  
8.3.2 Occupational epidemiological studies 
Epidemiological studies and risk estimates are presented in Appendix, Table A14. 
8.3.2.1 Nordic countries 
A Swedish cohort of 2 807 workers employed for at least 1 year before 1972 and 
exposed to MMMF during insulation of prefabricated wooden houses was followed 
for mortality 1969–1988. It was not possible to distinguish exposure to glass wool 
from rock wool since most plants used both types of insulation materials during 
different time periods. Exposure was categorised in the following way: 0) No 
exposure to MMMF; 1) Mean background exposure level of 0.06 (range 0.02–0.08) 
fibres/ml; 2) Work periods with full-time employment in locations where MMMF 
were handled, but without direct handling of MMMF, mean exposure level of 0.09 
(0.05–0.13) fibres/ml; and 3) Work periods with direct handling of MMMF during 
most of the working day associated with a mean exposure level of 0.11 (0.05–0.17) 
fibres/ml. The highest exposure in category 3 occurred 1975–1980 and was 
estimated as 0.20–0.25 fibres/ml. The total cohort had a lower than expected risk 
(SMR, 95% CI) for circulatory disease (0.84, 0.74–0.94), IHD (0.83, 0.72–0.95) 
and CeVD (0.77, 0.55–1.04). There was no clear exposure-response relationship for 
circulatory disease; the exposure categories 0, 1, 2 and 3 had SMRs of 0.77, 0.84, 
0.97 and 0.78, respectively. Nor was there a clear relationship between duration of 
employment and the occurrence of circulatory disease; duration categories < 10 
years, 10–19 years and ≥ 20 years had SMRs of 0.84, 0.91 and 0.75, respectively 
(363).  
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A cohort of 3 539 male and female MMVF production workers from three 
Swedish plants employed for at least 1 year before 1978 was followed for mortality 
1952–1990. National and regional rates were used to calculate expected numbers. 
No increased risks (SMR, 95% CI) of circulatory disease (1.01, 0.91–1.12), IHD 
(0.95, 0.83–1.08) or CeVD (0.96, 0.73–1.24) were observed (753).  
A cohort of 941 workers (616 males and 325 females) in the glass wool producing 
industry in Finland was identified. The group included workers employed in the 
Karhula plant 1941–1952, alive on January 1953, and who were employed at least 
3 months 1953–1977. The period of follow-up was 1953–1981. There were no 
significantly increased mortality regarding circulatory diseases for men (SMR 1.31) 
or women (SMR 0.81) (948) compared to the general population. 
8.3.2.2 Europe (non-Nordic countries) 
The workforces from two factories producing MMMF in England and Northern 
Ireland were followed until 1984. The factory in England produced mainly glass 
wool and the cohort comprised 3 548 men and 1 186 women. The expected 
mortality was calculated using rates from England and Wales. The mortality (SMR, 
95% CI) from circulatory diseases was not increased for males (1.04, 0.92–1.18) or 
females (0.92, 0.65–1.26). The factory in Northern Ireland (Dungannon district 
council area) produced mainly glass yarn from continuous filament and the cohort 
comprised 1 196 men and 714 women. The expected mortality was calculated using 
rates from Northern Ireland. The mortality (SMR, 95% CI) from circulatory 
diseases was not significantly increased for men (1.24, 0.95–1.58) or women (0.68, 
0.27–1.40). Higher mortality from IHD (SMR 1.09) and CeVD (SMR 1.29) was 
observed among men 1979–1981 (327).  
A German factory produced rock wool by a steam-blowing process 1942–1977. 
The exposed cohort of 2 096 male employees was compared with a reference  
cohort comprising 1 778 males selected from workers in cork and styropor panel 
production of the same company. The cohorts were followed until 1979. Mortality 
from circulatory disease was less common among the exposed than among referents 
(RR 0.70, 95% CI 0.51–0.97) (174). Basically the same cohorts of exposed (reduced 
to 2 092 men) and referents (reduced to 1 775 men) were followed until 1982. The 
mortality from circulatory diseases of the exposed workers was compared with 
national rates (SMR 0.90, 95% CI 0.73–1.11) and with the mortality of the referents 
(RR 0.74, 95% CI 0.60–0.92). The referents may have been exposed to coal tar, 
silica, urethane formaldehyde foam and polystyrene as these substances were used 
some time during the production processes. The referents had a higher overall 
mortality (SMR 1.22) and a significantly increased risk for circulatory diseases 
(SMR 1.31) (175).  
A cohort was formed comprising 1 098 male workers from an Italian man-made 
glass-fibre industry producing glass wool and continuous filament. Workers 
employed for at least 1 year 1944–1974 were included and followed 1944–1983. 
The CVD mortality (SMR, 95% CI) was lower than expected when compared with 
both national rates (0.60, 0.37–0.92) and local rates (0.50, 0.31–0.76) (90). 
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8.3.2.3 North America 
A cohort comprised 1 448 white male workers initially employed 1940–1949 in  
one major fibrous glass construction products manufacturing facility. Cohort 
participants were included when they achieved at least 5 years of employment in 
fibrous glass production, packing or maintenance activities. The cohort was 
followed until 1972. Expected deaths were calculated from rates of the general US 
white male population. The number of deaths from diseases of the heart was 163 
(SMR 0.91) and 30 from vascular lesions affecting the CNS (SMR 0.91). The mean 
concentration of fibres was 0.08 fibres/ml. The median diameter and length of the 
fibres was 1.8 µm and 28 µm, respectively (72). 
A cohort comprising 6 536 male employees that had been engaged in fibrous 
glass production for at least 10 years at any time during 1968–1977 was followed 
until 1978. Already in 1968, 4 046 workers were included in the cohort. Lists of 
eligible employees were developed by Owens-Corning Fibreglass from records at 
the company headquarters in Toledo and from records at the manufacturing plants. 
The majority of deceased individuals were white males and it was considered 
appropriate to use US white males as comparison group. The mortality due to 
circulatory diseases was not increased (SMR 0.84, based on 199 cases). The 
corresponding mortality in a subcohort comprising 1 240 workers with 20 years of 
employment and 30 years of latency was similar (SMR 0.73, based on 49 cases) 
(669). The mortality pattern from non-malignant respiratory diseases showed a 
clear healthy worker survivor effect. 
Totally 596 male rock and slag mineral wool production workers were exposed 
at least 1 year 1940–1948 in a Midwestern plant. The cohort was followed until 
1974. The observed number of deaths was compared with the expected number 
derived from the sex, age, race, calendar-time and cause-specific US mortality rates. 
The exposure to fibres was the following: until 1935, 1.2–2.5 fibres/ml; 1935–1948, 
0.5–1.0 fibres/ml; 1948–1967, 0.1–0.3 fibres/ml; 1967–1974, 0.5–0.7 fibres/ml. 
The mortality (SMR, 90% CI) from diseases of the heart among men employed in 
rock and slag mineral wool production and manufacturing was not increased (0.97, 
0.81–1.16). The mortality from heart disease was similar in a subcohort of mineral 
wool production workers (1.03, 0.84–1.24) (785). 
A cohort of 16 661 MMMF workers employed for at least 1 year 1945–1963 at 
one or more of 17 US manufacturing plants were followed until 1982. The cohort 
comprised 14 815 workers from the fibrous glass plants and 1 846 workers from the 
mineral wool plant. At the end of 1982, one third of the cohort had died. Race 
information was unknown for over 30% of the total cohort and of those with known 
race whites constituted over 96%. National white male rates were used to calculate 
the expected number of deaths. In the total follow-up period 1946–1982, there were 
no increased risks regarding all heart disease, IHD and CeVD (SMRs 0.98, 0.99 and 
1.00, respectively). In the later part of the follow-up period, 1979–1982, there was 
an increased risk for CeVD (SMR 1.27, P < 0.05) but not for all heart disease (SMR 
1.06) and IHD (SMR 1.06) (260). This cohort was further followed 1983–1985. In 
the total follow-up period 1946–1985 there were no increased risks for all heart 
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disease (SMR 1.00) and CeVD (SMR 1.01). In the later part of the follow-up period, 
1983–1985, there was an increased risk regarding all heart disease (SMR 1.15, 
P < 0.05) but not regarding CeVD (SMR 1.05) (604). This cohort was expanded to 
comprise 32 110 workers employed for at least 1 year 1945–1978 at any of ten US 
fibreglass manufacturing plants and followed until 1992. In the total follow-up 
period 1946–1992 there were no increased risks (SMR, 95% CI) regarding all heart 
disease (0.92, 0.88–0.95) and CeVD (0.86, 0.79–0.94). A comparison with local 
county rates showed approximately the same results (606). 
Totally 4 008 female fibre glass workers, employed for at least 1 year 1945–1978 
in production areas or maintenance in any of ten US fibreglass manufacturing 
plants, were followed until 1992. A majority of the women were hired in the 1940s 
and 1950s, two thirds were 20–39 years of age at the time of hire. The majority of 
the employed females (57%) worked for less than 5 years in the plants. A decreased 
mortality risk (SMR, 95% CI) of all heart disease (323 fatalities) was observed 
when the cohort was compared with national rates (0.77, 0.69–0.86) and local 
county rates (0.73, 0.65–0.82). Similar decreased mortality risks (SMR, 95% CI) 
were also observed for CeVD (82 fatalities) when the cohort was compared with 
national rates (0.74, 0.59–0.92) and local county rates (0.78, 0.62–0.97) (920). 
Respirable glass fibres (also called Beta fibres) were produced at the Anderson 
plant, South Carolina, US, 1963–1968. Totally 2 933 white male workers who had 
worked for at least 1 year between the start of the plant in 1951 and the end of 1991 
were followed until 1991. The mortality of the cohort was compared with the US 
national rates for white men. The majority of the continuous filament fibreglass 
produced had an average diameter of 10–12 µm or larger. The Beta fibres had an 
average diameter of 3.5 µm. There were no increased risks (SMR, 95% CI) of all 
heart disease (0.84, 0.70–1.00), IHD (0.83, 0.67–1.02) and CeVD (0.97, 0.54–1.60) 
(170). Further cohorts from the same plant included 1 074 white women, 130 non-
white women and 494 non-white men who worked for a minimum of 1 year from 
the opening of the plant in 1951 through 1991. No significantly increased risks of 
all heart disease, IHD and CeVD were reported (994). 
A cohort of 942 male workers with at least 1 year of employment producing 
refractory ceramic fibres in New York and Indiana was followed 1952–2000. The 
cohort comprised 446 former employees who terminated work before 1987 and 496 
currently employed at that time or hired subsequently. In the 1950s, the maximum 
exposure estimate was 10 fibres/ml for carding in textile operation. Subsequent 
improvements reduced the exposure to < 10 fibres/ml. In 1987–1988, the time-
weighted averages (TWAs) were 0.03–0.61 fibres/ml for dry fabrication, 0.01–0.27 
fibres/ml for wet fabrication, 0.01–0.47 fibres/ml for furnace operations and  
0.02–0.62 fibres/ml for maintenance. Subsequently, exposure levels remained 
relatively stable. The mortality of the cohort was compared with the US national 
rates and death rates between ethnic groups were analysed separately. There were 
no increased risks (SMR, 95% CI) for diseases of the heart (0.73, 0.48–1.06), IHD 
(0.85, 0.54–1.28) and CeVD (0.43 based on 2 cases) (552). 
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A cohort of 2 557 male insulating glass wool plant workers from Sarnia, Ontario, 
Canada, who had worked at least 90 days 1955–1977, was followed until 1984 and 
the mortality was compared with rates from Ontario. The total cohort was divided 
in three groups; those who had worked in the plant only; those who had worked in 
the office only; and those who had worked in both places. The mortality (SMR) 
from IHD was not increased in any of the three groups; for plant-only workers  
0.82 (based on 38 cases); for office-only workers 0.81 (based on 4 cases); and for 
plant-office workers 1.29 (based on 8 cases). CeVD mortality only occurred among 
plant-only workers (SMR 1.32, based on 10 cases) (860). The cohort was further 
followed until 1997. There was no increased mortality (SMR, 95% CI) of IHD 
(0.81, 0.63–1.02) or CeVD (0.91, 0.50–1.52) among plant-only workers (858).  
A cohort comprised 1 465 male and female glass filament producing workers 
from a Canadian plant in Guelph, Ontario. Workers who had worked at least 1 year 
1951–1986 were included in the cohort. Mortality was compared with that of the 
general population of Ontario. The TWAs of exposure were 0.02–0.05 fibres/ml 
with the highest value observed being 0.91 fibres/ml. The mortality (SMR) for 
circulatory disease was decreased for males (0.65, P < 0.05, based on 29 cases) and 
slightly increased for females (1.89, P = 0.07, based on 8 cases) (859).  
8.3.3 Pooled analyses 
A European cohort comprised totally 21 967 MMMF-production workers (18 753 
males and 3 214 females) from 13 plants in 7 countries including Denmark, Finland, 
Norway, Sweden, the United Kingdom, Germany and Italy. The rock wool – slag 
wool cohort contained 10 115 workers, the glass wool cohort contained 8 286 
workers and the continuous filament cohort contained 3 566 workers. The cohort 
was followed until 1982 and the mortality reference rates were computed from  
the WHO mortality data bank. No increased mortality risks (SMR, 95% CI)  
were observed for diseases of the circulatory system (1.00, 0.94–1.07), IHD (1.03, 
0.96–1.11) and CeVD (0.88, 0.75–1.02) (869, 870).  
A European cohort of totally 11 373 male MMVF-production workers from  
13 plants in 7 countries (same as above) who had worked at least 1 year during 
1933–1977 was followed until 1990–1992. The mortality reference rates were 
computed from the WHO mortality data bank. Seven factories produced rock  
or slag wool, five factories produced glass wool, and two factories produced 
continuous filament. Mortality from IHD (SMR, 95% CI) was increased for 
continuous filament workers (1.43, 1.06–1.88) but not for rock or slag wool workers 
(0.97, 0.87–1.08) or glass wool workers (1.05, 0.95–1.15). A higher mortality of 
IHD (SMR, 95% CI) was found among glass wool workers (1.20, 1.06–1.35) and 
continuous filament workers (1.58, 1.13–2.14) from the UK. However, when 
adjusting for local variation in IHD mortality by applying the ratio of local versus 
national mortalities to expected deaths, the SMR in the UK glass wool worker 
subcohort decreased to 1.03 (0.91–1.16). In internal analyses, rock or slag wool and 
continuous filament workers with ≥ 30 years since first employment had a higher 
risk from IHD than workers with < 30 years since first employment. On the other 
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hand, analysis by duration of employment suggested a decreasing risk among rock 
or slag wool workers with increasing duration. Glass wool workers employed in the 
early technological phase (with presumed higher fibre concentrations) had an 
increased mortality from IHD (RR 1.6, 95% CI 1.0–2.5) compared with workers 
employed in the late phase. This trend was stronger among glass wool workers from 
the largest UK factory than among other factories. No excess mortality from CeVD 
was reported for type of production, country or technological phase (822). 
8.3.4 Conclusion 
In 14 cohort studies of workers exposed to MMVF, there were generally no 
increased risks of CVD when the mortality of exposed workers was compared with 
national or regional reference rates. In one US cohort, an increased mortality was 
found regarding CeVD (260) and heart disease (604) in later parts of the follow-up 
periods. In a joint European cohort comprising 11 373 male production workers, an 
increased risk from IHD was found among workers exposed to continuous filaments 
(822). A higher IHD mortality was found among glass wool workers and continuous 
filament workers from the UK (822). 
 
There is insufficient evidence for an association between exposure to man-made 
vitreous fibres and CVD.  
8.4 Carbon nanotubes 
8.4.1 General 
The toxicity of carbon nanotubes (CNTs) was evaluated by NEG in 2013 (395). 
CNTs can be seen as graphene sheets rolled to form cylinders and may be 
categorised as single- (SWCNT) or multi-walled (MWCNT). Due to the small size, 
the number of particles as well as the surface area per mass unit are extremely high. 
CNTs are highly diverse, differing with respect to e.g. diameter, length, chiral 
angles, chemical functionalisation, purity, stiffness and bulk density. Today, CNTs 
are utilised primarily for the reinforcement of composite polymers, but there is 
considerable potential for other applications. The rapidly growing production and 
use of CNTs increases the risk for occupational exposure. CNTs may be absorbed 
via inhalation and ingestion. Since CNTs in bulk form are of very low density and 
much dust is produced during their handling, exposure by inhalation appears to 
represent the greatest potential risk in the workplace (395).  
8.4.2 Animal studies 
Both SWCNTs and MWCNTs cause inflammation and fibrosis in the lungs of 
animals. Mild granulomatous inflammation in the lungs and lung-draining lymph 
nodes have been observed in rats exposed for 13 weeks to 0.1 mg/m3 MWCNTs 
(LOAEC), with more pronounced inflammation in both mice and rats at higher 
exposures. Thus, inflammatory responses in the lungs may be considered as the 
critical effect (395). In addition, intratracheal and intrapharyngeal instillation  
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of CNTs led to accelerated plaque progression directly (143, 562), or indirectly 
through an induced acute phase response (757).  
8.4.3 Occupational epidemiological studies 
In a cross-sectional study, 22 workers in a company producing MWCNTs were 
compared with 42 gender- and age-matched unexposed participants. An upward 
trend was observed in the endothelial damage marker ICAM-1, indicating 
endothelial activation and an increased inflammatory state in workers exposed to 
MWCNTs. No consistent significant associations were found for 11 other cardio-
vascular markers (520). A similar group of 24 exposed workers and 43 controls 
from principally the same study base as above (520) was investigated regarding 
epigenetic alterations in blood cells. No difference in global methylation of the 
genomic DNA was observed but some significant changes in methylation of some 
sites in promoter regions were observed in the MWCNT-exposed group (334). 
A cross-sectional study was performed among 108 workers at 12 US facilities 
using CNTs and nanofibres. Some statistically significant positive associations 
were reported. Systolic blood pressure was associated with exposure to fine 
particulate matter. Resting heart rate was associated with the concentration of EC, 
both the respirable and inhalable size fractions. Haematocrit was associated with 
the logarithmic mass concentration of CNTs, and nanofibre counts. However, most 
health outcomes were not associated with exposure measures. The authors 
concluded that the associations between exposure and resting heart rate and 
haematocrit counts may not be causal and require examination in other studies 
(843). 
The industrial use of CNTs is rather new. Prospective long-term studies including 
occupationally exposed workers were not located. 
8.4.4 Conclusion 
No prospective long-term studies including occupationally exposed workers were 
located. A small cross-sectional study in the MWCNT production industry 
indicated endothelial damage and increased inflammation (520). Another cross-
sectional study indicated effects on blood pressure, resting heart rate and 
haematocrit (843). Mechanistic and animal studies showed evidence for athero-
sclerotic effects of CNTs (143, 562, 757).  
 
There is insufficient evidence for an association between exposure to carbon 
nanotubes and CVD.  
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9. Metals 
9.1 Aluminium  
9.1.1 General  
Aluminium is the third most common element in the earth’s crust and is found in 
several minerals such as feldspars, micas, cryolite and bauxite. Bauxite is the main 
raw material for aluminium production (517). Metallic aluminium is produced from 
bauxite in two stages. First alumina (Al2O3) is extracted from bauxite by a chemical 
process (Bayer process) followed by an electrolytic process; electrolytic aluminium 
production is described in Section 7.2. The present section covers health effects of 
exposure to alumina and aluminium powder (particulate aluminium).  
9.1.2 Occupational epidemiological studies 
In a cohort, comprising 5 770 male Australian bauxite miners and alumina refinery 
workers, there was an association between ever alumina exposure and mortality 
(RR, 95% CI) from CeVD based on 10 deaths (3.8, 1.1–13), but not from CVD (1.1, 
0.7–1.8). There was some evidence of a relationship between cumulative alumina 
exposure and mortality from CeVD (P for trend 0.04) (314). 
9.1.3 Exposure-response relationships 
Australian gold miners who inhaled aluminium powder in order to prevent silicosis 
had a slightly increased CVD mortality compared to other gold miners (HR 1.02 
per year of exposure, 95% CI 1.00–1.04). The authors remarked that duration of 
aluminium dust inhalation may not have been accurately assessed for all miners and 
observed trends were questionable. The actual exposure levels may have been lower 
given the aversion of the miners to the aluminium therapy. On the other hand, the 
comparison between miners ever and never exposed to aluminium dust was 
probably more reliable (HR 1.19, 95% CI% 0.99–1.44) (742). 
9.1.4 Conclusion  
The two epidemiological studies on aluminium exposed workers that were located 
showed increased risks of CeVD (alumina) (314) and CVD (aluminium powder) 
(742), respectively. 
 
There is insufficient evidence for an association between exposure to particulate 
aluminium and CVD.  
9.2 Arsenic 
9.2.1 General 
Arsenic (As) is a grey, crystalline solid with metallic lustre. Arsenic compounds are 
hygroscopic crystalline or amorphous substances, which occur in trivalent and 
pentavalent forms. Arsenic trioxide is the major arsenic compound regarding 
occupational exposures (304). 
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The most common sources of exposure to arsenic are contaminated drinking 
water and occupational exposure among primary copper smelter workers. CVD is 
one of several important outcomes of arsenic exposure and comprises peripheral 
vascular disease including blackfoot disease, IHD, stroke and hypertension (304). 
In 1900, an epidemic of a multisystem disease occurred in the Manchester area 
in England, with over 6 000 cases and more than 70 deaths. This epidemic has been 
described as the first metal-induced cardiotoxic syndrome produced by intake of 
beer contaminated with arsenic (16). The syndrome included the usual signs and 
symptoms of arsenic poisoning and an unusual but prominent aspect in this 
epidemic was heart failure. The source of arsenic was contaminated sulphuric acid 
which was used to treat cane sugar. It was observed that some persons seemed to 
have a “peculiar idiosyncrasy” and “that many persons became ill who drank less 
beer than others who were not affected”. The conclusion was drawn that arsenic 
predisposed susceptible persons develop alcoholic cardiomyopathy (497). Arsenic 
intoxication was associated with atypical ventricular tachycardia (346). 
Epidemiological studies and risk estimates are presented in Appendix, Table A15. 
9.2.2 Animal studies  
Mice treated orally with sodium arsenite (NaAsO2) for 2 days developed increased 
lipid peroxidation and abnormal ultra-structural changes in the cardiac tissue (600). 
9.2.3 Occupational epidemiological studies  
A Finnish cohort consisted of men who were in the same occupation in 1975 and 
1980 and were 25–64 years old in 1980. CVD mortality was followed 1981–1994. 
Information on marital status, education and income was updated in 1985 and 1990. 
Working conditions were evaluated from a JEM comprising three categories of 
arsenic exposure: unexposed, low-exposed (three lowest quartiles of the exposed) 
and high-exposed (top quartile of the exposed). A fully adjusted Poisson regression 
model was applied which included age, period, marital status, professional status, 
education, income, occupational class and category, and working conditions. The 
top quartile was compared with the lower exposed and unexposed workers. The 
resulting RR for CeVD mortality was 1.04 (95% CI 0.75–1.45) (1031). 
Low levels of arsenic are common in copper ore all over the world and primary 
copper smelter workers are exposed to arsenic but also to several other compounds 
like silica dust and sulphur dioxide (543).  
A case-control study from a Swedish primary copper smelter demonstrated a 
significantly increased mortality from CVD. There was also a significant exposure-
response relationship over increasing categories of arsenic exposure (56). A cohort 
of 3 916 male smelter workers from the same smelter showed a non-significantly 
increased mortality from IHD (SMR 1.07, 95% CI 0.97–1.17), but there was no 
exposure-response relationship (471). 
A cohort of 8 047 white male workers from copper smelters in US Montana 
exposed to arsenic trioxide was followed until 1963. An increased mortality from 
heart disease compared with regional rates was observed (SMR 1.18, P < 0.01). 
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However, these smelter workers were also exposed to sulphur dioxide, silica and 
some of them also to lead (543). A subcohort of 1 800 men from the same smelter 
was followed until 1978. Ceiling exposure was based on the highest arsenic 
exposure category in which a man had spent at least 30 days. In the group with high 
ceiling exposure (0.5–4.9 mg/m3), an increased SMR was found for IHD (1.59, 
P < 0.01), and in the group with very high ceiling exposure (≥ 5.0 mg/m3) the SMR 
was higher (1.71, P < 0.01). There was also an increased risk for IHD (SMR 1.31, 
P < 0.05) among smokers exposed to TWAs below 0.1 mg/m3 (1004). The total 
cohort now consisting of 8 045 arsenic exposed copper smelter workers, further 
followed until 1977, also had an increased mortality from heart disease (542). The 
cohort was further followed through 1990 with confounding control using para-
metric g-formula and the result indicated an exposure-response relationship (484). 
Totally 2 802 white males were included in a cohort of US copper smelter 
workers in Tacoma, Washington. After adjustment for the healthy worker survivor 
effect, a significant increased mortality from CVD (RR 1.7, 95% CI 1.1–2.6) was 
observed after high cumulative exposure to arsenic (≥ 20 mg/m3-years). After 
applying a 20-year lag, a cumulative exposure of 4–8 mg/m3-years was associated 
with an increased CVD mortality (RR 1.5, 95% CI 1.1–2.1) (402).  
9.2.4 Meta-analyses of epidemiological studies of the general population  
A meta-analysis of environmental arsenic exposure included seven studies on CVD, 
eight studies on CHD and four on stroke. CHD was defined as non-fatal MI, angina, 
coronary revascularisation (i.e. percutaneous transluminal coronary angioplasty or 
coronary artery bypass surgery) or CHD death. Stroke comprised both fatal and 
non-fatal stroke. Subjects were divided in three exposure groups using data on 
drinking water, toenails and urine. Comparisons of outcomes were made between 
the highest and lowest exposure group. Risk estimates from separate studies were 
typically adjusted for basic demographics e.g. age, sex, systolic blood pressure, 
smoking and history of diabetes. The calculated RR (95% CI) was 1.30 (1.04–1.63) 
for CVD, 1.23 (1.04–1.45) for CHD and 1.15 (0.92–1.43) for stroke (172). 
9.2.5 Pooled analyses of epidemiological studies of the general population 
Several types of studies were included in a pooled analysis of groups exposed to 
arsenic in drinking water. In studies with multiple exposure categories, comparisons 
were made between high (> 50 µg/l) and low (< 50 µg/l) arsenic levels. The pooled 
RRs (95% CIs) for CVD, CHD, stroke, and peripheral arterial disease were 1.32 
(1.05–1.67), 1.89 (1.33–2.69), 1.08 (0.98–1.19) and 2.17 (1.47–3.20), respectively 
(663).  
In an analysis 5 years later, pooled log-linear and non-linear RRs for each end-
point were estimated for drinking water arsenic concentrations of 20, 50, 100 and 
200 µg/l, using 10 µg/l as reference. There were significant trends regarding arsenic 
concentrations and incidence and mortality of CVD and CHD in the log-linear 
model. The resulting RRs (95% CIs) for 20 µg/l were 1.09 (1.03–1.14) for  
CVD incidence, 1.07 (1.01–1.14) for CVD mortality, 1.11 (1.05–1.17) for CHD 
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incidence, 1.16 (1.07–1.26) for CHD mortality, 1.08 (1.00–1.17) for stroke 
incidence and 1.06 (0.93–1.20) for stroke mortality (664, 665). 
9.2.6 Markers of effect 
Available data suggest that arsenic causes a range of effects related to oxidative 
stress and vascular inflammation. Findings from mechanistic studies suggest that 
arsenic causes inflammation in vascular tissues and activates oxidative signalling 
(17). In individuals with arsenic-related skin lesions in Bangladesh, plasma levels 
of systemic inflammation and endothelial dysfunction markers (such as the soluble 
intercellular and soluble vascular cell adhesion molecules, ICAM-1 and VCAM-1) 
were positively associated with serum arsenic concentrations (166). 
9.2.7 Previous evaluations 
In 2011, WHO evaluated the relationship between long-term exposure to arsenic in 
drinking water and CVD (e.g. blackfoot disease, CHD, peripheral arterial disease, 
MI, stroke, and other cardiovascular endpoints such as increased blood pressure and 
prolonged QT interval of the ECG). An association between blackfoot disease and 
inorganic arsenic exposure had been confirmed by many studies, but the disease  
has been reported primarily in an area along the south-western coast of Taiwan, 
China, where arsenic contamination in well water is very high (170–880 μg/l). 
Except for blackfoot disease, however, reported associations between inorganic 
arsenic exposure and CVD and other cardiovascular endpoints currently were not 
considered sufficient evidence of causality and were not considered pivotal for the 
assessment (1013).  
9.2.8 Conclusion 
Several studies on arsenic exposed workers were found (overlapping cohorts), some 
of which showing an increased risk of CVD. An occupational cumulative arsenic 
exposure of 4–8 mg/m3-years was associated with an increased mortality from CVD 
(402), which corresponds to 0.1–0.2 mg/m3 arsenic during 40 years.  
A meta-analysis showed an increased risk of CVD from environmental exposure 
(172). In a pooled analysis, 20 µg/l of arsenic in drinking water was associated with 
increased incidence and mortality from CVD (664, 665). Consumption of beer 
contaminated with arsenic has been associated with cardiomyopathy (16, 497). 
Mechanistic data of oxidative stress and vascular inflammation from arsenic 
exposure provide further support for a link with CVD (17, 166). 
 
There is strong evidence for an association between exposure to arsenic and 
CVD. 
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9.3 Beryllium 
9.3.1 General  
Beryllium is a steel-grey, shiny, hard and brittle metal. Beryllium is the lightest of 
all solid and chemically stable substances. It is lighter than aluminium, harder than 
steel and the melting point is unusually high (1 278 °C). Beryllium is found in rocks, 
coal, soil and volcanic dust. The overall market volume of beryllium is relatively 
small. Total world production of beryllium in 2008 was about 200 tonnes. Due to 
its unique combination of physico-chemical properties it is used in many specific 
industrial applications, such as medical diagnostics, nuclear fusion reactors, and 
aerospace applications where lightweight structures are required which are resistant 
to deformation under high stresses or high temperatures (848). 
9.3.2 Occupational epidemiological studies 
Some US cohort studies of beryllium exposed workers have reported heart diseases 
as an outcome. An early US cohort of 3 055 white male beryllium exposed workers 
employed in the Reading and Lorain plants sometime between 1942 and 1968 were 
followed until 1975. An increased risk of heart disease was observed (SMR 1.13, 
P < 0.05). Mortality due to heart disease differed between workers employed before 
1950 (SMR 1.16, P < 0.05) and workers employed after 1950 (SMR 0.92). This 
decrease in mortality was similar to that due to non-neoplastic respiratory disease 
observed during the same period. The risk (SMR) regarding heart disease was 1.29 
for workers exposed for > 5 years and 1.10 for workers exposed for < 5 years. 
Smoking habits was an unlikely cause of these increased risk estimates (978). It was 
estimated that air concentrations of beryllium in the 1940s frequently exceeded 
1 mg/m3 in these facilities (992). 
A US cohort comprising 9 225 males who had worked between 1940 and 1969 
was followed until 1988. The cohort members had worked in plants engaged in 
beryllium processing, including extraction of beryllium hydroxide from beryl ore, 
and production of beryllium oxide, pure beryllium metal, and beryllium copper 
alloy and machining of beryllium-containing products. Mortality from IHD was 
significantly increased in the total cohort (SMR 1.08, 95% CI 1.01–1.14). The 
Reading plant had a great impact on this result as it had an SMR of 1.12 (P < 0.01), 
whereas many of the other plants had SMRs around 1.0. Mortality from diseases of 
the arteries, veins and pulmonary circulation which includes cor pulmonale was 
increased only in the Lorain plant (SMR 1.78, P < 0.05) (992). The cohort was 
updated with quantitative exposure estimates and 9 199 workers were followed until 
December 2005. An increased mortality from cor pulmonale was reported (SMR 
1.17, 95% CI 1.08–1.26). No risk estimate of mortality from IHD was reported 
(842). 
9.3.3 Markers of effect 
Chronic beryllium exposure may stimulate the acquired immune response to release 
mediators of chronic inflammation in the lung involving cellular and molecular 
components of innate immunity. This vicious cycle driven by beryllium results in 
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progressive impairment of lung function, granuloma formation and progression to 
lung fibrosis, berylliosis (832). 
9.3.4 Exposure-response relationships  
In the US cohort comprising 9 199 workers, three out of seven plants had air 
measurements of beryllium. The diagnosis cor pulmonale was included among 
diseases of the arteries, veins and pulmonary circulation and caused most of the 
deaths within the category. There was a positive relationship between maximum 
daily weighted average beryllium exposure and diseases of the arteries, veins and 
pulmonary circulation. The highest (≥ 70 µg/m3) and second highest (25– < 70 
µg/m3) exposure categories were associated with risk estimates (SMR, 95% CI) of 
1.52 (1.23–1.85) and 1.31 (1.09–1.58), respectively, based on comparisons with the 
US population (842). 
9.3.5 Conclusion  
Few cohort studies were located. One of these demonstrated a marginal increase in 
IHD mortality (992). In an update of the same cohort, an increased mortality from 
diseases of the arteries, veins and pulmonary circulation (cor pulmonale) was 
observed at beryllium concentrations of 25– < 70 and ≥ 70 µg/m3 (842).  
 
There is limited evidence for an association between exposure to beryllium and 
pulmonary heart disease (cor pulmonale). 
9.4 Cadmium 
9.4.1 General  
Cadmium is widely spread in the environment. Human exposure occurs by 
ingestion of food contaminated with cadmium, by smoking and in certain industrial 
settings. Smokers have approximately twice the body burden of cadmium compared 
to non-smokers. In non-smokers, the primary source of exposure is food (322). 
Regarding the effect of tobacco smoke on CVD, attempts have been made to discern 
the contribution from cadmium. It has been estimated that for the sum of acute MI, 
bypass grafts and percutaneous coronary intervention, and death in IHD, about half 
of the increased risk in current smokers was mediated via cadmium (560). 
Exposure to cadmium has been associated with diseases of the cardiovascular 
system, bone, kidneys and lungs. The effects on the cardiovascular system have 
been suggested to be a result of the action on the cardiovascular endothelium and 
smooth muscle, mediated by generation of a proinflammatory state, endothelium 
dysfunction, increased oxidative stress, and down-regulation of the nitric oxide 
production (10, 17). 
Epidemiological studies and risk estimates are presented in Appendix, Table 
A16. 
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9.4.2 Occupational epidemiological studies  
In a mortality study, 869 Swedish battery workers exposed to nickel hydroxide and 
cadmium oxide (employed at least 1 year 1940–1980) were followed up until 1992. 
Compared with the general population, the SMRs (95% CIs) for IHD were 1.16 
(0.96–1.40) in males and 0.75 (0.25–1.76) in females, and those for CeVD were 
0.78 (0.47–1.21) in males and 1.34 (0.37–3.43) in females, after adjusting for 
smoking habits (470). 
A Finnish cohort of men who were in the same occupation in 1975 and 1980 and 
were 25–64 years old in 1980 was followed for mortality 1981–1994. Information 
on marital status, education and income was updated in 1985 and 1990. Working 
conditions were evaluated from a JEM. A fully adjusted Poisson regression model 
was applied which included age, period, marital status, professional status, 
education, income, occupational class and category, and working conditions.  
The RRs (95% CIs) for cadmium-exposed workers compared with unexposed 
workers were 1.01 (0.93–1.10) for CVD mortality and 1.07 (0.91–1.24) for CeVD 
mortality (1031).  
In a cohort from the UK, almost 7 000 male cadmium-exposed workers from five 
industries (primary production, copper-cadmium alloys, silver-cadmium alloys, 
pigments and oxide and stabilisers) who were exposed for more than 1 year during 
1942–1970 were followed for mortality to the end of 1984. Compared to the general 
population there was no significant excess of death due to hypertensive disease 
(SMR 1.19, 95% CI 0.85–1.52) and the mortality from CeVD was significantly 
lower than expected (SMR 0.77, 95 % CI 0.66–0.89) (483).  
The mortality of 347 male copper-cadmium alloy workers in the UK (first 
employed 1922–1978 and for at least 1 year) was investigated during the period 
1946–1992. Compared to the general population there was no excess of mortality 
from diseases of the circulatory system (SMR 1.03, 95% CI 0.83–1.27) (896). 
A cohort of 1 462 male workers at a UK tin smelter (employed for at least 1 year 
1967–1995) was followed through 2001. Mortality (SMR, 95% CI) from diseases 
of the circulatory system showed a deficit compared to the national population 
(0.96, 0.82–1.11) and to the regional population (0.94, 0.80–1.09). Similar results 
were found for IHD, CeVD and hypertensive diseases (94). 
A US cohort of 2 422 male workers (employed ≥ 3 years 1946–1996) exposed to 
arsenic, cadmium and other substances at a copper mine and smelter in Copperhill, 
Tennessee was followed-up through 2000. Based on national and local county 
comparisons there was no evidence of an increased mortality risk from CeVD, all 
heart disease or hypertension (605). 
9.4.3 Epidemiological studies of the general population  
In a cohort of 64-year-old Swedish women, cadmium levels in blood and urine were 
associated with the prevalence and future growth of atherosclerotic plaques in the 
carotid arteries (275), and with low ankle-brachial index as a measure of peripheral 
artery disease (276), after adjusting for smoking and other cardiovascular risk 
factors. 
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A prospective, population-based cohort study in the city of Malmö, Sweden, 
showed that blood cadmium levels were associated with increased incidence of 
heart failure. The HR (95% CI; 4th vs 1st quartile) was 2.64 (1.60–4.36) adjusted for 
age and 1.95 (1.02–3.71) after adjustment also for an extensive set of risk factors 
and biomarkers related to CVD. The blood cadmium level was not significantly 
associated with risk of incident atrial fibrillation (120). 
Another study based on the same cohort showed an association between blood 
cadmium levels and incidence of several cardiovascular outcomes such as acute 
coronary event, acute MI, any stroke and ischaemic stroke as well as CVD 
mortality. An increased HR for all these outcomes was noted for participants in the 
highest quartile of blood cadmium levels (0.50–5.1 μg/l) compared with the first 
quartile (< 0.17 μg/l). An increased incidence of major adverse cardiac event was 
found also for participants in the third quartile of blood cadmium levels (0.26–0.50 
μg/l). When the cohort was restricted to never-smokers, the same outcome was seen 
only for subjects in the highest quartile (0.50–5.1 μg/l), based on 8 cases (63). 
Based on the same cohort, an association was observed between blood cadmium 
levels and incidence of ischaemic stroke, both independently and in interaction with 
carotid plaques. The HR (95% CI; 4th vs 1st quartile) was 1.91 (1.33–2.74) when 
adjusted for age and sex, and 1.66 (1.01–2.72) when adjusted for additional risk 
factors (121).  
In a Belgian study, 480 subjects from a cadmium-contaminated area and 476 
subjects from a reference area with lower cadmium levels were randomly recruited. 
The subjects were followed by monitoring of blood cadmium (1985–2003), urinary 
cadmium (1985–1996) and mortality (1985–2007). At baseline, blood cadmium 
(14.6 vs 10.2 nmol/l) and urinary cadmium (14.1 vs 8.6 nmol/24-hour) levels were 
higher in deceased than in survivors. The risk (HR, 95% CI) for CVD mortality 
associated with a doubling of baseline blood cadmium was 1.20 (0.90–1.60).  
The corresponding risk associated with a doubling of urinary cadmium was 1.07 
(0.85–1.34). After adding 42 smelter workers to the study base, the calculated HRs 
(95% CI) for CVD were 1.29 (0.99–1.67) for a doubling of blood cadmium levels 
and 1.11 (0.89–1.38) for a doubling of urine cadmium levels (699).  
Blood cadmium levels were associated with an increased prevalence of peripheral 
arterial disease (defined as a blood pressure ankle brachial index < 0.9 in at least 
one leg) in a representative sample (cross-sectional analysis) of the general US 
population (696). A strong positive association between urinary cadmium levels 
and peripheral arterial disease were seen in the same population. After multivariate 
adjustment (age, sex, race, education level and smoking status), subjects with 
peripheral arterial disease had 36% higher urinary cadmium levels than subjects 
without the disease (697). The results support a possible role for cadmium in 
atherosclerosis. 
In another cross-sectional study of US adults (National Health and Nutrition 
Examination Survey, NHANES, 1999–2004), cadmium levels in blood, but not in 
urine, were associated with a modest elevation in blood pressure levels. The average 
differences in systolic and diastolic blood pressure, comparing participants in the 
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90th and 10th percentile of the blood cadmium distribution, were 1.36 mmHg (95% 
CI -0.28–3.00) and 1.68 mmHg (0.57–2.78), respectively. There was no association 
between cadmium levels and the prevalence of hypertension (945). 
A cross-sectional sample of 4 912 participants 45–79 years old in the US 
NHANES III 1988–1994 was included in a study of MI. In logistic regressions by 
gender, only women showed a significant association between urinary cadmium 
levels and MI. Women with urinary cadmium levels ≥ 0.88 µg/g creatinine showed 
an OR of 1.80 (95% CI 1.06–3.04) compared to women with urinary cadmium 
levels < 0.43 µg/g creatinine. When the analysis was restricted to never-smokers 
(n = 2 187 men and women), subjects with urinary cadmium levels ≥ 0.88 µg/g 
creatinine had an OR for MI of 1.85 (95% CI 1.10–3.14) compared to never-
smokers with urinary cadmium levels < 0.43 µg/g creatinine (272). 
Cadmium levels in blood and urine in the general US population (NHANES 
1999–2006) were positively associated with the risk of having a history of stroke or 
heart failure. Those with a history of stroke and heart failure had mean blood 
cadmium levels of 5.1 and 5.0 nmol/l compared to 3.8 nmol/l among those without 
disease. Corresponding urinary levels were 3.7 and 4.0 versus 2.6 nmol/l. After 
adjusting for demographic and cardiovascular risk factors, a 50% increase in blood 
cadmium corresponded to a 35% increased odds of a history of stroke (OR 1.35, 
95% CI 1.12–1.65) and a 48% increased odds for history of heart failure (OR 1.48, 
95% CI 1.17–1.87). A 50% increase in urinary cadmium corresponded to a 9% 
increase in odds for history of stroke (OR 1.09, 95% CI 1.00–1.19) and a 12% 
increase in odds for history of hypertension (OR 1.12, 95% CI 1.03–1.20) (741). 
A prospective study of US adults (NHANES 1999–2004, 8 989 participants ≥ 20 
years of age) showed that cadmium levels in blood and urine were associated with 
future CVD mortality, heart disease mortality, and for cadmium levels in urine also 
with IHD mortality, after adjusting for sociodemographic and cardiovascular risk 
factors, including smoking status, recent smoking dose and cumulative smoking 
dose. The adjusted HRs (95% CIs) for mortality, comparing the 80th and the  
20th percentiles of blood cadmium level distributions were 1.69 (1.03–2.77)  
for CVD, 1.98 (1.11–3.54) for heart disease and 1.73 (0.88–3.40) for IHD. 
Corresponding adjusted HRs (95% CIs) for urinary cadmium level distributions 
were 1.74 (1.07–2.83), 2.53 (1.54–4.16) and 2.09 (1.06–4.13). The population 
attributable risks for CVD mortality associated with having concentrations above 
the 80th percentile of the blood (0.80 µg/l) and urine (0.57 µg/g creatinine) cadmium 
distributions were 7.5% and 9.2%, respectively (946). 
A prospective cohort study of 3 348 American Indian adults 45–74 years of age 
showed that urine cadmium was associated with increased mortality and incidence 
of CVD. After adjusting for sociodemographic and cardiovascular risk factors, the 
HRs (95% CIs; 80th vs 20th percentile of urine cadmium concentrations) were 1.43 
(1.21–1.70) and 1.34 (1.10–1.63) for CVD and CHD mortality, respectively. The 
corresponding HRs for incident CVD, CHD, stroke, and heart failure were 1.24 
(1.11–1.38), 1.22 (1.08–1.38), 1.75 (1.17–2.59) and 1.39 (1.01–1.94), respectively 
(943).  
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A 15-year follow-up study among inhabitants of a cadmium-polluted area 
(Kakehashi River basin) in Japan showed that the mortality from heart failure was 
higher among subjects with high urinary cadmium (≥ 10 µg/g creatinine) than 
among those with moderate urinary cadmium (< 10 µg/g creatinine) levels, in both 
sexes after adjustment for age (690).  
Another follow-up study among the inhabitants living in the cadmium-polluted 
area Kakehashi River basin in Japan was performed. An excess mortality due to 
heart failure and cerebral infarction in both sexes was shown, and nephritis and 
nephrosis in men with renal tubular dysfunction (urinary β2-microglobulin > 1 000 
µg/g creatinine). A significant increase in mortality risk for cerebral infarction in 
men was observed during the first 5-year observation period. The mortality risk for 
heart failure and cerebral infarction increased in proportion to the increased urinary 
β2-microglobulin levels in both sexes (709).  
A cross-sectional study (Korean NHANES 2008–2010) comprised 5 919 adults 
≥ 20 years of age. A 2-fold increase in blood cadmium was associated with 0.76 
and 1.01 mmHg increases in diastolic blood pressure in women and men, 
respectively. Increases of 2.24 and 1.98 mmHg in diastolic pressure in women and 
men, respectively, were observed when the highest quartile was compared with the 
lowest quartile of blood cadmium. Effects on systolic blood pressure were similar 
to those on diastolic pressure. Doubling of blood cadmium resulted in 18.6% and 
31.5% increases in the risk of hypertension in women and men, respectively (545). 
9.4.4 Meta-analyses of epidemiological studies of the general population 
A meta-analysis of environmental cadmium exposure included in total eight studies, 
whereof six studies on CVD, five studies on CHD and three studies on stroke. CVD 
included CHD and stroke. CHD was defined as non-fatal MI, angina, coronary 
revascularisation (i.e. percutaneous transluminal coronary angioplasty or coronary 
artery bypass surgery) or CHD death. Stroke comprised both fatal and non-fatal 
stroke. Subjects were divided in three exposure groups using data on blood and 
urine cadmium concentrations. Comparisons of outcomes were made between the 
highest and lowest exposure groups. Risk estimates from separate studies were 
typically adjusted for basic demographics, e.g. age, sex, systolic blood pressure, 
lipids, smoking and history of diabetes. The calculated RRs (95% CIs) were 1.33 
(1.09–1.64) for CVD, 1.29 (0.98–1.71) for CHD, and 1.72 (1.29–2.28) for stroke. 
There was a linear dose-response relationship between cadmium levels and CVD 
(172). 
9.4.5 Pooled analyses 
In a systematic review by Tellez-Plaza et al., the authors concluded that their pooled 
analysis (12 studies included) together with experimental evidence supported an 
association between cadmium exposure and CVD, especially CHD. The number  
of studies with stroke, heart failure and peripheral artery disease endpoints was 
small. Overall, the pooled RRs (95% CIs) for CVD, CHD, stroke and peripheral 
artery disease were 1.36 (1.11–1.66), 1.30 (1.12–1.52), 1.18 (0.86–1.59) and 1.49 
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(1.15–1.92), respectively. The pooled RRs for CVD in men, women and never-
smokers were 1.29 (1.12–1.48), 1.20 (0.92–1.56) and 1.27 (0.97–1.67), respectively 
(944). 
9.4.6 Dose-response relationships 
Increased incidences of major adverse cardiac event were found in the two highest 
exposure quartiles (blood cadmium levels of 0.26–0.50 μg/l and 0.50–5.1 μg/l) after 
adjustment for sex, smoking, waist circumference, education, physical activity, 
alcohol intake, serum triglycerides, HbA1c (glycated haemoglobin), CRP, post-
menopausal status, hormonal replacement, treatment for hypertension, diabetes 
mellitus, lipid-lowering medication, diastolic blood pressure, LDL and HDL 
cholesterol. Among never-smokers, an increased incidence was observed in the 
highest exposure quartile (0.50–5.1 μg/l) (63). 
One study among American Indian adults showed dose-response relationships 
between urine cadmium concentrations and incidence and mortality due to CVD. 
Analyses with subjects divided in four groups depending on urinary cadmium levels 
(≤ 0.61, 0.62–0.92, 0.93–1.45, > 1.45 µg/g creatinine) showed a positive dose-
response relationship between cadmium concentration and all CVD outcomes. 
LOAELs for increased incidence of CVD, CHD and heart failure, and stroke were 
0.62–0.92, 0.93–1.45, and > 1.45 µg/g creatinine, respectively. The calculated  
HRs were adjusted for sex, postmenopausal status for women, education, BMI,  
total cholesterol, estimated LDL cholesterol, hypertension, diabetes, estimated 
glomerular filtration rate, smoking status and cumulative smoking dose (943).  
Among inhabitants of a cadmium-polluted area there was a dose-response 
relationship between urinary cadmium and heart failure mortality (690). In the same 
area, among subjects with renal tubular dysfunction induced by cadmium, a urinary 
β2-microglobulin level of 300–1 000 µg/g creatinine was associated with an 
increased mortality from heart failure (women) and cerebral infarction (men) (709). 
9.4.7 Conclusion 
None of five occupational mortality studies showed an increased risk of CVD 
among cadmium-exposed workers (quantitative exposure data lacking), whereas 11 
studies on the general population supported a relationship between blood or urine 
cadmium concentrations and the occurrence of CVD, IHD, arterial disease or 
hypertension and four of these also supported an association with stroke. Three of 
these studies showed dose-response relationships (63, 690, 943). The risk of CVD 
was increased for subjects with blood cadmium levels of 0.26–0.50 μg/l (2–4 
nmol/l) compared to subjects with levels < 0.17 μg/l (63) and for subjects with 
urinary cadmium levels of 0.62–0.92 μg/g creatinine (0.62–0.93 μmol/mol 
creatinine) compared to those with levels ≤ 0.61 μg/g creatinine (LOAELs) (943).  
The evidence from general population studies for a relationship between 
cadmium exposure and CVD is strong. However, the lack of positive findings in 
occupational studies and confounding from smoking weakens the relationship. 
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There is moderately strong evidence for an association between exposure to 
cadmium and CVD. 
9.5 Chromium (VI) 
9.5.1 General 
Chromium (Cr) is found in nature primarily as chromite ore with chromium in the 
trivalent form. This form of chromium seems to be a nutritional supplement for 
humans and may play a role in the metabolism of glucose. Chromium is an 
important metal due to its high corrosion resistance and hardness. Steel can be 
highly resistant to corrosion by adding chromium to form stainless steel. Chromium 
can oxidise to form hexavalent chromium or chromate and this form of chromium 
can cause cancer in the respiratory organs after long-term inhalation (537). 
9.5.2 Occupational epidemiological studies  
In the early 1960s, the University of Pittsburgh was contracted to study the mortality 
among males born 1890 or later, employed in three US chromate producing plants 
1937–1940 with follow-up through 1960. Arteriosclerotic heart disease mortality 
(SMR) was 1.93 in 1941–1945 and 0.64 in 1956–1960 (Table 5). A decreased 
mortality was also observed for stroke, but the number of cases was very small. 
During the initial period 1941–1945, death rates were very high for respiratory 
cancers. The decline in mortality due to respiratory cancer indicates a decreased 
exposure to a very potent carcinogen. The author suspected calcium chromate to be 
this carcinogenic agent in these old chromate producing plants. However, it was 
unknown if all of the excess deaths were related to exposures in chromate 
production (258). 
A US cohort of 1 737 male workers employed at least 1 month 1940–1969 in a 
chromium pigment factory in New Jersey, was followed until 1982. The pigments 
contained both lead and zinc chromates. The SMR (95% CI) was 0.85 (0.71–1.00) 
due to IHD and 0.56 (0.35–0.84) due to vascular lesions of the CNS (391). Another 
cohort originating from New Jersey comprised 3 408 workers who had worked 
between 1937 and 1971 in former chromate producing plants in the northern part of  
 
Table 5. Mortality among chromate production workers employed 1937–1940 and 
followed through 1960 (258). 
Year 1941–1945 1946–1950 1951–1955 1956–1960 
Cause of death Obs. SMR Obs. SMR Obs. SMR Obs. SMR 
All 59 1.58 55 1.26 75 1.35 57 1.00 
Respiratory cancer 16 29.1 19 15.7 19 7.92 15 4.75 
Arteriosclerotic 
heart disease 
11 1.93 12 1.13 18 1.03 13 0.64 
Stroke 2 1.21 2 0.78 1 0.26 3 0.80 
Obs.: number of observed cases, SMR: standardised mortality ratio. 
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the state. The PMRs regarding arteriosclerotic heart disease were 0.97 for white 
men, 0.90 for black men and 1.19 (95% CI 0.73–1.83) for white women. There was 
no increase of vascular lesions of the CNS among white men (PMR 0.78) and black 
men (PMR 0.68) (799).  
A cohort of 482 former US chromate production workers from Painesville, Ohio, 
was followed until 1997. Of these, 41% started working at the chromate plant 
during the 1940s, and 59% started before 1955. The average airborne concentration 
of hexavalent chromium in the indoor operating areas of the plant was 720 µg/m3 
during 1943–1948, 270 µg/m3 during 1957–1964 and 39 µg/m3 during 1965–1972. 
SMR (95% CI) for diseases of the heart was 1.13 (0.93–1.36) based on reference 
rates from Ohio and 1.21 (0.99–1.46) based on US reference rates. Corresponding 
SMRs for other circulatory diseases were 1.43 (0.96–2.04) and 1.51 (1.02–2.16) 
(205, 580). 
A US chromate chemical manufacturing facility in Castle Hayne, North Carolina, 
was built in 1971 and designed to reduce the high levels of chromium exposure 
found at most older facilities. The cohort comprised 398 workers employed during 
1971–1989 of which 45 had previously worked at the plant in Painesville, Ohio. 
More than 99% of the measurements of hexavalent chromium based on personal 
sampling were below 50 µg/m3. The SMR regarding all heart diseases was 0.65 
(90% CI 0.26–1.37) based on only 5 cases and North Carolina eight counties’ rates 
(732). 
A cohort was formed from two cohorts of chromate production employees 
constituting the current US chromium chemical industry, after major process 
changes. The exposure levels to hexavalent chromium at both plants were very low 
after changing from high-lime to no-lime processes. The geometric mean of 
personal air concentrations of hexavalent chromium remained << 1.5 µg/m3 for 
most years at both plants. The range of annual means was 0.36–4.36 µg/m3 and the 
highest personal air sampling values were generally < 10 µg/m3. The SMR for 
diseases of the heart was 0.59 (95% CI 0.24–1.21) based on 7 cases (581). 
Totally 2 298 chromate producing workers were identified from three factories 
(Bolton, Rutherglen and Eaglescliffe) in the UK. The subjects had worked for at 
least 1 year 1950–1976 and were followed until 1988. One fifth were exposed 
before 1945, and 50% were exposed before the major process changes in the end of 
the 1950s which improved working conditions. During the follow-up, no significant 
increased risks were observed in the different factories for IHD (SMRs 1.03–1.12) 
and CeVD (SMRs 1.06–1.30) (215). 
Two cohorts from two German chromate-producing factories comprised 1 417 
workers and were followed until 1988. Both factories were originally high-lime 
facilities. The plant in Leverkusen completed the changeover to a no-lime process 
in 1958 and the plant in Uerdingen completed the changeover in 1964. The SMRs 
(95% CIs) due to CVD were 1.16 (0.97–1.39) in Leverkusen and 0.96 (0.78–1.15) 
in Uerdingen (506). In a later study, 901 workers exposed only after the changeover 
formed a new cohort which was followed until 1998. The exposure had declined 
from the mid-1970s judged from urinary chromium levels. A total of 264 employees 
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had at least one urinalysis exceeding 40 µg/l chromium (corresponding to 52 µg/m3 
of hexavalent chromium in air) and were considered to have had a peak exposure. 
Consequently most of the urinary concentrations did not exceed 40 µg/l. The SMR 
(95% CI) for diseases of the heart was 0.66 (0.45–0.93) and that for other diseases 
of the circulatory system was 1.00 (0.57–1.63). In this latter category, the SMR 
(95% CI) for CeVD was 0.84 (0.38–1.60) (95). A calculated SMR based on diseases 
of the heart (32 observed vs 48.55 expected) and other diseases of the circulatory 
system (16 observed vs 15.90 expected) would be 0.75 [(32 + 16) / (48.55 + 15.90)] 
which is lower than the previous SMRs from Leverkusen and Uerdingen. 
A Japanese cohort study of 896 male workers manufacturing chromium com-
pounds showed an increased risk for lung cancer (SMR 9.5) but not for heart disease 
(SMR 0.6) and CeVD (SMR 1.0) (831). 
A cohort comprising 666 Japanese chromate pigment (including lead chromate) 
manufacturing workers employed at least 1 year 1950–1975 were followed until 
1989. From 1976, the geometric mean of hexavalent chromium was 3–19 µg/m3 at 
measurement sites in the factories. The number of observed deaths due to heart 
diseases was 5 versus 9.9 expected (SMR 0.50, 95% CI 0.16–1.18) (476).  
9.5.3 Markers of effect 
In a Chinese cross-sectional study, 86 male workers exposed to sodium dichromate 
were compared with 45 non-exposed referents. The air concentrations of chromium 
were < 50 µg/m3. The exposed workers had significantly higher levels of white cells 
in the blood and also higher concentrations of serum CRP, as an expression of an 
unspecific inflammatory response (986). 
9.5.4 Conclusion 
Around ten cohorts from chromate producing industries were located. Most studies 
used national or regional rates to calculate expected deaths. Two of the studies 
demonstrated increased risks of circulatory diseases (205, 580) and arteriosclerotic 
heart disease (258). The latter study showed decreasing trends of arteriosclerotic 
heart disease mortality over time (258), which may be associated with improve-
ments of the working environment and decreasing exposures.  
Some other studies did not show increased risks of CVD mortality. However, 
most risk estimates were based on small numbers (< 10 cases) (476, 581) and 
exposures < 50 µg/m3 (95, 732). 
 
There is insufficient evidence for an association between exposure to hexavalent 
chromium and CVD.  
9.6 Cobalt 
9.6.1 General  
Cobalt is the 33rd element in abundance in the earth’s crust and an essential element 
which enters in the composition of vitamin B12 (540). Because of cobalt’s practical 
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advantages of high melting point, strength and resistance to oxidation, about 70% 
of the cobalt consumed is used for the production of special alloys. Cobalt alloys 
include strong and corrosion-resistant superalloys used in components of gas 
turbines and jet engines; magnetic alloys used in telecommunications and for the 
manufacturing of special medical devices; cobalt-containing high-strength steels 
used in the aerospace and naval industries; electrodeposited alloys used in 
protective coatings, in recording systems and for computer applications; alloys with 
special properties such as for surgical and dental implants; and hard metal alloys 
(cemented carbides). The hard metal alloys were developed in Germany in the 
1920s, using powder metallurgy (568).  
In the early 1960s, cobalt chloride or cobalt sulphate was added to some brands 
of beer in order to stabilise the foam and as a result of this intervention heavy beer 
drinkers developed cardiomyopathy. However, it is likely that poor nutrition and 
ethanol played a synergistic role (540, 852). The cardiomyopathy among beer 
drinkers carried a high mortality rate (672). Cardiomyopathy was also described in 
two workers exposed to heavy dust concentrations from cobalt-containing ores for 
2 months and 2 years, respectively (454) and after exposure to hard metal dust in a 
man responsible for weighing and mixing tungsten carbide and cobalt powder 
(486).  
In 2016, Packer reviewed exposures behind the occurrence of cobalt cardio-
myopathy. This condition is not common but has been described after cobalt 
treatment for anaemia, among nutritionally deficient drinkers of cobalt-fortified 
beer, in haemodialysis patients with end-stage renal disease, among cobalt exposed 
industrial workers and in patients with total metal hip replacement or arthroplasty. 
Despite a large number of exposed industrial workers, reports have been 
exceptionally rare, with only 7 cases over a 20-year period. The clinical emergence 
of cobalt cardiomyopathy requires the coexistence of one or more cofactors, 
particularly a low-protein diet, thiamine deficiency, alcoholism or hypothyroidism 
(730).  
9.6.2 Animal studies  
The bioavailability of cobalt increases in the presence of tungsten carbide. Intra-
tracheal instillation of a tungsten carbide-cobalt mixture in rats caused severe 
alveolitis and fatal pulmonary oedema, whereas the corresponding dose of cobalt 
powder alone caused a moderate inflammatory response (540).  
Mice exposed to 3 mg/m3 of cobalt sulphate heptahydrate for 24 months (mass 
median aerodynamic diameter 1.5–1.8 µm) developed arteritis in the main coronary 
arteries (2/17 vs 0/18 in controls) and in other coronary arteries (2/48 vs 0/46). The 
number of animals with arteritis in the renal arteries was 5/48 versus 1/46. Overall, 
there was a significant increased risk of arteritis among the exposed (P < 0.05). 
Mice exposed to 30 mg/m3 for 90 days did not develop arteritis (679).  
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9.6.3 Occupational epidemiological studies 
In a cross-sectional study of 30 cemented tungsten carbide workers, a weak but 
significant inverse correlation was found between duration of cobalt exposure 
(mean 9.9 years) and resting left ventricular function. Nine workers with abnormal 
chest X-ray findings had relatively lower exercise right ventricular ejection 
fractions. Diminished right ventricular reserve was probably due to fibrotic lung 
disease and early cor pulmonale. Although overt left ventricular dysfunction was 
not present, prolonged exposure to industrial cobalt may have a weak cardio-
myopathic effect (421). 
A group of 31 hard metal workers in Italy were studied of which 20 were 
apparently healthy, 10 subjects presented pulmonary fibrosis of different degrees 
and 1 person had asthma. The average duration of exposure to cobalt containing 
dusts was 10.4 (range 1–30) years, while the air levels of cobalt ranged from 0.09 
to 13.6 mg/m3. Cardiac function was studied by ECG, exercise test, echocardiogram 
and radionuclide angiocardiography with 99Tc. Within the group of patients with 
hard metal lung disease, cases of cardiomyopathy of doubtful aetiology were found. 
The cardiac indexes obtained through radionuclide angiocardiography showed 
ventricular dysfunction in the healthy hard metal workers which could be a 
manifestation of initial pulmonary artery hypertension or of an early incipient cor 
pulmonale due to an unknown fibrotic lung disease (208). 
A higher pulse rate was recorded among 46 plate painters in a Danish porcelain 
factory exposed to cobalt blue dye compared with 51 top-glaze painters serving as 
referents (768). 
In two studies of 870 French cobalt production workers (676) and 7 459 hard 
metal workers (678), no increased risks (SMR, 95% CI) of circulatory diseases were 
observed (0.80, 0.36–1.51 and 0.88, 0.75–1.03, respectively). In a later study, a 
cohort was formed comprising the largest production site which was in operation 
since the 1940s. The mortality (SMR, 95% CI) due to circulatory diseases was 0.91 
(0.72–1.14) among men and 1.25 (0.75–1.95) among women. The IHD risks were 
similar. The overall smoking habits were close to a previous population survey 
(1022).  
A Swedish cohort of 3 163 male hard metal workers was followed 1951–1982. 
The SMRs (95% CIs) regarding circulatory diseases and IHD were 0.97 (0.81–1.15) 
and 0.99 (0.80–1.21), respectively. In a subgroup of high and long-term (> 10 years) 
exposed workers, a higher SMR for IHD was observed (1.69, 95% CI 0.96–2.75) 
(415). 
A later Swedish cohort of 15 633 white- and blue-collar workers in the hard metal 
industry was followed 1952–2012. Increased mortality (SMR, 95% CI) from IHD 
(1.22, 1.15–1.29) but not from CeVD (1.08, 0.97–1.19) was observed (1009). No 
exposure-response analysis was presented. 
9.6.4 Conclusion 
The majority of cohorts comprising cobalt-exposed hard metal workers did not 
exhibit an increased risk of circulatory diseases or IHD. 
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Cardiomyopathy has been described after intake of cobalt-containing beer and 
after inhalation of high cobalt dust concentrations. However, despite a large number 
of exposed industrial workers, such reports are exceptionally rare. Signs of cor 
pulmonale have been observed as a result of fibrotic lung disease.  
 
There is insufficient evidence for an association between exposure to cobalt and 
CVD.  
9.7 Lead 
9.7.1 General  
The general population may be exposed to lead from leaded gasoline, lead in paint 
and in soldered cans. Occupational exposures originate mainly from smelters, 
refineries, battery and paint production. Several mechanisms have been discussed 
to explain the observed increases of blood pressure associated with lead exposure, 
including impairment of renal function, and induction of oxidative stress, 
inflammation and endothelial dysfunction (694).  
Around the year 2000, an estimated 2% of the total global burden of CVD was 
due to lead exposure (annually 229 000 deaths and 3.1 million disability-adjusted 
life years, i.e. the sum of years of life lost due to death and years of life with 
disability) (287).  
9.7.2 Occupational epidemiological studies  
In a study of male Swedish primary smelter workers, no increased risk of IHD or 
CeVD was observed in the total cohort of 3 979 subjects or in the highest exposed 
subgroup comprising 1 026 workers, respectively (587).  
Among Swedish secondary lead smelter workers, an increased risk of IHD was 
found (SMR 1.72, 95% CI 1.20–2.42). The SMR did not increase with cumulative 
blood lead dose but was higher prior to 1969 which was the period with the highest 
exposure (329). 
A Finnish cohort of men who were in the same occupation in 1975 and 1980 and 
who were 25–64 years old in 1980 was followed for CVD mortality 1981–1994. 
Information on marital status, education and income was updated in 1985 and 1990. 
Working conditions were evaluated from a JEM comprising three categories of lead 
exposure: unexposed, low-exposed (three lowest quartiles of the exposed) and high-
exposed (top quartile). A fully adjusted Poisson regression model was applied 
which included age, period, marital status, professional status, education, income, 
occupational class and category, and working conditions. Compared to unexposed 
workers, the RR (95% CI) for CVD mortality was 1.00 (0.93–1.08) for low-exposed 
and 1.12 (1.03–1.23) for high-exposed. The corresponding RRs (95% CIs) for  
MI were 1.01 (0.93–1.10) and 1.13 (1.00–1.28). High-exposed workers had an 
increased risk of CeVD (1.24, 1.00–1.55) compared to low- and unexposed workers 
(1031).  
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In 1963, an increased mortality (SMR 2.6, P < 0.001) due to CeVD was reported 
among pensioners who died 1926–1961 and had worked in a British lead battery 
factory and were in the highest category of lead exposure (232). This population 
was later included in a study of 754 deaths 1925–1976 among workers from four 
battery factories. An increased mortality from CeVD was found again among 
workers in the highest category of lead exposure (232). The population was further 
enlarged with battery workers as well as non-lead exposed workers. This enlarged 
study base was used for a case-control study of 867 deaths 1926–1985 of men with 
relatively high occupational lead exposure (40–80 µg/100 ml blood) and 1 206 men 
with relatively low or absent lead exposure (< 40 µg/100 ml blood). CeVD fatalities 
were defined as cases, and fatalities from all other causes were defined as controls. 
A significant excess of deaths from CeVD was found 1946–1965 among the high 
lead-exposed workers, but no excess was found 1966–1985, due to assumed better 
working conditions (280). 
An increased mortality from CeVD (SMR 4.1, P < 0.001) was found among 57 
lead chromate pigment workers suffering from clinically diagnosed lead poisoning 
1930–1945 (214). 
Totally 1 990 male workers employed 1940–1965 at a US primary lead smelter 
in Idaho were followed until 1988. CeVD mortality was non-significantly elevated 
(SMR 1.05, 95% CI 0.82–1.32) with a tendency to increase with increasing duration 
of exposure (P = 0.07) (911). 
Two US cohorts of male lead workers, 4 519 battery plant workers and 2 300 
lead production workers, who had been employed for at least 1 year during the 
period 1946–1970 were followed until 1980. The cohort from Idaho (911) was not 
included in these cohorts. Among the battery plant workers, no increased mortality 
(SMR, 95% CI) of circulatory diseases was observed (1.00, 0.93–1.08), but a 
significantly increased mortality from other hypertensive diseases (mainly renal, 
3.20, 1.97–4.89), and chronic or unspecified nephritis (2.22, 1.35–3.43). Likewise, 
lead production workers did not have any increased mortality from circulatory 
diseases (0.91, 0.79–1.03), whereas they exhibited an increased mortality from 
other hypertensive diseases (4.75, 2.18–9.02), hypertensive heart disease (2.03, 
1.13–3.35) and chronic or unspecified nephritis (2.65, 1.14–5.22). The deaths from 
CeVD were not significantly increased in any of the cohorts, 0.93 (0.77–1.11) and 
1.32 (0.98–1.75), respectively. There was no significant exposure-response relation-
ship, as > 20 years of exposure was associated with SMRs for CeVD of 0.89 among 
the battery plant workers and 1.46 among the lead production workers. However, 
the distribution of CeVD was skewed against cerebral haemorrhage (45%) (193). 
This is a higher proportion than commonly reported including both haemorrhage in 
the brain tissue and the surrounding subarachnoid space (15%). Hypertension is 
closely related to intracerebral haemorrhage (1056).  
Typographers are a group with historically lower exposure levels than most other 
lead-exposed groups. A decreased risk of arteriosclerotic heart disease was 
observed among 1 261 type setters from New York employed in 1961 and followed 
until 1984. However, there was an increased risk (SMR, 95% CI) of CeVD (1.35, 
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0.98–1.82), especially among workers exposed for ≥ 30 years (1.68, 1.18–2.31) 
(639). 
A Russian study of printing workers comprised 1 423 men and 3 102 women.  
An increased risk of IHD was found among male typecasting machine operators 
(SMR 1.29, 95% CI 1.08–1.56). Information on exposure was based on an industrial 
hygiene survey and exposure duration in years. However, no exposure-response 
relationship was observed. In male and female manual typesetters and linotype 
operators, no increased risks of CeVD were observed (443). 
Totally 241 smelter workers from the Broken Hill area, New South Wales, 
Australia, were diagnosed with lead poisoning 1928–1959. The proportionate death 
rates for 140 lead poisoned smelter workers were compared with the rates for 695 
predominantly production workers free of known lead poisoning. An increased 
PMR was observed regarding chronic nephritis and cerebral haemorrhage, 3.06 and 
1.99, respectively (P < 0.05) (626).  
A cohort of male lead-exposed workers in Korea was followed 2000–2005. The 
HR for adjusted hospital admission due to CVD for each grade of blood lead level 
(10–20 and ≥ 20 µg/dl) was compared with that of the reference grade (< 10 µg/dl). 
The adjusted variables included age and exposure to other metals. HRs (95% CIs) 
of IHD (1.78, 1.17–2.72), angina pectoris (1.93, 1.13–3.29) and cerebral infarction 
(2.24, 1.14–4.39) were significantly higher among workers with a blood lead level 
≥ 20 µg/dl than among those with a level < 10 µg/dl. The HR (95% CI) for CeVD 
was significantly higher among workers with a blood lead level of 10–20 µg/dl than 
among those with a level < 10 µg/dl (1.52, 1.00–2.31). IHD, CeVD, angina pectoris 
and cerebral infarction all showed a positive linear relationship with blood lead 
levels (652). 
9.7.3 Pooled analyses of occupational epidemiological studies 
Three cohorts of lead-exposed workers with blood lead level data from the US, 
Finland and the UK were pooled. The US cohort of 58 000 male workers was 
assembled from the Adult Blood Lead Surveillance (ABLES) programme. Blood 
lead levels were measured at different times in different states, but generally started 
in the early 1990s and went through 2007. Eleven states were included which had 
the majority of the ABLES data. Mortality was followed through 2010. The Finnish 
cohort of 21 000 workers (12% women) was created from those with documented 
blood lead level in the period 1973–1983, based on laboratory reports and employer 
data. Finnish labour law mandated that if the blood lead level of any worker at the 
workplace exceeded 42 µg/dl, then all workers in that workplace should have their 
blood lead level measured. Most blood samples came from the battery industry, lead 
smelting, metal foundries, railroad machine shops and chemical factories. The 
cohort was followed through 2013. The UK cohort numbered 9 000 (15% women), 
and was followed through 2011. Blood lead levels were measured in the period 
1975–1979, as part of an effort to conduct a census of all workers exposed to lead. 
The principal industrial sectors included pottery and glaze (14%), lead battery 
(12%), lead smelting (10%) and demolition/scrap metal (9%). In the pooled 
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analysis, there was a positive dose-response relationship between blood lead levels 
and IHD (P for trend < 0.0001); HRs (95% CIs) were 1.14 (1.04–1.26), 1.16  
(1.03–1.31) and 1.41 (1.28–1.57) for blood lead levels of 20– < 30, 30– < 40 and 
≥ 40 µg/dl, respectively. There was also a relationship between blood lead levels 
and stroke (P for trend < 0.0002); HRs (95% CIs) were 1.24 (1.03–1.50), 1.49 
(1.20–1.85) and 1.41 (1.16–1.72) for levels of 20– < 30, 30– < 40 and ≥ 40 µg/dl, 
respectively. Referents had a maximum blood lead level < 20 μg/dl and the HRs 
were adjusted for gender, birth year decade and country. No association between 
smoking and blood lead levels was found in a small subsample of the US cohort 
(n = 115) (905). 
9.7.4 Epidemiological studies of the general population 
Based on the US 2000 census and analysis of NHANES II, it was estimated that 29 
million people (15% of the adult population older than 20 years) had blood lead 
levels of at least 1.0 µmol/l (207 µg/l) 1976–1980. A total of 4 292 persons aged 
30–74 years with blood lead measurements were followed up through December 
1992. After adjustments for potential confounders (age, sex, race, education, 
income, smoking, BMI, exercise and location), individuals with base line blood lead 
levels of 1.0–1.4 µmol/l had an increased mortality from circulatory diseases (RR 
1.39, 95% CI 1.01–1.91) (589). Lead exposure declined dramatically beginning in 
the late 1970s largely because of the removal of lead from gasoline, from paint  
and, to a lesser extent, from solder used in cans. NHANES III comprised 9 757 
participants and was conducted during 1988–1994 with follow-up to December 
2000. Blood lead levels < 240 nmol/l were used as reference and an increased 
mortality (RR, 95% CI) due to CVD was found for levels of 240–450 nmol/l  
(50–90 µg/l) (1.20, 0.93–1.55) and ≥ 460 nmol/l (100 µg/l) (1.55, 1.16–2.07). A 
significant linear trend was also observed (841). 
Navas-Acien and coworkers reviewed the literature regarding the relationship 
between lead exposure and CVD (694). The review comprised 12 studies of the 
general population; 5 prospective cohort studies, 1 cross-sectional study and 6 case-
control studies. Lead exposure was positively associated with CVD in all studies. 
The evaluation also included 18 studies with occupational exposures from different 
industrial settings; battery, ceramic, refinery and smelter industries. Most of these 
were cohort studies in which external comparisons to the general population were 
used to derive SMRs. RR estimates varied widely. In two of three studies that 
reported associations by duration of employment, CeVD mortality was related to 
increasing duration of exposure (639, 911). Navas-Acien and coworkers concluded 
that the evidence was sufficient to infer a causal relationship between lead exposure 
and hypertension. They also concluded that the evidence was suggestive but not 
sufficient to infer a causal relationship between lead exposure and CVD (694). 
After the review by Navas-Acien and coworkers some further studies have been 
published. Among 868 environmentally exposed men, lead levels in bone (patella 
and tibia) were measured and the average follow-up was 8.9 years. The highest 
tertile of lead in bone was compared with the lowest tertile. This comparison 
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resulted in significant increased mortalities (HR, 95% CI) regarding both CVD (2.5, 
1.1–5.6) and IHD (8.4, 1.3–54.4) after adjustment for age, smoking and education 
(1001). 
A total of 14 289 adults aged ≥ 20 years were enrolled in the US NHANES III 
1988–1994 and followed to the end of 2011. The geometric mean concentration of 
lead in blood was 2.71 μg/dl and 3 632 (20%) participants had a concentration of 
lead in blood of at least 5 μg/dl (≥ 0.24 μmol/l). Subjects with a blood lead 
concentration of 6.7 μg/dl (0.324 μmol/l) had an increased mortality risk (HR, 95% 
CI) of CVD (1.70, 1.30–2.22) and IHD (2.08, 1.52–2.85) compared to those with a 
blood lead level of 1.0 μg/dl (0.048 μmol/l) (90th vs 10th percentile). The estimates 
were adjusted for age, sex, household income, ethnic origin, BMI, smoking, hyper-
tension, urinary cadmium, alcohol consumption, physical activity in previous 
month, healthy eating index, serum cholesterol and glycated haemoglobin. The 
population attributable fraction of the concentration of lead in blood for all-cause 
mortality was 18.0% (95% CI 10.9–26.1), which is equivalent to 412 000 deaths 
annually. Respective fractions were 28.7% (15.5–39.5) for CVD mortality and 
37.4% (23.4–48.6) for IHD mortality, which correspond to 256 000 deaths a year 
from CVD and 185 000 deaths a year from IHD. The authors concluded that low-
level environmental lead exposure is an important, but largely overlooked, risk 
factor for CVD mortality in the US (538). 
9.7.5 Meta-analyses of epidemiological studies 
A meta-analysis focusing on blood lead levels and blood pressure comprised 31 
studies and included 58 518 subjects, recruited from the general population in 19 
surveys and from occupationally exposed groups in 12 studies. An association 
between blood lead levels and blood pressure was found in both men and women. 
A 2-fold increase of blood lead concentration was associated with a 1.0 mmHg 
(95% CI 0.5–1.4) rise in systolic blood pressure and with a 0.6 mmHg (0.4–0.8) 
rise in diastolic blood pressure (698). In another meta-analysis, three prospective 
studies and five cross-sectional studies had measurements of tibia lead levels. An 
increase of tibia lead levels by 10 µg/g bone was associated with a 0.26 mmHg 
(95% CI 0.02–0.5) rise in systolic blood pressure and the summary OR per 10 µg/g 
bone for hypertension was 1.04 (95% CI 1.01–1.07) (695). 
A meta-analysis of environmental lead exposure included ten studies on CVD, 
eight studies on CHD and six studies on stroke. CVD included CHD and stroke. 
CHD was defined as non-fatal MI, angina, coronary revascularisation (i.e. per-
cutaneous transluminal coronary angioplasty or coronary artery bypass surgery) or 
CHD death. Stroke comprised both fatal and non-fatal stroke. Subjects were divided 
in three exposure groups using data on blood concentrations. Comparisons of 
outcomes were made between the highest and lowest exposure tertile. Risk 
estimates from separate studies were typically adjusted for basic demographics, e.g. 
age, sex, systolic blood pressure, lipids, smoking and history of diabetes. The 
calculated RRs (95% CI) were 1.43 (1.16–1.76) for CVD, 1.85 (1.27–2.69) for 
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CHD, and 1.63 (1.14–2.34) for stroke. There was a linear relationship between 
blood lead levels and CVD (172). 
9.7.6 Markers of effect 
A total of 9 145 individuals ≥ 40 years of age participated in NHANES 1999–2004. 
No evidence of an association between blood lead levels and inflammatory markers 
such as CRP, fibrinogen and white blood cell count was observed (ORs around or 
below 1). Although men but not women appeared to be at increased risk of lead-
induced inflammation, no consistent dose-response patterns were observed across 
blood lead level quintiles (895).  
A group of 87 lead-exposed industrial workers and 61 controls were studied. The 
lead-exposed workers had significantly higher median blood lead levels than 
controls, 29.1 μg/dl (range 9.0–61.1) versus 8.3 μg/dl (1.0–21.7). CRP as a marker 
of inflammation was significantly increased (P ≤ 0.05) among the exposed workers. 
Blood lead levels showed a significant positive correlation with CRP (r = 0.75) 
(490). However, smoking habits being a possible confounder was not taken into 
account. 
9.7.7 Previous evaluations 
In 2012, the US National Toxicology Program (NTP) reviewed the health effects of 
low-level of lead exposure. NTP declared that there is sufficient evidence that blood 
lead levels < 10 µg/dl (0.5 µmol/l) were associated with small but detectable 
increases in blood pressure and risk of hypertension. NTP concluded that there is 
limited evidence for increased CVD mortality at blood levels < 10 µg/dl. Lead 
levels in bone reflecting long-term lead exposure were more consistently associated 
with hypertension and CVD mortality (717). 
9.7.8 Conclusion 
The association between occupational and environmental exposure to lead and 
CVD has been extensively documented.  
In a pooled analysis of Finnish, UK and US lead-exposed workers, there were 
significantly positive dose-response relationships between blood lead levels and 
IHD and stroke; blood lead levels of 20–30 μg/dl (0.97–1.45 μmol/l) were 
associated with increased risks (905). 
In a US study of the general population (NHANES), subjects with a blood lead 
concentration of 6.7 μg/dl (0.324 μmol/l) had an increased mortality of CVD 
compared to those with a blood lead level of 1.0 μg/dl (0.048 μmol/l) (90th vs 10th 
percentile) (538). 
 
There is strong evidence for an association between exposure to lead and CVD.  
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9.8 Manganese 
9.8.1 General 
Manganese is absorbed by ingestion and by inhalation after occupational exposure. 
Manganese ions may also be injected intravenously in order to use their strongly 
paramagnetic properties in magnetic resonance imaging. Cardiovascular magnetic 
resonance is an important diagnostic tool in cardiology. Manganese ions 
accumulate inside myocytes allowing for better imaging. In 15 healthy volunteers 
given manganese (MnCl2) intravenously, there was a slight increase in systolic 
blood pressure and heart rate after 3 and 4 minutes of infusion with normalisation 
of these parameters thereafter. At follow-up 6 months after the investigation, no 
volunteer reported any neurological or cardiological adverse events or symptoms 
(283).  
Manganese superoxide dismutase (MnSOD) is a member of the superoxide 
dismutase (SOD) family, which have antioxidant capacity. MnSOD may be the 
most important enzyme of the SOD family as it resides in mitochondria where 
cellular respiration takes place. One study demonstrated that MnSOD poly-
morphism (Ala16Val) may be associated with the development of type 2 diabetes 
among Japanese-Americans (691). Diabetes is an established risk factor for CVD 
(91). 
9.8.2 Occupational epidemiological studies  
Manganese exposed ferroalloy workers had decreased systolic blood pressure 
(829), whereas ferroalloy manufacturers in another investigation had higher systolic 
and diastolic blood pressure than non-exposed referents (202).  
In 1955, an interesting observation was made by Rodier (790) when studying 
manganese-exposed Moroccan miners. The ore was very rich in manganese and 
neurological symptoms were common among the underground miners and 150 
cases of poisoning were reported. Each year approximately 3.7% of the workers 
were affected with pneumonia. Death from heart failure could occur after a week 
with pneumonia or suddenly in patients regarded as cured. The manganese 
pneumonia was associated with a marked rise in erythrocyte sedimentation  
rate (790). The sedimentation rate can be influenced by several serum proteins,  
e.g. fibrinogen, haptoglobin, immunoglobulins and ceruloplasmin. Increased 
concentration of fibrinogen is an established risk factor for IHD (288) and has also 
been associated with sudden death (519). In another study of workers producing 
oxides and salts of manganese, the white blood cell count was significantly higher 
among exposed workers than among referents when smoking habits were taken into 
account (791). An increased white blood cell count is associated with an increased 
risk of CHD (1011). 
In a study of Norwegian ferromanganese/silicomanganese furnace workers, 3 
deaths due to pneumonia (411) and an increased mortality from sudden death (SMR 
2.47, 95% 1.28–4.32) based on 12 cases were reported (410) during active employ-
ment. However, the workers were also exposed to other agents such as carbon 
monoxide and heat.  
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9.8.3 Epidemiological studies of the general population 
In a Korean NHANES, 1 991 participants were studied in a cross-sectional design. 
Blood manganese concentration was positively and significantly associated with 
hypertension in this representative sample of the Korean adult population (544). A 
similar result was found among males from India (939).  
In a US cross-sectional study of 639 older men in the Normative Aging Study, 
toenail concentrations of several metals including manganese were assessed. 
Manganese was negatively but not significantly associated with blood pressure. 
After adjusting for other metals, an increase in manganese was more strongly 
associated with decreased blood pressure (667). 
9.8.4 Conclusion 
The only longitudinal study on workers exposed to manganese that was located 
showed an increased risk of sudden death (410). A few environmental studies 
showed inconsistent results regarding manganese exposure and hypertension.  
 
There is insufficient evidence for an association between exposure to manganese 
and CVD. 
9.9 Mercury 
9.9.1 General  
Mercury vapours, mercuric salts and methylmercury behave differently regarding 
absorption, distribution and toxicity in the human body. Vapour inhalation is the 
most important occupational exposure route for mercury, typically occurring in 
mercury mining and in chloralkali factories. In the general public, fish consumption 
is an important source of methylmercury exposure (881).  
9.9.2 Inorganic mercury 
9.9.2.1 Animal studies 
Two strains of mice were exposed to metallic mercury vapour at 6.6–7.5 mg/m3 
during 4 hours/day for 3 consecutive days. This exposure was lethal to over 60% of 
metallothionein (MT)-null mice but did not kill any wild-type mice. More severe 
pulmonary damage was found in MT-null mice than in wild-type mice by 
histopathological observation. MT levels in the lung were elevated in wild-type 
mice after mercury vapour exposure, and gel filtration of the lung cytosol revealed 
that most of the mercury was associated with MT. These findings suggest that MT 
plays a protective role against acute pulmonary toxicity (1046).  
9.9.2.2 Case reports 
Inhalation of large doses of elemental mercury vapour results in an influenza-like 
illness which will appear 1–4 hours after exposure. The fever is accompanied with 
severe pulmonary irritation, characterised by cough, dyspnoea and tightness in the 
chest (331, 651).  
  
84 
A 32-year-old woman broke a fluorescent lamp while trying to replace a damaged 
one. After one day she had malaise, fatigue, weakness of the lower and upper 
extremities, atypical chest pain and palpitation. ECG disclosed atrial fibrillation 
with T-wave inversion in lateral precordial leads. Analysis of biological media 
revealed a blood mercury level of 4.2 μg/l (reference value: < 10 μg/l), a spot urine 
mercury level of 61.3 μg/l (presumed reference value: < 10 μg/l) and a 24-hour  
urine mercury level of 344 μg/l (presumed reference value: < 15 μg/l). The woman 
was diagnosed with mercury poisoning and was given chelating therapy for 4 days. 
Her 24-hour urine mercury level normalised after 5 days. Neurological symptoms 
disappeared and ECG taken on the third day of admission showed sinus rhythm and 
normalisation of negative T-waves (477).  
9.9.2.3 Occupational epidemiological studies 
An increased CVD mortality was found among 1 190 male workers exposed  
to inorganic mercury from eight Swedish chloralkali plants compared with  
the national mortality rates and a latency time of ≥ 10 years (SMR 1.3, 95% CI  
1.0–1.5) (65). In contrast, a similar study from Norway comprising 674 male 
workers from two chloralkali plants did not observe an increased CVD mortality 
(250). An American study of 2 133 male workers exposed to mercury vapours 
during production of nuclear weapons did not have an increased mortality due to 
vascular lesions of the CNS (203). Other vascular diseases were not reported.  
No increase of CVD mortality was observed among workers compensated for 
mercury intoxication following exposure in the Italian fur hat industry. Mercury 
nitrate was used in fur carroting, a process where a mixture of mercury nitrate and 
nitric acid is applied to make the cut fur limp. The number of compensated women 
and men were 820 and 326, respectively (634). 
Mortality was studied among 6 784 male workers from four mercury mines and 
mills in Italy, Slovenia, Spain and Ukraine. Increased mortalities (SMR, 95% CI) 
were found from hypertension (1.46, 1.08–1.93), heart disease other than ischaemic 
(1.36, 1.20–1.53) and pneumoconiosis (27.1, 23.1–31.6). Workers in the mines had 
the highest SMR for other diseases of the heart than IHD, and they were probably 
exposed to the highest levels of silica. There were no significant trends between 
duration of employment or estimated cumulative exposure (based on urinary 
mercury levels) and hypertension and other diseases of the heart, respectively (115). 
No conclusion can be drawn regarding mercury exposure and circulatory diseases. 
In 2002, the first results were presented from the US Health Professionals 
Follow-up Study (HPFS), which is a cohort study of 33 737 men who supplied 
toenail clippings. The cohort was followed 1987–1992. Dentists had higher levels 
of mercury in their toenails (0.91 µg/g) than non-dentists (0.45 µg/g). The mercury 
levels were not significantly associated with CHD after adjustment for age, smoking 
and other risk factors (1047). The cohort was further followed and a female cohort 
from the Nurses’ Health Study was added. Subjects with higher levels of mercury 
in their toenails did not have increased risks of CHD, stroke or total CVD. The 
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median mercury concentration was 0.23 µg/g among cases with CVD and 0.25 µg/g 
among control participants (680). 
9.9.3 Methylmercury 
Methylmercury exposure causes oxidative stress which is an early biological 
response that can produce vascular endothelial cell damage by promoting 
inflammation and vasoconstriction as well as lipid peroxidation via generation of 
reactive oxygen species (355). 
9.9.3.1 Animal studies 
Rats exposed by gavage to 100 µg/kg/day of methylmercury chloride for 100 days 
had increased systolic blood pressure, a decreased level of glutathione in the 
erythrocytes and an increased level of malondialdehyde (MDA) in plasma. There 
was a negative correlation between nitrite/nitrate plasma levels and systolic blood 
pressure and a positive correlation between MDA and systolic blood pressure, 
suggesting increased inhibition of nitric oxide (NO) formation with increase of 
hypertension. This study suggests that long-term exposure to methylmercury 
increases the systolic blood pressure, at least in part with increased production of 
radical oxygen species as judged by increased production of MDA and depressed 
NO availability (355).  
9.9.3.2 Epidemiological studies of the general population 
In the general population, mercury originates mainly from fish consumption. In a 
population-based nested case-control study from northern Sweden, 78 cases of first-
ever MI were compared with 156 controls. High erythrocyte mercury levels or high 
plasma polyunsaturated fatty acids were associated with low risk of MI (375).  
A case-control study from northern Sweden comprised 431 cases with MI and 
499 controls. Mercury was measured in erythrocytes and the median level was 3.54 
µg/l. An increased level of mercury in erythrocytes was associated with a lower risk 
of MI. The authors considered the mercury levels to be a biomarker of fish intake 
and that the results indicated a protective effect of fish consumption (1007). 
In 1995, the first results were presented from the Finnish Kuopio Ischaemic Heart 
Disease (KIHD) study regarding a possible relation between mercury and heart 
disease. A total of 1 833 men were followed 1984–1991. Mercury was measured in 
hair, and men in the highest tertile (> 2.0 µg/g) had an increased mortality risk (RR, 
95% CI) of acute MI (2.0, 1.2–3.1) and CVD (2.9, 1.2–6.6) compared with those 
with a lower mercury content (824). The study in eastern Finland was slightly 
enlarged to comprise 1 871 men who were followed 1984–1997. A 44% reduction 
of acute coronary events was observed when the highest 5th of the serum n-3 end-
product fatty acids docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) 
was compared with the lowest 5th of these fatty acids. Men in the highest 5th of the 
DHA + DPA who had a low hair content of mercury had a 67% reduced risk of 
acute coronary events (779). This cohort was further followed until 2002 and now 
men in the highest 3rd of hair mercury content (> 2.03 µg/g) had an increased risk 
(RR, 95% CI) of acute coronary events (1.60, 1.24–2.06), CVD (1.68, 1.15–2.44) 
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and CHD (1.56, 0.99–2.46). High mercury content in hair attenuated the protective 
effects of high-serum levels of DHA and DPA (1030). The mercury concentration 
of 2 µg/g hair corresponds to blood concentration of 15 ng/g erythrocytes. This 
level was exceeded by only 2 subjects in one of the Swedish studies above (375). 
The discrepancy of the results between the Finnish and the Swedish study may be 
explained by the higher dose in the Finnish study.  
A case-control study conducted in eight European countries and Israel comprised 
684 men with first MI and 724 referents. The toenail mercury levels were 0.27 µg/g 
among cases and 0.25 µg/g among referents. The risk-factor-adjusted OR for MI 
was 2.16 (95% CI 1.09–4.29) when the highest quintile of toenail mercury level 
(0.66 µg/g) was compared with the lowest quintile. The DHA levels in adipose 
tissue were also included in this adjustment (357).  
Three out of four studies supported a link between methylmercury exposure and 
intima-media thickening of the carotid artery (793). In one of the studies comprising 
men from eastern Finland, a linear relationship was observed between their hair 
mercury concentration and plasma fibrinogen (823), indicating a possible weak 
inflammatory response. 
Blood pressure was studied among Nunavik Inuit adults from northern Quebec, 
Canada. The mean age of the 732 participants was 34.4 years and the mean blood 
mercury level was 50.2 nmol/l (10 µg/l). Mercury was significantly associated with 
systolic blood pressure (979). Blood pressure was also investigated in a cross-
sectional study among 1 240 US women in the NHANES 1999–2000. The mean 
concentration of mercury in blood was 1.8 µg/l. Fish consumers had a higher mean 
concentration than non-fish consumers, 2.3 and 0.8 µg/l, respectively. A significant 
relationship was found between blood mercury levels and systolic blood pressure 
among non-fish consumers but not among fish consumers. Intake of fish oils may 
counteract the harmful effects of mercury on blood pressure (1040).  
Mercury exposure and oxidative stress were studied among fish-eating riparians 
living in the Brazilian Amazon. Both mercury in whole blood and in hair were 
significantly inversely related to several biomarkers of oxidative stress such as 
glutathione peroxidase, glutathione, catalase and δ-aminolevulinate dehydratase. 
These results further demonstrate a relation between mercury exposure and 
oxidative stress (356). 
9.9.4 Meta-analysis of epidemiological studies of the general population 
A meta-analysis of environmentally mercury-exposed subjects was conducted, 
based on four studies addressing CVD and five studies addressing CHD only. CHD 
was defined as non-fatal MI, angina, coronary revascularisation (i.e. percutaneous 
transluminal coronary angioplasty or coronary artery bypass surgery) or CHD 
death. Baseline (i.e. start of study) exposure estimates were derived from data on 
mercury levels in blood, hair and toenails. The calculations were based on a 
comparison between the top 3rd and the bottom 3rd of baseline levels of mercury. 
Risk estimates from separate studies were typically adjusted for basic demographics 
  
87 
e.g. age, sex, systolic blood pressure, smoking and history of diabetes. The RR 
(95% CI) was 0.94 (0.66–1.36) for CVD and 0.99 (0.65–1.49) for CHD (172).  
9.9.5 Conclusion  
Only one out of six occupational studies showed an increased risk of CVD after 
exposure to inorganic mercury (65).  
Several population studies indicated a positive association between methyl-
mercury exposure via fish consumption and MI. Animal data provide some support 
for oxidative stress and increased blood pressure caused by methylmercury.  
 
There is insufficient evidence for an association between exposure to inorganic 
mercury and CVD. 
There is limited evidence for an association between exposure to methylmercury 
and CVD. 
9.10 Titanium dioxide 
9.10.1 General 
Titanium dioxide (TiO2) is used in a wide variety of products including paints, 
plastics, rubber, ink and food products. The titanium-containing ore is mixed with 
either sulphuric acid or chlorine and subsequently heated or oxidised to produce 
titanium dioxide, which is then ground. Further treatments result in various grades 
of pigment. Titanium tetrachloride (TiCl4) is produced as an intermediate in the 
chloride process (113). One commonly used welding electrode is coated with rutile 
(the most common crystal form of TiO2) (877).  
9.10.2 Animal studies 
Atherosclerosis-prone ApoE-/- (knockout) mice were exposed to nanoparticles of 
titanium dioxide with diameters of 5–10 nm. The mice were divided into five groups 
and exposed groups were given tracheal instillations of nanoparticles at doses of 
10, 50 or 100 µg, once per week for 6 weeks. One control group was given PBS 
vehicle intratracheally once weekly for 6 weeks, whereas the other control group 
received no tracheal instillation. After 6 weeks of exposure, there was a significant 
difference between the high-dose group and the PBS control group in terms of CRP, 
nitric oxide (NO), endothelial nitric oxide synthases (eNOS), total cholesterol and 
HDL cholesterol in serum. The results also showed significantly increased ratios of 
plaque area/luminal area and lipid-rich core area/plaque area in the mid- and high-
dose groups. In summary, the study showed that tracheal instillation of nano-
particles induced considerable systemic inflammation, endothelial dysfunction and 
lipid metabolism dysfunction, contributing to the progression of atherosclerosis 
(162). 
ApoE-/- mice were exposed to three different types of titanium dioxide particles 
(two nanosized and one fine sized). A single intratracheal instillation of one type of 
nanosized titanium dioxide particles (0.5 mg/kg bw) was associated with modest 
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plaque progression in the aorta while no effect on plaque progression was detected 
for the other types. No associations between the pulmonary titanium dioxide 
exposure and inflammation (influx of neutrophils) or vasodilatory dysfunction were 
detected (640). 
Rats were exposed whole-body to 2.62 mg/m3 of an aerosol of nanosized titanium 
dioxide for 2 hours, 1.72 mg/m3 4 hours/day for 2 days or 3.79 mg/m3 4 hours/day 
for 4 days. No significant pulmonary or cardiovascular changes were noted at low 
and middle exposure levels. However, the high exposure level caused significant 
increases in breathing rate, pulmonary inflammation and lung cell injury (623).  
After a single intratracheal instillation of titanium dioxide nanoparticles (18, 54 
and 162 µg) in mice, a dose-related increase of acute phase mRNA Saa3 was 
observed. Saa3 is expressed in various tissues in mice, including lung. In humans, 
SAA3 is a pseudogene, i.e. is no longer coding for a protein (814).  
9.10.3 Occupational epidemiological studies 
A total of 15 017 workers (14 331 men and 686 women) were employed at least 1 
month in 1 of 11 factories producing predominantly pigment-grade titanium dioxide 
in Europe. The period of follow-up ranged from 1950–1972 until 1997–2001.  
The SMRs (95% CIs) for IHD were 0.88 (0.81–0.95) for men and 0.63 (0.20–1.41) 
for women (113).  
A US cohort comprised 4 241 workers employed at least 6 months at four 
titanium dioxide plants. All workers were employed on or after 1 January 1960 and 
were followed until 2000. The cohort was compared with the US population 
regarding mortality. The SMR (95% CI) was 0.9 (0.7–1.0) for all heart disease and 
0.8 (0.5–1.2) for all CeVD. The RR (95% CI) regarding all heart disease did not 
increase with increasing cumulative exposure; lowest tertile 1.0 based on 22 cases, 
mid tertile 1.1 (0.7–1.8) based on 57 cases, and highest tertile 0.8 (0.5–1.4) based 
on 44 cases (319). Titanium dioxide was measured as total dust. Exact estimates of 
cumulative exposures were not presented.  
Another US cohort comprising 3 607 workers employed at least 6 months in three 
DuPont titanium dioxide production facilities were followed 1935–2006. A larger 
proportion of workers was exposed to titanium dioxide (97%) than to titanium 
tetrachloride (81%) and 77% of the workers were exposed to both compounds. An 
internal analysis was performed and increased risk estimates for heart disease 
mortality and cumulative titanium dioxide exposure after a 10-year lag were 
observed, but without clear exposure-response relationships (Table 6). No increased 
risk was observed among workers exposed to titanium tetrachloride (251). 
Exposure monitoring began around 1975 in the two US studies. Mean titanium 
dioxide exposures for packers, micronizers and addbacks were 6.2 mg/m3 in the 
first study (319) and 8.1 mg/m3 for packers and 8.46 mg/m3 for grinders (i.e. micro-
nizers) in the DuPont study (251). Similarly, mean exposure levels were 2.5 mg/m3 
(maintenance mechanics) (319) and 4.4 mg/m3 (maintenance), respectively (251).  
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Table 6. Relative risk estimates for heart disease mortality and cumulative titanium 
dioxide exposure after a 10-year lag (251). 
Cumulative TiO2 exposure (mg/m3-years) RR (95% CI) 
< 5 1 
5–15 1.47 (1.02–2.11) 
15–35 1.65 (1.16–2.34) 
35–80 1.36 (0.92–2.00) 
> 80 1.51 (1.00–2.25) 
CI: confidence interval, RR: relative risk, TiO2: titanium dioxide. 
9.10.5. Conclusion 
Three occupational cohort studies were found of which one showed an increased 
risk of heart disease mortality among titanium dioxide exposed workers (251). A 
few animal studies showed that pulmonary exposure to titanium dioxide nano-
particles induced modest plaque progression and increased the pulmonary acute 
phase Saa3-gene expression (162, 640, 814). 
 
There is insufficient evidence for an association between exposure to titanium 
dioxide and CVD. 
9.11 Zinc 
9.11.1 General  
Zinc is a bluish-white metal, which is stable in dry air but will be coated with zinc 
oxide in moist air. Zinc is used as protective coating for other metals (galvanised 
steel), in dye casting, in non-corrosive alloys and in brass. Inorganic zinc com-
pounds are used in automotive equipment, storage and dry cell batteries, and dental, 
medical and household applications (826). Zinc chloride-based smoke bombs and 
screens have been used since World War II (249). 
9.11.2 Human experimental studies  
Human volunteers inhaling 2.5 and 5 mg/m3 of zinc oxide fume for 2 hours 
exhibited mild fever and increased plasma concentrations of IL-6 (289). In a later 
study, sheet metal workers occupationally exposed to low levels of zinc oxide were 
experimentally exposed once to 5 mg/m3 zinc oxide for 2 hours. Despite a mild 
clinical response, the mean plasma IL-6 levels increased significantly after 
exposure. In naïve subjects, the inflammatory response decreased during exposure 
for 3 successive days (290). These experiments indicate an adaptation with a milder 
inflammatory response after repeated exposures. 
Sixteen healthy subjects were exposed to filtered air and nanosized zinc oxide 
particles (sham, 0.5, 1.0 and 2.0 mg/m3) for 4 hours on 4 different days, including 
2 hours of cycling at a low workload. Exposures were randomised and double-
blinded, with the exception of the exposure to 2.0 mg/m3, which was blinded 
according to instructions from the ethic committee. The effects were assessed 
before, immediately after, and about 24 hours after each exposure. Concentration-
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dependent increases in symptoms, body temperature, acute phase proteins and 
neutrophils in blood were detected after zinc oxide inhalation. Significant effects 
were detected at concentrations ≥ 1.0 mg/m3, with the most sensitive parameters 
being inflammatory markers in blood; CRP and SAA (659). 
Twelve healthy subjects were exposed to filtered air and 0.5 mg/m3 freshly 
generated zinc oxide in the fine or ultrafine fractions for 2 hours at rest. Exposure 
to zinc oxide did not cause any significant increase of symptoms, leukocyte surface 
markers, haemostasis, cardiac electrophysiology, IL-6, SAA or fibrinogen (78).  
The different outcomes of these two last experiments (78, 659) may be explained 
by differences in exposure time (4 vs 2 hours) and workload (cycling vs rest). 
9.11.3 Case reports  
A case report described a 25-year-old male welder exposed to zinc fumes with metal 
fume fever together with aseptic meningitis, pericarditis, pleuritis and pneumonitis 
(387). 
9.11.4 Occupational epidemiological studies  
Welders are sometimes exposed to zinc oxide fume when welding in galvanised 
steel. In a survey, 31% of welders aged 20–59 years had experienced metal fume 
fever on at least one occasion (801). However, all metal fume fevers are not caused 
by zinc oxide.  
Inhalation of zinc chloride smoke may cause airway irritation. Intoxication with 
clinical signs has mainly been associated with war situations and in military and 
fire emergency training sessions in enclosed spaces. Symptoms follow a biphasic 
course mainly characterised by dyspnoea, coughing and lacrimation, in the first  
6 hours, followed by reappearance of early signs complemented with inflammation 
related signs and tachycardia from 24 hours onwards (249). Two soldiers were 
fatally injured by accidental inhalation of zinc chloride from a smoke bomb. 
Although exposure was relatively short, but to a high smoke concentration,  
acute injury was minor and for 10 days the patients were clinically satisfactory. 
Unexpectedly, both then rapidly developed features typical of severe adult acute 
respiratory distress syndrome (ARDS) with pulmonary hypertension. Lung vascular 
injury was assessed by angiography and morphometric techniques. Vessels showed 
a significant lumen reduction in vessel external diameter. In microvessels, there was 
obliteration and widespread occlusion by endothelial cell proliferation and clot 
(419). 
9.11.5 Epidemiological studies of the general population  
The California Teachers Study comprised approximately 45 000 women who were 
followed 2002–2007. Long-term airborne exposure to PM2.5 doubled the mortality 
from IHD. Zinc exposure correlated with PM2.5 exposure but had a much weaker 
effect (727).  
In a joint analysis of 19 European cohorts, no statistically significant associations 
were found between zinc particulate (PM2.5 and PM10) exposure and CVD mortality 
(985).  
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9.11.6 Conclusion  
Inhalation of zinc oxide can cause an inflammatory response with fever. Environ-
mental zinc exposure was weakly associated with IHD in one study (727). No long-
term occupational cohort studies of zinc exposed workers were identified.  
In a human experimental study, inhalation of 1 and 2 mg/m3 of zinc oxide nano-
particles for 4 hours induced increased plasma levels of the acute phase proteins 
SAA and CRP, which have been suggested as biomarkers of particle-induced CVD 
(659).  
Inhalation of zinc chloride fume may affect the lung parenchyma and cause lung 
vascular injuries (249, 419). 
 
There is insufficient evidence for an association between exposure to zinc and 
CVD. 
10. Other dusts and fumes 
10.1 Welding and soldering fumes 
10.1.1 Welding fumes 
10.1.1.1 General 
Welding processes generate both respirable particles and gases. Welders are 
generally exposed to small particles of iron but also to many other particles of metal 
or non-metal origin (300). Most of the primary particles in welding aerosols have 
diameters of 5–40 nm. All types of primary particles have a tendency to form 
chainlike agglomerates and grow to sizes between 0.1 and 1 µm, regardless of the 
welding technique. A clear size dependence of the particle chemical composition 
was encountered in the case of manual metal arc welding aerosol. Small particles 
with diameters < 50 nm were mostly metal oxides in contrast to larger particles 
which also contained more volatile elements (87). Tungsten inert gas (TIG) welding 
generated the highest number of ultrafine particles (particles < 100 nm) but rather 
low mass concentrations expressed as mg/m3 (550). During friction stir welding of 
aluminium, the number of airborne nanoparticles may reach the same levels as 
during TIG-welding (746).  
The generation of fumes from different welding techniques and working 
conditions was studied. Flux cored arc welding generated more smoke than manual 
metal arc welding (mean 15 mg/m3 vs 4 mg/m3). In addition, welding in confined 
spaces was associated with higher levels of particles compared with welding in 
more open spaces or large workshops (mean 13 mg/m3 vs 4 mg/m3) (412). 
Epidemiological studies and risk estimates are presented in Appendix, Table 
A17. 
10.1.1.2 Animal studies 
Atherosclerosis-prone ApoE-/- mice were exposed to 40 mg/m3 of stainless steel 
welding fumes [generated from metal active gas (MAG) welding, with a shielding 
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gas containing 95% argon and 5% carbon dioxide], 3 hours/day for 10 days. 
Inflammatory serum proteins IL-1β and monocyte chemoattractant protein 3 were 
increased 2 weeks after welding fume exposure. Thus, the exposure caused 
systemic inflammation and in addition increased plaque progression (34, 262).  
10.1.1.3 Occupational epidemiological studies  
An increased mortality from IHD was observed in some studies among welders 
compared to the general population (441, 675, 705, 1039). Other cohort studies of 
welders did not demonstrate any significant differences regarding diseases of the 
circulatory system compared to the general population (75, 627, 641, 763, 868, 876, 
904), and in one study a significantly decreased risk was observed (74). An 
increased CeVD incidence or mortality among welders was found in two out of four 
studies (422, 441, 627, 675). 
Some cohort studies of welders with more adequate referent cohorts are available. 
In 2002, male welders were compared with gainfully employed men, and the SMRs 
regarding IHD were significantly increased; 1.06 in a long follow-up (25 years)  
and 1.35 in a short follow-up (5 years) (882). The different risk estimates between 
these follow-up periods may be explained by a larger proportion of retired and 
consequently non-exposed welders in the cohort with long-term follow-up. In 2012, 
Wiebert et al. compared welders with manual workers not exposed to particles. 
Welders had an increased risk of morbidity/ mortality due to MI with HRs of 1.19 
and 1.29, for males and females, respectively (1015). This sequence of studies with 
improving quality supports an association between welding fume exposure and 
IHD. 
A Swedish case-control study estimated the RR (95% CI) of first MI in various 
occupational groups. Male welders and flame cutters had an increased risk after 
adjustment for age, county and calendar year (1.1, 1.0–1.3), but not after adjustment 
for age, county and socioeconomic group (1.0, 0.9–1.2) (377).  
Later studies were better designed and included both fatal and non-fatal cases of 
disease. In a Danish study, 8 376 male metal workers answered a questionnaire 
about welding experience and lifestyle. The cohort of 5 866 welders was followed 
from the start of 1987 (baseline) until the end of 2006. A JEM based on more than 
1 000 measurements of ambient air particles in the workplace 1971–1985 was used 
to estimate the cumulative exposure to welding fume particles. Air samples had 
been collected on filters placed in the breathing zone inside welding helmets. 
Exposures before 1971 were estimated by extrapolation, assuming a declining trend 
in exposure in all welding processes during 1971–1985. Cumulative exposure after 
baseline was estimated by an average exposure for 1980–1985 multiplied by 
number of years in the welding industry after baseline. The mean cumulative 
estimated particulate exposure was 53.1 mg/m3-years before baseline (1924–1986) 
and 8.7 mg/m3-years after baseline (1987–2006). Information of CVD was retrieved 
from the Danish National Patient Registry. Increased risks (SIR, 95% CI) were 
observed regarding acute MI (1.1, 1.0–1.2), chronic IHD (1.2, 1.1–1.3) and cerebral 
infarction (1.2, 1.1–1.4) (441). 
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Gas welders are seldom separated from electric arc welders in epidemiological 
studies. However, one study showed a higher SMR regarding CVD in gas welders 
(SMR 1.22) than in electric arc welders (SMR 0.92) (763). This might be a chance 
finding, but gas welding in badly ventilated areas has been associated with high 
levels of carbon monoxide (35). A study of lung cancer found a higher risk among 
welders exposed for more than 25 years only to gas welding fumes than among 
welders exposed only to arc welding fumes (601). If this difference between gas 
and electric arc welders is real, agent(s) other than carbon monoxide must be 
responsible. There might be a common agent (e.g. PAH) causing both CVD and 
lung cancer among gas welders. A Finnish JEM presented associations between 
welding fume and PAH exposures particularly among smelters and foundry workers 
(866). 
A cohort of 2 818 male welders employed before 1980 with at least 6 months 
employment in an iron-steel plant in Anshan, China, was followed until 1993. Non-
exposed blue-collar workers from the same plant were used as referents. Increased 
mortality risks (SRR, 95% CI) were observed for acute MI (2.0, 1.1–3.6) and CeVD 
(1.3, 1.2–1.4) (422). 
10.1.1.4 Meta-analysis of epidemiological studies  
In a meta-analysis, 18 studies were identified with estimates of IHD morbidity or 
mortality among workers exposed to welding fumes. The weighted RR (95% CI) 
for IHD was 1.09 (1.00–1.19) based on 10 studies. The RR (95% CI) was 1.39 
(0.96–2.02) among studies using an internal reference group and 1.08 (0.99–1.18) 
among studies with an external reference group. The heterogeneity of the effect 
estimates in these calculations was moderate to high (I2: 65, 72 and 62%, 
respectively). An increased RR (95% CI) was observed for acute MI (1.69, 1.18–
2.42) but not for other IHD (1.06, 0.98–1.14). The heterogeneity of the effect 
estimates in the calculation of acute MI was low (I2: 0%). Information was lacking 
to evaluate risks related to specific welding characteristics (655). The study by 
Wiebert et al. (1015) was not included in this meta-analysis.  
10.1.1.5 Exposure-response relationships 
In a French study of 2 721 welders from 13 factories including 3 shipyards, a 
relationship was found between duration of employment and mortality from IHD. 
Employment for ≥ 20 years was associated with a significantly increased mortality 
from IHD (SMR 1.79, P < 0.05) (675). 
The Danish study of welders, designed with internal comparisons of the cohort 
with adjustment for tobacco smoking, alcohol and hypertension medicines, showed 
a significantly increasing HR for chronic IHD and non-significant increases for 
acute MI, angina pectoris and cerebral infarction with increasing exposure to 
particles. Cumulative particulate exposures of 10–50, 50–100 and > 100 mg/m3-
years were associated with HRs (95% CIs) for chronic IHD of 2.51 (1.15–5.49), 
2.79 (1.29–6.04) and 1.70 (0.78–3.72), respectively (441). The strength of this study 
is weakened by the low number of cases in the referent group (n = 7) and the broken 
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trend at the highest cumulative exposure, although the latter may be explained by 
the healthy worker survivor effect. The lowest cumulative exposure category of  
10–50 mg/m3-years of welding fumes corresponds to 0.25–1.25 mg/m3 for 40 years. 
10.1.1.6 Markers of effect 
An increase of the inflammatory marker CRP was observed 16 hours after exposure 
among welders from an apprentice welding school who worked mainly in low-alloy 
steel one day with a mean exposure of 1.7 mg/m3 measured as PM2.5 (492).  
Blood levels of acute phase proteins increased in a group of 15 human volunteers 
after experimental exposure for 6 hours to welding fumes containing copper and 
zinc (71). 
10.1.2 Soldering fumes 
The Copenhagen Male Study comprised 2 974 men in 1985–1986 when a new 
baseline or starting point was established. The cohort was followed until 1991. An 
increased incidence (RR, 95% CI) of IHD was found after 5–15 years of soldering 
fume exposure (2.0, 0.9–4.7) and after > 15 years of exposure (2.2, 1.2–4.0), after 
adjustment for age, smoking, alcohol, physical activity, systolic and diastolic blood 
pressure, hypertension, BMI, cholesterol, triglycerides and retirement status (923). 
A later study investigated lifetime prevalence of MI and incidence of IHD in an 
8-year follow-up. More than 5 years exposure to soldering fumes among men with 
blood type O was associated with an increased prevalence of MI (OR 3.0, 95% CI 
1.6–5.8). A similar but weaker association between blood type O and IHD incidence 
was found for those exposed more than 5 years to soldering fumes (OR 1.8, 95% 
CI 1.0–3.2) (924). 
10.1.3 Conclusion 
Epidemiological studies of welders with adequate referent groups showed increased 
risks of IHD. A meta-analysis demonstrated a significantly increased risk of IHD, 
from exposure to welding fumes. An increased risk of acute MI was also found, 
based on three studies, which was associated with low heterogeneity in effect 
estimates (655). One study of welders showed increasing risks for IHD with 
increasing cumulative particulate exposure, but the trend was broken at the highest 
level. A cumulative particulate exposure of 10–50 mg/m3-years (the lowest 
exposure category) was associated with a significantly increased risk for chronic 
IHD. Exposure to 10–50 mg/m3-years corresponds to 0.25–1.25 mg/m3 for 40 years 
of welding fumes (441). There were four epidemiological studies on welders 
addressing CeVD, two of which showed an increased risk (422, 441). 
An increased risk of IHD was reported in the only cohort located regarding 
exposure to soldering fumes (923, 924). 
 
There is moderately strong evidence for an association between exposure to 
welding fumes and IHD.  
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There is insufficient evidence for an association between exposure to soldering 
fumes and CVD. 
10.2 Metalworking fluids 
10.2.1 General 
Metalworking fluids are complex mixtures used as coolants, lubricants and anti-
corrosives in a variety of industrial metal machining operations. Metalworking 
fluids may be petroleum- or water-based and are generally classified in three 
categories: straight (mineral oil), soluble and synthetic. Exposure to metalworking 
fluids is widespread throughout the world (168). 
10.2.2 Animal studies 
Rats were exposed nose-only to aerosols of metalworking fluid (10 mg/m3) 
contaminated with endotoxins (0, 0.8, 1.6 and 3.2 µg/m3) for 3 hours. There was a 
significant exposure-related increase of neutrophils in the bronchoalveolar lavage 
when the metal working fluid was contaminated with endotoxins over the whole 
exposure range (220).  
Guinea pigs were exposed to neat (unused) or in-use metalworking fluids by 
inhalation. The animals exhibited significant inflammation resulting from metal-
working fluids exposure marked by a change in neutrophils in bronchoalveolar 
lavage fluid from 3% among controls (neat) to 60–79% among those exposed  
(in-use). The in-use metal working fluid contained varying concentrations of 
endotoxins (960). 
10.2.3 Occupational epidemiological studies 
A cohort of 4 825 female autoworkers was followed 1980–2004 and compared with 
the mortality in Michigan. The SMR (95% CI) from IHD was 1.08 (0.93–1.24), 
based on 201 cases (311). 
Hypersensitivity pneumonitis is a complex syndrome resulting from repeated 
exposures to a variety of organic particles (854). This type of pneumonitis has been 
observed in the automotive industry among metalworking fluid-exposed workers. 
Strong candidates for microbial aetiology are non-tuberculous mycobacteria and 
fungi (515). Acute hypersensitivity pneumonitis is characterised by an influenza-
like syndrome occurring hours after substantial exposure. Acute or subacute 
episodes may evolve to chronic hypersensitivity pneumonitis. Pulmonary hyper-
tension develops in approximately 20% of patients with chronic pneumonitis and is 
associated with an increased fatality rate (854). 
10.2.4 Exposure-response relationships 
A US cohort of 39 412 autoworkers (88% men) who had worked at least 3 years 
1938–1985 in one of three Michigan automobile manufacturing plants was followed 
through 1994. The relationship between current or cumulative exposure to straight  
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Table 7. Cumulative exposures to straight metalworking fluid (PM3.5) and hazard ratios 
for IHD mortality (200). a 
Cumulative exposure (mg/m3-years) No. of cases HR (95% CI)  
0  214 1.0 
< 0.06 67 1.42 (1.04–1.94) 
0.07–0.22 69 1.13 (0.83–1.55) 
0.23–0.68 68 0.88 (0.64–1.21) 
0.68–2.77  68 1.29 (0.97–1.72) 
> 2.77  67 1.53 (1.15–2.05) 
a The exposure-response model was weighted by the stabilised inverse probability of staying at work. 
CI: confidence interval, HR: hazard ratio, IHD: ischaemic heart disease, PM3.5: particulate matter 
with maximal aerodynamic diameter of 3.5 µm. 
 
metalworking fluid as PM3.5 and IHD mortality was investigated by Cox pro-
portional hazard models. Age, calendar year of follow-up, sex, race and plant were 
included in each model. There was a U-shaped cumulative exposure-response curve 
with an elevated HR of 1.42 in the category with lowest exposure and of 1.53 in the 
category with highest exposure to straight metalworking fluid (Table 7). There was 
no clear association with current exposure. The authors concluded that the results 
provided modest evidence that occupational exposure to fine particulate matter 
from straight fluids, especially those with higher PAH content, increases the risk of 
IHD mortality. There was no relationship between cumulative exposure to soluble 
or synthetic fluids and IHD mortality (200). Chevrier et al. used the cohort of 
Michigan autoworkers to address the healthy worker survivor effect. The cohort of 
38 747 workers, who had worked at least 3 years 1941–1982, was followed until 
1994. After adjustment for the healthy worker survivor effect by g-estimation of 
accelerated failure-time models, 5 years of exposure was related to an increased risk 
of IHD (HR 1.15, 95% CI 1.11–1.19) (168). 
A subcohort of US aluminium workers comprising 7 211 workers in aluminium 
fabrication, employed for more than 2 years 1996–2012, was followed 1998–2012. 
The PM2.5 exposure was mostly composed of water-based metalworking fluids. The 
median PM2.5 exposure was 0.20 mg/m
3 and the 10th percentile was 0.06 mg/m3. 
RRs were based on a comparison between exposures above and below these two 
concentrations. The RRs (95% CIs) regarding IHD at the cut-offs 0.20 mg/m3 and 
0.06 mg/m3 were 1.14 (0.80–1.63) and 1.45 (1.13–1.86), respectively (127). 
Another subcohort of US aluminium fabrication workers comprised 8 290 
workers who were employed at least 2 years. Follow-up started in 1998 in some 
facilities and in 2005 in others and was ended in 2009. The HR for recent PM2.5 
exposure and incidence of IHD rose in fabrication to 1.5 at 1.25 mg/m3 and was 
statistically significant throughout most of the exposure range (0.25–1.25 mg/m3) 
(199). 
10.2.5 Indirect evidence  
Several studies showed increased rates of respiratory symptoms such as cough and 
phlegm among workers exposed to metalworking fluids (26, 472, 607, 782). Auto-
mobile workers at three General Motors facilities were studied by questionnaire for 
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possible respiratory effects resulting from airborne exposures to metalworking 
fluids. A total of 1 042 machinists worked at the time of the study and were exposed 
to one of three types of metalworking fluid aerosols; straight mineral oils, soluble 
oil emulsions or water-based synthetic fluids that contained no oils. Assembly 
workers (n = 769) without direct exposure served as an internal reference group. 
Several respiratory symptoms as well as physician-diagnosed chronic bronchitis 
were primary outcomes. Machinists as a whole had higher prevalence of cough, 
phlegm, wheezing and breathlessness than assembly workers. Increased levels of 
current exposure to straight oils were associated with higher prevalences of phlegm 
and wheeze, after adjusting for confounders. Increased current exposure levels of 
synthetic fluids were associated with cough, phlegm, wheeze, chest tightness and 
chronic bronchitis. In models that included both past and current exposure, only 
current exposures to straight and synthetic fluids were associated with current 
symptoms (351). These relationships between exposure to metalworking fluids and 
respiratory symptoms may be regarded as an indirect evidence of a relation between 
exposure and CVD, as chronic bronchitis is related to CVD (Section 4.1).  
10.2.6 Conclusion 
Among the few epidemiological studies that were located on metalworking fluid 
exposure, increased risks of IHD were shown in the automotive industry (200) as 
well as in aluminium fabrication (127, 199). One of these studies demonstrated a 
significantly increased risk of IHD from recent metalworking fluid exposure in the 
range 0.25–1.25 mg/m3. Recent exposure to 1.25 mg/m3 (PM2.5) of metalworking 
fluid was associated with an HR of 1.5 (199). 
 
There is limited evidence for an association between exposure to metalworking 
fluids and IHD. 
10.3 Wood industry  
10.3.1 General  
Wood dust is a complex mixture, generated in the processing of wood. Its 
composition varies considerably depending on the species of tree being processed. 
Wood dust is composed mainly of cellulose (approximately 40–50%), polyoses, 
lignin and a large and variable number of substances of lower molecular mass which 
may significantly affect the properties of the wood (440). 
Trees are characterised botanically as gymnosperms (principally conifers, 
generally referred to as softwoods) and angiosperms (principally deciduous trees, 
generally referred to as hardwoods). Softwood and hardwood are not botanical 
concepts, referring to the species of tree and not directly describing the hardness of 
wood (440). 
In 2000–2003, about 3.6 million workers in the EU were occupationally exposed 
to inhalable wood dust. Of those, construction employed 1.2 million workers (33%), 
mostly construction carpenters. The proportions of exposed workers were 20% in 
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the furniture industry, 9% in the manufacture of builders’ carpentry, 5% in 
sawmilling, 4% in forestry and less than 100 000 in other wood industries. About 
half of the workers (52%) were exposed to inhalable dust concentrations > 1 mg/m3 
and 16% were exposed to levels > 5 mg/m3 (482). Airborne fungi or fungal spores 
have been present in sawmills (79, 274, 376). 
Epidemiological studies and risk estimates are presented in Appendix, Table 
A18. 
10.3.2 Occupational epidemiological studies  
Two Swedish studies showed an increased risk of heart disease among wood dust 
exposed workers. A cohort of 20 854 wood dust exposed construction workers was 
compared with 71 778 unexposed controls. Exposed workers had a higher risk of 
IHD (RR 1.12, 95% CI 1.04–1.20) after adjustment for age, smoking, hypertension 
and BMI. The risk for CeVD was, however, not increased (967). A case-control 
study of MI revealed an increased risk (RR, 95% CI) among male frame and circular 
sawyers and planers (1.7, 1.0–3.0) and among female bench carpenters and cabinet 
makers (2.0, 1.0–3.9) after adjustment for age, county and socioeconomic group 
(377). 
All economically active persons in Finland were included in a census study. 
Occupation was registered in 1970 and the follow-up period was 1971–1991. 
Increased risks regarding MI as well as CeVD were observed among both male and 
female forestry workers and log floaters (713). 
A cohort of 10 322 male workers in woodworking industries was compared with 
406 798 non-wood workers in the US. The study started in 1959 and the cohort was 
followed until 1972. No comparisons showed significantly increased risks of CHD 
among the wood workers (913). 
A cohort of model and pattern makers in a German automobile company was 
formed 1960–1985 and was exposed to a wide variety of different materials 
including wood, stone powder, metals, plastics and organic solvents (76, 77). These 
studies are therefore not included in the overall evaluation.  
Occupation and industry codes on death certificates from 19 US states were 
analysed to evaluate mortality risks among men and women usually employed in 
construction occupations and who died 1984–1986. There was a decreased PMR 
among white male carpenters for IHD (0.94, 95% CI 0.92–0.97) (784).  
The relationship between carpentry and development of CHD, stroke and total 
mortality was examined among men of Japanese ancestry participating in the 
Honolulu Heart Program. After 18 years of follow-up, men who indicated that their 
present and usual occupation was carpentry had a significantly lower age-adjusted 
rate of definite CHD and a significantly lower total mortality rate compared to 
participants who were never occupied as carpenters. These results were unchanged 
when controlling for several cardiovascular risk factors and potentially confounding 
variables (647). 
In general, a decreased risk of CVD was found in studies comparing a wood dust 
exposed group with national or regional populations (6, 644, 645, 726). 
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10.3.3 Pooled analyses 
A combined cohort consisted of 28 704 persons from five cohorts: British furniture 
workers, members of the union representing US furniture workers, two cohorts of 
plywood workers and one of wood model makers (6, 105, 106, 644, 645, 783, 796). 
Pooled analyses carried out for all cohorts combined, the two furniture worker 
cohorts combined, and the two plywood workers cohorts combined, showed no 
increased mortality from circulatory diseases or IHD. For all cohorts combined, 
SMRs (95% CIs) were 0.8 (0.7–0.8) and 0.8 (0.7–0.8), respectively (225).  
10.3.4 Indirect evidence 
Cryptogenic fibrosing alveolitis, synonymous with idiopathic pulmonary fibrosis, 
is probably a disease entity of increasing frequency (425). Idiopathic pulmonary 
fibrosis has been associated with a prothrombotic state (693) and with various co-
morbidities including cardiovascular manifestations such as pulmonary hyper-
tension, heart failure, coronary artery disease and atrial arrhythmias (11). Idiopathic 
pulmonary fibrosis has been associated with occupational wood dust exposure (55, 
359, 426, 448, 749). 
10.3.5 Conclusion 
Three studies from Sweden and Finland indicated a relationship between exposure 
in the wood industry and CVD, but no exposure-response information was found 
(377, 713, 967). A pooled analysis did not show increased risks for CVD (225). 
 
There is limited evidence for an association between exposure in the wood 
industry and CVD. 
10.4 Pulp and paper industry 
10.4.1 General 
Worldwide, the pulp and paper industry employs hundreds of thousands of workers. 
Production of pulp and paper is an important sector of Finnish, Norwegian and 
Swedish industries. The historical production was dominated by the sulphite 
process but today the sulphate process has taken the lead. The occupational 
chemical exposures in this industry comprise paper dust but also e.g. wood dust, 
calcium carbonate, chlorine, chlorine dioxide, formaldehyde, hydrogen sulphide, 
organic sulphides, sulphur dioxide, terpenes, and cutting and lubricating oils (31, 
481, 508, 712, 738). The exposures vary considerably between processes and 
departments (969). Further exposures include microorganisms (388), noise, heat 
and shift work (508, 536).  
Epidemiological studies and risk estimates are presented in Appendix, Table 
A19. 
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10.4.2 Occupational epidemiological studies  
A Swedish cohort of 18 163 male and 2 291 female pulp and paper mill workers 
employed 1939–1999 and with more than 1 year of employment was followed 
1952–2001. The total Swedish population served as referents. SMRs (95% CIs) for 
total mortality was 1.02 (0.98–1.06) among men in the sulphate mills and 0.93 
(0.90–0.97) among men in the sulphite mills. Mortality (SMR, 95% CI) from acute 
MI was increased among both the sulphate (1.22, 1.12–1.32) and sulphite (1.11, 
1.02–1.21) mill male workers. Male mortality was also increased due to the same 
diagnose in the department of sulphate pulping (1.29, 1.07–1.54), paper production 
(1.26, 1.06–1.49) and maintenance (1.16, 1.02–1.30). Mortality from CeVD was 
not increased in males. In female workers, there were no significantly increased 
risks (30).  
The mortality pattern among Swedish pulp and paper mill workers was evaluated 
in a case-control study encompassing 4 070 men deceased 1950–1987. The subjects 
were identified from the register of deaths and burials in six parishes and 619 were 
identified as pulp and paper mill workers. No increased risks of IHD or CeVD were 
observed (1028).  
In a Swedish case-control study, the risk of a first MI was estimated in various 
occupational groups. Totally 26 847 male cases were identified from both hospital 
discharge and death records. Two referents for each case were randomly selected 
from the study base. Increased risks (RR, 95% CI) were found among paper and 
paperboard workers (1.6, 1.0–2.7) and paper pulp workers (1.3, 1.0–1.7), after 
adjustment for age, county and socioeconomic group (377). 
Mortality among workers in the Finnish pulp and paper industry was evaluated 
in a retrospective cohort study of 3 520 workers who had been employed 
continuously for at least 1 year 1945–1961. Mortality was followed up until 1981. 
National mortality rates were used for comparison. Overall mortality for the entire 
cohort did not differ from that expected (1 044 observed vs 1 029 expected, SMR 
1.01), but there was an excess of deaths (SMR, 95% CI) from diseases of the 
circulatory system among men (1.21, 1.09–1.34). This was due to the excess of 
deaths from IHD found in the sulphite (1.31, 0.97–1.73), sulphate (1.42, 1.15–1.74) 
and paper (1.38, 0.95–1.93) mills and maintenance department (1.18, 1.01–1.38), 
but not in the saw mill. The existing smoking data did not explain the finding (467). 
The previously described cohort was further analysed regarding sulphite mill 
workers exposed to sulphur dioxide and sulphate mill workers exposed to hydrogen 
sulphide and organic sulphides. Among those exposed to sulphur dioxide, an excess 
of CVD deaths was noticed among males (24 observed vs 19.4 expected, SMR 1.23) 
due to an excess of coronary deaths (18 observed vs 12.4 expected, SMR 1.45). The 
CVD mortality was not affected by the duration of occupational exposure or follow-
up period. Among men exposed to hydrogen sulphide and organic sulphides, there 
was also an excess of CVD deaths (37 observed vs 24.7 expected, SMR 1.50) due 
to an excess of coronary deaths (25 observed vs 16.7 expected, SMR 1.50). These 
excesses increased with longer follow-up period. The increased CVD mortality in 
the sulphate mill cohort could not be explained by common cardiovascular risk 
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factors and may therefore have been associated with the occupational exposures 
(469). 
All economically active persons in Finland were included in a census study. 
Occupations were registered in 1970 and the total cohort follow-up period was 
1971–1991. Male pulp mill workers had an increased mortality caused by IHD other 
than MI (SMR 1.34, 95% CI 1.10–1.64) (713). 
A total of 3 143 female pulp and paper workers first employed 1920–1993 were 
included in a Norwegian cohort. The follow-up period was 1951–2000. SMRs were 
calculated using the national female mortality rates as referents. Poisson regression 
analysis was used to examine internal relations between the duration of employment 
in paper departments and the risk of death from selected causes. The study showed 
increased risks (SMR, 95% CI) for CVD (1.17, 1.05–1.30), IHD (1.22, 1.03–1.43) 
and CeVD (1.16, 0.94–1.42). Analysis by department showed that paper department 
workers with short-term employment had the highest mortality risk. Internal 
analyses revealed a 5% increase in the risk of dying from IHD among paper depart-
ment workers exposed to paper dust. The risk decreased with increasing duration of 
employment (536). 
A cohort of 4 242 men and women employed at a Scottish paper mill between 
1955 and 1992 was followed until 1994. No increased mortality (SMR, 95% CI) 
was found for CVD (1.00, 0.92–1.08), IHD (0.98, 0.88–1.09) and CeVD (1.12, 
0.94–1.33) (184). 
A French cohort comprising 5 529 male and 876 female pulp and paper mill 
workers employed in four factories was followed 1968–1992. The CVD mortality 
(SMR, 95% CI) was 0.80 (0.68–0.93) (1021). 
Mortality was studied in a cohort of 3 241 workers employed 1970–1992 in four 
pulp and paper mills in Catalonia, Spain. SMRs were derived using mortality rates 
of Spain as the reference. For all workers, the SMR (95% CI) from CVD was 0.55 
(0.39–0.74) (821).  
There are several studies from the US including two proportionate mortality 
studies utilising death certificates and work histories. Solet and coworkers collected 
data from 1 010 decedent members of the United Paperworkers International Union 
who died 1970–1984. A total of 201 white men had worked in pulp and paper 
production. The PMR regarding arteriosclerotic heart disease was 1.00 (95% CI 
0.78–1.26) (893). Another study comprised 2 113 US and Canadian members of  
the Pulp, Sulfite, and Paper Workers’ Union, 1935–1964. There was a non-
significantly increased risk of circulatory diseases (PMR 1.14) among pulp and 
paper workers. Similar risk estimates were observed in several subgroups (643). 
The US cohort studies of pulp and paper workers did not demonstrate any increased 
risks of CVD compared with national rates (398, 399, 609, 787, 1035). However, 
an internal comparison showed an increased risk of CVD in other chemical pulping 
processes, excluding sulphate (Kraft) and sulphite pulping (609). 
A cohort study of 8 456 pulp and paper mill workers from New Zealand who 
worked at least 1 year between 1978 and 1990 did not show any increased mortality 
due to diseases of the circulatory system (SMR 0.78, 95% CI 0.64–0.93) (624). 
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10.4.3 Pooled analyses  
A cohort comprised 57 613 pulp and paper workers (51 240 men and 6 373 women) 
who had worked at least 1 year in this industry in Brazil, Denmark, Finland, France, 
Japan, New Zealand, Norway, Poland, South Africa, Spain, Sweden or the US. The 
subgroup with high sulphur dioxide exposure did not exhibit an increased mortality 
of diseases of the circulatory system (SMR 0.96, 95% CI 0.86–1.07) (549). 
10.4.4 Exposure-response relationships  
The influence of exposure duration in the pulp and paper industry on the risk for 
CVD was addressed in a few studies, but no positive exposure-response relation-
ships were observed (184, 469, 536, 1035). 
10.4.5 Markers of effect 
The relationship between several metrics of exposure and some traditional markers 
of inflammation in blood (CRP, SAA and fibrinogen) was studied among workers 
in a Swedish pulp and paper mill. The mean 8-hour TWA concentration of personal 
sampled inhalable dust was 0.30 mg/m3 (range 0.005–3.3). Statistically significant 
relationships were found between personal sampled total dust exposure and the 
three inflammatory markers. There were also statistically significant relationships 
between inhalable dust levels (personal sampling) and levels of CRP and SAA. 
Exposure below 0.46 mg/m3 was not related to CRP and SAA (1010).  
10.4.6 Conclusion 
Five studies from Finland, Norway and Sweden indicated a relationship between 
exposure in the pulp and paper industry and CVD mortality, but no positive 
relationships between exposure duration and CVD were observed (30, 377, 467, 
536, 713). One study, however, showed a positive relationship between particle 
exposure and some inflammatory markers in the blood of pulp and paper mill 
workers (1010).  
 
There is moderately strong evidence for an association between exposure in the 
pulp and paper industry and CVD. 
10.5 Textile industry 
10.5.1 General 
Over 60 million people are employed in the textile or clothing industry worldwide 
(528). Textile workers are exposed to textile dusts, both natural and synthetic, 
throughout the textile manufacturing process. The largest single exposure in this 
industry is cotton dust. Airborne exposure to endotoxins occurs in cardrooms in the 
cotton industry and during wool carpet-weaving. Textile workers are also exposed 
to many chemicals which are used in dyeing processes and in crease-resistance and 
flame-retardant treatments (434). 
In 1861, Greenhow was one of the first British observers to describe a respiratory 
disease in the cotton trade characterised by difficulty in breathing. It was recorded 
  
103 
that card room workers were apt to become asthmatic about middle life and that 
few were very long-lived. This disease was later referred to as “byssinosis” (837). 
Subjects exposed by inhalation to dust from cotton, flax or soft hemp may develop 
a characteristic feeling of chest tightness on Mondays accompanied by an 
impairment of respiratory function. This reaction is classically referred to as the 
first stage of byssinosis (839). 
The first reference made to CVD mortality among cotton workers by the 
Registrar General is in the Annual Report from 1891. The mortality of cotton 
operatives from circulatory diseases showed an excess of one-fifth compared to 
occupied males. Also 10 years later, in 1901, the Registrar General recorded a slight 
excess in the death rates of cotton workers from circulatory diseases (837). Old 
reviews from the 1880–1932 Decennial Supplements to the Annual Report of the 
Registrar General of Births, Deaths and Marriages in England and Wales revealed 
increased overall mortality for employed males (particularly excesses among older 
cardroom and blowroom operatives) for CVD and respiratory diseases [cited in 
reference (633)]. 
Epidemiological studies and risk estimates are presented in Appendix, Table 
A20. 
10.5.2 Occupational epidemiological studies  
Two studies compared textile workers with gainfully employed or economically 
active persons. A Swedish study found an increased mortality among men due to 
IHD (SMR 1.15, 95% CI 1.08–1.22) based on 988 cases (888). A Finnish study 
showed an increased mortality due to CeVD among male weaving machine 
operators (SMR 2.05, 95% CI 1.02–3.70) based on only 11 cases (713).  
A cohort of all people in Denmark aged 20–59 years in 1981 was followed up for 
4 years for emigration, death and hospital admission for IHD as the primary 
diagnosis. The data set allowed tabulation of rates of hospitalisation by occupation, 
position and industry. A group at significant excess risk of IHD was e.g. self-
employed males in the textile industry (standardised hospitalisation ratio 1.85, 95% 
CI 1.03–3.35) (973). 
A Polish cohort of textile workers comprising 2 852 males and 4 693 females 
who had worked ≥ 10 years in one of the Lódź cotton plants 1964–1993 was 
followed through 1995. Polish national rates served to calculate SMR values.  
Male workers had an increased mortality (SMR, 95% CI) for atherosclerosis (1.45, 
1.25–1.67) but not for circulatory diseases (0.99, 0.91–1.08), IHD (0.92, 0.78–1.08) 
or CeVD (0.81, 0.62–1.05). The highest risks were found for atherosclerosis in the 
weaving (1.41, 1.07–1.83) and spinning (1.75, 1.29–2.33) departments. Female 
workers had no significantly increased risk for any CVD diagnosis (933). 
Occupational mortality data (1970–1972) for England and Wales showed an 
increased risk among male textile workers for circulatory disease (SMR 1.21) and 
CeVD (SMR 1.47). After social class standardisation, the SMRs decreased to 1.12 
and 1.36, respectively (350). 
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Two proportional mortality studies with subjects from England and Wales  
(1979–2000), and Rhode Island, US (1968–1978), showed increased risks for IHD 
with the most consistent increases found among weavers (243, 1051), spinners and 
winders (1051). 
A US cohort of 1 444 white workers (1 062 men and 382 women) employed at 
two cotton mills in North Carolina some time 1937–1940 was followed 1940–1975. 
There were increased mortalities from arteriosclerotic heart disease among males 
(SMR 1.37, P < 0.01) and females (SMR 1.58, P < 0.02) in the yarn processing 
(633). 
Most studies focused on cotton textile workers but one cohort study investigated 
workers of a synthetic textiles plant in Quebec, Canada. The cohort consisted of 
7 487 men and 2 724 women who had worked at least 1 year at the plant, and who 
were either working in 1947 or were newly employed between 1947 and 1977. The 
period of follow-up was 1947–1986. Relationships between duration of exposure 
and mortality were investigated by internal analyses. Among men, risks for IHD 
increased with length of service at the plant even though the SMRs were less than 
unity (overall SMR 0.76, 95% CI 0.70–0.83), whereas no trend was observed for 
women. SMRs and RRs were also calculated according to duration of employment 
in each processing unit; some associations of potential significance were observed 
(for IHD in the maintenance and janitor units and CeVD in the weaving unit) (344). 
10.5.3 Meta-analyses  
A meta-analysis comprised totally seven cohorts of cotton textile workers from the 
UK, Finland and the US. Comparisons were made with national or state standard 
populations. Risk estimates (meta-SMR, 95% CI) were not increased for circulatory 
system diseases for males (0.85 0.79–0.91) and females (0.94, 0.81–1.06) (922).  
10.5.4 Exposure-response relationships 
The mortality rates of cerebral vascular lesions were significantly higher among 
male strippers and grinders (6.4/1 000) compared with the general male population 
55–64 years of age (2.0/1 000) according to the Registrar General’s mortality 
figures for 1930–1932 in England and Wales. Strippers and grinders had the 
greatest dust exposure. Cotton spinners also had a significantly increased mortality 
(3.4/1 000) and their exposure may have been as high, as stripping dust may have 
reached the spinning rooms (837). No air levels were presented in the paper but 
photos illustrated a dusty work environment. 
The mortality of 3 458 workers in the British cotton industry, originally enrolled 
in a study of respiratory symptoms in the period 1968–1970, was followed to the 
end of 1984. Total mortality and mortality from respiratory disease were less than 
expected, and both decreased as length of service increased. These patterns of 
mortality indicate a healthy worker survivor effect. An increased mortality from 
circulatory diseases was found among those exposed for 15–29 years (SMR 1.25, 
95% CI 1.02–1.52). However, risk estimates were lower both for those with shorter 
exposure (SMR 0.88) and for those with longer exposure (SMR 0.79) (414).  
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Totally 267 400 female textile workers in Shanghai, China, were followed for 
CVD mortality 1989–2000. Factory exposures were approximated by sector 
classifications based on materials and processes. Quantitative endotoxin and cotton 
dust measures were available for a subcohort of 3 188 workers. Cox proportional 
hazards modelling was used to estimate risks. A slightly elevated mortality (HR, 
95% CI) for the cotton sector was seen for haemorrhagic stroke (1.12, 1.02–1.23) 
but not for ischaemic stroke (1.12, 0.97–1.31). Increased cumulative endotoxin 
exposure expressed as endotoxin units/m3-years tended to increase total stroke 
mortality, after adjustment for age and smoking (P for trend 0.09) (324). 
10.5.5 Indirect evidence 
A cohort of Chinese cotton textile workers was established in 1981 and followed 
for 20 years. These cotton workers had greater annual declines of FEV1 compared 
with silk workers. Chronic loss in lung function was more strongly associated with 
exposure to endotoxins than with dust (988) (for a description of the association 
between lung function and CVD, see Chapter 4).  
10.5.6 Conclusion 
Most studies comparing cohorts of cotton textile workers with the general 
population showed a decreased mortality due to CVD, which was also confirmed 
by a meta-analysis (922) comprising seven cohort studies. Two studies showed an 
increased risk for CVD among textile workers compared to other workers (713, 
888).  
One study showed that the highest risk from CeVD was seen in the highest 
exposed cotton workers, i.e. strippers and grinders (837).  
 
There is limited evidence for an association between exposure in the textile 
industry and CVD.  
10.6 Agriculture 
10.6.1 General 
The proportion of individuals involved in farming has decreased regularly in 
populations worldwide in the last decades, from 50% in 1980 to 40% in 2010. 
During the same period, the absolute number rose from 1 billion to 1.3 billion. 
However, in high-income countries, the proportion as well as the number of 
individuals working in agriculture decreased drastically from 13% (71 million) in 
1980 to 4% (26 million) in 2010 (554). 
Agricultural workers and farmers are exposed to a mixture of dusts with widely 
varying constituents and concentrations. Dairy farmers are exposed to dust during 
tilling, harvesting, and feeding animals with hay, ensilage, crushed grain and 
supplements containing minerals and proteins. The aerosols contain varying 
amounts of highly immunogenic and toxic agents, such as allergens, microbial 
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antigens, endotoxins, mycotoxins and proteolytic enzymes. Airborne particles from 
mouldy materials contain spores from moulds and Gram-positive bacteria (599). 
In 1555, Olaus Magnus, the last catholic archbishop in Sweden, wrote about 
threshing in winter time: “When separating the grain from the chaff, care must be 
taken to choose a time when there is a suitable wind which will sweep away the 
grain dust, so that it will not damage the vital organs of the threshers. This dust is 
so fine that it will almost unnoticeably penetrate into the mouth and accumulate in 
the throat. If this is not quickly dealt with by drinking fresh ale, the thresher may 
never again or only for a short period eat what he has threshed” (774). The 
pulmonary disorder known as farmer’s or thresher’s lung, due to the inhalation of  
the dust from mouldy hay, was first described in 1932 by Campbell in Britain (140). 
This disease is an example of hypersensitivity pneumonitis, also known as extrinsic 
allergic alveolitis, which is a syndrome caused by an exaggerated immune response 
to the inhalation of a variety of antigenic particles found in the environment (194).  
Fatal cases of farmer’s lung are rare; based on death certificates, 13 cases were 
identified in Finland 1980–1990. Compared with incidence data from the years 
1980–1982, the mortality was estimated to be 0.7%. On average, death occurred  
8 years after the diagnosis of farmer’s lung. One patient died acutely after a heavy 
mould exposure. The other patients had chronic disease and the immediate cause of 
death was pneumonia in 7 patients, respiratory insufficiency in 4 patients, and 
pneumothorax in 1 patient. The majority of these cases had suffered from symptoms 
of farmer’s lung for more than 1 year before the diagnosis was established and 
fibrotic changes were already visible in the chest radiograph at the time of the 
diagnosis. Cor pulmonale was diagnosed in 8 patients (504). 
Epidemiological studies and risk estimates are presented in Appendix, Table A21.  
10.6.2 Occupational epidemiological studies  
Most epidemiological studies observed no association between the occupational 
entities agricultural workers or farmers and CVD when the mortality in these 
occupations was compared with that of the general population. However, some 
studies of livestock workers (889), animal caretakers (713) and livestock farmers 
(546) indicated increased risks.  
10.6.3 Meta-analyses  
A meta-analysis comprising 12 studies has been presented regarding the relation-
ship between farming and the occurrence of CVD. The total number of deaths due 
to IHD was 65 898 and the meta-RR was 0.89 (95% CI 0.88–0.90). Two studies 
showed a non-significantly increased RR. Eight studies demonstrated an RR below 
1.0, whereof six studies showed a significantly decreased risk (107, 216).  
Acquavella and coworkers performed a meta-analysis comprising 14 studies of 
white male farmers from Finland, Iceland, Sweden, Italy, Canada and the US. The 
summary RR was 0.86 (95% CI 0.78–0.95) regarding IHD (7).  
Potential health effects from exposure to crop protection chemicals were 
investigated through systematic review and meta-analysis of 37 separate cohorts of 
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workers in the crop protection product manufacturing industry. The meta-SMRs 
(95% CIs) for CVD, CHD and CeVD were 0.91 (0.84–0.99), 0.99 (0.9–1.10) and 
1.05 (0.89–1.25), respectively (462).  
10.6.4 Exposure-response relationships  
The relationship between ambient PM2.5 and CVD mortality was studied in the US 
Agricultural Health Study cohort. The cohort (n = 83 378) included farmers, their 
spouses and commercial pesticide applicators residing primarily in Iowa and North 
Carolina. Deaths occurring between enrolment (1993–1997) and 30 December 2009 
were identified by record linkage. Six-year average (2001–2006) remote sensing-
based estimates of ground-level PM2.5 were assigned to participants’ residences at 
enrolment, and Cox proportional hazards models were used to estimate HRs in 
relation to a 10-µg/m3 increase in PM2.5, adjusted for individual-level covariates. In 
total 1 967 deaths due to CVD occurred over a median follow-up time of 13.9 years. 
Positive associations were observed between ambient PM2.5 and CVD mortality 
among men. These associations were strongest among men who did not move from 
their enrolment address (HR 1.63, 95% CI 0.94–2.84), and in particular, among 
non-moving participants with the most precise exposure geocoding (HR 1.87, 95% 
CI 1.04–3.36). The authors concluded that rural PM2.5 may be associated with CVD 
mortality in men, however, similar associations were not observed among women 
(999).  
10.6.5 Indirect evidence 
An increased risk of hospitalisation for venous thromboembolism was presented 
among both male and female blue-collar workers and farmers. This disease is 
associated with an increased tendency for blood coagulation. The results were 
observed in a nationwide database constructed by linking Swedish census data to 
the Hospital Discharge Register 1990–2007 (1059).  
10.6.6 Markers of effects 
Previously unexposed volunteers who inhaled dust in a swine confinement building 
during 4 hours had increased levels of IL-6 and fibrinogen in blood after exposure 
(887). A similar but lower increase in blood IL-6 levels was observed when swine 
farmers were exposed to this environment (731). 
Greenhouse workers, exposed to bioaerosols comprising e.g. bacteria and fungi, 
did not have higher serum levels of SAA and CRP than referents. However, 
endotoxin exposure was positively associated with serum concentrations of SAA 
and CRP (597).  
Plasma levels of fibrinogen were studied in some gross occupational groups in 
the Kuopio region of eastern Finland. The concentrations of fibrinogen were 
significantly higher among farmers than among white-collar workers after 
adjustment for alcohol consumption, BMI, physical fitness, smoking, coffee 
consumption, HDL cholesterol, LDL cholesterol, blood leukocyte count and 
prevalent disease (at least one sign of IHD, hypertension, diabetes or previous 
stroke) (1025). 
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10.6.7 Conclusion 
A meta-analysis did not demonstrate associations between farming and CVD (107, 
216). However, a few studies of animal caretakers and livestock farmers indicated 
increased risks (546, 713, 889). There were no indoor exposure-response data for 
agricultural workers or farmers and CVD, but one study showed a relationship 
between rural environmental particle exposure and CVD. 
Extreme exposures have caused hypersensitivity pneumonitis (farmer’s lung) 
which has further developed into cor pulmonale (194, 504). 
 
There is insufficient evidence for an association between agriculture work and 
CVD. 
10.7 Cleaning 
10.7.1 General 
Cleaners constitute a significant proportion of the workforce. Cleaning is associated 
with several chemical agents such as surfactants, acidic and alkaline substances, 
water softeners, disinfectants and solvents. Some of these agents are administered 
as aerosols and some may evaporate from surfaces. Consequently cleaners can be 
exposed to aerosols as well as gases (708). In a Swedish survey, 37% of female 
cleaners reported exposure to air pollutants during at least one fourth of their 
working hours, compared with 18% of all participating women (692). In a Spanish 
study, the majority of cleaners reported respiratory symptoms (1057). Nose and 
throat symptoms were common among 775 Danish female cleaners (44%) and most 
of them reported improvement of symptoms during holidays and weekends. 
Furthermore, chronic bronchitis was more common among the cleaners who 
continuously used sprayers (OR 3.2, 95% CI 1.0–10.4) (708). 
10.7.2 Mechanistic evidence 
House dusts collected from carpet, bed, shelf and floor by vacuum cleaning were 
found to trigger the production of IL-6 and IL-8 in a dose-dependent manner in  
lung epithelial cells in vitro. The interleukin production was several-fold higher 
compared with that obtained after swine dust exposure (827). In the Copenhagen 
School Study, dusts from schools with a high prevalence of building-related 
symptoms (e.g. eye, nose and throat irritation, nasal congestion, headache, fatigue 
and difficulties in concentration) had a higher potency to stimulate IL-8 secretion 
in lung epithelial cells compared with dusts from schools with a low prevalence of 
building-related symptoms (20). 
10.7.3 Occupational epidemiological studies 
A Swedish case-control study comprised 9 755 women with MIs. For each case two 
controls were selected from the study base through random sampling, stratified by 
age, county and socioeconomic group. An increased risk (RR, 95% CI) was found 
among female cleaners (1.2, 1.0–1.5), after adjustment for age, county and calendar 
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year. The risk decreased after adjustment for socioeconomic group (1.1, 0.9–1.4) 
(377). 
Three cohorts of female cleaners based on Swedish census information on 
gainfully employed women were followed until 31 December 1995: 1) all cleaners 
in the 1970 census, 2) all cleaners in the 1980 census who were also recorded as 
cleaners in the 1970 census, and 3) all cleaners in the 1990 census. These cohorts 
were not independent as one individual might belong to one, two or all three 
cohorts. Mortality (SMR, 95% CI) due to IHD was higher in all cohorts of cleaners; 
the 1st cohort (1.25, 1.21–1.28), the 2nd cohort (1.34, 1.22–1.46) and the 3rd cohort 
(1.25, 1.02–1.51) (883). 
A later Swedish cohort included all manual workers identified from the Swedish 
national census in 1980 who were alive as of 1 January 1987. First time events of 
ischaemic or haemorrhagic stroke during the period 1987–2005 were identified 
through linkage to the Hospital Discharge Register and the National Cause of Death 
Register. An increased risk (HR, 95% CI) of ischaemic stroke (1.11, 1.07–1.14) and 
haemorrhagic stroke (1.14, 1.05–1.23) was found among women exposed to low 
levels of large particles (> 1 µm). The dominant occupation in this group of women 
was cleaners (96%) (886).  
All economically active persons were included in the Finnish census of 1970 and 
followed until 1991 regarding mortality. CVD was more common among female 
cleaners and cleaning supervisors than in the reference population (SMR 1.10 based 
on 4 064 deaths). It is worth noting that younger persons (25–44 years in 1970; 
SMR 1.39, 95% CI 1.25–1.54) had a higher risk than older persons (45–64 years in 
1970; SMR 1.07, 95% CI 1.04–1.11). The same pattern was demonstrated for MI 
as well as CeVD (713). This result might be explained by a higher proportion of 
individuals who were retired and therefore not exposed during the whole follow-up 
period. 
An occupational study in the Nordic countries was based on censuses and their 
linkage to mortality statistics. The survey population consisted of individuals aged 
20–64 years around the first of January 1971. The follow-up period was 10 years, 
1971–1980. The reference population consisted of all economically active persons. 
The total number of deaths due to diseases of the circulatory system and “sudden 
death” among female cleaners was 4 046 with an SMR of 1.19. National SMRs 
were 1.48 (Finland), 1.16 (Denmark), 1.11 (Norway) and 1.06 (Sweden) (711). 
Occupational information was obtained from the 1971 census records of women 
in the Longitudinal Study carried out by the Office of Population Censuses and 
Surveys comprising a sample of 1% of the population of England and Wales.  
The analysis was based on 77 081 women aged 15–59 years. Charwomen, office 
cleaners and window cleaners had a non-significantly increased SMR for IHD of 
1.35, based on 10 deaths (673).  
The mortality of 53 140 male and 96 914 female cleaners aged 30–60 years 
selected from the 1991 census was compared with the mortality of the total non-
manual Belgian working population (854 540 men and 654 287 women). The 
population was followed until 2011. Male and female cleaners had smoking-
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adjusted SMRs (95% CIs) for IHD of 1.22 (1.13–1.31) and 1.40 (1.25–1.57), 
respectively. Smoking-adjusted SMRs (95% CIs) for CeVD mortality were also 
increased among male (1.20, 1.06–1.35) and female (1.13, 1.00–1.27) cleaners 
(981). 
10.7.4 Conclusion 
Six studies indicated an increased risk of CVD among female cleaners (377, 711, 
713, 883, 886, 981). No meta-analyses or exposure-response studies were found.  
 
There is limited evidence for an association between cleaning and CVD.  
11. Non-chlorinated organic solvents 
Organic solvents refer to chemicals with an ability to dissolve fats, resins, lipids and 
polymers. These compounds are generally colourless, liquid at room temperature 
and have high evaporating rates. Most solvents have a faint or pleasant odour. 
Styrene is a plastic monomer with similar properties often categorised as solvent 
although not strictly so. Mixtures of solvents are used in several occupations  
for many purposes as degreasant, thinner, solvent and extractant. Occupations 
associated with organic solvent exposures are painters, varnishers and carpet layers. 
(57). Chlorinated solvents are presented in Chapter 12. 
11.1 Carbon disulphide 
11.1.1 General  
The worldwide production capacity of carbon disulphide is approximately 1 million 
tonnes; most of it used in the production of viscose fibre and cellophane film. 
Carbon disulphide is also released as a by-product in oil and gas processing. 
Additional industrial releases result from its use in the chemical industry and tire 
manufacturing. Virtually all anthropogenic and natural releases are to air. Carbon 
disulphide is also produced naturally by soil and sediment microorganisms, 
vegetation, forest and grass fires, and volcanoes. Worldwide, at least 40% and 
possibly as much as 80% of releases are a result of natural or biogenic activity (447). 
Carbon disulphide is extensively absorbed by inhalation, but also via the skin. It 
is biotransformed to several metabolites, of which 2-thiothiazolidine-4-carboxylic 
acid is used for biomonitoring of exposure at the workplace (447). 
Available data to assess the potential of carbon disulphide to induce irritancy or 
sensitisation are limited. Inhalation in viscose rayon plants is irritating to the 
mucous membranes, including the respiratory system, but the role of concomitant 
exposure to hydrogen sulphide and sulphuric acid in induction of these effects is 
unknown (447).  
Based on the results of studies of workers exposed to carbon disulphide and 
supporting data from animal experiments, the nervous system appears to be the 
critical target for carbon disulphide-induced toxicity. Other effects for which there 
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is considerable weight of evidence in humans exposed to carbon disulphide include 
alterations in serum lipids and blood pressure that are associated with increased risk 
of CVD, systemic ophthalmological effects (including those on colour vision and 
damage to the blood vessels of the retina) and with higher exposures increased 
mortality from heart disease (447).  
Vigliani described 43 carbon disulphide poisonings during the period 1946–1953 
from four Italian plants producing artificial textile fibres by the viscose process. 
Cerebral arteriography of several cases and necropsy of 3 cases revealed that the 
encephalopathy was vascular in nature and due to a sclerosis of the small arteries 
and capillaries of the brain and spinal medulla. During the period 1938–1944 the 
concentrations of carbon disulphide were higher than 200–300 mg/m3 (60–90 ppm) 
in some departments of the factories. Vascular lesions have also been observed in 
animal studies (1019).  
11.1.2 Occupational epidemiological studies  
The CVD mortality of a cohort of 343 Finnish men exposed for at least 5 years to 
carbon disulphide in a viscose rayon plant was followed 1967–1982. There was an 
increased mortality among the exposed (RR 1.6, 95% CI 1.0–2.6) compared to that 
in an equally large cohort of male paper mill workers (718).  
A UK cohort of viscose rayon workers, previously described by Tiller et al. (961), 
was reconstructed and followed to the end of 1982. The cohort now comprised 
totally 2 848 men (930). The spinners, the workers most heavily exposed to carbon 
disulphide, had a significantly higher mortality from IHD (SMR 1.72). The IHD 
mortality tended to increase with increasing exposure score. However, over the age 
of 65 years mortality tended to decline with increasing exposure. This was contrary 
to expectation under the hypothesis that carbon disulphide promotes athero-
sclerosis. Instead it suggests that carbon disulphide has some type of reversible, 
direct cardiotoxic or thrombotic effect. This was supported by the findings that there 
was a strong significant trend for IHD mortality to increase with increasing 
exposure in the previous 2 years. Further, IHD mortality showed a highly significant 
trend with exposure among current workers but no such trend among workers who 
had left the industry (930). 
A Polish cohort of 2 085 male workers with a diagnosed chronic occupational 
carbon disulphide poisoning during 1970–1990 was followed until 1992. Increased 
mortalities (SMR, 95% CI) were observed for diseases of the circulatory system 
(1.39, 1.25–1.54), IHD (1.37, 1.14–1.64) and CeVD (1.88, 1.43–2.42). Increased 
mortality due to IHD was observed in the ages 40–59 years and due to CeVD in the 
ages 50–69 years (735). 
A cohort of 10 418 men employed 1957–1979 at four US rayon plants was 
followed until 1983. The national US population served as referents. There was a 
non-significantly increased mortality (SMR, 95% CI) due to all circulatory diseases 
(1.04, 0.98–1.10), arteriosclerotic heart disease (1.04, 0.97–1.12) and CeVD (1.08, 
0.90–1.28). When the cohort was restricted to 4 448 workers with intermediate or 
heavy exposure (based on job titles), the corresponding SMRs increased regarding 
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circulatory diseases (1.14, P < 0.05) and arteriosclerotic heart disease (1.24, 
P < 0.01), whereas the SMR for CeVD decreased to 1.03. Within the restricted 
group, men exposed for 15 years had increased mortalities (SMRs) from arterio-
sclerotic heart disease when starting exposure both prior to 1945 (1.38, P < 0.05) 
and 1945–1949 (1.92, P < 0.01), whereas there were no significant increases among 
men starting exposure after 1950 (596). 
Liss et al. investigated the proportional mortality in a viscose rayon plant in 
Ontario, Canada, with 279 deaths recorded. The general population in Ontario 
contributed with reference mortality numbers. In a subgroup of highly exposed 
carbon disulphide workers, mortality from IHD was less than expected (PMR 0.82), 
whereas mortality from stroke was greater than expected (PMR 2.07, P < 0.05). The 
excess was confined to workers who died at an age ≥ 65 years (PMR 2.29, P < 0.01), 
but workers who died at an age < 65 years (PMR 1.01) comprised only one fatality. 
In addition, highly exposed workers had an increased mortality from CeVD (OR 
4.92, 1.66–14.65) compared to viscose rayon workers with lower exposure (569).  
Nishiwaki and coworkers studied male workers from 11 Japanese rayon factories. 
The cohort comprised 217 exposed, 125 ex-exposed and 324 referent workers. All 
participants were investigated by magnetic resonance imaging (MRI) of the brain 
at base-line and after 6 years. Signs of hyperintensive spots were evaluated and may 
indicate silent cerebral infarctions. There was a significant increase of hyper-
intensive spots (OR 2.27, 95% CI 1.37–3.76) during the 6-year follow-up after 
adjustment for age, smoking, alcohol consumption, BMI, education, systolic blood 
pressure and HDL cholesterol. The geometric mean exposures of carbon disulphide 
and the biomarker 2-thiothiazolidine-4-carboxylic acid in urine during this period 
were 4.87 ppm [standard deviation (SD) 1.91] and 1.60 mg/g creatinine (SD 1.91), 
respectively. No exposure-response relationships were observed among the 
exposed workers. The authors concluded that exposure to carbon disulphide below 
10 ppm might increase the number of hyperintensive spots in brain MRI (710). 
11.1.3 Meta-analyses  
In 2002, Tan and coworkers performed a meta-analysis of 11 cohort studies on 
carbon disulphide exposed workers. The RR for CVD was 1.56 (95% CI 1.12–2.1) 
(938), however the Finnish cohort was included three times in the analysis (three 
follow-ups published). 
11.1.4 Exposure-response relationships 
In the UK cohort, there was a strong significant trend for IHD mortality to increase 
with increasing exposure score to carbon disulphide in the 2 years prior to death 
(930). 
The results from the first 5 years of follow-up of a Finnish cohort of carbon 
disulphide exposed workers showed a 4.7-fold (95% CI 1.4–16.1) excess mortality 
for CHD compared with a referent cohort of paper mill workers (962). After 1972, 
a preventive intervention programme instituted at the rayon plant included 
removing all workers with coronary risk factors from exposure. Exposure levels 
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were reduced after 1972 and complied with the occupational exposure limit (OEL) 
of 10 ppm. These measures were reflected in a normalisation of the mortality from 
IHD, with an RR of 1.0 in the period after the intervention (718). 
Among Japanese rayon factory workers, hyperintensive spots (may indicate 
silent cerebral infarctions) were observed on MRI of the brain after 6 years exposure 
to carbon disulphide concentrations around 5 ppm (710). 
11.1.5 Conclusion  
Several epidemiological studies showed a relationship between carbon disulphide 
exposure and CVD, including exposure-response relationships (718, 930). In one 
of the studies, compliance with the OEL of 10 ppm normalised the risk of IHD 
mortality (718). Hyperintensive spots, which may indicate silent cerebrovascular 
infarctions, were observed on MRI of the brain after 6 years exposure to carbon 
disulphide concentrations around 5 ppm (710). The increased risk of IHD caused 
by exposure to carbon disulphide may decrease when exposure ceases. It is not 
known if the occurrence of CeVD behaves in the same way.  
 
There is strong evidence for an association between exposure to carbon 
disulphide and CVD. 
11.2 Styrene 
11.2.1 General  
Styrene is a component of several types of resins used in the manufacture of a wide 
range of products. The six most common resins are polystyrene (building material, 
packaging material), styrene-butadiene rubber (tires and other vehicle components), 
unsaturated polyester resins in fibreglass-reinforced plastic (boats, storage tanks, 
bathtubs/shower stalls), styrene-butadiene latex (backings for floor coverings and 
paper), acrylonitrile-butadiene styrene (household and office equipment) and 
styrene-acrylonitrile (household products, battery casings) (661). 
11.2.2 Occupational epidemiological studies  
Mortality due to arteriosclerotic heart disease and CeVD was lower among US 
workers who developed and manufactured styrene-based products than among 
unexposed workers from the Michigan manufacturing location, with RRs (95% CIs) 
of 0.86 (0.76–0.98) and 0.95 (0.70–1.29), respectively (118). 
A cohort of 5 204 persons who produced plastic boats in two companies in the 
US 1959–1978 was followed until 1998 and was compared with Washington State 
rates. At one company, average styrene exposure was 42.5 ppm in the fibreglass 
department, and at the other company, average exposure was 71.7 ppm in the 
laminating department. These were the high-exposure departments. Workers in 
these departments did not show a significant elevation in risk for diseases of the 
heart or other diseases of the circulatory system. High-exposed workers were 
identified from air sampling results and from discussions at the plant. The high-
  
114 
exposed workers employed for more than 1 year had a mortality risk (SMR, 95% 
CI) of 1.39 (0.78–2.30) for IHD, and the mortality for IHD among low-exposed 
workers was 0.77 (0.58–0.99) (811). When the cohort was further followed until 
2011, the SMR (95% CI) for IHD was 1.15 (0.77–1.67) among high-exposed 
workers and 0.77 (0.62–0.94) among low-exposed workers. A comparison between 
high-exposed and low-exposed workers revealed a standardised relative risk (SRR) 
of 1.03 (95% CI 0.36–2.94). Mortality from CeVD was also presented. High- and 
low-exposed had SMRs (95% CIs) of 1.36 (0.59–2.68) and 1.06 (0.71–1.51), 
respectively. When comparing high-exposed and low-exposed the SRR (95% CI) 
was 1.15 (0.48–2.75). Mortality from cardiomyopathy showed significant increases 
with increasing levels of exposure, but numbers were small and not presented (809).  
A total of 15 826 people worked for at least 6 months with production of 
reinforced styrene plastic in 30 US factories during the years 1948–1977. Styrene 
exposure ranged from 1 to 200 ppm. The cohort was followed until 1989 (1036) 
and further followed until 2008 (186). Causes of death were compared with national 
mortality rates. None of these plants had been included in previous styrene studies. 
In 1977, the average exposure was 25 ppm and a decade earlier it was 35 ppm. The 
estimated TWA for all exposure was 28 ppm and the mean duration of exposure to 
styrene was 4.3 years. In the total cohort, an increased mortality (SMR, 95% CI) 
was observed for all heart diseases (1.05, 1.00–1.11) and IHD (1.08, 1.02–1.15) but 
not for CeVD (1.07, 0.94–1.22). There was an inverse trend between estimated 
cumulative styrene exposure and mortality by all heart diseases, but this trend was 
not reflected in the internal analysis (186).  
In a US case-cohort study, 498 fatal cases of IHD were compared with 997 
randomly selected persons employed 1943–1984 in two styrene-butadiene rubber 
plants. Both styrene and butadiene exposures were estimated, and ranked from 0 to 
10 in a JEM containing 579 job assignments (610). Exposure levels of styrene and 
butadiene decreased in these types of industries between the 1940s and the early 
1990s. Average exposure decreased, for styrene from 2.2 to 0.2 ppm and for 
butadiene from 5.9 to 0.8 ppm (593). Mortality (HR, 95% CI) due to acute IHD was 
elevated among those who had been exposed to styrene during the preceding 2 years 
(4.99, 1.07–23.34) but not among those exposed 2–5 years ago (0.95, 0.82–1.09), 
after adjustment for butadiene exposure (610). 
A later study examined the mortality due to IHD in a total of 16 579 men who 
worked in six styrene-butadiene rubber plants in the US and Canada. This study 
also included the two production plants from the previous study (610). No 
significant correlation between styrene exposure during the previous 2 years and 
mortality due to acute IHD could be observed in this study. There was, however, a 
correlation between average lifetime styrene exposure and chronic IHD for persons 
< 55 years of age but not among workers ≥ 55 years of age (222). The previous 
study raised the suspicion of a connection between IHD and exposure to styrene 
(610), but this later, larger study with similar design was unable to confirm such a 
connection. One possible explanation for this discrepancy may be that the previous 
  
115 
study reporting an elevated risk (610) included all employees, whereas the later 
study (222) included only persons who had been employed for at least 1 year. 
A cohort comprised 4 863 women employed for at least 1 day at eight styrene-
butadiene rubber plants in the US and Canada. The average follow-up time was 37 
years. A decreased mortality was observed regarding circulatory diseases (SMR 
0.87, 95% CI 0.79–0.95) (830).  
In a cross-sectional study of the US population during 1999–2004 (NHANES) 
comprising 3 408 subjects, a relationship was found between blood concentrations 
of styrene and several alkylbenzenes and reported physician-diagnosed CVD. 
Occupational exposure was not reported in the questionnaire (1043).  
11.2.3 Pooled analyses 
A pooled analysis included 40 688 persons who worked with reinforced plastic in 
Denmark, Finland, Norway, Sweden, Italy and the UK. Causes of death were 
compared with rates for the national populations. Mortality due to circulatory 
disease was lower than expected, SMRs for different job-categories ranged from 
0.91 to 0.97 (502). 
11.2.4 Exposure-response relationships  
A cohort of workers engaged in the development or manufacturing of styrene-based 
products in Dow Chemical Company plants in the US, 1940–1986, was followed 
until 1986. In a subcohort of workers exposed to a TWA of ≥ 5 ppm of styrene  
and ethylbenzene, an increased mortality from arteriosclerotic heart disease was 
found (SMR 1.34, 95% CI 1.04–1.71). The heart disease excess was concentrated 
primarily among the workers with relatively short (≤ 4 years) duration of exposure. 
The majority of deaths occurred many years after the workers had left their exposed 
work (118). 
In the US case-cohort study, 498 fatal cases of IHD were compared with 997 
randomly selected persons employed 1943–1982 in two rubber plants. There was a 
relationship between cumulative styrene exposure (ppm-years) and acute IHD 
mortality (HR 1.07, 95% CI 1.02–1.13), after adjustment for butadiene exposure. 
The relationship between styrene exposure the most recent 2 years and acute IHD 
mortality was estimated among workers employed 2 years or more. Recent TWA 
styrene exposures of < 0.1, 0.1–< 0.2, 0.2– < 0.3 and ≥ 0.3 ppm were associated with 
acute IHD mortality with risk estimates (HR, 95% CI) of 1.0, 1.24 (0.36–4.33), 
2.95 (1.02–8.57) and 4.30 (1.56–11.84), respectively (610). However, potential 
confounding exposures (e.g. butadiene) were not taken into account.  
11.2.5 Markers of effect 
A group of 29 hand lamination workers and sprayers exposed to styrene at 139.5 
mg/m3 (32 ppm) was compared with 19 clerks. An increased expression of ICAM-
1 on surfaces of lymphocytes, monocytes and granulocytes was observed. ICAM-1 
is responsible for cell-cell contact and for adhesion to endothelial cells and 
fibrinogen. There was a significantly lower level of soluble ICAM-1 in serum in the 
exposed group than in controls but no difference in the serum L-selectin level. The 
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authors concluded that the results indicate that styrene exposure activates the 
immune system and alters leukocyte adherence (450). 
11.2.6 Conclusion 
Four out of six longitudinal cohorts, including a subcohort, demonstrated an 
increased risk of IHD mortality among styrene exposed workers (118, 186, 222, 
610). In a subcohort of US workers, manufacturing styrene-based products and 
exposed to a TWA of ≥ 5 ppm of styrene and ethylbenzene, an increased mortality 
from arteriosclerotic heart disease was found (118). A cohort (222) and a subcohort 
(610) indicated an increased risk associated with recent styrene exposure. A 
correlation was observed between average lifetime styrene exposure and chronic 
IHD mortality among persons below the age of 55 years but not among those 55 
years and older (222), i.e. at a life period with a higher probability of retirement. 
Elevated acute IHD mortality was seen among workers recently exposed to styrene 
(0–2 years) but not among those exposed 2–5 years ago (610). These two studies 
indicated that an exposure free period decrease IHD mortality.  
A large pooled analysis showed no increased risk of CVD mortality among 
styrene-exposed workers producing reinforced plastic (502).  
 
There is limited evidence for an association between exposure to styrene and 
CVD.  
11.3 Dimethylformamide  
11.3.1 General  
N,N-Dimethylformamide (DMF) is a solvent used in factories handling poly-
urethane materials and acrylic fibres. DMF is also utilised in the pharmaceutical 
industry, in pesticide formulation and in the production of synthetic leathers, 
surface coatings, films and fibres. This colourless solvent is miscible with water 
and most organic liquids. DMF can be absorbed by inhalation and also through 
dermal contact (493). 
11.3.2 Animal studies  
Rats, mice, rabbits, guinea pigs and dogs were exposed to DMF for 58 days 
(5 days/week, 6 hours/day of which 5.5 hours at 23 ppm followed by 0.5 hour at 
426 ppm). No clinical signs of toxicity were observed in rats, mice, rabbits and 
guinea pigs. All 4 exposed dogs showed degenerative anatomical changes in the 
heart muscle (176). 
Within the US NTP, rats were exposed to DMF levels of 0, 50, 100, 200, 400  
and 800 ppm 6 hours/day, 5 days/week during 13 weeks. All rats survived the 
exposures. Body weight gains were reduced by 50–65% in rats exposed at 800 ppm 
and to a lesser extent in the 400-ppm group. Evidence of hepatocellular injury was 
noted as early as day 4, based on increases in activities of liver-specific enzymes in 
serum in both sexes exposed at 200–800 ppm. Serum cholesterol levels were 
increased at all exposure concentrations. Relative liver weights were increased in 
  
117 
males exposed at 100–800 ppm, and in females at all concentrations. Minimal to 
moderate centrilobular hepatocellular necrosis was seen in rats of both sexes 
exposed at 400 and 800 ppm; the lesion was more severe in females. Decreased 
absolute heart weights were observed at 400 and 800 ppm in both sexes, but there 
was no change regarding relative heart weights. Overall, the ECG changes were 
subtle, were not increased in incidence or severity by increased DMF exposure, and 
were not accompanied by any gross or microscopic evidence of cardiotoxicity, 
although they occurred in groups that also showed increases in serum creatine 
phosphokinase activity (591).  
11.3.3 Occupational epidemiological studies  
A cohort of 2 530 workers with potential exposure to DMF in the period 1950–1970 
was followed for mortality 1950–1982. Observed numbers of death were compared 
with the expected numbers based on Du Pont Company, national US and South 
Carolina rates. There was an increased mortality due to IHD among wage 
employees when compared with the Du Pont Company rates (62 observed vs 40.3 
expected, P < 0.01). A significant increase of IHD was also found when the cohort 
was compared with US rates, but not when compared with regional rates. There was 
no increased mortality regarding CeVD. The potential exposure for each job was 
ranked according to exposure level, but the exposure data were not used further in 
the analysis of mortality (156, 157).  
11.3.4 Conclusion 
The only cohort study located showed an increased risk of IHD mortality in workers 
with potential exposure to dimethylformamide, compared with national rates but 
not compared with local rates (157). 
 
There is insufficient evidence for an association between exposure to dimethyl-
formamide and CVD. 
11.4 Mixed organic solvents 
11.4.1 Occupational epidemiological studies 
Totally 1 292 male painters who worked in a dockyard for ≥ 12 months 1950–1992 
were followed for mortality 1960–1994. PMRs were calculated for the total cohort. 
A subcohort of 309 painters born 1900–1929 was followed 1975–1994 and 
compared with the male Scottish population. The solvents used were mainly white 
spirit, xylene, trimethylbenzene, n-butanol, trichloroethylene, naphtha and cumene. 
The total cohort had an increased risk (PMR, 95% CI) for IHD (1.32, 1.05–1.64), 
but not for CeVD (0.67, 0.35–1.17). No significant results were obtained for the 
subcohort (160). 
Painters from the International Brotherhood of Painters and Allied Trades in the 
US comprised 42 170 males with at least 1 year of union membership, born before 
1940 and alive at the end of 1975. The cohort was followed until 1994 and the 
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mortality of the painters was compared with US rates. Turpentine was used before 
World War II and was later replaced by organic solvents. The main solvents were 
toluene, xylene, ketones, alcohols, esters and glycol ethers. Metals in paint pigments 
included titanium oxide, chromium and iron compounds. The mortality (SMR,  
95% CI) was assessed regarding IHD (0.97, 0.95–1.00), cardiomyopathy (1.17, 
0.99–1.37) and hypertension with heart disease (1.19, 1.01–1.39). Based on a 
previous survey of painters in construction and maintenance, current smoking 
(48.9%) was more common in this occupation than in the entire male US population 
(36.3%) (908). 
A cohort of workers employed for at least 1 year at a large aircraft manufacturing 
facility in California since 1960 was followed until 1996. A subcohort of 9 201 
workers exposed to mixed solvents was compared with the general population in 
California for white workers and with the US general population for non-white 
workers. There was decreased mortality (SMR, 95% CI) regarding all heart disease 
(0.90, 0.85–0.96) and CeVD (0.77, 0.65–0.90). Among factory workers exposed to 
mixed solvents on a routine basis, no significant increases of any cause of death 
were found. Analyses were also conducted of workers routinely exposed to 
any mixed solvent excluding trichloroethylene and perchloroethylene. Fewer 
observations resulted in increased instability of the SMRs, but the pattern mirrored 
the previous presentations (116). 
11.4.2 Meta-analyses 
A meta-analysis included 55 published mortality studies of solvent exposed 
workers. There was a great variation of work titles (e.g. shoe manufactures, dry 
cleaners, painters, chemical and rubber industry workers) and of exposures (e.g. 
benzene, carbon disulphide, dichloromethane, DMF, dioxane, styrene and trichloro-
ethylene). The calculated risk (SMR, 95% CI) regarding circulatory diseases was 
0.85 (0.81–0.90) (161). 
11.4.3 Exposure-response relationships  
A Swedish case-control study (1 335 cases and 1 658 referents) identified first-time, 
non-fatal MI among men and women 45–70 years of age in the Stockholm County 
1992–1994. Referent subjects were selected from the population to match the 
demographic characteristics of the cases. A lifetime history of occupations with 
descriptions and durations of work tasks and specific occupational solvent 
exposures was obtained by questionnaire. The RRs were adjusted for age, sex, year 
of enrolment, hospital catchment area, smoking, alcohol drinking, hypertension, 
diabetes mellitus, overweight and physical inactivity at leisure time. There was no 
clear exposure-response relationship between solvent exposure and MI; risk 
estimates are presented in Tables 8–9 (364). 
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Table 8. Risk estimates for non-fatal myocardial infarction according to highest intensity 
of solvent exposure during at least 1 year of work (364). 
Exposure (hygienic effect a) Crude RR (95% CI) Adjusted RR (95% CI) 
Unexposed 1 1 
≤ 0.19 1.32 (1.08–1.61) 1.26 (1.02–1.55) 
0.2–0.5 1.13 (0.82–1.55) 1.05 (0.76–1.47) 
≥ 0.5 1.60 (1.04–2.48) 1.49 (0.94–2.35) 
a The sum of fractional contributions from different organic solvents in relation to their respective 
occupational exposure limit in 1993. 
CI: confidence interval, RR: relative risk. 
 
Table 9. Risk estimates for non-fatal myocardial infarction according to cumulative 
solvent exposure (364). 
Exposure (hygienic effect-years a) Crude RR (95% CI) Adjusted RR (95% CI) 
Unexposed 1 1 
> 0–0.55 1.50 (1.16–1.95) 1.50 (1.14–1.96) 
0.56–1.9 1.09 (0.82–1.44) 1.00 (0.74–1.34) 
≥ 2.0 1.31 (1.01–1.69) 1.20 (0.92–1.58) 
a The product of the average hygienic effect (see Table 8) during the exposure period and the 
exposure duration in years. 
CI: confidence interval, RR: relative risk. 
 
The Copenhagen Male Study comprised 2 974 males aged 53–75 years free from 
overt CVD at baseline (1985–1986) which were followed until December 1991. 
Adjustment was made for potential confounders including alcohol consumption, 
physical activity, tobacco smoking, serum cotinine, serum lipids, serum selenium, 
BMI, blood pressure, hypertension, social class and retirement status. There was an 
increased risk (RR, 95% CI) for first IHD event among workers exposed to organic 
solvents for ≥ 16 years (2.2, 1.2–3.9, P for trend 0.04) but not for 5–15 years (1.0, 
0.4–2.5) (923). 
Totally 7 540 middle-aged Japanese-American men participated in the Honolulu 
Heart Program during 1965–1968. The cohort was followed until 1998. Industrial 
hygienists assessed the participants’ potential for exposure to solvents based on  
their primary job. A cumulative exposure intensity score was calculated by multi-
plying the estimated exposure score (0, 1, 2 and 3) with the number of years of 
exposure for each individual. Cumulative exposure scores were categorised as none, 
low, medium and high, and were calculated as 0, 1–39, 40–79 and ≥ 80. All 
associations were assessed using Cox proportional hazards models and adjustments 
were made for education, smoking, triglycerides, physical activity, alcohol intake 
and systolic blood pressure. There was an increased risk for CHD in the highest 
exposure category with 15-year lag (151) (Table 10). 
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Table 10. Adjusted hazard ratios regarding cause-specific mortality by latency  
1965–1998 (151).  
Disease Exposure 0-year lag 
HR (95% CI) 
15-year lag 
HR (95% CI) 
Circulatory diseases None 1.0 1.0 
Low 0.83 (0.72–0.95) 0.88 (0.77–1.00) 
Medium 0.97 (0.81–1.15) 1.09 (0.86–1.39) 
High 1.05 (0.83–1.32) 
P for trend 0.526 
1.76 (0.99–3.12) 
P for trend 0.052 
CHD None 1.0 1.0 
Low 0.83 (0.68–1.02) 0.79 (0.65–0.96) 
Medium 0.81 (0.61–1.06) 1.15 (0.81–1.62) 
High 1.06 (0.75–1.48) 
P for trend 0.959 
2.27 (1.07–4.84) 
P for trend 0.333 
Stroke None 1.0 1.0 
Low 0.89 (0.71–1.13) 1.01 (0.82–1.23) 
Medium 1.11 (0.84–1.46) 1.12 (0.76–1.67) 
High 1.15 (0.80–1.67) 
P for trend 0.394 
1.18 (0.38–3.71) 
P for trend 0.083 
CHD: coronary heart disease, CI: confidence interval, HR: hazard ratio. 
11.4.4 Conclusion 
The data base on mixed organic solvent exposure comprises seven epidemiological 
studies and a meta-analysis. Out of these, two studies with internal referents 
demonstrated an increased risk for CVD. One of these showed a significantly 
increased risk for IHD after ≥ 16 years of organic solvent exposure (923). Another 
study with semi-quantitative exposure estimates showed an increased CHD 
mortality at the highest exposure (151). 
 
There is limited evidence for an association between exposure to mixed organic 
solvents and CVD.  
12. Halogenated hydrocarbons 
12.1 General  
Halogenated hydrocarbons are widely used as aerosol propellants, refrigerants, 
solvent cleaners, foam-blowing and fire-extinguishing agents and as anaesthetics. 
Stable fluorine-containing derivatives of methane and ethane often contain chlorine 
in addition to fluorine and sometimes bromine (408, 1020). These chlorofluoro-
carbons or freons are given names according to a system used worldwide. Some 
common groups are hydrofluorocarbons (HFC), hydrochlorofluorocarbons (HCFC) 
and chlorofluorocarbons (CFC); with “H” for hydrogen, the first “C” for chlorine, 
“F” for fluorine, and the last “C” for carbon. The following numbers denotes the 
number of atoms; the rightmost value is fluorine atoms, the next value to the left is 
hydrogen atoms +1 and the next value is carbon atoms -1. For the methanes there 
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is one single carbon (only two numbers), e.g. HCFC-22, chlorodifluoromethane. To 
identify isomers, letters are added after the numbers, e.g. HFC-134a and 1,1,1,2-
tetrafluoroethane. Refrigerants can also be named with the prefix R, followed by a 
number e.g. R-22 (109). 
A Finnish cohort of workers exposed to unspecified chlorinated hydrocarbon 
solvents comprised men who were in the same occupation in 1975 and 1980 and 
were 25–64 years old in 1980. The mortality for CVD was followed 1981–1994. 
Information on marital status, education and income was updated in 1985 and 1990. 
Working conditions were evaluated from a JEM comprising three categories: 
unexposed, low-exposed (three lowest quartiles of the exposed) and high-exposed 
(top quartile of the exposed). A fully adjusted Poisson regression model was applied 
which included age, period, marital status, professional status, education, income, 
occupational class and category, and working conditions. When high-exposed 
workers were compared with low- and unexposed workers, the RR (95% CI) for MI 
and CeVD mortality was 1.09 (0.95–1.25) and 1.11 (0.92–1.35), respectively 
(1031). 
12.2 Chemicals causing cardiac sensitisation to catecholamines  
12.2.1 General 
Already in 1911, Levy and Lewis reported that cats light anaesthetised with 
chloroform were unexpectedly sensitive to injected adrenaline, manifested as 
disturbances in heart rhythm (124). The tendency of volatile anaesthetic agents such 
as cyclopropane, chloroform, halothane, methoxyflurane and enflurane to sensitise 
the heart to the arrhythmogenic action of various catecholamines (monoamine 
neurotransmitters such as adrenaline, also called epinephrine) has been investigated 
in animal studies and in clinical human studies (424, 459). As an example of a 
clinical human study, Johnston et al. gave submucosal injections of adrenaline in 
saline solution during halothane or enflurane anaesthesia to 25 patients undergoing 
transsphenoidal removal of pituitary tumours. Positive evidence of ventricular 
irritability was given by the appearance of ≥ 3 premature ventricular contractions 
during or following injection. Positive or negative responses were plotted against 
the total dose of epinephrine. From these data, the effective doses for 50% of the 
exposed group (EDs50) were 2.1 µg/kg bw for halothane and 10.9 µg/kg bw for 
enflurane (459). Later studies have confirmed these results (408).  
Abusive sniffing of high concentrations of volatile halocarbons and hydrocarbons 
has been associated with sudden deaths. These chemicals involve aerosol products 
and propellants as well as industrial solvents. They include chemicals such as 
trichlorofluoromethane (CFC-11), dichlorodifluoromethane (CFC-12), chlorodi-
fluoromethane (HCFC-22), 1,1,1-trichloroethane, trichloroethylene, toluene and 
petrol (68, 124). Between 1959 and 1966 excess mortality among young asthmatic 
persons in England and Wales was associated with the use of fluorocarbon-
containing aerosols carrying sympathomimetic drugs (exogenous, e.g. isoprenaline,  
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and endogenous, e.g. adrenaline, stimulant agonists of the sympathetic nervous 
system) (245). 
12.2.2 Animal studies 
Evidence of cardiac sensitisation to catecholamines has been shown in dogs (Table 
11) (408, 812).  
12.2.3 Human experimental studies 
In this section, common names are used. For corresponding chemical names, see 
Table 11. 
Two volunteers were exposed to air, 1 000 ppm and 10 000 ppm CFC-12 for 2.5 
hours without knowing the order of exposure. ECG was continuously monitored 
and did not reveal any abnormalities (59). 
Healthy adult male and female volunteers were exposed in small groups (2–8 
subjects) to CFC-11 or CFC-12 in series of single exposures to 0, 250, 500 and 
1 000 ppm for periods of 1 minute to 8 hours. As there were no untoward health 
effects the subjects were then repeatedly exposed 5 days/week for 2–4 weeks to 
1 000 ppm CFC-11 or CFC-12. The concentrations of gases were recorded 
 
Table 11. Cardiac sensitisation to catecholamines in dogs after exposure to halogenated 
hydrocarbons (408, 812). 
Chemical name Common name Cardiac sensitisation to catechol-
amines, % in air (LOAEC) a 
Trichloromethane, chloroform –  0.5–2.0 
Trichloroethylene  –  0.7–1.0 
Trichlorofluoromethane  CFC-11  0.5 
Dichlorodifluoromethane  CFC-12  5.0 and 20 
Chlorodifluoromethane  HCFC-22  5.0 
Bromochlorodifluoromethane Halon 1211  1.0 
Bromotrifluoromethane Halon 1301  7.5 
Bromochlorotrifluoroethane, halothane Halon 2311   0.1–0.5 
Trichlorotrifluoroethane  CFC-113  0.5 
Dichlorotetrafluoroethane  CFC-114  2.5 
Chloropentafluoroethane CFC-115  15 
Dichlorotrifluoroethane  HCFC-123  2.0 
Chlorotetrafluoroethane  HCFC-124  2.5 
Pentafluoroethane  HFC-125  10 
Tetrafluoroethane  HFC-134a  7.5–8.0 
Dichlorofluoroethane  HCFC-141b  0.5–1.0 
Chlorodifluoroethane HCFC-142b  5 
Trifluoroethane  HFC-143a  30 
Difluoroethane  HFC-152a  15 
Heptafluoropropane  HFC-227ea  10.5 
Hexafluoropropane  HFC-236fa  15 
Pentafluoropropane  HFC-245ea  2 
a 1% equals 10 000 ppm. 
LOAEC: lowest observed adverse effect concentration. 
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continuously in the chamber atmosphere. A 12-lead ECG was performed pre-
exposure and after the last exposure. During exposure, left precordial ECG (lead 
V5) was monitored continuously. Single exposures for 1 minute to 8 hours did not 
produce any untoward effects on ECG monitoring. Repeated exposures were not 
associated with alterations of cardiac rhythm. However, male subjects repeatedly 
exposed to 1 000 ppm CFC-11 had significant decrements in cognitive test 
performance (914). 
One study describes ECG measurements in 10 volunteers after 15–60 seconds of 
controlled exposure to CFC-11, CFC-12, CFC-114 and mixtures thereof (976). The 
reported exposure concentrations are highly improbable (in the sub-ppb range), 
therefore the study is disregarded. 
Healthy volunteers (4/sex) were exposed in two separate double-blind chamber 
studies. The volunteers were exposed for 1 hour on 8 separate occasions, once 
weekly, first to air and then to ascending concentrations of either HFC-134a or 
HFC-227 (1 000, 2 000, 4 000 and 8 000 ppm), interspersed with a second air 
exposure and two CFC-12 exposures (1 000 and 4 000 ppm). Exposures did not 
result in any adverse effects on pulse, blood pressure or ECG (252). 
Ten healthy firefighters, aged 40–50 years, were exposed to 1 000 ppm Halon 
1211 and humidified air while exercising, in a double-blind crossover experiment, 
and were monitored during and after exposure. Two subjects displayed increased 
ventricular ectopy during Halon exposure. One subject had increased ventricular 
premature beats/hour during and 8 hours post-exposure to Halon compared to air 
exposure (49.5 vs 8.7 beats/hour). In addition, 8 of the 10 subjects had a smaller 
systolic blood pressure rise during Halon exposure than during air exposure. None 
of the observed differences were statistically significant. The authors pointed out 
that these results were consistent with findings in other investigations, suggesting 
that occupational fluorocarbon exposures may be cardiotoxic in certain individuals, 
although the small sample sizes used in this and other studies have resulted in 
limited statistical power to demonstrate such effects (479).  
12.2.4 Occupational studies  
In this section, common names are used. For corresponding chemical names, see 
Table 11. 
One fatality after occupational exposure to CFC-11 has been reported. However, 
hypoxemic asphyxiation may have contributed to death (354).  
One case report describes a 56-year old man with tachycardia with supra-
ventricular and ventricular extrasystoles. The man was admitted to hospital due to 
dyspnoea and returned to work after a month. At check-up, 1.5 months later, he had 
no symptoms and his ECG was normal with no arrhythmias. He had been exposed 
to CFC-12 during filling and adjusting air-conditioning systems in cars. The 
average 8-hour TWA was always below 500 ppm, but during adjustments, 
concentrations were above 750 ppm several times (averages during 15 minutes). 
Breaking a valve resulted in levels around 6 000 ppm during the first 15 minutes 
(1060).  
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Totally, 27 refrigeration repair workers exposed to different fluorocarbons and 
their thermal decomposition products were investigated and compared with 14 non-
exposed workers. Heart palpitations were more common among the exposed 
workers (26% vs 0%, P < 0.05). Standard 12-lead ECGs were all within normal 
limits (139). 
Ambulatory ECG were studied among 6 refrigeration repair workers (age 31–56, 
mean 46 years) exposed to CFC-12 and HCFC-22 and a control group of 6 plumbers 
(age 29–54, mean 45 years). The ambulatory ECGs were recorded for 24 hours on 
a day of exposure and on a control day. The ECG tapes were automatically analysed 
and all aberrant complexes recorded by the machine were checked. One person read 
all the tapes without knowledge of exposure. The number of ventricular ectopic 
beats was compared between the day of exposure and the control day and with the 
tape of the control. In addition, the number of ventricular ectopic beats during 
exposure was compared with the number occurring during the rest of the day.  
The concentrations of fluorocarbons were measured in four instances. High peak 
fluorocarbons levels (1 300–10 000 ppm) were measured during refrigerator repair 
work. No clear connection between fluorocarbons and cardiac arrhythmia was 
found, although one subject had several ventricular ectopic beats which may have 
been connected with exposure (36).  
In a cross-sectional study, 23 apparently healthy male workers at the refrigeration 
services workshop were compared with 23 unexposed healthy male security 
employees from the Suez Canal Authority. The refrigeration workers were exposed 
to CFC-12 and HCFC-22 and the average concentrations in the breathing zone were 
5 720 mg/m3 (1 140 ppm) and 4 310 mg/m3 (1 200 ppm), respectively. The results 
of ECG Holter monitoring revealed a significantly higher number of atrio-
ventricular arrhythmias in exposed than in non-exposed workers. Among the 
exposed workers, there was also a significantly higher number of arrhythmias 
during an exposed day than during a non-exposed day. Serum cholesterol levels 
were also raised (816). 
Totally 89 refrigerator repairmen were exposed to a number of fluorocarbons 
from leaking compressors or from emptying or refilling the systems. Most cooling 
systems (89%) contained CFC-12 or HCFC-22. The concentrations of fluoro-
carbons in the breathing zones and the heart activity were recorded simultaneously. 
The highest level recorded in one minute was 14 000 ppm and the highest 8-hour 
TWA was 280 ppm. Low-, medium- and high-exposure categories were based on 
the length of time that the levels exceeded 750 ppm [(Swedish 15-minute short-
term exposure limit (STEL)] as well as the peak level. Exposure never exceeding 
750 ppm was categorised as minimal. The ECGs were analysed blindly by a 
cardiologist. Two types of arrhythmia were recorded, ectopic beats and sudden 
bradycardia. A within-subject comparison design was applied and the main 
parameter was the difference in arrhythmia frequencies between exposed and 
unexposed periods. No appreciable differences between exposed and unexposed 
periods and no consistent exposure-effect relationships were observed, although 
subjects in the medium exposure category showed a difference of borderline 
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significance (Wilcoxon’s test: P = 0.05, one tailed). It was not possible to investigate 
the impact of specific fluorocarbons. Subjects with medium or high exposure to 
HCFC-22 tended to have the highest absolute differences of ectopic beats when 
comparing exposed and unexposed periods (P = 0.05). Of the men, 6 had peak 
exposures exceeding 10 000 ppm; 4 were exposed to CFC-12 and 2 were exposed 
to HCFC-22. For 5 of the 6 men, there were no differences between exposed and 
unexposed periods regarding arrhythmia. One subject exposed to the lowest peak 
CFC-12 (11 400 ppm) had an ectopic beat within 8 minutes after the peak exposure 
and no arrhythmia when unexposed. Regarding sudden bradycardia there was an 
increased frequency during exposed periods, but the difference was of borderline 
significance. The authors concluded that misclassification of the exposure and the 
possible confounding effect of physical workload and psychological strain may 
have obscured a causal relation and therefore a minor effect could not be ruled out. 
The results did not support the notion that fluorocarbons induce cardiac arrhythmia 
in occupationally exposed refrigerator repairmen (246). One drawback of the study 
is the lack of data for individual fluorocarbons. 
Totally 118 employees at the pathology department were exposed to fluoro-
carbons including HCFC-22 when spraying frozen tissues with an aerosol pre-
paration. The employees were compared with 85 participants from the radiological 
department. Heart palpitations were reported in a questionnaire. Half of the 
employees exposed to HCFC-22, 35% of those exposed to other fluorocarbons and 
53% of those exposed to both preparations had onset of palpitation versus 14% of 
the employees in the radiological department. There was also an exposure-response 
relationship between the numbers of treated frozen sections each week and episodes 
of palpitations (P < 0.03). Two subjects proceeded to use HCFC-22 in a manner 
similar to the general processing of tissues. A 2-minute sample was collected while 
two 10-second blasts were expelled over the tissue. The average exposure of HCFC-
22 was 300 ppm during the 2-minute period (898).  
Freons such as HCFC-22 can be decomposed to phosgene and many other 
chlorinated or non-chlorinated hydrocarbons such as aldehydes and hydrochloric 
acid by electric arc welding. After occupational exposure to decomposed HCFC-
22, a 65-year-old man developed respiratory symptoms such as cough, blood-
stained sputum, and increasing dyspnoea. Three weeks later, his family doctor 
diagnosed infectious bronchitis. Another week later he died due to MI. Inhalation 
of these highly irritative chemicals from decomposed freon may start an 
inflammatory process eventually leading to MI (884). However, this case is not an 
example of catecholamine sensitisation but rather an inflammatory process. 
A 16-year old male collapsed after cleaning a subfloor pit containing waste and 
spill material, including CFC-113. He became unconscious and had ventricular 
tachycardia and fibrillation, which did not respond to medical intervention. He died 
one hour after collapsing (622). Several young men, 19–32 years old, died during 
excessive occupational exposure to CFC-113 (480, 612). Two cases of atrial 
fibrillation and one case of sudden death occurred in workers exposed to CFC-113 
used for degreasing of the interior of military tanks. All three men were exposed 
  
126 
inside these tanks (480). Measurements performed inside a tank 24 hours after 
exposure showed a level of 7 600 ppm (737).  
Healthy workers were exposed to CFC-113 during cleaning rocket and ground 
support equipment for the National Aeronautic and Space Administration (NASA) 
programmes. Exposure and ambulatory ECG monitoring data were evaluated on 16 
workers, each of whom was examined on exposed and low-exposed workdays. The 
mean full-shift TWA exposure was 442 ppm during an exposed day and 64 ppm 
during a low-exposed day. There was no difference between exposed and low-
exposed days regarding rate of ventricular and supraventricular premature beats, or 
heart rate. However, an episode of sinus rhythm bradycardia for less than 15 
minutes occurred during a short-term exposure of 600 ppm (248). 
A 40-year old man collapsed after cleaning a degreasing tank. At autopsy, high 
concentrations of HCFC-141b were found in his blood (14 mg/l) and tissues (51).  
12.2.5 Conclusion 
There is strong evidence that inhalation of high concentrations of several volatile 
halocarbons and hydrocarbons induce cardiac arrhythmias in combination with 
catecholamines (surrogates for stress induction, e.g. adrenaline). 
This has been shown in humans for anaesthetics (cyclopropane, chloroform, 
halothane, methoxyflurane and enflurane) during general anaesthesia (424, 459). 
Additional similar substances (Table 11) induce arrhythmogenic action in com-
bination with catecholamines in animals (408, 812) and have been associated with 
sudden deaths in humans after abusive sniffing or asthma treatment with fluoro-
carbon containing aerosols (68, 124, 245). 
Some human experimental and occupational studies were located, the latter in 
particular on refrigeration repair workers. Selected substances were studied, in 
single and combined exposures. Results were mostly negative. Overall, the support 
for cardiac sensitisation at occupationally realistic exposure levels is inconclusive. 
 
There is insufficient evidence for an association between CVD and occupational 
exposure to chemicals known to cause cardiac arrhythmias at very high exposure 
levels, e.g. during asthma treatment and general anaesthesia. 
12.3 Methyl chloride 
12.3.1 General  
Methyl chloride is a colourless gas at ambient temperatures. It can be compressed 
to a liquid, which has a weak ethereal smell. In industry, methyl chloride is used in 
the production of silicones, as methylating agent, as solvent in the production of 
plastic and synthetic rubber, and as a refrigerant (446). 
12.3.2 Animal studies 
Fischer 344 rats and B6C3F1 mice were exposed to 0, 50, 225 or 1 000 ppm methyl 
chloride 6 hours/day, 5 days/week for 2 years. Mouse survival was low in the 1 000-
ppm exposure group compared with control animals. The relative heart weight was 
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increased in female mice and male and female rats at 1 000 ppm. Also, changes in 
relative or absolute kidney, liver and brain weights were seen at 1 000 ppm in both 
species (446). 
12.3.3 Occupational epidemiological studies 
A cohort comprised 852 male workers employed for at least 1 month 1943–1978 in 
a synthetic rubber manufacturing plant in Baton Rouge, Louisiana. Methyl chloride 
was one of the substances in the manufacturing process. The mortality of the cohort 
was compared with US national cause-specific death rates. No increased mortality 
regarding diseases of the circulatory system was observed in a subcohort of 661 
white male workers (SMR 0.97, 95% CI 0.76–1.23). However, a tendency to  
an exposure-response relationship was observed when methyl chloride exposure 
was estimated with a subjective procedure. SMRs were 0.48 (3 observed vs 6.3 
expected) among low exposed workers, 0.91 (10 vs 11.0) among medium exposed 
and 1.08 (43 vs 40.0) among high exposed (418). 
In 1963 on board an Icelandic trawler, methyl chloride was leaking from the 
refrigerator. Methyl chloride was refilled several times during the fishing trip, 
which lasted 4 days. One deckhand died from an acute intoxication on the second 
day. The total crew comprised 29 men, and 13 of these were hospitalised due to 
severe symptoms of methyl chloride intoxication. The exposed cohort comprised 
27 men (as one deckhand died and another returned to his native country) and was 
compared with an external referent group. Five referents were selected to each crew 
member from three different registers of seamen. These men were not more than 
two years older or younger than the crew member. The inclusion criterion for the 
referents was that they had all been active seamen or fishermen in 1963 or earlier. 
The 135 referents were categorised as deckhands or officers. The cohorts were 
followed 1963–2010. Based on previous knowledge, the exposure was roughly 
estimated to be in the order of 100–1 000 ppm. There were increased risks  
(HR, 95% CI) for all causes of deaths (2.10, 1.28–3.46), all CVD events (2.06,  
1.02–4.15), acute CHD (3.12, 1.11–8.78) and CeVD (5.35, 1.18–24.35) (770). 
12.3.4 Conclusion  
One occupational cohort study (418) and a follow-up after an accident (770) 
indicated an increased CVD risk after methyl chloride exposure. 
  
There is insufficient evidence for an association between exposure to methyl 
chloride and CVD. 
12.4 Dichloromethane 
12.4.1 General  
Dichloromethane (methylene chloride) is a colourless liquid with a sweet and 
pleasant odour. Dichloromethane has been used as a solvent in paint strippers and 
removers, in adhesives, as a propellant in aerosols, as a solvent in manufacture of 
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pharmaceuticals and drugs, in chemical processing, as a metal cleaning and 
finishing solvent, and in urethane foam blowing. This chemical has also been used 
as a solvent in the production of triacetate fibres and in film processing (716). 
Dichloromethane is a reproductive toxin and probably carcinogenic to humans. In 
1993, it was banned in consumer products in Sweden and in 1996 the ban also 
comprised industrial use, with some exceptions (662).  
Epidemiological studies and risk estimates are presented in Appendix, Table A22. 
12.4.2 Human experimental studies  
Inhalation of dichloromethane results in an increase of COHb due to biotrans-
formation of dichloromethane to CO. This increase reduces the transport capacity 
of oxygen in the blood. COHb levels around 20% may be lethal for patients with 
IHD (918). Data on COHb levels obtained after experimental CO exposure (Section 
15.1) have therefore been included in this section. 
Non-smoking volunteers were exposed for 7.5 hours to dichloromethane levels 
of 50, 100, 150 and 200 ppm. At the end of exposure, the COHb levels were 1.9, 
3.4, 5.3 and 6.8%, respectively. Repeated exposures to dichloromethane for 7.5 
hours/day for 5 consecutive days produced slightly higher blood concentrations of 
COHb than those found for single exposures (233). 
In controlled exposures of healthy volunteers to CO, COHb levels up to 5.1% 
have been related to effects on exercise performance but were not observed to 
induce myocardial ischaemia or cardiac arrhythmias (9, 496). 
In a controlled exposure study of patients with coronary artery disease, CO 
exposures resulting in COHb concentrations of 2.4% and 4.7% significantly 
reduced the time to onset of angina symptoms and of ST-segment changes of the 
ECG during exercise in a dose-dependent manner (21, 22). Other studies on patients 
also showed that CO exposure (COHb 2.9–5.9%) aggravated exercise-induced 
myocardial ischaemia including decreased time to onset of angina symptoms, 
decreased time to onset of ST-segment changes and increased duration of angina 
symptoms (8, 29, 499). In another study on patients, no change in time to onset of 
angina and of ST-segment changes were observed at a COHb of 3.8% (863). At a 
COHb level of 5.9%, but not at 4.0%, an increase in the number of ventricular 
arrhythmias was reported (864). In contrast, no such effect was seen in another 
study on patients at the same COHb level (5.8%) (409). 
12.4.3 Occupational epidemiological studies  
Cohorts of workers exposed to dichloromethane have been identified in plants 
manufacturing photographic film base and textile fibres. Workers manufacturing 
photographic film base in the UK (963, 964) and the US (309, 393, 394) did not 
have increased risks of CVD mortality, nor did US textile fibre workers (336, 531, 
728).  
12.4.4 Pooled analyses 
All the cohorts of photographic film base workers (394, 964) and textile fibre 
workers (336, 531) were pooled and comprised totally 6 964 participants. The 
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calculated SMR for IHD was 0.89 (95% CI 0.81–0.97) based on 500 deaths. When 
only active workers were included the SMR was 0.76 (95% CI 0.59–0.97) (394).  
12.4.5 Exposure-response relationships  
The UK cohort of 1 473 male workers employed 1946–1988 producing cellulose 
triacetate film in Brantham was followed until 2006. The relationship between 
cumulative exposure to dichloromethane and IHD mortality was analysed with  
Cox regression. The estimated RR (95% CI) for lifetime cumulative exposure to 
1 000 ppm-years was 1.47 (0.91–2.39) (963). Other studies did not show positive 
tendencies between cumulative dichloromethane exposures and IHD (336, 394).  
12.4.6 Markers of effect 
Fifty employees of two fibre production plants were selected for study, 24 of whom 
were occupationally exposed to dichloromethane. All the participants were white 
males between the ages of 37 and 63 years. Eleven of the men had reported a  
history of heart disease. Under the conditions of this study, neither an increase in 
ventricular or supraventricular ectopic activity nor episodic ST-segment depression 
was associated with exposure to dichloromethane that ranged from 60 ppm to 
approximately 475 ppm as TWAs (728). 
12.4.7 Conclusion 
A pooled analysis of four cohorts of workers exposed to dichloromethane in plants 
manufacturing photographic film base or textile fibres did not show increased risks 
of CVD (394). Exposure-response analyses did not show relationships between 
cumulative exposures to dichloromethane and CVD (393, 394, 963).  
Inhalation of dichloromethane results in an increase of COHb due to bio-
transformation of dichloromethane to CO. Among healthy volunteers, COHb blood 
levels up to 5.1% did not induce myocardial ischaemia or cardiac arrhythmias (918). 
However, among patients with coronary artery disease (IHD), CO exposures 
resulting in COHb concentrations of 2.4% and 4.7% induced angina pectoris 
symptoms. COHb levels around 20% may be lethal for patients with IHD. Exposure 
of non-smoking volunteers to dichloromethane for 7.5 hours at 50, 100 and 150 
ppm resulted in post-exposure COHb-values of 1.9, 3.4, and 5.3%, respectively 
(233). Thus, exposure to 50–150 ppm of dichloromethane may induce angina 
pectoris symptoms in subjects with IHD.  
 
There is moderately strong evidence for an association between exposure to 
dichloromethane and angina pectoris symptoms in subjects with previous angina 
pectoris (IHD).  
12.5 Trichloroethylene 
12.5.1 General  
Trichloroethylene (TCE, TRI) is a colourless liquid with a characteristic odour 
similar to chloroform. The chemical is absorbed by inhalation and also by dermal 
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exposure. TCE is rapidly oxidised by cytochrome P450 (mainly CYP2E1), via the 
respective epoxide, to trichloroacetaldehyde (chloral). This metabolite is further 
metabolised to trichloroethanol as well as trichloroacetic acid (846).  
In 1996, occupational use of TCE was banned in Sweden. During 2015–2016, 
the total registered use was 7–28 tonnes/year and country in Denmark, Finland  
and Sweden (data from Norway were confidential) (899). Within the EU REACH 
legislation (Registration, Evaluation, Authorisation and Restriction of Chemicals), 
TCE is identified as a substance of very high concern requiring authorisation before 
use since 2016 (244).  
TCE is one of the halogenated hydrocarbons that has been associated with cardiac 
sensitisation to catecholamines among dogs (Table 11, Section 12.2).  
12.5.2 Occupational epidemiological studies  
During 1930–1986, one plant in central Sweden produced TCE for the whole 
domestic market. TCE is sensitive to photochemical degradation and consequently 
various stabilisers were added to the commercial product. The producer provided 
two TCE formulas on the market; Standard TRI and TRI-plus. Standard TRI, the 
bulk TCE product, was stabilised with diisopropylamine and thymol. TRI-plus 
contained butylene oxides and epichlorohydrin as stabilisers. It is likely that 
standard TRI was the dominating product to which the cohort was exposed. The 
cohort of 1 670 persons (1 421 men and 249 women) was followed 1955–1986. 
National mortality rates were used for comparison. The mortality (SMR, 95% CI) 
due to circulatory diseases was significantly increased among males (1.17,  
1.00–1.37) but not among females (2.02, 0.97–3.71). Estimations of exposure were 
based on urinary levels of trichloroacetic acid. A slightly higher point estimate 
regarding circulatory disease was observed at the highest urinary concentration 
when a latency time of 10 years and an exposure time of at least 2 years were applied 
(58). In summary, no clear dose-response relationship was observed. 
A cohort study of workers employed for at least 1 year at a large US aircraft 
manufacturing facility in California since 1960 was followed until 1996. The 
primary organic solvent used in vapour degreasers until 1966 was TCE, when it was 
replaced by tetrachloroethylene. The mortality of a subcohort comprising 2 267 
TCE-exposed workers was compared with that of the general population in 
California for white workers and with the US general population for non-white 
workers. There was decreased mortality (SMR, 95% CI) regarding all heart disease 
(0.85, 0.78–0.94) and CeVD (0.66, 0.50–0.85). Analyses were also conducted of 
workers routinely exposed to TCE but not tetrachloroethylene. Fewer observations 
resulted in increased instability of the SMRs, but the pattern mirrored the previous 
presentations. Over 70% of the workers exposed to TCE were also estimated to 
have had exposure to compounds containing chromate (116). 
A retrospective cohort study comprised 14 457 workers at a US aircraft main-
tenance facility at Hill Air Force Base, Utah, 1952–1956. The study group consisted 
of all civilian employees who had worked for at least 1 year and the cohort was 
followed up through 1982. Observed deaths among white people were compared 
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with the expected number of deaths, based on the Utah white population. Significant 
deficits occurred for mortality from IHD (SMR 0.93, 95% CI 0.88–0.98). Detailed 
analysis of the 6 929 employees occupationally exposed to TCE (the most widely 
used solvent at the base during the 1950s and 1960s) did not show any significant 
increases (SMR, 95% CI) for men regarding IHD (0.98, 0.90–1.07) and CeVD 
(0.83, 0.66–1.03), or for women regarding IHD (0.90, 0.67–1.17) and CeVD  
(0.83, 0.52–1.25). Cumulative exposure categories were derived by cumulatively 
multiplying the exposure index assigned to each job by the time exposed at that 
level. Among white males, the SMRs for IHD were 0.94, 0.94 and 1.05 for 
cumulative exposures of < 5, 5–25 and > 25, respectively. There was no significant 
trend (900). This cohort was further followed (102, 764) (Section 12.5.3). 
12.5.3 Exposure-response relationships 
In total, 4 733 aircraft manufacturing workers (2 555 males and 2 178 females) in 
Arizona, employed for at least 6 months 1950–1985, and exposed to TCE mainly 
during degreasing 1952–1977, were followed through 1993. US rates were used for 
comparison. Jobs were classified in exposure categories of high, medium, low or 
none. The highest rating involved work on degreaser machines with an estimated 
TCE exposure of 50 ppm. Jobs with medium rating were near the degreasing area 
with more than occasional contact with TCE. A low exposure rating was given  
jobs away from the degreasing area, but with occasional TCE contact. All other jobs 
were assigned no exposure to TCE. Exposure scores were assigned 0 for no, 1  
for low, 4 for medium and 9 for high exposure. The score 0 was given to those  
with less than 6 months of TCE-exposure. For each job, the number of months  
with exposure to TCE was multiplied with the score 0, 1, 4 or 9. An individual 
cumulative exposure score was then calculated as the sum of months × score of all 
jobs of that individual. The exposed workers were categorised in low- or high-
exposed groups based on the cumulative exposure score, with the low-exposed 
group including those with low-exposed rating and up to 5 years of exposure or 
medium-exposed rating for at most 1.4 years. Mortality (SMR, 95% CI) from all 
heart disease was significantly decreased both among high-exposed workers (0.85, 
0.74–0.97) and among low-exposed workers (0.56, 0.44–0.70), although it seems 
to be higher among high-exposed. Corresponding SMRs (95% CIs) for mortality 
from CeVD were 0.55 (0.35–0.83) and 0.66 (0.39–1.06), respectively (670). 
The US cohort of workers at an aircraft maintenance facility (900) (Section 
12.5.2) was further followed until 1990. Based on a Poisson model, an increased 
mortality (RR, 95% CI) was observed for IHD (1.1, 1.0–1.3) but not for CeVD  
(1.0, 0.8–1.3) among TCE-exposed workers compared to referents with no chemical 
exposure. An exposure score for TCE was assigned to each job based on possible 
exposure intensity, frequency and duration of peak exposures from vapour 
degreasing and of low-level exposures at the work bench. Information from  
two surveys in the 1960s and 1970s on work practices at vapour degreasers and 
other potential exposures was used to create an intensity index of exposure to TCE  
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Table 12. Relative risks (95% CI) among workers with or without exposure to TCE 
followed through 1990. Cohort members with no chemical exposures as referents (102).  
Group No TCE  
exposure 
Cumulative TCE exposure 
< 5 unit-years 5–25 unit-years > 25 unit-years 
Men     
IHD 1.1 (1.0–1.3) 1.0 (0.9–1.2) 1.1 (1.0–1.4) 1.2 (1.0–1.4) 
CeVD 1.2 (0.9–1.6) 0.7 (0.5–1.1) 0.6 (0.4–1.0) 1.2 (0.8–1.7) 
Women     
IHD 1.3 (1.0–1.8) 1.1 (0.7–1.5) 0.6 (0.3–1.1) 1.2 (0.9–1.6) 
CeVD 1.5 (0.9–2.7) 0.5 (0.2–1.3) 1.0 (0.4–2.8) 1.8 (1.1–2.9) 
CeVD: cerebrovascular disease, CI: confidence interval, IHD: ischaemic heart disease, TCE: 
trichloroethylene. 
 
Table 13. Hazard ratios (95% CI) among workers exposed to TCE and followed through 
2000. Cohort members with no chemical exposures as referents (764).  
Group Cumulative TCE exposure 
< 5 unit-years 5–25 unit-years > 25 unit-years 
Men    
IHD 0.98 (0.85–1.13) 1.11 (0.95–1.30) 1.15 (1.00–1.33) 
CeVD 0.85 (0.63–1.16) 0.68 (0.47–0.99) 1.17 (0.87–1.56) 
Women    
IHD 1.17 (0.88–1.56) 0.70 (0.42–1.62) 1.11 (0.86–1.44) 
CeVD 0.84 (0.50–1.41) 1.23 (0.67–2.28) 1.32 (0.90–1.94) 
CeVD: cerebrovascular disease, CI: confidence interval, IHD: ischaemic heart disease, TCE: 
trichloroethylene. 
 
for various periods (600 for the years 1939–1954, 400 for 1955–1967 and 200 for 
1968–1978). These scores provide an indication of the relative exposures over time 
but should not be viewed as ppm. After 1978, TCE in the degreasers was replaced 
by 1,1,1-trichloroethane. Mortality from IHD was significantly increased in this 
follow-up. Small but significant excesses of IHD occurred among men exposed to 
TCE. A significant excess of CeVD occurred among the women with highest 
cumulative exposure (Table 12) (102). The cohort was further followed until 2000 
and exposure-response relationships were derived from a Cox model (Table 13). 
Exposure was also categorised as low-intermittent, low-continuous, peak-
infrequent and peak-frequent. The only significant mortality was found for CeVD 
among women at peak-frequent exposure (HR 1.50, 95% CI 1.05–2.13) (764). 
12.5.4 Conclusion 
Four occupational cohorts were found. One study of TCE-exposed workers showed 
an increased mortality from circulatory diseases among males (58). Another  
cohort study, with several follow-up periods, showed significant increases of IHD 
mortality among males in the highest cumulative exposure category and of CeVD 
mortality among females exposed to frequent peaks or high cumulative levels (102, 
764).  
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There is limited evidence for an association between exposure to trichloro-
ethylene and CVD. 
12.6 Tetrachloroethylene 
12.6.1 General  
Tetrachloroethylene, often called perchloroethylene, is a solvent mainly used for 
cleaning and for degreasing in metal cleaning (218). 
12.6.2 Occupational epidemiological studies  
The mortality patterns of 671 US female laundry and dry cleaning workers for the 
period 1963–1977 were analysed using Wisconsin death certificate data. The PMR 
for IHD was significantly increased (1.13, P < 0.05), but there was no significant 
increase for other CVD (PMR 1.03). When lower wage occupations were used as 
controls, no significant increased IHD risk was observed (PMR 1.05) (478). 
A US cohort was formed from four labour unions and included 1 690 dry cleaning 
workers exposed to tetrachloroethylene. The participants had worked at least 1 year 
prior to 1960 and were followed until 1982. The mortality from diseases of the 
circulatory system was decreased (SMR 0.70, 95% CI 0.60–0.82) (128). 
A retrospective cohort mortality study was conducted of workers employed for 
at least 1 year since 1960 at a large aircraft manufacturing facility in California. The 
cohort was followed until 1996. A subcohort of 2 631 tetrachloroethylene-exposed 
workers was identified. The mortality of the subcohort was compared with the 
mortality rates in the general population. There was no increased mortality (SMR, 
95% CI) regarding all heart disease (0.84, 0.71–0.99) and CeVD (0.86, 0.56–1.27) 
among these workers. The primary organic solvent used in vapour degreasers until 
1966 was TCE, when it was replaced by tetrachloroethylene. Analyses were also 
conducted of workers routinely exposed to tetrachloroethylene but not to TCE. 
Fewer observations resulted in increased instability of the SMRs, but the pattern 
mirrored the previous presentations. Over 70% of the workers exposed to tetra-
chloroethylene were also estimated to have had exposure to compounds containing 
chromate (116). 
A US cohort of 5 369 members of a dry cleaning union in St. Louis (entering 
1948–1979) was followed until December 1993. A number of organic solvents has 
been used by the dry cleaning industry over the years and tetrachloroethylene 
became the solvent of choice in the 1960s. An increased risk of IHD (SMR 1.1, 
95% CI 1.0–1.3) was observed for one of the follow-up periods (1979–1991) but 
not for an earlier follow-up period (103).  
Totally 1 708 workers identified from dry cleaning union records from four US 
cities (San Francisco, Chicago, Detroit and New York) who had worked for at least 
1 year prior to 1960 in shops using tetrachloroethylene as the primary cleaning 
solvent were followed until December 1996. The SMR in the entire cohort due to 
IHD was 1.01 (95% CI 0.89–1.15). In a subcohort containing 625 subjects who had 
worked only in shops where tetrachloroethylene was the primary cleaning solvent 
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the SMR was 1.27 (95% CI 1.02–1.55) (810). The same cohort now comprising 
1 704 workers was later followed until December 2004. The SMR in the entire 
cohort due to IHD was 1.10 (95% CI 0.99–1.22). In the subcohort now containing 
618 subjects who had worked only in shops where tetrachloroethylene was the 
primary cleaning solvent the SMR was 1.21 (95% CI 1.03–1.48). There was an 
increased risk of hypertensive end-stage renal disease in the subcohort (SIR 2.66, 
95% CI 1.15–5.23). Vascular disease of the kidney can both cause and arise from 
hypertension. However, it is thought that most hypertensive end-stage renal disease 
is caused by hypertensive nephrosclerosis, which is a consequence of hypertension 
(137).  
12.6.3 Markers of effect 
In a cross-sectional study of dry cleaners, two subgroups exposed to mean levels  
of 70 and 335 mg/m3 of tetrachloroethylene (range 11–750 mg/m3) had a higher 
total leukocyte count compared with blood donors, a possible expression of an 
inflammatory process (33). An increased total leukocyte count is an established risk 
indicator for IHD (209). 
12.6.4 Conclusion  
The results from two cohorts (103, 137, 810) out of four occupational cohorts 
indicated an increased risk for IHD in tetrachloroethylene exposed workers.  
 
There is limited evidence for an association between exposure to tetrachloro-
ethylene and IHD.  
12.7 Vinyl chloride and polyvinyl chloride production 
12.7.1 General 
Vinyl chloride (monomer), a colourless gas with a faintly sweet odour, is used for 
the production of polyvinyl chloride (PVC) resins, a widely used plastic material 
(558). 
In 1988, Richard Doll reviewed the literature regarding occupational exposures 
to vinyl chloride. Air concentrations around 10 000 ppm induced unconsciousness 
and cardiac arrhythmia, while prolonged exposures to concentrations an order of 
magnitude lower was associated with a specific pathological syndrome. This 
syndrome was characterised by four cardinal signs: enlargement of the liver and 
spleen with specific histological appearance, patchy infiltration of the skin 
resembling scleroderma, bony changes in the tips of the fingers described as 
acroosteolysis, and peripheral circulatory changes identical with the classical 
picture of Raynaud’s disease. These disturbances could be avoided if air exposure 
never exceeded the level of a few hundred ppm, which is the level to which 
exposures were generally reduced in the mid-1960s (235). 
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12.7.2 Animal studies 
Wistar rats were exposed to 5 000 ppm vinyl chloride 7 hours/day, 5 days/week 
during 52 weeks. Focal myodegeneration of the heart was more frequent in males 
(3/9 vs 0/10 controls) and females (8/10 vs 1/10 controls). Also thickened walls of 
the heart arteries was increased in males (2/9 vs 0/10 controls) and females (4/10 vs 
0/10) (285). 
12.7.3 Occupational epidemiological studies 
A Swedish factory started its production of vinyl chloride and PVC at the end  
of World War II. The cohort included totally 750 vinyl chloride-exposed workers 
who did not emigrate during the period of follow-up ending at October 1974. The 
level of exposure to vinyl chloride and PVC in the past was unknown. However, 
episodes of unconsciousness had occurred among autoclave cleaners during the 
1950s, which indicated vinyl chloride concentrations of at least 10 000–15 000 
ppm. The cohort mortality was compared with the general Swedish population. 
There were increased risks (SMRs) of circulatory diseases (1.53, based on 28 cases, 
P = 0.02), MI (1.64, 15 cases, P = 0.046) and cerebral haemorrhage (1.48, 5 cases, 
P = 0.018). The authors pointed out that vascular deaths is noteworthy as other dis-
orders observed in vinyl chloride exposed workers like acroosteolysis, Raynaud’s 
phenomenon and angiosarcomas are all associated with the vessels (136). 
Totally 2 073 workers from four PVC-processing industries in Sweden with  
at least 3 months of exposure 1945–1974 were included in a cohort. Different 
subcohorts were followed 1969–1976 and national mortality rates were used as 
referents. The RRs were 0.91 for CVD and 1.49 for MI for workers exposed for at 
least 6 months, including those who stopped working before 1961 (n = 1 771). The 
RRs were approximately the same for workers exposed for at least 6 months from 
1961 or later (n = 1 428), 0.99 for CVD and 1.25 for MI. The RRs were higher for 
workers exposed at least 2 years and followed up to 5 years after the end of exposure 
(n = 1 155), 1.18 (P < 0.05) for CVD and 2.03 (P < 0.05) for MI. When the follow-
up was extended to 10 years after the end of exposure, the RRs were 1.01 and 1.82 
(P < 0.05), respectively (658). The decreased risks after a longer period of non-
exposure may indicate reversibility of a causal effect when exposure cease.  
Workers from one of the Swedish PVC factories were further followed. Totally 
2 042 male workers employed at least 3 months in the period 1945–1980 were 
followed 1961–1985. The records contained no data on workers who had left the 
employment or died before 1961. The expected mortality was based on male rates 
from the Blekinge County. There were totally 60 CVD deaths (SMR 1.00, 95% CI 
0.77–1.29) and 44 IHD deaths (SMR 1.00, 95% CI 0.73–1.35). After a latency-
period of 10 years there were totally 47 CVD deaths (SMR 1.08, 95% CI 0.80–1.45) 
and 36 IHD deaths (SMR 1.11, 95% CI 0.79–1.56) (370). 
Workers from three of the four previously mentioned Swedish PVC factories 
(658) were further followed. Totally 717 male workers employed at least 3 months 
1964–1974 were followed 1964–1986. The calculated expected mortality was based 
on national male rates. There were totally 49 deaths from circulatory diseases (SMR 
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1.0, 95% CI 0.7–1.3) and 38 IHD deaths (SMR 1.0, 95% CI 0.7–1.4). Among 198 
immigrant workers (mostly from Finland), there was an increased mortality (SMR, 
95% CI); 15 deaths from circulatory diseases (2.5, 1.4–4.1) and 13 deaths from IHD 
(3.0, 1.6–5.1). The observed deaths among the immigrants were probably close to 
what should have been expected if the Finnish male population had constituted the 
reference category. Consequently the increased risks among the immigrants were 
not caused by occupational exposure (583). 
A cohort comprised totally 12 700 male workers from 19 vinyl chloride/PVC 
factories in Italy, Norway, Sweden (cohorts described above) and the UK. The 
cohort was followed until 1997 and the mortality was compared with the respective 
national rates. There was a decreased risk from diseases of the circulatory system 
(SMR 0.83, 95% CI 0.78–0.88) based on 1 136 fatalities. However, there was an 
increased risk from liver cancer as a possible expression of vinyl chloride exposure 
(991). 
A cohort included 1 658 male workers employed in a vinyl chloride production 
and polymerisation facility in Porto Marghera, Italy [subcohort of the previously 
described European cohort (991)]. All subjects working in the plant in 1956 or hired 
thereafter until end of 1985 were included and followed until 2017. The mortality 
of the cohort was compared with regional rates. A JEM was constructed and the 
cumulative exposure was categorised as 0–733, 734–2 378, 2 379–5 187 and 
≥ 5 188 ppm-years. Overall, there were decreased mortalities (SMR, 95% CI) from 
diseases of the circulatory system (0.66, 0.57–0.77) and IHD (0.66, 0.53–0.82), but 
no exposure-response analysis was presented (282).  
A proportionate mortality study was performed based on 4 341 deaths among 
current and former employees of 17 US PVC fabricators during 1964–1973. Sex-
race-cause-specific PMRs were computed using the corresponding US mortality as 
the standard. No angiosarcomas were found. There were no excesses of diseases  
of the circulatory system among men (PMR 1.05) or women (PMR 0.91). The 
mortality pattern for CeVD was about the same (PMR males 0.99 and females 0.92) 
(169). 
A US cohort consisted of 10 173 men employed during or after 1942 at 37 plants 
belonging to 17 companies. The men had been exposed to vinyl chloride at least 1 
year prior to December 1972 and were followed 1942–1982. The observed 
mortality, by cause, was compared with US mortality rates, standardised for age, 
race and calendar time. There were decreased SMRs (95% CIs) regarding diseases 
of the circulatory system (0.88, 0.81–0.95), atherosclerotic heart disease (0.82, 
0.75–0.89) and vascular lesions of the CNS (0.76, 0.60–0.96). The SMRs were 
higher when the duration of exposure was 10–20 years compared to < 10 years 
(Table 14). The SMRs were also higher when first exposure occurred before 1950 
compared with later (1037). The pattern of low–normal–low SMR with increasing 
duration of exposure may be explained by an exposure-response relationship (first 
phase) combined with a healthy worker survivor effect (second phase). 
The previous US cohort (now comprising 9 951 men) was further followed 
through 2013. Liver cancer was elevated and strongly associated with cumulative 
  
137 
a P < 0.01, b P < 0.05. 
CNS: central nervous system, CVD: cardiovascular disease, SMR: standardised mortality ratio. 
 
vinyl chloride exposure. Mortality (SMR, 95% CI) due to diseases of the heart 
(0.86, 0.82–0.90) and CeVD (0.83, 0.73–0.94) was not increased (683).  
12.7.4 Conclusion 
Two Swedish cohort studies provided support for a relationship between exposure 
in the vinyl chloride/PVC industry and CVD mortality (136, 658), whereas a pooled 
European cohort (991) and a US cohort (683, 1037) did not show increased risks 
for CVD. In one of the positive studies, there was a tentative decrease of incidence 
after exposure cessation (658). 
Prolonged exposure to vinyl chloride at high levels (approximately 1 000 ppm) is 
clearly associated with peripheral circulatory changes identical with the classical 
picture of Raynaud’s disease (235). However, such levels are far above current 
occupational exposure levels. 
  
There is insufficient evidence for an association between exposure to vinyl 
chloride/polyvinyl chloride and CVD. 
12.8 Dioxins and dioxin-like compounds 
12.8.1 General 
Dioxins (polychlorinated dibenzo-p-dioxins) are unwanted contaminants formed 
during the combustion or production of chlorinated compounds. 2,3,7,8-Tetra-
chlorodibenzo-p-dioxin (TCDD) is considered the most toxic of the dioxin 
congeners. TCDD has been a contaminant in e.g. phenoxy acid herbicides and 
chlorophenols (1005). Dioxins are highly persistent and bioaccumulative with 
biological half-times of 5–10 years (332). Dioxin-like compounds comprise 
polychlorinated dibenzofurans (which tend to co-occur with dioxins) and some 
polychlorinated biphenyls (PCBs) (190). Data on PCBs are presented in Section 
12.9.  
Table 14. Mortality (SMR) from CVD in vinyl chloride exposed men (1037). 
Mortality cause  Duration of exposure (no. of cases) 
< 10 years 10–20 years > 20 years 
Diseases of circulatory system 0.82 a (335) 1.07 (216) 0.75 a (84) 
Atherosclerotic heart disease  0.78 a (259) 1.02 (172) 0.60 a (57) 
Vascular lesions of the CNS 0.75 (39) 0.74 (19) 0.85 (12) 
 Year of first exposure (no. of cases) 
 < 1950 1950–1959 ≥ 1960 
Diseases of circulatory system  0.98 (398) 0.80 b (170) 0.65 b (67) 
Atherosclerotic heart disease  0.85 b (284) 0.84 a (150) 0.63 b (54) 
Vascular lesions of the CNS 0.81 (46) 0.71 (17) 0.62 (7) 
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12.8.2 Mechanistic evidence 
The aryl hydrocarbon receptor (AHR) is believed to play an important role in the 
development and function of the cardiovascular system, based on observations in 
AhR knockout mice which develop cardiac hypertrophy, abnormal vascular 
structure in multiple organs and altered blood pressure (1052). Several persistent 
substances activate AHR signalling, including PAH and halogenated aromatic 
hydrocarbons such as TCDD.  
12.8.3 Occupational epidemiological studies  
The epidemiological studies originate from accidents, manufacturing chlorinated 
compounds and handling or spraying TCDD-contaminated phenoxy acid herbicides 
(Appendix, Table A23). 
12.8.3.1 Accidents  
In 1953, an uncontrolled decomposition reaction occurred in a trichlorophenol 
production unit owned by BASF AG in Ludwigshafen, Germany. Totally 243 male 
workers were engaged in clean up, repair and demolition after the accident. The 
cohort was followed almost 40 years, until 1992. There was no increased mortality 
(SMR, 95% CI) regarding circulatory diseases (0.8, 0.6–1.2) or IHD (0.7, 0.4–1.1) 
and no dose-response relationships were observed (729). 
In 1963, an uncontrolled reaction occurred in the autoclave where 2,4,5-trichloro-
phenol was synthesised. An explosion followed and dioxins, including TCDD,  
and polychlorinated dibenzofurans were released. A group of 140 exposed male 
workers were followed until 1991 and was compared with the general male 
population in the Netherlands. The mortality (SMR, 95% CI) was not significantly 
increased for circulatory diseases (1.1, 0.6–1.7) or for IHD (1.5, 0.8–2.5). However, 
an increased mortality from IHD was observed among 29 workers with chloracne 
(3.7, 1.4–8.1) (420). 
In 1976, an accident occurred in a chemical plant manufacturing 2,4,5-trichloro-
phenol in Seveso, Italy. An uncontrolled exothermic reaction in a production kettle 
caused a sudden surge in temperature and pressure that blew a safety device. The 
reactor content, a fluid mixture containing some 2 900 kg of organic matter, 
released substantial amounts of TCDD into the air through an exhaust pipe. The 
blood concentration of TCDD in 7 subjects from the most contaminated area, nearly 
20 years after the accident, was 53.2 pg/g (ppt) blood lipids (geometric mean). The 
mortality (RR, 95% CI) due to circulatory diseases, 1976–1991, was increased for 
males (1.6, 1.1–2.5) but not for females (1.0, 0.6–1.7) (740).  
12.8.3.2 Manufacture of chlorinated compounds 
Totally 1 189 male chemical workers in Hamburg, Germany, employed for at least 
3 months, produced phenoxy herbicides 1952–1984, when the plant was closed. 
Concentrations of dioxins and polychlorinated dibenzofurans were measured in 
blood and the levels at the end of exposure were estimated based on half-times from 
an elimination study of workers in this cohort. The cohort was followed until 1992. 
There were significant dose-response relationships regarding both CVD and IHD 
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and the dose-response patterns were more pronounced for toxic equivalency (TEQ, 
a sum of individual toxic equivalency factors, TEF) than for TCDD alone (299). 
The cohort, now comprising 1 191 male workers and 398 female workers, was 
further followed until 2007. During the follow-up, there were increased mortality 
risks (SMR, 95% CI) for men regarding circulatory diseases (1.16, 1.02–1.31) and 
CeVD (1.57, 1.19–2.05) but not for women (0.74, 0.56–0.94 and 0.64, 0.32–1.15, 
respectively). The median estimated cumulative job exposure to TCDD was 77.4 
ppt (ng/kg) for men and 19.5 ppt for women, based on blood fat; no dose-response 
relationships were observed (602). Increasing time of follow-up since last exposure 
is likely associated with a decreasing total body burden of TCDD and consequently 
lower risks for CVD.  
A cohort of 562 workers were exposed to phenoxy herbicides or chlorophenols. 
In 1950, the factory started production of chlorophenoxy herbicides in the 
Netherlands, the main product being 2,4,5-trichlorophenoxyacetic acid. The 
production was contaminated with TCDD, other dioxins and polychlorinated 
dibenzofurans. In 1969, synthesis of phenoxy herbicides was ended and the last 
TCDD-contaminated process ended in 1976. Based on extrapolated TCDD levels 
measured in a subset of the cohort, TCDD levels were predicted at the time of 
maximum exposure. The cohort was followed until 1991 and exposed workers were 
compared with non-exposed workers. Workers in the highest category of exposure 
(serum levels > 124 ppt TCDD, lipid adjusted) had increased mortality (RR, 95% 
CI) from circulatory diseases (2.3, 1.2–4.3) and IHD (3.1, 1.4–6.5) (420). 
The cohort was further followed, now comprising 1 020 male workers (both 
exposed and non-exposed) from the same factory as above and a second group of 
1 036 male workers from another factory. This new cohort was followed until 2006. 
Exposure assessment was based on a predictive model for TCDD plasma levels at 
the time of assumed last exposure. The estimated highest exposure (≥ 9.9 ppt) was 
associated with an increased mortality from IHD (HR 2.6, 95% CI 1.6–4.3) (112). 
A cohort of 5 132 chemical workers from 12 US plants manufacturing products 
1942–1984 that were contaminated with TCDD was followed until 1993. In a 
restricted subcohort comprising 3 538 workers, there was a clear and positive 
relationship between cumulative TCDD exposure score and IHD mortality (909). 
12.8.3.3 Chlorophenoxy herbicide spraying and application 
A cohort of 1 909 male chlorophenoxy herbicide applicators that had worked 
between 1955 and 1971 was followed until 1989. No increased mortality regarding 
IHD or CeVD was observed compared to the male Finnish population (50). 
Large amounts of herbicides were used in the Vietnam War by US forces for 
defoliation 1962–1971. An increased mortality from circulatory disease was 
observed among exposed US veterans compared with non-exposed veterans (RR 
1.3, 95% CI 1.0–1.6) (489). In a similar study of Korean Vietnam veterans, an 
increased risk regarding circulatory mortality was observed when exposure was 
presented as a continuous variable (HR 1.02, 95% CI 1.00–1.04) (1045). 
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12.8.4 Pooled analyses 
An IARC multicentre cohort comprised 21 863 phenoxyacid herbicide and chloro-
phenol production workers and sprayers from 36 cohorts in 12 countries. An 
increased mortality risk (RR, 95% CI) from circulatory disease was observed 
among exposed workers compared to non-exposed workers (1.51, 1.17–1.96). The 
risk for IHD was approximately the same (1.67, 1.23–2.26). The risk for CeVD was 
not increased (1.54, 0.83–2.88). An increased risk (RR, 95% CI) from circulatory 
disease was also observed when workers exposed for 10–19 years were compared 
with non-exposed workers (1.28, 1.05–1.55). However, there was no increased 
mortality among workers exposed for ≥ 20 years (1005).  
12.8.5 Reviews  
In a systematic review of dioxin exposure, cohorts were excluded that were exposed 
either primarily to PCBs or in the leather and perfume industries, which include 
other cardiotoxic co-exposures. Totally 12 cohorts were included of which 10 
comprised occupationally exposed workers. The analyses were divided according 
to two well-recognised criteria of epidemiological study quality: the accuracy of the 
exposure assessment, and whether the exposed population was compared with an 
internal or an external reference group. In the highest-quality group, consistent and 
significant dose-related increases in IHD mortality and more modest associations 
with CVD mortality were observed. The primary limitation of the studies was a lack 
of adjustment for potential confounding by the major cardiovascular risk factors 
(428). 
Within the US National Academy of Medicine (NAM), a part of the National 
Academies of Sciences, Engineering, and Medicine, the Committee to Review the 
Health Effects in Vietnam Veterans of exposure to herbicides concluded in 2012 
that there is sufficient evidence to place hypertension, IHD and stroke in the limited 
or suggestive category (445). 
12.8.6 Dose-response relationships 
Three accidents have been reported. The Seveso accident (740) had the shortest 
mortality follow-up time, less than 20 years, and the other two had follow-up 
periods of 28 years or longer (420, 729). Only the Seveso study presented a 
significant effect, a higher mortality from circulatory diseases for males. One aspect 
of a longer follow-up is a likely lower body burden of TCDD as the half-time of 
serum levels is 5–7 years. 
Dose-response relationships have been observed between exposure among 
workers manufacturing products contaminated with TCDD in Germany (299), the 
Netherlands (112) and the US (909), and IHD. Plasma levels ≥ 9.9 ppt (ng/kg) 
TCDD were associated with an increased risk of IHD (HR 2.60, 95% CI 1.57–4.31) 
(112). 
12.8.7 Conclusion 
The epidemiological data on dioxins and dioxin-like compounds originate from 
accidents, manufacture of chlorinated compounds and spraying and applying 
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chlorophenoxy herbicides. A pooled IARC multicentre study comprising 36 
occupational cohorts showed increased mortality for circulatory disease and IHD, 
but not for CeVD (1005). Three studies demonstrated positive dose-response 
relationships between TCDD exposure and IHD (112, 299, 909). In two of these, 
plasma levels of TCDD were used as dose estimates (112, 299). Plasma levels ≥ 9.9 
ppt (ng/kg) TCDD were associated with an increased risk of IHD (112). 
 
There is strong evidence for an association between exposure to dioxins and 
dioxin-like compounds and IHD. 
12.9 Polychlorinated biphenyls 
12.9.1 General  
Polychlorinated biphenyls (PCBs) are a class of 209 congeners in which 1–10 
chlorine atoms are attached to biphenyl in different combinations. The PCBs have 
been commercially produced as complex mixtures since 1929. Because of the 
chemical and physical stability and electrical insulating properties, PCBs have had 
a variety of uses in industry. However, due to their harmful effect on the 
environment, the production and use of PCBs is banned or restricted worldwide. 
Nowadays, PCBs are mainly regarded as ubiquitous environmental pollutants,  
but they can still occur in work environments, especially when renovating and 
demolishing buildings and in recycling and waste management (567). PCBs may 
be divided in dioxin-like PCBs (e.g. PCBs 74, 118, 126, 156, 169) and non-dioxin-
like PCBs (e.g. PCBs 99, 138, 153, 170, 180 and 187) (366). 
PCBs, like many chlorinated compounds, are poorly metabolised and thus 
persistent (half-times in humans approximately 4–40 years) (567). The half-time 
generally increases with number of chlorine atoms, but other factors like the 
chlorine positions on the biphenyl also influence the half-time (145). 
12.9.2 Mechanistic evidence 
Co-planar or dioxin-like PCBs are AHR agonists and may compromise the normal 
functions of vascular endothelial cells by activating oxidative stress-sensitive 
signalling pathways and subsequent proinflammatory events critical in the 
pathology of atherosclerosis and CVD (400). 
12.9.3 Animal studies 
Female Harlan Sprague Dawley rats were exposed to the dioxin-like PCB 126 
(3,3',4,4',5-pentachlorobiphenyl) in an NTP study. The animals were gavaged  
5 days/week with up to 1 000 ng/kg bw/day of PCB 126 for up to 2 years. The 
control animals received a corn oil/acetone vehicle. After a full necropsy of all 
animals, a complete set of tissues was examined microscopically. PCB 126 was 
associated with exposure-related increases in the incidences of degenerative 
cardiovascular lesions. Cardiomyopathy and chronic active arteritis increased in an 
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exposure-related manner in all exposed groups (460). PCB 126 also increased heart 
weight, serum cholesterol levels and blood pressure in rats (565). 
Mice (LDLR-/-) fed a low-fat atherogenic diet were given 0 or 1 µmol/kg PCB 
126 twice (at week 2 and week 4) by gavage, and were sacrificed 8, 10 or 12 weeks 
post-exposure. Mice exposed to PCB 126 exhibited significantly increased plasma 
levels of inflammatory cytokines, increased circulating biomarkers of CVD, altered 
platelet and red blood cell counts, increased accumulation of hepatic fatty acids  
and accelerated atherosclerotic lesion formation in the aortic root. PCB 126 also 
increased circulating neutrophils, monocytes and macrophages as determined by 
flow cytometry analysis. Thus, exposure to the dioxin-like PCB 126 increased 
inflammation and accelerated atherosclerosis in mice (745). 
12.9.4 Occupational epidemiological studies 
A Swedish cohort of 242 male capacitor manufacturing workers exposed to PCBs 
for at least 6 months 1965–1978 was followed 1965–1991 and compared with 
national death rates. High-exposed workers had a higher risk for circulatory 
diseases (SMR 3.28, 95% CI 1.07–7.66, based on 5 cases) after at least 5 years of 
work and at least 20 years since first exposure, but this was not observed for IHD 
(361). 
In a study by Broding et al., 562 subjects who had worked for an average of 
14.7 years in a PCB-contaminated building in Germany scored significantly higher 
than the control group in subscale “cardiac complaints” on the 24-item Giessen 
Subjective Complaints List (GSCL-24). The subscale scores were, however, low in 
both groups. Multivariate analysis confirmed that work in the contaminated 
building influenced the intensity of complaints, although overall, thorough 
statistical analysis revealed no correlation between symptoms on the GSCL-24 
scale and current PCB congener plasma concentrations. The median sum of PCBs 
in air was 1.8 µg/m3. The median sum of PCBs in plasma (PCBs 28, 52, 101, 138, 
153, 180) in the exposed group was 2.3 µg/l (mean 2.6; 10th and 90th percentiles: 
1 and 4.6 µg/l). For PCBs 28 and 52, the mean plasma concentrations in the control 
group were about 20% of those in the exposed group (0.023 vs 0.117 µg/l and 
0.004 vs 0.019 µg/l). Several confounding variables (e.g. socioeconomic status, 
medication) were not controlled for (125).  
Between 1946 and 1977, the General Electric Company manufactured small and 
large capacitors using PCBs as dielectric fluid in two production plants located one 
mile apart in upstate New York. Large capacitors were filled manually with PCBs 
1946–1960 resulting in excessive spillage. In the mid-1960s, the filling process was 
automated. Small capacitors were impregnated by flooding racks of capacitors with 
heated PCBs under vacuum in large ovens. Upon removal of the capacitors from 
the ovens, a fog of condensed PCBs dispersed throughout the plant. Following 
impregnation, the capacitors dripping with PCBs were moved to the sealing station 
where the filling ports were soldered shut. Salvage and repair of large capacitors 
were also performed. It involved draining the PCBs, milling off the seal cover and 
manually removing and repairing the wet components. All of these activities 
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including cleaning the outside of the capacitors entailed significant direct dermal 
and inhalation exposure. Exposed surfaces in the plants were coated with PCBs. 
Totally 7 061 (4 056 male and 3 005 female) PCB capacitor workers were followed 
through 2008 (mean follow-up 41 years). National US and New York State rates 
were used for comparison. There was a decreased mortality (SMR, 95% CI) from 
heart disease (0.88, 0.82–0.94) and CeVD (0.81, 0.68–0.95) compared to the US 
population. However, there was an increased risk of cardiomyopathy among 
females based on 12 cases (1.95, 1.01–3.40) in the comparison with the New York 
State population (494). 
A cohort was formed of workers manufacturing electric capacitors employed for 
at least 90 days at a New York plant 1946–1977 (plant 1) or at a Massachusetts 
plant 1939–1976 (plant 2). The cohort comprised 2 572 workers who held jobs 
identified as having the highest exposure to PCBs (e.g. impregnation, sealing and 
testing capacitors). The death rates were compared with death rates from the state 
of New York (excluding New York City) and Massachusetts. The SMR (95% CI) 
regarding IHD was 1.12 (0.98–1.28) for the total cohort and 1.44 (1.06–1.91) for 
those with 5–9 years of employment, but lower for those with longer employment 
(0.97, 0.80–1.18) (758). The cohort was enlarged to comprise 14 458 PCB-exposed 
workers employed ≥ 90 days 1939–1977 and followed 1940–1998. Commercial 
PCB mixes, 41–54% chlorine, were used at both plants, with less chlorinated 
varieties used at a later period. At any given time, more than one mix was likely in 
use. NIOSH conducted exposure surveys in the spring 1977. TWAs for air samples 
were 24–476 μg/m3 at plant 1 and 50–1 260 μg/m3 at plant 2. The IHD mortality 
(SMR, 95% CI) was 0.97 (0.90–1.03) for the total cohort, and 0.87 (0.79–0.96) and 
1.07 (0.97–1.17) in plant 1 and 2, respectively (759).  
Totally 2 885 white electrical capacitor workers were exposed to PCBs and other 
chemicals 1944–1977 in a US plant in La Salle, Illinois. Before 1952, chlorinated 
naphthalenes were used as a dielectric and, in 1952, PCBs were introduced and were 
used in large capacitors until 1979. The main exposure to PCBs was through skin 
contact but airborne exposure occurred in one special department where heat 
volatilised the oil. The cohort was followed through 2000. When the IHD death rate 
of the cohort was compared with US standard rates, the SMR (95% CI) was 1.14 
(0.96–1.34) for white males and 0.96 (0.83–1.12) for white females (598). 
Totally 3 588 electrical capacitor workers exposed to PCBs 1957–1977 at an 
Indiana facility were followed until 1986. Mean levels of PCBs (with ≤ 4 chlorine 
atoms per molecule) varied between 100 and 760 µg/l serum. The comparison group 
was the US population and the SMR (95% CI) for diseases of the heart was 0.7 
(0.5–0.9) (873). The cohort comprising 3 569 workers was further followed through 
1998. Cumulative PCB exposure was calculated for each worker based on job titles, 
job codes and era of employment. The cumulative PCB exposure was 10–1 218 590 
unit-days (median 16 860 unit-days; 11 000 and 90 000 unit-days defined cut-points 
of tertiles). The overall mortality from IHD (SMR, 95% CI) was 0.84 (0.7–1.0). 
The IHD mortality in the highest tertile of exposure (0.88, 0.7–1.1) was similar to 
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that of the middle tertile of exposure (0.94, 0.7–1.2) but was slightly higher than 
that of the lowest tertile of exposure (0.72, 0.5–1.0) (808). 
A cohort was formed of 138 905 PCB-exposed men who had been employed full 
time (continuously for ≥ 6 months) at any of five US electric utility companies at 
any time in the period 1950–1986. Women were excluded because they rarely 
worked in jobs with exposures of interest. The mortality of the cohort was compared 
with that of the US population. The SMR (95% CI) for diseases of the heart was 
0.76 (0.74–0.78) (575).  
12.9.5 Epidemiological studies of the general population  
Fish consumption may promote cardiovascular health. The role of major food 
contaminants, such as PCBs common in fatty fish, was studied in the population-
based Swedish Mammography Cohort comprising 33 446 middle-aged and elderly 
women, free from CVD at baseline 1997. Validated estimates of dietary PCB 
exposure and intake of fish fatty acids (eicosapentaenoic acid and docosahexaenoic 
acid; EPA-DHA) were obtained via a food frequency questionnaire at baseline. The 
cohort was followed for 12 years. Women in the highest quartile of dietary PCB 
exposure (median 286 ng/day) had multivariable-adjusted RRs (95% CIs) of  
MI before and after adjusting for EPA-DHA intake of 1.21 (1.01–1.45) and 1.58 
(1.10–2.25), respectively, compared to women in the lowest quartile (median 101 
ng/day). Stratification by low and high EPA-DHA intake resulted in RRs (95% CIs) 
of 2.20 (1.18–4.12) and 1.73 (0.81–3.69), respectively, comparing the highest PCB 
tertile with the lowest. The intake of dietary EPA-DHA was inversely associated 
with risk of MI after but not before adjusting for dietary PCB (85). The same  
cohort of 34 591 women was followed for 12 years. There were 2 015 incident cases 
of total stroke (1 532 ischaemic strokes, 216 intracerebral haemorrhages, 94 sub-
arachnoid haemorrhages and 173 unspecified strokes). Multivariable-adjusted risk 
estimates (RR, 95% CI), controlled for known stroke risk factors and fish 
consumption, were 1.67 (1.29–2.17) for total stroke, 1.61 (1.19–2.17) for ischaemic 
stroke and 2.80 (1.42–5.55) for haemorrhagic stroke for women in the highest 
quartile of dietary PCB exposure (median 288 ng/day) compared to women in the 
lowest quartile (median 101 ng/day) (86).  
A Swedish population-based cohort comprised 36 759 men free from CVD  
at baseline 1997. Validated estimates of dietary PCB exposure and intake of fish 
fatty acids were obtained via a food frequency questionnaire at baseline. During 12 
years of follow-up, 3 005 incident cases of MI and 654 fatal cases of MI were 
observed. RRs were adjusted for known cardiovascular risk factors, long- 
chain omega-fatty acids and methylmercury exposure. Compared to men in the 
lowest quintile of dietary PCB exposure (median 113 ng/day), men in the highest 
quintile (median 436 ng/day) had multivariable-adjusted RRs (95% CIs) of 1.74 
(1.30–2.33; P trend < 0.001) and 1.97 (1.42–2.75; P trend < 0.001) for total, and 
non-fatal MI, respectively (84). 
Blood pressure was measured in 758 residents in Anniston, Alabama. Rates of 
hypertension increased significantly with age and concentration of serum PCBs. 
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Among 394 persons not on antihypertensive medication, linear regression analysis 
demonstrated a significant positive relation between serum PCB levels and both 
systolic and diastolic blood pressure. After adjustment for potentially confounding 
variables, logistic regression gave increased ORs (95% CIs) for both systolic  
(3.82, 1.1–12.8) and diastolic hypertension (4.15, 1.4–11.6) when comparing those 
in the highest and the lowest tertiles of total serum PCBs (348). Fasting serum 
samples were obtained from 575 Anniston residents who were not on any lipid-
lowering medication. Serum concentrations of total PCBs were significantly 
associated with elevated serum levels of total lipids, total cholesterol and 
triglycerides but not with levels of LDL and HDL after adjustment for age, gender, 
race, BMI, smoking and exercise. The PCBs with the strongest associations were 
those with 3, 4 or ≥ 8 total chlorine atoms (27). 
Results from NHANES 1999–2002 (final sample size 889 persons) indicated an 
association between serum concentrations of five dioxin-like PCBs (PCBs 74, 118, 
126, 156, 169) and six non-dioxin-like PCBs (PCBs 99, 138, 153, 170, 180, 187) 
and the prevalence of self-reported diagnosis of CVD, but only among females. 
Adjustment was made e.g. for age, BMI, total cholesterol, HDL cholesterol, tri-
glycerides, CRP, hypertension, smoking and exercise. Adjusted ORs (95% CIs) for 
quartiles compared to a reference category (lowest quartile) were 0.9 (0.2–3.5),  
2.0 (0.5–7.6) and 5.0 (1.2–20) for the sum of the dioxin-like PCBs (significant 
concentration-response relationship among the four quartiles, P for trend < 0.01). 
The highest ORs (95% CIs) were seen for PCB 156, i.e. 9.2 (2.1–39) and 10.4  
(2.3–47) in the two highest quartiles (P for trend < 0.01). For the sum of non-dioxin-
like PCBs, the adjusted ORs (95% CIs) were 1.2 (0.4–4.0), 1.2 (0.4–4.2) and 3.8 
(1.1–13) with P for trend of 0.02. ORs (95% CIs) in the highest quartile for PCBs 
138, 153 and 170 were 13.4 (1.6–115; P for trend < 0.01), 10.4 (1.1–94; P for trend 
< 0.01) and 9.2 (1.0–84; P for trend 0.01), respectively. The median concentrations 
in serum in the highest quartiles were 21, 91, 127 and 36 ng/g lipid, respectively, 
for PCBs 156, 138, 153 and 170. The authors emphasised that their results must be 
interpreted with caution, because of the cross-sectional design and use of self-
reported CVD (366).  
The same team reported suggestive associations between hypertension in men 
(but not in women) and both dioxin-like and non-dioxin-like PCBs when NHANES 
1999–2002 data were used (524 participants). Risks (OR, 95% CI) in the highest 
tertiles were 2.3 (0.8–6.6) and 2.8 (0.9–8.5), respectively. Hypertension was defined 
as systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg. 
Treated hypertensives were excluded (367).  
Another cross-sectional study using NHANES 1999–2002 investigated the 
association between 11 PCBs in serum and hypertension. Persons were assigned to 
the hypertensive category if a doctor had told them that they were hypertensive, if 
they were on antihypertensive drugs or had a systolic blood pressure ≥ 140 mmHg 
or diastolic blood pressure ≥ 90 mmHg. After adjustment (e.g. for age, gender, BMI, 
smoking, total cholesterol), several PCBs (PCBs 74, 99, 118, 126, 138/158, 170, 
187) remained significantly associated with hypertension (gender data were not 
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reported). The strongest adjusted associations were found for the dioxin-like PCBs 
118 and 126. The group with serum levels of PCB 118 > 27.5 ng/g lipid had an OR 
of 2.30 when compared with the group with levels < 12.5 ng/g lipid. In the group 
with concentrations of PCB 126 > 59.1 pg/g lipid, the OR was 2.45 (comparison 
group ≤ 26.1 pg/g lipid) (273).  
12.9.6 Conclusion 
Some studies of the general population suggest a relationship between PCB 
exposure and hypertension (273, 348, 367). These studies must be interpreted with 
caution because of their cross-sectional design. The possible relationship between 
PCB exposure and IHD has been investigated in a number of occupational cohort 
studies, but the results are inconsistent and dose-estimates are crude. Animal data 
support a relationship between exposure to the dioxin-like PCB 126 and CVD (460, 
565, 745).  
 
There is limited evidence for an association between exposure to PCBs and CVD.  
12.10 Per- and polyfluoroalkyl substances 
12.10.1 General 
Per- and polyfluoroalkyl substances (PFAS) are a group of man-made chemicals 
with extreme persistence in the environment, and potential risk to human health and 
ecosystems. PFAS have been produced since the 1950s and are used in multiple 
products and for industrial purposes due to their favourable properties such as 
repellence towards fat, dirt and water, temperature resistance and film-forming 
capacity (929). Application areas for PFAS are e.g. as ingredients in firefighting 
foams, impregnation of clothing and textiles, paint, wax, insecticides, detergents 
and food packaging. Occupational exposure is likely in relation to production and 
use of a multitude of PFAS-containing products. 
The most well-known PFAS (out of 4 700 identified varieties) are perfluoro-
octanesulphonic acid (PFOS) and perfluorooctanoic acid (PFOA), both also called 
C8. Due to the increased concern of environmental and human adverse effects, they 
are gradually substituted to shorter chain alternatives (722). The European Food 
Safety Authority (EFSA) recently performed an updated risk assessment opinion 
for PFOS and PFOA in food (247). This section is mainly based on the EFSA report. 
Mean estimated half-times (95% CIs) for PFOS and PFOA were 3.4 (3.1–3.7) 
and 2.7 years (2.5–2.9), respectively. There was a marked sex difference with more 
rapid elimination in women for PFOS, but only marginally for PFOA (561). 
In animal studies, the liver, one of the major sites of cholesterol synthesis, is the 
target organ. Human studies provide strong support for causal associations between 
exposure to PFOS and PFOA and increased serum concentrations of cholesterol 
(247, 263, 328, 700). The traditional view of a causal link between high cholesterol 
serum levels and CVD is under debate (775).  
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12.10.2 Occupational epidemiological studies 
Ammonium perfluorooctanoate (APFO) has been used in industry mainly as a 
polymerisation aid in the production of fluoropolymer high-performance materials. 
In the presence of water, APFO dissociates readily to PFOA. The latter compound 
has been found in serum of exposed production workers at concentrations of 0–100 
ppm (0–100 µg/ml), with the majority residing under 20 ppm. In 1948, the 
Washington Works (DuPont) started production of polymers in West Virginia. In a 
longitudinal study of 454 PFOA-exposed workers in this plant, blood was sampled 
at least twice 1979–2004. The mean serum PFOA level over the study period  
was 1.13 (0–22.7) ppm. Serum PFOA levels were positively associated with total 
cholesterol levels, with an increase of 1.06 mg/dl of cholesterol for each 1 ppm 
increase of PFOA (P = 0.011). Serum PFOA concentrations were not significantly 
associated with triglycerides, LDL or HDL (819).  
A cross-sectional study in the same industry comprised 1 025 active workers with 
potential exposure to APFO. The serum PFOA concentrations were 0.005–9.55 
ppm, with the highest levels found in those currently working in APFO areas 
(median serum PFOA 0.49 ppm) and the lowest in the non-exposed areas (median 
serum PFOA 0.11 ppm). Serum PFOA levels were significantly associated with 
three of five lipid outcomes (cholesterol and two fractions of LDL, but not with 
HDL or triglycerides). An increase of 1 ppm PFOA in serum was associated with a 
total cholesterol increase of 4.04 mg/dl (818). 
Totally 6 027 men (81%) and women who had ever worked at the Washington 
Works plant facility in Parkersburg, West Virginia 1948–2002 (see above), were 
included in a cohort and these years delimit the mortality follow-up period. SMRs 
were estimated by comparing observed numbers of deaths with expected numbers 
derived from mortality rates from the US population, the West Virginia state 
population and a regional DuPont reference worker population. Most SMR 
estimates based on US and state populations were below 1. Comparison with the 
employee population also resulted in many SMR estimates at or near a no-effect 
level. Relative to the regional worker population, the SMR for CVD among men 
was 1.10 (95% CI 0.98–1.23). Mortality from diabetes was significantly increased 
among male workers compared to the regional worker population (SMR 1.83, 95% 
CI 1.12–2.83) (553). 
A cohort of 4 747 employees who had ever worked in the Washington Works 
plant 1948–2002 was followed until 2002. Time-dependent APFO-exposures were 
estimated from detailed work histories for all employees using an exposure 
reconstruction model based on occupational information and PFOA serum data. RR 
estimates, based on Cox proportional hazards regression models, indicated no 
statistically significant increased mortality risk for IHD associated with estimated 
cumulative exposure. A positive trend was observed at an exposure lag of 10 years, 
but not at no lag or other lag calculations. The authors concluded that there was no 
convincing evidence of increased IHD mortality for APFO-exposed workers (820). 
The same cohort was enlarged and further followed. It included all workers  
with at least one day of work 1948–2002. Overall, 5 791 workers had work histories 
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with sufficient detail to allow estimation of PFOA serum levels over time. PFOA 
was used in the plant from 1950 onwards, with a peak in the 1990s and a sharp 
decline of usage and emissions after 2001. Referents were obtained from DuPont 
plants in the Appalachian region. The follow-up period was 1952–2008. The 
median serum PFOA concentration of the exposed workers was much higher  
than that of the general US population (400 vs 4 µg/l). Cumulative doses were 
categorised in quartiles: 0 – < 904, 904 – < 1 520, 1 520 – < 2 700 and ≥ 2 700 ppm-
years; the SMRs (95% CIs) for IHD were 1.07 (0.85–1.32), 1.02 (0.80–1.28),  
0.87 (0.67–1.11) and 0.93 (0.72–1.19), respectively. The corresponding SMRs 
(95% CIs) for stroke were 0.63 (0.85–1.32; mismatch between SMR and CI), 0.78 
(0.39–1.39), 1.34 (0.82–2.07) and 0.69 (0.32–1.31), respectively. No cumulative 
dose-response trend was seen for CVD mortality (912). 
In 1947, production of APFO started at the 3M Company manufacturing facility 
in Cottage Grove, Minnesota. A cohort of 3 993 employees was followed until 
2002. The eligibility criterion was a minimum of 365 days employment prior to 
1997. Cox regression models were used to estimate the risks, using an internal-
cohort of non-exposed workers as referents. Moderate and high APFO-exposures 
were positively associated with CeVD (HR, 95% CI: 1.8, 0.9–3.7, 19 cases and 4.6, 
1.3–17.0, 3 cases, respectively). There was no relationship regarding moderate or 
high exposures and IHD (HR, 95% CI: 1.2, 0.9–1.7 and 0.9, 0.4–2.1, respectively). 
Risk estimates were adjusted for sex and birth year. Including wage type and 
smoking habits in the model did not alter the results. High exposure was 
characterised as definite exposure ≥ 6 months and moderate exposure included 
definite exposure < 6 months or ever working in areas with probable occupational 
exposure. Comprehensive biological monitoring data were not available, but serum 
PFOA concentrations were collected from 131 employees. Subjects working in 
areas where jobs were classified as having definite or probable exposure had median 
serum concentrations in the range 2.6–5.2 ppm and 0.3–1.5 ppm, respectively (586).  
Perfluorooctanesulphonyl fluoride (POSF) has been produced almost exclusively 
at one facility in the US and one in Belgium. In the US, the manufacturing started 
in 1961 in Decatur, Alabama, and consisted of a film plant and a chemical plant. 
The 2 083 participants of the cohort had worked at least 1 year by the end of 1997 
and were followed until 1998. The mortality of the cohort was compared with the 
rates in Alabama. POSF can be degraded or metabolised to PFOS. Biological 
monitoring of serum PFOS levels was performed among 232 randomly selected 
employees to estimate occupational exposure to POSF. The geometric mean serum 
PFOS concentrations at the film and chemical plant were 0.1 and 0.9 ppm, 
respectively. Because production processes remained constant over time, a simple 
JEM was developed based on work histories and job specific serum PFOS levels. 
Workplace exposure was characterised as no, or potentially low or high. The 
mortality (SMR, 95% CI) for all heart disease and CeVD among workers employed 
for at least 1 year in a high-exposed job were 0.61 (0.32–1.07) and 0.93 (0.11–3.37), 
respectively. There was no indication of dose-response relationships (15). 
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12.10.3 Epidemiological studies of the general population 
A subgroup of 560 US adults from The C8 Short-Term Follow-up Study, exposed 
from public drinking water contaminated with PFOA, was studied in 2005–2006 
and followed until 2010. The serum concentrations of PFOA and PFOS fell by half 
from initial geometric means of 74.8 and 18.5 ng/ml, respectively, with little 
corresponding change in LDL cholesterol levels. However, participants with greater 
declines in serum PFOA or PFOS had greater decreases in LDL cholesterol. For a 
person whose serum PFOA fell by half, the predicted fall in LDL cholesterol  
was 3.6% (95% CI 1.5–5.7%). For PFOS, the decrease in LDL cholesterol was even 
stronger, 5% (95% CI 2.5–7.4%). The corresponding decreases of total cholesterol 
were smaller for both PFOA and PFOS, 1.7 and 3.2%, respectively (296).  
Totally 32 254 participants from two US sources, the community-based C8 
Health Project 2005–2006 and the cohort of 3 713 workers from Leonard et al. 
(553), completed surveys in 2008–2011 regarding medical histories of stroke. In a 
cross-sectional retrospective study, year-by-year serum PFOA concentration 
estimates were based on information on residential history, drinking water habits 
and sources, and public water supply maps. Cumulative PFOA serum levels for 
each year were calculated as the sum of the serum concentration estimate that year 
and all previous years. Compared to the lowest quintile of cumulative dose, 
subsequent quintiles in the retrospective analysis had risk estimates (HR, 95% CI) 
of 1.39 (1.11–1.76), 1.36 (1.08–1.71), 1.45 (1.15–1.82) and 1.13 (0.90–1.44). The 
cumulative doses in these categories (quintiles 2–5) were > 178–319, > 319–912, 
> 912–4 490 and > 4 490 µg/l, respectively. Tests for trend with linear or log-
transformed cumulative dose were not significant (P = 0.52 and 0.59, respectively). 
The failure to incorporate those who died from stroke before 2005–2006 could bias 
the result of the retrospective analysis. A restriction of the analysis to earlier 
calendar time provided some suggestion that this could be the case, since dose-
response trends were consistently more pronounced and significant in earlier 
calendar periods than in later ones. A second prospective study included only 
participants from the C8 Health Project 2005–2006 followed until 2008–2011. The 
result of this follow-up did not indicate a positive trend. The authors concluded that 
the data provided modest evidence of an association between PFOA exposure and 
stroke incidence (871).  
A US NHANES cross-sectional study comprised 1 216 participants from the 
1999–2000 and 2003–2004 surveys. Serum PFOA levels were presented in 
quartiles and the outcomes were self-reported CVD including physician-diagnosed 
CHD, heart attack and stroke, and objectively measured peripheral arterial disease, 
defined as an ankle-brachial blood pressure index < 0.9. Increasing serum PFOA 
levels were positively associated with CVD and peripheral arterial disease, 
independent of confounders such as age, sex, race/ethnicity, smoking status, BMI, 
diabetes mellitus, hypertension, and serum cholesterol level. Compared to subjects 
among quartile 1 (reference) of PFOA level, the OR (95% CI) among subjects in 
quartile 4 was 2.01 (1.12–3.60; P for trend 0.01) for CVD and 1.78 (1.03–3.08; P 
for trend 0.04) for peripheral arterial disease (856). 
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A Swedish population-based cohort included farmers and rural residents. Totally 
1 782 males participated in the base-line examination (1990–1991) and 1 587 took 
part in the second examination 2002–2003. The examinations included question-
naires, physical measurements and blood sampling. The total cohort was followed 
1992–2009 and CHD diagnoses were retrieved from the National Cause of Death 
Register and Patient Register. Conditional logistic analyses were used to investigate 
the relationship between levels of PFAS and CHD. Eight different PFAS were 
analysed, e.g. PFOA, PFOS and perfluoroheptanoic acid (PFHpA). All PFAS were 
significantly correlated with each other. Most PFAS increased between base-line 
and the second examination but PFOA and PFOS decreased. There was a significant 
association between PFHpA and CHD (OR, 95% CI) for the 3rd and 4th quartile 
(2.72, 1.52–4.84 and 2.45, 1.40–4.29) compared to the lowest quartile. After adjust-
ment for BMI, systolic blood pressure, total cholesterol, HDL and tobacco use, the 
risk estimates were slightly attenuated. There were no statistically significant 
associations between the concentrations of the other seven PFAS at baseline and 
CHD. The authors suggested that the association observed was probably a chance 
finding (611).  
In the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) 
study, 1 016 individuals were investigated at age 70 years of which 826 were 
reinvestigated at age 75 and 602 at age 80 years. The carotid artery intima-media 
thickness increased 0.058 mm during the 10-year period (P < 0.0001). Following 
adjustment for baseline values of PFAS and sex, the changes in plasma levels  
of six of the eight measured PFAS (including PFOS) were significantly positively 
related to the change in intima-media thickness over the 10-year follow-up period. 
Further adjustment for traditional cardiovascular risk factors (HDL and LDL 
cholesterol, smoking, systolic blood pressure, statin use, fasting glucose and serum 
triglycerides) affected these relationships only marginally (566). Furthermore, 801 
subjects was also studied with a cross-sectional design. Left ventricular geometry 
was determined with echocardiography. Increased levels of several PFAS were 
associated with increased left ventricular end-diastolic diameter and decreased 
relative wall thickness, which was calculated from interventricular septum and 
posterior wall thickness. These associations were mainly found for the longer-
chained PFAS (654). 
12.10.4 Reviews 
In 2018, the EFSA Panel on Contaminants in the Food Chain evaluated the risks to 
human health related to the presence of PFOS and PFOA in food. The derivation of 
a health-based guidance value was based on human epidemiological studies. For 
PFOS, the increase in serum total cholesterol in adults, and the decrease in antibody 
response at vaccination in children were identified as the critical effects. For PFOA, 
the increase in serum total cholesterol was the critical effect (247). 
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12.10.5 Dose-response relationships  
Serum concentrations of PFOS (247) or PFOA (818, 819) were positively related 
to concentrations of cholesterol. In a prospective study of seniors (PIVUS) there 
was a positive relationship between the changes in plasma levels of several PFAS 
(including PFOS) and the change in intima-media thickness over the 10-year 
follow-up period (566). In an NHANES cross-sectional study, serum PFOA levels 
were positively associated with peripheral arterial disease, defined as an ankle-
brachial blood pressure index, and with self-reported CVD (856). 
Workers exposed to APFO ≥ 6 months had an increased CeVD mortality (586). 
In a cross-sectional study on stroke, dose-response trends among PFOA-exposed 
subjects were more pronounced in earlier calendar periods than during later 
calendar periods. A prospective design, did not reveal any dose-response relation-
ship (871). There were significantly increased CHD risks at the two highest 
quartiles of PFHpA serum levels, but the increase was not continuous (611). 
12.10.6 Conclusion  
Human studies provide strong support for associations between exposure to PFOS 
or PFOA and increased serum concentrations of cholesterol (247). 
Some studies of occupationally exposed workers and non-occupationally 
exposed subjects have demonstrated relationships between PFAS exposure and 
CVD (586, 611, 856, 871). However, two of the studies had a cross-sectional design 
(856, 871), one study did not demonstrate clear dose-response relationships (611) 
and the remaining study had a low number of participants in the high-exposed group 
(586). 
  
There is insufficient evidence for an association between exposure to per- and 
polyfluoroalkyl substances (PFAS) and CVD. 
13. Nitrated explosives 
13.1 General 
Nitroglycerine (glyceryl trinitrate), a highly explosive substance, was synthesised 
by the Italian chemist Ascanio Sobrero in 1847. Alfred Nobel added silica guhr to 
nitroglycerine to make it a stable explosive. In 1879, nitroglycerine was introduced 
as treatment for angina pectoris (416). It has also been used in rocket propellants. 
Nitroglycerine is often mixed with ethylene glycol dinitrate (nitroglycol) to make 
dynamite. Propylene glycol dinitrate is the principal constituent in Otto fuel II,  
a torpedo propellant. The vapour pressures of ethylene and propylene glycol 
dinitrates are more than 100 times higher than the corresponding vapour pressure 
for nitroglycerine (2-4). Dinitrotoluene has principally been used as intermediate  
in the production of toluene diisocyanate. It has also been a component in the 
production of dyes, explosives and propellants (556).  
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Nitroglycerine (341), ethylene glycol dinitrate (417, 458) and propylene glycol 
dinitrate (458) are easily absorbed through the skin. The skin permeability of both 
2,4-dinitrotoluene and 2,6-dinitrotoluene was categorised as moderate (458). 
Symptoms among workers exposed to nitroglycerine and other organic nitrates 
are often developing in three stages. The first stage is characterised by vasodilation 
and workers experience headaches, flushes and palpitations. After days, weeks or 
months, a second stage comes into play comprising compensatory responses of 
vasoconstriction. This phase is manifested by an increase in diastolic blood 
pressure, a decrease in pulse pressure, and the relief of headaches or other first stage 
symptoms. A third stage relates to the withdrawal of nitroglycerine exposure. 
Withdrawal from the sustained vasodilatory effects over a 48–72 hour period leaves 
the more persistent vasoconstrictor response unopposed. This response results  
in general arteriolar constriction clinically manifest in cutaneous and coronary 
arteries. Intermittent chest pain can be relieved by nitroglycerine. Coronary 
insufficiency or acute MI may develop. This period of vasoconstriction subsides 
after 96–120 hours (534). This third stage has been called Monday morning angina 
or Monday morning death (518). 
13.2 Nitroglycerine and ethylene glycol dinitrate 
Cases of angina pectoris and sudden death following withdrawal from occupational 
exposure to nitroglycerine and ethylene glycol dinitrate have been reported from 
Norway (93), Sweden (582), Germany (932), France (532), Italy (66), Israel (82), 
the US (144) and South Africa (760).  
The most obvious symptom is a pain resembling that of angina pectoris which 
starts as a rule 1–3 days after interruption of exposure to nitroglycerine or ethylene 
glycol dinitrate (582). 
The relationship between occupational exposure to nitroglycerine and ethylene 
glycol dinitrate and cardiovascular disturbances has been reviewed and established 
by many authors (518, 522) and committees (2-4, 584). 
13.3 Propylene glycol dinitrate 
In a chamber experiment, volunteers were exposed to propylene glycol dinitrate. 
Exposure to 0.2 ppm for 2–8 hours caused headache in 7 out of 9 volunteers. Both 
frequency and intensity of headaches decreased dramatically after repeated daily 
exposures to 0.2 ppm (915). 
Propylene glycol dinitrate has been used as a torpedo propellant in the US Navy. 
Forman et al. studied 1 352 torpedomen exposed to propylene glycol dinitrate from 
1970 through 1979. The average yearly strength was 822 persons. The control group 
comprised 14 336 torpedomen unexposed to propylene glycol dinitrate, with an 
average yearly strength of 4 906. A second control group comprised 29 129 fire 
control technicians with an average yearly strength of 11 198. The peak airborne 
exposures were 0.00–0.22 ppm, with 88% of grab samples (short duration) 
≤ 0.1 ppm and 50% of grab samples ≤ 0.05 ppm. Measured 8-hour TWAs were 
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< 0.05 ppm. Incident cases of MI and angina pectoris were recorded during  
the 10-year period. After age-adjustment, the RRs (95% CIs) for MI were 2.22 
(0.74–6.72) and 2.61 (1.33–5.14), compared to unexposed torpedomen and fire 
control technicians, respectively. The corresponding risks (RR, 95% CI) regarding 
angina pectoris were 3.77 (0.43–32.11) and 3.77 (1.01–14.10). When MI and angina 
pectoris were added together, the risks (RR, 95% CI) were 2.60 (1.11–6.12) and 
2.93 (1.71–5.03) (302). 
13.4 Dinitrotoluene 
Headache and weakness was common (50%) among workers exposed to dinitro-
toluene during the first year of production during World War II in the US. After 
1942, the prevalence of symptoms was reduced to around 10% after improved 
ventilation, training, protective equipment, job rotation and medical surveillance 
(621). 
Workers at two US ammunition plants (Joliet, Illinois and Radford, Virginia) 
were exposed to dinitrotoluene. Cohorts of 156 and 301 men who had worked at 
least 1 month during the 1940s and 1950s at jobs with opportunity for substantial 
dinitrotoluene exposure were followed through the end of 1980. Numbers of 
expected deaths were calculated using rates of US white males as the standard. 
When combining the two cohorts, there was an increased SMR of circulatory 
diseases (1.40, P < 0.01) and IHD (1.41, P < 0.01) but not of CeVD (1.00). Deaths 
from IHD remained high (1.37, P = 0.05) even when the combined cohort was 
compared with expected numbers derived from rates of the counties in which the 
plants were located. Additional analyses revealed evidence of a 15-year latency 
period and suggested a relationship with duration of exposure. More than 5 months 
of exposure was associated with an SMR for IHD of 1.68 (P < 0.001), whereas the 
SMR for < 5 months of exposure was 1.03. Mortality from lung cancer, a marker 
of smoking habits, was less than expected (556).  
A later US study comprised 4 989 white male munitions workers from Radford, 
Virginia, with probable exposure to dinitrotoluene (903). This cohort included 
workers from a later time-period (1949–1980) than the previous study (556). All 
workers had been employed for at least 5 months. A non-exposed comparison group 
comprised 5 136 white male workers. The cohorts were followed until December 
1982. There were no increased risks regarding mortality due to IHD and CeVD 
when dinitrotoluene-exposed workers were compared with US national rates (SMR 
0.98 and 0.95, respectively) and with unexposed workers (SRR 0.99 and 0.89, 
respectively). An excess in mortality from CeVD was observed in the 55–59-year 
age group when dinitrotoluene-exposed workers were compared with unexposed 
workers (SRR 4.46, 95% CI 1.11–17.84). There was an inverse trend between 
duration of dinitrotoluene exposure and IHD mortality (P = 0.003) (903).  
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13.5 Conclusion 
Nitroglycerine and ethylene glycol dinitrate both have established acute and chronic 
effects on the cardiovascular system. The acute symptoms result from blood vessel 
dilation and consist primarily of headache, heart palpitations, dizziness and nausea 
(2-4, 518, 522, 584). 
The two studies located for propylene glycol dinitrate showed an increased risk 
of CVD among torpedomen (302) and headache in volunteers chamber exposed to 
0.2 ppm (915).  
Three occupational cohorts exposed to dinitrotoluene were found. One of these 
showed an increased risk of CVD (556), and headache was observed in a cross-
sectional study (621).  
The data on propylene glycol dinitrate and dinitrotoluene are meagre, but the 
association with CVD is strengthened by similarities with the other nitrated 
explosives regarding chemical structure and properties, and in reported health 
effects. 
 
There is strong evidence for an association between exposure to nitroglycerine 
and ethylene glycol dinitrate and CVD.  
There is limited evidence for an association between exposure to propylene glycol 
dinitrate and dinitrotoluene and CVD. 
14. Irritant gases 
14.1 Formaldehyde 
14.1.1 General  
Formaldehyde is a colourless gas with a pungent odour. The substance is extremely 
reactive and is easily polymerised. It is also flammable, and can form explosive 
mixtures with air. Formaldehyde is a component of normal human metabolism and 
occurs naturally in fruits and other foods. The substance is also formed e.g. in 
decomposition or incineration of organic materials. The primary industrial use of 
formaldehyde is for production of resins; phenol, urea and melamine are used as 
adhesives and binders in paper and wood products, in production of plastics and in 
surface treatments of textiles. Polyacetal resins are used mostly in production of 
plastics. Formaldehyde occurs in manufacture of various types of plywood, particle 
board, medium-density fibreboard, etc. It is formed by acid-cured varnishes during 
the curing process, although the varnishes themselves contain very little form-
aldehyde. Formaldehyde or formaldehyde-releasing substances are often used as 
preservatives in products such as cutting fluids and water-based paints, and are  
also widely used as preservatives in cosmetics, hygiene products and foodstuffs. In 
addition, formaldehyde is used in pathology and cytology laboratories and for 
embalming. According to the Scientific Committee on Occupational Exposure 
Limits (SCOEL), formaldehyde is a genotoxic carcinogen, with a mode of action 
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including inflammation and cellular proliferation, for which a practical threshold is 
supported (849).  
14.1.2 Occupational epidemiological studies  
The mortality of a cohort of 4 512 British pathologists who were members of the 
Royal College of Pathologists 1974–1987 was compared with the general mortality 
in England and Wales. There were totally 91 deaths from diseases of the circulatory 
system and the SMR was 0.46 (95% CI 0.37–0.56) (374). 
A cohort containing 14 014 men employed after 1937 at six British factories 
where formaldehyde was produced or used was followed 1941–2000. The mortality 
was compared with the expected numbers of deaths for the national population. 
Identification data and occupational histories were abstracted from employment 
records, and each job was classified as belonging to one of five categories of 
formaldehyde exposure (background, low, moderate, high or unknown). No 
measurements of formaldehyde had been performed before 1970, but from later 
measurements and from workers’ recall of irritant symptoms, it was estimated  
that background exposure corresponded to TWA concentrations < 0.1 ppm; low 
exposure to 0.1–0.5 ppm; moderate exposure to 0.6–2.0 ppm; and high exposure to 
> 2.0 ppm. Some of the exposures may have occurred through inhalation of 
paraformaldehyde particles or particles of formaldehyde-based products. The 
mortality (SMR, 95% CI) from circulatory diseases among high-exposed men and 
in the total cohort was 1.04, (0.97–1.11, 849 deaths) and 0.98 (0.94–1.02, 2 266 
deaths), respectively (182). 
A proportionate mortality study compared the causes of death among embalmers 
in California with those of the general US population. The study group consisted of 
embalmers who were first licensed to practice in California 1916–1978 and who 
died 1925–1980. There were totally 1 007 fatalities among white male embalmers. 
There was an increased mortality ratio from IHD (PMR 1.19, P < 0.05) but not from 
CeVD (PMR 0.94). Smoking was an unlikely explanation as mortality from lung 
cancer was not increased (PMR 0.96). The same pattern of IHD mortality was 
observed in a parallel study of totally 1 132 fatalities among white male embalmers 
from New York (PMR 1.12, P < 0.05) (980). 
The proportional mortality was studied among 3 649 white and 397 non-white 
male US embalmers and funeral directors who had died 1975–1985. Comparisons 
were based on the US general population. Increased mortality ratios (PMR, 95% 
CI) were observed from IHD among whites (1.13, 1.07–1.19) and non-whites  
(1.45, 1.22–1.72) but not from vascular lesions of the CNS among whites (1.02, 
0.90–1.15) and non-whites (0.90, 0.61–1.27). The corresponding PMRs for lung 
cancer were 0.97 and 0.75, respectively (390). 
A cohort of 1 477 male Ontario undertakers first licensed during 1928 through 
1957 was followed until 1977. Numbers of observed and expected deaths were 
determined for the period 1950–1977, using rates of Ontario men as the standard. 
Mortality ratios were not significantly increased for circulatory diseases (SMR 
1.07), IHD (SMR 1.07) and CeVD (SMR 0.78). However, the mortality from 
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cirrhosis of the liver was increased (SMR 2.38, P < 0.001), which suggests that the 
undertakers had consumed more alcoholic beverages than the general population. 
This may explain the small increases of circulatory disease mortality (557).  
In a cohort study, mortality was evaluated among 26 561 workers employed in 
ten US formaldehyde-producing or -using facilities. The cohort was composed of 
all workers first employed at the selected plants before 1966, and was followed 
through 1980. Among white men, there was no exposure-response relationship for 
atherosclerotic heart disease. At cumulative formaldehyde exposures of 0, ≤ 0.5, 
0.51–5.5 and > 5.5 ppm-years, the SMRs (95% CIs) were 0.97 (0.80–1.16), 1.15 
(1.05–1.26), 0.94 (0.86–1.03) and 0.90 (0.79–1.01), respectively (105). This cohort 
was further followed through 1994. The mortality risk (SMR, 95% CI)  
for circulatory diseases was lower than expected for both exposed workers (0.88, 
0.85–0.91) and non-exposed workers (0.77, 0.72–0.83). The use of slightly different 
categories of formaldehyde exposure resulted in SMRs for circulatory diseases of 
0.97, 1.00, 0.98 and 1.05 at cumulative exposures of 0, > 0– < 1.5, 1.5– < 5.5 and 
≥ 5.5 ppm-years, respectively. There was no significant exposure-response trend 
(389). 
A cohort of 3 929 male workers was exposed to formaldehyde and employed at 
an automotive iron foundry for at least 6 months 1960–1987, when the foundry was 
permanently closed. The exposed workers were compared with the US population 
and an internal population of 2 032 men who had worked in the same foundry 
during the same time period but not in formaldehyde-exposed jobs. Only workers 
in the core making and related operation were exposed to formaldehyde. The 
highest levels of formaldehyde exposure were experienced by workers operating 
the two-stage core machines with predicted mean breathing zone concentrations of 
2.6 ppm through 1978, 1.8 ppm 1978–1983 and 1.2 ppm from 1984. The follow-up 
continued through 1989. Compared to the general population, the SMR (95% CI) 
for IHD for formaldehyde-exposed workers and non-exposed foundry workers was 
0.97 (0.82–1.14) and 0.87 (0.73–1.04), respectively. Corresponding figures for 
CeVD were 1.10 (0.81–1.48) and 1.07 (0.73–1.50) (32). It should be mentioned that 
foundry workers have many confounding exposures such as noise, silica and PAH.  
A cohort of 11 039 workers was exposed to formaldehyde for ≥ 3 months in three 
garment plants in Georgia and Pennsylvania. Formaldehyde was first introduced in 
1955 in one plant and in 1959 in the other plants. The cohort was followed through 
1998. These garment facilities produced shirts from fabrics which were treated with 
formaldehyde resins to impact crease resistance. The mean TWA formaldehyde 
exposure at the plants in the early 1980s was 0.15 ppm, but past exposures  
may have been substantially higher. The expected numbers of death were based on 
rates from the US population. There was no increased mortality (SMR, 95% CI) 
from heart disease (0.96, 0.89–1.04) and IHD (0.95, 0.86–1.03), but an increased 
mortality from cardiomyopathy, conductive disorders and other heart diseases 
(1.17, 1.00–1.36). When duration of exposure (< 3 years, 3–9 years and ≥ 10 years) 
was related to mortality, there was a significantly negative trend regarding heart 
disease and IHD. Mortality from cardiomyopathy, conductive disorders and other 
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heart diseases had the highest SMR at the lowest duration (1.45, 99% CI excluded 
1.0). With year of first exposure categorised as prior to 1963, 1963–1970 and 1971 
or later, SMRs for heart disease were 0.93, 1.04 and 1.14, respectively. The 
corresponding numbers for IHD were 0.90, 1.05 and 1.40 (750). This pattern may 
reflect a high SMR when there is a short time period between exposure and 
outcome. A longer period between exposure and outcome may increase the 
likelihood for a longer non-exposure period due to movement to other employment 
or retirement. 
14.1.3 Conclusion 
One occupational cohort of formaldehyde exposed workers presented an increased 
mortality regarding cardiomyopathy, conductive disorders and other heart diseases 
(750). In addition, two proportionate mortality studies reported an increased risk for 
IHD among embalmers (390, 980). The remaining five cohort studies did not show 
increased CVD risks. 
 
There is insufficient evidence for an association between exposure to form-
aldehyde and CVD. 
14.2 Phosgene 
14.2.1 General 
Phosgene (COCl2) was used during World War I in chemical warfare. In chemical 
industry it is used as an agent for direct chlorination (766). 
14.2.2 Occupational epidemiological studies 
A cohort of 694 male chemical workers was exposed to low levels of phosgene 
while working at a uranium processing plant in Tennessee 1943–1945. The 
expected numbers of deaths were based on rates for US white males. The total 
number of deaths due to diseases of the circulatory system was 101 (SMR 0.86, 
95% CI 0.70–1.04). The SMR was slightly higher among 106 workers with acute 
exposure to high levels of phosgene (SMR 1.06, 95% CI 0.63–1.67). On the basis 
of reported symptoms most of the 106 workers had been exposed to around 50 ppm-
minutes (754).  
14.2.3 Conclusion 
The only located occupational study on phosgene did not show an increased risk for 
CVD (754). 
 
There is insufficient evidence for an association between exposure to phosgene 
and CVD.  
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14.3 Sulphur dioxide 
14.3.1 General 
Exposure to sulphur dioxide (SO2) is prevalent in many occupational settings, e.g. 
paper and pulp factories, smelters, steel works and chemical industries (254). 
Ambient sulphur dioxide remains a major air pollutant in many parts of the world. 
14.3.2 Human experimental studies 
Healthy volunteers and patients with stable angina pectoris, multivessel coronary 
artery disease (i.e. IHD) and good left ventricular function (20/group) were exposed 
to 200 ppb (540 µg/m3) sulphur dioxide and air for 1 hour. Baseline concentrations 
of CRP were higher in patients with IHD than in healthy subjects. There were no 
changes in CRP, fibrinogen or D-dimer during exposure. A significant reduction in 
HRV was observed 4 hours post-exposure in volunteers, but not in patients (805). 
14.3.3 Occupational epidemiological studies 
A group of 400 male workers were employed for at least 6 months during the period 
1961–1981 in a Swedish sulphuric acid factory. The cohort was followed until  
1985 and mortality was compared with rates from the regional county. The relative 
SMR for CVD was 1.33 (22 cases, P = 0.17) which increased to 1.51 (22 cases, 
P = 0.05) after a latency period of at least 5 years. The SMRs increased slightly with 
time of employment (254) (Table 15). 
The mortality of Finnish sulphite mill workers employed for at least 1 year during 
1945–1961 was followed until 1981. Among those exposed to sulphur dioxide 
(2 268 person-years), a non-significantly increased mortality (SMR, 95% CI) was 
observed from CVD (1.23, 0.79–1.84) and IHD (1.45, 0.86–2.29) (469).  
A cohort comprised 1 096 male workers from a plant producing sulphuric acid, 
in Tuscany, Italy. The workers had been employed at least 1 year at the plant in the 
period 1962–1997 and were followed until 2000. The mortality from circulatory 
diseases was decreased (SMR 0.64, 95% CI 0.49–0.84) (739).  
14.3.4 Epidemiological studies of the general population  
Epidemiological evidence about the health effects in the general population of 
sulphur dioxide exposure is not abundant. 
 
Table 15. Relationship between time of employment and risk of CVD mortality (latency 
time ≥ 5 years) among workers in a sulphuric acid factory (254).  
< 2 years employment 2–5 years employment > 5 years employment 
Observed SMR SSMR Observed SMR SSMR Observed SMR SSMR a 
3 1.29 1.29 6 1.50 1.72 13 1.57 1.82 
a P for trend > 0.5. 
CVD: cardiovascular disease, SMR: standardised mortality ratio, SSMR: SMR standardised to the 
age distribution in the group with < 2 years employment.  
 
  
159 
During 2000–2007, the CVD mortality was investigated in Seoul, Korea,  
with a time-stratified case-cross-over design. The mean daily sulphur dioxide 
concentration was 5.4 ppb (14 µg/m3) (SD 2.4 ppb). An interquartile increase of 
sulphur dioxide concentration was associated with an increased risk (OR, 95% CI) 
of CVD mortality (3.64, 1.46–5.87). The CVD mortality was higher for males  
than for females (1.05, 1.01–1.09) and higher for manual than for professional 
occupations (1.19, 1.03–1.37) (894).  
A nationwide time-series analysis was conducted in China during 2013–2015 
including 272 major cities. The annual-mean of sulphur dioxide concentrations was 
29.8 µg/m3. The associations between exposure and daily cause-specific mortality 
were investigated with the 2-day moving average of the present and previous  
day concentrations of sulphur dioxide. Risk estimates were adjusted for age, sex 
and educational level. A 10-μg/m3 increase in sulphur dioxide concentration was 
associated with an increment in mortality of 0.70% (95% CI 0.49–0.91%) from 
CVD, 0.64% (95% CI 0.30–1.58%) from hypertension disease, 0.65% (95% CI 
0.42–0.89%) from CHD and 0.58% (95% CI 0.33–0.84%) from stroke. The risk 
estimates did not change after adjusting for fine particulate matter, carbon 
monoxide and ozone, but decreased substantially after adjusting for nitrogen 
dioxide. However, the estimate regarding CVD was still increased after adjusting 
for nitrogen dioxide (0.97%, 95% CI 0.45–1.49%). The authors concluded that the 
associations might not be independent from nitrogen dioxide (984).  
14.3.5 Conclusion  
Two occupational cohort studies showed non-significant increases of CVD among 
workers exposed to sulphur dioxide (254, 469), whereas two environmental studies 
showed positive associations between ambient sulphur dioxide exposure and risk 
for CVD (894, 984). 
 
There is limited evidence for an association between exposure to sulphur dioxide 
and CVD.  
14.4 Nitrogen dioxide 
14.4.1 General  
Nitrogen dioxide (NO2) is formed when nitrogen in the air is oxidised by electrical 
discharges or combustion, notably in internal combustion engines and around 
welding. These processes create mostly nitrogen monoxide (NO), which is then 
oxidised to nitrogen dioxide. Nitrogen dioxide occurs in the general environment in 
concentrations around 0.01–0.05 ppm (1 ppm = 2 mg/m3). In Sweden, the major 
source is diesel engine exhaust. Nitrogen dioxide is also formed during combustion 
of bottled gas and city gas for cooking and heating, and in vehicles run on liquefied 
petroleum gas (LPG). In indoor arenas where LPG-powered ice machines are used, 
nitrogen dioxide levels are commonly around 0.1–0.8 ppm with peaks approaching 
3–4 ppm, but considerably higher concentrations have been measured under special 
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circumstances. Tobacco smoking also contributes to the occurrence of nitrogen 
dioxide (660). 
Occupational exposures to very high levels of nitrogen dioxide can occur in 
enclosed areas, notably during gas welding, work in fodder silos, and dynamiting 
in mines. The most common source of exposure is diesel engine exhaust, 
particularly in enclosed, poorly ventilated locations such as tunnels and mines 
(660).  
Studies from Norway and Sweden in 1996–2004 among tunnel construction 
workers showed nitrogen dioxide concentrations of 0.2–0.9 ppm. A more recent 
study from Norway conducted in 2010–2011 indicated a decrease in diesel exhaust 
emissions, reflected as a lowered nitrogen dioxide concentration of 0.09 ppm. In 
seven non-metal mining facilities in the US in 1998–2001, the average nitrogen 
dioxide exposure was 0.1–0.6 ppm among underground workers and 0.01–0.06 ppm 
among surface workers (941). 
14.4.2 Human experimental studies  
Healthy, non-smoking subjects were exposed to air and 2 ppm nitrogen dioxide  
for 4 hours in random order on separate occasions. Endobronchial biopsies and 
bronchial washing were done 1.5 hour or 6 hours after exposure. The nitrogen 
dioxide exposure induced a 1.5-fold increase in IL-8 (P < 0.05) at 1.5 hour and a 
2.5-fold increase in neutrophils (P < 0.01) at 6 hours in the bronchial washing. 
Immunohistological examination of bronchial biopsy specimens showed no signs 
of upregulation of adhesion molecules, and failed to reveal any significant changes 
in inflammatory cells at either time-point after nitrogen dioxide exposure. The 
increase in neutrophils may be a consequence of the enhanced IL-8 secretion 
observed 1.5 hour after exposure (110).  
Ten healthy male volunteers were exposed to 4 ppm nitrogen dioxide or filtered 
air for 1 hour during intermittent exercise in a randomised double-blind crossover 
study. Bilateral forearm blood flow and fibrinolytic markers were measured before 
and during unilateral intrabrachial infusion of bradykinin, acetylcholine, sodium 
nitroprusside or verapamil 4 hours after the exposure. Inhalation of nitrogen dioxide 
did not impair vascular vasomotor or fibrinolytic function (535). 
Twenty-one healthy volunteers were exposed on separate occasions to air and 0.6 
and 1.5 ppm nitrogen dioxide for 3 hours with intermittent moderate exercise. 
Respiratory symptom scores were generally highest after exposure to 1.5 ppm, but 
differences between exposures to nitrogen dioxide and air were not significant for 
any single symptom. In an analysis of variance, haematological results revealed a 
4.1% exposure-related decrease in haematocrit (P = 0.003). Also circulating total 
lymphocytes (P = 0.024) and T-lymphocytes (P = 0.049) decreased with nitrogen 
dioxide exposure. Exposure to nitrogen dioxide increased the blood lymphocyte 
CD4+-to-CD8+ ratio from 1.74 to 1.85 in males but decreased the ratio from 1.88 to 
1.78 in females (P < 0.001 for gender difference). Polymorphonuclear leukocytes 
in bronchial lavage increased with nitrogen dioxide exposure (P = 0.003). Thus, 
these levels of exposure caused mild airway inflammation (307). 
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14.4.3 Occupational epidemiological studies 
A cohort consisting of 53 814 men employed in 1985 at four US trucking companies 
was followed until 2000. Using an exposure model, each worker was assigned a 
unique annual exposure based on his address. Time-varying variables for years 
employed and years off work were used to adjust for a healthy worker survivor 
effect. HRs were calculated in units of the interquartile range. There was a 10.9% 
(95% CI 2.7–19.8%) increased risk of CVD mortality when the average ambient 
nitrogen dioxide exposure increased 8 ppb in the single pollutant model. In the 
multi-pollutant model, including PM10 and sulphur dioxide, the risk was attenuated 
to 8.3% (95% CI -2.5–20.4%). There were no increased risks regarding PM10 or 
sulphur dioxide (384). 
14.4.4 Epidemiological studies of the general population  
It has been suggested that previous associations between environmental nitrogen 
dioxide exposure and CVD do not reflect adverse health effects of nitrogen dioxide 
itself but rather that of other air pollutants, mainly particulate matter or other 
components of the complex mixture of traffic-related air pollutants. Primarily, this 
is due to the strong correlations between nitrogen dioxide and other combustion-
derived air pollutants, especially particulate matter (649). 
A total of 11 428 patients with ST-elevation MI (STEMI) were included in a 
Belgian study 2009–2013. Each 10-μg/m3 increase in ambient nitrogen dioxide was 
associated with an increased OR of STEMI of 1.05 (95% CI 1.02–1.08), which  
was higher than the increase associated with particulate exposure. Among subjects 
≤ 54 years old the corresponding OR was 1.07 (95% CI 1.01–1.14) (42). 
14.4.5 Meta-analyses 
A meta-analysis of ten studies estimated an increased risk of death from CVD of 
1.07% (95% CI 0.43–1.72%) per 10-μg/m3 increase in 24-hour nitrogen dioxide. 
All the studies also had exposure information on particulate matter. Following 
adjustment for particulate matter, the estimate was attenuated to 0.82% (95% CI 
0.22–1.42%). The results support an association between short-term nitrogen 
dioxide exposure and adverse health outcome that is largely independent of 
particulate matter mass (649). 
Another meta-analysis comprised four studies and involved 461 441 participants. 
The studies included environmental air pollutants from particles and gases (ozone, 
carbon monoxide, sulphur dioxide and nitrogen dioxide) and investigated the 
association with atrial fibrillation. There was a statistically significant association 
between atrial fibrillation development and all gaseous pollutants as well as PM2.5. 
Nitrogen dioxide was the most frequently studied gaseous pollutant and an increase 
of 10 ppb was associated with an increased risk of atrial fibrillation (1.19%, 95% 
CI 0.70–1.67%). The authors suggested that gaseous or particulate pollutants are 
associated with an increased risk of atrial fibrillation (861). 
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14.4.6 Conclusion  
Experimental human studies have shown inflammatory responses after nitrogen 
dioxide exposure (110, 307). There is also some evidence from meta-analyses of 
relationships between ambient nitrogen dioxide exposure and CVD mortality (649) 
and atrial fibrillation (861). However, the environmental exposures always occur 
together with other particulate and gaseous exposures. 
 
There is limited evidence for an association between exposure to nitrogen dioxide 
and CVD.  
14.5 Ozone 
14.5.1 General  
Ozone (O3) is both a source of protection and risk for all species. In the stratosphere, 
where the majority of atmospheric ozone is found, ozone plays an important role in 
preventing harmful ultraviolet radiation from reaching the surface of the earth. At 
ground level, ozone was first identified as a component of photochemical pollution 
in the Los Angeles’ basin in the 1940s (681). 
Exposure of humans to ozone, either during an air pollution episode or under 
controlled chamber conditions, has elicited a wide spectrum of responses. These 
effects include subjective perceptions of respiratory discomfort (substernal soreness 
and pain on deep inspiration), putative alterations in lung function, development of 
airway inflammation, as well as tissue injury. Generally these responses have been 
studied over relatively short periods (681).  
High concentrations of ozone may occur in aircraft cabins (50–100 ppb, 100–200 
μg/m3) as a consequence of compressed ambient air from high altitudes. Use  
of air cleaning devices and photocopiers in offices may add substantially to the 
background level (1033). Metal inert gas (MIG) welding of aluminium generates  
a characteristic UV-irradiation which produces ozone from oxygen. Ozone 
concentrations up to 250 μg/m3 have been observed during this type of welding 
(386). In the early 1990s, pulp mills in the Nordic countries started to use ozone as 
a bleaching agent (968). 
14.5.2 Human experimental studies  
Male and female volunteers were exposed to 0, 100 and 200 ppb ozone (200 and 
400 µg/m3) in random order for 4 hours with intermittent exercise. Inhalation of 
ozone induced exposure-dependent adverse changes in the frequency domains  
of HRV across exposures, consistent with increased sympathetic tone and an 
exposure-dependent increase in serum CRP levels across exposures at 24 hours. 
Changes in HRV and CRP did not correlate with ozone-induced local lung 
inflammatory responses (granulocytes, IL-6 or IL-8 in BAL). According to the 
authors, inhalation of ozone caused adverse systemic inflammatory and cardiac 
autonomic effects that may contribute to the CVD mortality associated with short-
term exposure (43). 
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Obese and non-obese non-smoking women were exposed to 400 ppb (800 µg/m3) 
ozone and air for 2 hours with intermittent light exercise. The pre- to post-exposure 
decrease in forced vital capacity from ozone was significantly greater in the obese 
group. Plasma IL-6 levels were significantly increased at 4 hours post-exposure in 
both groups and had returned to pre-exposure levels 20 hours post-exposure (83). 
14.5.3 Epidemiological studies of the general population  
Associations between daily ozone concentrations and mortality during 1990–2010 
among persons with and without previous CVD hospitalisation were analysed with 
a generalised additive model adjusted for time trend, influenza and weather. An 
average 10-μg/m3 increase in the same and preceding day was associated with an 
increased mortality of 1.72% (95% CI 0.44–3.02%) in those with prior admission 
for acute MI, which was more than 3 times higher than for those with no previous 
acute MI (0.50%, 95% CI 0.10–0.89%) (88).  
No effect of ozone was observed in the previously referred Belgian study on 
STEMI patients (Section 14.4.4) (42). 
14.5.4 Meta-analyses 
A meta-analysis of associations between ambient ozone exposure and mortality 
from CVD comprised totally 12 studies, published 1988–2013. The CVD mortality 
was non-significantly higher for older persons than for younger persons. The 
increase in risk for a 10-ppb increase in daily 8-hour ozone concentration was 
0.73% (95% CI 0.43–1.04) for older persons and 0.53% (95% CI 0.20–0.86) for 
younger persons (80). 
14.5.5 Conclusion  
Experimental human studies have shown inflammatory responses after ozone 
exposure (43, 83). 
One meta-analysis (80) and one further study (88) demonstrated relationships 
between ambient ozone exposure and CVD mortality. However, ambient ozone 
exposure always occur in combination with other particulate and gaseous 
exposures. Long-term occupational cohort studies of ozone-exposed workers are 
lacking.  
 
There is limited evidence for an association between exposure to ozone and CVD. 
15. Asphyxiants 
15.1 Carbon monoxide 
15.1.1 General 
Carbon monoxide (CO) is a colourless and odourless gas. It is an atmospheric 
pollutant in urban areas, chiefly from exhaust of combustion engines, but also from 
incomplete burning of other fuels. CO is an important constituent of tobacco smoke. 
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Exposure to CO is common in many occupational areas, mainly in those associated 
with exhaust emissions. CO is also an important industrial gas, which is used for 
the production of chemical intermediates (918).  
The main mechanism behind CO-induced toxicity is the binding of CO to haemo-
globin, resulting in COHb formation and hypoxia. COHb levels around 20% may 
be lethal for patients with IHD. This short review is mainly based on a previous 
criteria document on carbon monoxide from NEG (918). 
15.1.2 Human experimental studies  
In controlled exposure studies of healthy volunteers, COHb levels up to 5.1% have 
been related to effects on exercise performance but not to myocardial ischaemia or 
cardiac arrhythmias (9, 496). 
In controlled exposures of patients with coronary artery disease, CO exposures 
resulting in COHb concentrations of 2.4% and 4.7% significantly reduced the time 
to onset of angina symptoms and of ST-segment changes of the ECG during 
exercise in a dose-dependent manner (21, 22). Other studies on patients with angina 
pectoris have also shown that CO exposure (COHb 2.9–5.9%) aggravated exercise-
induced myocardial ischaemia including decreased time to onset of angina 
symptoms, decreased time to onset of ST-segment changes and increased duration 
of angina symptoms (8, 29, 499). In another study on patients with angina pectoris, 
no changes in time to onset of angina symptoms and of ST-segment changes were 
observed at a COHb level of 3.8% (863). At a COHb level of 5.9%, but not at 4.0%, 
an increase in number of ventricular arrhythmias was reported among patients with 
coronary artery disease (IHD) (864). No such effect was seen in another study on 
such patients at a similar COHb level (5.8%) (409). 
15.1.3 Occupational epidemiological studies 
IHD mortality was studied among 931 male foundry workers in Finland who 
participated in a health examination in 1973. The workers were followed up to 1993 
through registers and by using a questionnaire (513). In 1973, the systolic and 
diastolic blood pressures of workers exposed to CO were slightly higher than those 
of unexposed workers. The prevalence of angina pectoris was associated with 
occupational CO exposure and smoking, separately and combined (401). In the 
1987 follow-up, the RR for IHD mortality was estimated as 4.4 for CO-exposed 
smokers compared to unexposed non-smokers. The IHD mortality in 1973–1993 
was analysed by the Cox proportional hazards model. A statistically significant 
relationship was found between regular CO exposure and IHD mortality (HR 2.15, 
95% CI 1.00–4.63). The HR decreased slightly when age and smoking were taken 
into account (513).  
15.1.4 Conclusion  
The established mechanism behind CO-induced toxicity is COHb formation leading 
to hypoxia. The evaluation of the association between exposure to CO and CVD is 
entirely based on evidence from controlled human exposure studies.  
  
165 
Among healthy volunteers, COHb levels up to 5.1% did not induce myocardial 
ischaemia or cardiac arrhythmias. However, among subjects with coronary artery 
disease (IHD), CO-exposures resulting in COHb concentrations of 2.4% and 4.7% 
significantly reduced the time to onset of angina pectoris symptoms and of ST-
segment changes of the ECG during exercise. COHb levels around 20% may be 
lethal for subjects with IHD (918). Two occupational studies support an association 
between CO exposure and CVD, but exposure-response data are lacking (401, 513). 
 
There is strong evidence for an association between exposure to carbon monoxide 
and angina pectoris symptoms among subjects with previous angina pectoris 
(IHD). 
15.2 Cyanide  
15.2.1 General 
Cyanide originates from both natural sources and chemical manufacture with the 
highest exposure occurring in the latter. Manufacture of products used in building 
construction and transportation vehicle interiors as well as in residential and com-
mercial building interiors and furnishings accounts for the majority of the use of 
cyanide. Cyanide is also used in the manufacture of e.g. nylon, rayon, PVC, 
modacrylic, polyurethane foam, polyester wadding, neoprene foam, rubber, plastics 
and adhesive resins (840). Cyanide as lixiviant for gold has been utilised in the 
mining industries for more than one century. It has also been used to recover gold 
and other metals from electronic waste (206). The salts of cyanide are commonly 
used in the jewellery industry (180).  
Acute cyanide poisoning in humans is predominantly caused by inhalation of 
smoke from fires (303). Cyanide has been assumed to be a likely terrorist weapon 
(840).  
Cyanide poisoning produces rapid blockage of cellular respiration due to binding 
to cytochrome a3, resulting in accumulation of lactate. Lactic acidosis is a 
recognised hallmark of acute cyanide poisoning in humans (180). 
15.2.2 Accidents  
Medical records were reviewed of 161 fire survivors with suspected or confirmed 
cyanide poisoning. Cardiac arrest was common; 58 asystole and 3 ventricular 
fibrillation. Cardiac rhythm disorders were almost as common with 56 supra-
ventricular tachycardias. Twelve repolarisation disorders and five intracardiac 
conduction disorders were observed. Of the 161 patients, 26 displayed no cardiac 
disorder. Of the patients initially in cardiac arrest, 30 died at the scene, 24 died  
in hospital and 5 survived without cardiovascular sequelae. Cardiac disorders 
improved with increasing doses of hydroxocobalamin, and higher doses of the 
antidote seem to be associated with a superior outcome in patients with initial 
cardiac arrest (303). 
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15.2.3 Conclusion 
Acute cyanide poisoning is often associated with cardiotoxic effects such as cardiac 
arrest and cardiac rhythm disorders (303). However, supraventricular tachycardias 
may be an expression of increased circulatory demands. No epidemiological studies 
were located on the relationship between long-term exposure to cyanides and CVD. 
  
There is insufficient evidence for an association between exposure to cyanide and 
CVD. 
15.3 Hydrogen sulphide 
15.3.1 General 
Hydrogen sulphide is a gas found in volcanic gases, swamps, and sulphur springs. 
It is produced by bacterial processes during the decay of both plant and animal 
protein (e.g. in sewage water) or through the direct reduction of sulphate. 
Generation of hydrogen sulphide can be expected whenever oxygen is depleted and 
organic material containing sulphur is present. Hydrogen sulphide occurs in most 
petroleum and natural gas deposits and in mines where sulphur is present. 
Occupational exposure to hydrogen sulphide is primarily a problem in the “sour 
gas” segment of the natural gas industry, where natural gas with a high 
concentration of sulphur is processed (931). 
There have been several reports of accidental deaths and injuries at a number of 
work situations and workplaces such as flat fish farming, asphalt roofing, liquid 
manure pits in farming, oil fields, oil refineries and sewage handling. Hydrogen 
sulphide is formed in manufacturing processes whenever elemental sulphur or 
sulphur compounds are present with organic chemicals at high temperatures. 
Examples of industries where this gas can be generated include petroleum 
refineries, natural gas plants, petrochemical plants, coke oven plants, kraft paper 
mills, viscose rayon manufacture, sulphur production, iron smelters, food 
processing plants and tanneries (931). 
15.3.2 Mechanistic evidence 
Hydrogen sulphide inhibits cytochrome oxidase, which is an important mito-
chondrial enzyme. Upon binding to cytochrome oxidase, hydrogen sulphide 
prevents the enzyme from combining electrons with oxygen and thus prevents the 
reduction of oxygen to water, creating chemical suffocation and preventing ATP 
(adenosine triphosphate) formation (666). A direct toxic action of sulphide on the 
heart has been associated with various arrhythmias, disorders of conduction and 
disorders of ventricular repolarisation (430, 485, 917). 
Hydrogen sulphide is endogenously produced in small amounts and plays a role 
as a secondary messenger in cellular signalling. Hydrogen sulphide is considered a 
gasotransmitter, a signalling gas, together with carbon monoxide and nitrogen 
oxide. Like nitrogen oxide, hydrogen sulphide causes smooth muscle relaxation 
(666). 
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15.3.3 Accidents 
From 1980 through 2013, there were 35 accidents in the Netherlands with manure 
storage involving 56 adults with hydrogen sulphide intoxication. The survival  
rate was 43% as 24 patients survived. Of the 8 patients with documented 
cardiopulmonary resuscitation on the scene, 6 survived without neurological 
complications. The authors pointed out that this survival rate (75%) is far better 
than the survival rates after out-of-hospital cardiac arrest (5–8%). The authors 
concluded that manure related hydrogen sulphide intoxication is associated with a 
high mortality, although in some cases, recovery appears to be far more favourable 
than the initial presentation would suggest. Possibly, protection from hypoxic injury 
due to induction of a suspended animation-like state (a state in which life is 
temporarily slowed down or stopped) by hydrogen sulphide may be responsible 
(666). 
15.3.4 Occupational epidemiological studies 
A cohort comprising men employed continuously for at least 1 year 1945–1961 at 
three pulp and paper mills in south eastern Finland was followed until 1981. A 
subcohort of men exposed to hydrogen sulphide and organic sulphides contained 
4 179 person-years. There was an increased mortality (SMR, 95% CI) due to CVD 
(1.50, 1.05–2.06) and IHD (1.50, 0.97–2.22). The CVD mortality (SMR, 95% CI) 
was higher among men with a work duration of 1–4 years (2.16, 0.99–4.10) than 
among those with a work duration of ≥ 5 years (1.36, 0.91–1.97). The IHD mortality 
(SMR, 95% CI) was also higher among workers with a short work duration (2.54, 
1.02–5.23) than among those with a longer work duration (1.29, 0.77–2.05). There 
was also an increased CVD mortality (SMR, 95% CI) among workers who had 
worked ≥ 5 years and had been followed > 15 years (1.73, 1.09–2.62). The 
corresponding mortality for IHD was 1.62 (0.88–2.72) (469). 
15.3.5 Conclusion  
Hydrogen sulphide poisoning is associated with fatal cardiotoxic effects. One 
epidemiological study provides some weak support for a relationship between 
occupational hydrogen sulphide exposure and CVD, but no exposure-response 
relationships were presented (469).  
 
There is insufficient evidence for an association between exposure to hydrogen 
sulphide and CVD. 
15.4 Phosphine 
15.4.1 General 
Aluminium phosphide is a cheap solid fumigant and highly toxic pesticide which is 
commonly used for grain preservation in many Asian countries. The compound has 
currently aroused interest due to increasing number of intoxications in the past four 
decades when used for agricultural and non-agricultural purposes. Upon contact 
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with moisture, aluminium phosphide undergoes a chemical reaction yielding 
phosphine gas (PH3). Phosphine inhibits cellular oxygen utilisation and can induce 
lipid peroxidation. The specified fatal dose of aluminium phosphide when ingested 
is 0.15–0.5 g. The average time interval between ingestion and death is 3 hours  
(1–48 hours), 95% of the patients die within 24 hours and the commonest cause of 
death is cardiac dysrhythmia (656). 
Phosphine can inhibit cytochrome c oxidase in vitro but has much less activity 
in vivo. It can rapidly perturb mitochondrial conformation and inhibit oxidative 
respiration (656). 
15.4.2 Accidents 
Two children and 29 of 31 crew members aboard a grain freighter became acutely 
ill after inhaling the fumigant phosphine; one child died. Predominant symptoms 
were headache, fatigue, nausea, vomiting, cough and shortness of breath. Abnormal 
physical findings included jaundice, paraesthesia, ataxia, intention tremor and 
diplopia. Focal myocardial infiltration with necrosis, pulmonary oedema and wide-
spread small-vessel injury were found at post-mortem examination of the 2-year-
old child. The surviving 4-year-old child showed several signs indicating 
myocardial injury, including ECG and echocardiographic changes and transient 
elevation of the MB (myocardial band) fraction of serum creatinine phosphokinase 
(a marker of acute MI). Four crew members were hospitalised and three had 
experienced shortness of breath and substernal burning. Illness was significantly 
associated with living or working amidships or on the forward deck areas of the 
vessel. The highest concentration of phosphine (20–30 ppm) was measured in a 
void space of the main deck adjacent to the air intake system for ventilation 
amidships. Substantial phosphine leakage (7.5–10 ppm) was noted around one 
hatch on the forward deck and at an air intake ventilator aft of the main house (12 
ppm). Levels of 0.5 ppm of phosphine gas were measured in some of the living 
quarters amidships (1024).  
In 2008, 80 000 tonnes of peas were treated with 1–1.5 g/m3 of aluminium 
phosphide on board a bulk carrier with 13 seafarers. A 56-year-old seafarer with 
intense abdominal and chest pains, associated with dizziness, was rescued by 
helicopter and admitted rapidly to hospital. His heart rate decreased and the 
respiratory distress increased. He finally died of pulmonary oedema, major 
metabolic acidosis and acute multiorgan failure. The following day, a 41-year-old 
man turned ill also with abdominal pain, vomiting and dizziness. The ECG only 
revealed type 1 Brugada syndrome (abnormal electrical activity of the heart). Of 
the 11 other seafarers evacuated for observation, 3 showed clinical abnormalities. 
One crew member had a right bundle branch block which spontaneously improved 
after several hours of monitoring. The authors concluded that the seafarers were 
poisoned by phosphine gas spreading through cabins above the hold (573). No 
measurements of phosphine were performed. 
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15.4.3 Occupational epidemiological studies 
A cross-sectional study investigated 22 Indian workers engaged in fumigation of 
stored grains and exposed to phosphine. The mean age of the workers was 48 years 
and the mean duration of exposure was 11.1 years (range 0.5–29). The workers 
placed aluminium phosphide tablets on the stacks of grains and covered it with a 
gas-proof plastic cover. After fumigation, they reported symptoms which included 
cough (18%), dyspnoea (32%), tightness around the chest (27%) and headache 
(32%). The symptoms lasted for 10 minutes to 3 hours. The abnormal physical signs 
included bilateral diffuse rhonchi and absent ankle reflex each occurring in one 
worker. Phosphine concentrations in the work environment ranged from 0.17 to 
2.11 ppm. The workers were also exposed to other pesticides but not during the last 
4 weeks (653). 
Aluminium phosphide was used for fumigation of bulk wheat in country storages 
in New South Wales, Australia. Exposures to phosphine occurred over a wide range 
of concentrations, from zero when adding tablets to 35 ppm when shipping. In all, 
67 men were interviewed and the majority stated that they were aware of the odour 
of phosphine most of the time. The most common symptoms were headache (83%), 
diarrhoea (82%), nausea (73%) and epigastric pain (65%). Cardio-respiratory 
symptoms were slightly less common; tightness of chest (52%), breathlessness 
(34%), soreness or pain in chest (29%), palpitations (27%) and severe retrosternal 
pain (6%) (461). 
15.4.4 Conclusion 
Phosphine inhibits mitochondrial cytochrome oxidase and cellular oxygen 
utilisation. It is well established that excessive exposure to phosphine causes fatal 
cardiac dysrhythmias (573, 656). The epidemiological data on phosphine exposure 
and CVD are meagre. 
 
There is insufficient evidence for an association between exposure to phosphine 
and CVD. 
16. Evaluation of human health risks 
16.1 Assessment of health risks 
The evaluations on occupational chemical exposures in relation to CVD were 
categorised according to the strength of evidence (Chapter 6) as: 
1. Strong, 2. Moderately strong, 3. Limited, or 4. Insufficient. 
Summary of evaluations, categorisations of strength of evidence and critical 
exposure-response data are presented in Tables 16–17. In the text below, agents 
with strong or moderately strong evidence for an association with CVD are 
presented. The categorisations were mostly based on epidemiological data on 
workers or the general population, but in some cases on human experimental data.  
Effects only seen at excessive concentrations (e.g. during anaesthesia or during 
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occupational conditions no longer valid) were not considered relevant for the 
categorisation. 
In subjects with previous angina pectoris (IHD), exposure to dichloromethane 
and carbon monoxide have elicited angina pectoris symptoms. Such subjects may 
well be part of the work force. These findings were therefore considered relevant 
for occupational exposure and have driven the assessment of the strength of 
evidence for these substances. 
16.1.1 Combustion-generated air pollutants  
Exposure occurs in many industrial processes and occupational activities (e.g. 
electrolytic aluminium smelting, coke and graphite electrode production, coal 
gasification, chimney sweeping, asphalt paving, tar distillation) and includes many 
sources of air pollutants (e.g. diesel engine exhaust, cooking fumes, second-hand 
smoke and smoke from fires). 
It should be noted that air pollution generated from different types of combustion 
processes differ in composition, and that the content of several active agents used 
as indicators of exposure (e.g. PAH, BaP and EC) varies. Therefore, e.g. air 
concentrations of BaP from different types of combustion-generated processes are 
not directly comparable.  
Overall, there is moderately strong evidence for an association between exposure 
to combustion-generated particles and CVD. PM2.5 exposure around 0.2–0.3 mg/m3 
to different combustion-generated particles (e.g. diesel engine exhaust) was 
associated with effects on blood vessels or the heart in human experimental (585, 
650, 736, 965) and epidemiological (364, 442) studies.  
16.1.2 Mineral dusts  
Asbestos, crystalline silica, MMVF and CNTs were evaluated.  
There is strong evidence for an association between exposure to asbestos and 
CVD. An exposure of 0.04–0.2 asbestos fibres/ml for 40 years was associated with 
an increased mortality from CVD (539).  
Evidence is also strong for an association between exposure to crystalline silica 
and CVD. Exposure at 0.01–0.02 mg/m3 of respirable crystalline silica for 40 years 
was associated with an increased mortality from IHD (570). 
16.1.3 Metals  
Totally 11 metals were evaluated.  
There is strong evidence for an association between arsenic exposure and CVD. 
Exposure to arsenic air concentrations of 0.1–0.2 mg/m3 for 40 years was associated 
with an increased mortality from CVD (402). 
Evidence is also strong for an association between lead exposure and CVD. A 
blood lead level of 6.7 µg/dl (0.32 µmol/l) was associated with an increased CVD 
mortality (538).  
There is moderately strong evidence for an association between cadmium 
exposure and CVD. Blood cadmium levels of 0.26–0.50 µg/l (2–4 nmol/l) were 
associated with an increased risk of major adverse cardiac events (63) and urinary 
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cadmium levels of 0.62–0.92 µg/g creatinine (0.62–0.93 µmol/mol creatinine) were 
associated with CVD (943). 
16.1.4 Other dusts and fumes  
There is moderately strong evidence for an association between exposure to welding 
fumes and IHD; exposure to 0.25–1.25 mg/m3 for 40 years was associated with an 
increased risk of chronic IHD (441).  
Evidence is also moderately strong for an association between exposure in the 
pulp and paper industry and CVD. 
16.1.5 Pulmonary heart disease 
Some dusts and metals cause pneumoconiosis (e.g. asbestosis, silicosis and 
berylliosis) and extrinsic allergic alveolitis (metalworking fluids, wood dust and 
agricultural dust), which may lead to pulmonary arterial hypertension (pulmonary 
heart disease or cor pulmonale).  
The evidence for an association between crystalline silica and cor pulmonale is 
strong. Occupational exposure-response relationships were observed for crystalline 
silica and beryllium, respectively, and pulmonary heart disease. 
16.1.6 Non-chlorinated organic solvents  
Some organic solvents, including mixed solvent exposures, were evaluated.  
For carbon disulphide, the evidence is strong for an association between exposure 
and CVD. 
16.1.7 Halogenated hydrocarbons 
There is moderately strong evidence that exposure to dichloromethane elicits 
angina pectoris symptoms in subjects with previous IHD. 
There is strong evidence for a relationship between exposure to dioxins and 
dioxin-like compounds and IHD; plasma levels ≥ 9.9 ppt (ng/kg) TCDD were 
associated with an increased risk (112).  
16.1.8 Nitrated explosives  
Strong evidence supports an association between exposure to both nitroglycerine 
and ethylene glycol dinitrate and CVD. Some of the explosives are easily absorbed 
through the skin (nitroglycerine, ethylene glycol dinitrate and propylene glycol 
dinitrate), thus the unprotected skin may be the major route of exposure. 
16.1.9 Asphyxiants  
For carbon monoxide, there is strong evidence for a relationship between exposure 
and angina pectoris symptoms among subjects with previous IHD; COHb 
concentrations of 3–5% reduced the time to onset of angina symptoms (918). 
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Table 16. Evaluations of chemical exposures associated to CVD by strength of evidence. 
Chemical agent Strength of evidence for CVD  
 Strong Moderately 
strong 
Limited Insufficient 
Combustion-generated particles      
Overall evaluation a  x   
Mineral dusts     
Asbestos x    
Crystalline silica x    
Man-made vitreous fibres    x 
Carbon nanotubes    x 
Metals     
Aluminium    x 
Arsenic x    
Beryllium    x 
b  
Cadmium  x   
Chromium (VI)    x 
Cobalt     x 
c 
Lead x    
Manganese    x 
Mercury (inorganic)    x 
Methylmercury   x  
Titanium dioxide    x 
Zinc    x 
Other dusts and fumes     
Welding fumes  x   
Soldering fumes    x 
Metalworking fluids   x  
Wood industry   x  
Pulp and paper industry  x   
Textile industry   x  
Agriculture work     x 
d 
Cleaning   x  
Non-chlorinated organic solvents     
Carbon disulphide x    
Styrene   x  
Dimethylformamide    x 
Mixed organic solvents   x  
Halogenated hydrocarbons     
Chemicals causing cardiac sensitisation to 
catecholamines  
    x e 
Methyl chloride    x 
Dichloromethane   x
 f   
Trichloroethylene   x  
Tetrachloroethylene   x  
Vinyl chloride/polyvinyl chloride (PVC)      x 
g 
Dioxins and dioxin-like compounds x    
Polychlorinated biphenyls (PCBs)   x  
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Table 16. Evaluations of chemical exposures associated to CVD by strength of evidence. 
Chemical agent Strength of evidence for CVD  
 Strong Moderately 
strong 
Limited Insufficient 
Per- and polyfluoroalkyl substances (PFAS)     x 
Nitrated explosives     
Nitroglycerine x    
Ethylene glycol dinitrate x    
Propylene glycol dinitrate   x  
Dinitrotoluene   x  
Irritant gases     
Formaldehyde    x 
Phosgene    x 
Sulphur dioxide   x  
Nitrogen dioxide   x  
Ozone   x  
Asphyxiants     
Carbon monoxide x
 f    
Cyanide     x
 h 
Hydrogen sulphide     x
 h 
Phosphine     x
 h 
a Including data from electrolytic aluminium smelting, coke production, coal gasification, graphite 
electrode production, chimney sweeping, asphalt paving, tar distillation work, roofing and creosote 
work, diesel engine exhaust, cooking fumes, second-hand smoke, firefighting and smoke from 
fires. 
b Beryllium: Pulmonary heart disease (cor pulmonale). 
c Cobalt: For cardiomyopathy (a rare condition after probably high exposures), limited evidence.  
d Agriculture work: After extreme exposures, moderately strong evidence for cor pulmonale.  
e Chemicals causing arrhythmia due to cardiac sensitisation to catecholamines: 
During anaesthesia, strong evidence for an association with cardiac arrhythmia (cyclopropane, 
chloroform, halothane, methoxyflurane, enflurane);  
At high levels (1 000–100 000 ppm), moderately strong evidence for an association between 
inhalation of some other volatile halocarbons and hydrocarbons and cardiac arrhythmia (Table 11, 
Section 12.2).  
f Dichloromethane and carbon monoxide: In subjects with previous angina pectoris (IHD).  
g Vinyl chloride: After exposure to several hundreds of ppm, strong evidence for Raynaud’s disease. 
h Cyanide, hydrogen sulphide, phosphine: After excessive exposure, strong evidence for fatal 
cardiotoxicity.  
CVD: cardiovascular disease, IHD: ischaemic heart disease.  
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Table 17. Summary of critical exposure levels and corresponding occupational exposure limits and biological limit values. 
Agent or 
occupation 
Evaluation 
of evidence  
Critical effects (CVD, or more 
specific sub-diagnosis) 
Critical exposure levels  
 
Corresponding OELs/BLVs in the Nordic countries  
and the EU a  
Combustion-generated air pollutants 
Combustion-
generated 
particles (overall) 
Moderately 
strong 
Increased risk of CVD.  0.2–0.3 mg/m3 of PM2.5 
(364, 442, 585, 650, 736, 965) b, c. 
3–5 mg/m3 organic dust, total (DK, NO) (38, 39). 
5 mg/m3 organic dust, inh. (FI, SE) (40, 892). 
– (EU). 
Electrolytic 
aluminium 
smelting 
Moderately 
strong 
Increased risk of IHD. 
 
Increased risk of IHD. 
0.26–1.47 mg/m3 of PM2.5; 
0.86 mg/m3, class midpoint (702). 
111 µg/m3-y of BaP (312); 
2.78 µg/m3 for 40 y. 
See organic dust above. 
 
2–10 µg/m3 BaP (FI, SE) (40, 892). 
– (DK, NO, EU). 
Asphalt paving Limited Increased risk of CVD. 68–105 ng/m3 of BaP (134). See BaP above. 
Diesel engine 
exhaust 
Moderately 
strong 
Decreased brachial artery 
diameter. 
Exercise-induced ST-segment 
depression in ECG in subjects 
with stable coronary artery 
disease. 
Transient increase in arterial 
stiffness. 
Increased risk of MI. 
200–300 µg DEP/m3 (736, 965) b. 
 
300 µg DEP/m3 (650) b. 
 
 
330 µg DEP/m3 (585) b. 
 
87.5 µg EC/m3 (442) c; 
~ 330 µg/m3 of PM2.5 (559). 
See organic dust above.  
1 µg DEP/m3 ~ 1 µg/m3 of PM2.5, since nearly all of the 
mass emitted by diesel engines is in the fine particle range 
(< 2.5 µm) (495). 
 
 
 
0.05 mg EC/m3 (EU, from Feb 2023 d) (270). 
– (DK, FI, NO, SE). 
1 µg DEP/m3 ~ 0.75 µg EC/m3 (0.30–0.90) for  
older technology heavy-duty diesel engines (941). 
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Table 17. Summary of critical exposure levels and corresponding occupational exposure limits and biological limit values. 
Agent or 
occupation 
Evaluation 
of evidence  
Critical effects (CVD, or more 
specific sub-diagnosis) 
Critical exposure levels  
 
Corresponding OELs/BLVs in the Nordic countries  
and the EU a  
Mineral dusts      
Asbestos 
1321-21-4 
Strong Increased CVD mortality.  1.4–8.6 f/ml-y (539);  
0.04–0.2 f/ml for 40 y. 
0.1 f/cm3 (DK, FI, NO, SE) (38-40, 892). 
0.1 f/cm3 (EU) (269). 
Crystalline silica 
14808-60-7 
Strong Increased IHD mortality. 0.56–0.87 mg/m3-y (570);  
0.01–0.02 mg/m3 for 40 y. 
0.05–0.1 mg/m3, resp. (DK, FI, NO, SE) (38-40, 892). 
0.1 mg/m3, resp. (EU) (268). 
< 0.05 mg/m3, resp. (SCOEL) (845). 
0.025 mg/m3, resp. (ACGIH) (5). 
Metals     
Arsenic 
7440-38-2 
Strong Increased risk of CVD. 4–8 mg/m3-y (402); 
0.1–0.2 mg/m3 for 40 y. 
0.01 mg/m3, total (DK, NO, SE) (38-40). 
0.01 mg/m3, inh. (FI) (892). 
0.01 mg/m3, inh. (EU, from July 2021 e) (271). 
Beryllium 
7440-41-7 
Limited Diseases of the arteries, veins  
and pulmonary circulation;  
most of the deaths due to  
cor pulmonale. 
25–< 70 µg/m3 (842). 0.1–2 µg/m3 (DK, FI, NO, SE) (38-40, 892). 
0.6 µg/m3, inh. (EU, July 2021–July 2026 f ) (271). 
0.02 µg/m3, inh. (SCOEL) (848). 
0.05 µg/m3, inh. (ACGIH) (5). 
Cadmium 
7440-43-9 
Moderately 
strong 
Increased risk of CVD. 
 
Increased risk of CVD.  
0.26–0.50 μg/l blood (63);  
2–4 nmol/l. 
0.62–0.92 µg/g creatinine  
in urine (943); 
0.62–0.93 µmol/mol creatinine. 
50 nmol/l blood (5.6 µg/l) (SE) (41). 
5 µg/l blood (ACGIH) (5). 
20 nmol/l urine (FI) (892). 
2 µg/g creatinine, urine (SCOEL) (847). 
5 µg/g creatinine, urine (ACGIH) (5). 
Lead 
7439-92-1 
Strong Increased risk of CVD. 6.7 μg/dl blood (538);  
0.324 μmol/l. 
20 µg/100 ml (DK) (39). 
1.4 μmol/l (FI) (892). 
0.5 μmol/l, fertile women (NO, SE) (38, 41). 
1.5 μmol/l, men/non-fertile women (NO, SE) (38, 41). 
70 μg/100 ml (EU) (201). 
30 μg/100 ml (SCOEL) (844).  
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Table 17. Summary of critical exposure levels and corresponding occupational exposure limits and biological limit values. 
Agent or 
occupation 
Evaluation 
of evidence  
Critical effects (CVD, or more 
specific sub-diagnosis) 
Critical exposure levels  
 
Corresponding OELs/BLVs in the Nordic countries  
and the EU a  
Other dusts and fumes    
Welding fumes  Moderately 
strong 
Increased risk of IHD. 10–50 mg/m3-y, resp. (441); 
0.25–1.25 mg/m3 for 40 y. 
0.5–1.7 mg/m3, welding process dependent g (DK) (39). 
5 mg/m3, unspecified, total (NO) (38). 
2.5–10 mg/m3, inorganic dust, resp. (SE) (40). 
5–10 mg/m3, inorganic dust, inh. (FI, SE) (40, 892). 
– (EU). 
Metalworking 
fluids 
Limited Increased risk of IHD. 0.25–1.25 mg/m3 of PM2.5 (199). 0.2 mg/m3, inh., guidance value (SE) (40).  
– (DK, FI, NO, EU). 
Organic solvents     
Carbon disulphide 
75-15-0 
Strong Hyperintensive spots indicating 
silent cerebral infarction. 
5 ppm (710). 5 ppm, 15–16 mg/m3 (DK, FI, NO, SE) (38-40, 892). 
5 ppm, 15 mg/m3 (EU) (266). 
1 ppm (ACGIH) (5). 
Halogenated hydrocarbons    
Dichloromethane 
75-09-2 
Moderately 
strong 
Increased COHb in blood,  
which may elicit angina 
symptoms in subjects with 
previous angina pectoris 
(observed after exposure to 
carbon monoxide, see below). 
50–150 ppm; resulted in  
1.9–5.3% COHb in blood after 
7.5 h exposure (233) b. 
15–50 ppm, 50–177 mg/m3 (DK, FI, NO, SE) (38-40, 892). 
100 ppm, 353 mg/m3 (EU) (267). 
 
BLVs for COHb: see “Carbon monoxide” below. 
Vinyl chloride 
75-01-4 
Strong  Peripheral circulatory changes 
(Raynaud’s disease). 
~1 000 ppm (235).  
 
1 ppm, 2.5–3 mg/m3 (DK, FI, NO, SE) (38-40, 892). 
1 ppm, 2.6 mg/m3 (EU, from Feb 2021) (270). 
Dioxins and 
dioxin-like 
substances 
Strong Increased risk of IHD. ≥ 9.9 ppt (ng/kg) TCDD in  
plasma (112). 
– 
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Table 17. Summary of critical exposure levels and corresponding occupational exposure limits and biological limit values. 
Agent or 
occupation 
Evaluation 
of evidence  
Critical effects (CVD, or more 
specific sub-diagnosis) 
Critical exposure levels  
 
Corresponding OELs/BLVs in the Nordic countries  
and the EU a  
Asphyxiants     
Carbon monoxide 
630-08-0 
Strong Reduced time to onset of angina 
symptoms and of ST-segment 
changes of the ECG during 
exercise in subjects with 
previous angina pectoris. 
2.4% and 4.7 % COHb in blood  
(2.4% COHb ~ 14 ppm CO)  
(21, 22) b. 
4% COHb, end of shift (FI) (892). 
4% COHb (SCOEL) (851). 
3.5% COHb, end of shift (ACGIH) (5). 
– (DK, NO, SE, EU). 
a SCOEL and ACGIH limit values added only if being below the corresponding limit values of the Nordic countries and the EU. 
b Human experimental studies. 
c Epidemiological studies. 
d For underground mining and tunnel work from February 2026. 
e For copper smelting sector from July 2023. 
f 0.2 µg/m3 from July 2026. 
g Includes electric-arc welding, MAG/MIG/TIG welding and flame cutting. 
ACGIH: American Conference of Governmental Industrial Hygienists, BaP: benzo(a)pyrene, BLV: biological limit value, CO: carbon monoxide, COHb: 
carboxyhaemoglobin, CVD: cardiovascular disease, DEP: diesel exhaust particles, DK: Denmark, EC: elemental carbon, ECG: electrocardiography, EU: European 
Union, FI: Finland, IHD: ischaemic heart disease, inh.: inhalable fraction, MAG: metal active gas, MI: myocardial infarction, MIG: metal inert gas, NO: Norway, 
OEL: occupational exposure limit, PM2.5: particulate matter with maximal aerodynamic diameter of 2.5 µm, resp.: respirable fraction, SCOEL: Scientific Committee 
on Occupational Exposure Limits, SE: Sweden, TCDD: tetrachlorodibenzo-p-dioxin, TIG: tungsten inert gas. 
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16.2 Groups at extra risk 
This section presents some data of sensitive groups and cardiovascular risk factors 
which need further attention regarding possible interactions with occupational 
chemical exposures. 
16.2.1 Women 
There is some evidence that women may be more prone to CVD from particulate 
air pollution. Among Swedish manual workers occupationally exposed to particles, 
the risk of acute MI was somewhat higher in women than in men (1015). Based on 
the same cohort, there was also a higher risk of MI in women than in men associated 
to occupational exposure to respirable silica dust (1016). Another Swedish study 
showed a statistically significantly increased risk of MI among female (but not 
male) cooks, restaurant and kitchen assistants, and waiting staff exposed to cooking 
fumes or second-hand smoke (92). There was an association between ambient 
particulate air pollution and fatal CHD in women but not in men in a cohort of  
non-smoking Californian adults (158). Another Californian study reported an 
association between ambient PM2.5 exposure and atherosclerosis (carotid intima-
media thickness), with larger effects in women than in men (525). There is also 
some evidence that women may be more sensitive than men to tobacco smoking 
regarding CHD and stroke (369, 433).  
16.2.2 Blood group O 
It has been recognised that individuals with non-O blood groups may be at elevated 
risk of venous thromboembolic events, MI, cerebrovascular ischaemic events, and 
peripheral vascular disease compared with individuals with blood group O; this risk 
increase has been attributed to higher concentrations of factor VIII and von 
Willebrand factor (993).  
In The Copenhagen Male Study, a cohort of 3 321 men without overt CVD was 
followed for 8 years. Among men with blood group O, 4.7% had a history of MI 
compared with 5.7% among men with other blood phenotypes. However, long-term 
occupational exposure (> 5 years of exposure) to various airborne pollutants, 
soldering fumes, welding fumes and plastic fumes was associated with a 
significantly increased lifetime prevalence of MI among men with blood group O. 
The ORs (95% CIs) for these exposures were 3.0 (1.6–5.8), 2.1 (1.05–4.2) and 8.3 
(2.6–27.0), respectively. The corresponding incidence odds of IHD during a 8-year 
follow-up was lower but still significantly increased for soldering fumes (OR 1.8, 
1.0–3.2). No increased risks were observed among occupationally exposed men 
with other blood groups (924). No other studies focusing on the possible relation 
between chemical occupational exposures, blood groups and CVD were located. 
Thus, occupational chemical exposures may be associated with increased risks for 
CVD among workers with blood group O. 
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16.2.3 Shift workers 
A review showed limited evidence for relationships between shift work and stroke 
and between night work and IHD (834, 953). 
Interaction between shift work and exposure to carbon disulphide was suggested 
in a cohort study of 1 873 workers at a New York manufacturing plant. The CHD 
mortality was significantly higher among workers with ≥ 4 years of exposure to 
both shift work and carbon disulphide than among workers with < 4 years of 
exposure to both shift work and carbon disulphide. Mortality was not higher among 
workers with ≥ 4 years of just one of the two exposures (146).  
16.2.4 Smokers 
Smoking is an established risk factor for CVD (464). Adjustment for smoking is a 
standard procedure in many epidemiological studies, in order to exclude the 
confounding effect of smoking. Information about the interaction between smoking 
and many occupational chemical exposures is scarce. 
16.2.5 Diabetics 
Diabetes is an established risk factor for CVD (91). Diabetic patients have shown 
evidence of proinflammatory response to both recent and chronic exposure to 
environmental air pollution (449). 
There is a potential interaction between exposure to second-hand smoke and 
diabetes regarding MI. As many as half of the non-fatal MIs were associated with 
exposure to second-hand smoke among diabetics in a case-control study of never-
smokers (798). A Canadian cohort study compared the CVD mortality among 
diabetics and non-diabetics regarding ambient exposure to PM2.5. Among subjects 
with diabetes on the death certificate, the HR (95% CI) for CVD mortality from 
PM2.5 exposure was 1.51 (1.39–1.65) per 10 µg/m3 versus 1.20 (1.16–1.25) among 
subjects without diabetes (748). 
16.2.6 Obesity 
Epidemiological evidence suggests that obesity may increase the susceptibility to 
CVD from ambient PM2.5 exposure (998). Studies regarding the possible interaction 
between obesity and occupational chemical exposures and CVD were not found. 
16.2.7 Chronic bronchitis 
Chronic bronchitis is defined as cough and sputum for at least 3 months a year 
(1012). An association has been reported between chronic bronchitis and MI after 
adjustment for age, gender, smoking, diabetes mellitus, systolic blood pressure, 
angina pectoris and total cholesterol (371). Chronic bronchitis was also associated 
with IHD among men and women after adjustment for smoking, systolic blood 
pressure and cholesterol (465). Furthermore, chronic non-productive cough was 
associated with increased plasma levels of fibrinogen (371).  
Chronic bronchitis was a significant predictor of IHD among granite workers (RR 
2.2, 95% CI 1.5–3.3), foundry workers (RR 2.3, 95% CI 1.6–3.4) and iron foundry 
workers (RR 2.0, 95% CI 1.4–3.0) (514). 
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16.2.8 Previous heart disease 
Subjects with CHD may experience angina symptoms from CO exposure. Smokers 
have higher levels of COHb as a consequence of inhalation of cigarette smoke and 
smokers with CHD may experience angina symptoms at even lower levels of CO 
exposure (918). 
Exposure to 300 µg DEP/m3 for 1 hour was associated with exercise-induced ST-
segment depression in ECG among subjects with stable coronary artery disease 
(650). 
Subjects with previous acute MI had a 3-fold increased acute MI mortality 
associated with a 10-µg/m3 increase of ozone exposure compared with persons 
without previous infarction (88). Consequently persons with previous heart disease 
may have a higher risk regarding CVD related to air pollutant exposures.  
17. Recommendation for revision of occupational exposure limits 
Among the evaluations presented in this document, some agents have been strongly 
or moderately strongly associated with CVD (summarised in Table 16), in some 
cases at levels near or below current OELs. A re-assessment of the OELs for these 
agents should be considered. The agents of concern are briefly described and 
compared to existing OELs below and in Table 17. For more detailed descriptions, 
see Chapters 7–15.  
17.1 Strong evidence for cardiovascular disease 
Asbestos: Exposure at 0.04–0.2 fibres/ml for 40 years, estimated from cumulative 
exposure data, was associated with CVD (Section 8.1). This range is similar to the 
binding OEL in the EU and the TLV set by the American Conference of Govern-
mental Industrial Hygienists (ACGIH) of 0.1 fibres/ml. 
Respirable crystalline silica: Exposure at 0.01–0.02 mg/m3 for 40 years, 
estimated from cumulative exposure data, was associated with IHD (Section 8.2). 
This range is clearly below the binding OEL in the EU of 0.1 mg/m3 and the TLV 
of 0.025 mg/m3 set by ACGIH. 
Lead: A blood concentration of 6.7 µg/dl (0.324 µmol/l) was associated with 
increased CVD mortality (Section 9.7). These data indicate effects well below 
current biological exposure limits in the Nordic countries (0.5–1.5 μmol/l and 20 
μg/100 ml). 
Carbon disulphide: Exposure around 5 ppm was associated with an increase of 
hyperintensive spots indicating silent cerebral infarctions (Section 11.1). These data 
suggest effects at the same level as the Nordic and EU OELs.  
Carbon monoxide: In subjects with previous IHD, blood concentrations of 2.4% 
and 4.7% COHb reduced the time to onset of angina pectoris symptoms (Section 
15.1). The data suggest effects around the biological exposure limit/index of 
Finland and ACGIH of 3.5–4% COHb. Also SCOEL considered 4% COHb a level 
that should not be exceeded. 
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17.2 Moderately strong evidence for cardiovascular disease 
Combustion-generated particles: Exposure has been associated with CVD and 
especially IHD. Experimental and epidemiological data, predominantly on diesel 
engine exhaust, indicate that 0.2–0.3 mg/m3 of PM2.5 (respirable dust) generated 
from combustion is associated with an increased risk of IHD. The OELs for organic 
dusts in the Nordic countries are far higher, 3–5 mg/m3. Elemental carbon (EC)  
has been suggested as a better marker for diesel engine exhaust. One of the 
epidemiological studies on diesel engine exhaust measured EC, and exposure to 
87.5 µg EC/m3 was associated with an increased risk of MI (Chapter 7). In the EU, 
a binding OEL for diesel engine exhaust emissions of 50 µg/m3 measured as EC 
applies from the year 2023. 
Cadmium: Levels of 0.26–0.50 μg/l (2–4 nmol/l) in blood and 0.6–0.9 μg/g  
(0.6–0.9 μmol/mol) creatinine in urine in environmental studies were associated 
with increased risks for major adverse cardiac events (Section 9.4). The effect 
concentrations are clearly below current biological exposure limits, e.g. 20 and 50 
nmol/l blood in Finland and Sweden, respectively, and the value of 2 µg/g creatinine 
in urine recommended by SCOEL.  
Welding fumes: Exposure of 0.25–1.25 mg/m3 for 40 years, estimated from 
cumulative exposure data, has been associated with IHD (Section 10.1). These 
levels are similar to the Danish OELs for welding fumes (0.5–1.7 mg/m3) and lower 
than the Nordic OELs for inorganic dust. 
Dichloromethane: In subjects with previous IHD, angina pectoris symptoms 
developed at blood COHb levels of 3–5%, which corresponds to dichloromethane 
exposure at 50–150 ppm (Section 12.4). The effect concentration is similar to the 
OELs in the Nordic countries of 15–50 ppm and biological exposure limits of 4% 
COHb (Finland, SCOEL). 
18. Research needs 
Little is known about gender differences in susceptibility to CVD from chemical 
exposures (Section 16.2.1). Occupations with identical chemical exposures among 
women and men should therefore be studied. Further, there are gender differences 
regarding exposures. One women dominated occupation is cleaning. In a recent 
study, women cleaning at home or working as occupational cleaners had an 
accelerated decline in lung function. Both work with cleaning sprays and other 
cleaning agents were associated with accelerated FEV1 decline (928). Decreased 
lung function is associated with CVD (872), but evidence is limited for an 
association between cleaning and CVD (Section 10.7). Studies to explore the 
relation between specific cleaning agents and CVD are needed. 
The relationship between occupational air pollutants and atrial fibrillation needs 
to be further explored. Almost 1% of the male population in Sweden younger than 
60 years of age has experienced atrial fibrillation. The occurrence of this arrhythmia 
is lower among women. Among smokers, the disease is twice as common compared 
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to non-smokers (148). There is also an established relationship between atrial 
fibrillation and the occurrence of stroke (463). 
CeVD is generally less studied than IHD in relation to occupational chemical 
exposures. Consequently both fatal and non-fatal CeVD should be studied. A recent 
study of Swedish foundry workers found an elevated morbidity and mortality from 
stroke, but not from MI (278). Ischaemic and haemorrhagic stroke should be 
separated as the mechanisms behind these diseases may be different.  
Diseases such as diabetes, obesity and chronic bronchitis have been associated 
with an increased risk of CVD. Diabetes and obesity are common conditions and 
the relationships between these conditions in combination with occupational 
chemical exposures and CVD need to be further explored. It is also important to 
increase the knowledge regarding the susceptibility of persons with previous CVD 
who return to their previous work. 
Interactions between chemical and non-chemical occupational exposures needs 
to be studied, as there are many non-chemical aspects of work that are related to 
CVD. The Swedish Agency for Health Technology Assessment and Assessment of 
Social Services evaluated contributions of the work environment from non-
chemical occupational exposures to IHD. There was moderately strong evidence 
for a relationship between job strain and small decision latitude on one hand and 
IHD incidence on the other. Limited evidence was found for iso-strain, pressing 
work, effort-reward imbalance, low support, lack of justice, lack of skill discretion, 
insecure employment, night work, long working week and noise in relation to IHD 
(834, 953). 
The transition from exposure to non-exposure may have consequences regarding 
further development of CVD and needs to be investigated. Studies on smoking 
cessation have given some experiences regarding further development of heart 
disease. A meta-analysis including 20 studies showed a 36% reduction in crude RR 
of mortality for patients with CHD who quit smoking compared with those who 
continued smoking (204). Levels of inflammatory markers such as fibrinogen 
decrease after smoking cessation, but it takes more than 10 years to reach the level 
of non-smokers (990). Leaving an occupational exposure may be associated with a 
decreased risk of CVD. The effect of disease progression or regression from 
cessation of exposure may vary between different chemical exposures. 
Exposed groups of workers may be studied by biomarkers of inflammation in a 
cross-sectional design, as several inflammatory markers such as IL-6, CRP, SAA, 
fibrinogen and leukocyte cell count are related to CVD (209-211). The cross-
sectional design may be adequate when prospective cohort studies are impossible 
to perform. 
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19. Summary 
Sjögren B, Bigert C, Gustavsson P. The Nordic Expert Group for Criteria 
Documentation of Health Risks from Chemicals. 153. Occupational chemical 
exposures and cardiovascular disease. Arbete och Hälsa 2020;54(2):1–428. 
 
This document reviews and evaluates the scientific literature on the association 
between occupational chemical exposures and cardiovascular disease (CVD), with 
emphasis on epidemiological data. Exposures – chemical agents, industries and 
occupational activities – were divided in four categories according to the strength 
of the scientific evidence for an association between exposure and CVD as follows: 
1. Strong evidence: asbestos, crystalline silica, arsenic, lead, carbon disulphide, 
dioxins and dioxin-like compounds, nitroglycerine, ethylene glycol dinitrate and 
carbon monoxide. 
2. Moderately strong evidence: combustion-generated particles, cadmium, di-
chloromethane, welding fumes, and pulp and paper industry. 
3. Limited evidence: beryllium, methylmercury, styrene, mixed organic solvents, 
trichloroethylene, tetrachloroethylene, polychlorinated biphenyls (PCBs), 
propylene glycol dinitrate, dinitrotoluene, sulphur dioxide, nitrogen dioxide, 
ozone, metalworking fluids, cleaning, and textile and wood industries. 
4. Insufficient evidence: man-made vitreous fibres, carbon nanotubes, aluminium, 
chromium (VI), cobalt, manganese, inorganic mercury, titanium dioxide, zinc, 
dimethylformamide, methyl chloride, vinyl chloride, per- and polyfluoroalkyl 
substances (PFAS), formaldehyde, phosgene, cyanide, hydrogen sulphide, 
phosphine, soldering fumes, work in agriculture, and chemicals causing cardiac 
arrhythmias, e.g. during asthma treatment and general anaesthesia. 
Combustion-generated air pollutants present a special challenge. The evidence is 
strong for second-hand smoke, moderately strong for electrolytic aluminium 
smelting, diesel engine exhaust, smoke from fires, and limited for coal gasification, 
chimney sweeping, asphalt paving, cooking fumes and firefighting. The different 
evidence levels are likely due to differences in number and size of studies as well 
as differences in exposure levels and chemical composition. The mode of action is 
likely the same or similar for all subcategories of combustion generated particles. 
When possible, lowest observed adverse effect concentrations (LOAECs) for 
CVD were identified for each agent and compared with corresponding occupational 
exposure limits (OELs) or biological limit values (BLVs) in the Nordic countries 
and the EU. LOAECs suggesting CVD below current limit values were found for 
combustion-generated particles, crystalline silica, cadmium, lead and welding 
fumes. LOAECs close to current limit values were found for asbestos, carbon 
disulphide, dichloromethane and carbon monoxide. A reassessment of these limit 
values should be considered. 
 
Keywords: biological limit value, cardiovascular disease, chemical, occupational 
exposure limit, review, risk assessment, toxicity.   
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20. Summary in Swedish 
Sjögren B, Bigert C, Gustavsson P. The Nordic Expert Group for Criteria 
Documentation of Health Risks from Chemicals. 153. Occupational chemical 
exposures and cardiovascular disease. Arbete och Hälsa 2020; 54(2):1–428. 
 
Detta dokument utvärderar den vetenskapliga litteraturen om sambandet mellan 
kemisk exponering i arbetsmiljön och hjärtkärlsjukdom, med tyngdpunkt på 
epidemiologiska studier. Exponeringarna – kemiska ämnen, industrier och yrkes-
aktiviteter – delades in i fyra kategorier baserat på styrkan i det vetenskapliga 
underlaget (graden av evidens) enligt följande: 
1. Stark evidens: asbest, kristallin kvarts, arsenik, bly, koldisulfid, dioxin och 
dioxinlika föreningar, nitroglycerin, etylenglykoldinitrat och kolmonoxid. 
2. Måttligt stark evidens: förbränningspartiklar, kadmium, diklormetan, svetsrök 
och pappers- och pappersmassaindustri. 
3. Begränsad evidens: beryllium, metylkvicksilver, styren, organiska lösnings-
medel, trikloretylen, tetrakloretylen, polyklorerade bifenyler (PCB), propylen-
glykoldinitrat, dinitrotoluen, svaveldioxid, kvävedioxid, ozon, skärvätskor, 
städning, textilindustri och skogsindustri. 
4. Otillräcklig evidens: mineralfibrer, kolnanorör, aluminium, kobolt, krom (VI), 
mangan, oorganiskt kvicksilver, titandioxid, zink, dimetylformamid, metyl-
klorid, vinylklorid, per- och polyfluorerade alkylsubstanser (PFAS), form-
aldehyd, fosgen, cyanid, svavelväte, fosfin, lödrök, jordbruksarbete och ämnen 
som orsakar hjärtarytmier vid astmabehandling och under narkos. 
Luftföroreningar som bildas vid förbränning innebär en speciell utmaning. 
Evidensen är stark för passiv rökning, måttligt stark för elektrolytisk aluminium-
smältning, dieselavgaser och brandrök, och begränsad för gasframställning  
från stenkol, sotning, asfaltsläggning, matlagningsrök och brandbekämpning. 
Variationen i evidensstyrka beror sannolikt på skillnader i studiernas antal och 
storlek samt på skillnader i exponeringsnivåer och kemisk sammansättning. 
Mekanismen är sannolikt densamma eller likartad för alla partiklar som bildas vid 
förbränning. 
När det var möjligt jämfördes de lägsta observerade effektnivåerna (LOAEC) för 
hjärtkärlsjukdom med gällande hygieniska luftgränsvärden eller biologiska 
gränsvärden i Norden och i EU. Förbränningspartiklar, kristallin kvarts, bly, 
kadmium och svetsrök hade lägsta effektnivåer under aktuella hygieniska/ 
biologiska gränsvärden. För asbest, koldisulfid, kolmonoxid och diklormetan låg de 
lägsta effektnivåerna nära respektive gränsvärde. En översyn av dessa gränsvärden 
bör övervägas. 
 
Nyckelord: biologiska gränsvärden, hjärtkärlsjukdom, hygieniska gränsvärden, 
kemisk exponering, riskbedömning, toxicitet, översikt.  
  
 185 
 
21. References 
1. Abdolghaffari AH, Baghaei A, Solgi R, Gooshe M, Baeeri M, Navaei-Nigjeh M, Hassani S, 
Jafari A, Rezayat SM, Dehpour AR, Mehr SE, Abdollahi M. Molecular and biochemical 
evidences on the protective effects of triiodothyronine against phosphine-induced cardiac and 
mitochondrial toxicity. Life Sci 2015;139:30-39. 
2. ACGIH. Ethylene glycol dinitrate. In: Documentation of the threshold limit values and 
biological exposure indices. 3 pp., 7th ed. Cincinnati, Ohio: American Conference of 
Governmental Industrial Hygienists, 2001. 
3. ACGIH. Nitroglycerin. In: Documentation of the threshold limit values and biological 
exposure indices. 3 pp., 7th ed. Cincinnati, Ohio: American Conference of Governmental 
Industrial Hygienists, 2001. 
4. ACGIH. Propylene glycol dinitrate. In: Documentation of the threshold limit values and 
biological exposure indices. 3 pp., 7th ed. Cincinnati, Ohio: American Conference of 
Governmental Industrial Hygienists, 2001. 
5. ACGIH. TLVs and BEIs. Based on the documentation of the threshold limit values for 
chemical substances and physical agents and biological exposure indices. Cincinnati, Ohio: 
American Conference of Governmental Industrial Hygienists, 2019. 
6. Acheson ED, Pippard EC, Winter PD. Mortality of English furniture makers. Scand J Work 
Environ Health 1984;10:211-217. 
7. Acquavella J, Olsen G, Cole P, Ireland B, Kaneene J, Schuman S, Holden L. Cancer among 
farmers: a meta-analysis. Ann Epidemiol 1998;8:64-74. 
8. Adams KF, Koch G, Chatterjee B, Goldstein GM, O'Neil JJ, Bromberg PA, Sheps DS. Acute 
elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates 
symptoms in patients with ischemic heart disease. J Am Coll Cardiol 1988;12:900-909. 
9. Adir Y, Merdler A, Ben Haim S, Front A, Harduf R, Bitterman H. Effects of exposure to low 
concentrations of carbon monoxide on exercise performance and myocardial perfusion in 
young healthy men. Occup Environ Med 1999;56:535-538. 
10. Agarwal S, Zaman T, Tuzcu EM, Kapadia SR. Heavy metals and cardiovascular disease: 
results from the National Health and Nutrition Examination Survey (NHANES) 1999-2006. 
Angiology 2011;62:422-429. 
11. Agrawal A, Verma I, Shah V, Agarwal A, Sikachi RR. Cardiac manifestations of idiopathic 
pulmonary fibrosis. Intractable Rare Dis Res 2016;5:70-75. 
12. Ahlman K, Koskela RS, Kuikka P, Koponen M, Annanmäki M. Mortality among sulfide ore 
miners. Am J Ind Med 1991;19:603-617. 
13. Ahlmark A, Gerhardsson L. [Silicosis in Sweden since 1930]. Arbete och Hälsa 1981:15, 55 
pp. Solna, Sweden: National Board of Occupational Safety and Health, 1981 (in Swedish with 
English summary). 
14. Albin M, Jakobsson K, Attewell R, Johansson L, Welinder H. Mortality and cancer morbidity 
in cohorts of asbestos cement workers and referents. Br J Ind Med 1990;47:602-610. 
15. Alexander BH, Olsen GW, Burris JM, Mandel JH, Mandel JS. Mortality of employees of a 
perfluorooctanesulphonyl fluoride manufacturing facility. Occup Environ Med 2003;60:722-
729. 
16. Alexander CS. Cobalt and the heart. Ann Intern Med 1969;70:411-413. 
17. Alissa EM, Ferns GA. Heavy metal poisoning and cardiovascular disease. J Toxicol 2011; 
2011:870125, 21 pp. 
18. Allen EM, Alexander BH, MacLehose RF, Ramachandran G, Mandel JH. Mortality 
experience among Minnesota taconite mining industry workers. Occup Environ Med 2014; 
71:744-749. 
 186 
 
19. Allen LP, Baez J, Stern MEC, Takahashi K, George F. Trends and the economic effect of 
asbestos bans and decline in asbestos consumption and production worldwide. Int J Environ 
Res Public Health 2018;15:531, 9 pp. 
20. Allermann L, Meyer HW, Poulsen OM, Nielsen JB, Gyntelberg F. Inflammatory potential of 
dust from schools and building related symptoms. Occup Environ Med 2003;60:e5, 5 pp. 
21. Allred EN, Bleecker ER, Chaitman BR, Dahms TE, Gottlieb SO, Hackney JD, Pagano M, 
Selvester RH, Walden SM, Warren J. Short-term effects of carbon monoxide exposure on the 
exercise performance of subjects with coronary artery disease. N Engl J Med 1989;321:1426-
1432. 
22. Allred EN, Bleecker ER, Chaitman BR, Dahms TE, Gottlieb SO, Hackney JD, Pagano M, 
Selvester RH, Walden SM, Warren J. Effects of carbon monoxide on myocardial ischemia. 
Environ Health Perspect 1991;91:89-132. 
23. Altínay L, Coşkun E, Tekin A, Tütün U. Epicardial anthracosis in a patient undergoing 
coronary artery bypass graft surgery. Am J Ind Med 2018;61:1005-1007. 
24. Amandus HE, Shy C, Castellan RM, Blair A, Heineman EF. Silicosis and lung cancer among 
workers in North Carolina dusty trades. Scand J Work Environ Health 1995;21 Suppl 2:81-
83. 
25. Amandus HE, Shy C, Wing S, Blair A, Heineman EF. Silicosis and lung cancer in North 
Carolina dusty trades workers. Am J Ind Med 1991;20:57-70. 
26. Ameille J, Wild P, Choudat D, Ohl G, Vaucouleur JF, Chanut JC, Brochard P. Respiratory 
symptoms, ventilatory impairment, and bronchial reactivity in oil mist-exposed automobile 
workers. Am J Ind Med 1995;27:247-256. 
27. Aminov Z, Haase RF, Pavuk M, Carpenter DO, Anniston Environmental Health Research 
Consortium. Analysis of the effects of exposure to polychlorinated biphenyls and chlorinated 
pesticides on serum lipid levels in residents of Anniston, Alabama. Environ Health 
2013;12:108, 13 pp. 
28. Andersen MHG, Saber AT, Pedersen PB, Loft S, Hansen AM, Koponen IK, Pedersen JE, 
Ebbehøj N, Nørskov EC, Clausen PA, Garde AH, Vogel U, Møller P. Cardiovascular health 
effects following exposure of human volunteers during fire extinction exercises. Environ 
Health 2017;16:96, 9 pp. 
29. Anderson EW, Andelman RJ, Strauch JM, Fortuin NJ, Knelson JH. Effect of low-level carbon 
monoxide exposure on onset and duration of angina pectoris. A study in ten patients with 
ischemic heart disease. Ann Intern Med 1973;79:46-50. 
30. Andersson E, Persson B, Bryngelsson IL, Magnuson A, Torén K, Wingren G, Westberg H. 
Cohort mortality study of Swedish pulp and paper mill workers-nonmalignant diseases. Scand 
J Work Environ Health 2007;33:470-478. 
31. Andersson E, Persson B, Bryngelsson IL, Magnuson A, Westberg H. Cancer mortality in a 
Swedish cohort of pulp and paper mill workers. Int Arch Occup Environ Health 2010;83:123-
132. 
32. Andjelkovich DA, Janszen DB, Brown MH, Richardson RB, Miller FJ. Mortality of iron 
foundry workers: IV. Analysis of a subcohort exposed to formaldehyde. J Occup Environ Med 
1995;37:826-837. 
33. Andrýs C, Hanovcová I, Chýlková V, Tejral J, Eminger S, Procházková J. Immunological 
monitoring of dry-cleaning shop workers--exposure to tetrachloroethylene. Cent Eur J Public 
Health 1997;5:136-142. 
34. Antonini JM, Afshari AA, Stone S, Chen B, Schwegler-Berry D, Fletcher WG, Goldsmith 
WT, Vandestouwe KH, McKinney W, Castranova V, Frazer DG. Design, construction, and 
characterization of a novel robotic welding fume generator and inhalation exposure system for 
laboratory animals. J Occup Environ Hyg 2006;3:194-203; quiz D145. 
35. Antonsson AB, Christensson B, Berge J, Sjögren B. Fatal carbon monoxide intoxication after 
acetylene gas welding of pipes. Ann Occup Hyg 2013;57:662-666. 
 187 
 
36. Antti-Poika M, Heikkila J, Saarinen L. Cardiac arrhythmias during occupational exposure to 
fluorinated hydrocarbons. Br J Ind Med 1990;47:138-140. 
37. Applebaum KM, Malloy EJ, Eisen EA. Reducing healthy worker survivor bias by restricting 
date of hire in a cohort study of Vermont granite workers. Occup Environ Med 2007;64:681-
687. 
38. Arbeidstilsynet. Forskrift om tiltaks- og grenseverdier for fysiske og kjemiske faktorer i 
arbeidsmiljøet samt smitterisikogrupper for biologiske faktorer. Trondheim, Norway: 
Arbeidstilsynet (Norwegian Labour Inspection Authority), 2018. 
39. Arbejdstilsynet. Bekendtgørelse om grænseværdier for stoffer og materialer. nr. 1458, 13 
December 2019. Copenhagen, Denmark: Arbejdstilsynet (Work Environment in Denmark), 
2019. 
40. Arbetsmiljöverket. Hygieniska gränsvärden. Arbetsmiljöverkets författningssamling, AFS 
2018:1. Stockholm, Sweden: Arbetsmiljöverket (Swedish Work Environment Authority), 
2018. 
41. Arbetsmiljöverket. Medicinska kontroller i arbetslivet. Arbetsmiljöverkets författnings-
samling, AFS 2019:3. Stockholm, Sweden: Arbetsmiljöverket (Swedish Work Environment 
Authority), 2019. 
42. Argacha JF, Collart P, Wauters A, Kayaert P, Lochy S, Schoors D, Sonck J, de Vos T, Forton 
M, Brasseur O, Beauloye C, Gevaert S, Evrard P, Coppieters Y, Sinnaeve P, Claeys MJ. Air 
pollution and ST-elevation myocardial infarction: a case-crossover study of the Belgian 
STEMI registry 2009-2013. Int J Cardiol 2016;223:300-305. 
43. Arjomandi M, Wong H, Donde A, Frelinger J, Dalton S, Ching W, Power K, Balmes JR. 
Exposure to medium and high ambient levels of ozone causes adverse systemic inflammatory 
and cardiac autonomic effects. Am J Physiol Heart Circ Physiol 2015;308:H1499-1509. 
44. Armitage TL, Mitchell D, Schenker M. Mortality in the California Farmer Health Study 
cohort. J Agromedicine 2012;17:288-299. 
45. Armstrong B, Hutchinson E, Unwin J, Fletcher T. Lung cancer risk after exposure to 
polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ Health Perspect 
2004;112:970-978. 
46. Armstrong BK, de Klerk NH, Musk AW, Hobbs MS. Mortality in miners and millers of 
crocidolite in Western Australia. Br J Ind Med 1988;45:5-13. 
47. Armstrong BK, McNulty JC, Levitt LJ, Williams KA, Hobbs MS. Mortality in gold and coal 
miners in Western Australia with special reference to lung cancer. Br J Ind Med 1979;36:199-
205. 
48. Arndt V, Rothenbacher D, Daniel U, Zschenderlein B, Schuberth S, Brenner H. All-cause and 
cause specific mortality in a cohort of 20 000 construction workers; results from a 10 year 
follow up. Occup Environ Med 2004;61:419-425. 
49. Arrighi HM, Hertz-Picciotto I. The evolving concept of the healthy worker survivor effect. 
Epidemiology 1994;5:189-196. 
50. Asp S, Riihimäki V, Hernberg S, Pukkala E. Mortality and cancer morbidity of Finnish 
chlorophenoxy herbicide applicators: an 18-year prospective follow-up. Am J Ind Med 1994; 
26:243-253. 
51. Astier A, Paraire F. Fatal intoxication with 1,1-dichloro-1-fluoroethane. N Engl J Med 1997; 
337:940. 
52. Attfield MD, Schleiff PL, Lubin JH, Blair A, Stewart PA, Vermeulen R, Coble JB, Silverman 
DT. The Diesel Exhaust in Miners study: a cohort mortality study with emphasis on lung 
cancer. J Natl Cancer Inst 2012;104:869-883. 
53. Auerbach O, Conston AS, Garfinkel L, Parks VR, Kaslow HD, Hammond EC. Presence of 
asbestos bodies in organs other than the lung. Chest 1980;77:133-137. 
54. Austin SG, Huang N, Woernle CW. PMR study of mortality among Alabama workers and 
farmers. Am J Ind Med 1995;27:29-36. 
 188 
 
55. Awadalla NJ, Hegazy A, Elmetwally RA, Wahby I. Occupational and environmental risk 
factors for idiopathic pulmonary fibrosis in Egypt: a multicenter case-control study. Int 
J Occup Environ Med 2012;3:107-116. 
56. Axelson O, Dahlgren E, Jansson CD, Rehnlund SO. Arsenic exposure and mortality: a case-
referent study from a Swedish copper smelter. Br J Ind Med 1978;35:8-15. 
57. Axelson O, Hane M, Hogstedt C. A case-referent study on neuropsychiatric disorders among 
workers exposed to solvents. Scand J Work Environ Health 1976;2:14-20. 
58. Axelson O, Seldén A, Andersson K, Hogstedt C. Updated and expanded Swedish cohort study 
on trichloroethylene and cancer risk. J Occup Med 1994;36:556-562. 
59. Azar A, Reinhardt CF, Maxfield ME, Smith PE, Jr., Mullin LS. Experimental human 
exposures to fluorocarbon 12 (dichlorodifluoromethane). Am Ind Hyg Assoc J 1972;33:207-
216. 
60. Baigi A, Holmén A, Högstedt B, Odén A, Herrström P. Birthplace and social characteristics 
as risk factors for acute myocardial infarction in the province of Halland, Sweden. Public 
Health 2002;116:279-284. 
61. Baillargeon J. Characteristics of the healthy worker effect. Occup Med 2001;16:359-366. 
62. Baris D, Garrity TJ, Telles JL, Heineman EF, Olshan A, Zahm SH. Cohort mortality study of 
Philadelphia firefighters. Am J Ind Med 2001;39:463-476. 
63. Barregård L, Sällsten G, Fagerberg B, Borné Y, Persson M, Hedblad B, Engström G. Blood 
cadmium levels and incident cardiovascular events during follow-up in a population-based 
cohort of Swedish adults: the Malmö Diet and Cancer Study. Environ Health Perspect 
2016;124:594-600. 
64. Barregård L, Sällsten G, Gustafson P, Andersson L, Johansson L, Basu S, Stigendal L. 
Experimental exposure to wood-smoke particles in healthy humans: effects on markers of 
inflammation, coagulation, and lipid peroxidation. Inhal Toxicol 2006;18:845-853. 
65. Barregård L, Sällsten G, Järvholm B. Mortality and cancer incidence in chloralkali workers 
exposed to inorganic mercury. Br J Ind Med 1990;47:99-104. 
66. Barsotti M. [Stenocardiac attacks in workers employed in production of dynamite with 
nitroglycols]. Med Lav 1954;45:544-548 (in Italian). 
67. Bartůňková J, Pelclová D, Fenclová Z, Šedivá A, Lebedová J, Tesař V, Hladíková M, 
Klusáčková P. Exposure to silica and risk of ANCA-associated vasculitis. Am J Ind Med 
2006;49:569-576. 
68. Bass M. Sudden sniffing death. JAMA 1970;212:2075-2079. 
69. Bates JT. Coronary artery disease deaths in the Toronto Fire Department. J Occup Med 
1987;29:132-135. 
70. Battista G, Belli S, Comba P, Fiumalbi C, Grignoli M, Loi F, Orsi D, Paredes I. Mortality due 
to asbestos-related causes among railway carriage construction and repair workers. Occup 
Med (Lond) 1999;49:536-539. 
71. Baumann R, Gube M, Markert A, Davatgarbenam S, Kossack V, Gerhards B, Kraus T, Brand 
P. Systemic serum amyloid A as a biomarker for exposure to zinc and/or copper-containing 
metal fumes. J Expo Sci Environ Epidemiol 2018;28:84-91. 
72. Bayliss DL, Dement JM, Wagoner JK, Blejer HP. Mortality patterns among fibrous glass 
production workers. Ann N Y Acad Sci 1976;271:324-335. 
73. Beaumont JJ, Singleton JA, Doebbert G, Riedmiller KR, Brackbill RM, Kizer KW. 
Adjustment for smoking, alcohol consumption, and socioeconomic status in the California 
Occupational Mortality Study. Am J Ind Med 1992;21:491-506. 
74. Beaumont JJ, Weiss NS. Mortality of welders, shipfitters, and other metal trades workers in 
boilermakers Local No. 104, AFL-CIO. Am J Epidemiol 1980;112:775-786. 
75. Becker N. Cancer mortality among arc welders exposed to fumes containing chromium and 
nickel. Results of a third follow-up: 1989-1995. J Occup Environ Med 1999;41:294-303. 
 189 
 
76. Becker N, Kuhn G, Marschall B. Follow-up study among model and pattern makers in a 
German automobile company. Results of a second follow-up. J Occup Environ Med 
1997;39:1228-1232. 
77. Becker N, Kuhn G, Marschall B, Angerer R, Frentzel-Beyme R, Wahrendorf J. Follow-up 
study among model and pattern makers in an automobile company in the Federal Republic of 
Germany. J Occup Med 1992;34:552-558. 
78. Beckett WS, Chalupa DF, Pauly-Brown A, Speers DM, Stewart JC, Frampton MW, Utell MJ, 
Huang LS, Cox C, Zareba W, Oberdörster G. Comparing inhaled ultrafine versus fine zinc 
oxide particles in healthy adults: a human inhalation study. Am J Respir Crit Care Med 
2005;171:1129-1135. 
79. Belin L. Sawmill alveolitis in Sweden. Int Arch Allergy Appl Immunol 1987;82:440-443. 
80. Bell ML, Zanobetti A, Dominici F. Who is more affected by ozone pollution? A systematic 
review and meta-analysis. Am J Epidemiol 2014;180:15-28. 
81. Belli S, Bruno C, Comba P, Grignoli M. [Cause-specific mortality of asbestos-cement workers 
compensated for asbestosis in the city of Bari]. Epidemiol Prev 1998;22:8-11 (in Italian). 
82. Ben-David A. Cardiac arrest in an explosives factory worker due to withdrawal from 
nitroglycerin exposure. Am J Ind Med 1989;15:719-722. 
83. Bennett WD, Ivins S, Alexis NE, Wu J, Bromberg PA, Brar SS, Travlos G, London SJ. Effect 
of obesity on acute ozone-induced changes in airway function, reactivity, and inflammation in 
adult females. PLoS One 2016;11:e0160030, 13 pp. 
84. Bergkvist C, Berglund M, Glynn A, Julin B, Wolk A, Åkesson A. Dietary exposure to 
polychlorinated biphenyls and risk of myocardial infarction in men - A population-based 
prospective cohort study. Environ Int 2016;88:9-14. 
85. Bergkvist C, Berglund M, Glynn A, Wolk A, Åkesson A. Dietary exposure to polychlorinated 
biphenyls and risk of myocardial infarction - a population-based prospective cohort study. Int 
J Cardiol 2015;183:242-248. 
86. Bergkvist C, Kippler M, Larsson SC, Berglund M, Glynn A, Wolk A, Åkesson A. Dietary 
exposure to polychlorinated biphenyls is associated with increased risk of stroke in women. 
J Intern Med 2014;276:248-259. 
87. Berlinger B, Benker N, Weinbruch S, L'Vov B, Ebert M, Koch W, Ellingsen DG, Thomassen 
Y. Physicochemical characterisation of different welding aerosols. Anal Bioanal Chem 
2011;399:1773-1780. 
88. Bero Bedada G, Raza A, Forsberg B, Lind T, Ljungman P, Pershagen G, Bellander T. Short-
term exposure to ozone and mortality in subjects with and without previous cardiovascular 
disease. Epidemiology 2016;27:663-669. 
89. Berry G, Molyneux MK. A mortality study of workers in Lancashire cotton mills. Chest 
1981;79:11S-15S. 
90. Bertazzi PA, Zocchetti C, Riboldi L, Pesatori A, Radice L, Latocca R. Cancer mortality of an 
Italian cohort of workers in man-made glass-fiber production. Scand J Work Environ Health 
1986;12 Suppl 1:65-71. 
91. Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol 
Metab Syndr 2017;9:25, 13 pp. 
92. Bigert C, Lönn M, Feychting M, Sjögren B, Lewné M, Gustavsson P. Incidence of myocardial 
infarction among cooks and other restaurant workers in Sweden 1987-2005. Scand J Work 
Environ Health 2013;39:204-211. 
93. Bille S, Sivertssen E. [Sudden death in a dynamite worker]. Nord Med 1963;70:842-843 (in 
Norwegian). 
94. Binks K, Doll R, Gillies M, Holroyd C, Jones SR, McGeoghegan D, Scott L, Wakeford R, 
Walker P. Mortality experience of male workers at a UK tin smelter. Occup Med (Lond) 
2005;55:215-226. 
 190 
 
95. Birk T, Mundt KA, Dell LD, Luippold RS, Miksche L, Steinmann-Steiner-Haldenstaett W, 
Mundt DJ. Lung cancer mortality in the German chromate industry, 1958 to 1998. J Occup 
Environ Med 2006;48:426-433. 
96. Birk T, Mundt KA, Guldner K, Parsons W, Luippold RS. Mortality in the German porcelain 
industry 1985-2005: first results of an epidemiological cohort study. J Occup Environ Med 
2009;51:373-385. 
97. Björ B, Burström L, Eriksson K, Jonsson H, Nathanaelsson L, Nilsson T. Mortality from 
myocardial infarction in relation to exposure to vibration and dust among a cohort of iron-ore 
miners in Sweden. Occup Environ Med 2010;67:154-158. 
98. Björ B, Burström L, Jonsson H, Nathanaelsson L, Damber L, Nilsson T. Fifty-year follow-up 
of mortality among a cohort of iron-ore miners in Sweden, with specific reference to 
myocardial infarction mortality. Occup Environ Med 2009;66:264-268. 
99. Björ O, Damber L, Edström C, Nilsson T. Long-term follow-up study of mortality and the 
incidence of cancer in a cohort of workers at a primary aluminum smelter in Sweden. Scand 
J Work Environ Health 2008;34:463-470. 
100. Björ O, Jonsson H, Damber L, Wahlström J, Nilsson T. Reduced mortality rates in a cohort of 
long-term underground iron-ore miners. Am J Ind Med 2013;56:531-540. 
101. Blair A, Dosemeci M, Heineman EF. Cancer and other causes of death among male and female 
farmers from twenty-three states. Am J Ind Med 1993;23:729-742. 
102. Blair A, Hartge P, Stewart PA, McAdams M, Lubin J. Mortality and cancer incidence of 
aircraft maintenance workers exposed to trichloroethylene and other organic solvents and 
chemicals: extended follow up. Occup Environ Med 1998;55:161-171. 
103. Blair A, Petralia SA, Stewart PA. Extended mortality follow-up of a cohort of dry cleaners. 
Ann Epidemiol 2003;13:50-56. 
104. Blair A, Sandler DP, Tarone R, Lubin J, Thomas K, Hoppin JA, Samanic C, Coble J, Kamel 
F, Knott C, Dosemeci M, Zahm SH, Lynch CF, Rothman N, Alavanja MC. Mortality among 
participants in the agricultural health study. Ann Epidemiol 2005;15:279-285. 
105. Blair A, Stewart P, O'Berg M, Gaffey W, Walrath J, Ward J, Bales R, Kaplan S, Cubit D. 
Mortality among industrial workers exposed to formaldehyde. J Natl Cancer Inst 1986;76: 
1071-1084. 
106. Blair A, Stewart PA, Hoover RN. Mortality from lung cancer among workers employed in 
formaldehyde industries. Am J Ind Med 1990;17:683-699. 
107. Blair A, Zahm SH, Pearce NE, Heineman EF, Fraumeni JF, Jr. Clues to cancer etiology from 
studies of farmers. Scand J Work Environ Health 1992;18:209-215. 
108. Blaizot A, Vergnes JN, Nuwwareh S, Amar J, Sixou M. Periodontal diseases and cardio-
vascular events: meta-analysis of observational studies. Int Dent J 2009;59:197-209. 
109. Blasing TJ, Jones S. Name the compound: the numbers game for the CFCs, HFCs, HCFCs, 
and Halons. https://cdiac.ess-dive.lbl.gov/pns/cfcinfo.html (accessed January 2019). US 
Department of Energy. Carbon Dioxide Information Analysis Center, 2012. 
110. Blomberg A, Krishna MT, Bocchino V, Biscione GL, Shute JK, Kelly FJ, Frew AJ, Holgate 
ST, Sandström T. The inflammatory effects of 2 ppm NO2 on the airways of healthy subjects. 
Am J Respir Crit Care Med 1997;156:418-424. 
111. Blot WJ, Fryzek JP, Henderson BE, Sadler CJ, McLaughlin JK. A cohort mortality study 
among gas generator utility workers. J Occup Environ Med 2000;42:194-199. 
112. Boers D, Portengen L, Turner WE, Bueno-de-Mesquita HB, Heederik D, Vermeulen R. 
Plasma dioxin levels and cause-specific mortality in an occupational cohort of workers 
exposed to chlorophenoxy herbicides, chlorophenols and contaminants. Occup Environ Med 
2012;69:113-118. 
113. Boffetta P, Soutar A, Cherrie JW, Granath F, Andersen A, Anttila A, Blettner M, Gaborieau 
V, Klug SJ, Langard S, Luce D, Merletti F, Miller B, Mirabelli D, Pukkala E, Adami HO, 
 191 
 
Weiderpass E. Mortality among workers employed in the titanium dioxide production industry 
in Europe. Cancer Causes Control 2004;15:697-706. 
114. Boffetta P, Stellman SD, Garfinkel L. Diesel exhaust exposure and mortality among males in 
the American Cancer Society prospective study. Am J Ind Med 1988;14:403-415. 
115. Boffetta P, Sällsten G, Garcia-Gómez M, Pompe-Kirn V, Zaridze D, Bulbulyan M, Caballero 
JD, Ceccarelli F, Kobal AB, Merler E. Mortality from cardiovascular diseases and exposure 
to inorganic mercury. Occup Environ Med 2001;58:461-466. 
116. Boice JD, Jr., Marano DE, Fryzek JP, Sadler CJ, McLaughlin JK. Mortality among aircraft 
manufacturing workers. Occup Environ Med 1999;56:581-597. 
117. Bolm-Audorff U, Siegrist J. Occupational morbidity data in myocardial infarction. A case-
referent study in West Germany. J Occup Med 1983;25:367-371. 
118. Bond GG, Bodner KM, Olsen GW, Cook RR. Mortality among workers engaged in the 
development or manufacture of styrene-based products--an update. Scand J Work Environ 
Health 1992;18:145-154. 
119. Boor P, Casper S, Celec P, Hurbankova M, Beno M, Heidland A, Amann K, Sebekova K. 
Renal, vascular and cardiac fibrosis in rats exposed to passive smoking and industrial dust 
fibre amosite. J Cell Mol Med 2009;13:4484-4491. 
120. Borné Y, Barregård L, Persson M, Hedblad B, Fagerberg B, Engström G. Cadmium exposure 
and incidence of heart failure and atrial fibrillation: a population-based prospective cohort 
study. BMJ Open 2015;5:e007366, 8 pp. 
121. Borné Y, Fagerberg B, Persson M, Östling G, Söderholm M, Hedblad B, Sällsten G, Barregård 
L, Engström G. Cadmium, carotid atherosclerosis, and incidence of ischemic stroke. J Am 
Heart Assoc 2017;6:e006415, 6 pp. 
122. Borron SW, Baud FJ. Antidotes for acute cyanide poisoning. Curr Pharm Biotechnol 2012;13: 
1940-1948. 
123. Brackbill RM, Cameron LL, Behrens V. Prevalence of chronic diseases and impairments 
among US farmers, 1986-1990. Am J Epidemiol 1994;139:1055-1065. 
124. Brock WJ, Rusch GM, Trochimowicz HJ. Cardiac sensitization: methodology and inter-
pretation in risk assessment. Regul Toxicol Pharmacol 2003;38:78-90. 
125. Broding HC, Schettgen T, Hillert A, Angerer J, Goen T, Drexler H. Subjective complaints in 
persons under chronic low-dose exposure to lower polychlorinated biphenyls (PCBs). Int 
J Hyg Environ Health 2008;211:648-657. 
126. Brook RD, Rajagopalan S, Pope CA, 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin 
F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC, Jr., Whitsel L, 
Kaufman JD. American Heart Association Council on Epidemiology and Prevention, Council 
on the Kidney in Cardiovascular Disease and Council on Nutrition, Physical Activity and 
Metabolism. Particulate matter air pollution and cardiovascular disease: an update to the 
scientific statement from the American Heart Association. Circulation 2010;121:2331-2378. 
127. Brown DM, Petersen M, Costello S, Noth EM, Hammond K, Cullen M, Laan M, Eisen E. 
Occupational exposure to PM2.5 and incidence of ischemic heart disease: longitudinal targeted 
minimum loss-based estimation. Epidemiology 2015;26:806-814. 
128. Brown DP, Kaplan SD. Retrospective cohort mortality study of dry cleaner workers using 
perchloroethylene. J Occup Med 1987;29:535-541. 
129. Brown DP, Kaplan SD, Zumwalde RD, Kaplowitz M, Archer VE. Retrospective cohort 
mortality study of underground gold mine workers. In: Goldsmith DF, Winn DM, Shy CM, 
eds. Silica, silicosis, and cancer: controversy in occupational medicine. Pp. 335-350. New 
York, United States: Praeger, 1986. 
130. Brown LM, Gridley G, Olsen JH, Mellemkjær L, Linet MS, Fraumeni JF, Jr. Cancer risk and 
mortality patterns among silicotic men in Sweden and Denmark. J Occup Environ Med 
1997;39:633-638. 
 192 
 
131. Brown TP, Rushton L. Mortality in the UK industrial silica sand industry: 2. A retrospective 
cohort study. Occup Environ Med 2005;62:446-452. 
132. Brumby S, Chandrasekara A, McCoombe S, Kremer P, Lewandowski P. Cardiovascular risk 
factors and psychological distress in Australian farming communities. Aust J Rural Health 
2012;20:131-137. 
133. Burmeister LF, Morgan DP. Mortality in Iowa farmers and farm laborers, 1971-1978. J Occup 
Med 1982;24:898-900. 
134. Burstyn I, Kromhout H, Partanen T, Svane O, Langård S, Ahrens W, Kauppinen T, Stücker I, 
Shaham J, Heederik D, Ferro G, Heikkilä P, Hooiveld M, Johansen C, Randem BG, Boffetta 
P. Polycyclic aromatic hydrocarbons and fatal ischemic heart disease. Epidemiology 
2005;16:744-750. 
135. Bye T, Romundstad PR, Rønneberg A, Hilt B. Health survey of former workers in a 
Norwegian coke plant: Part 2. Cancer incidence and cause specific mortality. Occup Environ 
Med 1998;55:622-626. 
136. Byrén D, Engholm G, Englund A, Westerholm P. Mortality and cancer morbidity in a group 
of Swedish VCM and PCV production workers. Environ Health Perspect 1976;17:167-170. 
137. Calvert GM, Ruder AM, Petersen MR. Mortality and end-stage renal disease incidence among 
dry cleaning workers. Occup Environ Med 2011;68:709-716. 
138. Calvert GM, Wall DK, Sweeney MH, Fingerhut MA. Evaluation of cardiovascular outcomes 
among U.S. workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Environ Health Perspect 
1998;106 Suppl 2:635-643. 
139. Campbell DD, Lockey JE, Petajan J, Gunter BJ, Rom WN. Health effects among refrigeration 
repair workers exposed to fluorocarbons. Br J Ind Med 1986;43:107-111. 
140. Campbell JM. Acute symptoms following work with hay. Br Med J 1932;2:1143-1144. 
141. Campbell M, Thomas H, Hodges N, Paul A, Williams J. A 24 year cohort study of mortality 
in slate workers in North Wales. Occup Med (Lond) 2005;55:448-453. 
142. Campen MJ, Lund AK, Knuckles TL, Conklin DJ, Bishop B, Young D, Seilkop S, Seagrave 
J, Reed MD, McDonald JD. Inhaled diesel emissions alter atherosclerotic plaque composition 
in ApoE(-/-) mice. Toxicol Appl Pharmacol 2010;242:310-317. 
143. Cao Y, Jacobsen NR, Danielsen PH, Lenz AG, Stoeger T, Loft S, Wallin H, Roursgaard M, 
Mikkelsen L, Møller P. Vascular effects of multiwalled carbon nanotubes in dyslipidemic 
ApoE-/- mice and cultured endothelial cells. Toxicol Sci 2014;138:104-116. 
144. Carmichael P, Lieben J. Sudden death in explosives workers. Arch Environ Health 1963;7: 
424-439. 
145. Carpenter DO. Exposure to and health effects of volatile PCBs. Rev Environ Health 2015; 
30:81-92. 
146. Carreón T, Hein MJ, Hanley KW, Viet SM, Ruder AM. Coronary artery disease and cancer 
mortality in a cohort of workers exposed to vinyl chloride, carbon disulfide, rotating shift 
work, and o-toluidine at a chemical manufacturing plant. Am J Ind Med 2014;57:398-411. 
147. Carta P, Aru G, Manca P. Mortality from lung cancer among silicotic patients in Sardinia: an 
update study with 10 more years of follow up. Occup Environ Med 2001;58:786-793. 
148. Chamberlain AM, Agarwal SK, Folsom AR, Duval S, Soliman EZ, Ambrose M, Eberly LE, 
Alonso A. Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk 
in Communities (ARIC) study. Heart Rhythm 2011;8:1160-1166. 
149. Chan CK, Leung CC, Tam CM, Yu TS, Wong TW. Lung cancer mortality among a cohort of 
men in a silicotic register. J Occup Environ Med 2000;42:69-75. 
150. Chapman EM. Acute silicosis. JAMA 1932;98:1439-1441. 
151. Charles LE, Burchfiel CM, Fekedulegn D, Gu JK, Petrovitch H, Sanderson WT, Masaki K, 
Rodriguez BL, Andrew ME, Ross GW. Occupational exposure to pesticides, metals, and 
solvents: the impact on mortality rates in the Honolulu Heart Program. Work 2010;37:205-
215. 
 193 
 
152. Chau N, Bertrand JP, Mur JM, Figueredo A, Patris A, Moulin JJ, Pham QT. Mortality in retired 
coke oven plant workers. Br J Ind Med 1993;50:127-135. 
153. Checkoway H, Heyer NJ, Demers PA, Breslow NE. Mortality among workers in the 
diatomaceous earth industry. Br J Ind Med 1993;50:586-597. 
154. Checkoway H, Heyer NJ, Seixas NS, Welp EA, Demers PA, Hughes JM, Weill H. Dose-
response associations of silica with nonmalignant respiratory disease and lung cancer mortality 
in the diatomaceous earth industry. Am J Epidemiol 1997;145:680-688. 
155. Chen J, McLaughlin JK, Zhang JY, Stone BJ, Luo J, Chen RA, Dosemeci M, Rexing SH, Wu 
Z, Hearl FJ, Cawley MA, Blot WJ. Mortality among dust-exposed Chinese mine and pottery 
workers. J Occup Med 1992;34:311-316. 
156. Chen JL, Fayerweather WE, Pell S. Cancer incidence of workers exposed to dimethyl-
formamide and/or acrylonitrile. J Occup Med 1988;30:813-818. 
157. Chen JL, Fayerweather WE, Pell S. Mortality study of workers exposed to dimethylformamide 
and/or acrylonitrile. J Occup Med 1988;30:819-821. 
158. Chen LH, Knutsen SF, Shavlik D, Beeson WL, Petersen F, Ghamsary M, Abbey D. The 
association between fatal coronary heart disease and ambient particulate air pollution: are 
females at greater risk? Environ Health Perspect 2005;113:1723-1729. 
159. Chen M, Tse LA, Au RK, Yu IT, Wang XR, Lao XQ, Au JS. Mesothelioma and lung cancer 
mortality: a historical cohort study among asbestosis workers in Hong Kong. Lung Cancer 
2012;76:165-170. 
160. Chen R, Dick F, Seaton A. Health effects of solvent exposure among dockyard painters: 
mortality and neuropsychological symptoms. Occup Environ Med 1999;56:383-387. 
161. Chen R, Seaton A. A meta-analysis of mortality among workers exposed to organic solvents. 
Occup Med (Lond) 1996;46:337-344. 
162. Chen T, Hu J, Chen C, Pu J, Cui X, Jia G. Cardiovascular effects of pulmonary exposure to 
titanium dioxide nanoparticles in ApoE knockout mice. J Nanosci Nanotechnol 2013;13:3214-
3222. 
163. Chen W, Liu Y, Wang H, Hnizdo E, Sun Y, Su L, Zhang X, Weng S, Bochmann F, Hearl FJ, 
Chen J, Wu T. Long-term exposure to silica dust and risk of total and cause-specific mortality 
in Chinese workers: a cohort study. PLoS Med 2012;9:e1001206, 11 pp. 
164. Chen W, Yang J, Chen J, Bruch J. Exposures to silica mixed dust and cohort mortality study 
in tin mines: exposure-response analysis and risk assessment of lung cancer. Am J Ind Med 
2006;49:67-76. 
165. Chen Y, Ho KF, Ho SS, Ho WK, Lee SC, Yu JZ, Sit EH. Gaseous and particulate polycyclic 
aromatic hydrocarbons (PAHs) emissions from commercial restaurants in Hong Kong. 
J Environ Monit 2007;9:1402-1409. 
166. Chen Y, Santella RM, Kibriya MG, Wang Q, Kappil M, Verret WJ, Graziano JH, Ahsan H. 
Association between arsenic exposure from drinking water and plasma levels of soluble cell 
adhesion molecules. Environ Health Perspect 2007;115:1415-1420. 
167. Cherry NM, Burgess GL, Turner S, McDonald JC. Crystalline silica and risk of lung cancer 
in the potteries. Occup Environ Med 1998;55:779-785. 
168. Chevrier J, Picciotto S, Eisen EA. A comparison of standard methods with g-estimation of 
accelerated failure-time models to address the healthy-worker survivor effect: application in a 
cohort of autoworkers exposed to metalworking fluids. Epidemiology 2012;23:212-219. 
169. Chiazze L, Jr., Nichols WE, Wong O. Mortality among employees of PVC fabricators. 
J Occup Med 1977;19:623-628. 
170. Chiazze L, Jr., Watkins DK, Fryar C. Historical cohort mortality study of a continuous 
filament fiberglass manufacturing plant. I. White men. J Occup Environ Med 1997;39:432-
441. 
171. Chiyotani K, Saito K, Okubo T, Takahashi K. Lung cancer risk among pneumoconiosis 
patients in Japan, with special reference to silicotics. IARC Sci Publ 1990:95-104. 
 194 
 
172. Chowdhury R, Ramond A, O'Keeffe LM, Shahzad S, Kunutsor SK, Muka T, Gregson J, 
Willeit P, Warnakula S, Khan H, Chowdhury S, Gobin R, Franco OH, Di Angelantonio E. 
Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review 
and meta-analysis. BMJ 2018;362:k3310. 
173. Clancy L, Goodman P, Sinclair H, Dockery DW. Effect of air-pollution control on death rates 
in Dublin, Ireland: an intervention study. Lancet 2002;360:1210-1214. 
174. Claude J, Frentzel-Beyme R. A mortality study of workers employed in a German rock wool 
factory. Scand J Work Environ Health 1984;10:151-157. 
175. Claude J, Frentzel-Beyme R. Mortality of workers in a German rock-wool factory--a second 
look with extended follow-up. Scand J Work Environ Health 1986;12 Suppl 1:53-60. 
176. Clayton JW, Jr., Barnes JR, Hood DB, Schepers GW. The inhalation toxicity of dimethyl-
formamide (DMF). Am Ind Hyg Assoc J 1963;24:144-154. 
177. Cocco PL, Carta P, Belli S, Picchiri GF, Flore MV. Mortality of Sardinian lead and zinc 
miners: 1960-88. Occup Environ Med 1994;51:674-682. 
178. Cocco PL, Carta P, Flore V, Picchiri GF, Zucca C. Lung cancer mortality among female mine 
workers exposed to silica. J Occup Med 1994;36:894-898. 
179. Cochrane AL, Haley TJ, Moore F, Hole D. The mortality of men in the Rhondda Fach, 1950-
-1970. Br J Ind Med 1979;36:15-22. 
180. Coentrão L, Moura D. Acute cyanide poisoning among jewelry and textile industry workers. 
Am J Emerg Med 2011;29:78-81. 
181. Coggiola M, Bosio D, Pira E, Piolatto PG, La Vecchia C, Negri E, Michelazzi M, Bacaloni A. 
An update of a mortality study of talc miners and millers in Italy. Am J Ind Med 2003;44:63-
69. 
182. Coggon D, Harris EC, Poole J, Palmer KT. Extended follow-up of a cohort of British chemical 
workers exposed to formaldehyde. J Natl Cancer Inst 2003;95:1608-1615. 
183. Coggon D, Wield G. Mortality of army cooks. Scand J Work Environ Health 1993;19:85-88. 
184. Coggon D, Wield G, Pannett B, Campbell L, Boffetta P. Mortality in employees of a Scottish 
paper mill. Am J Ind Med 1997;32:535-539. 
185. Cojocaru M. Relationship between serum total sialic acid and C-reactive protein in silicosis. 
Rom J Intern Med 1997;35:77-82. 
186. Collins JJ, Bodner KM, Bus JS. Cancer mortality of workers exposed to styrene in the U.S. 
Reinforced plastics and composite industry. Epidemiology 2013;24:195-203. 
187. Colt JS, Stallones L, Cameron LL, Dosemeci M, Zahm SH. Proportionate mortality among 
US migrant and seasonal farmworkers in twenty-four states. Am J Ind Med 2001;40:604-611. 
188. Committee on Nonoccupational Health Risks of Asbestiform Fibers. Asbestiform fibers, 
nonoccupational health risks. 334 pp. Board on Toxicology and Environmental Health 
Hazards, Commission on Life Sciences, National Research Council. Washington DC, United 
States: National Academy Press, 1984. 
189. Conklin DJ, Kong M, HEI Health Review Committee. Part 4. Assessment of plasma markers 
and cardiovascular responses in rats after chronic exposure to new-technology diesel exhaust 
in the ACES bioassay. Res Rep Health Eff Inst 2015;184:111-139; discussion 141-171. 
190. Connell DW, ed. Polychlorinated biphenyls (PCBs) and dioxins. In: Basic concepts of environ-
mental chemistry. Pp. 121-146, 2nd ed. Boca Raton, Florida, United States: CRC Press, 2005. 
191. Cookson WO, Musk AW, Glancy JJ, de Klerk NH, Yin R, Mele R, Carr NG, Armstrong BK, 
Hobbs MS. Compensation, radiographic changes, and survival in applicants for asbestosis 
compensation. Br J Ind Med 1985;42:461-468. 
192. Cooper WC, Wong O, Graebner R. Mortality of workers in two Minnesota taconite mining 
and milling operations. J Occup Med 1988;30:506-511. 
193. Cooper WC, Wong O, Kheifets L. Mortality among employees of lead battery plants and lead-
producing plants, 1947-1980. Scand J Work Environ Health 1985;11:331-345. 
 195 
 
194. Costabel U, Bonella F, Guzman J. Chronic hypersensitivity pneumonitis. Clin Chest Med 
2012;33:151-163. 
195. Costello J, Castellan RM, Swecker GS, Kullman GJ. Mortality of a cohort of U.S. workers 
employed in the crushed stone industry, 1940-1980. Am J Ind Med 1995;27:625-640. 
196. Costello J, Graham WG. Vermont granite workers' mortality study. In: Goldsmith DF, Winn 
DM, Shy CM, eds. Silica, silicosis, and cancer: controversy in occupational medicine. Pp. 
437-440. New York, United States: Praeger, 1986. 
197. Costello J, Graham WG. Vermont granite workers' mortality study. Am J Ind Med 1988;13: 
483-497. 
198. Costello J, Ortmeyer CE, Morgan WK. Mortality from heart disease in coal miners. Chest 
1975;67:417-421. 
199. Costello S, Brown DM, Noth EM, Cantley L, Slade MD, Tessier-Sherman B, Hammond SK, 
Eisen EA, Cullen MR. Incident ischemic heart disease and recent occupational exposure to 
particulate matter in an aluminum cohort. J Expo Sci Environ Epidemiol 2014;24:82-88. 
200. Costello S, Garcia E, Hammond SK, Eisen EA. Ischemic heart disease mortality and PM3.5 in 
a cohort of autoworkers. Am J Ind Med 2013;56:317-325. 
201. Council of the European Union. Council Directive 98/24/EC of 7 April 1998 on the protection 
of the health and safety of workers from the risks related to chemical agents at work (fourteenth 
individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC). Official 
Journal of the European Union L 131, 5.5.1998, pp. 11-23. 
202. Cowan DM, Zheng W, Zou Y, Shi X, Chen J, Rosenthal FS, Fan Q. Manganese exposure 
among smelting workers: relationship between blood manganese-iron ratio and early onset 
neurobehavioral alterations. Neurotoxicology 2009;30:1214-1222. 
203. Cragle DL, Hollis DR, Qualters JR, Tankersley WG, Fry SA. A mortality study of men 
exposed to elemental mercury. J Occup Med 1984;26:817-821. 
204. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in 
patients with coronary heart disease: a systematic review. JAMA 2003;290:86-97. 
205. Crump C, Crump K, Hack E, Luippold R, Mundt K, Liebig E, Panko J, Paustenbach D, Proctor 
D. Dose-response and risk assessment of airborne hexavalent chromium and lung cancer 
mortality. Risk Anal 2003;23:1147-1163. 
206. Cui J, Zhang L. Metallurgical recovery of metals from electronic waste: a review. J Hazard 
Mater 2008;158:228-256. 
207. Cypel YS, Kress AM, Eber SM, Schneiderman AI, Davey VJ. Herbicide exposure, Vietnam 
service, and hypertension risk in army chemical corps veterans. J Occup Environ Med 
2016;58:1127-1136. 
208. D'Adda F, Borleri D, Migliori M, Mosconi G, Medolago G, Virotta G, Colombo F, Seghizzi 
P. Cardiac function study in hard metal workers. Sci Total Environ 1994;150:179-186. 
209. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, 
albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. 
JAMA 1998;279:1477-1482. 
210. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, 
Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V. Long-term 
interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies 
and a systematic review. PLoS Med 2008;5:e78, 11 pp. 
211. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys 
MB. Low grade inflammation and coronary heart disease: prospective study and updated meta-
analyses. BMJ 2000;321:199-204. 
212. Davies D, Andrews MI, Jones JS. Asbestos induced pericardial effusion and constrictive 
pericarditis. Thorax 1991;46:429-432. 
213. Davies GM. A mortality study of coke oven workers in two South Wales integrated 
steelworks. Br J Ind Med 1977;34:291-297. 
 196 
 
214. Davies JM. Long term mortality study of chromate pigment workers who suffered lead 
poisoning. Br J Ind Med 1984;41:170-178. 
215. Davies JM, Easton DF, Bidstrup PL. Mortality from respiratory cancer and other causes in 
United Kingdom chromate production workers. Br J Ind Med 1991;48:299-313. 
216. Davis DL, Blair A, Hoel DG. Agricultural exposures and cancer trends in developed countries. 
Environ Health Perspect 1993;100:39-44. 
217. de Klerk NH, Musk AW, Cookson WO, Glancy JJ, Hobbs MS. Radiographic abnormalities 
and mortality in subjects with exposure to crocidolite. Br J Ind Med 1993;50:902-906. 
218. De Raat K. The Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals and The Dutch Expert Committee on Occupational Standards. 133. Tetrachloro-
ethylene (PER). Arbete och Hälsa 2003:14, 110 pp. Stockholm, Sweden: National Institute for 
Working Life, 2003. 
219. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate 
variability from short electrocardiographic recordings predicts mortality from all causes in 
middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 1997;145:899-908. 
220. DeLorme MP, Gao X, Doyon-Reale N, Barraclough-Mitchell H, Bassett DJ. Inflammatory 
effects of inhaled endotoxin-contaminated metal working fluid aerosols in rats. J Toxicol 
Environ Health A 2003;66:7-24. 
221. Delzell E, Grufferman S. Mortality among white and nonwhite farmers in North Carolina, 
1976-1978. Am J Epidemiol 1985;121:391-402. 
222. Delzell E, Sathiakumar N, Graff J, Matthews R. Styrene and ischemic heart disease mortality 
among synthetic rubber industry workers. J Occup Environ Med 2005;47:1235-1243. 
223. Dement JM, Brown DP, Okun A. Follow-up study of chrysotile asbestos textile workers: 
cohort mortality and case-control analyses. Am J Ind Med 1994;26:431-447. 
224. Dement JM, Harris RL, Jr., Symons MJ, Shy CM. Exposures and mortality among chrysotile 
asbestos workers. Part II: mortality. Am J Ind Med 1983;4:421-433. 
225. Demers PA, Boffetta P, Kogevinas M, Blair A, Miller BA, Robinson CF, Roscoe RJ, Winter 
PD, Colin D, Matos E, Vainio H. Pooled reanalysis of cancer mortality among five cohorts of 
workers in wood-related industries. Scand J Work Environ Health 1995;21:179-190. 
226. Demers PA, Heyer NJ, Rosenstock L. Mortality among firefighters from three northwestern 
United States cities. Br J Ind Med 1992;49:664-670. 
227. Denison MS, Nagy SR. Activation of the aryl hydrocarbon receptor by structurally diverse 
exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003;43:309-334. 
228. Dennekamp M, Howarth S, Dick CA, Cherrie JW, Donaldson K, Seaton A. Ultrafine particles 
and nitrogen oxides generated by gas and electric cooking. Occup Environ Med 2001;58:511-
516. 
229. Dennekamp M, Straney LD, Erbas B, Abramson MJ, Keywood M, Smith K, Sim MR, Glass 
DC, Del Monaco A, Haikerwal A, Tonkin AM. Forest fire smoke exposures and out-of-
hospital cardiac arrests in Melbourne, Australia: a case-crossover study. Environ Health 
Perspect 2015;123:959-964. 
230. Dibbs E, Thomas HE, Jr., Weiss ST, Sparrow D. Fire fighting and coronary heart disease. 
Circulation 1982;65:943-946. 
231. Diderichsen F, Hallqvist J. Trends in occupational mortality among middle-aged men in 
Sweden 1961-1990. Int J Epidemiol 1997;26:782-787. 
232. Dingwall-Fordyce I, Lane RE. A follow-up study of lead workers. Br J Ind Med 1963;20:313-
315. 
233. DiVincenzo GD, Kaplan CJ. Uptake, metabolism, and elimination of methylene chloride 
vapor by humans. Toxicol Appl Pharmacol 1981;59:130-140. 
234. Dixit S, Pletcher MJ, Vittinghoff E, Imburgia K, Maguire C, Whitman IR, Glantz SA, Olgin 
JE, Marcus GM. Secondhand smoke and atrial fibrillation: data from the Health eHeart Study. 
Heart Rhythm 2016;13:3-9. 
 197 
 
235. Doll R. Effects of exposure to vinyl chloride. An assessment of the evidence. Scand J Work 
Environ Health 1988;14:61-78. 
236. Doll R, Fisher RE, Gammon EJ, Gunn W, Hughes GO, Tyrer FH, Wilson W. Mortality of 
gasworkers with special reference to cancers of the lung and bladder, chronic bronchitis, and 
pneumoconiosis. Br J Ind Med 1965;22:1-12. 
237. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' 
observations on male British doctors. BMJ 1994;309:901-911. 
238. Doll R, Vessey MP, Beasley RW, Buckley AR, Fear EC, Fisher RE, Gammon EJ, Gunn W, 
Hughes GO, Lee K, Norman-Smith B. Mortality of gasworkers - final report of a prospective 
study. Br J Ind Med 1972;29:394-406. 
239. Donaldson K, Stone V, Clouter A, Renwick L, MacNee W. Ultrafine particles. Occup Environ 
Med 2001;58:211-216. 
240. Donato F, Monarca S, Marchionna G, Rossi A, Cicioni C, Chiesa R, Colin D, Boffetta P. 
Mortality from cancer and chronic respiratory diseases among workers who manufacture 
carbon electrodes. Occup Environ Med 2000;57:484-487. 
241. Dong D, Xu G, Sun Y, Hu P. Lung cancer among workers exposed to silica dust in Chinese 
refractory plants. Scand J Work Environ Health 1995;21 Suppl 2:69-72. 
242. Du L, Wang X, Wang M, Lan Y. Analysis of mortality in chrysotile asbestos miners in China. 
J Huazhong Univ Sci Technolog Med Sci 2012;32:135-140. 
243. Dubrow R, Gute DM. Cause-specific mortality among male textile workers in Rhode Island. 
Am J Ind Med 1988;13:439-454. 
244. ECHA. Authorisation list. List of substances included in Annex XIV of REACH. Trichloro-
ethylene. https://echa.europa.eu/authorisation-list (accessed April 2019). Helsinki, Finland: 
European Chemicals Agency, 2016. 
245. Editorial. Asthma deaths: a question answered. Br Med J 1972;4:443-444. 
246. Edling C, Ohlson CG, Ljungkvist G, Oliv A, Söderholm B. Cardiac arrhythmia in refrigerator 
repairmen exposed to fluorocarbons. Br J Ind Med 1990;47:207-212. 
247. EFSA Panel on Contaminants in the Food Chain. Risk to human health related to the presence 
of perfluorooctane sulfonic acid and perfluorooctanoic acid in food (scientific opinion). EFSA 
Journal 2018;16(12):5194, 284 pp. 
248. Egeland GM, Bloom TF, Schnorr TM, Hornung RW, Suruda AJ, Wille KK. Fluorocarbon 113 
exposure and cardiac dysrhythmias among aerospace workers. Am J Ind Med 1992;22:851-
857. 
249. El Idrissi A, van Berkel L, Bonekamp NE, Dalemans DJ, van der Heyden MA. The toxicology 
of zinc chloride smoke producing bombs and screens. Clin Toxicol (Phila) 2017;55:167-174. 
250. Ellingsen DG, Andersen A, Nordhagen HP, Efskind J, Kjuus H. Incidence of cancer and 
mortality among workers exposed to mercury vapour in the Norwegian chloralkali industry. 
Br J Ind Med 1993;50:875-880. 
251. Ellis ED, Watkins JP, Tankersley WG, Phillips JA, Girardi DJ. Occupational exposure and 
mortality among workers at three titanium dioxide plants. Am J Ind Med 2013;56:282-291. 
252. Emmen HH, Hoogendijk EM, Klopping-Ketelaars WA, Muijser H, Duistermaat E, 
Ravensberg JC, Alexander DJ, Borkhataria D, Rusch GM, Schmit B. Human safety and 
pharmacokinetics of the CFC alternative propellants HFC 134a (1,1,1,2-tetrafluoroethane) and 
HFC 227 (1,1,1,2,3,3,3-heptafluoropropane) following whole-body exposure. Regul Toxicol 
Pharmacol 2000;32:22-35. 
253. Engholm G, Englund A. Asbestos hazard in the Swedish construction industry--recent trends 
in mesothelioma incidence. Scand J Work Environ Health 2005;31 Suppl 2:27-30. 
254. Englander V, Sjöberg A, Hagmar L, Attewell R, Schütz A, Möller T, Skerfving S. Mortality 
and cancer morbidity in workers exposed to sulphur dioxide in a sulphuric acid plant. Int Arch 
Occup Environ Health 1988;61:157-162. 
 198 
 
255. Enterline P, DeCoufle P, Henderson V. Mortality in relation to occupational exposure in the 
asbestos industry. J Occup Med 1972;14:897-903. 
256. Enterline PE. Mortality among asbestos products workers in the United States. Ann N Y Acad 
Sci 1965;132:156-165. 
257. Enterline PE. A review of mortality data for American coal miners. Ann N Y Acad Sci 1972; 
200:260-272. 
258. Enterline PE. Respiratory cancer among chromate workers. J Occup Med 1974;16:523-526. 
259. Enterline PE, Hartley J, Henderson V. Asbestos and cancer: a cohort followed up to death. 
Br J Ind Med 1987;44:396-401. 
260. Enterline PE, Marsh GM, Henderson V, Callahan C. Mortality update of a cohort of U.S. man-
made mineral fibre workers. Ann Occup Hyg 1987;31:625-656. 
261. Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. 
Circulation 1999;100:e20-28. 
262. Erdely A, Hulderman T, Salmen-Muniz R, Liston A, Zeidler-Erdely PC, Chen BT, Stone S, 
Frazer DG, Antonini JM, Simeonova PP. Inhalation exposure of gas-metal arc stainless steel 
welding fume increased atherosclerotic lesions in apolipoprotein E knockout mice. Toxicol 
Lett 2011;204:12-16. 
263. Eriksen KT, Raaschou-Nielsen O, McLaughlin JK, Lipworth L, Tjønneland A, Overvad K, 
Sørensen M. Association between plasma PFOA and PFOS levels and total cholesterol in a 
middle-aged Danish population. PLoS One 2013;8:e56969, 7 pp. 
264. Ernstgård L, Bottai M, Johanson G, Sjögren B. Down-regulation of the inflammatory response 
after short-term exposure to low levels of chemical vapours. Occup Environ Med 2019;76:482-
487. 
265. European Committee for Standardization (CEN). Workplace atmospheres - Size fractions 
definitions for measurement of airborne particles. EN 481;1993, 9 pp. Brussels, Belgium: 
European Committee for Standardization, 1993. 
266. European Commission. Commission Directive 2009/161/EU of 17 December 2009 
establishing a third list of indicative occupational exposure limit values in implementation of 
Council Directive 98/24/EC and amending Commission Directive 2000/39/EC. Official 
Journal of the European Union L 338, 19.12.2009, pp. 87-89. 
267. European Commission. Commission Directive (EU) 2017/164 of 31 January 2017 establishing 
a fourth list of indicative occupational exposure limit values pursuant to Council Directive 
98/24/EC, and amending Commission Directives 91/322/EEC, 2000/39/EC and 2009/161/EU. 
Official Journal of the European Union L 27, 1.2.2017, pp. 115-120. 
268. European Parliament and the Council of the European Union. Directive (EU) 2017/2398 of 
the European Parliament and the Council of the European Union of 12 December 2017 
amending Directive 2004/37/EC on the protection of workers from the risks related to 
exposure to carcinogens or mutagens at work. Official Journal of the European Union L 345, 
27.12.2017, pp. 87-95. 
269. European Parliament and the Council of the European Union. Directive 2009/148/EC of the 
European Parliament and of the Council of 30 November 2009 on the protection of workers 
from the risks related to exposure to asbestos at work. Official Journal of the European Union 
L 330, 16.12.2009, pp. 28–36. 
270. European Parliament and the Council of the European Union. Directive (EU) 2019/130 of the 
European Parliament and of the Council of 16 January 2019 amending Directive 2004/37/EC 
on the protection of workers from the risks related to exposure to carcinogens or mutagens at 
work. Official Journal of the European Union L 30, 31.1.2019, pp. 112-120. 
271. European Parliament and the Council of the European Union. Directive (EU) 2019/983 of the 
European Parliament and of the Council of 5 June 2019 amending Directive 2004/37/EC on 
the protection of workers from the risks related to exposure to carcinogens or mutagens at 
work. Official Journal of the European Union L 164, 20.6.2019, pp. 23-29. 
 199 
 
272. Everett CJ, Frithsen IL. Association of urinary cadmium and myocardial infarction. Environ 
Res 2008;106:284-286. 
273. Everett CJ, Mainous AG, 3rd, Frithsen IL, Player MS, Matheson EM. Association of 
polychlorinated biphenyls with hypertension in the 1999-2002 National Health and Nutrition 
Examination Survey. Environ Res 2008;108:94-97. 
274. Færden K, Lund MB, Mogens Aaløkken T, Eduard W, Søstrand P, Langård S, Kongerud J. 
Hypersensitivity pneumonitis in a cluster of sawmill workers: a 10-year follow-up of exposure, 
symptoms, and lung function. Int J Occup Environ Health 2014;20:167-173. 
275. Fagerberg B, Bergström G, Borén J, Barregård L. Cadmium exposure is accompanied by 
increased prevalence and future growth of atherosclerotic plaques in 64-year-old women. 
J Intern Med 2012;272:601-610. 
276. Fagerberg B, Bergström G, Borén J, Barregård L. Cadmium exposure, intercellular adhesion 
molecule-1 and peripheral artery disease: a cohort and an experimental study. BMJ Open 
2013;3:e002489, 8 pp. 
277. Fagerberg B, Borné Y, Sällsten G, Smith JG, Acosta S, Persson M, Melander O, Forsgård N, 
Gottsäter A, Hedblad B, Barregård L, Engström G. Circulating cadmium concentration and 
risk of aortic aneurysms: a nested case-control study within the Malmö Diet and Cancer cohort. 
Atherosclerosis 2017;261:37-43. 
278. Fan C, Graff P, Vihlborg P, Bryngelsson IL, Andersson L. Silica exposure increases the risk 
of stroke but not myocardial infarction-a retrospective cohort study. PLoS One 2018;13: 
e0192840, 9 pp. 
279. Fang SC, Cassidy A, Christiani DC. A systematic review of occupational exposure to 
particulate matter and cardiovascular disease. Int J Environ Res Public Health 2010;7:1773-
1806. 
280. Fanning D. A mortality study of lead workers, 1926-1985. Arch Environ Health 1988;43:247-
251. 
281. Faustini A, Forastiere F, Di Betta L, Magliola EM, Perucci CA. Cohort study of mortality 
among farmers and agricultural workers. Med Lav 1993;84:31-41. 
282. Fedeli U, Girardi P, Gardiman G, Zara D, Scoizzato L, Ballarin MN, Baccini M, Pirastu R, 
Comba P, Mastrangelo G. Mortality from liver angiosarcoma, hepatocellular carcinoma, and 
cirrhosis among vinyl chloride workers. Am J Ind Med 2019;62:14-20. 
283. Fernandes JL, Storey P, da Silva JA, de Figueiredo GS, Kalaf JM, Coelho OR. Preliminary 
assessment of cardiac short term safety and efficacy of manganese chloride for cardiovascular 
magnetic resonance in humans. J Cardiovasc Magn Reson 2011;13:6, 9 pp. 
284. Fernandez Rego G, Ocio Achaerandio G, González Cuervo V, Rodríquez Menéndez C, 
Martínez Gonezález C, Alvarez Alvarez C. Presence of acute phase response in coal workers' 
pneumoconiosis. Br J Ind Med 1991;48:193-195. 
285. Feron VJ, Kroes R. One-year time-sequence inhalation toxicity study of vinyl chloride in rats. 
II. Morphological changes in the respiratory tract, ceruminous glands, brain, kidneys, heart 
and spleen. Toxicology 1979;13:131-141. 
286. Ferris BG, Jr., Puleo S, Chen HY. Mortality and morbidity in a pulp and a paper mill in the 
United States: a ten-year follow-up. Br J Ind Med 1979;36:127-134. 
287. Fewtrell LJ, Pruss-Ustun A, Landrigan P, Ayuso-Mateos JL. Estimating the global burden of 
disease of mild mental retardation and cardiovascular diseases from environmental lead 
exposure. Environ Res 2004;94:120-133. 
288. Fibrinogen Studies Collaboration, Danesh J, Lewington S, Thompson SG, Lowe GD, Collins 
R, Kostis JB, Wilson AC, Folsom AR, Wu K, Benderly M, Goldbourt U, Willeit J, Kiechl S, 
Yarnell JW, Sweetnam PM, Elwood PC, Cushman M, Psaty BM, Tracy RP, Tybjærg-Hansen 
A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, 
Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, 
Arocha-Pinango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa 
E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, 
 200 
 
Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez 
B, Yano K, Salonen JT, Nyyssonen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig 
W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, 
Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler 
D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, 
Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, 
Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, 
Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson 
A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler 
J, White I, Wood A. Plasma fibrinogen level and the risk of major cardiovascular diseases and 
nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-1809. 
289. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Beckett WS. Metal fume fever: 
characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc 
oxide fume at and below the threshold limit value. J Occup Environ Med 1997;39:722-726. 
290. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Sparer J, Beckett WS. Characterization 
of clinical tolerance to inhaled zinc oxide in naive subjects and sheet metal workers. J Occup 
Environ Med 2000;42:1085-1091. 
291. Finkelstein M, Liss GM, Krammer F, Kusiak RA. Mortality among workers receiving 
compensation awards for silicosis in Ontario 1940-85. Br J Ind Med 1987;44:588-594. 
292. Finkelstein MM. Mortality among long-term employees of an Ontario asbestos-cement 
factory. Br J Ind Med 1983;40:138-144. 
293. Finkelstein MM. Mortality among employees of an Ontario asbestos-cement factory. Am Rev 
Respir Dis 1984;129:754-761. 
294. Finkelstein MM. Radiographic abnormalities and the risk of lung cancer among workers 
exposed to silica dust in Ontario. CMAJ 1995;152:37-43. 
295. Fischbein L, Namade M, Sachs RN, Robineau M, Lanfranchi J. Chronic constrictive 
pericarditis associated with asbestosis. Chest 1988;94:646-647. 
296. Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, Armstrong B. 
Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and 
perfluorooctanesulfonic acid. Epidemiology 2013;24:569-576. 
297. Fleming LE, Bean JA, Rudolph M, Hamilton K. Mortality in a cohort of licensed pesticide 
applicators in Florida. Occup Environ Med 1999;56:14-21. 
298. Fleming LE, Gómez-Marin O, Zheng D, Ma F, Lee D. National Health Interview Survey 
mortality among US farmers and pesticide applicators. Am J Ind Med 2003;43:227-233. 
299. Flesch-Janys D, Berger J, Gurn P, Manz A, Nagel S, Waltsgott H, Dwyer JH. Exposure to 
polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a 
herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol 1995; 
142:1165-1175. 
300. Flynn MR, Susi P. Manganese, iron, and total particulate exposures to welders. J Occup 
Environ Hyg 2010;7:115-126. 
301. Forastiere F, Lagorio S, Michelozzi P, Perucci CA, Axelson O. Mortality pattern of silicotic 
subjects in the Latium region, Italy. Br J Ind Med 1989;46:877-880. 
302. Forman SA, Helmkamp JC, Bone CM. Cardiac morbidity and mortality associated with 
occupational exposure to 1,2 propylene glycol dinitrate. J Occup Med 1987;29:445-450. 
303. Fortin JL, Desmettre T, Manzon C, Judic-Peureux V, Peugeot-Mortier C, Giocanti JP, 
Hachelaf M, Grangeon M, Hostalek U, Crouzet J, Capellier G. Cyanide poisoning and cardiac 
disorders: 161 cases. J Emerg Med 2010;38:467-476. 
304. Fowler BA, Chou CHSJ, Jones RL, Sullivan Jr DW, Chen C-J. 28. Arsenic. In: Nordberg GF, 
Fowler BA, Nordberg M, eds. Handbook on the toxicology of metals. Pp. 581-624, 4th ed. 
London, United Kingdom: Elsevier Academic Press Inc., 2015. 
 201 
 
305. Fox AJ, Goldlbatt P, Kinlen LJ. A study of the mortality of Cornish tin miners. Br J Ind Med 
1981;38:378-380. 
306. Fragar L, Depczynski J, Lower T. Mortality patterns of Australian male farmers and farm 
managers. Aust J Rural Health 2011;19:179-184. 
307. Frampton MW, Boscia J, Roberts NJ, Jr., Azadniv M, Torres A, Cox C, Morrow PE, Nichols 
J, Chalupa D, Frasier LM, Gibb FR, Speers DM, Tsai Y, Utell MJ. Nitrogen dioxide exposure: 
effects on airway and blood cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L155-165. 
308. Franco F, Chellini E, Seniori Costantini A, Gioia A, Carra G, Paolinelli F, Martelli C, Vigotti 
M. Mortality in the coke oven plant of Carrara, Italy. Med Lav 1993;84:443-447. 
309. Friedlander BR, Hearne T, Hall S. Epidemiologic investigation of employees chronically 
exposed to methylene chloride. Mortality analysis. J Occup Med 1978;20:657-666. 
310. Friesen MC, Benke G, Del Monaco A, Dennekamp M, Fritschi L, de Klerk N, Hoving JL, 
MacFarlane E, Sim MR. Relationship between cardiopulmonary mortality and cancer risk and 
quantitative exposure to polycyclic aromatic hydrocarbons, fluorides, and dust in two prebake 
aluminum smelters. Cancer Causes Control 2009;20:905-916. 
311. Friesen MC, Betenia N, Costello S, Eisen EA. Metalworking fluid exposure and cancer risk 
in a retrospective cohort of female autoworkers. Cancer Causes Control 2012;23:1075-1082. 
312. Friesen MC, Demers PA, Spinelli JJ, Eisen EA, Lorenzi MF, Le ND. Chronic and acute effects 
of coal tar pitch exposure and cardiopulmonary mortality among aluminum smelter workers. 
Am J Epidemiol 2010;172:790-799. 
313. Friesen MC, Demers PA, Spinelli JJ, Lorenzi MF, Le ND. Comparison of two indices of 
exposure to polycyclic aromatic hydrocarbons in a retrospective aluminium smelter cohort. 
Occup Environ Med 2007;64:273-278. 
314. Friesen MC, Fritschi L, Del Monaco A, Benke G, Dennekamp M, de Klerk N, Hoving JL, 
MacFarlane E, Sim MR. Relationships between alumina and bauxite dust exposure and cancer, 
respiratory and circulatory disease. Occup Environ Med 2009;66:615-618. 
315. Fritschi L, Lakhani R, Nadon L, Bulsara M. Mortality in an Australian cohort of textile 
workers. Occup Med (Lond) 2004;54:255-257. 
316. Frost G, Brown T, Harding AH. Mortality and cancer incidence among British agricultural 
pesticide users. Occup Med (Lond) 2011;61:303-310. 
317. Frost G, Harding AH, Darnton A, McElvenny D, Morgan D. Occupational exposure to 
asbestos and mortality among asbestos removal workers: a Poisson regression analysis.  
Br J Cancer 2008;99:822-829. 
318. Frostegård J. Rheumatic diseases: insights into inflammation and atherosclerosis. Arterioscler 
Thromb Vasc Biol 2010;30:892-893. 
319. Fryzek JP, Chadda B, Marano D, White K, Schweitzer S, McLaughlin JK, Blot WJ. A cohort 
mortality study among titanium dioxide manufacturing workers in the United States. J Occup 
Environ Med 2003;45:400-409. 
320. Fukagawa NK, Li M, Sabo-Attwood T, Timblin CR, Butnor KJ, Gagne J, Steele C, Taatjes 
DJ, Huber S, Mossman BT. Inhaled asbestos exacerbates atherosclerosis in apolipoprotein E-
deficient mice via CD4+ T cells. Environ Health Perspect 2008;116:1218-1225. 
321. Fuster V, Walsh RA, Harrington RA, ed. Hurst’s the heart, 13th ed. York, United States: The 
McGraw-Hill Education, Inc. 2011. 
322. Gallagher CM, Meliker JR. Blood and urine cadmium, blood pressure, and hypertension: a 
systematic review and meta-analysis. Environ Health Perspect 2010;118:1676-1684. 
323. Gallagher LG, Park RM, Checkoway H. Extended follow-up of lung cancer and non-malignant 
respiratory disease mortality among California diatomaceous earth workers. Occup Environ 
Med 2015;72:360-365. 
324. Gallagher LG, Ray RM, Li W, Psaty BM, Gao DL, Thomas DB, Checkoway H. Occupational 
exposures and mortality from cardiovascular disease among women textile workers in 
Shanghai, China. Am J Ind Med 2012;55:991-999. 
 202 
 
325. Gambini GF, Mantovani C, Pira E, Piolatto PG, Negri E. Cancer mortality among rice growers 
in Novara Province, northern Italy. Am J Ind Med 1997;31:435-441. 
326. Gardner MJ, Winter PD, Pannett B, Powell CA. Follow up study of workers manufacturing 
chrysotile asbestos cement products. Br J Ind Med 1986;43:726-732. 
327. Gardner MJ, Winter PD, Pannett B, Simpson MJ, Hamilton C, Acheson ED. Mortality study 
of workers in the man-made mineral fiber production industry in the United Kingdom. Scand 
J Work Environ Health 1986;12 Suppl 1:85-93. 
328. Geiger SD, Xiao J, Ducatman A, Frisbee S, Innes K, Shankar A. The association between 
PFOA, PFOS and serum lipid levels in adolescents. Chemosphere 2014;98:78-83. 
329. Gerhardsson L, Hagmar L, Rylander L, Skerfving S. Mortality and cancer incidence among 
secondary lead smelter workers. Occup Environ Med 1995;52:667-672. 
330. Germani D, Belli S, Bruno C, Grignoli M, Nesti M, Pirastu R, Comba P. Cohort mortality 
study of women compensated for asbestosis in Italy. Am J Ind Med 1999;36:129-134. 
331. Gerstner HB, Huff JE. Clinical toxicology of mercury. J Toxicol Environ Health 1977;2:491-
526. 
332. Geyer HJ, Schramm KW, Feicht EA, Behechti A, Steinberg C, Bruggemann R, Poiger H, 
Henkelmann B, Kettrup A. Half-lives of tetra-, penta-, hexa-, hepta-, and octachlorodibenzo-
p-dioxin in rats, monkeys, and humans--a critical review. Chemosphere 2002;48:631-644. 
333. Ghio AJ, Churg A, Roggli VL. Ferruginous bodies: implications in the mechanism of fiber 
and particle toxicity. Toxicol Pathol 2004;32:643-649. 
334. Ghosh M, Oner D, Poels K, Tabish AM, Vlaanderen J, Pronk A, Kuijpers E, Lan Q, Vermeulen 
R, Bekaert B, Hoet PH, Godderis L. Changes in DNA methylation induced by multi-walled 
carbon nanotube exposure in the workplace. Nanotoxicology 2017;11:1195-1210. 
335. Giaroli C, Belli S, Bruno C, Candela S, Grignoli M, Minisci S, Poletti R, Ricco G, Vecchi G, 
Venturi G, Ziccardi A, Comba P. Mortality study of asbestos cement workers. Int Arch Occup 
Environ Health 1994;66:7-11. 
336. Gibbs GW, Amsel J, Soden K. A cohort mortality study of cellulose triacetate-fiber workers 
exposed to methylene chloride. J Occup Environ Med 1996;38:693-697. 
337. Gibbs GW, Armstrong B, Sevigny M. Mortality and cancer experience of Quebec aluminum 
reduction plant workers. Part 2: mortality of three cohorts hired on or before january 1, 1951. 
J Occup Environ Med 2007;49:1105-1123. 
338. Gibbs GW, Labreche F, Busque MA, Duguay P. Mortality and cancer incidence in aluminum 
smelter workers: a 5-year update. J Occup Environ Med 2014;56:739-764. 
339. Gibbs GW, Sevigny M. Mortality and cancer experience of Quebec aluminum reduction plant 
workers. Part 3: monitoring the mortality of workers first employed after January 1, 1950. 
J Occup Environ Med 2007;49:1269-1287. 
340. Gilmour MI, Kim YH, Hays MD. Comparative chemistry and toxicity of diesel and biomass 
combustion emissions. Anal Bioanal Chem 2015;407:5869-5875. 
341. Gjesdal K, Bille S, Bredesen JE, Bjørge E, Halvorsen B, Langseth K, Lunde PK, Silvertssen 
E. Exposure to glyceryl trinitrate during gun powder production: plasma glyceryl trinitrate 
concentration, elimination kinetics, and discomfort among production workers. Br J Ind Med 
1985;42:27-31. 
342. Glass DC, Del Monaco A, Pircher S, Vander Hoorn S, Sim MR. Mortality and cancer 
incidence among male volunteer Australian firefighters. Occup Environ Med 2017;74:628-
638. 
343. Glass DC, Pircher S, Del Monaco A, Hoorn SV, Sim MR. Mortality and cancer incidence in 
a cohort of male paid Australian firefighters. Occup Environ Med 2016;73:761-771. 
344. Goldberg MS, Theriault G. Retrospective cohort study of workers of a synthetic textiles plant 
in Quebec: I. General mortality. Am J Ind Med 1994;25:889-907. 
345. Goldsmith DF, Beaumont JJ, Morrin LA, Schenker MB. Respiratory cancer and other chronic 
disease mortality among silicotics in California. Am J Ind Med 1995;28:459-467. 
 203 
 
346. Goldsmith S, From AH. Arsenic-induced atypical ventricular tachycardia. N Engl J Med 1980; 
303:1096-1098. 
347. Gómez-Puerta JA, Gedmintas L, Costenbader KH. The association between silica exposure 
and development of ANCA-associated vasculitis: systematic review and meta-analysis. 
Autoimmun Rev 2013;12:1129-1135. 
348. Goncharov A, Bloom M, Pavuk M, Birman I, Carpenter DO. Blood pressure and hypertension 
in relation to levels of serum polychlorinated biphenyls in residents of Anniston, Alabama. 
J Hypertens 2010;28:2053-2060. 
349. Graham WG, Costello J, Vacek PM. Vermont granite mortality study: an update with an 
emphasis on lung cancer. J Occup Environ Med 2004;46:459-466. 
350. Great Britain. General Register Office. The Registrar-General's statistical review of England 
and Wales. Occupational mortality. Decennial supplement, England and Wales, 1970-1972, 
224 pp. London, United Kingdom: H. M. Stationery Office, 1978. 
351. Greaves IA, Eisen EA, Smith TJ, Pothier LJ, Kriebel D, Woskie SR, Kennedy SM, Shalat S, 
Monson RR. Respiratory health of automobile workers exposed to metal-working fluid 
aerosols: respiratory symptoms. Am J Ind Med 1997;32:450-459. 
352. Greenberg M. Silica, silicosis, and cancer in the United Kingdom. In: Goldsmith DF, Winn 
DM, Shy CM, eds. Silica, silicosis, and cancer: controversy in occupational medicine. Cancer 
Research Monograph Vol. 2. Pp. 423-435. New York, United States: Praeger, 1986. 
353. Griggs TR. The role of exertion as a determinant of carboxyhemoglobin accumulation in 
firefighters. J Occup Med 1977;19:759-761. 
354. Groppi A, Polettini A, Lunetta P, Achille G, Montagna M. A fatal case of trichlorofluoro-
methane (Freon 11) poisoning. Tissue distribution study by gas chromatography-mass 
spectrometry. J Forensic Sci 1994;39:871-876. 
355. Grotto D, de Castro MM, Barcelos GR, Garcia SC, Barbosa F, Jr. Low level and sub-chronic 
exposure to methylmercury induces hypertension in rats: nitric oxide depletion and oxidative 
damage as possible mechanisms. Arch Toxicol 2009;83:653-662. 
356. Grotto D, Valentini J, Fillion M, Passos CJ, Garcia SC, Mergler D, Barbosa F, Jr. Mercury 
exposure and oxidative stress in communities of the Brazilian Amazon. Sci Total Environ 
2010;408:806-811. 
357. Guallar E, Sanz-Gallardo MI, van't Veer P, Bode P, Aro A, Gómez-Aracena J, Kark JD, 
Riemersma RA, Martín-Moreno JM, Kok FJ, Heavy Metals and Myocardial Infarction Study 
Group. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med 2002;347:1747-
1754. 
358. Guidotti TL. Human factors in firefighting: ergonomic-, cardiopulmonary-, and psychogenic 
stress-related issues. Int Arch Occup Environ Health 1992;64:1-12. 
359. Gustafson T, Dahlman-Höglund A, Nilsson K, Ström K, Tornling G, Torén K. Occupational 
exposure and severe pulmonary fibrosis. Respir Med 2007;101:2207-2212. 
360. Gustavsson P, Bellander T, Johansson L, Salmonsson S. Surveillance of mortality and cancer 
incidence among Swedish graphite electrode workers. Environ Res 1995;70:7-10. 
361. Gustavsson P, Hogstedt C. A cohort study of Swedish capacitor manufacturing workers 
exposed to polychlorinated biphenyls (PCBs). Am J Ind Med 1997;32:234-239. 
362. Gustavsson P, Jansson C, Hogstedt C. Incidence of myocardial infarction in Swedish chimney 
sweeps 1991-2005: a prospective cohort study. Occup Environ Med 2013;70:505-507. 
363. Gustavsson P, Plato N, Axelson O, Brage HN, Hogstedt C, Ringbäck G, Tornling G, Wingren 
G. Lung cancer risk among workers exposed to man-made mineral fibers (MMMF) in the 
Swedish prefabricated house industry. Am J Ind Med 1992;21:825-834. 
364. Gustavsson P, Plato N, Hallqvist J, Hogstedt C, Lewné M, Reuterwall C, Scheele P. A 
population-based case-referent study of myocardial infarction and occupational exposure to 
motor exhaust, other combustion products, organic solvents, lead, and dynamite. Stockholm 
Heart Epidemiology Program (SHEEP) Study Group. Epidemiology 2001;12:222-228. 
 204 
 
365. Gustavsson P, Reuterwall C. Mortality and incidence of cancer among Swedish gas workers. 
Br J Ind Med 1990;47:169-174. 
366. Ha MH, Lee DH, Jacobs DR. Association between serum concentrations of persistent organic 
pollutants and self-reported cardiovascular disease prevalence: results from the National 
Health and Nutrition Examination Survey, 1999-2002. Environ Health Perspect 2007;115: 
1204-1209. 
367. Ha MH, Lee DH, Son HK, Park SK, Jacobs DR, Jr. Association between serum concentrations 
of persistent organic pollutants and prevalence of newly diagnosed hypertension: results from 
the National Health and Nutrition Examination Survey 1999-2002. J Hum Hypertens 2009;23: 
274-286. 
368. Haarala A, Kähonen M, Eklund C, Jylhävä J, Koskinen T, Taittonen L, Huupponen R, 
Lehtimäki T, Viikari J, Raitakari OT, Hurme M. Heart rate variability is independently 
associated with C-reactive protein but not with serum amyloid A. The Cardiovascular Risk in 
Young Finns Study. Eur J Clin Invest 2011;41:951-957. 
369. Hackshaw A, Morris JK, Boniface S, Tang JL, Milenkovic D. Low cigarette consumption and 
risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study 
reports. BMJ 2018;360:j5855. 
370. Hagmar L, Åkesson B, Nielsen J, Andersson C, Lindén K, Attewell R, Möller T. Mortality 
and cancer morbidity in workers exposed to low levels of vinyl chloride monomer at a 
polyvinyl chloride processing plant. Am J Ind Med 1990;17:553-565. 
371. Haider AW, Larson MG, O'Donnell CJ, Evans JC, Wilson PW, Levy D. The association of 
chronic cough with the risk of myocardial infarction: the Framingham Heart Study. Am J Med 
1999;106:279-284. 
372. Haikerwal A, Akram M, Del Monaco A, Smith K, Sim MR, Meyer M, Tonkin AM, Abramson 
MJ, Dennekamp M. Impact of fine particulate matter (PM2.5) exposure during wildfires on 
cardiovascular health outcomes. J Am Heart Assoc 2015;4, 10 pp. 
373. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus 
erythematosus and the risk of cardiovascular disease: results from the nurses' health study. 
Arthritis Rheum 2009;61:1396-1402. 
374. Hall A, Harrington JM, Aw TC. Mortality study of British pathologists. Am J Ind Med 1991; 
20:83-89. 
375. Hallgren CG, Hallmans G, Jansson JH, Marklund SL, Huhtasaari F, Schütz A, Strömberg U, 
Vessby B, Skerfving S. Markers of high fish intake are associated with decreased risk of a first 
myocardial infarction. Br J Nutr 2001;86:397-404. 
376. Halpin DM, Graneek BJ, Lacey J, Nieuwenhuijsen MJ, Williamson PA, Venables KM, 
Newman Taylor AJ. Respiratory symptoms, immunological responses, and aeroallergen 
concentrations at a sawmill. Occup Environ Med 1994;51:165-172. 
377. Hammar N, Alfredsson L, Smedberg M, Ahlbom A. Differences in the incidence of 
myocardial infarction among occupational groups. Scand J Work Environ Health 1992;18: 
178-185. 
378. Hammond EC, Selikoff IJ, Lawther PL, Seidman H. Inhalation of benzpyrene and cancer in 
man. Ann N Y Acad Sci 1976;271:116-124. 
379. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. 
Ann N Y Acad Sci 1979;330:473-490. 
380. Han SG, Howatt DA, Daugherty A, Gairola CG. Atherogenic and pulmonary responses of 
ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke. Toxicology 2012;299: 
133-138. 
381. Hansen ES. Mortality from cancer and ischemic heart disease in Danish chimney sweeps: a 
five-year follow-up. Am J Epidemiol 1983;117:160-164. 
382. Harding AH, Darnton A, Osman J. Cardiovascular disease mortality among British asbestos 
workers (1971-2005). Occup Environ Med 2012;69:417-421. 
 205 
 
383. Harding AH, Darnton A, Wegerdt J, McElvenny D. Mortality among British asbestos workers 
undergoing regular medical examinations (1971-2005). Occup Environ Med 2009;66:487-
495. 
384. Hart JE, Garshick E, Dockery DW, Smith TJ, Ryan L, Laden F. Long-term ambient multi-
pollutant exposures and mortality. Am J Respir Crit Care Med 2011;183:73-78. 
385. Hart JE, Garshick E, Smith TJ, Davis ME, Laden F. Ischaemic heart disease mortality and 
years of work in trucking industry workers. Occup Environ Med 2013;70:523-528. 
386. Hartmann L, Bauer M, Bertram J, Gube M, Lenz K, Reisgen U, Schettgen T, Kraus T, Brand 
P. Assessment of the biological effects of welding fumes emitted from metal inert gas welding 
processes of aluminium and zinc-plated materials in humans. Int J Hyg Environ Health 2014; 
217:160-168. 
387. Hassaballa HA, Lateef OB, Bell J, Kim E, Casey L. Metal fume fever presenting as aseptic 
meningitis with pericarditis, pleuritis and pneumonitis. Occup Med (Lond) 2005;55:638-641. 
388. Haug T, Søstrand P, Langård S. Exposure to culturable microorganisms in paper mills and 
presence of symptoms associated with infections. Am J Ind Med 2002;41:498-505. 
389. Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. Mortality from solid cancers among 
workers in formaldehyde industries. Am J Epidemiol 2004;159:1117-1130. 
390. Hayes RB, Blair A, Stewart PA, Herrick RF, Mahar H. Mortality of U.S. embalmers and 
funeral directors. Am J Ind Med 1990;18:641-652. 
391. Hayes RB, Sheffet A, Spirtas R. Cancer mortality among a cohort of chromium pigment 
workers. Am J Ind Med 1989;16:127-133. 
392. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK. Passive smoking and the risk 
of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med 1999;340: 
920-926. 
393. Hearne FT, Grose F, Pifer JW, Friedlander BR, Raleigh RL. Methylene chloride mortality 
study: dose-response characterization and animal model comparison. J Occup Med 1987;29: 
217-228. 
394. Hearne FT, Pifer JW. Mortality study of two overlapping cohorts of photographic film base 
manufacturing employees exposed to methylene chloride. J Occup Environ Med 1999;41: 
1154-1169. 
395. Hedmer M, Kåredal M, Gustavsson P, Rissler J. The Nordic Expert Group for Criteria 
Documentation of Health Risks from Chemicals. Carbon nanotubes. Arbete och Hälsa 
2013;47(5), 238 pp. Gothenburg, Sweden: University of Gothenburg, 2013. 
396. Hein MJ, Stayner LT, Lehman E, Dement JM. Follow-up study of chrysotile textile workers: 
cohort mortality and exposure-response. Occup Environ Med 2007;64:616-625. 
397. Henderson V, Enterline PE. An unusual mortality experience in cotton textile workers. 
J Occup Med 1973;15:717-719. 
398. Henneberger PK, Ferris BG, Jr., Monson RR. Mortality among pulp and paper workers in 
Berlin, New Hampshire. Br J Ind Med 1989;46:658-664. 
399. Henneberger PK, Lax MB. Lung cancer mortality in a cohort of older pulp and paper workers. 
Int J Occup Environ Health 1998;4:147-154. 
400. Hennig B, Meerarani P, Slim R, Toborek M, Daugherty A, Silverstone AE, Robertson LW. 
Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl 
Pharmacol 2002;181:174-183. 
401. Hernberg S, Käräva R, Koskela RS, Luoma K. Angina pectoris, ECG findings and blood 
pressure of foundry workers in relation to carbon monoxide exposure. Scand J Work Environ 
Health 1976;2 Suppl 1:54-63. 
402. Hertz-Picciotto I, Arrighi HM, Hu SW. Does arsenic exposure increase the risk for circulatory 
disease? Am J Epidemiol 2000;151:174-181. 
403. Heyer N, Weiss NS, Demers P, Rosenstock L. Cohort mortality study of Seattle fire fighters: 
1945-1983. Am J Ind Med 1990;17:493-504. 
 206 
 
404. Hillerdal G. Pleural plaques in the general population. Ann N Y Acad Sci 1991;643:430-437. 
405. Hilt B, Lien JT, Lund-Larsen PG, Lund K, Langård S. Asbestos-related findings in chest 
radiographs of the male population of the county of Telemark, Norway--a cross-sectional 
study. Scand J Work Environ Health 1986;12:567-573. 
406. Hilt B, Qvenild T, Holme J, Svendsen K, Ulvestad B. Increase in interleukin-6 and fibrinogen 
after exposure to dust in tunnel construction workers. Occup Environ Med 2002;59:9-12. 
407. Hilt B, Qvenild T, Rømyhr O. Morbidity from ischemic heart disease in workers at a stainless 
steel welding factory. Norsk Epidemiologi 1999;9:21-26. 
408. Himmel HM. Mechanisms involved in cardiac sensitization by volatile anesthetics: general 
applicability to halogenated hydrocarbons? Crit Rev Toxicol 2008;38:773-803. 
409. Hinderliter AL, Adams KF, Jr., Price CJ, Herbst MC, Koch G, Sheps DS. Effects of low-level 
carbon monoxide exposure on resting and exercise-induced ventricular arrhythmias in patients 
with coronary artery disease and no baseline ectopy. Arch Environ Health 1989;44:89-93. 
410. Hobbesland A, Kjuus H, Thelle DS. Mortality from cardiovascular diseases and sudden death 
in ferroalloy plants. Scand J Work Environ Health 1997;23:334-341. 
411. Hobbesland A, Kjuus H, Thelle DS. Mortality from nonmalignant respiratory diseases among 
male workers in Norwegian ferroalloy plants. Scand J Work Environ Health 1997;23:342-350. 
412. Hobson A, Seixas N, Sterling D, Racette BA. Estimation of particulate mass and manganese 
exposure levels among welders. Ann Occup Hyg 2011;55:113-125. 
413. Hodgson JT, Jones RD. Mortality of a cohort of tin miners 1941-86. Br J Ind Med 1990;47: 
665-676. 
414. Hodgson JT, Jones RD. Mortality of workers in the British cotton industry in 1968-1984. 
Scand J Work Environ Health 1990;16:113-120. 
415. Hogstedt C, Alexandersson R. [Mortality among hard metal workers] Dödsorsaker hos 
hårdmetallarbetare. Arbete och Hälsa 1990:21, 26 pp. Solna, Sweden: National Institute of 
Occupational Health, 1990 (in Swedish with English summary). 
416. Hogstedt C, Axelson O. Mortality from cardio-cerebrovascular diseases among dynamite 
workers--an extended case-referent study. Ann Acad Med Singapore 1984;13:399-403. 
417. Hogstedt C, Ståhl R. Skin absorption and protective gloves in dynamite work. Am Ind Hyg 
Assoc J 1980;41:367-372. 
418. Holmes TM, Buffler PA, Holguin AH, Hsi BP. A mortality study of employees at a synthetic 
rubber manufacturing plant. Am J Ind Med 1986;9:355-362. 
419. Homma S, Jones R, Qvist J, Zapol WM, Reid L. Pulmonary vascular lesions in the adult 
respiratory distress syndrome caused by inhalation of zinc chloride smoke: a morphometric 
study. Hum Pathol 1992;23:45-50. 
420. Hooiveld M, Heederik DJ, Kogevinas M, Boffetta P, Needham LL, Patterson DG, Jr., Bueno-
de-Mesquita HB. Second follow-up of a Dutch cohort occupationally exposed to phenoxy 
herbicides, chlorophenols, and contaminants. Am J Epidemiol 1998;147:891-901. 
421. Horowitz SF, Fischbein A, Matza D, Rizzo JN, Stern A, Machac J, Solomon SJ. Evaluation 
of right and left ventricular function in hard metal workers. Br J Ind Med 1988;45:742-746. 
422. Hoshuyama T, Pan G, Tanaka C, Feng Y, Yu L, Liu T, Liu L, Hanaoka T, Takahashi K. 
Mortality of iron-steel workers in Anshan, China: a retrospective cohort study. Int J Occup 
Environ Health 2006;12:193-202. 
423. Hours M, Fevotte J, Lafont S, Bergeret A. Cancer mortality in a synthetic spinning plant in 
Besancon, France. Occup Environ Med 2007;64:575-581. 
424. Huang L, Sang CN, Desai MS. Beyond ether and chloroform-a major breakthrough with 
halothane. J Anesth Hist 2017;3:87-102. 
425. Hubbard R. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis. 
Eur Respir J Suppl 2001;32:119s-121s. 
 207 
 
426. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or 
wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996;347:284-289. 
427. Hughes JM, Weill H, Hammad YY. Mortality of workers employed in two asbestos cement 
manufacturing plants. Br J Ind Med 1987;44:161-174. 
428. Humblet O, Birnbaum L, Rimm E, Mittleman MA, Hauser R. Dioxins and cardiovascular 
disease mortality. Environ Health Perspect 2008;116:1443-1448. 
429. Hurley JF, Archibald RM, Collings PL, Fanning DM, Jacobsen M, Steele RC. The mortality 
of coke workers in Britain. Am J Ind Med 1983;4:691-704. 
430. Hurwitz LJ, Taylor GI. Poisoning by sewer gas with unusual sequelae. Lancet 1954;266:1110-
1112. 
431. Huuskonen MS, Järvisalo J, Koskinen H, Nickels J, Räsänen J, Asp S. Preliminary results 
from a cohort of workers exposed to wollastonite in a Finnish limestone quarry. Scand J Work 
Environ Health 1983;9:169-175. 
432. Huuskonen MS, Tossavainen A. Nordiska expertgruppen för gränsvärdesdokumentation. 39. 
Asbest. Arbete och Hälsa 1982:29, 44 pp. Solna, Sverige: Arbetarskyddsstyrelsen (National 
Board of Occupational Safety and Health), 1982 (in Swedish). 
433. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in 
women compared with men: a systematic review and meta-analysis of prospective cohort 
studies. Lancet 2011;378:1297-1305. 
434. IARC. Exposures in the textile manufacturing industry. In: Some flame retardants and textile 
chemicals, and exposures in the textile manufacturing industry. IARC monographs on the 
evaluation of carcinogenic risks to humans Vol. 48. Pp. 215-278. Lyon, France: International 
Agency for Research on Cancer, 1990. 
435. IARC. Man-made vitreous fibres. IARC monographs on the evaluation of carcinogenic risks 
to humans Vol. 81. 418 pp. Lyon, France: International Agency for Research on Cancer, 2002. 
436. IARC. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of 
carcinogenic risks to humans Vol. 83. 1473 pp. Lyon, France: International Agency for 
Research on Cancer, 2004. 
437. IARC. Household use of solid fuels and high-temperature frying. IARC monographs on the 
evaluation of carcinogenic risks to humans Vol. 95. 430 pp. Lyon, France: International 
Agency for Research on Cancer, 2010. 
438. IARC. Painting, firefighting, and shiftwork. IARC monographs on the evaluation of 
carcinogenic risks to humans Vol. 98. 804 pp. Lyon, France: International Agency for 
Research on Cancer, 2010. 
439. IARC. Asbestos. In: Arsenic, metals, fibres, and dusts. IARC monographs on the evaluation 
of carcinogenic risks to humans Vol. 100C. Pp. 219-294. Lyon, France: International Agency 
for Research on Cancer, 2012. 
440. IARC. Wood dust. In: Arsenic, metals, fibres, and dusts. IARC monographs on the evaluation 
of carcinogenic risks to humans Vol. 100C. Pp. 407-465. Lyon, France: International Agency 
for Research on Cancer, 2012. 
441. Ibfelt E, Bonde JP, Hansen J. Exposure to metal welding fume particles and risk for 
cardiovascular disease in Denmark: a prospective cohort study. Occup Environ Med 2010;67: 
772-777. 
442. Ilar A, Lewné M, Plato N, Hallqvist J, Alderling M, Bigert C, Hogstedt C, Gustavsson P. 
Myocardial infarction and occupational exposure to motor exhaust: a population-based case-
control study in Sweden. Eur J Epidemiol 2014;29:517-525. 
443. Ilychova SA, Zaridze DG. Cancer mortality among female and male workers occupationally 
exposed to inorganic lead in the printing industry. Occup Environ Med 2012;69:87-92. 
444. Infante-Rivard C, Armstrong B, Petitclerc M, Cloutier LG, Theriault G. Lung cancer mortality 
and silicosis in Quebec, 1938-85. Lancet 1989;2:1504-1507. 
 208 
 
445. Institute of Medicine. Committee to Review the Health Effects in Vietnam Veterans of 
Exposure to Herbicides. Veterans and Agent Orange: update 2012. 1006 pp. Washington, DC, 
United States: The National Academies Press, 2014. 
446. IPCS/WHO. Methyl chloride. Concise International Chemical Assessment Document No. 28. 
44 pp. Geneva, Switzerland: International Programme on Chemical Safety, World Health 
Organization, 2001. 
447. IPCS/WHO. Carbon disulphide. Concise International Chemical Assessment Document No. 
46. 46 pp. Geneva, Switzerland: International Programme on Chemical Safety, World Health 
Organization, 2002. 
448. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis. 
Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1994;150: 
670-675. 
449. Jacobs L, Emmerechts J, Mathieu C, Hoylaerts MF, Fierens F, Hoet PH, Nemery B, Nawrot 
TS. Air pollution related prothrombotic changes in persons with diabetes. Environ Health 
Perspect 2010;118:191-196. 
450. Jahnová E, Tulinská J, Weissová S, Dusinská M, Fuortes L. Effects of occupational exposure 
to styrene on expression of adhesion molecule on leukocytes. Hum Exp Toxicol 2002;21:235-
240. 
451. Jakobsson K, Gustavsson P. Systematiska kunskapsöversikter; 5. Arbetsmiljöexponeringar 
och stroke – en kritisk granskning av evidens för samband mellan exponeringar i arbetsmiljön 
och stroke. Arbete och Hälsa 2013;47(4), 68 pp. Gothenburg, Sweden: University of 
Gothenburg, 2013 (in Swedish). 
452. Janosik T, Rannug A, Rannug U, Wahlström N, Slätt J, Bergman J. Chemistry and properties 
of indolocarbazoles. Chem Rev 2018;118:9058-9128. 
453. Jansson C, Alderling M, Hogstedt C, Gustavsson P. Mortality among Swedish chimney 
sweeps (1952-2006): an extended cohort study. Occup Environ Med 2012;69:41-47. 
454. Jarvis JQ, Hammond E, Meier R, Robinson C. Cobalt cardiomyopathy. A report of two cases 
from mineral assay laboratories and a review of the literature. J Occup Med 1992;34:620-626. 
455. Jenkins PL, Earle-Richardson G, Bell EM, May JJ, Green A. Chronic disease risk in central 
New York dairy farmers: results from a large health survey 1989-1999. Am J Ind Med 2005;47: 
20-26. 
456. Jiang Y, Shao F. A stone miner with both silicosis and constrictive pericarditis: case report 
and review of the literature. BMC Pulm Med 2013;13:71. 
457. Johanson G, Carlander U. Uptake and biodistribution of nanoparticles – a review. Report 
12/16, 131 pp. Stockholm, Sweden: Swedish Chemicals Agency, 2016. 
458. Johanson G, Rauma M. Basis for skin notation. Part I. Dermal penetration data for substances 
on the Swedish OEL list. Arbete och Hälsa 2008;42:2, 230 pp. Gothenburg, Sweden: 
University of Gothenburg, 2008. 
459. Johnston RR, Eger EI, II, Wilson C. A comparative interaction of epinephrine with enflurane, 
isoflurane, and halothane in man. Anesth Analg 1976;55:709-712. 
460. Jokinen MP, Walker NJ, Brix AE, Sells DM, Haseman JK, Nyska A. Increase in 
cardiovascular pathology in female Sprague-Dawley rats following chronic treatment with 
2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3',4,4',5-pentachlorobiphenyl. Cardiovasc Toxicol 
2003;3:299-310. 
461. Jones AT, Jones RC, Longley EO. Environmental and clinical aspects of bulk wheat 
fumigation with aluminum phosphide. Am Ind Hyg Assoc J 1964;25:376-379. 
462. Jones DR, Sutton AJ, Abrams KR, Fenty J, Warren F, Rushton L. Systematic review and meta-
analysis of mortality in crop protection product manufacturing workers. Occup Environ Med 
2009;66:7-15. 
 209 
 
463. Joundi RA, Cipriano LE, Sposato L.A, Saposnik G, Stroke Outcomes Research Working 
Group. Ischemic stroke risk in patients with atrial fibrillation and CHA2DS2-VASc Score of 
1: systematic review and meta-analysis. Stroke 47;1364-1367. 
464. Jousilahti P, Patja K, Salomaa V. Environmental tobacco smoke and the risk of cardiovascular 
disease. Scand J Work Environ Health 2002;28 Suppl 2:41-51. 
465. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the 
risk of coronary disease. Lancet 1996;348:567-572. 
466. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Occupation, fibrinogen, and heart disease. 
Lancet 1997;349:506. 
467. Jäppinen P. A mortality study of Finnish pulp and paper workers. Br J Ind Med 1987;44:580-
587. 
468. Jäppinen P, Tola S. Smoking among Finnish pulp and paper workers--evaluation of its 
confounding effect on lung cancer and coronary heart disease rates. Scand J Work Environ 
Health 1986;12:619-626. 
469. Jäppinen P, Tola S. Cardiovascular mortality among pulp mill workers. Br J Ind Med 1990;47: 
259-262. 
470. Järup L, Bellander T, Hogstedt C, Spång G. Mortality and cancer incidence in Swedish battery 
workers exposed to cadmium and nickel. Occup Environ Med 1998;55:755-759. 
471. Järup L, Pershagen G, Wall S. Cumulative arsenic exposure and lung cancer in smelter 
workers: a dose-response study. Am J Ind Med 1989;15:31-41. 
472. Järvholm B. Cutting oil mist and bronchitis. Eur J Respir Dis Suppl 1982;118:79-83. 
473. Järvholm B, Reuterwall C, Bystedt J. Mortality attributable to occupational exposure in 
Sweden. Scand J Work Environ Health 2013;39:106-111. 
474. Kales SN, Soteriades ES, Christophi CA, Christiani DC. Emergency duties and deaths from 
heart disease among firefighters in the United States. N Engl J Med 2007;356:1207-1215. 
475. Kameda T, Takahashi K, Kim R, Jiang Y, Movahed M, Park EK, Rantanen J. Asbestos: use, 
bans and disease burden in Europe. Bull World Health Organ 2014;92:790-797. 
476. Kano K, Horikawa M, Utsunomiya T, Tati M, Satoh K, Yamaguchi S. Lung cancer mortality 
among a cohort of male chromate pigment workers in Japan. Int J Epidemiol 1993;22:16-22. 
477. Karakulak UN, Gündüzöz M, Tutkun E, Yilmaz OH. An arrhythmic episode after mercury 
exposure and successful treatment with chelation therapy: a case report. Anatol J Cardiol 
2015;15:589-590. 
478. Katz RM, Jowett D. Female laundry and dry cleaning workers in Wisconsin: a mortality 
analysis. Am J Public Health 1981;71:305-307. 
479. Kaufman JD, Morgan MS, Marks ML, Greene HL, Rosenstock L. A study of the cardiac 
effects of bromochlorodifluoromethane (halon 1211) exposure during exercise. Am J Ind Med 
1992;21:223-233. 
480. Kaufman JD, Silverstein MA, Moure-Eraso R. Atrial fibrillation and sudden death related to 
occupational solvent exposure. Am J Ind Med 1994;25:731-735. 
481. Kauppinen T, Teschke K, Astrakianakis G, Boffetta P, Colin D, Keefe A, Korhonen K, 
Liukkonen T, Nicol AM, Pannett B, Westberg H. Assessment of exposure in an international 
study on cancer risks among pulp, paper, and paper product workers. AIHA J (Fairfax, Va) 
2002;63:254-261. 
482. Kauppinen T, Vincent R, Liukkonen T, Grzebyk M, Kauppinen A, Welling I, Arezes P, Black 
N, Bochmann F, Campelo F, Costa M, Elsigan G, Goerens R, Kikemenis A, Kromhout H, 
Miguel S, Mirabelli D, McEneany R, Pesch B, Plato N, Schlunssen V, Schulze J, Sonntag R, 
Verougstraete V, De Vicente MA, Wolf J, Zimmermann M, Husgafvel-Pursiainen K, 
Savolainen K. Occupational exposure to inhalable wood dust in the member states of the 
European Union. Ann Occup Hyg 2006;50:549-561. 
483. Kazantzis G, Lam TH, Sullivan KR. Mortality of cadmium-exposed workers. A five-year 
update. Scand J Work Environ Health 1988;14:220-223. 
 210 
 
484. Keil AP, Richardson DB. Reassessing the link between airborne arsenic exposure among 
Anaconda copper smelter workers and multiple causes of death using the parametric g-
formula. Environ Health Perspect 2017;125:608-614. 
485. Kemper FD. A near-fatal case of hydrogen sulfide poisoning. Can Med Assoc J 1966;94:1130-
1131. 
486. Kennedy A, Dornan JD, King R. Fatal myocardial disease associated with industrial exposure 
to cobalt. Lancet 1981;1:412-414. 
487. Kerley-Hamilton JS, Trask HW, Ridley CJ, Dufour E, Lesseur C, Ringelberg CS, Moodie KL, 
Shipman SL, Korc M, Gui J, Shworak NW, Tomlinson CR. Inherent and benzo[a]pyrene-
induced differential aryl hydrocarbon receptor signaling greatly affects life span, athero-
sclerosis, cardiac gene expression, and body and heart growth in mice. Toxicol Sci 2012; 
126:391-404. 
488. Kermanizadeh A, Balharry D, Wallin H, Loft S, Møller P. Nanomaterial translocation--the 
biokinetics, tissue accumulation, toxicity and fate of materials in secondary organs--a review. 
Crit Rev Toxicol 2015;45:837-872. 
489. Ketchum NS, Michalek JE. Postservice mortality of Air Force veterans occupationally 
exposed to herbicides during the Vietnam War: 20-year follow-up results. Mil Med 2005;170: 
406-413. 
490. Khan DA, Qayyum S, Saleem S, Khan FA. Lead-induced oxidative stress adversely affects 
health of the occupational workers. Toxicol Ind Health 2008;24:611-618. 
491. Kim IS, Sohn J, Lee SJ, Park JK, Uhm JS, Pak HN, Lee MH, Kim C, Joung B. Association of 
air pollution with increased incidence of ventricular tachyarrhythmias recorded by implantable 
cardioverter defibrillators: Vulnerable patients to air pollution. Int J Cardiol 2017;240:214-
220. 
492. Kim JY, Chen JC, Boyce PD, Christiani DC. Exposure to welding fumes is associated with 
acute systemic inflammatory responses. Occup Environ Med 2005;62:157-163. 
493. Kim TH, Kim SG. Clinical outcomes of occupational exposure to N,N-dimethylformamide: 
perspectives from experimental toxicology. Saf Health Work 2011;2:97-104. 
494. Kimbrough RD, Krouskas CA, Xu W, Shields PG. Mortality among capacitor workers 
exposed to polychlorinated biphenyls (PCBs), a long-term update. Int Arch Occup Environ 
Health 2015;88:85-101. 
495. Kittelson DB. Engines and nanoparticles: a review. J Aerosol Sci 1998;29:575-588. 
496. Kizakevich PN, McCartney ML, Hazucha MJ, Sleet LH, Jochem WJ, Hackney AC, Bolick K. 
Noninvasive ambulatory assessment of cardiac function in healthy men exposed to carbon 
monoxide during upper and lower body exercise. Eur J Appl Physiol 2000;83:7-16. 
497. Klatsky AL. Re: "Arsenic exposure and cardiovascular disease: a systematic review of the 
epidemiologic evidence". Am J Epidemiol 2006;164:194-195; author reply 195-196. 
498. Kleinfeld M, Messite J, Zaki MH. Mortality experiences among talc workers: a follow-up 
study. J Occup Med 1974;16:345-349. 
499. Kleinman MT, Davidson DM, Vandagriff RB, Caiozzo VJ, Whittenberger JL. Effects of short-
term exposure to carbon monoxide in subjects with coronary artery disease. Arch Environ 
Health 1989;44:361-369. 
500. Klepczyńska-Nyström A, Sanchez-Crespo A, Andersson M, Falk R, Lundin A, Larsson BM, 
Svartengren M. The pulmonary deposition and retention of indium-111 labeled ultrafine 
carbon particles in healthy individuals. Inhal Toxicol 2012;24:645-651. 
501. Knox JF, Holmes S, Doll R, Hill ID. Mortality from lung cancer and other causes among 
workers in an asbestos textile factory. Br J Ind Med 1968;25:293-303. 
502. Kogevinas M, Ferro G, Andersen A, Bellander T, Biocca M, Coggon D, Gennaro V, Hutchings 
S, Kolstad H, Lundberg I, Lynge E, Partanen T, Saracci R. Cancer mortality in a historical 
cohort study of workers exposed to styrene. Scand J Work Environ Health 1994;20:251-261. 
 211 
 
503. Kohama A, Masuyama T, Hori M, Tanouchi J. Non-ischemic myocardial fibrosis after long-
term asbestos exposure. Intern Med 1996;35:605-610. 
504. Kokkarinen J, Tukiainen H, Terho EO. Mortality due to farmer's lung in Finland. Chest 
1994;106:509-512. 
505. Kollanus V, Tiittanen P, Niemi JV, Lanki T. Effects of long-range transported air pollution 
from vegetation fires on daily mortality and hospital admissions in the Helsinki metropolitan 
area, Finland. Environ Res 2016;151:351-358. 
506. Korallus U, Ulm K, Steinmann-Steiner-Haldenstaett W. Bronchial carcinoma mortality in the 
German chromate-producing industry: the effects of process modification. Int Arch Occup 
Environ Health 1993;65:171-178. 
507. Korhola O, Hiltunen A, Karjalainen A, Martikainen R, Riihimäki H. Association between 
pleural plaques and coronary heart disease. Scand J Work Environ Health 2001;27:154-155. 
508. Korhonen K, Liukkonen T, Ahrens W, Astrakianakis G, Boffetta P, Burdorf A, Heederik D, 
Kauppinen T, Kogevinas M, Osvoll P, Rix BA, Saalo A, Sunyer J, Szadkowska-Stanczyk I, 
Teschke K, Westberg H, Widerkiewicz K. Occupational exposure to chemical agents in the 
paper industry. Int Arch Occup Environ Health 2004;77:451-460. 
509. Koskela RS, Klockars M, Järvinen E. Mortality and disability among cotton mill workers.  
Br J Ind Med 1990;47:384-391. 
510. Koskela RS, Klockars M, Järvinen E, Kolari PJ, Rossi A. Mortality and disability among 
granite workers. Scand J Work Environ Health 1987;13:18-25. 
511. Koskela RS, Klockars M, Järvinen E, Rossi A, Kolari PJ. Cancer mortality of granite workers 
1940-1985. IARC Sci Publ 1990:43-53. 
512. Koskela RS, Klockars M, Laurent H, Holopainen M. Silica dust exposure and lung cancer. 
Scand J Work Environ Health 1994;20:407-416. 
513. Koskela RS, Mutanen P, Sorsa JA, Klockars M. Factors predictive of ischemic heart disease 
mortality in foundry workers exposed to carbon monoxide. Am J Epidemiol 2000;152:628-
632. 
514. Koskela RS, Mutanen P, Sorsa JA, Klockars M. Respiratory disease and cardiovascular 
morbidity. Occup Environ Med 2005;62:650-655. 
515. Kreiss K, Cox-Ganser J. Metalworking fluid-associated hypersensitivity pneumonitis: a work-
shop summary. Am J Ind Med 1997;32:423-432. 
516. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad 
Dermatol 2007;57:347-354. 
517. Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz 
AM, Rondeau V. Human health risk assessment for aluminium, aluminium oxide, and 
aluminium hydroxide. J Toxicol Environ Health B Crit Rev 2007;10 Suppl 1:1-269. 
518. Kristensen TS. Cardiovascular diseases and the work environment. A critical review of the 
epidemiologic literature on chemical factors. Scand J Work Environ Health 1989;15:245-264. 
519. Kucharska-Newton AM, Couper DJ, Pankow JS, Prineas RJ, Rea TD, Sotoodehnia N, 
Chakravarti A, Folsom AR, Siscovick DS, Rosamond WD. Hemostasis, inflammation, and 
fatal and nonfatal coronary heart disease: long-term follow-up of the atherosclerosis risk in 
communities (ARIC) cohort. Arterioscler Thromb Vasc Biol 2009;29:2182-2190. 
520. Kuijpers E, Pronk A, Kleemann R, Vlaanderen J, Lan Q, Rothman N, Silverman D, Hoet P, 
Godderis L, Vermeulen R. Cardiovascular effects among workers exposed to multiwalled 
carbon nanotubes. Occup Environ Med 2018;75:351-358. 
521. Kurppa K, Gudbergsson H, Hannunkari I, Koskinen H, Hernberg S, Koskela R-S, Ahlman K. 
Lung cancer among silicotics in Finland. In: Goldsmith DF, Winn DM, Shy CM, eds. Silica, 
silicosis, and cancer: controversy in occupational medicine. Cancer Research Monograph 
Vol. 2. Pp. 311-319. New York, United States: Praeger, 1986. 
522. Kurppa K, Hietanen E, Klockars M, Partinen M, Rantanen J, Rönnemaa T, Viikari J. Chemical 
exposures at work and cardiovascular morbidity. Atherosclerosis, ischemic heart disease, 
 212 
 
hypertension, cardiomyopathy and arrhythmias. Scand J Work Environ Health 1984;10:381-
388. 
523. Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, 
Ko DT, McGeer AJ, McNally D, Richardson DC, Rosella LC, Simor A, Smieja M, Zahariadis 
G, Gubbay JB. Acute myocardial infarction after laboratory-confirmed influenza infection. 
N Engl J Med 2018;378:345-353. 
524. Kyjovska ZO, Jacobsen NR, Saber AT, Bengtson S, Jackson P, Wallin H, Vogel U. DNA 
strand breaks, acute phase response and inflammation following pulmonary exposure by 
instillation to the diesel exhaust particle NIST1650b in mice. Mutagenesis 2015;30:499-507. 
525. Künzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, Thomas D, Peters J, 
Hodis HN. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect 
2005;113:201-206. 
526. Laden F, Hart JE, Smith TJ, Davis ME, Garshick E. Cause-specific mortality in the unionized 
U.S. trucking industry. Environ Health Perspect 2007;115:1192-1196. 
527. Lai H, Liu Y, Zhou M, Shi T, Zhou Y, Weng S, Chen W. Combined effect of silica dust 
exposure and cigarette smoking on total and cause-specific mortality in iron miners: a cohort 
study. Environ Health 2018;17:46, 10 pp. 
528. Lai PS, Christiani DC. Long-term respiratory health effects in textile workers. Curr Opin Pulm 
Med 2013;19:152-157. 
529. Landen DD, Wassell JT, McWilliams L, Patel A. Coal dust exposure and mortality from 
ischemic heart disease among a cohort of U.S. coal miners. Am J Ind Med 2011;54:727-733. 
530. Lanes SF, Cohen A, Rothman KJ, Dreyer NA, Soden KJ. Mortality of cellulose fiber 
production workers. Scand J Work Environ Health 1990;16:247-251. 
531. Lanes SF, Rothman KJ, Dreyer NA, Soden KJ. Mortality update of cellulose fiber production 
workers. Scand J Work Environ Health 1993;19:426-428. 
532. Lanfranchi A, Beraud P. [On the chronic poisoning by nitrated compounds in the workers of 
explosive factories]. Presse Med 1969;77:795-796 (in French). 
533. Lang T, Ducimetière P, Arveiler D, Amouyel P, Cambou JP, Ruidavets JB, Montaye M, Meyer 
V, Bingham A. Incidence, case fatality, risk factors of acute coronary heart disease and 
occupational categories in men aged 30-59 in France. Int J Epidemiol 1997;26:47-57. 
534. Lange RL, Reid MS, Tresch DD, Keelan MH, Bernhard VM, Coolidge G. Nonatheromatous 
ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. 
Circulation 1972;46:666-678. 
535. Langrish JP, Lundbäck M, Barath S, Söderberg S, Mills NL, Newby DE, Sandström T, 
Blomberg A. Exposure to nitrogen dioxide is not associated with vascular dysfunction in man. 
Inhal Toxicol 2010;22:192-198. 
536. Langseth H, Kjærheim K. Mortality from non-malignant diseases in a cohort of female pulp 
and paper workers in Norway. Occup Environ Med 2006; 63:741-745. Errata in Occup 
Environ Med 2006; 63:856. 
537. Langård S, Costa M. Chromium. In: Nordberg GF, Fowler BA, Nordberg M and Friberg LT, 
eds. Pp. 487-510. Handbook on the toxicology of metals, 3rd ed. London, United Kingdom: 
Elsevier Academic Press Inc., 2007. 
538. Lanphear BP, Rauch S, Auinger P, Allen RW, Hornung RW. Low-level lead exposure and 
mortality in US adults: a population-based cohort study. Lancet Public Health 2018;3:e177-
e184. 
539. Larson TC, Antao VC, Bove FJ. Vermiculite worker mortality: estimated effects of 
occupational exposure to Libby amphibole. J Occup Environ Med 2010;52:555-560. 
540. Lauwerys R, Lison D. Health risks associated with cobalt exposure--an overview. Sci Total 
Environ 1994;150:1-6. 
541. Lawler AB, Mandel JS, Schuman LM, Lubin JH. A retrospective cohort mortality study of 
iron ore (hematite) miners in Minnesota. J Occup Med 1985;27:507-517. 
 213 
 
542. Lee-Feldstein A. Arsenic and respiratory cancer in humans: follow-up of copper smelter 
employees in Montana. J Natl Cancer Inst 1983;70:601-610. 
543. Lee AM, Fraumeni JF, Jr. Arsenic and respiratory cancer in man: an occupational study. J Natl 
Cancer Inst 1969;42:1045-1052. 
544. Lee BK, Kim Y. Relationship between blood manganese and blood pressure in the Korean 
general population according to KNHANES 2008. Environ Res 2011;111:797-803. 
545. Lee BK, Kim Y. Association of blood cadmium with hypertension in the Korean general 
population: analysis of the 2008-2010 Korean National Health and Nutrition Examination 
Survey data. Am J Ind Med 2012;55:1060-1067. 
546. Lee E, Burnett CA, Lalich N, Cameron LL, Sestito JP. Proportionate mortality of crop and 
livestock farmers in the United States, 1984-1993. Am J Ind Med 2002;42:410-420. 
547. Lee PN, Thornton AJ, Forey BA, Hamling JS. Environmental tobacco smoke exposure and 
risk of stroke in never smokers: an updated review with meta-analysis. J Stroke Cerebrovasc 
Dis 2017;26:204-216. 
548. Lee WJ, Cha ES, Moon EK. Disease prevalence and mortality among agricultural workers in 
Korea. J Korean Med Sci 2010;25:S112-118. 
549. Lee WJ, Teschke K, Kauppinen T, Andersen A, Jäppinen P, Szadkowska-Stanczyk I, Pearce 
N, Persson B, Bergeret A, Facchini LA, Kishi R, Kielkowski D, Rix BA, Henneberger P, 
Sunyer J, Colin D, Kogevinas M, Boffetta P. Mortality from lung cancer in workers exposed 
to sulfur dioxide in the pulp and paper industry. Environ Health Perspect 2002;110:991-995. 
550. Lehnert M, Pesch B, Lotz A, Pelzer J, Kendzia B, Gawrych K, Heinze E, Van Gelder R, 
Punkenburg E, Weiss T, Mattenklott M, Hahn JU, Möhlmann C, Berges M, Hartwig A, 
Brüning T, Weldox Study Group. Exposure to inhalable, respirable, and ultrafine particles in 
welding fume. Ann Occup Hyg 2012;56:557-567. 
551. Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, Saarelainen S, 
Järvenpää R, Uitti J, Moilanen E. Increased alveolar nitric oxide concentration and high levels 
of leukotriene B(4) and 8-isoprostane in exhaled breath condensate in patients with asbestosis. 
Thorax 2007;62:602-607. 
552. LeMasters GK, Lockey JE, Yiin JH, Hilbert TJ, Levin LS, Rice CH. Mortality of workers 
occupationally exposed to refractory ceramic fibers. J Occup Environ Med 2003;45:440-450. 
553. Leonard RC, Kreckmann KH, Sakr CJ, Symons JM. Retrospective cohort mortality study of 
workers in a polymer production plant including a reference population of regional workers. 
Ann Epidemiol 2008;18:15-22. 
554. Levêque-Morlais N, Tual S, Clin B, Adjemian A, Baldi I, Lebailly P. The AGRIculture and 
CANcer (AGRICAN) cohort study: enrollment and causes of death for the 2005-2009 period. 
Int Arch Occup Environ Health 2015;88:61-73. 
555. Levin JL, McLarty JW, Hurst GA, Smith AN, Frank AL. Tyler asbestos workers: mortality 
experience in a cohort exposed to amosite. Occup Environ Med 1998;55:155-160. 
556. Levine RJ, Andjelkovich DA, Kersteter SL, Arp EW, Jr., Balogh SA, Blunden PB, Stanley 
JM. Heart disease in workers exposed to dinitrotoluene. J Occup Med 1986;28:811-816. 
557. Levine RJ, Andjelkovich DA, Shaw LK. The mortality of Ontario undertakers and a review 
of formaldehyde-related mortality studies. J Occup Med 1984;26:740-746. 
558. Lewis R. Vinyl chloride and polyvinyl chloride. Occup Med 1999;14:719-741. 
559. Lewné M, Plato N, Gustavsson P. Exposure to particles, elemental carbon and nitrogen dioxide 
in workers exposed to motor exhaust. Ann Occup Hyg 2007;51:693-701. 
560. Li H, Fagerberg B, Sällsten G, Borné Y, Hedblad B, Engström G, Barregård L, Andersson 
EM. Smoking-induced risk of future cardiovascular disease is partly mediated by cadmium in 
tobacco: Malmö Diet and Cancer Cohort Study. Environ Health 2019;18:56, 10 pp. 
561. Li Y, Fletcher T, Mucs D, Scott K, Lindh CH, Tallving P, Jakobsson K. Half-lives of PFOS, 
PFHxS and PFOA after end of exposure to contaminated drinking water. Occup Environ Med 
2018;75:46-51. 
 214 
 
562. Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, Shvedova A, Luster MI, 
Simeonova PP. Cardiovascular effects of pulmonary exposure to single-wall carbon 
nanotubes. Environ Health Perspect 2007;115:377-382. 
563. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-
1143. 
564. Liddell FD, McDonald JC. Radiological findings as predictors of mortality in Quebec asbestos 
workers. Br J Ind Med 1980;37:257-267. 
565. Lind PM, Orberg J, Edlund UB, Sjöblom L, Lind L. The dioxin-like pollutant PCB 126 
(3,3',4,4',5-pentachlorobiphenyl) affects risk factors for cardiovascular disease in female rats. 
Toxicol Lett 2004;150:293-299. 
566. Lind PM, Salihovic S, Stubleski J, Kärrman A, Lind L. Changes in plasma levels of 
perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness 
over 10 years - a longitudinal study. Environ Health 2018;17:59, 7 pp. 
567. Lindell B. The Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals. 146. Polychlorinated biphenyls (PCBs). Arbete och Hälsa 2012;46(1), 177 pp. 
Gothenburg, Sweden: University of Gothenburg, 2012. 
568. Lison D. Human toxicity of cobalt-containing dust and experimental studies on the mechanism 
of interstitial lung disease (hard metal disease). Crit Rev Toxicol 1996;26:585-616. 
569. Liss GM, Finkelstein MM. Mortality among workers exposed to carbon disulfide. Arch 
Environ Health 1996;51:193-200. 
570. Liu Y, Rong Y, Steenland K, Christiani DC, Huang X, Wu T, Chen W. Long-term exposure 
to crystalline silica and risk of heart disease mortality. Epidemiology 2014;25:689-696. 
571. Liu Y, Zhou Y, Hnizdo E, Shi T, Steenland K, He X, Chen W. Total and cause-specific 
mortality risk associated with low-level exposure to crystalline silica: a 44-year cohort study 
from China. Am J Epidemiol 2017;186:481-490. 
572. Lloyd JW. Long-term mortality study of steelworkers. V. Respiratory cancer in coke plant 
workers. J Occup Med 1971;13:53-68. 
573. Loddé B, Lucas D, Letort JM, Jegaden D, Pougnet R, Dewitte JD. Acute phosphine poisoning 
on board a bulk carrier: analysis of factors leading to a fatal case. J Occup Med Toxicol 
2015;10:10, 7 pp. 
574. Loke J, Farmer WC, Matthay RA, Virgulto JA, Bouhuys A. Carboxyhemoglobin levels in fire 
fighters. Lung 1976;154:35-39. 
575. Loomis D, Browning SR, Schenck AP, Gregory E, Savitz DA. Cancer mortality among 
electric utility workers exposed to polychlorinated biphenyls. Occup Environ Med 1997;54: 
720-728. 
576. Loomis D, Dement JM, Wolf SH, Richardson DB. Lung cancer mortality and fibre exposures 
among North Carolina asbestos textile workers. Occup Environ Med 2009;66:535-542. 
577. Lostao L, Regidor E, Aïach P, Domínguez V. Social inequalities in ischaemic heart and 
cerebrovascular disease mortality in men: Spain and France, 1980-1982 and 1988-1990. Soc 
Sci Med 2001;52:1879-1887. 
578. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, 
Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, 
Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, 
Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, 
Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, 
Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, 
Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, 
Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, 
Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, 
Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, 
Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller 
R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, 
 215 
 
Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, 
Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre 
MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, 
McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller 
M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi 
L, Narayan KM, Nasseri K, Norman P, O'Donnell M, Omer SB, Ortblad K, Osborne R, 
Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, 
Pierce K, Pope CA, 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, 
Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon 
JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton 
J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, 
Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang 
W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, 
Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA. Global and 
regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic 
analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128. 
579. Luberto F, Amendola P, Belli S, Bruno C, Candela S, Grignoli M, Comba P. [Mortality study 
of asbestos cement workers in Emilia-Romagna]. Epidemiol Prev 2004;28:239-246 (in 
Italian). 
580. Luippold RS, Mundt KA, Austin RP, Liebig E, Panko J, Crump C, Crump K, Proctor D. Lung 
cancer mortality among chromate production workers. Occup Environ Med 2003;60:451-457. 
581. Luippold RS, Mundt KA, Dell LD, Birk T. Low-level hexavalent chromium exposure and rate 
of mortality among US chromate production employees. J Occup Environ Med 2005;47:381-
385. 
582. Lund RP, Häggendal J, Johnsson G. Withdrawal symptoms in workers exposed to nitro-
glycerine. Br J Ind Med 1968;25:136-138. 
583. Lundberg I, Gustavsson A, Holmberg B, Molina G, Westerholm P. Mortality and cancer 
incidence among PVC-processing workers in Sweden. Am J Ind Med 1993;23:313-319. 
584. Lundberg P, ed. Swedish Criteria Group for Occupational Standards. Consensus report for 
nitroglycol and nitroglycerin. In: Scientific basis for Swedish occupational standards VI. 
Arbete och Hälsa 1985:32. Pp. 48-57. Solna, Sweden: National Board of Occupational Safety 
and Health, 1985. 
585. Lundbäck M, Mills NL, Lucking A, Barath S, Donaldson K, Newby DE, Sandström T, 
Blomberg A. Experimental exposure to diesel exhaust increases arterial stiffness in man. Part 
Fibre Toxicol 2009;6:7, 6 pp. 
586. Lundin JI, Alexander BH, Olsen GW, Church TR. Ammonium perfluorooctanoate production 
and occupational mortality. Epidemiology 2009;20:921-928. 
587. Lundström NG, Nordberg G, Englyst V, Gerhardsson L, Hagmar L, Jin T, Rylander L, Wall 
S. Cumulative lead exposure in relation to mortality and lung cancer morbidity in a cohort of 
primary smelter workers. Scand J Work Environ Health 1997;23:24-30. 
588. Luo JC, Shih TS, Chang CP, Huang CC. Blood oxidative stress in Taiwan workers exposed 
to carbon disulfide. Am J Ind Med 2011;54:637-645. 
589. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002;162:2443-
2449. 
590. Luster MI, Simeonova PP. Asbestos induces inflammatory cytokines in the lung through redox 
sensitive transcription factors. Toxicol Lett 1998;102-103:271-275. 
591. Lynch D. NTP technical report on the toxicity studies of N,N-Dimethylformamide (CAS No. 
68-12-2) administered by inhalation to F344/N rats and B6C3F1 mice. Toxic Rep Ser 1992; 
22:1-D20, 87 pp. 
592. Ma F, Fleming LE, Lee DJ, Trapido E, Gerace TA, Lai H, Lai S. Mortality in Florida 
professional firefighters, 1972 to 1999. Am J Ind Med 2005;47:509-517. 
 216 
 
593. Macaluso M, Larson R, Delzell E, Sathiakumar N, Hovinga M, Julian J, Muir D, Cole P. 
Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the 
synthetic rubber industry. Toxicology 1996;113:190-202. 
594. MacDonald G, Piggot AP, Gilder FW. Two cases of acute silicosis, with a suggested theory 
of causation. Lancet 1930;216:846-848  
595. Maclaren WM, Hurley JF. Mortality of tar distillation workers. Scand J Work Environ Health 
1987;13:404-411. 
596. MacMahon B, Monson RR. Mortality in the US rayon industry. J Occup Med 1988;30:698-
705. 
597. Madsen AM, Thilsing T, Bælum J, Garde AH, Vogel U. Occupational exposure levels of 
bioaerosol components are associated with serum levels of the acute phase protein serum 
amyloid A in greenhouse workers. Environ Health 2016;15:9, 9 pp. 
598. Mallin K, McCann K, D'Aloisio A, Freels S, Piorkowski J, Dimos J, Persky V. Cohort 
mortality study of capacitor manufacturing workers, 1944-2000. J Occup Environ Med 2004; 
46:565-576. 
599. Malmberg P. Health effects of organic dust exposure in dairy farmers. Am J Ind Med 1990;17: 
7-15. 
600. Manna P, Sinha M, Sil PC. Arsenic-induced oxidative myocardial injury: protective role of 
arjunolic acid. Arch Toxicol 2008;82:137-149. 
601. 't Mannetje A, Brennan P, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, Lissowska J, 
Fabiánová E, Cassidy A, Mates D, Bencko V, Foretova L, Janout V, Fevotte J, Fletcher T, 
Boffetta P. Welding and lung cancer in central and eastern Europe and the United Kingdom. 
Am J Epidemiol 175:706-714. 
602. Manuwald U, Velasco Garrido M, Berger J, Manz A, Baur X. Mortality study of chemical 
workers exposed to dioxins: follow-up 23 years after chemical plant closure. Occup Environ 
Med 2012;69:636-642. 
603. Marinaccio A, Scarselli A, Gorini G, Chellini E, Mastrantonio M, Uccelli R, Altavista P, 
Pirastu R, Merlo DF, Nesti M. Retrospective mortality cohort study of Italian workers 
compensated for silicosis. Occup Environ Med 2006;63:762-765. 
604. Marsh GM, Enterline PE, Stone RA, Henderson VL. Mortality among a cohort of US man-
made mineral fiber workers: 1985 follow-up. J Occup Med 1990;32:594-604. 
605. Marsh GM, Esmen NA, Buchanich JM, Youk AO. Mortality patterns among workers exposed 
to arsenic, cadmium, and other substances in a copper smelter. Am J Ind Med 2009;52:633-
644. 
606. Marsh GM, Youk AO, Stone RA, Buchanich JM, Gula MJ, Smith TJ, Quinn MM. Historical 
cohort study of US man-made vitreous fiber production workers: I. 1992 fiberglass cohort 
follow-up: initial findings. J Occup Environ Med 2001;43:741-756. 
607. Massin N, Bohadana AB, Wild P, Goutet P, Kirstetter H, Toamain JP. Airway responsiveness, 
respiratory symptoms, and exposures to soluble oil mist in mechanical workers. Occup 
Environ Med 1996;53:748-752. 
608. Mastrangelo G, Fadda E, Rylander R, Milan G, Fedeli U, Rossi di Schio M, Lange JH. Lung 
and other cancer site mortality in a cohort of Italian cotton mill workers. Occup Environ Med 
2008;65:697-700. 
609. Matanoski GM, Kanchanaraksa S, Lees PS, Tao XG, Royall R, Francis M, Lantry D. Industry-
wide study of mortality of pulp and paper mill workers. Am J Ind Med 1998;33:354-365. 
610. Matanoski GM, Tao XG. Styrene exposure and ischemic heart disease: a case-cohort study. 
Am J Epidemiol 2003;158:988-995. 
611. Mattsson K, Rignell-Hydbom A, Holmberg S, Thelin A, Jönsson BA, Lindh CH, Sehlstedt A, 
Rylander L. Levels of perfluoroalkyl substances and risk of coronary heart disease: findings 
from a population-based longitudinal study. Environ Res 2015;142:148-154. 
 217 
 
612. May DC, Blotzer MJ. A report of occupational deaths attributed to fluorocarbon-113. Arch 
Environ Health 1984;39:352-354. 
613. Mayerl C, Lukasser M, Sedivy R, Niederegger H, Seiler R, Wick G. Atherosclerosis research 
from past to present--on the track of two pathologists with opposing views, Carl von 
Rokitansky and Rudolf Virchow. Virchows Arch 2006;449:96-103. 
614. McDonald AD, Fry JS, Woolley AJ, McDonald JC. Dust exposure and mortality in an 
American factory using chrysotile, amosite, and crocidolite in mainly textile manufacture. 
Br J Ind Med 1983;40:368-374. 
615. McDonald AD, Fry JS, Woolley AJ, McDonald JC. Dust exposure and mortality in an 
American chrysotile asbestos friction products plant. Br J Ind Med 1984;41:151-157. 
616. McDonald AD, McDonald JC, Rando RJ, Hughes JM, Weill H. Cohort mortality study of 
North American industrial sand workers. I. Mortality from lung cancer, silicosis and other 
causes. Ann Occup Hyg 2001;45:193-199. 
617. McDonald JC, Gibbs GW, Liddell FD, McDonald AD. Mortality after long exposure to 
cummingtonite-grunerite. Am Rev Respir Dis 1978;118:271-277. 
618. McDonald JC, Harris J, Armstrong B. Mortality in a cohort of vermiculite miners exposed to 
fibrous amphibole in Libby, Montana. Occup Environ Med 2004;61:363-366. 
619. McDonald JC, Liddell FD, Dufresne A, McDonald AD. The 1891-1920 birth cohort of Quebec 
chrysotile miners and millers: mortality 1976-88. Br J Ind Med 1993;50:1073-1081. 
620. McDonald JC, McDonald AD, Hughes JM, Rando RJ, Weill H. Mortality from lung and 
kidney disease in a cohort of North American industrial sand workers: an update. Ann Occup 
Hyg 2005;49:367-373. 
621. McGee LC, Reed HL, Nereim TJ, Plume CA, McCausland A. Metabolic disturbances in 
workers exposed to dinitrotoluene during World War II. Gastroenterology 1947;8:293-295. 
622. McGee MB, Meyer RF, Jejurikar SG. A death resulting from trichlorotrifluoroethane 
poisoning. J Forensic Sci 1990;35:1453-1460. 
623. McKinney W, Jackson M, Sager TM, Reynolds JS, Chen BT, Afshari A, Krajnak K, Waugh 
S, Johnson C, Mercer RR, Frazer DG, Thomas TA, Castranova V. Pulmonary and 
cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing 
titanium dioxide nanoparticles. Inhal Toxicol 2012;24:447-457. 
624. McLean D, Colin D, Boffetta P, Pearce N. Mortality and cancer incidence in New Zealand 
pulp and paper mill workers. N Z Med J 2002;115:186-190. 
625. McMichael AJ. Standardized mortality ratios and the "healthy worker effect": scratching 
beneath the surface. J Occup Med 1976;18:165-168. 
626. McMichael AJ, Johnson HM. Long-term mortality profile of heavily-exposed lead smelter 
workers. J Occup Med 1982;24:375-378. 
627. McMillan GH, Pethybridge RJ. The health of welders in naval dockyards: proportional 
mortality study of welders and two control groups. J Soc Occup Med 1983;33:75-84. 
628. Mehnert WH, Staneczek W, Möhner M, Konetzke G, Müller W, Ahlendorf W, Beck B, 
Winkelmann R, Simonato L. A mortality study of a cohort of slate quarry workers in the 
German Democratic Republic. IARC Sci Publ 1990:55-64. 
629. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk 
of first-time acute myocardial infarction. Lancet 1998;351:1467-1471. 
630. Meijers JM, Swaen GM, Slangen JJ. Mortality of Dutch coal miners in relation to 
pneumoconiosis, chronic obstructive pulmonary disease, and lung function. Occup Environ 
Med 1997;54:708-713. 
631. Menegozzo M, Belli S, Bruno C, Canfora V, Costigliola A, Di Cintio P, Di Liello L, Grignoli 
M, Palumbo F, Sapio P, Comba P. [Mortality due to causes correlatable to asbestos in a cohort 
of workers in railway car construction]. Med Lav 1993;84:193-200 (in Italian). 
 218 
 
632. Menegozzo S, Comba P, Ferrante D, De Santis M, Gorini G, Izzo F, Magnani C, Pirastu R, 
Simonetti A, Tunesi S, Menegozzo M. Mortality study in an asbestos cement factory in 
Naples, Italy. Ann Ist Super Sanita 2011;47:296-304. 
633. Merchant JA, Ortmeyer C. Mortality of employees of two cotton mills in North Carolina. 
Chest 1981;79:6S-11S. 
634. Merler E, Boffetta P, Masala G, Monechi V, Bani F. A cohort study of workers compensated 
for mercury intoxication following employment in the fur hat industry. J Occup Med 1994; 
36:1260-1264. 
635. Merlo DF, Garattini S, Gelatti U, Simonati C, Covolo L, Ceppi M, Donato F. A mortality 
cohort study among workers in a graphite electrode production plant in Italy. Occup Environ 
Med 2004;61:e9, 7 pp. 
636. Merlo F, Costantini M, Reggiardo G, Ceppi M, Puntoni R. Lung cancer risk among refractory 
brick workers exposed to crystalline silica: a retrospective cohort study. Epidemiology 
1991;2:299-305. 
637. Merlo F, Doria M, Fontana L, Ceppi M, Chesi E, Santi L. Mortality from specific causes 
among silicotic subjects: a historical prospective study. IARC Sci Publ 1990:105-111. 
638. Merlo F, Fontana L, Reggiardo G, Ceppi M, Barisione G, Garrone E, Doria M. Mortality 
among silicotics in Genoa, Italy, from 1961 to 1987. Scand J Work Environ Health 1995;21 
Suppl 2:77-80. 
639. Michaels D, Zoloth SR, Stern FB. Does low-level lead exposure increase risk of death? A 
mortality study of newspaper printers. Int J Epidemiol 1991;20:978-983. 
640. Mikkelsen L, Sheykhzade M, Jensen KA, Saber AT, Jacobsen NR, Vogel U, Wallin H, Loft 
S, Møller P. Modest effect on plaque progression and vasodilatory function in atherosclerosis-
prone mice exposed to nanosized TiO2. Part Fibre Toxicol 2011;8:32, 17 pp. 
641. Milatou-Smith R, Gustavsson A, Sjögren B. Mortality among welders exposed to high and to 
low levels of hexavalent chromium and followed for more than 20 Years. Int J Occup Environ 
Health 1997;3:128-131. 
642. Milham S, Jr. Mortality in aluminum reduction plant workers. J Occup Med 1979;21:475-480. 
643. Milham S, Jr., Demers RY. Mortality among pulp and paper workers. J Occup Med 1984;26: 
844-846. 
644. Miller BA, Blair A, Reed EJ. Extended mortality follow-up among men and women in a U.S. 
furniture workers union. Am J Ind Med 1994;25:537-549. 
645. Miller BA, Blair AE, Raynor HL, Stewart PA, Zahm SH, Fraumeni JF, Jr. Cancer and other 
mortality patterns among United States furniture workers. Br J Ind Med 1989;46:508-515. 
646. Miller BG, MacCalman L. Cause-specific mortality in British coal workers and exposure to 
respirable dust and quartz. Occup Environ Med 2010;67:270-276. 
647. Miller FD, Reed DM, MacLean CJ. A prospective study of mortality and morbidity among 
carpenters in the Honolulu Heart Program Cohort. J Occup Med 1988;30:879-882. 
648. Miller MR, McLean SG, Duffin R, Lawal AO, Araujo JA, Shaw CA, Mills NL, Donaldson K, 
Newby DE, Hadoke PW. Diesel exhaust particulate increases the size and complexity of 
lesions in atherosclerotic mice. Part Fibre Toxicol 2013;10:61, 12 pp. 
649. Mills IC, Atkinson RW, Anderson HR, Maynard RL, Strachan DP. Distinguishing the 
associations between daily mortality and hospital admissions and nitrogen dioxide from 
those of particulate matter: a systematic review and meta-analysis. BMJ Open 2016;6: 
e010751, 10 pp. 
650. Mills NL, Törnqvist H, Gonzalez MC, Vink E, Robinson SD, Söderberg S, Boon NA, 
Donaldson K, Sandström T, Blomberg A, Newby DE. Ischemic and thrombotic effects of 
dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med 2007;357: 
1075-1082. 
651. Milne J, Christophers A, de Silva P. Acute mercurial pneumonitis. Br J Ind Med 1970;27:334-
338. 
 219 
 
652. Min YS, Ahn YS. The association between blood lead levels and cardiovascular diseases 
among lead-exposed male workers. Scand J Work Environ Health 2017;43:385-390. 
653. Misra UK, Bhargava SK, Nag D, Kidwai MM, Lal MM. Occupational phosphine exposure in 
Indian workers. Toxicol Lett 1988;42:257-263. 
654. Mobacke I, Lind L, Dunder L, Salihovic S, Lind PM. Circulating levels of perfluoroalkyl 
substances and left ventricular geometry of the heart in the elderly. Environ Int 2018;115:295-
300. 
655. Mocevic E, Kristiansen P, Bonde JP. Risk of ischemic heart disease following occupational 
exposure to welding fumes: a systematic review with meta-analysis. Int Arch Occup Environ 
Health 2015;88:259-272. 
656. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru 2012;20:25, 8 pp. 
657. Mohebbi I. Letter to the editor: a research report. Inhal Toxicol 2007;19:913. 
658. Molina G, Holmberg B, Elofsson S, Holmlund L, Moosing R, Westerholm P. Mortality and 
cancer rates among workers in the Swedish PVC processing industry. Environ Health Perspect 
1981;41:145-151. 
659. Monsé C, Hagemeyer O, Raulf M, Jettkant B, van Kampen V, Kendzia B, Gering V, Kappert 
G, Weiss T, Ulrich N, Marek EM, Bunger J, Brüning T, Merget R. Concentration-dependent 
systemic response after inhalation of nano-sized zinc oxide particles in human volunteers. Part 
Fibre Toxicol 2018;15:8, 11 pp. 
660. Montelius J, ed. Swedish Criteria Group for Occupational Standards. Consensus report for 
nitrogen dioxide. In: Scientific basis for Swedish occupational standards XXVIII. Arbete och 
Hälsa 2008;42(6). Pp. 67-83. Gothenburg, Sweden: University of Gothenburg, 2008. 
661. Montelius J, ed. Swedish Criteria Group for Occupational Standards. Consensus report for 
styrene. In: Scientific basis for Swedish occupational standards XXX. Arbete och Hälsa 
2010;44(5). Pp. 44-89. Gothenburg, Sweden: University of Gothenburg, 2010. 
662. Montelius, J, ed. Swedish Criteria Group for Occupational Standards. Dichloromethane 
(Methylene chloride). In: Scientific basis for Swedish occupational standards XXXIV. Arbete 
och Hälsa 2017;51(3). Pp. 95-123. Gothenburg, Sweden: University of Gothenburg, 2017. 
663. Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated 
systematic review. Curr Atheroscler Rep 2012;14:542-555. 
664. Moon KA, Oberoi S, Barchowsky A, Chen Y, Guallar E, Nachman KE, Rahman M, Sohel N, 
D'Ippoliti D, Wade TJ, James KA, Farzan SF, Karagas MR, Ahsan H, Navas-Acien A. A dose-
response meta-analysis of chronic arsenic exposure and incident cardiovascular disease. 
Int J Epidemiol 2017;46:1924-1939. 
665. Moon KA, Oberoi S, Barchowsky A, Chen Y, Guallar E, Nachman KE, Rahman M, Sohel N, 
D'Ippoliti D, Wade TJ, James KA, Farzan SF, Karagas MR, Ahsan H, Navas-Acien A. 
Corrigendum: A dose-response meta-analysis of chronic arsenic exposure and incident 
cardiovascular disease. Int J Epidemiol 2018;47:1013, 1 p. 
666. Mooyaart EAQ, Gelderman ELG, Nijsten MW, de Vos R, Hirner JM, de Lange DW, 
Leuvenink HDG, van den Bergh WM. Outcome after hydrogen sulphide intoxication. 
Resuscitation 2016;103:1-6. 
667. Mordukhovich I, Wright RO, Hu H, Amarasiriwardena C, Baccarelli A, Litonjua A, Sparrow 
D, Vokonas P, Schwartz J. Associations of toenail arsenic, cadmium, mercury, manganese, 
and lead with blood pressure in the normative aging study. Environ Health Perspect 
2012;120:98-104. 
668. Morfeld P, Noll B, Büchte SF, Derwall R, Schenk V, Bicker HJ, Lenaerts H, Schrader N, 
Dahmann D. Effect of dust exposure and nitrogen oxides on lung function parameters of 
German coalminers: a longitudinal study applying GEE regression 1974-1998. Int Arch Occup 
Environ Health 2010;83:357-371. 
669. Morgan RW, Bratsberg JA. Mortality study of fibrous glass production workers. Arch Environ 
Health 1981;36:179-183. 
 220 
 
670. Morgan RW, Kelsh MA, Zhao K, Heringer S. Mortality of aerospace workers exposed to 
trichloroethylene. Epidemiology 1998;9:424-431. 
671. Mori I. Cancer mortality among man-made graphite electrode manufacturing workers: results 
of a 38 year follow up. Occup Environ Med 2002;59:473-480. 
672. Morin Y, Tetu A, Mercier G. Cobalt cardiomyopathy: clinical aspects. Br Heart J 1971;33: 
Suppl:175-178. 
673. Moser KA, Goldblatt PO. Occupational mortality of women aged 15-59 years at death in 
England and Wales. J Epidemiol Community Health 1991;45:117-124. 
674. Moulin JJ, Clavel T, Buclez B, Laffitte-Rigaud G. A mortality study among workers in a 
French aluminium reduction plant. Int Arch Occup Environ Health 2000;73:323-330. 
675. Moulin JJ, Wild P, Haguenoer JM, Faucon D, De Gaudemaris R, Mur JM, Mereau M, Gary 
Y, Toamain JP, Birembaut Y, Blanc M, Debiolles MP, Jegaden D, Laterriere B, Leonard M, 
Marini F, Massardier C, Moulin M, Reure M, Rigal L, Robert G, Viossat M. A mortality study 
among mild steel and stainless steel welders. Br J Ind Med 1993;50:234-243. 
676. Moulin JJ, Wild P, Mur JM, Fournier-Betz M, Mercier-Gallay M. A mortality study of cobalt 
production workers: an extension of the follow-up. Am J Ind Med 1993;23:281-288. 
677. Moulin JJ, Wild P, Mur JM, Lafontaine M, Lefer M, Mercier-Gallay M, Villemot P, Whebi 
V, Coulon JP. Risk of lung, larynx, pharynx and buccal cavity cancers among carbon electrode 
manufacturing workers. Scand J Work Environ Health 1989;15:30-37. 
678. Moulin JJ, Wild P, Romazini S, Lasfargues G, Peltier A, Bozec C, Deguerry P, Pellet F, 
Perdrix A. Lung cancer risk in hard-metal workers. Am J Epidemiol 1998;148:241-248. 
679. Moyer CF, Kodavanti UP, Haseman JK, Costa DL, Nyska A. Systemic vascular disease in 
male B6C3F1 mice exposed to particulate matter by inhalation: studies conducted by the 
National Toxicology Program. Toxicol Pathol 2002;30:427-434. 
680. Mozaffarian D, Shi P, Morris JS, Spiegelman D, Grandjean P, Siscovick DS, Willett WC, 
Rimm EB. Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N Engl 
J Med 2011;364:1116-1125. 
681. Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med 2000;21:1-48. 
682. Mulero-Navarro S, Fernandez-Salguero PM. New trends in aryl hydrocarbon receptor biology. 
Front Cell Dev Biol 2016;4:45, 14 pp. 
683. Mundt KA, Dell LD, Crawford L, Gallagher AE. Quantitative estimated exposure to vinyl 
chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-
wide vinyl chloride cohort: mortality update through 2013. Occup Environ Med 2017;74:709-
716. 
684. Mur JM, Meyer-Bisch C, Pham QT, Massin N, Moulin JJ, Cavelier C, Sadoul P. Risk of lung 
cancer among iron ore miners: a proportional mortality study of 1,075 deceased miners in 
Lorraine, France. J Occup Med 1987;29:762-768. 
685. Mur JM, Moulin JJ, Meyer-Bisch C, Massin N, Coulon JP, Loulergue J. Mortality of 
aluminium reduction plant workers in France. Int J Epidemiol 1987;16:257-264. 
686. Murray J, Reid G, Kielkowski D, de Beer M. Cor pulmonale and silicosis: a necropsy based 
case-control study. Br J Ind Med 1993;50:544-548. 
687. Musk AW, de Klerk NH, Reid A, Ambrosini GL, Fritschi L, Olsen NJ, Merler E, Hobbs MS, 
Berry G. Mortality of former crocidolite (blue asbestos) miners and millers at Wittenoom. 
Occup Environ Med 2008;65:541-543. 
688. Musk AW, Monson RR, Peters JM, Peters RK. Mortality among Boston firefighters, 1915--
1975. Br J Ind Med 1978;35:104-108. 
689. Naeher LP, Brauer M, Lipsett M, Zelikoff JT, Simpson CD, Koenig JQ, Smith KR. 
Woodsmoke health effects: a review. Inhal Toxicol 2007;19:67-106. 
690. Nakagawa H, Nishijo M, Morikawa Y, Miura K, Tawara K, Kuriwaki J, Kido T, Ikawa A, 
Kobayashi E, Nogawa K. Urinary cadmium and mortality among inhabitants of a cadmium-
polluted area in Japan. Environ Res 2006;100:323-329. 
 221 
 
691. Nakanishi S, Yamane K, Ohishi W, Nakashima R, Yoneda M, Nojima H, Watanabe H, Kohno 
N. Manganese superoxide dismutase Ala16Val polymorphism is associated with the 
development of type 2 diabetes in Japanese-Americans. Diabetes Res Clin Pract 2008;81:381-
385. 
692. National Board of Occupational Safety and Health and Statistics Sweden. Arbetsmiljön 1999 
[The work environment 1999]. AM 68 SM 0001, 259 pp. Solna, Sweden: National Board of 
Occupational Safety and Health, 2000 (in Swedish with English summary). 
693. Navaratnam V, Fogarty AW, McKeever T, Thompson N, Jenkins G, Johnson SR, Dolan G, 
Kumaran M, Pointon K, Hubbard RB. Presence of a prothrombotic state in people with 
idiopathic pulmonary fibrosis: a population-based case-control study. Thorax 2014;69:207-
215. 
694. Navas-Acien A, Guallar E, Silbergeld EK, Rothenberg SJ. Lead exposure and cardiovascular 
disease--a systematic review. Environ Health Perspect 2007;115:472-482. 
695. Navas-Acien A, Schwartz BS, Rothenberg SJ, Hu H, Silbergeld EK, Guallar E. Bone lead 
levels and blood pressure endpoints: a meta-analysis. Epidemiology 2008;19:496-504. 
696. Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, 
cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 2004;109: 
3196-3201. 
697. Navas-Acien A, Silbergeld EK, Sharrett R, Calderon-Aranda E, Selvin E, Guallar E. Metals 
in urine and peripheral arterial disease. Environ Health Perspect 2005;113:164-169. 
698. Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA. An epidemiological re-appraisal 
of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens 
2002;16:123-131. 
699. Nawrot TS, Van Hecke E, Thijs L, Richart T, Kuznetsova T, Jin Y, Vangronsveld J, Roels 
HA, Staessen JA. Cadmium-related mortality and long-term secular trends in the cadmium 
body burden of an environmentally exposed population. Environ Health Perspect 2008;116: 
1620-1628. 
700. Nelson JW, Hatch EE, Webster TF. Exposure to polyfluoroalkyl chemicals and cholesterol, 
body weight, and insulin resistance in the general U.S. population. Environ Health Perspect 
2010;118:197-202. 
701. Nemmar A, Nemery B, Hoet PH, Van Rooijen N, Hoylaerts MF. Silica particles enhance 
peripheral thrombosis: key role of lung macrophage-neutrophil cross-talk. Am J Respir Crit 
Care Med 2005;171:872-879. 
702. Neophytou AM, Costello S, Brown DM, Picciotto S, Noth EM, Hammond SK, Cullen MR, 
Eisen EA. Marginal structural models in occupational epidemiology: application in a study of 
ischemic heart disease incidence and PM2.5 in the US aluminum industry. Am J Epidemiol 
2014;180:608-615. 
703. Neophytou AM, Noth EM, Liu S, Costello S, Hammond SK, Cullen MR, Eisen EA. Ischemic 
heart disease incidence in relation to fine versus total particulate matter exposure in a U.S. 
aluminum industry cohort. PLoS One 2016;11:e0156613, 13 pp. 
704. Newhouse ML. Mortality study of bleachers and dyers. Ann Occup Hyg 1978;21:293-296. 
705. Newhouse ML, Oakes D, Woolley AJ. Mortality of welders and other craftsmen at a shipyard 
in NE England. Br J Ind Med 1985;42:406-410. 
706. Ng TP. Occupational mortality in Hong Kong, 1979-1983. Int J Epidemiol 1988;17:105-110. 
707. Ng TP, Chan SL, Lee J. Mortality of a cohort of men in a silicosis register: further evidence 
of an association with lung cancer. Am J Ind Med 1990;17:163-171. 
708. Nielsen J, Bach E. Work-related eye symptoms and respiratory symptoms in female cleaners. 
Occup Med (Lond) 1999;49:291-297. 
709. Nishijo M, Morikawa Y, Nakagawa H, Tawara K, Miura K, Kido T, Ikawa A, Kobayashi E, 
Nogawa K. Causes of death and renal tubular dysfunction in residents exposed to cadmium in 
the environment. Occup Environ Med 2006;63:545-550. 
 222 
 
710. Nishiwaki Y, Takebayashi T, O'Uchi T, Nomiyama T, Uemura T, Sakurai H, Omae K. Six 
year observational cohort study of the effect of carbon disulphide on brain MRI in rayon 
manufacturing workers. Occup Environ Med 2004;61:225-232. 
711. Nordic Statistical Secretariat. Occupational mortality in the Nordic countries 1971-1980. 
Statistical reports of the Nordic countries Vol. 49. 152 pp. Copenhagen, Denmark: Nordic 
Statistical Secretariat, 1988. 
712. Nordström T, Sjöberg U, Teder A, Tormund D, Vikström B. Farliga svavelföreningar i 
sulfatmassafabriken – Var finns riskerna? [Toxic compounds of sulphur in the sulphate pulp 
plant – Where are the risks?]. 63 pp. Stockholm, Sweden: Svenska Träforskningsinstitutet, 
1988 (in Swedish). 
713. Notkola V, Pajunen A, Leino-Arjas P. Occupational mortality by cause in Finland 1971-1991 
and occupational mobility 1997:1, 146 pp. Helsinki, Finland: Statistics Finland, 1997. 
714. Notkola VJ, Husman KR. Mortality among female farmers in Finland in 1979-1985. Scand 
J Soc Med 1988;16:187-191. 
715. Notkola VJ, Husman KR, Laukkanen VJ. Mortality among male farmers in Finland during 
1979-1983. Scand J Work Environ Health 1987;13:124-128. 
716. NTP. Dichloromethane. Report on carcinogens. Pp. 148-150, 12 ed. Research Triangle Park, 
North Carolina: US Department of Health and Human Services, Public Health Service, 
National Toxicology Program, 2011. 
717. NTP. NTP monograph on health effects of low-level lead. NTP Monogr 2012:xiii, xv-148. 
718. Nurminen M, Hernberg S. Effects of intervention on the cardiovascular mortality of workers 
exposed to carbon disulphide: a 15 year follow up. Br J Ind Med 1985;42:32-35. 
719. Nurminen M, Karjalainen A. Epidemiologic estimate of the proportion of fatalities related to 
occupational factors in Finland. Scand J Work Environ Health 2001;27:161-213. 
720. O'Shea E. Male mortality differentials by socio-economic group in Ireland. Soc Sci Med 1997; 
45:803-809. 
721. Oberdörster G, Ferin J, Lehnert BE. Correlation between particle size, in vivo particle 
persistence, and lung injury. Environ Health Perspect 1994;102 Suppl 5:173-179. 
722. OECD. Portal on per and poly fluorinated chemicals. Organisation for Economic  
Co-operation and Development (OECD) http://www.oecd.org/chemicalsafety/portal-
perfluorinated-chemicals/ (accessed January 2019). Organisation for Economic Co-operation 
and Development, 2019. 
723. Ohlson CG, Hogstedt C. Lung cancer among asbestos cement workers. A Swedish cohort 
study and a review. Br J Ind Med 1985;42:397-402. 
724. Oksa P, Pukkala E, Karjalainen A, Ojajärvi A, Huuskonen MS. Cancer incidence and mortality 
among Finnish asbestos sprayers and in asbestosis and silicosis patients. Am J Ind Med 
1997;31:693-698. 
725. Oldham PD, Bevan C, Elwood PC, Hodges NG. Mortality of slate workers in north Wales. 
Br J Ind Med 1986;43:550-555. 
726. Olsen J, Sabroe S. A follow-up study of non-retired and retired members of the Danish 
Carpenter/Cabinet Makers' Trade Union. Int J Epidemiol 1979;8:375-382. 
727. Ostro B, Lipsett M, Reynolds P, Goldberg D, Hertz A, Garcia C, Henderson KD, Bernstein L. 
Long-term exposure to constituents of fine particulate air pollution and mortality: results from 
the California Teachers Study. Environ Health Perspect 2010;118:363-369. 
728. Ott MG, Skory LK, Holder BB, Bronson JM, Williams PR. Health evaluation of employees 
occupationally exposed to methylene chloride. Scand J Work Environ Health 1983;9 Suppl 
1:1-38. 
729. Ott MG, Zober A. Cause specific mortality and cancer incidence among employees exposed 
to 2,3,7,8-TCDD after a 1953 reactor accident. Occup Environ Med 1996;53:606-612. 
730. Packer M. Cobalt cardiomyopathy: a critical reappraisal in light of a recent resurgence. Circ 
Heart Fail 2016;9, 10 pp. 
 223 
 
731. Palmberg L, Larsson BM, Malmberg P, Larsson K. Airway responses of healthy farmers and 
nonfarmers to exposure in a swine confinement building. Scand J Work Environ Health 2002; 
28:256-263. 
732. Pastides H, Austin R, Lemeshow S, Klar J, Mundt KA. A retrospective-cohort study of 
occupational exposure to hexavalent chromium. Am J Ind Med 1994;25:663-675. 
733. Pedersen JE, Ugelvig Petersen K, Ebbehøj NE, Bonde JP, Hansen J. Incidence of cardio-
vascular disease in a historical cohort of Danish firefighters. Occup Environ Med 2018;75:337-
343. 
734. Pekdemir H, Camsari A, Akkus MN, Cicek D, Tuncer C, Yildirim Z. Impaired cardiac 
autonomic functions in patients with environmental asbestos exposure: a study of time domain 
heart rate variability. J Electrocardiol 2003;36:195-203. 
735. Peplonska B, Szeszenia-Dabrowska N, Sobala W, Wilczynska U. A mortality study of workers 
with reported chronic occupational carbon disulfide poisoning. Int J Occup Med Environ 
Health 1996;9:291-299. 
736. Peretz A, Sullivan JH, Leotta DF, Trenga CA, Sands FN, Allen J, Carlsten C, Wilkinson CW, 
Gill EA, Kaufman JD. Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ 
Health Perspect 2008;116:937-942. 
737. Perry GF, Jr. Occupational Medicine Forum. J Occup Environ Med 1995;37:120-123. 
738. Persson B, Magnusson A, Westberg H, Andersson E, Torén K, Wingren G, Axelson O. 
Cardiovascular mortality among Swedish pulp and paper mill workers. Am J Ind Med 2007; 
50:221-226. 
739. Pesatori AC, Consonni D, Rubagotti M, Bonzini M, Catalano P, Bertazzi PA. [Mortality study 
in a cohort of workers employed in a plant producing sulphuric acid]. Med Lav 2006;97:735-
748 (in Italian). 
740. Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA. Dioxin exposure 
and non-malignant health effects: a mortality study. Occup Environ Med 1998;55:126-131. 
741. Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association 
with history of stroke and heart failure. Environ Res 2010;110:199-206. 
742. Peters S, Reid A, Fritschi L, de Klerk N, Musk AW. Long-term effects of aluminium dust 
inhalation. Occup Environ Med 2013;70:864-868. 
743. Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared 
with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 
individuals and 42,401 strokes. Stroke 2013;44:2821-2828. 
744. Peto J, Doll R, Hermon C, Binns W, Clayton R, Goffe T. Relationship of mortality to measures 
of environmental asbestos pollution in an asbestos textile factory. Ann Occup Hyg 1985;29: 
305-355. 
745. Petriello MC, Brandon JA, Hoffman J, Wang C, Tripathi H, Abdel-Latif A, Ye X, Li X, Yang 
L, Lee E, Soman S, Barney J, Wahlang B, Hennig B, Morris AJ. Dioxin-like PCB 126 
increases systemic inflammation and accelerates atherosclerosis in lean LDL receptor-
deficient mice. Toxicol Sci 2018;162:548-558. 
746. Pfefferkorn FE, Bello D, Haddad G, Park JY, Powell M, McCarthy J, Bunker KL, 
Fehrenbacher A, Jeon Y, Virji MA, Gruetzmacher G, Hoover MD. Characterization of 
exposures to airborne nanoscale particles during friction stir welding of aluminum. Ann Occup 
Hyg 2010;54:486-503. 
747. Pham QT, Gaertner M, Mur JM, Braun P, Gabiano M, Sadoul P. Incidence of lung cancer 
among iron miners. Eur J Respir Dis 1983;64:534-540. 
748. Pinault L, Brauer M, Crouse DL, Weichenthal S, Erickson A, van Donkelaar A, Martin RV, 
Charbonneau S, Hystad P, Brook JR, Tjepkema M, Christidis T, Menard R, Robichaud A, 
Burnett RT. Diabetes status and susceptibility to the effects of PM2.5 exposure on cardio-
vascular mortality in a national Canadian cohort. Epidemiology 2018;29:784-794. 
 224 
 
749. Pinheiro GA, Antao VC, Wood JM, Wassell JT. Occupational risks for idiopathic pulmonary 
fibrosis mortality in the United States. Int J Occup Environ Health 2008;14:117-123. 
750. Pinkerton LE, Hein MJ, Stayner LT. Mortality among a cohort of garment workers exposed 
to formaldehyde: an update. Occup Environ Med 2004;61:193-200. 
751. Piolatto G, Negri E, La Vecchia C, Pira E, Decarli A, Peto J. An update of cancer mortality 
among chrysotile asbestos miners in Balangero, northern Italy. Br J Ind Med 1990;47:810-
814. 
752. Pira E, Pelucchi C, Piolatto PG, Negri E, Bilei T, La Vecchia C. Mortality from cancer and 
other causes in the Balangero cohort of chrysotile asbestos miners. Occup Environ Med 
2009;66:805-809. 
753. Plato N, Westerholm P, Gustavsson P, Hemmingsson T, Hogstedt C, Krantz S. Cancer 
incidence, mortality and exposure-response among Swedish man-made vitreous fiber 
production workers. Scand J Work Environ Health 1995;21:353-361. 
754. Polednak AP, Hollis DR. Mortality and causes of death among workers exposed to phosgene 
in 1943-45. Toxicol Ind Health 1985;1:137-151. 
755. Pomrehn PR, Wallace RB, Burmeister LF. Ischemic heart disease mortality in Iowa farmers. 
The influence of life-style. JAMA 1982;248:1073-1076. 
756. Pope CA, 3rd, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, Thun MJ. Cardiovascular 
mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the 
exposure-response relationship. Circulation 2009;120:941-948. 
757. Poulsen SS, Saber AT, Mortensen A, Szarek J, Wu D, Williams A, Andersen O, Jacobsen NR, 
Yauk CL, Wallin H, Halappanavar S, Vogel U. Changes in cholesterol homeostasis and acute 
phase response link pulmonary exposure to multi-walled carbon nanotubes to risk of 
cardiovascular disease. Toxicol Appl Pharmacol 2015;283:210-222. 
758. Prince MM, Hein MJ, Ruder AM, Waters MA, Laber PA, Whelan EA. Update: cohort 
mortality study of workers highly exposed to polychlorinated biphenyls (PCBs) during the 
manufacture of electrical capacitors, 1940-1998. Environ Health 2006;5, 13 pp. 
759. Prince MM, Ruder AM, Hein MJ, Waters MA, Whelan EA, Nilsen N, Ward EM, Schnorr TM, 
Laber PA, Davis-King KE. Mortality and exposure response among 14,458 electrical capacitor 
manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environ Health 
Perspect 2006;114:1508-1514. 
760. Przybojewski JZ, Heyns MH. Acute coronary vasospasm secondary to industrial nitroglycerin 
withdrawal. A case presentation and review. S Afr Med J 1983;63:158-165. 
761. Puledda S, Marconi A. Study of the count-to-mass conversion factor for asbestos fibres in 
samples collected at the emissions of three industrial plants. Ann Occup Hyg 1991;35:517-
524. 
762. Puntoni R, Goldsmith DF, Valerio F, Vercelli M, Bonassi S, Di Giorgio F, Ceppi M, Stagnaro 
E, Filiberti R, Santi L, Merlo F. A cohort study of workers employed in a refractory brick 
plant. Tumori 1988;74:27-33. 
763. Puntoni R, Merlo F, Borsa L, Reggiardo G, Garrone E, Ceppi M. A historical cohort mortality 
study among shipyard workers in Genoa, Italy. Am J Ind Med 2001;40:363-370. 
764. Radican L, Blair A, Stewart P, Wartenberg D. Mortality of aircraft maintenance workers 
exposed to trichloroethylene and other hydrocarbons and chemicals: extended follow-up. 
J Occup Environ Med 2008;50:1306-1319. 
765. Raffaelli I, Festa G, Costantini AS, Leva G, Gorini G. [Mortality in a cohort of asbestos cement 
workers in Carrara, Italy]. Med Lav 2007;98:156-163 (in Italian). 
766. Raffle PAB, Lee WR, McCallum RI, Murray R, eds. Hunter's diseases of occupations. 1005 
pp., 6th ed. London, United Kingdom: Hodder and Stoughton, 1978. 
767. Raffn E, Lynge E, Juel K, Korsgaard B. Incidence of cancer and mortality among employees 
in the asbestos cement industry in Denmark. Br J Ind Med 1989;46:90-96. 
 225 
 
768. Raffn E, Mikkelsen S, Altman DG, Christensen JM, Groth S. Health effects due to 
occupational exposure to cobalt blue dye among plate painters in a porcelain factory in 
Denmark. Scand J Work Environ Health 1988;14:378-384. 
769. Rafnsson V, Gunnarsdottir H. Mortality among farmers in Iceland. Int J Epidemiol 1989;18: 
146-151. 
770. Rafnsson V, Kristbjornsdottir A. Increased cardiovascular mortality and suicide after methyl 
chloride exposure. Am J Ind Med 2014;57:108-113. 
771. Rannug A, Rannug U. The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a 
dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth 
and differentiation. Crit Rev Toxicol 2018;48:555-574. 
772. Rannug A, Rannug U, Rosenkranz HS, Winqvist L, Westerholm R, Agurell E, Grafström AK. 
Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor 
and are likely to be endogenous signal substances. J Biol Chem 1987;262:15422-15427. 
773. Rappold AG, Stone SL, Cascio WE, Neas LM, Kilaru VJ, Carraway MS, Szykman JJ, Ising 
A, Cleve WE, Meredith JT, Vaughan-Batten H, Deyneka L, Devlin RB. Peat bog wildfire 
smoke exposure in rural North Carolina is associated with cardiopulmonary emergency 
department visits assessed through syndromic surveillance. Environ Health Perspect 2011; 
119:1415-1420. 
774. Rask-Andersen A. Pulmonary reactions to inhalation of mould dust in farmers with special 
reference to fever and allergic alveolitis, 74 pp. Uppsala, Sweden: Uppsala university, 1988 
(thesis). 
775. Ravnskov U, de Lorgeril M, Diamond DM, Hama R, Hamazaki T, Hammarskjöld B, Hynes 
N, Kendrick M, Langsjoen PH, Mascitelli L, McCully KS, Okuyama H, Rosch PJ, Schersten 
T, Sultan S, Sundberg R. LDL-C does not cause cardiovascular disease: a comprehensive 
review of the current literature. Expert Rev Clin Pharmacol 2018;11:959-970. 
776. Reid PJ, Sluis-Cremer GK. Mortality of white South African gold miners. Occup Environ Med 
1996;53:11-16. 
777. Reviere R, Schneider S, Woolbright K. Associations between disease and occupation: hypo-
theses generated from the National Mortality Followback Survey. Am J Ind Med 1995;27:195-
205. 
778. Ridker PM. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. 
Blood Coagul Fibrinolysis 1999;10 Suppl 1:S9-12. 
779. Rissanen T, Voutilainen S, Nyyssönen K, Lakka TA, Salonen JT. Fish oil-derived fatty acids, 
docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the 
Kuopio ischaemic heart disease risk factor study. Circulation 2000;102:2677-2679. 
780. Robbins SL. Pathology, 3rd ed. Philadelphia, Pennsylvania, United States: W.B. Saunders 
Company, 1967. 
781. Robertson S, Miller MR. Ambient air pollution and thrombosis. Part Fibre Toxicol 2018;15:1, 
16 pp. 
782. Robins T, Seixas N, Franzblau A, Abrams L, Minick S, Burge H, Schork MA. Acute 
respiratory effects on workers exposed to metalworking fluid aerosols in an automotive 
transmission plant. Am J Ind Med 1997;31:510-524. 
783. Robinson C, Fowler D, Brown DP, Lemen RA. Plywood mill workers' mortality patterns 
1945-1977. NTIS Publication PB90-147075. 34 pp. Cincinnati, Ohio, United States: National 
Institute for Occupational Safety and Health, 1986. 
784. Robinson C, Stern F, Halperin W, Venable H, Petersen M, Frazier T, Burnett C, Lalich N, 
Salg J, Sestito J, Fingerhut M. Assessment of mortality in the construction industry in the 
United States, 1984-1986. Am J Ind Med 1995;28:49-70. 
785. Robinson CF, Dement JM, Ness GO, Waxweiler RJ. Mortality patterns of rock and slag 
mineral wool production workers: an epidemiological and environmental study. Br J Ind Med 
1982;39:45-53. 
 226 
 
786. Robinson CF, Walker JT, Sweeney MH, Shen R, Calvert GM, Schumacher PK, Ju J, Nowlin 
S. Overview of the National Occupational Mortality Surveillance (NOMS) system: leukemia 
and acute myocardial infarction risk by industry and occupation in 30 US states 1985-1999, 
2003-2004, and 2007. Am J Ind Med 2015;58:123-137. 
787. Robinson CF, Waxweiler RJ, Fowler DP. Mortality among production workers in pulp and 
paper mills. Scand J Work Environ Health 1986;12:552-560. 
788. Rockette HE. Cause specific mortality of coal miners. J Occup Med 1977;19:795-801. 
789. Rockette HE, Arena VC. Mortality studies of aluminum reduction plant workers: potroom and 
carbon department. J Occup Med 1983;25:549-557. 
790. Rodier J. Manganese poisoning in Moroccan miners. Br J Ind Med 1955;12:21-35. 
791. Roels H, Lauwerys R, Buchet JP, Genet P, Sarhan MJ, Hanotiau I, de Fays M, Bernard A, 
Stanescu D. Epidemiological survey among workers exposed to manganese: effects on lung, 
central nervous system, and some biological indices. Am J Ind Med 1987;11:307-327. 
792. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic inflammatory diseases 
and cardiovascular risk: a systematic review. Can J Cardiol 2011;27:174-182. 
793. Roman HA, Walsh TL, Coull BA, Dewailly E, Guallar E, Hattis D, Marien K, Schwartz J, 
Stern AH, Virtanen JK, Rice G. Evaluation of the cardiovascular effects of methylmercury 
exposures: current evidence supports development of a dose-response function for regulatory 
benefits analysis. Environ Health Perspect 2011;119:607-614. 
794. Romundstad P, Andersen A, Haldorsen T. Nonmalignant mortality among workers in six 
Norwegian aluminum plants. Scand J Work Environ Health 2000;26:470-475. 
795. Rong Y, Luo X, Zhang Z, Cui X, Liu Y, Chen W. Occupational exposure to asbestos and 
cardiovascular related diseases: a meta-analysis. Prev Med Rep 2015;2:920-926. 
796. Roscoe RJ, Steenland K, McCammon CS, Jr., Schober SE, Robinson CF, Halperin WE, 
Fingerhut MA. Colon and stomach cancer mortality among automotive wood model makers. 
J Occup Med 1992;34:759-768; discussion 769-770. 
797. Rosengren A, Wedel H, Wilhelmsen L. Coronary heart disease and mortality in middle aged 
men from different occupational classes in Sweden. BMJ 1988;297:1497-1500. 
798. Rosenlund M, Berglind N, Gustavsson A, Reuterwall C, Hallqvist J, Nyberg F, Pershagen G, 
SHEEP Study Group. Environmental tobacco smoke and myocardial infarction among never-
smokers in the Stockholm Heart Epidemiology Program (SHEEP). Epidemiology 2001;12: 
558-564. 
799. Rosenman KD, Stanbury M. Risk of lung cancer among former chromium smelter workers. 
Am J Ind Med 1996;29:491-500. 
800. Rosenman KD, Stanbury MJ, Reilly MJ. Mortality among persons with silicosis reported to 
disease surveillance systems in Michigan and New Jersey in the United States. Scand J Work 
Environ Health 1995;21 Suppl 2:73-76. 
801. Ross DS. Welders' metal fume fever. Occup Med 1974;24:125-129. 
802. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362: 
801-809. 
803. Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999;340:115-126. 
804. Rothman KJ, Greeenland S, eds. Modern epidemiology, 2nd ed. Philadelphia, Pennsylvania, 
United States: Lippincott-Raven, 1998. 
805. Routledge HC, Manney S, Harrison RM, Ayres JG, Townend JN. Effect of inhaled sulphur 
dioxide and carbon particles on heart rate variability and markers of inflammation and 
coagulation in human subjects. Heart 2006;92:220-227. 
806. Rubino GF, Piolatto G, Newhouse ML, Scansetti G, Aresini GA, Murray R. Mortality of 
chrysotile asbestos workers at the Balangero Mine, Northern Italy. Br J Ind Med 1979;36:187-
194. 
 227 
 
807. Rubino GF, Scansetti G, Piolatto G, Romano CA. Mortality study of talc miners and millers. 
J Occup Med 1976;18:187-193. 
808. Ruder AM, Hein MJ, Nilsen N, Waters MA, Laber P, Davis-King K, Prince MM, Whelan E. 
Mortality among workers exposed to polychlorinated biphenyls (PCBs) in an electrical 
capacitor manufacturing plant in Indiana: an update. Environ Health Perspect 2006;114:18-
23. 
809. Ruder AM, Meyers AR, Bertke SJ. Mortality among styrene-exposed workers in the 
reinforced plastic boatbuilding industry. Occup Environ Med 2016;73:97-102. 
810. Ruder AM, Ward EM, Brown DP. Mortality in dry-cleaning workers: an update. Am J Ind 
Med 2001;39:121-132. 
811. Ruder AM, Ward EM, Dong M, Okun AH, Davis-King K. Mortality patterns among workers 
exposed to styrene in the reinforced plastic boatbuilding industry: an update. Am J Ind Med 
2004;45:165-176. 
812. Rusch GM. The development of environmentally acceptable fluorocarbons. Crit Rev Toxicol 
2018;48:615-665. 
813. Rønneberg A. Mortality and cancer morbidity in workers from an aluminium smelter with 
prebaked carbon anodes--Part III: Mortality from circulatory and respiratory diseases. Occup 
Environ Med 1995;52:255-261. 
814. Saber AT, Jacobsen NR, Jackson P, Poulsen SS, Kyjovska ZO, Halappanavar S, Yauk CL, 
Wallin H, Vogel U. Particle-induced pulmonary acute phase response may be the causal link 
between particle inhalation and cardiovascular disease. Wiley Interdiscip Rev Nanomed 
Nanobiotechnol 2014;6:517-531. 
815. Saber AT, Lamson JS, Jacobsen NR, Ravn-Haren G, Hougaard KS, Nyendi AN, Wahlberg P, 
Madsen AM, Jackson P, Wallin H, Vogel U. Particle-induced pulmonary acute phase response 
correlates with neutrophil influx linking inhaled particles and cardiovascular risk. PLoS One 
2013;8:e69020, 10 pp. 
816. Sabik LM, Abbas RA, Ismail MM, El-Refaei S. Cardiotoxicity of Freon among refrigeration 
services workers: comparative cross-sectional study. Environ Health 2009;8:31, 11 pp. 
817. Saftlas AF, Blair A, Cantor KP, Hanrahan L, Anderson HA. Cancer and other causes of death 
among Wisconsin farmers. Am J Ind Med 1987;11:119-129. 
818. Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. Cross-sectional 
study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium 
perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally 
exposed workers. J Occup Environ Med 2007;49:1086-1096. 
819. Sakr CJ, Leonard RC, Kreckmann KH, Slade MD, Cullen MR. Longitudinal study of serum 
lipids and liver enzymes in workers with occupational exposure to ammonium perfluoro-
octanoate. J Occup Environ Med 2007;49:872-879. Erratum in: J Occup Environ Med 2007; 
49:1294. 
820. Sakr CJ, Symons JM, Kreckmann KH, Leonard RC. Ischaemic heart disease mortality study 
among workers with occupational exposure to ammonium perfluorooctanoate. Occup Environ 
Med 2009;66:699-703. 
821. Sala-Serra M, Sunyer J, Kogevinas M, McFarlane D, Antó JM. Cohort study on cancer 
mortality among workers in the pulp and paper industry in Catalonia, Spain. Am J Ind Med 
1996;30:87-92. 
822. Sali D, Boffetta P, Andersen A, Cherrie JW, Claude JC, Hansen J, Olsen JH, Pesatori AC, 
Plato N, Teppo L, Westerholm P, Winter P, Saracci R. Non-neoplastic mortality of European 
workers who produce man made vitreous fibres. Occup Environ Med 1999;56:612-617. 
823. Salonen JT, Seppänen K, Lakka TA, Salonen R, Kaplan GA. Mercury accumulation and 
accelerated progression of carotid atherosclerosis: a population-based prospective 4-year 
follow-up study in men in eastern Finland. Atherosclerosis 2000;148:265-273. 
 228 
 
824. Salonen JT, Seppänen K, Nyyssönen K, Korpela H, Kauhanen J, Kantola M, Tuomilehto J, 
Esterbauer H, Tatzber F, Salonen R. Intake of mercury from fish, lipid peroxidation, and the 
risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish 
men. Circulation 1995;91:645-655. 
825. Sandén A, Järvholm B, Larsson S. The importance of lung function, non-malignant diseases 
associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard 
workers exposed to asbestos. Br J Ind Med 1993;50:785-790. 
826. Sandstead HH. Zinc. In: Nordberg GF, Fowler BA, Nordberg M, eds. Handbook on the 
toxicology of metals. Pp. 1369-1385, 4th ed. London, United Kingdom: Elsevier B.V., 2015. 
827. Saraf A, Larsson L, Larsson BM, Larsson K, Palmberg L. House dust induces IL-6 and IL-8 
response in A549 epithelial cells. Indoor Air 1999;9:219-225. 
828. Sardinas A, Miller JW, Hansen H. Ischemic heart disease mortality of firemen and policemen. 
Am J Public Health 1986;76:1140-1141. 
829. Saric M, Hrustic O. Exposure to airborne manganese and arterial blood pressure. Environ Res 
1975;10:314-318. 
830. Sathiakumar N, Delzell E. A follow-up study of mortality among women in the North 
American synthetic rubber industry. J Occup Environ Med 2009;51:1314-1325. 
831. Satoh K, Fukuda Y, Torii K, Katsuno N. Epidemiological study of workers engaged in the 
manufacture of chromium compounds. J Occup Med 1981;23:835-838. 
832. Sawyer RT, Maier LA. Chronic beryllium disease: an updated model interaction between 
innate and acquired immunity. Biometals 2011;24:1-17. 
833. SBU. Utvärdering av metoder i hälso- och sjukvården. En handbok. 187 pp., 2nd ed. 
Stockholm, Sweden: Statens beredning för medicinsk och social utvärdering (Swedish Agency 
for Health Technology Assessment and Assessment of Social Services), 2014 (in Swedish). 
834. SBU. Arbetsmiljöns betydelse för hjärt-kärlsjukdom. En systematisk litteraturöversikt 
[Occupational exposures and cardiovascular disease]. SBU-rapport Nr 240, 225 pp. 
Stockholm, Sweden: Statens beredning för medicinsk och social utvärdering (Swedish Agency 
for Health Technology Assessment and Assessment of Social Services), 2015 (in Swedish). 
835. SBU. Arbetsmiljöns betydelse för hjärt-kärlsjukdom. Exponering för kemiska ämnen: en 
systematisk översikt och utvärdering av medicinska, sociala och etiska aspekter. 
[Occupational exposures and cardiovascular disease. Chemical exposures]. SBU-rapport Nr 
261, 218 pp. Stockholm, Sweden: Statens beredning för medicinsk och social utvärdering 
(Swedish Agency for Health Technology Assessment and Assessment of Social Services), 
2017 (in Swedish). 
836. Scarselli A, Binazzi A, Forastiere F, Cavariani F, Marinaccio A. Industry and job-specific 
mortality after occupational exposure to silica dust. Occup Med (Lond) 2011;61:422-429. 
837. Schilling R, Goodman N. Cardiovascular disease in cotton workers: part I. Br J Ind Med 1951; 
8:77-90. 
838. Schilling RS, Goodman N, O'Sullivan JG. Cardiovascular disease in cotton workers. II. A 
clinical study with special reference to hypertension. Br J Ind Med 1952;9:146-166. 
839. Schilling RS, Hughes JP, Dingwall-Fordyce I, Gilson JC. An epidemiological study of 
byssinosis among Lancashire cotton workers. Br J Ind Med 1955;12:217-227. 
840. Schnepp R. Cyanide: sources, perceptions, and risks. J Emerg Nurs 2006;32:S3-7. 
841. Schober SE, Mirel LB, Graubard BI, Brody DJ, Flegal KM. Blood lead levels and death from 
all causes, cardiovascular disease, and cancer: results from the NHANES III mortality study. 
Environ Health Perspect 2006;114:1538-1541. 
842. Schubauer-Berigan MK, Couch JR, Petersen MR, Carreon T, Jin Y, Deddens JA. Cohort 
mortality study of workers at seven beryllium processing plants: update and associations with 
cumulative and maximum exposure. Occup Environ Med 2011;68:345-353. 
843. Schubauer-Berigan MK, Dahm MM, Erdely A, Beard JD, Eileen Birch M, Evans DE, 
Fernback JE, Mercer RR, Bertke SJ, Eye T, de Perio MA. Association of pulmonary, 
 229 
 
cardiovascular, and hematologic metrics with carbon nanotube and nanofiber exposure among 
U.S. workers: a cross-sectional study. Part Fibre Toxicol 2018;15:22, 14 pp. 
844. SCOEL. Recommendation from the Scientific Committee on Occupational Exposure Limits 
for lead and its inorganic compounds. SCOEL/SUM/83. 26 pp. Scientific Committee on 
Occupational Exposure Limits. Luxembourg, Luxembourg: European Commission, 
Employment, Social Affairs and Inclusion, 2002. 
845. SCOEL. Recommendation from the Scientific Committee on Occupational Exposure Limits 
for silica, crystalline (respirable dust). SCOEL/SUM/94. 4 pp. Scientific Committee on 
Occupational Exposure Limits. Luxembourg, Luxembourg: European Commission, 
Employment, Social Affairs and Inclusion, 2003. 
846. SCOEL. Recommendation from the Scientific Committee on Occupational Exposure Limits 
for trichloroethylene. SCOEL/SUM/142. 53 pp. Luxembourg, Luxembourg: European 
Commission, Employment, Social Affairs and Inclusion, 2009. 
847. SCOEL. Opinion from the Scientific Committee on Occupational Exposure Limits for 
cadmium and its inorganic compounds. SCOEL/OPIN/336. 52 pp. Scientific Committee on 
Occupational Exposure Limits. Luxembourg, Luxembourg: European Commission, 
Employment, Social Affairs and Inclusion, 2017. 
848. SCOEL. Recommendation from the Scientific Committee on Occupational Exposure Limits 
for beryllium and inorganic beryllium compounds. SCOEL/REC/175. 53 pp. Scientific 
Committee on Occupational Exposure Limits. Luxembourg, Luxembourg: European 
Commission, Employment, Social Affairs and Inclusion, 2017. 
849. SCOEL. Recommendation from the Scientific Committee on Occupational Exposure Limits 
for formaldehyde. SCOEL/SUM/125. 21 pp. Luxembourg, Luxembourg: European 
Commission, Employment, Social Affairs and Inclusion, 2016. 
850. Seaton A, MacNee W, Donaldson K, Godden D. Particulate air pollution and acute health 
effects. Lancet 1995;345:176-178. 
851. SEG. Recommendation from the Scientific Expert Group on Occupational Exposure Limits for 
carbon monoxide. SEG/SUM/57. 13 pp. Luxembourg, Luxembourg: Scientific Expert Group 
on Occupational Exposure Limits, 1995. 
852. Seghizzi P, D'Adda F, Borleri D, Barbic F, Mosconi G. Cobalt myocardiopathy. A critical 
review of literature. Sci Total Environ 1994;150:105-109. 
853. Seidman H, Selikoff IJ, Gelb SK. Mortality experience of amosite asbestos factory workers: 
dose-response relationships 5 to 40 years after onset of short-term work exposure. Am J Ind 
Med 1986;10:479-514. 
854. Selman M, Pardo A, King TE, Jr. Hypersensitivity pneumonitis: insights in diagnosis and 
pathobiology. Am J Respir Crit Care Med 2012;186:314-324. 
855. Semenciw RM, Morrison HI, Riedel D, Wilkins K, Ritter L, Mao Y. Multiple myeloma 
mortality and agricultural practices in the Prairie provinces of Canada. J Occup Med 1993;35: 
557-561. 
856. Shankar A, Xiao J, Ducatman A. Perfluorooctanoic acid and cardiovascular disease in US 
adults. Arch Intern Med 2012;172:1397-1403. 
857. Shannahan JH, Schladweiler MC, Thomas RF, Ward WO, Ghio AJ, Gavett SH, Kodavanti 
UP. Vascular and thrombogenic effects of pulmonary exposure to Libby amphibole. J Toxicol 
Environ Health A 2012;75:213-231. 
858. Shannon H, Muir A, Haines T, Verma D. Mortality and cancer incidence in Ontario glass fiber 
workers. Occup Med (Lond) 2005;55:528-534. 
859. Shannon HS, Jamieson E, Julian JA, Muir DC. Mortality of glass filament (textile) workers. 
Br J Ind Med 1990;47:533-536. 
860. Shannon HS, Jamieson E, Julian JA, Muir DC, Walsh C. Mortality experience of Ontario glass 
fibre workers--extended follow-up. Ann Occup Hyg 1987;31:657-662. 
 230 
 
861. Shao Q, Liu T, Korantzopoulos P, Zhang Z, Zhao J, Li G. Association between air pollution 
and development of atrial fibrillation: a meta-analysis of observational studies. Heart Lung 
2016;45:557-562. 
862. Shaposhnikov D, Revich B, Bellander T, Bedada GB, Bottai M, Kharkova T, Kvasha E, 
Lezina E, Lind T, Semutnikova E, Pershagen G. Mortality related to air pollution with the 
moscow heat wave and wildfire of 2010. Epidemiology 2014;25:359-364. 
863. Sheps DS, Adams KF, Jr., Bromberg PA, Goldstein GM, O'Neil JJ, Horstman D, Koch G. 
Lack of effect of low levels of carboxyhemoglobin on cardiovascular function in patients with 
ischemic heart disease. Arch Environ Health 1987;42:108-116. 
864. Sheps DS, Herbst MC, Hinderliter AL, Adams KF, Ekelund LG, O'Neil JJ, Goldstein GM, 
Bromberg PA, Dalton JL, Ballenger MN, Davis SM, Koch GG. Production of arrhythmias by 
elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med 
1990;113:343-351. 
865. Sichletidis L, Chloros D, Spyratos D, Haidich AB, Fourkiotou I, Kakoura M, Patakas D. 
Mortality from occupational exposure to relatively pure chrysotile: a 39-year study. 
Respiration 2009;78:63-68. 
866. Siew SS, Kauppinen T, Kyyrönen P, Heikkilä P, Pukkala E. Exposure to iron and welding 
fumes and the risk of lung cancer. Scand J Work Environ Health 2008;34:444-450. 
867. Sim MR, Del Monaco A, Hoving JL, MacFarlane E, McKenzie D, Benke G, de Klerk N, 
Fritschi L. Mortality and cancer incidence in workers in two Australian prebake aluminium 
smelters. Occup Environ Med 2009;66:464-470. 
868. Simonato L, Fletcher AC, Andersen A, Anderson K, Becker N, Chang-Claude J, Ferro G, 
Gérin M, Gray CN, Hansen KS, Kalliomäki P-L, Kurppa K, Långard S, Merló F, Moulin JJ, 
Newhouse ML, Peto J, Pukkala E, Sjögren B, Wild P, Winkelmann R, Saracci R. A historical 
prospective study of European stainless steel, mild steel, and shipyard welders. Br J Ind Med 
1991;48:145-154. 
869. Simonato L, Fletcher AC, Cherrie J, Andersen A, Bertazzi PA, Charnay N, Claude J, Dodgson 
J, Esteve J, Frentzel-Beyme R, Gardner MJ, Jensen OM, Saracci R, Teppo L, Winkelmann R, 
Westerholm P, Winter PD, Zocchetti C. The man-made mineral fiber European historical 
cohort study. Extension of the follow-up. Scand J Work Environ Health 1986;12 Suppl 1:34-
47. 
870. Simonato L, Fletcher AC, Cherrie JW, Andersen A, Bertazzi P, Charnay N, Claude J, Dodgson 
J, Esteve J, Frentzel-Beyme R, Gardner MJ, Jensen OM, Olsen J, Teppo L, Winkelmann R, 
Westerholm P, Winter PD, Zocchetti C, Saracci R. The International Agency for Research on 
Cancer historical cohort study of MMMF production workers in seven European countries: 
extension of the follow-up. Ann Occup Hyg 1987;31:603-623. 
871. Simpson C, Winquist A, Lally C, Steenland K. Relation between perfluorooctanoic acid 
exposure and strokes in a large cohort living near a chemical plant. Environ Res 2013;127:22-
28. 
872. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular 
mortality: a population-based study and a systematic review of the literature. Chest 2005;127: 
1952-1959. 
873. Sinks T, Steele G, Smith AB, Watkins K, Shults RA. Mortality among workers exposed to 
polychlorinated biphenyls. Am J Epidemiol 1992;136:389-398. 
874. Sjaastad AK, Jørgensen RB, Svendsen K. Exposure to polycyclic aromatic hydrocarbons 
(PAHs), mutagenic aldehydes and particulate matter during pan frying of beefsteak. Occup 
Environ Med 2010;67:228-232. 
875. Sjaastad AK, Svendsen K. Exposure to mutagenic aldehydes and particulate matter during 
panfrying of beefsteak with margarine, rapeseed oil, olive oil or soybean oil. Ann Occup Hyg 
2008;52:739-745. 
 231 
 
876. Sjögren B. Respiratory disorders and biological monitoring among electric-arc welders and 
brazers. Arbete och Hälsa 1985;9, 48 pp. Solna, Sweden: National Board of Occupational 
Safety and Health, 1985 (thesis). 
877. Sjögren B. Effects of gases and particles in welding and soldering. In: Zenz C, Dickerson OB, 
Horvath EP, eds. Occupational medicine. Pp. 917-925, 3rd ed. St. Louis, Missouri, United 
States: Mosby-Year Book, Inc., 1994. 
878. Sjögren B. Occupational exposure to dust: inflammation and ischaemic heart disease. Occup 
Environ Med 1997;54:466-469. 
879. Sjögren B. Re: "Lung cancer among industrial sand workers exposed to crystalline silica". Am 
J Epidemiol 2001;154:785. 
880. Sjögren B, Barlow L, Weiner J. Ischemic heart disease among cooks, cold buffet managers, 
kitchen assistants, and wait staff. Scand J Work Environ Health Suppl 2009;(7):24-29. 
881. Sjögren B, Bigert C, Gustavsson P. Cardiovascular disease. In: Nordberg GF, Fowler BA, 
Nordberg M, eds. Handbook on the toxicology of metals. Pp. 313-331, 4th ed. London, United 
Kingdom: Elsevier Academic Press Inc., 2015. 
882. Sjögren B, Fossum T, Lindh T, Weiner J. Welding and ischemic heart disease. Int J Occup 
Environ Health 2002;8:309-311. 
883. Sjögren B, Fredlund P, Lundberg I, Weiner J. Ischemic heart disease in female cleaners. Int 
J Occup Environ Health 2003;9:134-137. 
884. Sjögren B, Gunnare S, Sandler H. Inhalation of decomposed chlorodifluoromethane (freon-
22) and myocardial infarction. Scand J Work Environ Health 2002;28:205-207. 
885. Sjögren B, Knutsson A, Bergström H, Fellenius E, Fernström B, Isling D, Söderholm M. 
Fibrinogen concentrations in aluminium smelter workers (short communication). C Eur 
J Occup Environ Med 2002;8:49-54. 
886. Sjögren B, Lönn M, Fremling K, Feychting M, Nise G, Kauppinen T, Plato N, Wiebert P, 
Gustavsson P. Occupational exposure to particles and incidence of stroke. Scand J Work 
Environ Health 2013;39:295-301. 
887. Sjögren B, Wang Z, Larsson BM, Larsson K, Larsson PH, Westerholm P. Increase in 
interleukin-6 and fibrinogen in peripheral blood after swine dust inhalation. Scand J Work 
Environ Health 1999;25:39-41. 
888. Sjögren B, Weiner J. Mortality from ischaemic heart disease in textile workers. Occup Environ 
Med 2011;68:706. 
889. Sjögren B, Weiner J, Larsson K. Ischaemic heart disease among livestock and agricultural 
workers. Occup Environ Med 2003;60:e1, 4 pp. 
890. Smith CJ, Hansch C. The relative toxicity of compounds in mainstream cigarette smoke 
condensate. Food Chem Toxicol 2000;38:637-646. 
891. Smyth B, Evans DS, Kelly A, Cullen L, O'Donovan D. The farming population in Ireland: 
mortality trends during the 'Celtic Tiger' years. Eur J Public Health 2013;23:50-55. 
892. Social- och hälsovårdsministeriet. HTP-värden 2018. Koncentrationer som befunnits 
skadliga. Helsinki, Finland: Social- och hälsovårdsministeriets publikationer 10/2018. 
893. Solet D, Zoloth SR, Sullivan C, Jewett J, Michaels DM. Patterns of mortality in pulp and paper 
workers. J Occup Med 1989;31:627-630. 
894. Son JY, Lee JT, Kim H, Yi O, Bell ML. Susceptibility to air pollution effects on mortality in 
Seoul, Korea: a case-crossover analysis of individual-level effect modifiers. J Expo Sci 
Environ Epidemiol 2012;22:227-234. 
895. Songdej N, Winters PC, McCabe MJ, Jr., van Wijngaarden E. A population-based assessment 
of blood lead levels in relation to inflammation. Environ Res 2010;110:272-277. 
896. Sorahan T, Lister A, Gilthorpe MS, Harrington JM. Mortality of copper cadmium alloy 
workers with special reference to lung cancer and non-malignant diseases of the respiratory 
system, 1946-92. Occup Environ Med 1995;52:804-812. 
 232 
 
897. Soteriades ES, Smith DL, Tsismenakis AJ, Baur DM, Kales SN. Cardiovascular disease in US 
firefighters: a systematic review. Cardiol Rev 2011;19:202-215. 
898. Speizer FE, Wegman DH, Ramirez A. Palpitation rates associated with fluorocarbon exposure 
in a hospital setting. N Engl J Med 1975;292:624-626. 
899. SPIN database. Substances in Preparations in Nordic Countries. http://spin2000.net/ (accessed 
December 2018). 
900. Spirtas R, Stewart PA, Lee JS, Marano DE, Forbes CD, Grauman DJ, Pettigrew HM, Blair A, 
Hoover RN, Cohen JL. Retrospective cohort mortality study of workers at an aircraft 
maintenance facility. I. Epidemiological results. Br J Ind Med 1991;48:515-530. 
901. Stark AD, Chang HG, Fitzgerald EF, Riccardi K, Stone RR. A retrospective cohort study of 
mortality among New York State Farm Bureau members. Arch Environ Health 1987;42:204-
212. 
902. Starzyński Z, Marek K, Kujawska A, Szymczak W. Mortality among different occupational 
groups of workers with pneumoconiosis: results from a register-based cohort study. Am J Ind 
Med 1996;30:718-725. 
903. Stayner LT, Dannenberg AL, Thun M, Reeve G, Bloom TF, Boeniger M, Halperin W. 
Cardiovascular mortality among munitions workers exposed to nitroglycerin and dinitro-
toluene. Scand J Work Environ Health 1992;18:34-43. 
904. Steenland K. Ten-year update on mortality among mild-steel welders. Scand J Work Environ 
Health 2002;28:163-167. 
905. Steenland K, Barry V, Anttila A, Sallmén M, McElvenny D, Todd AC, Straif K. A cohort 
mortality study of lead-exposed workers in the USA, Finland and the UK. Occup Environ Med 
2017;74:785-791. 
906. Steenland K, Beaumont J, Elliot L. Lung cancer in mild steel welders. Am J Epidemiol 1991; 
133:220-229. 
907. Steenland K, Brown D. Mortality study of gold miners exposed to silica and nonasbestiform 
amphibole minerals: an update with 14 more years of follow-up. Am J Ind Med 1995;27:217-
229. 
908. Steenland K, Palu S. Cohort mortality study of 57,000 painters and other union members: a 
15 year update. Occup Environ Med 1999;56:315-321. 
909. Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI. Cancer, heart disease, and 
diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst 1999; 
91:779-786. 
910. Steenland K, Sanderson W. Lung cancer among industrial sand workers exposed to crystalline 
silica. Am J Epidemiol 2001;153:695-703. 
911. Steenland K, Selevan S, Landrigan P. The mortality of lead smelter workers: an update. Am 
J Public Health 1992;82:1641-1644. 
912. Steenland K, Woskie S. Cohort mortality study of workers exposed to perfluorooctanoic acid. 
Am J Epidemiol 2012;176:909-917. 
913. Stellman SD, Garfinkel L. Cancer mortality among woodworkers. Am J Ind Med 1984;5:343-
357. 
914. Stewart RD, Newton PE, Baretta ED, Herrmann AA, Forster HV, Soto RJ. Physiological 
response to aerosol propellants. Environ Health Perspect 1978;26:275-285. 
915. Stewart RD, Peterson JE, Newton PE, Hake CL, Hosko MJ, Lebrun AJ, Lawton GM. 
Experimental human exposure to propylene glycol dinitrate. Toxicol Appl Pharmacol 1974; 
30:377-395. 
916. Stiernström EL, Holmberg S, Thelin A, Svärdsudd K. A prospective study of morbidity and 
mortality rates among farmers and rural and urban nonfarmers. J Clin Epidemiol 2001;54:121-
126. 
917. Stine RJ, Slosberg B, Beacham BE. Hydrogen sulfide intoxication. A case report and 
discussion of treatment. Ann Intern Med 1976;85:756-758. 
 233 
 
918. Stockmann-Juvala H. The Nordic Expert Group for Criteria Documentation of Health Risks 
from Chemicals. 147. Carbon monoxide. Arbete och Hälsa 2012;46(7), 78 pp. Gothenburg, 
Sweden: University of Gothenburg, 2012. 
919. Stolt P, Källberg H, Lundberg I, Sjögren B, Klareskog L, Alfredsson L, the EIRA study group. 
Silica exposure is associated with increased risk of developing rheumatoid arthritis: results 
from the Swedish EIRA study. Ann Rheum Dis 2005;64:582-586. 
920. Stone RA, Youk AO, Marsh GM, Buchanich JM, Smith TJ. Historical cohort study of U.S. 
man-made vitreous fiber production workers IX: summary of 1992 mortality follow up and 
analysis of respiratory system cancer among female workers. J Occup Environ Med 2004;46: 
55-67. 
921. Stubbs HA, Harris J, Spear RC. A proportionate mortality analysis of California agricultural 
workers, 1978-1979. Am J Ind Med 1984;6:305-320. 
922. Su WL, Chen YH, Liou SH, Wu CP. Meta-analysis of standard mortality ratio in cotton textile 
workers. Eur J Epidemiol 2004;19:989-997. 
923. Suadicani P, Hein HO, Gyntelberg F. Do physical and chemical working conditions explain 
the association of social class with ischaemic heart disease? Atherosclerosis 1995;113:63-69. 
924. Suadicani P, Hein HO, Gyntelberg F. Airborne occupational exposure, ABO phenotype and 
risk of ischaemic heart disease in the Copenhagen Male Study. J Cardiovasc Risk 2002;9:191-
198. 
925. Sunyer J, Zock JP, Kromhout H, Garcia-Esteban R, Radon K, Jarvis D, Torén K, Künzli N, 
Norbäck D, d'Errico A, Urrutia I, Payo F, Olivieri M, Villani S, Van Sprundel M, Antó JM, 
Kogevinas M, Occupational Group of the European Community Respiratory Health Survey. 
Lung function decline, chronic bronchitis, and occupational exposures in young adults. Am J 
Respir Crit Care Med 2005;172:1139-1145. 
926. Swaen GM, Slangen JJ, Volovics A, Hayes RB, Scheffers T, Sturmans F. Mortality of coke 
plant workers in the Netherlands. Br J Ind Med 1991;48:130-135. 
927. Swaen GM, Slangen JM. Mortality in a group of tar distillery workers and roofers. Int Arch 
Occup Environ Health 1997;70:133-137. 
928. Svanes O, Bertelsen RJ, Lygre SHL, Carsin AE, Antó JM, Forsberg B, García-García JM, 
Gullón JA, Heinrich J, Holm M, Kogevinas M, Urrutia I, Leynaert B, Moratalla JM, Le Moual 
N, Lytras T, Norbäck D, Nowak D, Olivieri M, Pin I, Probst-Hensch N, Schlünssen V, 
Sigsgaard T, Skorge TD, Villani S, Jarvis D, Zock JP, Svanes C. Cleaning at home and at 
work in relation to lung function decline and airway obstruction. Am J Respir Crit Care Med 
2018;197:1157-1163. 
929. Swedish Chemicals Agency (Kemikalieinspektionen). Förekomst och användning av hög-
fluorerade ämnen och alternativ. Rapport från ett regeringsuppdrag. Rapport 6/15, 120 pp. 
https://www.kemi.se/global/rapporter/2015/rapport-6-15-forekomst-och-anvandning-av-
hogfluorerade-amnen-och-alternativ.pdf (accessed March 2019). Sundbyberg, Sweden: 
Kemikalieinspektionen, 2015 (in Swedish). 
930. Sweetnam PM, Taylor SW, Elwood PC. Exposure to carbon disulphide and ischaemic heart 
disease in a viscose rayon factory. Br J Ind Med 1987;44:220-227. 
931. Svendsen K. The Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals and The Dutch Expert Committee on Occupational Standards. 127. Hydrogen 
sulphide. Arbete och Hälsa 2001;14, 31 pp. Stockholm, Sweden: National Institute for 
Working Life, 2001. 
932. Symanski H. [Severe health damage by occupational contact with nitroglycol]. Arch Hyg 
Bakteriol 1952;136:139-158 (in German). 
933. Szeszenia-Dabrowska N, Wilczyńska U, Strzelecka A, Sobala W. Mortality in the cotton 
industry workers: results of a cohort study. Int J Occup Med Environ Health 1999;12:143-158. 
934. Szeszenia-Dabrowska N, Wilczyńska U, Szymczak W. Mortality of workers at two asbestos-
cement plants in Poland. Int J Occup Med Environ Health 2000;13:121-130. 
 234 
 
935. Tabor CM, Shaw CA, Robertson S, Miller MR, Duffin R, Donaldson K, Newby DE, Hadoke 
PW. Platelet activation independent of pulmonary inflammation contributes to diesel exhaust 
particulate-induced promotion of arterial thrombosis. Part Fibre Toxicol 2016;13:6, 14 pp. 
936. Takala J, Hämäläinen P, Saarela KL, Yun LY, Manickam K, Jin TW, Heng P, Tjong C, Kheng 
LG, Lim S, Lin GS. Global estimates of the burden of injury and illness at work in 2012. 
J Occup Environ Hyg 2014;11:326-337. 
937. Tan WC, Qiu D, Liam BL, Ng TP, Lee SH, van Eeden SF, D'Yachkova Y, Hogg JC. The 
human bone marrow response to acute air pollution caused by forest fires. Am J Respir Crit 
Care Med 2000;161:1213-1217. 
938. Tan X, Peng X, Wang F, Joyeux M, Hartemann P. Cardiovascular effects of carbon disulfide: 
meta-analysis of cohort studies. Int J Hyg Environ Health 2002;205:473-477. 
939. Taneja SK, Mandal R. Mineral factors controlling essential hypertension--a study in the 
Chandigarh, India population. Biol Trace Elem Res 2007;120:61-73. 
940. Tarantini L, Bonzini M, Tripodi A, Angelici L, Nordio F, Cantone L, Apostoli P, Bertazzi PA, 
Baccarelli AA. Blood hypomethylation of inflammatory genes mediates the effects of metal-
rich airborne pollutants on blood coagulation. Occup Environ Med 2013;70:418-425. 
941. Taxell P, Santonen T. The Nordic Expert Group for Criteria Documentation of Health  
Risks from Chemicals and the Dutch Expert Committee on Occupational Safety. 149. Diesel 
engine exhaust. Arbete och Hälsa 2016;49(6), 147 pp. Gothenburg, Sweden: University of 
Gothenburg, 2016. 
942. Tedders SH, Jobin TL, Vogel RL, Dever GE. Estimated risk of death among employees in 
agriculture and agriculture-related industries in Georgia, 1985-1994. J Agromedicine 2003;9: 
27-38. 
943. Tellez-Plaza M, Guallar E, Howard BV, Umans JG, Francesconi KA, Goessler W, Silbergeld 
EK, Devereux RB, Navas-Acien A. Cadmium exposure and incident cardiovascular disease. 
Epidemiology 2013;24:421-429. 
944. Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A. Cadmium 
exposure and clinical cardiovascular disease: a systematic review. Curr Atheroscler Rep 2013; 
15:356,15 pp. 
945. Tellez-Plaza M, Navas-Acien A, Crainiceanu CM, Guallar E. Cadmium exposure and 
hypertension in the 1999-2004 National Health and Nutrition Examination Survey 
(NHANES). Environ Health Perspect 2008;116:51-56. 
946. Tellez-Plaza M, Navas-Acien A, Menke A, Crainiceanu CM, Pastor-Barriuso R, Guallar E. 
Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. 
Environ Health Perspect 2012;120:1017-1022. 
947. Tepperman PB. Fatality due to acute systemic fluoride poisoning following a hydrofluoric 
acid skin burn. J Occup Med 1980;22:691-692. 
948. Teppo L, Kojonen E. Mortality and cancer risk among workers exposed to man-made mineral 
fibers in Finland. Scand J Work Environ Health 1986;12 Suppl 1:61-64. 
949. Teta MJ, Ott MG, Schnatter AR. Population based mortality surveillance in carbon products 
manufacturing plants. Br J Ind Med 1987;44:344-350. 
950. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate 
variability and cardiovascular disease risk factors. Int J Cardiol 2010;141:122-131. 
951. Thelin A. Morbidity in Swedish farmers, 1978-1983, according to national hospital records. 
Soc Sci Med 1991;32:305-309. 
952. Thelin N, Holmberg S, Nettelbladt P, Thelin A. Mortality and morbidity among farmers, 
nonfarming rural men, and urban referents: a prospective population-based study. Int J Occup 
Environ Health 2009;15:21-28. 
953. Theorell T, Jood K, Järvholm LS, Vingård E, Perk J, Östergren PO, Hall C. A systematic 
review of studies in the contributions of the work environment to ischaemic heart disease 
development. Eur J Public Health 2016;26:470-477. 
 235 
 
954. Theriault GP, Tremblay CG, Armstrong BG. Risk of ischemic heart disease among primary 
aluminum production workers. Am J Ind Med 1988;13:659-666. 
955. Thomas CR, Kelley TR. A brief review of silicosis in the United States. Environ Health 
Insights 2010;4:21-26. 
956. Thomas TL. A preliminary investigation of mortality among workers in the pottery industry. 
Int J Epidemiol 1982;11:175-180. 
957. Thomas TL, Stewart PA. Mortality from lung cancer and respiratory disease among pottery 
workers exposed to silica and talc. Am J Epidemiol 1987;125:35-43. 
958. Thompson JC, Wilson PG, Shridas P, Ji A, de Beer M, de Beer FC, Webb NR, Tannock LR. 
Serum amyloid A3 is pro-atherogenic. Atherosclerosis 2018;268:32-35. 
959. Thorén K, Järvholm B, Morgan U. Mortality from asthma and chronic obstructive pulmonary 
disease among workers in a soft paper mill: a case-referent study. Br J Ind Med 1989;46:192-
195. 
960. Thorne PS, DeKoster JA. Pulmonary effects of machining fluids in guinea pigs and mice. Am 
Ind Hyg Assoc J 1996;57:1168-1172. 
961. Tiller JR, Schilling RS, Morris JN. Occupational toxic factor in mortality from coronary heart 
disease. Br Med J 1968;4:407-411. 
962. Tolonen M, Nurminen M, Hernberg S. Ten-year coronary mortality of workers exposed to 
carbon disulfide. Scand J Work Environ Health 1979;5:109-114. 
963. Tomenson JA. Update of a cohort mortality study of workers exposed to methylene chloride 
employed at a plant producing cellulose triacetate film base. Int Arch Occup Environ Health 
2011;84:889-897. 
964. Tomenson JA, Bonner SM, Heijne CG, Farrar DG, Cummings TF. Mortality of workers 
exposed to methylene chloride employed at a plant producing cellulose triacetate film base. 
Occup Environ Med 1997;54:470-476. 
965. Tong H, Rappold AG, Caughey M, Hinderliter AL, Graff DW, Berntsen JH, Cascio WE, 
Devlin RB, Samet JM. Cardiovascular effects caused by increasing concentrations of diesel 
exhaust in middle-aged healthy GSTM1 null human volunteers. Inhal Toxicol 2014;26:319-
326. 
966. Torchio P, Lepore AR, Corrao G, Comba P, Settimi L, Belli S, Magnani C, di Orio F. Mortality 
study on a cohort of Italian licensed pesticide users. Sci Total Environ 1994;149:183-191. 
967. Torén K, Bergdahl IA, Nilsson T, Järvholm B. Occupational exposure to particulate air 
pollution and mortality due to ischaemic heart disease and cerebrovascular disease. Occup 
Environ Med 2007;64:515-519. 
968. Torén K, Blanc PD. The history of pulp and paper bleaching: respiratory-health effects. Lancet 
1997;349:1316-1318. 
969. Torén K, Hagberg S, Westberg H. Health effects of working in pulp and paper mills: exposure, 
obstructive airways diseases, hypersensitivity reactions, and cardiovascular diseases. Am J Ind 
Med 1996;29:111-122. 
970. Tornling G, Gustavsson P, Hogstedt C. Mortality and cancer incidence in Stockholm fire 
fighters. Am J Ind Med 1994;25:219-228. 
971. Trogrlic S, Gevenois PA, Schroeven M, De Vuyst P. Pericardial effusion associated with 
asbestos exposure. Thorax 1997;52:1097-1098. 
972. Tsuji H, Larson MG, Venditti FJ, Jr., Manders ES, Evans JC, Feldman CL, Levy D. Impact of 
reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. 
Circulation 1996;94:2850-2855. 
973. Tuchsen F, Bach E, Marmot M. Occupation and hospitalization with ischaemic heart diseases: 
a new nationwide surveillance system based on hospital admissions. Int J Epidemiol 1992;21: 
450-459. 
 236 
 
974. Ulm K, Gerein P, Eigenthaler J, Schmidt S, Ehnes H. Silica, silicosis and lung-cancer: results 
from a cohort study in the stone and quarry industry. Int Arch Occup Environ Health 
2004;77:313-318. 
975. USGS. Asbestos. Mineral commodity summaries 2019. 
 https://www.usgs.gov/centers/nmic/mineral-commodity-summaries (accessed October 2019). 
Reston, Virginia: US Geological Survey, 2019. 
976. Vacek PM, Verma DK, Graham WG, Callas PW, Gibbs GW. Mortality in Vermont granite 
workers and its association with silica exposure. Occup Environ Med 2011;68:312-318. 
977. Waggoner JK, Kullman GJ, Henneberger PK, Umbach DM, Blair A, Alavanja MC,  
Kamel F, Lynch CF, Knott C, London SJ, Hines CJ, Thomas KW, Sandler DP, Lubin JH, 
Beane Freeman LE, Hoppin JA. Mortality in the agricultural health study, 1993-2007. Am 
J Epidemiol 2011;173:71-83. 
978. Wagoner JK, Infante PF, Bayliss DL. Beryllium: an etiologic agent in the induction of lung 
cancer, nonneoplastic respiratory disease, and heart disease among industrially exposed 
workers. Environ Res 1980;21:15-34. 
979. Valera B, Dewailly E, Poirier P. Environmental mercury exposure and blood pressure among 
Nunavik Inuit adults. Hypertension 2009;54:981-986. 
980. Walrath J, Fraumeni JF, Jr. Cancer and other causes of death among embalmers. Cancer Res 
1984;44:4638-4641. 
981. Van den Borre L, Deboosere P. Health risks in the cleaning industry: a Belgian census-linked 
mortality study (1991-2011). Int Arch Occup Environ Health 2018;91:13-21. 
982. van der Bij S, Koffijberg H, Lenters V, Portengen L, Moons KG, Heederik D, Vermeulen RC. 
Lung cancer risk at low cumulative asbestos exposure: meta-regression of the exposure-
response relationship. Cancer Causes Control 2013;24:1-12. 
983. van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, Qui D, Vincent R, Hogg 
JC. Cytokines involved in the systemic inflammatory response induced by exposure to 
particulate matter air pollutants (PM10). Am J Respir Crit Care Med 2001;164:826-830. 
984. Wang L, Liu C, Meng X, Niu Y, Lin Z, Liu Y, Liu J, Qi J, You J, Tse LA, Chen J, Zhou M, 
Chen R, Yin P, Kan H. Associations between short-term exposure to ambient sulfur dioxide 
and increased cause-specific mortality in 272 Chinese cities. Environ Int 2018;117:33-39. 
985. Wang M, Beelen R, Stafoggia M, Raaschou-Nielsen O, Andersen ZJ, Hoffmann B, Fischer P, 
Houthuijs D, Nieuwenhuijsen M, Weinmayr G, Vineis P, Xun WW, Dimakopoulou K, Samoli 
E, Laatikainen T, Lanki T, Turunen AW, Oftedal B, Schwarze P, Aamodt G, Penell J, De Faire 
U, Korek M, Leander K, Pershagen G, Pedersen NL, Östenson CG, Fratiglioni L, Eriksen KT, 
Sørensen M, Tjønneland A, Bueno-de-Mesquita B, Eeftens M, Bots ML, Meliefste K, Krämer 
U, Heinrich J, Sugiri D, Key T, de Hoogh K, Wolf K, Peters A, Cyrys J, Jaensch A, Concin 
H, Nagel G, Tsai MY, Phuleria H, Ineichen A, Künzli N, Probst-Hensch N, Schaffner E, Vilier 
A, Clavel-Chapelon F, Declerq C, Ricceri F, Sacerdote C, Marcon A, Galassi C, Migliore E, 
Ranzi A, Cesaroni G, Badaloni C, Forastiere F, Katsoulis M, Trichopoulou A, Keuken M, 
Jedynska A, Kooter IM, Kukkonen J, Sokhi RS, Brunekreef B, Katsouyanni K, Hoek G. Long-
term exposure to elemental constituents of particulate matter and cardiovascular mortality in 
19 European cohorts: results from the ESCAPE and TRANSPHORM projects. Environ Int 
2014;66:97-106. 
986. Wang TC, Jia G, Song YS, Zhang J, Ma YH, Feng WY, Liu LZ, Zhang N, Zhou JW, Yan L, 
Zhen S, Qian Q. Effects of chronic chromate exposure on human serum prostate specific 
antigen: a cross sectional study. Ind Health 2012;50:95-102. 
987. Wang X, Lin S, Yu I, Qiu H, Lan Y, Yano E. Cause-specific mortality in a Chinese chrysotile 
textile worker cohort. Cancer Sci 2013;104:245-249. 
988. Wang XR, Zhang HX, Sun BX, Dai HL, Hang JQ, Eisen EA, Wegman DH, Olenchock SA, 
Christiani DC. A 20-year follow-up study on chronic respiratory effects of exposure to cotton 
dust. Eur Respir J 2005;26:881-886. 
 237 
 
989. Wang Z, Dong D, Liang X, Qu G, Wu J, Xu X. Cancer mortality among silicotics in China's 
metallurgical industry. Int J Epidemiol 1996;25:913-917. 
990. Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations 
between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and 
inflammatory markers for cardiovascular disease. Eur Heart J 2005;26:1765-1773. 
991. Ward E, Boffetta P, Andersen A, Colin D, Comba P, Deddens JA, De Santis M, Engholm G, 
Hagmar L, Langård S, Lundberg I, McElvenny D, Pirastu R, Sali D, Simonato L. Update of 
the follow-up of mortality and cancer incidence among European workers employed in the 
vinyl chloride industry. Epidemiology 2001;12:710-718. 
992. Ward E, Okun A, Ruder A, Fingerhut M, Steenland K. A mortality study of workers at seven 
beryllium processing plants. Am J Ind Med 1992;22:885-904. 
993. Vasan SK, Rostgaard K, Majeed A, Ullum H, Titlestad KE, Pedersen OB, Erikstrup C, Nielsen 
KR, Melbye M, Nyrén O, Hjalgrim H, Edgren G. ABO blood group and risk of thrombo-
embolic and arterial disease: a study of 1.5 million blood donors. Circulation 2016;133:1449-
1457; discussion 1457. 
994. Watkins DK, Chiazze L, Jr., Fryar C. Historical cohort mortality study of a continuous 
filament fiberglass manufacturing plant. II. Women and minorities. J Occup Environ Med 
1997;39:548-555. 
995. Vehmas T, Hiltunen A, Kivisaari L, Leino-Arjas P. Atherosclerotic and pleural calcifications 
are related among asbestos-exposed workers. Eur J Cardiovasc Prev Rehabil 2008;15:599-
601. 
996. Vehmas T, Oksa P. Chest HRCT signs predict deaths in long-term follow-up among asbestos 
exposed workers. Eur J Radiol 2014;83:1983-1987. 
997. Vehmas T, Oksa P, Kivisaari L. Lung and pleural CT signs predict deaths: 10-year follow-up 
after lung cancer screening of asbestos-exposed workers. Int Arch Occup Environ Health 
2012;85:207-213. 
998. Weichenthal S, Hoppin JA, Reeves F. Obesity and the cardiovascular health effects of fine 
particulate air pollution. Obesity (Silver Spring) 2014;22:1580-1589. 
999. Weichenthal S, Villeneuve PJ, Burnett RT, van Donkelaar A, Martin RV, Jones RR, 
DellaValle CT, Sandler DP, Ward MH, Hoppin JA. Long-term exposure to fine particulate 
matter: association with nonaccidental and cardiovascular mortality in the agricultural health 
study cohort. Environ Health Perspect 2014;122:609-615. 
1000. Weiner J, Barlow L, Sjögren B. Ischemic heart disease mortality among miners and other 
potentially silica-exposed workers. Am J Ind Med 2007;50:403-408. 
1001. Weisskopf MG, Jain N, Nie H, Sparrow D, Vokonas P, Schwartz J, Hu H. A prospective study 
of bone lead concentration and death from all causes, cardiovascular diseases, and cancer in 
the Department of Veterans Affairs Normative Aging Study. Circulation 2009;120:1056-
1064. 
1002. Weitzenblum E. Chronic cor pulmonale. Heart 2003;89:225-230. 
1003. Weitzenblum E, Chaouat A. Cor pulmonale. Chron Respir Dis 2009;6:177-185. 
1004. Welch K, Higgins I, Oh M, Burchfiel C. Arsenic exposure, smoking, and respiratory cancer 
in copper smelter workers. Arch Environ Health 1982;37:325-335. 
1005. Vena J, Boffetta P, Becher H, Benn T, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-
Janys D, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, 
Pesatori AC, Saracci R, Steenland K, Kogevinas M. Exposure to dioxin and nonneoplastic 
mortality in the expanded IARC international cohort study of phenoxy herbicide and 
chlorophenol production workers and sprayers. Environ Health Perspect 1998;106 Suppl 
2:645-653. 
1006. Vena JE, Fiedler RC. Mortality of a municipal-worker cohort: IV. Fire fighters. Am J Ind Med 
1987;11:671-684. 
 238 
 
1007. Wennberg M, Bergdahl IA, Hallmans G, Norberg M, Lundh T, Skerfving S, Strömberg U, 
Vessby B, Jansson JH. Fish consumption and myocardial infarction: a second prospective 
biomarker study from northern Sweden. Am J Clin Nutr 2011;93:27-36. 
1008. Wergeland E, Andersen A, Bærheim A. Morbidity and mortality in talc-exposed workers. Am 
J Ind Med 1990;17:505-513. 
1009. Westberg H, Bryngelsson IL, Marsh G, Buchanich J, Zimmerman S, Kennedy K, Esmen N, 
Svartengren M. Mortality among hardmetal production workers: the Swedish cohort. J Occup 
Environ Med 2017;59:e263-e274. 
1010. Westberg H, Elihn K, Andersson E, Persson B, Andersson L, Bryngelsson IL, Karlsson C, 
Sjögren B. Inflammatory markers and exposure to airborne particles among workers in a 
Swedish pulp and paper mill. Int Arch Occup Environ Health 2016;89:813-822. 
1011. Wheeler JG, Mussolino ME, Gillum RF, Danesh J. Associations between differential 
leucocyte count and incident coronary heart disease: 1764 incident cases from seven 
prospective studies of 30,374 individuals. Eur Heart J 2004;25:1287-1292. 
1012. WHO, Working Group on Early Detection of Chronic Lung Diseases. Early detection of 
chronic lung diseases: report on a WHO meeting, Vienna, 31 May-2 June 1978. 32 pp. 
Copenhagen, Denmark: Regional Office for Europe, World Health Organization, 1980. 
1013. WHO. Arsenic in drinking-water: background document for development of WHO guidelines 
for drinking-water quality. 16 pp. Geneva, Switzerland: World Health Organization, 2011. 
1014. WHO. International statistical classification of diseases and related health problems,  
10th revision, 2016. http://apps.who.int/classifications/icd10/browse/2016/en. Geneva, 
Switzerland: World Health Organization, 2016. 
1015. Wiebert P, Lönn M, Fremling K, Feychting M, Sjögren B, Nise G, Kauppinen T, Plato N, 
Gustavsson P. Occupational exposure to particles and incidence of acute myocardial infarction 
and other ischaemic heart disease. Occup Environ Med 2012;69:651-657. 
1016. Wiebert P, Plato N, Feychting M, Sjögren B, Gustavsson A, Andersson T, Gustavsson P. 
Occupational exposure to respirable silica dust in men and women and risk for acute 
myocardial infarction. Occup Environ Med 2017;74, Suppl 1:A112 (conference abstract). 
1017. Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Moller W, Kreyling 
WG, Svartengren M. No significant translocation of inhaled 35-nm carbon particles to the 
circulation in humans. Inhal Toxicol 2006;18:741-747. 
1018. Wigle DT, Semenciw RM, Wilkins K, Riedel D, Ritter L, Morrison HI, Mao Y. Mortality 
study of Canadian male farm operators: non-Hodgkin's lymphoma mortality and agricultural 
practices in Saskatchewan. J Natl Cancer Inst 1990;82:575-582. 
1019. Vigliani EC. Carbon disulphide poisoning in viscose rayon factories. Br J Ind Med 1954;11: 
235-244. 
1020. Wilcosky TC, Simonsen NR. Solvent exposure and cardiovascular disease. Am J Ind Med 
1991;19:569-586. 
1021. Wild P, Bergeret A, Moulin JJ, Lahmar A, Hours M. [Mortality in the French paper and pulp 
industry]. Rev Epidemiol Sante Publique 1998;46:85-92 (in French). 
1022. Wild P, Perdrix A, Romazini S, Moulin JJ, Pellet F. Lung cancer mortality in a site producing 
hard metals. Occup Environ Med 2000;57:568-573. 
1023. Williams PR, Phelka AD, Paustenbach DJ. A review of historical exposures to asbestos among 
skilled craftsmen (1940-2006). J Toxicol Environ Health B Crit Rev 2007;10:319-377. 
1024. Wilson R, Lovejoy FH, Jaeger RJ, Landrigan PL. Acute phosphine poisoning aboard a grain 
freighter. Epidemiologic, clinical, and pathological findings. JAMA 1980;244:148-150. 
1025. Wilson TW, Kaplan GA, Kauhanen J, Cohen RD, Wu M, Salonen R, Salonen JT. Association 
between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio 
Ischemic Heart Disease Risk Factor Study. Am J Epidemiol 1993;137:292-300. 
 239 
 
1026. Wincent E, Amini N, Luecke S, Glatt H, Bergman J, Crescenzi C, Rannug A, Rannug U. The 
suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-
formylindolo[3,2-b]carbazole is present in humans. J Biol Chem 2009;284:2690-2696. 
1027. Vincent JH. Health-related aerosol measurement: a review of existing sampling criteria and 
proposals for new ones. J Environ Monit 2005;7:1037-1053. 
1028. Wingren G, Persson B, Thorén K, Axelson O. Mortality pattern among pulp and paper mill 
workers in Sweden: a case-referent study. Am J Ind Med 1991;20:769-774. 
1029. Winter PD, Gardner MJ, Fletcher AC, Jones RD. A mortality follow-up study of pottery 
workers: preliminary findings on lung cancer. IARC Sci Publ 1990:83-94. 
1030. Virtanen JK, Voutilainen S, Rissanen TH, Mursu J, Tuomainen TP, Korhonen MJ, Valkonen 
VP, Seppänen K, Laukkanen JA, Salonen JT. Mercury, fish oils, and risk of acute coronary 
events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in 
eastern Finland. Arterioscler Thromb Vasc Biol 2005;25:228-233. 
1031. Virtanen SV, Notkola V. Socioeconomic inequalities in cardiovascular mortality and the role 
of work: a register study of Finnish men. Int J Epidemiol 2002;31:614-621. 
1032. Witte DR, Grobbee DE, Bots ML, Hoes AW. A meta-analysis of excess cardiac mortality on 
Monday. Eur J Epidemiol 2005;20:401-406. 
1033. Wolkoff P, Crump DR, Harrison PT. Pollutant exposures and health symptoms in aircrew and 
office workers: is there a link? Environ Int 2016;87:74-84. 
1034. Wong O, Harris F. Retrospective cohort mortality study and nested case-control study of 
workers exposed to creosote at 11 wood-treating plants in the United States. J Occup Environ 
Med 2005;47:683-697. 
1035. Wong O, Ragland DR, Marcero DH. An epidemiologic study of employees at seven pulp and 
paper mills. Int Arch Occup Environ Health 1996;68:498-507. 
1036. Wong O, Trent LS, Whorton MD. An updated cohort mortality study of workers exposed to 
styrene in the reinforced plastics and composites industry. Occup Environ Med 1994;51:386-
396. 
1037. Wong O, Whorton MD, Foliart DE, Ragland D. An industry-wide epidemiologic study of 
vinyl chloride workers, 1942-1982. Am J Ind Med 1991;20:317-334. 
1038. Wu ML, Deng JF, Fan JS. Survival after hypocalcemia, hypomagnesemia, hypokalemia and 
cardiac arrest following mild hydrofluoric acid burn. Clin Toxicol (Phila) 2010;48:953-955. 
1039. Wu WT, Lu YH, Lin YJ, Yang YH, Shiue HS, Hsu JH, Li CY, Yang CY, Liou SH, Wu TN. 
Mortality among shipbreaking workers in Taiwan--a retrospective cohort study from 1985 to 
2008. Am J Ind Med 2013;56:701-708. 
1040. Vupputuri S, Longnecker MP, Daniels JL, Guo X, Sandler DP. Blood mercury level and blood 
pressure among US women: results from the National Health and Nutrition Examination 
Survey 1999-2000. Environ Res 2005;97:195-200. 
1041. Wyndham CH, Bezuidenhout BN, Greenacre MJ, Sluis-Cremer GK. Mortality of middle aged 
white South African gold miners. Br J Ind Med 1986;43:677-684. 
1042. Vågerö D, Norell SE. Mortality and social class in Sweden--exploring a new epidemiological 
tool. Scand J Soc Med 1989;17:49-58. 
1043. Xu X, Freeman NC, Dailey AB, Ilacqua VA, Kearney GD, Talbott EO. Association between 
exposure to alkylbenzenes and cardiovascular disease among National Health and Nutrition 
Examination Survey (NHANES) participants. Int J Occup Environ Health 2009;15:385-391. 
1044. Yesalis CE, 3rd, Lemke JH, Wallace RB, Kohout FJ, Morris MC. Health status of the rural 
elderly according to farm work history: the Iowa 65 + rural health study. Arch Environ Health 
1985;40:245-253. 
1045. Yi SW, Ryu SY, Ohrr H, Hong JS. Agent Orange exposure and risk of death in Korean 
Vietnam veterans: Korean Veterans Health Study. Int J Epidemiol 2014;43:1825-1834. 
 240 
 
1046. Yoshida M, Satoh M, Shimada A, Yasutake A, Sumi Y, Tohyama C. Pulmonary toxicity 
caused by acute exposure to mercury vapor is enhanced in metallothionein-null mice. Life Sci 
1999;64:1861-1867. 
1047. Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh CC, Spiegelman D, Stampfer MJ, 
Willett WC. Mercury and the risk of coronary heart disease in men. N Engl J Med 2002; 
347:1755-1760. 
1048. Yu IT, Tse LA, Leung CC, Wong TW, Tam CM, Chan AC. Lung cancer mortality among 
silicotic workers in Hong Kong--no evidence for a link. Ann Oncol 2007;18:1056-1063. 
1049. Zambon P, Simonato L, Mastrangelo G, Winkelmann R, Saia B, Crepet M. A mortality study 
of workers compensated for silicosis during 1959 to 1963 in the Veneto region of Italy. In: 
Goldsmith DF, Winn DM, Shy CM, eds. Silica, silicosis, and cancer: controversy in 
occupational medicine. Cancer Research Monograph Vol. 2. Pp. 367-374. New York, United 
States: Praeger, 1986. 
1050. Zambon P, Simonato L, Mastrangelo G, Winkelmann R, Saia B, Crepet M. Mortality of 
workers compensated for silicosis during the period 1959-1963 in the Veneto region of Italy. 
Scand J Work Environ Health 1987;13:118-123. 
1051. Zanardi F, Harris EC, Brown T, Rice S, Palmer KT, Coggon D. Mortality from diabetes and 
ischaemic heart disease in textile workers. Occup Environ Med 2011;68:172-175. 
1052. Zhang N. The role of endogenous aryl hydrocarbon receptor signaling in cardiovascular 
physiology. J Cardiovasc Dis Res 2011;2:91-95. 
1053. Zhang X, Wang H, Zhu X, Liu Y, Wang L, Dai Q, Cai N, Wu T, Chen W. Cohort mortality 
study in three ceramic factories in Jingdezhen in China. J Huazhong Univ Sci Technolog Med 
Sci 2008;28:386-390. 
1054. Zhong Y, Li D. Potential years of life lost and work tenure lost when silicosis is compared 
with other pneumoconioses. Scand J Work Environ Health 1995;21 Suppl 2:91-94. 
1055. Zitting AJ, Karjalainen A, Impivaara O, Tossavainen A, Kuusela T, Maki J, Huuskonen MS. 
Radiographic small lung opacities and pleural abnormalities as a consequence of asbestos 
exposure in an adult population. Scand J Work Environ Health 1995;21:470-477. 
1056. Zivin JA. Approaches to cerebrovascular diseases. In: Goldman L, Ausiello D, eds. Cecil 
textbook of medicine. Pp. 2280-2298, 22th ed. Philadelphia, Pennsylvania, United States: 
Saunders, 2004. 
1057. Zock JP, Kogevinas M, Sunyer J, Almar E, Muniozguren N, Payo F, Sánchez JL, Antó JM, 
Spanish Working Group of the European Community Respiratory Health Survey. Asthma risk, 
cleaning activities and use of specific cleaning products among Spanish indoor cleaners. Scand 
J Work Environ Health 2001;27:76-81. 
1058. Zukel WJ, Lewis RH, Enterline PE, Painter RC, Ralston LS, Fawcett RM, Meredith AP, 
Peterson B. A short-term community study of the epidemiology of coronary heart disease. A 
preliminary report on the North Dakota study. Am J Public Health Nations Health 1959;49: 
1630-1639. 
1059. Zöller B, Li X, Sundquist J, Sundquist K. Socioeconomic and occupational risk factors for 
venous thromboembolism in Sweden: a nationwide epidemiological study. Thromb Res 
2012;129:577-582. 
1060. Åström T, Jonsson A, Järvholm B. Exposure to fluorocarbons during the filling and repair of 
air-conditioning systems in cars--a case report. Scand J Work Environ Health 1987;13:527-
528. 
1061. Öberg M, Jaakkola MS, Prüss-Üstün A, Schweizer C, Woodward A. Second-hand smoke: 
assessing the environmental burden of disease at national and local levels. Environmental 
Burden of Disease Series, No. 18. 103 pp. Geneva, Switzerland: World Health Organization, 
2010. 
1062. Öberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Üstün A. Worldwide burden of disease 
from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. 
Lancet 2011;377:139-146.   
 241 
 
22. Data bases used in search of literature 
 
A complete search for literature based on PubMed and Embase, covering the period 
1970–2016, was performed in January 2017 (835). Supplementary searches in 
PubMed were performed in 2018. 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Nordic countries        
Cohort: 2 264 males 
employed > 6 mo 1942–1987 
at a primary aluminium 
smelter. 
Referents: Swedish national, 
regional (northern Sweden), 
and local (Västernorrland 
County) male rates.  
1952–2004 Mortality (ICD-7) 
from MI (420.0–
420.2) and CeVD 
(330–334). 
MI 
National rates 
Regional rates 
Local rates 
Employment 
0.5– ≤ 2 y 
2–10 y 
> 10 y 
CeVD 
National rates 
Regional rates 
Local rates 
Employment 
0.5– ≤ 2 y 
2–10 y 
> 10 y 
 
157 
 
 
 
37 
43 
77 
 
54 
 
 
 
14 
16 
24 
SMR 
0.97 (0.83–1.14) 
0.87 (0.74–1.02) 
0.73 (0.62–0.85) 
HR 
1.00 
0.99 (0.64–1.54) 
1.15 (0.77–1.74) 
SMR 
1.14 (0.86–1.49) 
1.00 (0.75–1.31) 
0.89 (0.67–1.17) 
HR 
1.00 
0.94 (0.46–1.93) 
0.89 (0.45–1.77) 
No exposure information. 
 
 
 
 
 
 
P(trend): 0.37. 
 
 
 
 
 
 
 
P(trend): 0.78. 
(99) 
Cohort: 1 085 male smelter 
workers employed ≥ 6 mo 
1922–1975 using prebaked 
electrodes. 
Referents: Norwegian 
national male rates. 
1962–1991 Mortality (ICD-9) 
from IHD (410–
414), CeVD 
(430–438), 
peripheral arterio-
sclerosis (440, 
444) and sudden 
death (798). 
 
 
All atherosclerotic 
disease: IHD, 
Employment < 3 y 
IHD 
CeVD 
Peripheral arterioscler. 
Sudden death 
Employment ≥ 3 y 
IHD 
CeVD 
Peripheral arterioscler.  
Sudden death 
All atherosclerotic 
disease  
 
46 
11 
4 
6 
 
94 
36 
9 
10 
 
 
SMR 
1.00 (0.73–1.33) 
0.80 (0.40–1.43) 
3.08 (0.84–7.88) 
1.26 (0.46–2.75) 
 
0.88 (0.71–1.07) 
1.01 (0.72–1.43) 
2.61 (1.19–4.95) 
0.93 (0.45–1.72)  
 
 
Cumulative exposure: 
Intensity by a semi-
quantitative scale  
(0–1.0) × years of exposure. 
Cumulative CTPV exposure 
(cum exp) was calculated for 
661 smelter workers with ≥ 3 
y employment. Restricted 
time window for exposure 
before observation; 0–19 y 
(RE0–19), 20–39 y (RE20–
39) and ≥ 40 y (RE40). 
(813) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
peripheral arterio-
sclerosis and 
sudden death. 
RE0–19, cum exp 
0 
< 3 
≥ 3 
RE20–39, cum exp 
0 
< 3 
≥ 3 
RE40, cum exp 
0 
< 3 
≥ 3 
RE40, cum exp 
0 
< 3 
≥ 3 
 
46 
14 
9 
 
64 
12 
16 
 
47 
11 
13 
 
47 
11 
13 
 
0.80 
1.47 
1.00 
 
0.90 
0.80 
1.17 
 
0.93 
1.40 
1.71 
RR 
1.0 
1.7 (0.9–3.2) 
1.8 (1.0–3.3) 
 
 
 
RE0–19, P(trend): 0.21. 
 
 
 
RE20–39, P(trend): 0.47. 
 
 
 
RE40, P(trend): 0.03. 
 
 
 
RE40, P(trend): 0.03. 
Cohort: 10 857 male smelter 
workers from 6 plants 
employed ≥ 3 y before 1962 
or 1962–1996.  
Referents: Norwegian 
national male rates. 
1962–1996 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
IHD (410–414), 
CeVD (431–438), 
arteriosclerosis 
(440, 444, 785), 
hypertensive 
disease (401–405) 
and sudden death 
(798). 
 
Circulatory disease 
IHD 
CeVD 
Arteriosclerosis 
Hypertension 
Sudden death 
 
1 618 
986 
307 
34 
46 
115 
SMR 
0.95 (0.91–1.00) 
0.92 (0.86–0.98) 
0.94 (0.84–1.05) 
1.01 (0.70–1.41) 
1.17 (0.85–1.56) 
1.03 (0.86–1.24) 
No association between 
cumulative PAH exposure 
and mortality from IHD. 
(794) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Europe (non-Nordic)        
Cohort: 6 455 male smelter 
workers from 11 plants 
employed ≥ 1 y 1950–1976.  
Referents: French national 
male rates. 
1950–1976 Mortality (ICD-8) 
from circulatory 
disease (390–458). 
Circulatory disease 
Electrolysis 
Maintenance 
Smelting 
Employment at 
electrolysis 
< 10 y 
10–20 y 
> 20 y  
As above and 20 y 
since first exposure 
< 10 y 
10–20 y 
> 20 y 
 
101 
62 
23 
 
 
24 
39 
32 
SMR 
0.89 (0.74–1.04) 
0.83 (0.66–1.02) 
0.90 (0.61–1.22) 
 
 
0.90 (0.63–1.23) 
1.30 (0.95–1.67) 
0.81 (0.58–1.07) 
 
 
0.78 (0.48–1.21) 
1.29 (0.92–1.75) 
0.83 (0.57–1.17) 
Two thirds of the workers 
were hired before 1960.  
The majority had worked 
with the Söderberg process, 
which was later replaced by 
the prebake process. 
The percentage of smokers 
was 64% among electrolytic 
workers exposed < 10 y, 
55% among workers 
exposed 10–20 y and 75% 
among workers exposed 
> 20 y.  
(685) 
Cohort: 2 133 male smelter 
workers from 1 plant 
employed ≥ 1 y 1950–1994 
(423 workers active 1950 and 
1 710 workers first employed 
1950–1994). 
Referents: French national 
male rates. 
1968–1994 Mortality (ICD-8–
9) from circulatory 
disease, hyper-
tensive disease, 
IHD, cardiac 
arrhythmias, 
CeVD and heart 
failure. 
 
Circulatory disease 
Hypertension 
IHD 
Arrhythmias 
CeVD 
Heart failure 
 
93 
3 
39 
3 
14 
12 
SMR 
0.81 (0.65–0.99) 
1.05 (0.22–3.08) 
0.97 (0.69–1.33) 
0.43 (0.09–1.25) 
0.47 (0.26–0.79) 
0.88 (0.46–1.54) 
A follow-up of 1 plant of 
the above described cohort. 
(674) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
North America        
Cohort: 2 103 male 
aluminium workers from 
a prebake-type reduction 
plant in Washington state, 
employed ≥ 3 y and ≥ 1 y 
1946–1962. 
Referents: US national male 
population. 
Until 1976 Mortality (ICD-7) 
from circulatory 
disease (400–468). 
 
Circulatory disease 
Exposed 
Non-exposed 
Employment duration 
3–4 y 
5–9 y 
10–14 y 
15–19 y 
20–24 y 
≥ 25 y 
Years between hire and 
death 
3–4 y 
5–9 y 
10–14 y 
15–19 y 
20–24 y 
≥ 25 y 
 
162 
66 
96 
 
14 
40 
30 
49 
19 
10 
 
 
4 
13 
21 
46 
38 
38 
SMR 
0.77 (P < 0.05) 
0.77 (P < 0.05) 
0.76 (P < 0.05) 
 
0.41 (P < 0.05) 
0.86 
0.70 
0.96 
0.67 
1.13 
 
 
0.27 (P < 0.05) 
0.46 (P < 0.05) 
0.49 (P < 0.05) 
0.88 
0.78 
1.56 (P < 0.05) 
Jobs were categorised in  
5 exposed and 14 non-
exposed, based on air 
sampling. Most workers 
were characterised as non-
exposed. 
519 workers were hired in 
1946 when the plant 
changed ownership. 
 
(642) 
Cohort: 21 829 aluminium 
workers from 14 reduction 
plants employed ≥ 5 y 1946–
1977. 
Referents: US national male 
population.  
Until 1977 Mortality from 
major CVD  
(ICD-7). 
CVD 
White  
Non-white 
Horizontal Söderberg 
pot 
Vertical Söderberg pot 
Prebake 
Remainder 
 
1 850 
243 
363 
 
53 
1 352 
325 
SMR 
0.92 (P < 0.01) 
0.71 (P < 0.01) 
0.80 (P < 0.01) 
 
0.58 (P < 0.01) 
0.97 
0.78 (P < 0.01) 
SMR was increased for  
all other heart disease for 
white workers in the 
Söderberg process (SMR 
1.60, P < 0.05).  
Most death certificates 
listed heart failure as the 
cause of death. 
(789) 
 247 
 
Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Cohort: 11 966 aluminium 
workers from 8 US plants 
(2 194 smelters, 8 290 
fabricators, 960 refinery 
workers and 522 other 
workers) enrolled in the 
primary insurance plan and 
employed ≥ 2 y.  
Almost 70% of the cohort 
and 90% of the cases were 
employed in 1996 at study 
start. 
1998–2009 Incident IHD  
cases from health 
insurance claims 
(ICD-9, 410–414). 
IHD 
Recent PM2.5, mg/m3 
(restricted to exposures 
measured with high 
confidence)  
≤ 0.05 
> 0.05–0.16 
> 0.16–0.37 
> 0.37–1.47 
> 1.47 
 
 
 
 
 
15 
132 
148 
139 
143 
HR 
 
 
 
 
1 
1.58 (0.88–2.63) 
1.78 (1.02–3.11) 
1.48 (0.83–2.66) 
1.48 (0.77–2.85) 
To exclude prevalent cases a 
2-y wash-out period without 
IHD claims was required.  
In fabricators, PM was 
composed of water-based 
metalworking fluids (soluble 
or synthetic). In smelters, 
PM was composed of 
inorganic materials and 
CTPV. HRs adjusted for 
age, race, gender, calendar 
year, smoking, facility type, 
BMI, job grade, and past 
exposure. No relationship 
with cumulative exposure. 
(199) 
Cohort: 12 949 aluminium 
workers from 11 US plants of 
5 555 smelters and 7 349 
fabricators, enrolled in the 
primary insurance plan and 
employed ≥ 2 y. 
Extension of the study above 
(199). Subjects were enrolled 
either at the start of follow-up 
or on their dates of hire. 
1998–2012 Incident IHD 
cases from health 
insurance claims 
(ICD-9, 410–414; 
ICD-10, I20–I25). 
IHD 
Smelters 
Fabricators 
Smelters, PM2.5, mg/m3 
< 0.26 (10th percentile) 
0.26–1.46 
1.47–1.95 
1.96–2.58 
≥ 2.59 
 
< 0.26 (10th percentile) 
0.26–1.46 
1.47–1.95 
 HR, Cox MSM 
1.98 (1.18–3.32) 
1.38 (0.98–1.94) 
HR, Cox standard 
1.00 
1.51 (0.98–2.37) 
1.73 (1.06–2.86) 
1.53 (0.97–2.45) 
1.53 (0.97–2.46) 
HR, Cox MSM 
1.00 
2.00 (1.16–3.45) 
1.97 (1.06–3.67) 
To exclude prevalent cases 
a 2-y wash-out period 
without IHD claims was 
required. 
Standard Cox proportional 
hazard regression to 
estimate HR for PM2.5 
exposure and incident IHD. 
Marginal structural model 
(MSM) and inverse pro-
bability weighting was used 
to adjust for a time-varying 
confounder (feature of 
(702) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
1.96–2.58 
≥ 2.59 
1.78 (1.00–3.18) 
1.77 (1.01–3.11) 
healthy worker survivor 
effect). 
Case-control study  
Cases: 306 males (150 anginas 
and 156 MI) from a large 
primary aluminium production 
complex.  
Controls: 575 controls; 2 per 
case from the same plant, 
matched for birth date, hiring 
date and length of service 
(within 5 y), with no known 
IHD or peripheral vascular 
disease. 
1975–1983 Episodes of IHD 
(angina and MI).  
IHD 
Reduction workers 
Söderberg 
Prebake 
Years in reduction 
plant 
< 1 y 
1–4 y 
5–9 y 
10–14 y 
15–19 y 
≥ 20 y 
Cases/refs 
182/257 
137/192 
  67/71 
 
 
  70/135 
  44/49 
  31/42 
  19/31 
  13/41 
  75/94 
OR 
1.72 (1.09–2.97) 
1.71 (1.07–2.72) 
2.26 (1.27–4.02) 
 
 
1.00 
2.22 (1.17–4.20) 
1.98 (0.92–4.28) 
1.39 (0.62–3.13) 
0.80 (0.36–1.80) 
1.86 (1.05–3.28) 
OR was calculated by 
conditional logistic 
regression.  
(954) 
Cohort: 6 423 male workers 
at an aluminium smelter or its 
power-generating station in 
British Columbia employed 
≥ 3 y 1954–1997. 
1954–1999 Mortality from 
acute MI (ICD-9, 
410). 
Acute MI 
 
184 RR (only presented 
in figures). 
Roughly monotonically 
increasing risk for acute MI 
with increasing cumulative 
exposure for both BaP and 
benzene-soluble material in 
categorical analyses. The 
slopes of the exposure-
response relationships were 
not significant. 
(313) 
Cohort: 6 423 male and 603 
female workers at an 
aluminium smelter in British 
Columbia employed ≥ 3 y 
1954–1997. Same male 
cohort as above. 
1954–1999 Mortality (ICD-9) 
from IHD (410–
414, 429.2), acute 
MI (410), CeVD 
(430–438) and 
other circulatory 
Males 
IHD 
Acute MI 
CeVD 
Other circulatory disease 
Females 
 
281 
184 
58 
63 
 
SMR 
0.90 (0.80–1.01) 
1.00 (0.88–1.13) 
0.89 (0.68–1.15) 
0.89 (0.68–1.14) 
 
Smoking information from 
88% of the cohort. 
 
 
 
 
(312) 
 249 
 
Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Referents: British Columbia, 
Canada, population. 
disease (399–400, 
406–409, 415–
423.9, 424.4–
429.1, 429.3–
429.9, 439–459, 
480–486). 
IHD 
Acute MI 
CeVD 
Other circulatory disease 
Males, IHD  
Cum exposure 5-y lag 
0 
> 0–7.78 
7.79–24.2 
24.3– 66.6 
≥ 66.7 
Continuous 
Cum exposure recent 5 y 
0 
> 0–0.14 
0.15–2.85 
2.86–10.4 
≥ 10.5 
Males, acute MI 
Cum exposure 5-y lag 
0 
> 0–7.50 
7.51–27.6 
27.7–67.3 
≥ 67.4 
Continuous 
Cum exposure recent 5 y 
0 
> 0–0.03 
8 
7 
8 
4 
 
 
56 
56 
57 
56 
56 
281 
 
221 
15 
15 
15 
15 
 
 
35 
37 
37 
38 
37 
184 
 
144 
10 
0.84 (0.39–1.59) 
1.27 (0.60–2.40) 
1.64 (0.71–3.23) 
1.08 (0.30–2.82) 
 
HR 
1 
1.11 (0.76–1.62) 
1.48 (1.01–2.17) 
1.28 (0.86–1.91) 
1.62 (1.06–2.46) 
1.002 (1.000–1.005) 
 
1 
1.03 (0.61–1.75) 
0.77 (0.44–1.36) 
1.02 (0.56–1.87) 
1.09 (0.57–20.9) 
 
 
1 
1.14 (0.71–1.82) 
1.21 (0.75–1.96) 
1.36 (0.84–2.22) 
1.46 (0.87–2.45) 
1.001 (0.997–1.005) 
 
1 
1.19 (0.62–2.28) 
 
 
 
 
 
Cumulative BaP exposure 
(cum exposure) expressed 
as µg/m3-y. Smoking-
adjusted HRs. 
 
P(trend): 0.053.  
 
 
 
 
 
 
P(trend): 0.61.  
 
 
 
 
 
 
P(trend): 0.19.  
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
0.04–2.14 
2.15–9.18 
≥ 9.19 
Males, CeVD 
Cum exposure 5-y lag 
0 
> 0–11.3 
11.4–76.7 
≥ 76.8 
Males, IHD, actively 
employed  
Cum exposure 5-y lag 
< 8.75 
8.75–35.6 
35.7–76.9 
≥ 77.0 
Continuous 
Current exposure 
0 
> 0–4 
≥ 5 
Males, acute MI, 
actively employed 
Cum exposure 5-y lag 
< 9.18 
9.18–41.3 
41.4–75.9 
≥ 76.0 
Continuous 
10 
10 
10 
 
 
15 
14 
15 
14 
 
 
 
16 
12 
12 
12 
56 
 
22 
19 
11 
 
 
 
10 
8 
8 
8 
34 
0.77 (0.39–1.55) 
0.96 (0.46–2.00) 
0.98 (0.44–2.19) 
 
 
1 
0.88 (0.42–1.83) 
0.65 (0.31–1.34) 
1.42 (0.67–2.99) 
 
 
 
1 
1.88 (0.84–4.19) 
1.99 (0.85–4.65) 
2.39 (0.95–6.05) 
1.002 (0.995–1.009) 
 
1 
0.84 (0.43–1.64) 
1.25 (0.51–3.04) 
 
 
 
1 
1.59 (0.60–4.22) 
1.95 (0.71–5.40) 
1.87 (0.62–5.60) 
1.001 (0.993–1.010) 
 
 
P(trend): 0.92.  
 
 
 
 
 
P(trend): 0.20.  
 
 
 
 
 
 
P(trend): 0.10.  
 
 
 
 
 
 
 
 
 
 
 
P(trend): 0.29.  
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Current exposure 
0 
> 0–4 
≥ 5 
 
16 
11 
7 
 
1 
0.63 (0.27–1.44) 
1.39 (0.44–4.33) 
Cohorts: Cohorts of Quebec 
male aluminium smelter 
workers. 
A: 5 285 men employed 1950. 
B: 529 men employed 1951. 
C: 163 men employed 1950. 
Referents: Quebec male 
population. 
1950–1999 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
IHD (410–414, 
429.2) and CeVD 
(430–438). 
Circulatory disease 
Cohort A 
Cohort B 
Cohort C 
Cohort A+B+C 
IHD 
Cohort A 
Cohort B 
Cohort C 
Cohort A+B+C 
CeVD 
Cohort A 
Cohort B 
Cohort C 
Cohort A+B+C 
CeVD 
Cumulative BaP 
exposure, µg/m3-y 
0 
< 20 
20– 
40– 
80– 
160– 
320– 
 
1 686 
141 
42 
1 869 
 
1 095 
90 
28 
1 213 
 
274 
33 
10 
317 
 
 
 
32 
154 
23 
24 
43 
31 
10 
SMR 
0.95 (0.91–1.00) 
0.87 (0.73–1.02) 
0.79 (0.57–1.07) 
0.94 (0.90–0.98) 
 
0.94 (0.88–0.99) 
0.82 (0.66–1.01) 
0.79 (0.53–1.15) 
0.92 (0.87–0.98) 
 
1.10 (0.97–1.23) 
1.52 (1.05–2.14) 
1.35 (0.65–2.49) 
1.14 (1.01–1.27) 
 
 
 
0.98 (0.67–1.38) 
1.09 (0.93–1.28) 
1.31 (0.83–1.97) 
1.06 (0.68–1.58) 
1.54 (1.11–2.07) 
0.91 (0.62–1.29) 
2.79 (1.34–5.13) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Calculations based on 
cohort A+B+C. 
 
 
 
 
 
 
P(trend): 0.16.  
(337) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Cumulative exposure to 
benzene soluble matter, 
mg/m3-y 
0 
< 2 
2– 
4– 
8– 
16– 
32– 
 
 
 
32 
106 
37 
43 
41 
45 
14 
 
 
 
0.98 (0.67–1.39) 
1.07 (0.87–1.29) 
1.01 (0.71–1.40) 
1.39 (1.01–1.87) 
1.29 (0.91–1.72) 
1.18 (0.86–1.57) 
1.42 (0.78–2.39) 
 
Calculations based on 
cohort A+B+C. 
 
 
 
 
 
 
P(trend): 0.2. 
Cohorts: Quebec aluminium 
smelter workers. 
A: 6 697 men and 588 women 
employed after 1950. 
B: 1 082 men and 56 women 
employed after 1951. 
C: 1 379 men and 42 women 
employed after 1950. 
D: 568 men and 42 women 
only employed at prebake 
technology plant. 
Referents: Quebec population. 
1950–1999 Mortality (ICD-9) 
from circulatory 
disease (390–459),  
IHD (410–414, 
429.2) and CeVD 
(430–438). 
Circulatory disease 
Cohort A+B+C 
Cohort A 
Cohort B 
Cohort C 
Cohort D 
IHD 
Cohort A+B+C 
Cohort A 
Cohort B 
Cohort C 
Cohort D 
CeVD  
Cohort A+B+C 
Cohort A 
Cohort B 
Cohort C 
Cohort D 
CeVD 
 
322 
202 
19 
101 
3 
 
221 
148 
12 
61 
3 
 
47 
25 
3 
19 
0 
 
SMR 
0.89 (0.80–0.99) 
0.97 (0.84–1.11) 
0.70 (0.42–1.10) 
0.81 (0.66–0.98) 
0.65 (0.14–1.91) 
 
0.87 (0.75–0.99) 
1.00 (0.84–1.17) 
0.63 (0.33–1.10) 
0.69 (0.53–0.89) 
0.93 (0.19–2.71) 
 
1.13 (0.83–1.50) 
1.05 (0.68–1.55) 
0.96 (0.20–2.81) 
1.29 (0.78–2.02) 
0.5 expected 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(339) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Cumulative BaP 
exposure, µg/m3-y 
0 
< 20 
20– 
40– 
80– 
160– 
320– 
CeVD 
> 20 y since first 
exposure 
1950–1959 
1960–1969 
1970–1979 
1950–1999 
 
 
5 
19 
6 
6 
4 
6 
1 
 
 
 
29 
5 
2 
36 
 
 
1.25 (0.41–2.91) 
0.91 (0.55–1.41) 
1.53 (0.56–3.33) 
1.56 (0.57–3.40) 
0.76 (0.21–1.95) 
2.29 (0.84–4.98) 
1.01 (0.03–5.64) 
 
 
 
1.17 (0.79–1.69) 
1.70 (0.55–3.96) 
1.34 (0.16–4.84) 
1.24 (0.87–1.71) 
Calculations based on 
cohort A+B+C.  
 
 
 
 
 
 
P(trend): > 0.2. 
 
Calculations based on 
cohort A+B+C.  
The corresponding risk 
estimate for the cohorts 
employed pre-1950 was 
1.18 (1.05–1.33).  
Quebec aluminium reduction 
plant workers. 
Fixed cohorts: 
A: 5 285 at work in 1950.  
B: 529 at work in 1951. 
C: 163 at work in 1950. 
Dynamic cohorts: 
A: 6 751 hired since 1950.  
B: 1 132 hired since 1951. 
C: 1 401 hired since 1950. 
Referents: Quebec population. 
1950–2004 Mortality (ICD-
10) from IHD 
(I20–I25, I51.6, 
429.2) and CeVD 
(I60–I69). 
IHD 
Fixed cohorts 
1950–1999 
2000–2004 
Dynamic cohorts 
1950–1999 
2000–2004 
CeVD 
Fixed cohorts 
1950–1999 
2000–2004 
Dynamic cohorts 
 
 
1 213 
81 
 
221 
54 
 
 
317 
20 
 
 
 
0.92 (0.87–0.98) 
0.83 (0.66–1.04) 
 
0.87 (0.75–0.99) 
0.83 (0.62–1.08) 
 
 
1.14 (1.01–1.27) 
0.69 (0.42–1.06) 
 
Plants A and B started 
before the 1930s with 
prebake lines, changed to 
Söderberg lines around 
early 1940s. Plant C started 
in 1943 with Söderberg 
lines exclusively.  
(338) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
1950–1999 
2000–2004 
47 
8 
1.13 (0.83–1.50) 
0.61 (0.26–1.20) 
Australia        
Cohort: 4 396 male workers 
who had worked in 2 
Australian prebake aluminium 
smelters ≥ 3 mo. 
Referents: Australian 
population. 
1983–2002 Mortality from 
circulatory 
disease, CVD and 
CeVD (ICD-
codes not given). 
All smelters 
Circulatory disease 
CVD 
CeVD 
Ever production 
Circulatory disease 
CVD 
CeVD 
Ever maintenance  
Circulatory disease 
CVD 
CeVD 
Duration in production 
or maintenance 
Circulatory disease 
3 mo– < 10 y 
10–20 y 
> 20 y 
CVD 
3 mo– < 10 y 
10–20 y 
> 20 y 
CeVD 
3 mo– < 10 y 
10–20 y 
> 20 y 
 
86 
68 
13 
 
59 
49 
7 
 
19 
14 
4 
 
 
 
21 
39 
11 
 
17 
32 
8 
 
1 
6 
3 
SMR 
0.87 (0.70–1.07) 
0.88 (0.69–1.12) 
0.91 (0.53–1.56) 
 
0.94 (0.73–1.22) 
1.00 (0.76–1.32) 
0.78 (0.37–1.65) 
 
0.71 (0.46–1.12) 
0.68 (0.40–1.14) 
1.02 (0.38–2.71) 
 
 
 
0.92 (0.60–1.42) 
0.93 (0.68–1.28) 
0.6 (0.33–1.08) 
 
0.96 (0.60–1.54) 
0.98 (0.70–1.39) 
0.55 (0.28–1.10) 
 
3.3 expected 
0.98 (0.44–2.19) 
1.19 (0.39–3.70) 
The cohort comprised three 
groups:  
1. Subjects participating in 
health survey 1995/1996 
(36%).  
2. Subjects starting employ-
ment after 1995/1996 (8%). 
3. Subjects employed on or 
after 1983 and who left 
before 1995/1996 (56%). 
The PAH exposure is 
known to be lower for 
prebake smelters than for 
Söderberg smelters. 
(867) 
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Table A1. Electrolytic aluminium smelting.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Cohort: 4 316 male workers 
who had worked in 2 prebake 
aluminium smelters ≥ 3 mo. 
Same cohort as above (867) 
comprising ever- and never-
exposed to CTPV and 
inhalable dust. 
1983–2002 Mortality from 
circulatory 
disease (ICD-9, 
390–459; ICD-10, 
I00–I99), CVD 
(ICD-9, 410–429; 
ICD-10, I20–I52), 
and CeVD (ICD-
9, 430–432.8; 
ICD-10, I60–I69). 
Ever- vs never-exposed 
Circulatory disease 
CTPV 
Inhalable dust 
CVD 
CTPV 
Inhalable dust 
CeVD 
CTPV 
Inhalable dust 
Medium-high vs  
low-unexposed 
CeVD 
 
 
 30/55 
 63/22 
 
 21/46 
 50/17 
 
   6/7 
   9/4 
RR 
 
0.7 (0.4–1.1) 
0.7 (0.4–1.2) 
 
0.6 (0.3–1.0) 
0.7 (0.4–1.2) 
 
1.1 (0.4–3.3) 
0.6 (0.2–1.8) 
 
 
1.8 (0.5–5.8) 
56% were exposed to 
CTPV and 85% to inhalable 
dust. 
Median and maximum 
cumulative exposures 
0.18 and 90 µg/m3-y for 
BaP-exposed workers,  
0.08 and 30 mg/m3-y for 
workers exposed to the 
benzene-soluble fraction, 
12 and 750 mg/m3-y  
for inhalable dust-exposed 
workers. 
(310) 
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Table A2. Coke production.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Nordic countries        
Cohort: 888 male workers 
employed ≥ 1 y in a coke 
plant operating 1964–1988. 
Referents: Norwegian 
national male rates. 
1962–1993 Mortality (ICD-9) 
from IHD (410–
414), CeVD 
(431–438) and 
sudden death 
(798). 
 
IHD 
CeVD 
Sudden death 
Cumulative PAH 
exposure, µg/m3-y 
IHD 
Unexposed 
< 50 
50–149 
≥ 150 
IHD + sudden death 
Unexposed 
< 50 
50–149 
≥ 150 
IHD + sudden death,  
15 y latency  
Unexposed 
< 50 
50–149 
≥ 150 
 
47 
3 
4 
 
 
 
29 
9 
4 
5 
 
32 
10 
4 
5 
 
 
35 
11 
2 
3 
SMR 
1.09 (0.80–1.45) 
0.33 (0.07–0.97) 
0.88 (0.24–2.26) 
 
 
 
1.06 
1.18 
1.04 
1.19 
 
1.06 
1.29 
0.95 
1.08 
 
 
0.96 
1.76 
0.71 
1.38 
Smoking habits were lower 
than in the general 
Norwegian population;  
24–56% lower depending on 
age group. 
No significant trends for 
cumulative PAH exposure 
but a significant trend 
(P = 0.01) for peak CO 
exposure and IHD, 3 y before 
death.  
(135) 
Europe (non-Nordic)        
Cohort: 610 UK male coke 
oven workers employed 1954. 
Referents: rates from England 
and Wales. 
1954–1965 Mortality from 
CVD. 
CVD 29 45.5 expected  (213) 
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Table A2. Coke production.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort I: 2 753 male workers 
employed in coke work 
January 1966–July 1967 by 
the British Steel Corporation. 
Cohort II: 3 855 male 
workers employed January 
1967 by the National 
Smokeless Fuel Limited. 
Referents: rates from 
Scotland, England and Wales. 
Cohort I: 
12 y 
Cohort II: 
13 y 
Mortality (ICD-8) 
from IHD (410–
414) and CeVD 
(430–438). 
 
IHD 
CeVD 
IHD, age at death 
< 45 y 
45–54 y 
55–64 y 
≥ 65 y 
IHD, cohort I 
Non-oven 
Part oven 
Oven 
IHD, cohort II 
Non-oven 
Part oven 
Oven 
IHD by years of oven 
work, subcohort (91%) 
of cohort I 
< 5 y 
5–9 y 
≥ 10 y 
 
409 
81 
 
18 
74 
166 
151 
 
26 
32 
88 
 
136 
23 
94 
 
 
 
16 
25 
34 
SMR/rSMR 
0.91/1.02 
0.71/0.80 
Expected 
11.9 
72.5 
178.1 
188.4 
SMR 
0.97 
0.92 
1.04 
 
0.96 
0.73 
1.19 
 
 
 
0.99 
1.36 
0.88 
rSMR (relative SMR) means 
cause-specific SMR/SMR all 
causes. 
The proportion of smokers 
among coke workers was 
similar to that among other 
manual workers in Britain. 
The SMR for all oven 
workers was 1.11 (P = 0.06). 
The healthy worker survivor 
effect was discussed. 
(429) 
Cohort: 5 639 male Dutch 
coke plant workers employed 
≥ 6 mo 1945–1969. 
Subcohorts of coke oven and 
by-product workers. 
Referents: national Dutch 
male rates. 
Until 1984 Mortality from 
circulatory 
disease (ICD-9).  
Circulatory disease 
Coke oven work 
By-product work 
 
186 
338 
SMR 
0.98 
0.94 
 (926) 
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Table A2. Coke production.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 536 male coke oven 
plant workers in Lorraine 
Collieries, retired 1963–1982. 
Referents: French national 
male rates. 
1963–1987 Mortality from 
CVD (ICD-9, 
390–459). 
CVD 
Entire cohort 
Ovens  
All 
Non-smokers 
Smokers 
Near ovens 
All 
Non-smokers 
Smokers 
Non-exposed 
All 
Non-smokers 
Smokers 
 
64 
 
6 
2 
3 
 
22 
7 
12 
 
23 
8 
14 
SMR 
1.33 (P < 0.05) 
 
1.23 
1.72 
1.02 
 
1.55 (P < 0.05) 
2.24 (P < 0.05) 
1.34 
 
1.79 (P < 0.01) 
2.35 (P < 0.05) 
1.69 (P < 0.05) 
Exposure classification:  
Ovens, constant presence on 
coke ovens. 
Near ovens, near ovens or 
intermittent presence on coke 
ovens. 
Non-exposed, administrative 
personnel, time keeper, 
maintenance workers without 
direct contact with ovens. 
(152) 
Cohort: 538 male workers 
employed at a coke plant in 
Carrara 1960–1985. 
Referents: Italian national and 
regional Tuscany male rates.  
1960–1990 Mortality from 
circulatory 
disease. 
Circulatory disease 
National rates 
Regional rates 
 
37 
37 
SMR 
0.74 (0.52–1.02) 
0.88 (0.62–1.21) 
 (308) 
North America        
Cohort: 3 530 male coke 
plant workers (2 369 white 
and 1 161 non-white) 
employed 1953 or before. 
Referents: total population of 
steel workers, 58 828 males 
from several plants in the US. 
1953–1961 Mortality from 
heart disease and 
vascular lesions 
of CNS. 
All 
Heart disease 
Vascular CNS lesions 
White workers 
Heart disease 
Vascular CNS lesions 
Non-white workers 
Heart disease 
Vascular CNS lesions 
 
111 
28 
 
87 
17 
 
24 
11 
SMR 
0.98 
1.15 
 
1.07 
1.11 
 
0.76 
1.22 
 (572) 
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Table A2. Coke production.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Coke oven workers, all 
Heart disease 
Vascular CNS lesions 
White workers 
Heart disease 
Vascular CNS lesions 
Non-white workers 
Heart disease 
Vascular CNS lesions 
Non-oven workers, all 
Heart disease 
Vascular CNS lesions 
White workers 
Heart disease 
Vascular CNS lesions 
Heart disease 
Coke oven, all 
Side oven 
Partial topside 
Full topside 
Coke oven employment 
< 5 y 
≥ 5 y 
 
49 
15 
 
29 
6 
 
20 
9 
 
62 
13 
 
58 
11 
 
49 
34 
5 
10 
 
24 
25 
 
0.80 
1.06 
 
0.86 
0.94 
 
0.72 
1.15 
 
1.20 
1.29 
 
1.22 
1.24 
 
0.80 
0.85 
0.46 
0.94 
 
0.93 
0.70 
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Table A3. Coal gasification. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI)  
Confounder adjustments and 
comments  
Ref. 
Nordic countries        
Cohort: 295 gas production 
workers employed ≥ 1 y 
1965–1972. 
Referents: rates from 
occupationally active and 
employed in Greater 
Stockholm or from the 
general population of Greater 
Stockholm. 
1966–1986 Mortality (ICD-8) 
from circulatory 
disease (390–458), 
IHD (410–414) 
and CeVD (430–
438). 
Cohort vs general pop. 
Circulatory disease 
IHD 
CeVD 
Cohort vs employed 
Circulatory disease 
IHD 
CeVD 
Years since first 
employment 
1–19 y 
Circulatory disease 
IHD 
20–39 y  
Circulatory disease 
IHD 
≥ 40 y  
Circulatory disease 
IHD 
30 y after first 
employment 
Employed 1–29 y  
Circulatory disease 
IHD 
Employed ≥ 30 y 
Circulatory disease 
IHD 
 
39 
28 
6 
 
39 
28 
6 
 
 
9 
7 
 
 
15 
11 
 
15 
10 
 
 
 
7 
5 
 
16 
11 
SMR 
1.09 (0.77–1.48) 
1.09 (0.73–1.58) 
1.25 (0.46–2.72) 
 
1.27 (0.90–1.74) 
1.25 (0.83–1.81) 
1.52 (0.56–3.31) 
 
 
1.38 (0.63–2.52) 
1.49 (0.60–3.07) 
 
 
0.93 (0.52–1.53) 
0.91 (0.46–1.64) 
 
1.89 (1.06–3.12) 
1.76 (0.85–3.25) 
 
 
 
0.84 (0.34–1.74) 
0.81 (0.26–1.90) 
 
1.75 (1.00–2.84) 
1.67 (0.83–2.99) 
Mean (range) exposure to BaP 
measured on top of ovens 
1964: 4.3 µg/m3 (0.007–33).  
1965: 0.52 µg/m3 (0.021–1.29). 
52% of workshop and main-
tenance workers were daily 
smokers. In a sample of the 
Swedish population 56–57% 
were daily smokers.  
(365) 
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Table A3. Coal gasification. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI)  
Confounder adjustments and 
comments  
Ref. 
Europe (non-Nordic)        
Cohort: 11 499 male produc-
tion workers from 4 UK Gas 
Boards employed ≥ 5 y or in 
receipt of pension 1953. 
Referents: national rates from 
England and Wales. 
1953–1961 Mortality from 
arteriosclerotic 
and degenerative 
heart disease 
(ICD-7). 
 
Exposure category 
A. Heavy 
B. Intermittent 
C. Less/minimal/no 
Referents 
 Annual death 
rate/1 000 men 
3.34 
3.53 
3.68 
4.48 
A: Coal carbonising process 
workers. 
B: Periodic entry into gas-
producing plant and other 
process workers.  
(236) 
Cohort I: same as above. 
Cohort II: 4 687 male 
workers from 4 additional 
Gas Boards. 
Referents: national rates from 
England and Wales. 
Cohort I: 
1953–1965 
Cohort II: 
1957–1965 
Mortality from 
arteriosclerotic 
and degenerative 
heart disease 
(ICD-7). 
Cohort I 
Exposure category 
A. Heavy 
C. Less/minimal/no 
Referents 
Cohort II 
Exposure category 
A. Heavy 
B. Intermittent 
C. Less/minimal/no 
Referents 
 
 
119 
27 
 
 
 
47 
59 
70 
 
Annual death 
rate/1 000 men 
4.63 
3.54 
5.41 
 
 
5.65 
5.09 
4.81 
5.00 
Exposure categories as above. (238) 
North America        
Cohorts: 51 899 male workers 
employed ≥ 6 mo in Pacific 
Gas and Electric Company 
before 1986 and alive 1971. 
513 male gas generator 
workers.  
Referents: US national and 
Californian male rates.  
Until 1997 Mortality from 
heart disease and 
CeVD. 
All workers 
Heart disease 
CeVD 
Gas generator workers 
Heart disease 
CeVD 
 
3 472 
608 
 
29 
6 
SMR a 
0.86 (0.83–0.89) 
0.91 (0.84–0.98) 
 
0.74 (0.50–1.06) 
1.06 (0.38–2.30) 
Employment start before 1970 
All workers: 60% 
Gas generator workers: 49%. 
a Californian rates.  
(111) 
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Table A4. Graphite electrode production. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Nordic countries        
Cohort: 901 Swedish electrode 
manufacturing workers (807 
men, 94 women) employed 
> 3 mo 1968–1988. 
Referents: Swedish national 
rates standardised for age, 
gender, calendar time and 
geographical region.  
1969–1989 Mortality (ICD-8) 
from circulatory 
disease (390–458), 
IHD (410–414) 
and CeVD (430–
438). 
 
Circulatory disease 
IHD 
CeVD 
IHD, cumulative BaP 
exposure, µg/m3-y 
0–5 
5–10 
> 10 
 
11 
7 
2 
 
 
4 
0 
3 
SMR 
0.95 (0.47–1.69) 
0.87 (0.35–1.80) 
1.03 (0.12–3.70) 
 
 
0.86 
– 
1.21 
BaP was measured on 
six occasions 1974–1989  
(n = 164). In the highest 
cumulative exposure group, 
the mean was 3 µg/m3. 
Smoking habits in 1990 
among 181 male workers: 
current smokers 22%,  
ex-smokers 42% and  
non-smokers 35%. 
Corresponding figures for 
males in the county were 
28%, 30% and 41%. 
(360) 
Europe (non-Nordic)        
Cohort: 1 115 male carbon 
electrode manufacturers 
employed on January 1957 
in a French factory. 
Referents: French national 
population.  
1957–1984 Mortality from 
circulatory 
disease (ICD-8, 
390–458).  
 
Circulatory disease 
 
40 
SMR 
0.71 (0.51–0.97) 
Mean BaP exposure:  
170 ng/m3 (range 15–740), 
measured 1983–1984. 
(677) 
Cohort: 1 291 male graphite 
electrode manufacturing 
workers employed ≥ 1 y 
1950–1989 in Brescia, Italy. 
Referents: Italian national  
and regional male rates 
(1970–1997). 
1950–1997 Mortality (ICD-9) 
from circulatory 
disease (390–459) 
and silicosis (500, 
502).  
 
Circulatory disease 
Silicosis 
Circulatory disease  
Time since first 
employment 
< 10 y 
 
126 
79 
 
 
 
4 
SMR 
0.88 (0.73–1.05) 
66.4 (52.6–82.7) 
 
 
 
0.86 (0.23–2.20) 
The rods were baked at 850–
1 200 º C in pit furnaces fed 
by naphtha and filled with a 
coke siliceous sand stuffing. 
The siliceous sand was 
replaced with rice husks in 
1967. 
(635) 
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Table A4. Graphite electrode production. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
10–19 y 
> 19 y 
Length of employment 
< 10 y 
10–19 y 
> 19 y 
23 
99 
 
21 
42 
63 
1.48 (0.94–2.22) 
0.81 (0.65–0.98) 
 
0.92 (0.57–1.41) 
0.83 (0.60–1.12) 
0.90 (0.69–1.15) 
All deaths from silicosis 
occurred among workers 
hired before 1967.  
Cohort: 1 006 male carbon 
(graphite) electrode 
manufacturing workers 
employed ≥ 1 y 1945–1971 
in Umbria region, Italy. 
Referents: Italian national 
male population.  
1955–1996 Mortality from 
circulatory 
disease (ICD-8, 
390–459). 
 
Circulatory disease 
 
181 
SMR 
0.91 (0.78–1.06) 
About half of the workers 
had been substantially 
exposed to PAH. 
(240) 
North America        
Cohorts: 2 219 white male 
workers employed in carbon 
based electrode and specialty 
products operations on 1 Jan 
1974 and ≥ 10 y service in 
Union Carbide. 
Referents: US national white 
male rates. 
1974–1983 Mortality (ICD-8) 
from circulatory 
disease and 
CeVD. 
 
Circulatory disease  
CeVD 
Circulatory disease  
Supervisory, office 
employee 
Crafts 
Operators, labour 
Years of employment 
10–19 y 
20–29 y 
≥ 30 y 
 
91 
11 
 
24 
 
18 
49 
 
 
SMR 
0.60 (0.48–0.74) 
0.67 (0.33–1.19) 
RR 
0.8 
 
1.4 
1.0 
 
0.5 
1.1 
1.1 
P(trend): 0.02 
 
 
 
Conditional RRs were 
calculated. 
 
 
 
 
 
 
 
(949) 
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Table A4. Graphite electrode production. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Asia        
Cohorts: 332 male workers 
employed in graphite 
electrode manufacturing plant 
> 5 y 1951–1974. 
Referents: rates from Vital 
Statistics of Japan. 
1951–1988 Mortality (ICD-9) 
from CVD (420–
438) and CeVD 
(430–438). 
 
CVD 
CeVD 
 
7 
2 
SMR 
1.13 (0.46–2.33) 
0.14 (0.02–0.50) 
Mean BaP exposure:  
32.2 and 55.7 µg/m3 (highest  
102 µg/m3). 
Documents from 200 workers 
who resigned from the plant 
1965–1969; 121 (60%) left 
the plant by the end of the  
2nd year of employment.  
166 worked with graphite 
electrode manufacturing, and 
38 (23%) reported improper 
working environment and 
serious concern about health 
conditions as reason for 
resignation.  
(671) 
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Table A5. Chimney sweeping. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates  
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Nordic countries        
Cohort: 6 374 male chimney 
sweeps from Swedish 
nationwide trade union 
records 1918–2006.  
Referents: Swedish national 
male rates.  
1952–2006 Mortality  
(ICD-6–10) from 
circulatory disease, 
IHD and CeVD.  
 
Circulatory disease 
IHD 
Years of employment 
> 0–9.9 y 
10–19.9 y 
20–29.9 y 
≥ 30 y 
CeVD  
Years of employment 
> 0–9.9 y 
10–19.9 y 
20–29.9 y 
≥ 30 y 
 
724 
462 
 
95 
89 
64 
214 
99 
 
20 
21 
17 
41 
SMR 
1.18 (1.10–1.27) 
1.20 (1.10–1.32) 
 
1.29 (1.05–1.58) 
1.40 (1.13–1.73) 
1.07 (0.82–1.37) 
1.14 (1.00–1.31) 
0.96 (0.78–1.16) 
 
1.05 (0.64–1.62) 
1.26 (0.78–1.92) 
1.09 (0.63–1.74) 
0.79 (0.56–1.07) 
 (453) 
Cohort: 4 436 male chimney 
sweeps from nationwide trade 
union records 1918–2006. 
Referents: skilled manual 
workers in the service sector 
in Sweden. 
1991–2005 Lethal and non-
lethal first-time 
MI (ICD-6–10). 
 
MI 
Years of employment 
> 0–9 y 
10–19 y 
20–29 y 
≥ 30 y 
Years since 1st employment 
20–29 y 
≥ 30 y 
 
318 
 
137 
67 
45 
69 
SIR 
1.39 (1.24–1.55) 
 
1.53 (1.28–1.81) 
1.28 (0.99–1.63) 
1.18 (0.86–1.59) 
1.39 (1.08–1.76) 
 
1.54 (1.03–2.23) 
1.36 (1.21–1.53) 
Dust levels 3–19 mg/m3 
during most common work 
operations 1985–1986. 
Sweeping in private homes 
was associated with inhalable 
dust levels of 3.8 mg/m3 and 
sweeping in industrial settings 
could exceed 1 000 mg/m3. 
Exposure comprised dust, 
PAH and metals. 
(362) 
Males from Danish census 
1970. Cohort: 713 chimney 
sweeps. Referents: employed. 
1970–1975 Mortality from 
IHD (ICD-8, 410–
414). 
 
IHD 
 
12 
SMR 
2.21, P < 0.05 
No exposure information. (381) 
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Table A6. Asphalt paving. 
Study group and design Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Pooled analysis 
Cohort: 12 367 male asphalt 
workers from 217 companies 
in Denmark, Finland, France, 
Germany, Israel, the 
Netherlands and Norway 
employed ≥ 1 work season in 
asphalt paving 1913–1999. 
Earliest 
follow-up 
started 1953 
and latest 
ended 2000. 
Mortality  
(ICD-9) from 
circulatory 
disease (390–
459) and IHD 
(410–414). 
Circulatory, average 
BaP exposure, ng/m3 
0–68 
68–105 
106–146 
147–272 
≥ 273 
Circulatory, cumulative 
BaP exposure, ng/m3-y 
0–189 
189–501 
502–931 
932–2 012 
≥ 2 013 
IHD, average BaP 
exposure, ng/m3 
0–68 
68–105 
106–146 
147–272 
≥ 273 
IHD, cumulative BaP 
exposure, ng/m3-y 
0–189 
189–501 
502–931 
932–2 012 
≥ 2 013 
 
 
128 
142 
143 
139 
108 
 
 
137 
145 
118 
132 
128 
 
 
83 
83 
83 
86 
83 
 
 
83 
83 
84 
83 
85 
RR 
 
1.00 
1.30 (1.01–1.67) 
1.55 (1.18–2.05) 
1.45 (1.09–1.93) 
1.58 (1.16–2.15) 
 
 
1.00 
1.08 (0.85–1.38) 
1.06 (0.80–1.42) 
1.24 (0.89–1.71) 
1.42 (0.96–2.09) 
 
 
1.00 
1.13 (0.82–1.55) 
1.33 (0.94–1.90) 
1.20 (0.84–1.71) 
1.64 (1.13–2.38) 
 
 
1.00 
0.99 (0.72–1.36) 
1.22 (0.86–1.74) 
1.24 (0.82–1.85) 
1.58 (0.98–2.55) 
Differences in smoking habits 
were an unlikely explanation 
for the observed exposure-
response relationships.  
 
 
P(trend): < 0.001. 
 
 
 
 
 
 
P(trend): 0.09. 
 
 
 
 
 
 
P(trend): 0.02. 
 
 
 
 
 
 
P(trend): 0.06. 
(134) 
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Table A7. Tar distillation work, roofing and creosote work. 
Study group and design Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
Europe (non-Nordic)        
Cohort: 255 male tar distillery 
workers at 4 distillation plants, 
employed January 1967.  
Referents: regional population 
of England and Wales. 
1967–1983 Mortality (ICD-8) 
from circulatory 
disease (390–458), 
IHD (410–414), 
CeVD (430–438), 
and diseases of 
arteries, arterioles, 
capillaries and 
veins (440–458). 
 
Circulatory disease 
IHD 
CeVD 
Vessels 
IHD, age at death 
≤ 54 y 
55–64 y 
≥ 65 y 
IHD, time at death since 
joining tar plant 
≤ 19 y 
20–39 y 
≥ 40 y 
 
45 
29 
7 
5 
 
8 
9 
12 
 
 
17 
10 
2 
SMR 
1.19 (P = 0.14) 
1.14 (P = 0.26) 
1.03 
2.42 (P = 0.06) 
 
2.06 (P = 0.04) 
1.06 
0.93 
 
 
1.69 (P = 0.03) 
0.89 
0.5 
No exposure 
information. 
(595) 
Cohort: 907 male tar distillery 
workers and 866 male roofers 
employed ≥ 0.5 y 1947–1980. 
Referents: Dutch national male 
rates. 
1947–1988 Mortality from 
circulatory 
disease (ICD-9). 
Circulatory disease 
Tar workers 
Roofers 
 
119 
114 
SMR 
0.78 (0.65–0.94) 
1.00 (0.83–1.20) 
No exposure 
information. 
(927) 
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Table A7. Tar distillation work, roofing and creosote work. 
Study group and design Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
North America        
Cohort: 5 939 active, 
probational and retired males, 
members ≥ 9 y of a union of 
roofers and waterproofers in 
1960. 
Referents: US national male 
rates. 
1960–1971 Mortality from 
heart disease and 
cerebral vascular 
lesions (CeVD). 
Heart disease  
Years since joining union 
9–19 y 
≥ 20 y 
CeVD 
Years since joining union 
9–19 y 
≥ 20 y 
 
 
179 
518 
 
 
27 
101 
SMR 
 
0.95 
0.99 
 
 
0.84 
0.88 
No smoking 
information. 
Mean exposure was 
1.4–53 µg BaP per 7-h 
working day. 
(378) 
Cohort: 2 179 employees 
(2 010 males, 169 females) at 
11 wood-treating plants in the 
US using creosote-based 
preservatives 1979–1999. 
Referents: US national male 
rates. 
1979–2001 Mortality (ICD-8) 
from all heart 
disease, IHD, 
chronic endo-
cardial disease,  
all other heart 
disease, and 
CeVD. 
All cohort 
All heart disease 
IHD 
Endocardial disease  
Other heart disease 
CeVD 
Hourly employed 
All heart disease 
IHD 
Endocardial disease 
Other heart disease 
CeVD  
All heart disease 
Length of employment 
< 15 y 
15.0–24.9 y 
25.0–34.9 y 
≥ 35 y 
Time since first employment 
< 15 y 
 
88 
52 
5 
29 
14 
 
81 
47 
5 
27 
13 
 
 
40 
13 
18 
10 
 
15 
SMR 
0.91 (0.73–1.13) 
0.73 (0.54–0.95) 
1.15 (0.37–2.69) 
1.16 (0.78–1.67) 
0.89 (0.49–1.50) 
 
0.96 (0.76–1.19) 
0.76 (0.56–1.00) 
1.30 (0.42–3.03) 
1.21 (0.80–1.76) 
0.93 (0.49–1.58) 
 
 
1.34 
0.56 (P < 0.05) 
0.95 
0.80 
 
0.93 
Approximately 90% of 
the employees were 
hourly salaried and 
with a generally higher 
exposure. 
(1034) 
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Table A7. Tar distillation work, roofing and creosote work. 
Study group and design Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments 
Ref. 
15.0–24.9 y 
25.0–34.9 y 
≥ 35 y 
IHD 
Length of employment 
< 15 y 
15.0–24.9 y 
25.0–34.9 y 
≥ 35 y  
Time since first employment 
< 15 y 
15.0–24.9 y 
25.0–34.9 y 
≥ 35 y  
29 
18 
19 
 
 
21 
8 
12 
6 
 
7 
15 
11 
14 
1.20 
0.82 
0.85 
 
 
0.98 
0.46 (P < 0.05) 
0.84 
0.65 
 
0.62 
0.85 
0.67 
0.83 
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Table A8. Cooking fumes. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Nordic countries        
Manual workers in the service sector 
identified in the Swedish national census 
1985. 
Cohorts: cooks (12 398 females and 
3 779 males), cold buffet managers 
(1 948 and 17), waiting staff (4 532 and 
2 218) and restaurant and kitchen 
assistants (15 049 and 1 331). 
Referents: skilled manual workers (for 
cooks, cold-buffet managers and waiting 
staff), and unskilled manual workers (for 
restaurant and kitchen assistants). 
1987–2005 Incidence of first 
MI (ICD-9, 410; 
ICD-10, I21). 
Cooks 
Males 
Females  
Cold buffet managers 
Males 
Females 
Waiting staff 
Males 
Females 
Restaurant and kitchen 
assistants 
Males 
Females 
 
201 
609 
 
2 
56 
 
110 
167 
 
 
86 
595 
HR 
1.09 (0.94–1.27) 
1.34 (1.21–1.48) 
 
3.28 (0.82–13.12) 
1.19 (0.91–1.55) 
 
1.02 (0.84–1.24) 
1.25 (1.06–1.47) 
 
 
1.14 (0.93–1.41) 
1.12 (1.03–1.21) 
Adjustment for age, 
hypertension and 
diabetes. 
(92) 
All gainfully employed men and women 
identified in the Swedish national census 
1970. 
Cohorts: cooks and cold buffet 
managers (12 348 females and 3 051 
males), kitchen assistants (34 609 and 
924) and waiting staff (27 802 and 
3 745).  
Referents: all gainfully employed. 
1970–1995 Mortality from 
IHD (ICD-7 and 
ICD-8, 410–414). 
Cooks and cold buffet 
managers 
Males 
Females 
Kitchen assistants 
Males 
Females 
Waiting staff 
Males 
Females 
 
 
142 
852 
 
96 
1 905 
 
243 
1 343 
SMR 
 
1.33 (1.12–1.56) 
1.29 (1.20–1.37) 
 
1.55 (1.26–1.90) 
1.21 (1.14–1.26) 
 
1.23 (1.08–1.39) 
1.01 (0.95–1.06) 
No smoking adjustment. 
An increased risk of IHD 
among male and female 
kitchen workers with the 
same occupation in both 
1970 and 1980 was 
observed. 
(882) 
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Table A8. Cooking fumes. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Case-control study: 26 847 Swedish 
men with first MI, 2 controls for each 
case. 
Stockholm 
County: 
1976–1984 
Other 
counties: 
1976–1981 
Incidence of first 
MI, mortality 
(ICD-8, 410) and 
hospital 
discharges 
(410.00, 410.99). 
Kitchen assistants 
Males 
Females 
Waitresses 
Males 
Females 
 
– 
– 
 
– 
– 
RR 
No incr. or decr. a  
1.4 (0.9–2.0)  
 
No incr. or decr. a  
0.8 (0.6–0.9) 
Adjustment for age, 
county and socio-
economic group. 
a RR not shown. 
(377) 
All economically active men and 
women identified in the Finnish 
censuses 1970, 1975, 1980, 1985 and 
1990. 
Cohorts: restaurant and kitchen 
workers. 
Referents: all economically active men 
and women 25–64 y of age in 1970, 
including nearly 6 million residents. 
1971–1991 Mortality from 
CVD, MI, IHD 
other than MI, 
and CeVD. 
CVD 
Restaurant service work, 
males 
Kitchen assistants, 
females 
Head waiters, restaurant 
waiters, females 
MI 
Kitchen assistants, 
females 
IHD other than MI 
Cooks and kitchen staff, 
females 
Kitchen assistants, 
females 
Head waiters, restaurant 
waiters, females 
CeVD 
All occupations in 
restaurants, males or 
females 
 
64 
 
822 
 
346 
 
 
347 
 
 
151 
 
142 
 
62 
 
 
– 
SMR 
1.35 (1.04–1.72) 
 
1.13 (1.06–1.21) 
 
1.19 (1.07–1.33) 
 
 
1.17 (1.06–1.31) 
 
 
1.30 (1.11–1.54) 
 
1.40 (1.18–1.65) 
 
1.54 (1.19–1.98) 
 
 
No increased risk 
(SMRs not shown) 
Adjustment for age. (713) 
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Table A8. Cooking fumes. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Europe (non-Nordic)        
Study base: 77 081 women aged 15–59 
y in 1971, comprising a 1% sample of 
the population of England and Wales. 
Cohort: cooks. 
Referents: all employed women. 
1971–1981 Mortality from 
circulatory 
disease and IHD. 
Female cooks 
Circulatory disease 
IHD 
 
8 
8 
SMR 
1.80  
3.60 (1.55–7.09) 
 (673) 
Cohort: 1 798 male cooks who had 
retired from the Royal Army Catering 
Corps, UK, and were at the reserve list 
at any time 1974–1984. 
Internal referents: 1 310 referents 
retired from the Royal Army Pay 
Corps.  
External referents: national population.  
1974–1989 Mortality from 
CVD, IHD and 
CeVD. 
National rates 
CVD 
IHD 
CeVD 
 
Internal referents 
CVD 
IHD 
CeVD 
 
110 
83 
18 
 
 
110 
83 
18 
SMR 
1.45 (1.19–1.75) 
1.42 (1.13–1.76) 
2.05 (1.22–3.24) 
 
SMR a 
1.45 (1.07–1.96) 
1.43 (1.01–2.02) 
2.17 (0.94–4.99) 
 
 
 
 
 
a Poisson regression 
analysis.  
(183) 
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Table A9. Asbestos cement. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CIs) 
Confounder adjustments and 
comments  
Ref. 
Nordic countries        
Cohort: 1 176 male asbestos 
cement workers employed  
> 3 mo 1943–1976. 
Referents: Swedish national 
male rates. 
1951–1982 Mortality from 
circulatory 
disease. 
 
Circulatory disease 
Duration of exposure 
Latency time 0 y 
< 2 y 
2–4.9 y 
≥ 5 y 
Latency time 20 y 
< 2 y 
2–4.9 y 
≥ 5 y 
 
103 
SMR 
1.05 
 
 
1.11 
1.24 
0.94 
 
1.31 
1.00 
0.88 
Fibre concentrations averaged 
1 f/ml based on several hundred 
samples from five investigations 
1970–1976. During earlier decades 
ventilation was inferior and the 
fibre concentration was estimated 
to have been 2 f/ml in accordance 
with total dust measurements.  
The vast majority of asbestos used 
was chrysotile, but 630 tons of 
amosite were used 1949–1951 and 
400 tons of crocidolite in 1962. 
(723) 
Cohort: 1 929 male Swedish 
asbestos cement workers 
registered in the company 
personnel records 1907–1977 
employed ≥ 3 mo. 
Referents: 1 233 Swedish 
industrial workers. 
1927–1986 Mortality from 
heart disease 
(ICD-8, 410–
429). 
Heart disease 
Latency time 20 y, 
cum exp, f/ml-y 
< 15 
15–39 
≥ 40 
 
219 
RR 
1.1 (0.86–1.4) 
 
1.1 (0.87–1.5) 
0.9 (0.6–1.4) 
1.2 (0.8–1.9) 
P(slope): 0.7 
Estimated median cumulative 
exposure: 2–3 f/ml-y (median  
1–2 f/ml, predominantly 
chrysotile). 
13 cases of mesothelioma. 
 
(14) 
Cohort: 7 996 male Danish 
asbestos cement workers 
employed 1928–1984. 
Referents: Danish national 
male rates. 
1943–1984 Mortality from 
circulatory 
disease (ICD-6–
8, 410–429). 
 
Circulatory disease 
 
489 
SMR 
1.01 (0.92–1.11) 
Year and no. of particles (f/ml)  
1948: 50–800 
1957: 10–100 
1973: 41% of measurements > 2.  
(767) 
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Table A9. Asbestos cement. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CIs) 
Confounder adjustments and 
comments  
Ref. 
Europe (non-Nordic)        
Cohort: 1 510 men and 657 
women employed 1941–1983 
at an asbestos cement factory 
in England.  
Referents: national rates and 
local rates from the Tamworth 
Municipal Borough. 
1941–1984 Mortality from 
circulatory 
disease (ICD-9, 
390–459). 
Circulatory disease 
Males 
National rates 
Local rates 
Females 
National rates 
Local rates 
 
 
172 
 
 
54 
SMR 
 
0.87 (0.74–1.01) 
1.18 
 
1.16 (0.87–1.51) 
1.19 
Measured personal airborne fibre 
concentrations available since 1970 
showed mean levels < 1 f/ml. 
No excess of lung cancer and one 
case of mesothelioma. 
(326) 
Cohort: 2 525 male and 591 
female asbestos cement 
workers employed ≥ 3 mo 
1959–1980. 
Referents: Polish general 
population. 
Until 1991 Mortality (ICD-
9) from cir-
culatory disease 
(390–459), IHD 
(410–414) and 
CeVD (430–
438). 
Males 
Circulatory disease 
IHD 
CeVD 
Females 
Circulatory disease 
CeVD 
 
148 
65 
17 
 
8 
2 
SMR  
0.83 (0.78–0.98) 
0.96 (0.74–1.22) 
0.77 (0.45–1.23) 
 
0.69 (0.30–1.36) 
0.85 (0.10–3.07) 
Mainly chrysotile. 1970–mid 1980 
20% of the asbestos was crocidolite 
and amosite. 
An excess of mesothelioma was 
found, 7 vs 0.2 expected. 
(934) 
Cohort: 200 male and 62 
female asbestos cement 
workers employed in 1963 
and newly employed 1963–
1981 in a Carrara plant, Italy. 
Referents: general population 
of Toscana, Italy.  
1963–2003 Mortality from 
CVD (ICD-9, 
390–458). 
CVD 
Males 
Females 
 
30 
8 
SMR 
0.96 (0.65–1.37) 
0.62 (0.27–1.21) 
Exposure was to a mixture of 
chrysotile and crocidolite asbestos 
in a ratio of 2:5. 
An excess of pleura tumours was 
found, 4 vs 0.16 expected. 
(765) 
Cohort: 2 712 male and 646 
female asbestos cement 
workers 1952–1987 from 10 
plants in Emilia-Romagna, 
Italy. 
1952–1998 Mortality from 
CVD (ICD-9, 
390–459). 
 
CVD 
 
164 
SMR 
0.99 (0.84–1.15) 
This cohort was previously 
followed until 1989.  
Asbestos concentrations were up to 
40 f/ml prior to 1975 and < 0.5 f/ml 
in the late 1980s (335). 
(579) 
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Table A9. Asbestos cement. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CIs) 
Confounder adjustments and 
comments  
Ref. 
Referents: general population 
of Emilia-Romagna, Italy. 
An excess of pleura tumours was 
found, 18 vs 0.94 expected. 
Cohort: 1 247 male asbestos 
cement workers employed 
1950–1986 in a plant in 
Naples, Italy. 
Referents: general population 
of the Campania Region, 
Italy. 
1965–2005 Mortality (ICD-
9) from CVD 
(390–459) and 
IHD (410–414). 
 
CVD 
IHD 
CVD, latency time 
0–19 y 
20–29 y 
30–39 y 
≥ 40 y 
 
124 
41 
 
10 
28 
40 
46 
SMR 
0.57 (0.48–0.68) 
0.47 (0.34–0.64) 
 
0.51 (0.25–0.94) 
0.65 (0.43–0.94) 
0.62 (0.44–0.84) 
0.51 (0.38–0.68) 
An excess of pleura tumours was 
found, 24 vs 0.9 expected.  
In 1979, total asbestos concen-
trations were 0.03–1.033 f/ml, 
while crocidolite concentrations 
were 0.250–0.526 f/ml. 
(632) 
Cohort: 317 asbestos cement 
workers exposed ≥ 5 y  
1968–2006 in a plant near 
Thessaloniki, Greece. 
Referents: Greek male 
population. 
1968–2006 Mortality from 
circulatory 
disease. 
 
Circulatory disease 
 
23 
SMR 
0.77 (0.49–1.16) 
Asbestos fibre concentrations (f/ml)  
Before 1980: 3.5–6.5  
1981–1983: 1.1–1.7  
After 1983: < 1. 
(865) 
North America        
Cohort: 6 931 males 
employed ≥ 1 mo before 1970 
in 2 asbestos cement products 
manufacturing plants in New 
Orleans, Louisiana. 
Referents: US and Louisiana 
male populations.  
1970–1982 Mortality from 
CVD (ICD-8, 
390–448). 
CVD 
≥ 20 y after initial 
exposure 
 
638 
SMR 
0.88 
Employed after 1942 in plant A 
and after 1937 in plant B. 
Mean exposure (mppcf-y)  
Plant A: 7.8  
Plant B: 7.5. 
(427) 
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Table A9. Asbestos cement. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CIs) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 535 asbestos-exposed 
workers from an asbestos-
cement factory in Ontario, 
Canada. Hired before 1960 
and employed ≥ 1 y. 
Internal referents: 205 non-
exposed workers from the 
same factory. 
External referents: Ontario 
male population. 
1960–1981 Mortality from 
IHD (ICD-8, 
410–414). 
IHD, y since first 
exposure 
10–14 y 
Production workers 
Factory controls 
15–19 y 
Production workers 
Factory controls 
20–34 y 
Production workers 
Factory controls 
 
20 y latency from first 
exposure 
Factory controls 
Production workers 
Cum exposure, f/ml-y  
≤ 30 
30.1–75 
75.1–105 
105.1–150 
> 150 
 
 
 
4 
1 
 
7 
4 
 
10 
11 
 
 
 
11 
10 
 
1 
1 
3 
4 
1 
SMR 
 
 
0.86 
0.35 
 
0.98 
1.00 
 
0.58 
1.06 
 
Rate/1 000 man-y 
 
6.4 
 
 
1.0 
1.5 
6.7 
17.8 
2.4 
This study is also presented in 
reference (292). 
Exposure sampling started in 1969. 
Exposures were assumed to be the 
same 1962–1970, 30% higher 
1955–1961, and twice as high 
1948–1954. 
There were exposure-response 
relationships regarding both lung 
cancer and mesothelioma. 
 
Mortality rate/1 000 man-y, 
standardised to the age and latency 
distribution of the cohort as a 
whole for the period beyond 20 y 
from first exposure.  
 
 
 
 
P(trend): > 0.3. 
(293) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Nordic countries        
Cohort: 238 (192 men, 46 
women) quarry workers 
employed ≥ 1 y.  
Referents: Finnish 
population. 
1923–1980 Mortality from 
CVD (ICD-8, 
390–458). 
CVD, all 
Males 
Females 
CVD, highest exposures 
Males 
Females 
 
40 
9 
 
28 
4 
SMR 
1.01 
0.99 
 
1.10 
1.33 
Exposure was to wollastonite 
fibres which are similar to 
amphibole asbestos fibres in 
form, length and diameter but 
mineralogically different. 
Highest exposures: drilling, 
transport and crushing. 
(431) 
Europe (non-Nordic)        
Cohort: 878 asbestos 
textile workers in 
Rochdale, UK. 
Referents: national rates 
from the Registrar-
General. 
1916–1966 Mortality from 
circulatory disease 
(ICD-codes 400–
468, according to 
classification at 
relevant period). 
Circulatory disease, men 
Exposure duration,  
> 20 y, > 10 y before 
1933 (57 men) 
> 20 y, < 10 y before 
1933 (63 men) 
> 20 y, 0 y before 1933 
(136 men) 
10–19 y, 0 y before 1933 
(538 men) 
 
 
13 
 
8 
 
9 
 
24 
 
 
5.33 expected 
(P: 0.003) 
5.66 expected 
(P: 0.211) 
4.03 expected 
(P: 0.022) 
22.6 expected 
(P: 0.412) 
Chrysotile was predominantly 
used, but also small amounts 
of crocidolite.  
In 1933, ventilation was 
introduced in carding and 
weaving. 
Exposure concentrations 
1961: 2–8 f/ml 
1966: 1–8 f/ml. 
(501) 
Cohorts: asbestos textile 
workers in Rochdale, UK. 
Same factory as above. 
A: 145 men employed  
≥ 20 y, including some 
time before 1933. 
B: 283 women first 
employed 1933–1962,  
total employment ≥ 10 y,  
Until 1983 Mortality from 
circulatory 
disease (ICD-
codes not given). 
Circulatory disease  
(vs national rates) 
Cohort A 
≥ 10 y before 1933 
< 10 y before 1933 
Cohort B 
Employed 1933–1950 
Employed 1950–1974 
Cohort C 
 
 
 
26 
23 
 
10 
0 
 
SMR 
 
 
1.94 
1.22 
 
0.81 
3.29 expected 
 
Conditions were much dustier 
before 1933 than after.  
Exposure 1951–1955 
157–978 particles/ml  
(5–28 f/ml). 
Exposure 1956–1960 
153–978 particles/ml  
(4–28 f/ml).  
Exposure 1961–1970 
(744) 
 278 
 
Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
C: 3 211 men employed 
1933–1974.  
Referents: national rates 
from England and Wales, 
and local Rockdale rates. 
Exposure < 10 y 
Exposure ≥ 10 y 
407 
129 
1.16 
1.10 
2.5–20 f/ml.  
Exposure 1971–1974 
2.5–7.5 f/ml. 
Cohort: 94 403 men and 
4 509 women from the 
1971 Asbestos Workers 
Survey in Great Britain. 
Main activities were 
manufacturing and 
removal. 
Referents: national rates 
from Great Britain. 
1971–2005 Mortality from 
IHD (ICD-9, 410–
414; ICD-10, I20–
I25) and CeVD 
(ICD-9, 430–438; 
ICD-10, I60–I69). 
IHD 
Males 
Females 
Exposure duration 
< 10 y 
10–19 y 
20–29 y 
30–39 y 
≥ 40 y 
CeVD 
Males 
Females 
Exposure duration 
< 10 y 
10–19 y 
20–29 y 
30–39 y 
≥ 40 y 
 
3 870 
175 
 
 
 
 
 
 
 
933 
90 
SMR 
1.28 (1.24–1.32) 
1.61 (1.38–1.87) 
RR 
1 
1.16 (1.03–1.30) 
1.10 (0.98–1.24) 
1.15 (1.02–1.30) 
1.25 (1.10–1.42) 
SMR 
1.51 (1.42–1.61) 
1.86 (1.49–2.28) 
RR 
1 
1.20 (0.93–1.56) 
1.05 (0.80–1.37) 
1.04 (0.79–1.38) 
1.22 (0.93–1.62) 
Adjustment for age and 
smoking.  
Duration of exposure was 
significantly related to IHD. 
Lack of information 
regarding individual 
exposure. 
The model included job,  
year of birth, duration of 
exposure, sex, age attained, 
and smoking status. 
(382, 
383) 
Cohort: 31 302 stripping/ 
removal workers from the 
1971 Asbestos Workers 
Survey in Great Britain. 
Referents: national rates 
from England, Wales and 
1971–2005 Mortality from 
circulatory 
disease, IHD and 
CeVD. 
Weekly hours stripping 
Circulatory disease 
< 10 h 
10– < 20 h 
20– < 30 h 
30– < 40 h 
 
 
133 
16 
28 
32 
RR 
 
1.0 
0.8 (0.5–1.4) 
1.1 (0.7–1.6) 
1.4 (0.9–2.1) 
RR adjusted with Poisson 
regression for age, calendar 
period and sex. 
(317) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Scotland. ≥ 40 h 
IHD 
< 10 h 
10– < 20 h 
20– < 30 h 
30– < 40 h 
≥ 40 
CeVD 
< 10 h 
10– < 30 h 
30– < 40 h 
≥ 40 h 
47 
 
86 
12 
16 
24 
32 
 
21 
10 
10 
– 
1.7 (1.2–2.4) 
 
1.0 
1.0 (0.5–1.8) 
0.9 (0.6–1.6) 
1.6 (1.0–2.6) 
1.9 (1.2–2.8) 
 
1.0 
1.4 (0.6–2.9) 
1.2 (0.6–2.7) 
Cohort: 933 male 
chrysotile asbestos miners 
employed ≥ 30 d 1930–
1965 in Balangero, North 
Italy. 
Referents: Italian national 
rates. 
1946–1975 Mortality from 
CVD (ICD-7, 
400–468). 
 
CVD 
Years since 1st exposure 
≤ 19 y 
≥ 20 y 
 
122 
 
22 
100 
SMR 
1.48 (P < 0.01) 
 
1.49 
1.48 (P < 0.01) 
When cumulative exposure 
≥ 101 f/ml-y was compared 
with ≤ 100 f/ml-y, the RR 
was 1.27.  
(806) 
Cohort: 1 058 male 
chrysotile asbestos miners 
who had worked ≥ 1 y 
1946–1987 in Balangero, 
North Italy. 
Referents: Italian national 
rates. 
1946–1987 Mortality from 
unspecified CVD, 
IHD and stroke. 
 
CVD 
IHD 
Exposure duration 
< 10 y 
10–20 y 
> 20 y 
Stroke 
Exposure duration 
< 10 y 
 
100 
37 
 
16 
11 
10 
31 
 
20 
SMR 
1.63 
0.8 
 
0.8 
1.1 
0.6 
1.0  
 
1.4 
No relationship with duration 
of exposure. 
(751) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
10–20 y 
> 20 y 
2 
9 
0.3 
0.9 
Cohort: 1 056 male 
chrysotile asbestos miners 
who had worked ≥ 1 y 
1930–1975 in Balangero, 
North Italy. 
Referents: Italian national 
rates before 1981 and 
regional rates from the 
province of Turin 1981–
2001. 
1946–2003 Mortality from 
circulatory 
disease (ICD-9, 
390–459), IHD 
and CeVD. 
 
Circulatory disease 
IHD 
CeVD 
 
212 
59 
38 
SMR 
Not given a 
0.93 (0.71–1.20) 
0.90 (0.64–1.24) 
Workers employed 1930–1945 
who did not survive until 
January 1946 were excluded. 
The mine was closed in 1990. 
a The excess mortality from 
circulatory disease contributed 
an important no. of excess 
deaths (no expected numbers 
presented). Excessive alcohol 
intake might explain some of 
the excess; SMR for liver 
cirrhosis 2.9 (2.2–3.8).  
(752) 
Cohort: 1 534 male rail-
way carriage construction 
workers employed 1970 or 
hired 1970–1989. 
Referents: regional male 
rates from Regione 
Campania, Italy. 
1970–1989 Mortality from 
circulatory 
disease. 
 
Circulatory disease 
 
58 
SMR 
0.64 (0.51–0.80) 
3 cases of pleural cancer:  
SMR 4.72 (1.3–12.2).  
(631) 
Cohort: 734 workers  
in railway carriage 
construction and repair 
employed 1945–1969. 
Referents: regional rates 
from Tuscany Region, 
Italy. 
1970–1997 Mortality from 
circulatory 
disease (ICD-8 
and ICD-9). 
 
Circulatory disease 
 
55 
SMR (90% CI) 
0.73 (0.58–0.92) 
5 cases of malignant pleural 
neoplasms: SMR 13.3 (90% 
CI 5.23–27.9) of which 4 
were confirmed cases of 
mesothelioma. 
(70) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
North America        
Cohort: 3 641 men 
employed ≥ 1 mo 1938–
1958 in a plant producing 
friction materials and 
packings in Connecticut. 
Referents: regional rates 
from Connecticut, US.  
Until 1977 Mortality (ICD-7) 
from heart disease 
(400–443) and 
CeVD (330–334).  
Heart disease 20 y after 
first employment 
Duration of service 
< 1 y 
1– < 5 y 
5– < 20 y 
≥ 20 y 
CeVD 20 y after first 
employment 
Duration of service 
< 1 y 
1– < 5 y 
5– < 20 y 
≥ 20 y 
Heart disease 20 y after 
first employment,  
cum exp, mppcf-y 
< 10 
10– < 2 
20– < 40 
40– < 80 
≥ 80 
CeVD 20 y after first 
employment,  
cum exp, mppcf-y 
< 10 
10– < 20 
20– < 40 
 
322 
 
99 
79 
44 
100 
 
67 
 
18 
14 
15 
20 
 
 
 
60 
14 
13 
18 
13 
 
 
 
43 
8 
7 
SMR 
1.03 
 
1.25 
1.05 
0.84 
0.93 
 
1.20 
 
1.38 
1.08 
1.43 
1.02 
 
 
 
1.02 
0.84 
0.77 
1.06 
0.93 
 
 
 
1.23 
1.02 
1.18 
Until 1957, only chrysotile 
was used in the production 
and after that also a little 
anthophyllite. 
No cases of mesothelioma. 
SMR for respiratory cancer 
was 1.49 for the total cohort, 
1.67 for men with exposure 
< 10 mppcf-y and 1.63 for 
men with exposure 40–80 
mppcf-y. 
The authors considered the 
possibility that the short-term 
employees had worked in 
other hazardous industries 
before or after employment 
in the asbestos plant. This 
appeared to explain nearly all 
deaths from pneumoconiosis. 
Of 12 deaths from pneumo-
coniosis all but 2 were 
ascribed to anthraco-silicosis 
or silicosis and none to 
asbestosis. 
(615) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
40– < 80 
≥ 80 
5 
4 
1.17 
1.35 
Cohort: 4 137 men em-
ployed ≥ 1 mo 1938–1959 
in a plant manufacturing 
mainly textiles but also 
friction products and 
packings in Pennsylvania. 
Referents: regional rates 
from Pennsylvania, US. 
Until 1977 Mortality (ICD-7) 
from heart disease 
(400–443) and 
CeVD (330–334). 
Heart disease 20 y after 
first employment 
Duration of service 
< 1 y 
1– < 5 y 
5– < 20 y 
≥ 20 y 
CeVD 20 y after first 
employment 
Duration of service 
< 1 y 
1– < 5 y 
5– < 20 y 
≥ 20 y 
Heart disease 20 y after 
first employment, cum 
exp, mppcf-y 
< 10 
10– < 20 
20– < 40 
40– < 80 
≥ 80 
CeVD 20 y after first 
employment, cum exp, 
mppcf-y 
< 10 
10– < 20 
 
385 
 
77 
77 
78 
153 
 
47 
 
7 
10 
10 
20 
 
 
 
221 
41 
60 
34 
29 
 
 
 
27 
1 
SMR 
1.09 
 
0.93 
1.25 
1.00 
1.16 
 
0.81 
 
0.55 
1.07 
0.78 
0.88 
 
 
 
1.03 
0.89 
1.31 
1.31 
1.09 
 
 
 
0.78 
0.13 
Chrysotile was the main type 
of asbestos used; 3 000–6 000 
tons annually. Crocidolite 
and amosite were used from 
1924 onwards for making 
insulation blankets, for 
locomotives and turbines and 
equipment for chemical 
factories and paper mills. In 
1943, the use of amosite 
reached a peak of 600 tons. 
About 1939, exhaust 
ventilation was installed in 
the textile mill.  
14 mesothelioma cases  
(10 pleural, 4 peritoneal). 
The SMR for respiratory 
cancer was 1.05 for all the 
cohort, but risk rose linearly 
from 0.67 for men with  
< 10 mppcf-y to 4.16 for 
those with ≥ 80 mppcf-y. 
(614) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
20– < 40 
40– < 80 
≥ 80 
10 
8 
1 
1.34 
1.87 
0.29 
Cohort: 820 male amosite 
asbestos factory workers in 
Paterson, New Jersey, 
recruited 1941–1945. 
Referents: white male 
population of New Jersey, 
US. 
1945–1982 Mortality from 
CVD (ICD-7–9). 
Years since first exposure 
5–9 y 
10–14 y 
15–19 y 
20–24 y 
25–29 y 
30–34 y 
35–39 y 
 
16 
29 
41 
47 
49 
29 
21 
SMR 
0.64 
0.92 
1.11 
1.30 
1.44 (P < 0.05) 
1.10 
1.14 
Underlying cause of death 
coded according to best 
evidence available.  
Amosite was used virtually 
exclusively; no crocidolite, 
very little chrysotile. 
Estimated median fibre 
exposure; 50 f/ml.  
17 mesothelioma cases  
(8 pleural, 9 peritoneal).  
SMR for respiratory cancer 
significantly increased after 
10 y since onset of work. 
(853) 
Cohort: 406 vermiculite 
mine workers in Libby, 
Montana, employed ≥ 1 y 
before 1963. 
Referent: US white male 
population. 
1963–1999 Mortality from 
circulatory 
disease (ICD-9, 
390–459). 
 
Circulatory disease 
 
104 
SMR 
0.95 (0.77–1.15) 
The miners were exposed to 
fibrous tremolite, an 
amphibole asbestiform 
mineral. Before 1970, fibre 
concentrations were very 
high at many locations, 
especially in the dry mill, 
where they were estimated to 
> 100 f/ml. After that levels 
fell and by 1980 almost all 
were < 1 f/ml.  
(618) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
There was a significantly 
increased risk of respiratory 
cancers. 
Cohort: 1 862 vermiculite 
workers exposed to Libby 
amphibole ≥ 6 mo before 
the mine closed 1990. 
Referent: US national 
rates. 
Until 2006 Mortality from 
heart disease 
(ICD-9–10), IHD 
(ICD-9, 410–414, 
429.2; ICD-10, 
I20–I22, I24–I25, 
151.3, 151.6), 
other heart disease 
(ICD-9, 420–423, 
428, 429.0–429.1, 
429.3–429.9), 
diseases of the 
circulatory system 
(ICD-9, 430–438, 
401, 403, 405, 
415–417, 440–
459), hypertension 
without heart 
disease (ICD-9, 
401, 403, 405), 
diseases of 
arteries, veins or 
lymphatic vessels 
(ICD-9, 415–417, 
440–459) and 
CVD (ICD-9, 
 
Heart disease 
IHD 
Other heart disease 
Circulatory disease 
Hypertension 
Vessels 
CVD with 20-y lag,  
cum exp, f/ml-y 
< 1.4 
1.4– < 8.6 
8.6– < 44.0 
≥ 44.0 
 
 
 
552 
247 
120 
258 
42 
136 
 
 
97 
125 
107 
114 
 
 
SMR 
0.9 (0.9–1.0) 
0.7 (0.6–0.8) 
1.5 (1.2–1.8) 
1.4 (1.2–1.6) 
1.7 (1.2–2.4) 
1.7 (1.4–2.0) 
 
RR 
1.0 
1.3 (1.0–1.6) 
1.3 (1.0–1.6) 
1.5 (1.1–2.0) 
Model P-value 
0.0067 
 
Libby vermiculite also 
contains actinolite and 
unregulated asbestos-like 
fibres, including winchite and 
richterite. 
19 cases of mesothelioma. 
Lung cancer RRs increased 
monotonically with 
cumulative fibre exposure. 
Smoking was an unmeasured 
confounder for much of this 
cohort. Based on smoking 
data available for 336 
workers who participated in a 
screening, the proportion of 
smokers was 50–66% among 
the unexposed and 66–85% 
among the exposed.  
With a Monte Carlo-approach 
the adjusted and unadjusted 
RRs for CVD were 1.5 and 
1.6, respectively. 
(539) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
410–414, 426–
438, 440–448; 
ICD-10, I25, I70–
I79). 
Cohort: 5 770 asbestos 
textile workers (3 975 
males, 1 795 females) from 
4 plants in North Carolina, 
exposed ≥ 1 d 1950–1973. 
Referents: US national 
population. 
1950–2003 Mortality (ICD-6–
10) from diseases 
of the heart and 
other circulatory 
disease. 
 
Heart disease 
Other circulatory disease 
 
730 
229 
SMR 
1.32 (1.22–1.42) 
1.47 (1.29–1.66) 
Only chrysotile was used 
except for one plant in which 
limited amounts of amosite 
was used around 1963–1976. 
Mean cumulative exposure: 
17.1 f/ml-y  
(range < 0.1–2 943). 
Increased risk of meso-
thelioma based on 4 cases 
(SMR 10.9, 95% CI 3.0–28.0). 
36 deaths from asbestosis. 
(576) 
Cohort: 1 261 white male 
chrysotile textile workers 
from South Carolina, 
exposed ≥ 1 mo 1940–
1965. 
Referents: US population. 
1940–1975 Mortality (ICD-7) 
from diseases of 
the circulatory 
system (400–468) 
and vascular 
lesions of the 
CNS (330–334, 
345). 
 
Circulatory disease 
Vascular CNS lesions 
Circulatory disease,  
cum exposure, f/ml-d 
< 1 000 
1 000–10 000 
10 000–40 000 
40 000–100 000 
> 100 000 
 
105 
15 
 
 
34 
24 
24 
8 
2 
SMR 
1.25 (P < 0.05) 
1.37 
 
 
1.39 
1.12 
1.58 (P < 0.05) 
1.23 
1.57 
Only 1 mesothelioma 
(peritoneal) was observed. 
Several deaths from cancer of 
the abdomen (suspected 
mesothelioma, but no 
autopsies were performed).  
An exposure-response 
relationship was found for 
lung cancer.  
(224) 
Cohort: 3 022 chrysotile 
textile workers from South 
Carolina, exposed ≥ 1 mo 
1940–1990 Mortality (ICD-9) 
from heart disease 
(390–398, 402, 
Heart disease 
All 
White males 
 
414 
226 
SMR (90% CI) 
1.22 (1.12–1.32) 
1.41 (1.26–1.58) 
Chrysotile was the only type  
of asbestos processed as raw 
fibre. Crocidolite yarn was 
(223) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
1940–1965. 
Referents: US population. 
404, 410–414, 
420–429), IHD 
(410–414) and 
CeVD (430–438). 
White females 
Black males 
 
IHD 
All 
White males 
White females 
Black males 
 
CeVD 
All 
White males 
White females 
Black males 
106 
82 
 
 
321 
188 
76 
57 
 
 
75 
31 
22 
22 
1.13 (0.95–1.32) 
0.96 (0.79–1.16) 
 
 
1.25 (1.13–1.37) 
1.43 (1.26–1.61) 
1.10 (0.90–1.33) 
1.02 (0.81–1.27) 
 
 
1.12 (0.91–1.35) 
1.50 (1.08–2.02) 
0.93 (0.63–1.32) 
0.93 (0.66–1.40) 
used in small quantities 
(~ 2 000 pounds crocidolite 
and 6–8 million pounds/y of 
chrysotile) from 1950s until 
1975. Crocidolite was never 
carded, spun, or twisted: thus, 
the predominant exposure by 
far was to chrysotile asbestos. 
Most changes to control dust 
exposures were in place by 
1940 and processes remained 
fairly constant from 1940 until 
production ceased in the late 
1970s. Median cumulative 
exposures for white males, 
white females and black males 
were 1 462, 1 531 and 5 316 
f/ml-d, respectively.  
2 cases of mesothelioma 
(white males). 
The lung cancer risk increased 
by 2% for each f/ml-y. 
Cohort: 3 072 chrysotile 
textile workers from South 
Carolina, exposed ≥ 1 mo 
1940–1965. In principle 
the same cohort as above 
(223). 
1940–2001 Mortality (ICD 
according to the 
revision at the 
time of death) 
from heart 
disease, IHD, 
other disease of 
Cohort vs US rates 
Heart disease 
All 
White males 
Non-white males 
Females 
IHD 
 
 
594 
295 
101 
198 
 
SMR 
 
1.20 (1.10–1.30) 
1.38 (1.23–1.55) 
0.95 (0.77–1.15) 
1.12 (0.97–1.29) 
 
3 cases of mesothelioma.  
A strong exposure-response 
relationship between 
estimated chrysotile exposure 
and lung cancer mortality. 
(396) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Referents: US and South 
Carolina populations. 
the heart, other 
disease of the 
circulatory 
system, and 
CeVD. 
All 
White males 
Non-white males 
Females 
Other heart disease 
All 
White males 
Non-white males 
Females 
Other circulatory disease 
All 
White males 
Non-white males 
Females 
CeVD 
All 
White males 
Non-white males 
Females 
469 
250 
70 
149 
 
81 
28 
20 
33 
 
185 
65 
42 
78 
 
131 
49 
28 
54 
1.20 (1.10–1.32) 
1.39 (1.22–1.58) 
0.92 (0.72–1.17) 
1.11 (0.94–1.30) 
 
1.27 (1.01–1.58) 
1.28 (0.85–1.86) 
1.16 (0.71–1.78) 
1.34 (0.92–1.88) 
 
1.28 (1.10–1.47) 
1.46 (1.12–1.86) 
1.11 (0.80–1.50) 
1.25 (0.99–1.56) 
 
1.29 (1.08–1.53) 
1.70 (1.25–2.24) 
1.03 (0.69–1.49) 
1.19 (0.90–1.56) 
Cohort: 1 130 former 
workers of a plant in Tyler, 
Texas, manufacturing 
asbestos pipe insulation 
materials containing 
amosite 1954–1972. 
The mortality analysis 
included 753 men ≥ 10 y 
since first employment. 
Black men and women 
Until 1993 Mortality (ICD-9) 
from all heart 
disease and CeVD.  
 
All heart disease  
CeVD 
 
60 
13 
SMR 
1.18 (0.90–1.52) 
2.21 (1.17–3.77) 
81% current or ex-smokers. 
Duration of employment:  
1 d to 17.3 y, mean (median) 
12.7 (1.6) mo. 
Exposure levels measured in 
1967, 1970 and 1971 were 
15.9–91.4 f/ml. 
6 mesothelioma cases  
(4 pleural and 2 peritoneal). 
(555) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
were excluded. 
Referents: US population. 
Cohort: 2 833 white men 
who worked in the US 
asbestos products industry 
1948–1951. Most men 
worked in the asbestos 
textile industry. 
Referents: US white male 
population. 
1948–1963 Mortality (ICD-7) 
from CVD (400–
468), heart disease 
(400–443), CHD 
(420), hyper-
tensive heart 
disease (440–443) 
and stroke (330–
334). 
 
CVD 
Heart disease 
CHD 
Hypertension 
Stroke  
 
130 
122 
87 
14 
9 
SMR 
1.18 
1.19 
1.04 
2.41 (P < 0.05) 
0.68 
There was a significantly 
increased risk for respiratory 
cancers (24 vs 11.9 
expected).  
(256) 
Cohort: 1 464 men retired 
from the US asbestos 
industry during 1941–1967 
(1 026 production workers 
and 438 maintenance-
service workers). 
Referents: US white male 
population. 
1941–1969 Mortality (ICD-7) 
from all heart 
disease (400–
443), CHD (420), 
all other heart 
disease, and 
stroke (330–334). 
 
All heart disease 
Cum exposure, mppcf-y 
< 125 
125–249 
250–499 
500–749 
≥ 750 
CHD 
Cum exposure, mppcf-y 
< 125 
125–249 
250–499 
500–749 
≥ 750 
All other heart disease  
Cum exposure, mppcf-y 
< 125 
 
362 
 
168 
72 
75 
36 
11 
275 
 
129 
59 
55 
24 
8 
87 
 
39 
SMR 
1.08 
 
1.04 
1.10 
1.02 
1.53 (P < 0.05) 
0.89 
1.04 
 
1.03 
1.13 
0.95 
1.28 
0.81 
1.20 
 
1.07 
Other heart diseases included 
cor pulmonale. 
Average duration of 
employment 25 (3–51) y. 
Historical exposure levels 
sometimes > 50 mppcf. 
6.4% of production workers 
and 4.3% of maintenance 
service workers had retired 
due to disability.  
There was almost a linear 
relationship between asbestos 
exposure and respiratory 
cancer.  
1 case of mesothelioma.  
(255) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
125–249 
250–499 
500–749 
≥ 750 
Stroke 
Cum exposure, mppcf-y 
< 125 
125–249 
250–499 
500–749 
≥ 750 
13 
20 
12 
3 
68 
 
31 
14 
15 
5 
3 
0.98 
1.29 
2.55 (P < 0.05) 
1.25 
0.80 
 
0.74 
0.86 
0.82 
0.89 
1.00 
Cohort: 1 074 white men 
retired from a US asbestos 
company 1941–1967. 
Referents: US white male 
population. 
1941–1980 Mortality (ICD-7) 
from all heart 
disease (400–
443), CHD (420), 
other heart 
disease, and 
stroke (330–334). 
 
All heart disease  
CHD 
Other heart disease 
Stroke 
 
395 
315 
53 
85 
SMR 
1.12 (P < 0.05) 
1.12 (P < 0.05) 
1.13 
0.92 
Average duration of employ-
ment: 25 (3–51) y. The re-
lationship between asbestos 
exposure and respiratory 
cancer was linear. 
8 mesothelioma cases. 
(259) 
Cohort: 17 800 male mem-
bers of the International 
Association of Heat and 
Frost Insulators and 
Asbestos Workers in the 
US and Canada.  
Referents: 73 763 white 
male workers with a 
history of occupational 
exposure to dust, fumes, 
vapours, gases, chemicals 
1967–1976 CVD mortality  CVD 
Referent workers 
Referent workers 
 
US rates 
US rates 
 
638 
566 
 
638 
566 
RR  
0.97 DC 
0.86 BE 
 
0.85 DC 
0.75 BE 
Cause of death according to:  
DC: death certificate 
BE: best evidence available. 
(379) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
or radiation, and US white 
male national rates. 
Cohort: 11 000 men born 
1891–1920 and employed 
≥ 1 mo in the chrysotile 
mines and mills of Quebec. 
Follow-up of 5 335 men 
alive in 1976 and ≥ 55 y 
old.  
Referents: Quebec male 
rates. 
1976–1988 Mortality (ICD 8–
9) from all IHD 
(410–413), other 
heart disease 
(391, 392.0, 402, 
415–429) and 
CeVD (430–438). 
 
IHD 
Other heart disease 
CeVD 
IHD ≥ 20 y after first 
employment, cum exp, 
mppcf-y 
< 30 
30– < 100 
100– < 300 
≥ 300 
CeVD, cum exp, mppcf-y  
< 30 
30– < 100 
100– < 300 
≥ 300  
 
828 
185 
225 
 
 
 
302 
155 
166 
181 
 
81 
32 
44 
59 
SMR 
1.02 
1.00 
1.06 
 
 
 
0.92 
0.97 
1.09 
1.24 
 
0.89 
0.79 
1.16 
1.62 
No adjustment for smoking 
habits. 
25 cases of mesothelioma. 
(619) 
Australia         
Cohort: 6 498 males who 
had worked at the 
Wittenoom crocidolite 
mine and mill in Australia 
at any time 1943–1966.  
Referents: male rates from 
Western Australia. 
Until 2000 Mortality from 
circulatory 
disease  
(ICD-7–10). 
 
Circulatory disease 
 
699 
SMR 
0.79 (0.73–0.85) a 
1.35 (1.25–1.45) b 
a Lost to follow-up assumed 
alive at 2000. 
b Lost to follow-up censored 
at their date last known to be 
alive. 
316 mesothelioma cases (190 
pleural and 32 peritoneal).  
(687) 
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Table A10. Miscellaneous asbestos exposures.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 411 women 
employed in the mining 
and milling of crocidolite 
at Wittenoom 1943–1966. 
Referents: female rates 
from Western Australia. 
Until 1980 Mortality from 
circulatory 
disease (ICD-
codes not given). 
 
Circulatory disease 
 
6 
SMR 
0.60 (0.27–1.32) a 
1.03 (0.46–2.29) b 
a Lost to follow-up assumed 
alive at 1980.  
b Lost to follow-up censored 
at their date last known to be 
alive. 
(46) 
Asia        
Cohort: 1 932 chrysotile 
asbestos miners in China 
who worked ≥ 1 y 1981–
1988. Exposed: miners, 
blasters, mechanics, and 
maintenance and transport 
workers. Not directly 
exposed (internal referents): 
management and service 
workers.  
Referents: Chinese national 
rates. 
1981–2010 Mortality from 
CVD and CeVD. 
National rates 
CVD 
CeVD 
Internal referents 
CVD 
CeVD 
 
56 
50 
 
56 
50 
SMR 
1.27 (0.96–1.63) 
1.38 (1.03–1.79) 
RR 
1.30 (0.79–2.14) 
1.75 (1.00–3.08) 
In 2009, dust concentrations 
were 4.3–196.7 mg/m3. 
There was a significantly 
increased risk for pulmonary 
heart disease, SMR 2.70.  
The RR was adjusted for 
gender and smoking habits. 
No cases of mesothelioma.  
(242) 
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Table A11. Asbestosis and pleural plaques as proxies for asbestos exposure. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Nordic countries        
Cohort: 1 725 male shipyard 
workers born 1910–1929, 
exposed to asbestos in Sweden, 
80 died from IHD. Indicators  
of exposure were asbestosis or 
pleural plaques. 
Internal comparison (referents): 
men with asbestosis or suspected 
asbestosis vs men without 
asbestosis. Men with pleural 
plaques vs men without pleural 
plaques.  
1977–1988 Mortality from 
IHD (ICD-8, 410–
414). 
IHD 
Asbestosis or 
suspected 
asbestosis 
Pleural plaques 
 RR 
3.1 (1.5–6.4)  
 
 
1.3 (0.8–2.0) 
Adjustment for age and smoking 
habits. 
(825) 
Case-control study 
Cases: 148 patients (101 men, 
47 women) referred to Helsinki 
hospital for coronary angio-
graphy. 
Controls: 100 lung cancer 
patients (72 men, 28 women) 
from the same hospital.  
 Patients referred  
to hospital for 
coronary angio-
graphy. 
Prevalence of 
calcified pleural 
plaques 
Cases, 35 % 
Controls, 19% 
 
 
 
52 
19 
RR 
 
 
2.19 (1.44–3.32) 
Adjustment for age and gender. (507) 
Cohort: 584 (574 men, 10 
women) asbestos-exposed 
construction workers screened 
with computed tomography (CT), 
1996–1997.  
Until 
2007–2008 
Mortality from 
CVD (ICD-10, 
I00–I99). 
CVD 
Paraseptal 
Emphysema 
bullae 
64 HR 
1.32 (1.11–1.56) 
1.19 (1.01–1.41) 
85 workers had asbestosis and 
probably all had pleural plaques. 
(997) 
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Table A11. Asbestosis and pleural plaques as proxies for asbestos exposure. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 633 (627 men, 6 
women) asbestos-exposed 
workers investigated with 
HRCT. Workers participating in 
a screening program 1990–1992, 
and workers with asbestosis or 
asbestos-related pleural patho-
logy visiting clinics in Helsinki 
or Tampere, Finland.  
Until 2013 Mortality from 
CVD (ICD-10, 
I00–I99). 
CVD 
Emphysema 
Visceral pleural 
abnormalities 
Bronchial wall 
thickening 
38 HR 
1.09 (1.02–1.12) 
2.36 (1.16–4.80) 
 
1.69 (0.80–3.54) 
HRCT: high-resolution 
computed tomography. 
Cox regression with adjustment 
for age, sex, smoked pack-years 
and asbestos exposure index. 
Almost all had parietal pleural 
abnormalities. 
(996) 
Europe (non-Nordic)        
Cohort: 233 asbestos cement 
workers employed by a 
company in Bari, Italy, and 
compensated for asbestosis. 
Referents: regional population 
of Apulia Region, Italy.  
1979–1997 Mortality from 
circulatory disease 
(ICD-9). 
 
Circulatory dis. 
 
18 
SMR (90% CI) 
0.64 (0.41–0.95) 
Criteria for compensation were  
not described and changed over 
time (presented in Italian). 
Mortality (observed vs expected):  
Pneumoconiosis: 14 vs 0.12  
Pleural tumours: 4 vs 0.16. 
(81) 
Cohort: 631 Italian women 
compensated for asbestosis. 
Referents: Italian female 
population. 
1980–1997 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
hypertension (401–
404), IHD (410–
414) and CeVD 
(430–438). 
 
Circulatory dis. 
Hypertension 
IHD 
CeVD 
 
77 
10 
12 
25 
SMR 
0.89 (0.70–1.12) 
1.47 (0.70–2.70) 
0.53 (0.28–0.93) 
0.87 (0.56–1.28) 
Subjects may have been 
diagnosed with asbestosis 
according to different criteria,  
as diagnostic procedures and 
standards for evaluation have 
evolved over time. 
Mortality (SMR): 
Pneumoconiosis: ~ 41  
Pleural tumours: 64. 
(330) 
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Table A11. Asbestosis and pleural plaques as proxies for asbestos exposure. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
North America        
Cohort: 4 559 male chrysotile 
miners and millers in Quebec 
born 1891–1920 who worked 
≥ 1 mo. Last radiograph 1967. 
Workers with abnormal radio-
logical signs were compared 
with workers with normal 
radiological examinations. 
Until 1975 Mortality (ICD-7) 
from diseases of 
the heart (400–443) 
and CeVD (330–
334). 
Heart diseases 
Normal 
Less than normal 
Small opacities 
Large opacities 
PC 
UPC 
 
CeVD 
Normal 
Less than normal 
566 
331 
235 
 
 
 
 
 
 
62 
39 
RR 
1 
1.53 (X2 25.25) 
1.71 (X2 27.92) 
1.12 (X2 0.05) 
1.34 (X2 2.25) 
1.54 (X2 13.96, 
P < 0.005) 
 
1 
1.17 (X2 0.59) 
Chest radiographs were read by 
six experienced readers.  
 
 
 
PC: Pleural calcification. 
UPC: Uncalcified pleural 
changes. 
(564) 
Australia        
Cohort: 354 male claimants for 
compensation for asbestosis 
1947–1982 among former 
workers of the Wittenoom 
crocidolite mine and mill in 
Western Australia. 
Referents: male rates from 
Western Australia. 
Until 1982 Mortality from 
IHD (ICD-9, 
410.0–414.9). 
 
IHD 
 
22 
SMR 
1.43 (P = 0.065) 
No smoking information. (191) 
Cohort: Plain chest radiographs 
from a 1/6 random sample of the 
workforce, 1 106 men, of the 
asbestos industry at Wittenoom, 
Western Australia 1943–1966 
were classified for degree of 
profusion and pleural thickening. 
Until 1986 Mortality from 
other causes, in 
which IHD formed 
the largest 
proportion. 
 
Pleural 
thickening 
 RR  
1.5 (1.3–1.8)  
 (217) 
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Table A11. Asbestosis and pleural plaques as proxies for asbestos exposure. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Asia        
Cohort: 124 male workers with 
asbestosis in Hong Kong 1981–
2008. Asbestosis defined as 
positive radiographic findings of 
the lungs (profusion on small 
opacities of ≥ 1/0).  
Referents: Hong Kong male 
population. 
1981–2008 Mortality (ICD-9) 
from heart disease 
(410–414, 428), 
acute MI (410) and 
chronic IHD (414). 
 
Heart disease 
Acute MI 
Chronic IHD 
 
7 
4 
2 
SMR 
3.24 (1.30–6.67) 
4.32 (1.17–11.1) 
3.12 (0.37–11.3) 
Indirect smoking adjustment:  
2.32 (0.93–4.79) 
3.10 (0.84–7.94). 
(159) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Nordic countries         
Case-control study: 26 847 
men with first MI, 2 controls 
for each case. 
Stockholm 
County: 
1976–1984 
Other 
counties: 
1976–1981 
Incidence of first 
MI, mortality 
(ICD-8, 410) and 
hospital 
discharges 
(410.00, 410.99). 
First MI 
Stonecutters and 
carvers 
 RR 
2.0 (1.2–3.6) 
 
1.9 (1.1–3.4) 
 
Adjustment for age, county and 
calendar year. 
Adjustment for age, county and 
socioeconomic group.  
(377) 
All gainfully employed men 
identified in the Swedish 
census 1970. 
Cohort: 6 814 miners, 1 369 
well borers, 743 dressing 
plant workers and 2 970 
other male mine and stone 
workers. 
Referents: 2 million gainfully 
employed men.  
1970–1995 Mortality from 
IHD (ICD-8–9, 
410–414). 
IHD 
Miners 
Well borers 
Dressing plant 
Other workers 
All workers 
 
886 
141 
107 
298 
1 432 
SMR 
1.29 (1.21–1.38) 
1.28 (1.08–1.51) 
1.40 (1.15–1.69) 
1.35 (1.20–1.51) 
1.31 (1.24–1.38) 
No adjustment for smoking 
habits or socioeconomic status. 
(1000) 
Cohort: 13 621 male miners 
from Malmberget and Kiruna 
employed ≥ 1 y 1923–1996 
and living in Sweden 1952. 
Referents: Swedish northern 
regional male population. 
1952–2001 Mortality (ICD-
10) from CVD 
(I00–I99) and MI 
(I20–I24). 
CVD 
Surface work 
Underground work 
Exposure duration 
0–5 y 
5–15 y 
> 15 y 
MI < 60 y of age 
Surface work 
Underground work 
Exposure duration 
0–5 y 
 
651 
1 589 
 
450 
552 
587 
 
115 
256 
 
88 
SMR 
1.04 (0.96–1.12) 
1.04 (0.99–1.09) 
 
1.02 (0.93–1.12) 
1.07 (0.98–1.16) 
1.02 (0.94–1.11) 
 
1.47 (1.21–1.76) 
1.30 (1.15–1.48) 
 
1.21 (0.97–1.50) 
 (98) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
5–15 y 
> 15 y 
MI > 60 y of age 
Surface work 
Underground work 
Exposure duration 
0–5 y 
5–15 y 
> 15 y 
84 
84 
 
307 
799 
 
189 
272 
338 
1.23 (0.98–1.52) 
1.51 (1.21–1.87) 
 
1.02 (0.91–1.14) 
1.08 (1.00–1.16) 
 
0.97 (0.83–1.11) 
1.10 (0.97–1.23) 
1.14 (1.02–1.26) 
Cohort: 13 621 male miners 
from Malmberget and Kiruna 
employed ≥ 1 y 1923–1996 
and living in Sweden in 1952 
(same as above). 
1952–2001 Mortality from 
MI (ICD-6–10) 
Respirable dust, 
mg/m3-y 
Not exposed 
> 0–35 
> 35–100 
> 100 
Age ≤ 60 y 
Not exposed 
> 0–35 
> 35–100 
> 100 
Age > 60 y 
Not exposed 
> 0–35 
> 35–100 
> 100 
 
 
311 
361 
355 
450 
 
89 
114 
85 
83 
 
222 
247 
270 
367 
RR 
 
1 
0.98 (0.85–1.15) 
1.21 (1.03–1.40) 
1.31 (1.13–1.52) 
 
1 
0.93 (0.71–1.23) 
1.36 (1.01–1.84) 
1.82 (1.33–2.49) 
 
1 
1.04 (0.87–1.25) 
1.12 (0.94–1.34) 
1.16 (0.98–1.37) 
The content of crystalline silica 
dioxide in the respirable fraction 
dust was estimated to 2.5%. 
(97) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 94 talc-exposed male 
miners employed ≥ 1 y 
1944–1972, and 295 male 
millers employed ≥ 2 y 
1935–1972. 
Referents: national 
Norwegian male rates.  
1953–1987 Mortality (ICD-7) 
from circulatory 
diseases (400–
468) and IHD 
(420–422). 
 
Circulatory disease 
IHD 
 
68 
44 
SMR 
0.86 (0.67–1.10) 
0.85 (0.62–1.14) 
Exposure was to non-
asbestiform talc with low quartz 
content. 
Silicosis was mentioned twice 
and talcosis once as contributory 
causes of death. 
(1008) 
Cohort: 1 026 granite 
workers in quarries and 
processing yards employed 
≥ 3 mo 1940–1971. 
Referents: Finnish national 
male rates. 
Until 1981 Mortality (ICD-8) 
from CVD and 
CHD.  
CVD/CHD  
Time since entry 
into exposure 
0 y 
5 y 
10 y 
15 y 
20 y 
25 y 
30 y 
CVD/CHD 
 
 
100/60 
  98/59 
  88/56 
  71/46 
  47/29 
  24/12 
  12/7 
SMR 
 
 
0.87/0.79 
0.95/0.86 
1.02/1.00 
1.12/1.12 
1.13/1.09 
1.00/0.78 
1.17/1.09 
The cohort seems to contain 
both prevalently exposed 
workers 1940 and incidentally 
exposed workers 1940–1971. 
7% had been employed in other 
industrial work. However, in 
1981 only 15% of the cohort 
could be followed at least 20 y. 
Smoking habits similar to other 
male workers in Finland. 
(510) 
Cohort: 1 026 granite 
workers in quarries and 
processing yards entering 
work 1940–1971 and 
employed at least 3 mo.  
Referents: Finnish national 
rates. 
Until 1985 Mortality from 
CVD (ICD-8). 
CVD 
1972 
1975 
1981 
1985 
 
 
 
 
128 
SMR 
0.71 (P < 0.05) 
0.70 (P < 0.05) 
0.87 
0.95 
62% smokers 1970–1972. (511) 
Same cohort as above. Until 1989 Mortality (ICD-8) 
from CVD and 
IHD. 
 
CVD 
IHD 
 
162 
97 
SMR 
0.94 
0.82 
 (512) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohorts: 597 miners first 
employed 1954–1973 who 
had worked ≥ 3 y under-
ground, and 338 surface 
workers first employed 
1954–1973. 
Referents: Finnish national 
and North Karelian male 
rates. 
1954–1986 Mortality (ICD-8) 
from CVD and 
IHD. 
Miners, CVD 
national rates 
regional rates 
Miners, IHD 
national rates 
regional rates 
Surface workers, 
CVD 
national rates 
regional rates 
Surface workers, IHD 
national rates 
regional rates 
55 
 
 
44 
 
 
 
35 
 
 
26 
SMR 
1.79 (P < 0.05) 
1.28 
 
1.99 (P < 0.05) 
1.41 (P < 0.05) 
 
 
1.32 
1.03 
 
1.38  
1.08 
 
Exposure in the old mine 
during dry drilling:  
> 50 mg/m3 total dust 
> 2 mg/m3 respirable silica.  
Wet drilling decreased 
exposure and total dust was 
< 10 mg/m3 after 1948.  
Highest exposure to respirable 
silica during loading in the new 
copper mine (mg/m3): 
1954–1965: 0.8  
1966–1975: 0.5  
1975–: 0.15. 
Other exposures were discussed 
such as nitroglycerine, noise, 
vibration and heavy work. 
(12) 
All gainfully employed men 
identified in the Finnish 
census 1970. 
Cohort: male miners and 
quarry workers. 
Referents: gainfully 
employed men. 
1971–1991 Mortality (ICD-9) 
from CVD, other 
IHD (except MI) 
and MI. 
Age 25–64 y 
CVD 
IHD (except MI) 
MI 
 
444 
102 
235 
SMR 
1.23 (1.11–1.35) 
1.50 (1.23–1.83) 
1.20 (1.06–1.37) 
The SMRs in the age interval 
25–44 y were always higher 
than in the interval 45–64 y. 
No adjustment for 
socioeconomic status. 
(713) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Europe (non-Nordic)        
Cohort: 1 333 male Cornish 
tin miners retrieved from the 
National Health Service 
Central Register 1939.  
Referents: rates from 
England and Wales. 
1939–1976 Mortality from 
circulatory 
diseases (ICD-8, 
390–458). 
 
Circulatory disease 
 
378 
SMR 
0.99 
12.5% of the cohort was ≥ 65 y 
of age in 1939. 
(305) 
Cohort: 3 010 male miners 
from 2 tin mines employed 
≥ 1 y 1941–1984. 
Referents: rates from 
England and Wales. 
1941–1986 Mortality from 
IHD (ICD-5–9). 
 
IHD 
 
208 
SMR 
1.08 
 (413) 
Cohort: non-coal miners and 
quarrymen age 15–64 y from 
the Registrar General for 
England and Wales. 
Referents: men in the same 
social classes. 
 Mortality from 
CeVD. 
CeVD 
Surface workers 
 
 
 
32 
 
 
 
PMR 
1.02 
 
 
 
 (352) 
Cohort: 4 093 male pottery 
workers retrieved 1970–1971 
from 40 potteries in the UK.  
Referents: national and local 
rates. 
1970–1985 Mortality from 
circulatory 
diseases. 
Circulatory disease 
Local rates 
National rates 
Time since entering 
employment, 
local rates 
0–19 y 
20–39 y 
40– y 
 
205 
 
 
 
 
40 
77 
88 
SMR 
1.04 
1.14 
 
 
 
0.9 
1.1 
1.1 
 (1029) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 4 822 male workers 
from pottery, refractory and 
sandstone industries first 
employed 1929–1992. 
Referents: national and 
Stoke-on-Trent rates. 
1985–1992 Mortality (ICD-
9) from heart 
disease (391–
429) and CeVD 
(430–438). 
Stoke-on-Trent rates 
Heart disease 
CeVD 
National rates 
Heart disease 
CeVD 
 
171 
17 
 
171 
17 
SMR 
0.98 (0.83–1.13) 
0.80 (0.46–1.28) 
 
1.36 (1.16–1.58) 
0.91 (0.53–1.46) 
Respirable dust exposure:  
0–0.8 (mostly 0.05–0.2) mg/m3. 
(167) 
Cohort: 2 703 subjects  
(2 365 men, 338 women) in 
UK silica sand producing 
quarries employed ≥ 1 y 
1950–1986. 
Referents: rates from 
Scotland, England and 
Wales. 
1950–2001 Mortality (ICD-
7–10) from cir-
culatory diseases, 
IHD and other 
heart disease. 
Men 
Circulatory disease 
IHD 
Other heart disease 
Women 
Circulatory disease 
IHD 
Other heart disease 
 
334 
231 
103 
 
17 
7 
10 
SMR 
0.90 (0.80–1.00) 
0.93 (0.82–1.06) 
0.82 (0.67–1.00) 
 
0.82 (0.48–1.32) 
0.67 (0.27–1.38) 
0.98 (0.47–1.80) 
Geometric mean cumulative 
respirable crystalline silica 
exposure: 
0.31 (0.01–23.2) mg/m3-y.  
(131) 
Cohorts: 725 slate exposed 
and 530 non-slate exposed 
workers, North Wales. 
1975–1981 Mortality from 
CVD (ICD-8). 
CVD 
Slate exposed 
Non-slate exposed 
 
61 
41 
 
65.1 expected 
36.9 expected 
 (725) 
Cohorts: 726 slate exposed 
and 529 non-slate exposed 
workers, North Wales. 
Same cohort as above. 
1975–1998 Mortality from 
IHD and stroke.  
 
Slate exposed 
IHD 
Stroke 
Non-slate exposed 
IHD 
Stroke 
 
 
110 
33 
 
70 
21 
Rate/1 000 
person-y 
8.8 
2.6 
 
7.1 
2.1 
 (141) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Study base: distribution of 
miners among 22 689 males 
with first MI, aged 35–64 y 
participating in a rehabilita-
tion program 1977–1978, 
compared with distribution  
of miners in the total male 
working population in West 
Germany.  
 Incidence of first 
MI (ICD-410). 
Miners 
MI 
 
340 
OR 
1.97 (P < 0.001) 
 (117) 
Cohort: males employed  
≥ 1 y 1953–1985 from 9 slate 
quarries in the German 
Democratic Republic. 
Silicotics excluded. 
Referents: national rates. 
1970–1985  Mortality from 
circulatory 
diseases (ICD-8, 
390–458). 
 
Circulatory disease 
 
120 
SMR 
0.86 (0.71–1.03) 
 (628) 
Cohort: 19 827 male 
construction workers with 
health examination 1986–
1992. 
Referents: rates from Baden-
Württemberg. 
Until 
1998–2000 
Mortality (ICD-9) 
from circulatory 
diseases (390–
459), IHD (410–
414), other heart 
disease (420–
429), CeVD 
(430–438) and 
pneumoconiosis 
(500–508). 
 
Circulatory disease 
IHD 
Other heart disease 
CeVD 
Pneumoconiosis 
 
185 
109 
29 
22 
3 
SMR 
0.59 (0.51–0.68) 
0.61 (0.50–0.74) 
0.55 (0.37–0.80) 
0.45 (0.28–0.68) 
2.30 (0.48–6.74) 
Asbestos exposure reported by 
7.5% and silica exposure by 
2.4%. 
Smoking data available from 
84% and 57% were smokers. 
(48) 
Cohort: 17 644 German 
porcelain production workers 
(8 288 men, 9 356 women) 
included in medical 
Until 2005 Mortality (ICD-
10) from 
circulatory 
diseases, I00–
All men 
Circulatory disease 
Silicosis 
All women 
 
371 
5 
 
SMR 
1.00 (0.90–1.11) 
7.20 (2.32–16.8)  
 
The preparation department 
was the work area with highest 
potential crystalline silica 
exposures over time. 
(96) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
surveillance program 1985–
1987. Subcohort of 15 045 
Bavarian porcelain workers 
(7 001 men, 8 044 women). 
Referents: national rates from 
Western Germany 1985–
1997 and total Germany 
1998–2005 and regional rates 
from Bavaria. 
I99) and silicosis 
(J62). 
Circulatory disease 
Silicosis 
Bavarian men 
Circulatory disease 
Silicosis 
Bavarian women 
Circulatory disease 
Silicosis 
Bavarian men, 
exposed in 
preparation 
Circulatory disease 
Silicosis 
Never exposed in 
preparation 
Circulatory disease 
Silicosis 
125 
0 
 
315 
5 
 
119 
0 
 
 
 
37 
3 
 
 
278 
2 
0.83 (0.69–0.98) 
– 
 
1.17 (1.05–1.31) 
11.4 (3.66–26.5) 
 
1.03 (0.85–1.23) 
– 
 
 
 
1.40 (0.99–1.93) 
67.2 (13.5–196) 
 
 
1.15 (1.02–1.29) 
5.06 (0.57–18.3) 
 
 
Study base: proportion of 
deaths among 1 067 iron ore 
miners in Lorraine compared 
with that in the French 
population.  
1960–1976 Mortality from 
circulatory 
diseases (ICD-8, 
390–458). 
 
Circulatory disease 
Age at death 
< 40 y 
40–49 y 
50–59 y 
60–69 y 
70–79 y 
> 80 y 
 
294 
 
6 
20 
42 
95 
88 
43 
PMR 
0.83 
 
1.43 
1.26 
1.10 
0.86 
0.70 
0.70 
 (684) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 1 173 iron mine 
workers aged 35–55 y in 
1975 (185 surface workers) 
with normal chest X-ray. 
Referents: French population. 
1975–1980 Mortality from 
CVD. 
 
CVD 
 
6 
SMR 
0.5 (0.2–1.1) 
The number of deaths from 
lung cancer was higher (n = 13) 
than from CVD. 
The proportion of smokers was 
higher among miners (66%) 
than in the French male general 
population (52%). 
Diesel engines were used after 
1970. 
(747) 
Cohort: 231 workers actively 
employed in 1960 in a 
refractory brick plant; sub-
cohort of 95 non-silicotics. 
Referents: regional rates 
from the male population of 
Genoa, Italy. 
1960–1979 Mortality from 
CVD (ICD-8, 
390–429, 439–
458). 
CVD 
All workers 
Non-silicotics 
 
25 
6 
SMR 
1.32 (0.85–1.95) 
0.74 (0.27–1.61) 
Geometric mean of respirable 
dust concentrations for the total 
cohort: 0.20–0.56 mg/m3. 
Geometric mean of crystalline 
silica content: 6–21%. 
Silicotics are described in Table 
A13.  
(762) 
Cohort: 1 022 male workers 
actively employed 1954–
1977 in a refractory brick 
plant in Genoa, Italy. 
Referents: Italian male rates. 
1954–1986 Mortality from 
CVD (ICD-9, 
390–459). 
CVD 
All 
Employed ≤ 1957 
 
80 
62 
SMR 
0.93 (0.74–1.15) 
1.14 (0.87–1.46) 
Geometric mean respirable dust 
concentrations: 
0.20–0.56 mg/m3.  
Maximum percentage of 
crystalline silica: 30–65%. 
(636) 
Cohort: 1 346 male talc 
miners and 438 millers who 
worked ≥ 1 y 1921–1950 in 
Germanasca and Chisone 
Valley, Italy. 
Referents: the population of 
town Alba with similar 
1921–1974 Mortality from 
CVD. 
Cum exposure, 
mppcf-y 
Miners 
566–1 699 
1 700–5 665 
5 666–12 750 
Millers 
 
 
 
66 
71 
71 
 
RR 
 
 
1.04 
1.23 (P < 0.01) 
0.82 (P < 0.05) 
 
Increased risk of silicosis among 
miners after latency, but not 
among millers. 
The mineral contained quartz. 
Small amounts of tremolite was 
detected.  
(807) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
ethnic, social and economic 
conditions. 
25–141 
142–424 
425–906 
28 
20 
24 
1.05 
1.32 
0.79 
No cases of mesothelioma 
among exposed. 
Cohort: 1 795 male talc 
miners and millers who 
worked ≥ 1 y 1946–1995 in 
Val Chisone, Italy. 
Referents: Italian national 
and regional rates. 
1946–1995 Mortality from 
CVD, IHD and 
CeVD.  
 
CVD 
IHD 
CeVD 
CVD, exposure 
duration 
< 10 y 
10–19 y 
20–29 y 
≥ 30 y 
Miners only 
< 10 y 
10–20 y 
> 20 y 
 
288 
88 
60 
 
 
66 
70 
108 
44 
 
43 
45 
89 
SMR 
0.93 (0.83–1.05) 
0.87 (0.70–1.07) 
0.67 (0.51–0.86) 
 
 
1.13 (0.88–1.44) 
1.07 (0.84–1.35) 
0.91 (0.75–1.10) 
0.66 (0.48–0.88) 
 
1.24 (0.89–1.67) 
1.04 (0.76–1.39) 
0.78 (0.62–0.95) 
The current talc was free from 
asbestiform fibres. 
Excess mortality from 
respiratory diseases was mainly 
silicosis. 
(181) 
Cohort: 4 740 male miners 
employed 1932–1971 and 
still employed 1960 or ≥ 1 y 
1960–1971, from 2 mines in 
Sardinia, Italy. > 65% were 
hired before 1960. 
Referents: Italian national 
and regional rates. 
1960–1988 Mortality from 
CVD (ICD-9, 
390–459.9). 
CVD 
All 
Underground 
Surface 
 
Underground 
Mine A 
Mine B 
Surface 
Mine A 
Mine B 
 
258 
160 
88 
 
 
86 
74 
 
67 
21 
SMR 
0.63 (0.56–0.72) 
0.66 (0.56–0.77) 
0.57 (0.46–0.71) 
 
 
0.75 (0.60–0.92) 
0.58 (0.45–0.73) 
 
0.65 (0.51–0.83) 
0.41 (0.26–0.63) 
Dust exposure mine A and B 
1945–1960: 3–5 mg/m3 
1962–1970: 2.5–2.6 mg/m3 
1971–: 1.6–1.8 mg/m3 
Surface exposure: < 1 mg/m3. 
Median quartz proportion of 
dust 1.2% in mine A and 12.8% 
in mine B.  
65% smokers in mine A,  
67% in mine B, versus 
63% in Sardinia. 
(177) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Diesel transport started in the 
early 1970s. 
In mine B, the lower SMR may 
be explained by a more 
effective medical selection. No 
deaths from diabetes vs 7.8 
expected. In mine A, 10 deaths 
from diabetes vs 12.5 expected. 
Cohort: 483 female workers 
employed ≥ 1 y 1932–1971 
in ore screening in Sardinian 
lead and zinc mines. 310 belt 
pickers. 
Referents: Italian national 
rates. 
1951–1988 Mortality from 
CVD. 
CVD 
Total cohort 
Belt pickers 
Mine A 
Mine B 
Both mines ≥ 6 y 
employed 
 
70 
44 
23 
21 
 
11 
SMR 
0.70 (0.54–0.88) 
0.65 (0.47–0.87) 
0.81 (0.51–1.21) 
0.53 (0.33–0.81) 
 
0.64 (0.32–1.15) 
Belt pickers exposed to silica. 
Average silica exposure:  
0.007 mg/m3 in mine A  
0.09 mg/m3 in mine B.  
(178) 
North America         
Cohort: 5 414 male quarry 
and shed workers employed 
1950–1982 in Vermont 
granite industry. 
Referents: US white male 
rates. 
1950–1983 Mortality (ICD-8) 
from circulatory 
diseases (390–
458), athero-
sclerotic heart 
disease (410–413) 
and silicosis 
(515.0). 
 
Circulatory disease 
Heart disease 
Year of hire 
< 1930 
Circulatory disease 
Heart disease 
Silicosis 
1930–1939 
Circulatory disease 
Heart disease 
Silicosis 
1940–1949 
 
711 
482 
 
 
424 
282 
36 
 
93 
69 
4 
 
SMR 
0.75 (0.69–0.80) 
0.75 (0.68–0.82) 
 
 
0.85 (P < 0.01) 
0.88 (P < 0.05) 
9.99 (P < 0.01) 
 
0.70 (P < 0.01) 
0.73 (P < 0.01) 
4.30 (P < 0.05) 
 
Dust exposure prior to 1940 
was 10 times higher than after 
1940. 
Preliminary results were 
presented by Costello and 
Graham 1986 (196). 
(197) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Circulatory disease 
Heart disease 
Silicosis 
1950–1959 
Circulatory disease 
Heart disease 
Silicosis 
1960–1969 
Circulatory disease 
Heart disease 
Silicosis 
133 
91 
1 
 
46 
31 
0 
 
12 
7 
0 
0.79 (P < 0.01) 
0.76 (P < 0.01) 
0.95 
 
0.41 (P < 0.01) 
0.38 (P < 0.01) 
– 
 
0.35 (P < 0.01) 
0.27 (P < 0.01) 
– 
Cohort: 5 408 male quarry 
and shed workers employed 
1950–1982 in Vermont 
granite industry. 
Referents: US white male 
rates. 
Until 1996 Mortality  
(ICD-9) from  
all circulatory 
diseases (390–
459), IHD (410–
414) and silicosis 
(502). 
 
Circulatory disease 
IHD 
Silicosis 
Exposure  
Before 1940 
Circulatory disease 
IHD 
Silicosis 
After 1940 
Circulatory disease 
IHD 
Silicosis 
 
842 
710 
53 
 
 
520 
443 
50 
 
 
322 
267 
3 
SMR 
0.79 (0.74–0.85) 
0.74 (0.69–0.80) 
20.6 (15.4–26.9) 
 
 
0.94 (0.86–1.03) 
0.89 (0.81–0.97) 
27.4 (20.3–36.1) 
 
 
0.63 (0.56–0.70) 
0.58 (0.51–0.65) 
3.98 (0.82–11.6) 
Quartz exposure decreased by 
80–90% after 1940. 
Quartz exposure before 1940 
General stone shed air con-
tained ~ 0.2 mg/m3, and 
pneumatic chisel workers were 
exposed on average to 0.6 
mg/m3. 
Quartz exposure after 1940 
(average) 
0.05–0.06 mg/m3. 
(349) 
Cohort: 7 052 male workers 
in Vermont granite industry 
1947–1998. 
Until 2004 Mortality (ICD-9) 
from all heart 
disease, CeVD 
and silicosis. 
 
All heart disease 
CeVD 
Silicosis 
 
1 219 
217 
55 
SMR 
0.89 (0.84–0.94) 
1.02 (0.89–1.16) 
59.1 (44.6–77.0) 
71% of the cohort were born 
before 1940. 24% of the cohort 
were exposed before 1940.  
(976) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Referents: US white male 
rates. 
Most deaths from silicosis 
occurred in men who began  
to work before 1940, prior to 
implementation of dust control. 
Cohort: 10 403 white male 
Minnesota iron-ore miners 
employed ≥ 1 y before 1966. 
Referents: US and St. Louis 
County white male rates. 
1937–1978 Mortality (ICD-8) 
from arterio-
sclerotic heart 
disease (410–
413) and vascular 
lesions of CNS 
(430–438). 
All miners 
Heart disease 
Vascular CNS lesions 
Underground 
Heart disease 
Vascular CNS lesions 
Aboveground 
Heart disease 
Vascular CNS lesions 
 
Heart disease 
Native born 
All foreign born 
Finnish born 
 
1 783 
405 
 
1 020 
260 
 
763 
145 
 
 
1 034 
749 
194 
SMR 
1.02 
0.91 
 
1.01 
0.92 
 
1.03 
0.89 
 
SMR/SMR a 
1.07 b/0.96 
0.97/0.81 c 
1.26 c/1.05 
Aboveground miners were 
basically not exposed to 
underground mining while 
underground miners included 
persons working in both areas. 
39% of underground miners 
and 12% of aboveground 
miners were foreign born. 
~ 8% silica in the ore.  
Strict smoking prohibition 
underground. Absence of 
underground diesel fuel.  
a US rates/St Louis County rates. 
b P < 0.05. 
c P < 0.01. 
(541) 
Cohort: 1 321 male gold 
miners, members of the 
Homestake Veterans 
Association who worked 
≥ 21 y in Homestake, South 
Dakota. 
Referents: US or South 
Dakota male rates. 
1937–1973 Mortality (ICD-7) 
from heart 
diseases (400–
443), vascular 
lesions of CNS 
(330–334), 
pneumoconiosis 
(523–524) and 
1937–1955 
Heart disease 
Vascular CNS lesions 
Respiratory cancer 
1956–1973 
Heart disease 
Vascular CNS lesions 
Respiratory cancer 
Heart disease 
 
107 
24 
6 
 
157 
40 
11 
 
SMR 
1.41 
1.06 
1.76 
 
1.01 
0.99 
0.84 
 
The ore contained crystalline 
cummingtonite-grunerite, 
which when crushed divides by 
cleavage into fragments defined 
as fibres. These resemble 
amosite fibres but lack their 
strength and elasticity. 
(617) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
respiratory cancer 
(160–164). 
Exposure 
Very low 
Low 
Moderate 
High 
Very high 
Vascular CNS lesions 
Exposure 
Very low 
Low 
Moderate 
High 
Very high 
Pneumoconiosis 
Exposure 
Very low/low 
Moderate 
High/very high 
Respiratory cancer 
Exposure 
Very low/low 
Moderate 
High/very high  
 
39 
108 
34 
34 
56 
 
 
6 
39 
4 
5 
11 
 
 
3 
2 
35 
 
 
7 
3 
7 
 
0.83 
0.96 
1.03 
0.99 
1.28 
 
 
0.49 
1.31 
0.58 
0.76 
1.18 
 
 
0.14 
0.39 
2.71 
 
 
0.78 
1.30 
1.21 
Silicosis was stated as the cause 
in 35 of 37 pneumoconiotic 
deaths. 
One case of mesothelioma 
which may have been caused 
by exposure outside the mine. 
Cohort: 3 328 white male 
gold miners who worked 
underground ≥ 1 y 1940–
1965 in Homestake, South 
Dakota. 
1941–1977 Mortality from 
circulatory 
diseases (ICD-7, 
400–468). 
 
Circulatory disease 
Year of first 
employment 
–1930 
1930–1934 
 
285 
 
 
117 
50 
SMR 
0.84 (0.75–0.95) 
 
 
0.98 
0.82 
30% of the cohort worked 
before 1940. 
Smoking was prohibited in the 
mine from early 1930s until 
1952. 
(129) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Referents: US white male 
rates. 
1935–1939 
1940–1944 
1945–1949 
1950–1954 
1955–1959 
1960–1964 
30 
20 
38 
21 
6 
3 
0.56 
0.82 
0.90 
0.87 
0.65 
0.72 
Based on pathological reports 
at least two-thirds of the miners 
who died from non-malignant 
respiratory disease had 
silicosis. 
Cohort: 3 328 male gold 
miners who worked under-
ground ≥ 1 y 1940–1965 in 
South Dakota, same as 
above. 
Referents: US white male 
rates. 
1941–1990 Mortality (ICD-9) 
from IHD (410–
414), CeVD 
(430–438), 
diseases of 
arteries, veins, 
circulation (415–
417, 440–459), 
other myocardial 
degeneration 
(429.0, 429.1) 
and pneumo-
coniosis and 
other respiratory 
disease (470–478, 
494–519). 
 
IHD 
Multiple cause 
mortality from 1960 
IHD 
CeVD 
Vessels 
Other myocardial 
degeneration 
Respiratory disease 
Employed, –1930 
Other myocardial 
degeneration 
 
431 
 
 
527 
128 
180 
20 
 
251 
 
15 
SMR 
0.94 (0.85–1.03) 
 
 
0.88 (0.80–0.95) 
0.95 (0.75–1.18) 
1.19 (1.02–1.38) 
3.03 (1.85–4.68) 
 
2.08 (1.82–2.35) 
 
9.20 (5.14–15.2) 
Exposure to silica and to non-
asbestiform amphibole fibres 
(cummingtonite-grunerite, 69%, 
tremolite-actinolite, 15%, and 
other non-asbestiform varieties, 
16%). 
Median silica exposure 
estimation, mg/m3: 
–1930: 0.15 
1930–1950: 0.07 
1950–: 0.02. 
9% of all death certificates 
mentioned silicosis. 1 death of 
pneumoconiosis was asbestosis. 
Current smoking was more 
common among miners (65%) 
than among US males (57%). 
(907) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 2 570 white male 
workers employed ≥ 12 mo 
and who worked ≥ 1 d 1942–
1987 in the diatomaceous 
earth mining and processing 
industry, Lompoc California. 
Referents: US white male 
rates. 
1942–1987 Mortality from 
IHD and CeVD 
(ICD-5–9). 
 
IHD 
CeVD 
 
159 
30 
SMR 
0.85 (0.72–0.99) 
0.97 (0.66–1.39) 
 (153) 
Cohort: 2 342 white male 
workers employed ≥ 12 mo 
and who worked ≥ 1 d 1942–
1987 in the diatomaceous 
earth mining and processing 
industry, Lompoc California. 
Referents: US white male 
rates. 
1942–1994 Mortality from 
IHD and CeVD 
(ICD-5–9). 
 
IHD 
CeVD 
 
191 
34 
SMR 
0.82 (0.71–0.95) 
0.86 (0.60–1.20) 
Same cohort as above except 
for exclusion of men from a 
smaller plant. 
(154) 
Cohort: same as above. 1942–2011 Mortality (ICD-
8–10) from IHD, 
CeVD, and 
pneumoconiosis 
and other 
respiratory 
disorders. 
1942–1992 
IHD 
CeVD 
Respiratory disease 
1993–2011 
IHD 
CeVD 
Respiratory disease 
 
203 
34 
28 
 
112 
17 
15 
SMR 
0.83 (0.72–0.96) 
0.86 (0.60–1.20) 
3.96 (2.63–5.72) 
 
0.71 (0.58–0.85) 
0.46 (0.27–0.74) 
1.12 (0.63–1.84) 
About 88% of the cohort had 
ceased working by 1994. 
(323) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Study base: proportion of 
deaths among miners com-
pared with that among 10 
million deaths aged 18–64 y 
in 550 occupations in the 
National Occupational 
Mortality Surveillance 
system in 30 US states.  
1985–1999, 
2003–2004, 
2007 
Mortality from 
acute MI (ICD-
10, I21). 
Acute MI 
Mining 
Black males 
Coal mining 
White males 
Black males 
 
 
73 
 
1 794 
36 
PMR 
 
1.63 (1.29–2.06) 
 
1.21 (1.16–1.26) 
1.67 (1.19–2.35) 
Adjustment for age and 
smoking. 
(786) 
Cohort: 3 246 male workers 
employed ≥ 1 y 1940–1980 
in 20 crush stone operations 
in US. 
Referents: US white and non-
white male rates. 
1940–1980 Mortality (ICD-8) 
from circulatory 
diseases (390–
458) and arterio-
sclerotic heart 
disease (410–
413). 
Whites and non-
whites 
Circulatory disease 
Heart disease 
 
 
294 
198 
SMR 
 
0.84 (0.75–0.94) 
0.86 (0.75–0.99) 
 (195) 
Cohort: 2 670 male sand 
workers employed ≥ 3 y 
1909–1979, of which ≥ 1 mo 
1940 or later. 7 plants in the 
US and 1 in Canada. 
Referents: US white male 
rates. 
Until 1994 Mortality from 
heart disease 
(ICD) and CeVD. 
Time since first 
exposure 
< 20 y 
Heart disease  
CeVD 
≥ 20 y 
Heart disease  
CeVD 
 
 
 
93 
12 
 
300 
37 
SMR 
 
 
0.98 
0.90 
 
1.05 
0.79 
About 10% of the cohort was 
hired before 1940. 41% (15/37) 
of silicosis occurred in this 
group. 
(616) 
Cohort: 2 452 male sand 
workers, same as above 
excluding the Canadian 
plant. 
Referents: US male rates. 
Until 2000 Mortality from all 
heart disease 
(ICD-9, 380.0–
389.9, 402.0–
402.9, 404.0, 
410.0–519.9). 
All heart disease, 
≥ 20 y since first 
exposure 
–1994 
1995–2000 
 
 
 
297 
72 
SMR 
 
 
1.06 
1.36 
 (620) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 4 626 industrial sand 
workers employed ≥ 1 wk 
from 18 plants in 11 US 
states. Cohort based on 
records of former and current 
workers collected 1987–
1988. 
Referents: US national rates. 
1960–1996 Mortality (ICD-9) 
from IHD (410–
414) and silicosis 
(502). 
IHD 
Based on under-
lying cause 
Based on multiple 
causes 
Silicosis 
 
330 
 
474 
 
11 
SMR 
1.22 (1.09–1.36) 
 
1.22 (1.11–1.33) 
 
66.3 (33.1–119) 
Geometric mean silica exposure 
in breathing zone 1974–1996: 
26 µg/m3. 
Smoking was slightly more 
common among sand workers 
than among US referents. 
(910) 
Study base: proportion of 
deaths among pottery 
workers (International 
Brotherhood of Potters and 
Allied Workers; 2 924 white 
males, 946 white females) 
compared with the proportion 
among US white males and 
females. 
1955–1977 Mortality (ICD-8) 
from circulatory 
diseases (390–
458), arterio-
sclerotic heart 
disease (410–
413) and vascular 
lesions of CNS 
(430–438). 
Males 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
Females 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
 
1 657 
1 199 
233 
 
559 
342 
114 
PMR 
0.99 
1.07 (P < 0.01) 
0.88 
 
1.06 
1.17 (P < 0.01) 
0.94 
< 20% of the pottery workers 
were < 55 y at death.  
Among males, 96 out of 268 
respiratory disease deaths were 
diagnosed as pneumoconiosis 
due to silica and silicates. The 
corresponding proportion 
among females was 3 out of 45. 
Some fibrous material such as 
talc was introduced 20–30 y 
before the investigation; 
asbestos was not mentioned.  
2 workers died from meso-
thelioma.  
Talc workers were sometimes 
also exposed to asbestos e.g. 
tremolite and anthophyllite 
(498). 
(956) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 2 055 white male 
pottery workers employed 
≥ 1 y, 1939–1966 in 3 US 
plants. 
Referents: US white male 
rates. 
1940–1980 Mortality (ICD-8) 
from IHD (410–
413) and vascular 
lesions of CNS 
(430–438). 
 
IHD 
Vascular CNS lesions 
 
231 
34 
SMR 
1.04 
0.74 
The workers were exposed 
to silica dust and non-fibrous 
(non-asbestiform) talc in  
the production of ceramic 
plumbing fixtures.  
(957) 
Africa        
Cohort: 3 971 white miners, 
born 1916–1930, who 
attended the Medical Bureau 
for Occupational Diseases 
in 1969 for a certificate of 
fitness.  
Referents: South African 
white male rates. 
Case-control study 
Cases: 166 cases of IHD  
Controls: 2/case randomly 
selected from miners born in 
the same year as the case and 
who survived the case. 
Cases and controls were 
miners who had spent ≥ 85% 
of their service in gold 
mines. 
1970–1978 Mortality (ICD-8) 
from IHD (410–
414) and CeVD 
(430–438). 
 
IHD 
CeVD 
 
 
IHD 
 
203 
23 
 
 
166 
SMR 
1.15 (1.00–1.32) 
0.89 (0.56–1.33) 
 
RR a 
1.54 (1.04–2.28) 
 
 
 
 
a In the case-control study, 
exposure was defined as 10 y  
of underground gold mining 
service. P = 0.004 after 
adjustment for smoking, 
systolic blood pressure and 
BMI.  
(1041) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 4 925 white miners 
who attended the Medical 
Bureau for Occupational 
Diseases in 1969 for a 
certificate of fitness.  
Referents: South African 
white male rates. 
Case-control study  
Cases: 484 cases of IHD. 
Controls: 1/case randomly 
selected from miners born in 
the same year as the case and 
who survived the case. 
Cases and controls were 
miners who had spent ≥ 85% 
of their service in gold mines. 
1970–1989 Mortality (ICD-9) 
from IHD (410–
414), cor 
pulmonale (416) 
and CeVD (430–
438). 
 
IHD 
Cor pulmonale 
CeVD 
 
 
IHD 
 
 
687 
22 
109 
 
 
484 
SMR 
1.24 (1.15–1.34) 
3.32 (2.08–5.03) 
1.09 (0.89–1.31) 
 
RR a 
0.97 (0.83–1.1) 
0.98 (0.83–1.2) b 
 
 
 
 
 
a In the case-control study, 
exposure was defined as 10 y 
of underground gold mining 
service (2 400 shifts) 5 y before 
death. The lag period of 5 y 
decreased exposure and may 
have weakened possible 
relationships. 
b Adjusted for smoking. 
(776) 
Asia         
Cohort: 68 241 workers (85% 
men) in employment records 
≥ 1 y from mines and pottery 
factories a, 1972–1974.  
52% begun employment 
1950–1959. 
Referents: Chinese national 
rates. 
a 28 442 in tungsten mines, 
18 231 in copper/iron mines, 
7 849 in tin mines, and 
13 719 pottery workers. 
1972–1989 Mortality from 
heart disease 
(IHD, hyper-
tensive and 
pulmonary heart 
disease) and 
CeVD. 
 
IHD 
Hypertensive heart 
Pulmonary heart 
disease 
CeVD 
Exposure category 
Heart disease 
Medium 
High  
 
IHD 
 
152 
99 
695 
 
730 
SMR 
1.25 (1.05–1.45) 
3.30 (2.68–4.02) 
5.81 (5.38–6.26) 
 
0.77 (0.72–0.83) 
 
RR b 
1.03 (0.9–1.2) 
1.55 (1.3–1.8) 
P(trend): < 0.01 
 
Average annual exposure, mg/m3 
Tungsten: 6.1 (2.0–26.3)  
Copper/iron: 5.6 (3.8–16.1)  
Tin: 7.7 (3.4–29.7)  
Pottery: 11.4 (9.4–23.8).  
Exposure categories 
High (mostly from underground 
open cast or separation jobs), 
medium, low, and not dust-
exposed. 
b High or medium vs low/none. 
(155) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
 
 
Medium 
High 
Hypertension 
Medium 
High 
Pulmonary heart 
disease 
Medium 
High 
 
CeVD 
Medium 
High 
0.65 (0.3–1.3) 
1.16 (0.7–1.9) 
 
0.99 (0.6–1.7) 
1.38 (0.9–2.0) 
 
 
1.27 (1.0–1.6) 
1.93 (1.6–2.4) 
P(trend): < 0.01 
 
0.99 (0.8–1.2) 
0.92 (0.8–1.1) 
Cohort: 7 837 workers in 
employment records ≥ 1 y 
from 4 tin mines, 1972–1974 
(4 629 dust-exposed miners 
and 3 208 non-exposed 
workers). 
Referents: Chinese national 
rates. 
1972–1994 Mortality from 
CVD and CeVD. 
 
CVD 
CeVD 
Cum dust exposure, 
mg/m3-y 
CVD 
< 0.1 
0.1–29 
30–69 
≥ 70 
CeVD 
< 0.1 
0.1–29 
30–69 
≥ 70 
 
151 
188 
 
 
 
42 
25 
24 
60 
 
70 
22 
30 
66 
SMR 
0.77 (0.65–0.90) 
1.15 (1.00–1.33) 
 
 
 
0.65 a 
0.94 
0.75 
0.83 
 
1.35 a 
1.11 
1.16 
1.01 
Increased mortality among 
dust-exposed miners vs non-
exposed for CeVD (RR 1.75, 
P < 0.01). 
 
 
a 95% CI of SMR excludes 
1.00.  
(164) 
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Table A12. Crystalline silica.  
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 4 851 workers in 
employment records ≥ 1 y 
from 3 ceramic factories in 
Jingdezhen city, 1972–1974. 
Referents: Chinese national 
rates. 
1972–2003 Mortality from 
CVD and CeVD. 
 
CVD 
CeVD 
Cum dust exposure, 
mg/m3-y 
CVD 
0.1–119 
120–219 
≥ 220 
CeVD 
0.1–119 
120–219 
≥ 220 
 
294 
221 
SMR 
1.06 (0.94–1.19) 
0.81 (0.71–0.93) 
 
 
RR 
0.5 (0.4–0.8) 
0.8 (0.6–1.1) 
1.0 (0.7–1.3) 
 
0.8 (0.6–1.2) 
0.8 (0.5–1.1) 
1.1 (0.7–1.5) 
Total dust exposure 
~ 15–28 mg/m3 1950–1960s, 
10–12 mg/m3 1970–1980s after 
ventilation was improved. 
In the late 1980s, gas and 
electricity was used instead  
of coal as main energy, and  
dust exposure was lowered to  
2–5 mg/m3 in 1990s and  
1.6 mg/m3 in 2003. 
(1053) 
Australia        
Cohort: 1 974 Kalgoorlie 
gold miners identified in a 
survey 1961–1962. 
Referents: Western Australia 
male rates. 
1961–1975 Mortality (ICD-8) 
from IHD (410–
414) and CeVD 
(430–438). 
 
IHD 
CeVD 
 
178 
40 
SMR 
1.0 
1.0 
57% worked > 10 y under-
ground. 
66% smoked among miners vs 
53% among referents. 
(47) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Nordic countries        
Cohort: 1 130 Swedish male 
silicotic patients identified in 
the Hospital Discharge 
Register in 1965–1983. 
Silicotics had ICD-codes; 
ICD-7, 523.00 and ICD-8, 
515.00, 515.01, 515.05 and 
515.09. 
The cohort was linked to the 
Swedish Registry of Causes 
of Death. 
Referents: Swedish national 
rates. 
Until 1989 Mortality from 
circulatory disease, 
arteriosclerotic heart 
disease, other heart 
disease, CeVD and 
arterial disease. 
 
Circulatory dis. 
Heart disease 
Other heart dis.  
CeVD 
Arterial disease  
 
324 
235 
29 
32 
16 
SMR 
1.4 (1.3–1.6) 
1.5 (1.4–1.8) 
1.8 (1.2–2.6) 
0.9 (0.6–1.2) 
1.2 (0.7–1.9) 
Approximately 70% of the cohort 
was deceased, with a median age 
at death of 74 y. 88% of the 
silicotics with arteriosclerotic 
heart disease had this diagnosis 
prior to their first hospitalisation 
in which silicosis was recorded. 
Because only hospitalised patients 
were included, the study 
population probably had a 
disproportionate number of 
silicotics with more advanced 
disease that required hospital 
admission. 
The diagnosis of heart disease 
prior to silicosis does not exclude 
a causal relation between silica 
dust exposure and IHD because 
silicosis will occur after decades 
of silica exposure.  
(130) 
Cohort: 961 diagnosed cases 
of silicosis in Finnish men 
1935–1977. 
Referents: Finnish national 
male rates. 
Until 1982 Mortality from CVD 
(ICD-8, 390–458). 
 
CVD 
 
203 
SMR (99% CI) 
1.11 (0.90–1.31) 
 (521) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 163 male silicotics 
visiting the Finnish Institute 
of Occupational Health, 
1967–1985. 
Referents: Finnish national 
male rates. 
Until 1994 Mortality from 
circulatory diseases. 
 
Circulatory 
 
30 
SMR 
1.0 (0.7–1.4) 
Adjustment for age and calendar 
year.  
Mean duration of exposure: 
24 (9–43) y. 
(724) 
 
Europe (non-Nordic)        
Cohort: males employed  
≥ 1 y during 1953–1985 from 
9 slate quarries in the German 
Democratic Republic, divided 
in non-silicotics and silicotics 
(retrieved from a silicosis 
register). 
Referents: German national 
rates. 
1970–1985  Mortality from 
circulatory diseases 
(ICD-8, 390–458). 
Circulatory 
Silicotics 
Non-silicotics 
 
34 
120 
SMR 
0.75 (0.52–1.05) 
0.86 (0.71–1.03) 
 (628) 
Cohort: 440 male silicotics 
compensated during 1988–
2000 from stone and quarry 
industry in Germany. 
Referents: German national 
rates. 
Until 2001 Mortality (ICD-9) 
from circulatory 
diseases (390–459) 
and IHD (410–414). 
 
Circulatory 
IHD 
 
29 
9 
SMR 
0.89 (0.59–1.28) 
0.55 (0.25–1.04) 
Median cumulative exposure: 
18.9 mg/m3-y (range 0.79–55.5). 
Average median exposure: 
0.58 mg/m3 (range 0.10–1.5).  
(974) 
Cohort: 1 796 male silicotics 
from metallurgical and 
foundry workers in Poland. 
Silicosis diagnosed 1970–
1985. 
Referents: Polish national 
Until 1991 Mortality (ICD-9) 
from circulatory 
diseases (390–459), 
hypertensive disease 
(401–405), IHD 
(410–414), CeVD 
 
Circulatory 
Hypertension 
IHD 
CeVD 
Atherosclerosis 
 
227 
6 
69 
16 
45 
SMR 
0.99 (0.87–1.13) 
0.67 (0.25–1.46) 
0.92 (0.72–1.16) 
0.56 (0.32–0.91) 
0.82 (0.60–1.10) 
 (902) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
male rates. (430–438) and 
atherosclerosis (440). 
Cohort: 1 439 male silicotics 
from refractory materials, 
china, ceramics and quarry 
workers in Poland. Silicosis 
diagnosed 1970–1985. 
Referents: Polish national 
male rates. 
Until 1991 Same as above.  
Circulatory 
IHD 
CeVD 
Atherosclerosis 
 
181 
56 
17 
37 
SMR 
0.91 (0.78–1.05) 
0.88 (0.66–1.14) 
0.69 (0.40–1.11) 
0.77 (0.54–1.06) 
The proportion of ever-smokers 
was 78% and non-smokers 22%. 
During the observation period, the 
proportion of ever-smokers to 
non-smokers in the Polish general 
male population was 75% and 
25%, respectively.  
(902) 
Cohort: 231 workers actively 
employed in 1960 in a 
refractory brick plant. 136 
workers received compen-
sation for silicosis as they 
were at least 21% disabled. 
Referents: regional male rates 
from Genoa, Italy. 
Until 1979 Mortality from CVD 
(ICD-8, 390–429, 
439–458). 
CVD 
Silicotics 
Non-silicotics 
 
19 
6 
SMR  
1.73 (1.04–2.69) 
0.74 (0.27–1.61) 
Exposure concentrations 
(geometric mean), total cohort: 
respirable dust concentrations 
0.20–0.56 mg/m3. Proportion of 
crystalline silica 6–21%.  
(762) 
Cohort: 520 silicotics 
diagnosed 1961–1980 at the 
San Martino Hospital, Genoa, 
Italy.  
Referents: Italian national and 
regional Genoa male rates. 
Until 1981  Mortality from CVD 
(ICD-9, 390–458.9). 
 
CVD 
 
28 
SMR  
0.80 (0.27–0.58) a 
a Mismatch 
between SMR 
and CI. 
The proportion of smokers among 
the silicotics and the male 
population of Genoa were 47% 
and 49%, respectively. 
52 subjects lost to follow-up. 
The majority of participants was 
the same as in (638) (below). 
(637) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 450 silicotics (with 
complete data) diagnosed 
1961–1980 at the San Martino 
Hospital, Genoa, Italy.  
Referents: Italian national and 
regional Genoa male rates. 
Until 1987 Mortality from CVD 
(ICD-9, 390–459). 
 
CVD 
 
35 
SMR 
0.51 (0.36–0.71) 
The proportion of smokers among 
the silicotics and the Italian male 
population were 49% and 46%, 
respectively. 
The majority of participants was 
the same as in (637). 
(638) 
Cohort: 14 929 (14 098 men 
and 831 women) compensated 
for silicosis 1946–1979 in 
Tuscany, Italy. 
Referents: regional Tuscany 
rates. 
1980–1999 Mortality (ICD-9) 
from CVD (390–
459), hypertension 
(401–405), IHD 
(410–414) and 
CeVD (430–438). 
Males 
CVD 
Hypertension 
IHD 
CeVD 
Females 
CVD 
Hypertension 
IHD 
CeVD 
 
2 526.5 
64.5 
868.0 
811.2 
 
160.6 
15.4 
49.5 
42.9 
SMR 
0.65 (0.63–0.68) 
0.54 (0.43–0.69) 
0.70 (0.65–0.75) 
0.65 (0.61–0.70) 
  
0.74 (0.63–0.86) 
1.60 (0.98–2.62) 
0.98 (0.74–1.29) 
0.54 (0.40–0.73) 
Causes of death were ascertained 
for 7 724 out of 8 521 deceased 
subjects and calculated for the 
remaining 797 subjects according 
to the distribution among the 
ascertained subjects. 
(603) 
Cohort: 1 313 men 
compensated for silicosis 
1959–1963 in Veneto region, 
Italy. 
Referents: Italian national 
male rates. 
Until 1984 Mortality from 
circulatory diseases 
(ICD-8, 390–458). 
 
Circulatory  
 
181 
SMR 
1.07 (0.92–1.23) 
Out of 1 225 members of the 
cohort with known smoking 
habits, 975 (80%) were current 
smokers at the time of the claim 
for compensation. 
For a previous follow-up until 
1980, see (1049). 
(1050) 
Cohort: 595 men 
compensated for silicosis 
1946–1984 in Latium region, 
Italy.  
1969–1984 Mortality from 
circulatory diseases 
(ICD-8, 390–458). 
 
 
Circulatory 
 
 
165 
Mortality odds 
ratio (MOR) 
0.81 (0.69–0.94) 
 (301) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Referents: regional male 
Latium population (1969–
1979).  
Cohort: 2 043 men 
compensated for silicosis 
1943–1986 in Latium region, 
Italy. 
Referents: regional male 
Latium rates. 
1987–2006 Mortality (ICD-9) 
from CVD (390–
459), hypertension 
(401–405), IHD 
(410–414) and 
CeVD (430–438). 
 
CVD 
Hypertension 
IHD 
CeVD 
 
366.2 
15.0 
131.3 
100.4 
SMR 
0.81 (0.73–0.89) 
0.45 (0.27–0.75) 
0.73 (0.61–0.86) 
0.91 (0.75–1.10) 
Causes of death were ascertained 
for 1 173 out of 1 258 deceased 
subjects and calculated for the 
remaining 85 subjects according 
to the distribution among the 
ascertained subjects. 
(836) 
Cohort: 714 silicotics 
diagnosed 1964–1970 in 
Sardinia, Italy. 
Referents: regional Sardinian 
rates. 
1964–1997 Mortality from 
cardiocirculatory 
disease (ICD-9, 390–
459.9). 
 
Cardiocirculatory 
 
112 
SMR 
0.94 (0.78–1.13) 
 (147) 
North America        
Cohort: 1 190 miners 
compensated for silicosis 
1940–1975 and 289 surface 
workers compensated 1940–
1984 in Ontario, Canada. 
Referents: regional Ontario 
rates. 
 Mortality from IHD 
(ICD-8, 410–414). 
IHD 
Miners 
Surface workers 
Silica brick 
Ceramics 
Granite quarry 
Other 
 
131 
48 
3 
22 
16 
7 
SMR 
0.74 
1.28 
0.42 
1.72 
1.25 
1.49 
The surface worker cohort 
comprised 13 women. All but two 
worked in ceramics.  
The percentage of current and 
former smokers among surface 
workers was 85%. 
(291) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 523 silicotic and 
1 568 non-silicotic workers 
from the Ontario Silicosis 
Surveillance Registry, first 
exposed 1950 or later and still 
employed 1979 or later. 
Referents: regional rates from 
Ontario, Canada. 
1974–1992 Mortality from IHD. IHD 
Silicotics 
Non-silicotics 
 
5 
25 
SMR 
0.31 
0.51 
Differences in smoking habits 
likely accounted for only a small 
part of the difference in incidence 
of lung cancer between the two 
groups. Consequently the effect 
on IHD is even smaller. 
(294) 
Cohort: 1 072 male silicotics 
compensated 1938–1985 in 
Quebec, Canada. 
Referents: regional Quebec 
rates. 
Until 1986 Mortality from 
circulatory diseases 
(ICD-9, 390–459). 
 
Circulatory 
 
130 
SMR 
0.98 (0.90–1.08) 
Deaths after 85 y of age were not 
included.  
The percentage of smokers was 
50% based on 860 workers. 
(444) 
Cohort: 288 silicotics from 
New Jersey (1979–1992) and 
372 silicotics from Michigan, 
US (1988–1992). 
Referents: US male 
population. 
Until 1992 Mortality from 
circulatory diseases 
(ICD-9, 390–459). 
 
Circulatory 
 
80 
PMR 
0.54 (0.44–0.68) 
The analysis was limited to black 
and white men. 
(800) 
Cohort: 760 silicotics (655 
whites and 105 non-whites) 
diagnosed 1940–1983 in 
North Carolina, US. 
Referents: US national rates 
1940–1983 and North 
Carolina rates from 1950. 
Until 1983 Mortality (ICD-8) 
from circulatory 
diseases (390–398, 
400.1–400.3, 400.9, 
401–404, 410–414, 
420–438, 440–444.1, 
444.3–458) and IHD 
(410–413). 
Whites 
Circulatory  
IHD 
Non-whites 
Circulatory 
IHD 
 
150 
93 
 
17 
13 
SMR 
1.2 
1.1 
 
1.3 
2.1 a 
Published also in condensed form, 
see (24). 
 
 
 
a Comparison with US rates for 
white males, P < 0.05. 
(25) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 590 (5 women) 
silicotic claims from 
California Workers’ 
Compensation 1945–1975, 
US. 
Referents: US male national 
rates. 
1946–1991 Mortality (ICD-9) 
from all heart 
diseases (390–398, 
402, 404, 410–429), 
IHD (410–414) and 
CeVD (430–438). 
 
All heart disease 
IHD 
CeVD 
 
97 
80 
16 
SMR 
0.68 (0.55–0.83) 
0.66 (0.53–0.83) 
0.58 (0.33–0.95) 
55% current smokers from a 
sample of 70%. 
(345) 
Africa        
Case-control study: study  
base comprised white South 
African gold miners aged ≥ 45 
y with necropsy 1974–1988. 
391 cases with cor pulmonale. 
341 controls without cor 
pulmonale. 
 Determinants: 
Silicosis and 
thromboembolic 
disease 
 
Silicosis 
Extensive 
Moderate 
Slight 
Thromboembolic 
disease 
 Cases/ 
controls 
 30/7 
 47/26 
 123/98 
 57/12 
 
OR 
4.95 (2.92–8.38) 
1.63 (0.93–2.84) 
1.46 (1.03–2.08) 
1.92 (1.37–2.69) 
The risk for cor pulmonale 
increased with the severity of 
silicosis. 
(686) 
Asia        
Cohort: 3 335 male 
hospitalised pneumoconiosis 
patients (1 941 silicosis, 1 278 
anthracosilicosis and 22 
asbestosis). 
Referents: Japanese national 
rates. 
1979–1983 Mortality (ICD-8) 
from IHD (410–414) 
and CeVD (430–438). 
All  
IHD 
CeVD  
Silicosis only 
IHD 
CeVD 
 
8 
28 
 
3 
18 
SMR 
0.50 (0.00–1.00) 
0.66 (0.36–0.97) 
 
0.32 (0.00–0.97) 
0.73 (0.33–1.14) 
The first year following the 
diagnosis (pneumoconiosis) was 
excluded in the calculation of 
mortality to avoid the inclusion of 
cases with already diagnosed 
serious disease. 
(171) 
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Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 1 827 male silicotics 
employed as refractory brick 
workers before 1962 and 
diagnosed 1963–1985. 
Referents: 1 470 male workers 
from 10 rough rolling steel 
mills. 
Until 1985 Mortality from CHD, 
pulmonary heart 
disease and CeVD 
(according to Chinese 
classification, similar 
to ICD-7).  
 
CHD 
Pulmonary heart 
CeVD 
Pulmonary heart 
Silicosis grade I 
Silicosis II 
Silicosis III 
 
8 
71 
20 
 
39 
21 
11 
SRR 
0.73 
3.08 (P < 0.01) 
0.43 
 
2.85 (P < 0.01) 
3.04 (P < 0.01) 
4.45 (P < 0.01) 
 (241) 
Cohort: prevalent cases of 
silicosis in 1972 and incident 
cases through 1989. Almost 
6 500 silicotics (85% males). 
Referents: other miners and 
pottery workers (totally 
68 241) in south central 
China.  
1972–1989 Mortality from total 
heart disease, hyper-
tensive heart disease, 
IHD, pulmonary 
heart disease and 
CeVD (according to 
the Chinese Health 
Ministry coding 
system). 
 
Total heart 
disease 
Hypertensive  
IHD 
Pulmonary heart 
CeVD 
 RR  
2.74 (2.4–3.1) 
 
1.17 (0.8–1.8) 
1.10 (0.7–1.8) 
4.92 (4.1–5.8) 
0.77 (0.6–0.9) 
 (155) 
Cohort: 932 cases of silicosis 
out of 7 837 tin miners from 
the cohort above retrieved 
1972–1974.  
Referents: Chinese national 
rates. 
Until 1994 Mortality from CVD 
(according to the 
Chinese Health 
Ministry coding 
system).  
CVD 
Silicotics 
Non-silicotics 
 SMR 
1.07 
0.66 
The highest prevalence of 
silicotics was found in the Limu 
mine which had the highest 
cumulative dust exposure and the 
lowest amount of arsenic in the 
ore. 
(164) 
Cohort: 4 372 silicotic males 
from 47 metallurgical mines 
and plants in China, diagnosed 
and alive before January 1980. 
Referents: Chinese national 
rates. 
Until 1989 Mortality (ICD-9) 
from IHD (410–414), 
hypertensive heart 
disease (402) and 
CeVD (430–438). 
 
IHD 
Hypertensive 
CeVD 
 
28 
13 
91 
SMR  
0.40 (0.28–0.57) 
1.41 (0.75–2.62) 
0.49 (0.40–0.60) 
 (989) 
 326 
 
Table A13. Silicotics. 
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments  
Ref. 
Cohort: 1 419 male silicotics 
registered in 1980 in the Hong 
Kong Silicosis Register. 
Referents: Hong Kong male 
population. 
Until 1986 Mortality (ICD-9) 
from CVD (390–
459), IHD (410–414) 
and pulmonary heart 
disease (415–417). 
 
CVD 
IHD 
Pulmonary heart  
 
25 
7 
13 
SMR 
0.74 (0.48–1.09) 
0.63 (0.25–1.30) 
2.58 (1.37–4.41) 
More than half of the registered 
had tuberculosis (56%). 
(707) 
Cohort: 1 490 male silicotics 
registered in 1981–1996 in 
the Hong Kong Silicosis 
Register. 
Referents: Hong Kong male 
population. 
Until 1997 Mortality (ICD-9) 
from CVD (390–
459), IHD (410–414) 
and pulmonary heart 
disease (415–417). 
 
CVD 
IHD 
Pulmonary heart 
 
29 
10 
11 
SMR 
0.79 (0.53–1.14) 
0.73 (0.35–1.34) 
5.45 (2.72–9.76) 
Subjects with concomitant 
asbestos or PAH exposure from 
iron foundries were excluded. 
The proportion of ever-smokers 
were 91% among silicotics and 
49% among referents.  
(149) 
Cohort: 2 789 cases of 
silicosis in Hong Kong 
diagnosed 1981–1998. 
Referents: Hong Kong male 
population. 
Until 1999 Mortality (ICD-9) 
from circulatory 
diseases (390–459), 
IHD (410–414), 
pulmonary heart 
disease (415–417) 
and CeVD (430–
438). 
 
Circulatory  
IHD 
Pulmonary heart 
CeVD 
 
77 
26 
14 
25 
SMR 
0.71 (0.56–0.89)  
0.60 (0.39–0.88)  
4.33 (2.37–7.27 a) 
0.65 (0.42–0.96)  
a calculated by B. 
Sjögren (author 
of the present 
document). 
Pulmonary heart disease 
Surface construction workers: 
SMR 3.46 (1.49–6.81), 8 cases 
Caisson workers: 
SMR 8.84 (2.38–22.64), 4 cases 
Other workers:  
SMR 4.31 (0.48–15.57), 2 cases. 
Mean dust exposure: 0.45 mg/m3. 
Cumulative mean dust exposure: 
10.9 mg/m3-y. 
History of tuberculosis 49%. 
(1048) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Nordic countries        
Cohort: 2 807 male workers 
employed ≥ 1 y before 1972, 
from 11 Swedish companies 
manufacturing wooden houses. 
1 068 were exposed to MMMF.  
Referents: Swedish male 
population. 
1969–1988 Mortality (ICD-8) 
from circulatory 
diseases (390–
458), IHD (410–
414) and CeVD 
(430–438).  
 
Circulatory disease 
IHD 
CeVD 
Circulatory disease 
Exposure, f/ml 
0 
0.06 (0.02–0.08) 
0.09 (0.05–0.13) 
0.11 (0.05–0.1) with  
a peak 1975–1980 of 
0.20–0.25 
Duration of employment 
< 10 y 
10–19 y 
≥ 20 y 
 
288 
208 
40 
 
 
152 
23 
49 
29 
 
 
 
105 
70 
89 
SMR 
0.84 (0.74–0.94) 
0.83 (0.72–0.95) 
0.77 (0.55–1.04) 
 
 
0.77 
0.84 
0.97 
0.78  
 
 
 
0.84 
0.91 
0.75 
Smoking data obtained 
from 73% of the cohort: 
45% current or former 
smokers. According to a 
national survey, 50% were 
current smokers in ages 
18–49 y in corresponding 
geographical areas. 
Most plants had used both 
rock wool and glass wool. 
(363) 
Cohort: 3 539 male and 
female MMVF production 
workers employed ≥ 1 y 
before 1978, at 1 fibre glass 
plant and 2 rock wool plants in 
Sweden. 
Referents: Swedish regional 
rates.  
1952–1990 Mortality (ICD-8) 
from circulatory 
diseases (390–
458), IHD (410–
414) and CeVD 
(430–438). 
 
Circulatory disease 
IHD 
CeVD 
 
371 
228 
60 
SMR 
1.01 (0.91–1.12) 
0.95 (0.83–1.08) 
0.96 (0.73–1.24) 
Adjustment for age, 
gender, calendar year and 
geographic region. 
(753) 
Cohort: 941 workers (616 
males, 325 females) employed 
≥ 3 mo 1941–1952 and alive 
1 January 1953 in glass wool 
1953–1981 Mortality from 
circulatory 
diseases (ICD-8, 
390–458). 
Circulatory disease 
Males 
Females 
 
42 
14 
SMR 
1.31 
0.81 
Adjustment for age, gender 
and calendar year. 
(948) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
producing industry in Finland.  
Referents: Finnish population. 
 
Europe (non-Nordic)        
Cohort I: 3 548 male and 
1 186 female workers 
manufacturing glass fibre and 
employed 1946–1978 in 
England.  
Cohort II: 1 196 male and 714 
female workers producing 
glass yarns from continuous 
filaments employed 1956–
1978 in Northern Ireland. 
Referents: national rates from 
England and Wales, and 
Northern Ireland. Local rates 
from St Helens County 
Borough, England. 
Until 1984 Mortality from 
circulatory 
diseases (ICD-8, 
390–458). 
Cohort I 
Males  
National rates 
Local rates 
Females 
National rates 
Local rates 
Cohort II 
Males 
Females 
 
252 
 
 
39 
 
 
 
64 
7 
SMR 
 
1.04 (0.92–1.18) 
1.13  
 
0.92 (0.65–1.26) 
1.10  
 
1.24 (0.95–1.58) 
0.68 (0.27–1.40) 
Adjustment for age, gender 
and calendar year.  
(327) 
Cohort: 2 096 male rock wool 
production workers 1942–1977. 
Referents: 1 778 male workers 
from cork and styropor panel 
production.  
Until 1979 Mortality from 
circulatory 
diseases (ICD-8, 
390–458). 
 
Circulatory disease 
 
 
70 
RR 
0.70 (0.51–0.97) 
 (174) 
Cohort: 2 092 male rock wool 
production workers 1942–
1977. 
Internal referents: 1 775 male 
workers recruited from cork 
and styropor panel production. 
Until 1982 Mortality from 
circulatory 
diseases (ICD-8, 
390–459). 
Circulatory disease 
National rates 
 
Internal rates 
 
89 
 
90 
SMR 
0.90 (0.73–1.11) 
RR 
0.74 (0.60–0.92) 
Adjustment for age, gender 
and calendar year.  
Internal referents were 
sometimes exposed to  
coal tar, silica, urethane 
formaldehyde foam and 
(175) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Basically the same cohorts as 
above. 
Referents: national rates from 
the Federal Republic of 
Germany. 
polystyrene. They had  
a significantly higher 
mortality for circulatory 
disease, SMR 1.31.  
Cohort: 1 098 male glass-fibre 
production workers employed 
≥ 1 y 1942–1977. 
Referents: Italian national and 
local rates. 
1944–1983 Mortality from 
CVD (ICD-8, 
390–458). 
CVD 
National rates 
Local rates 
21 SMR 
0.60 (0.37–0.92) 
0.50 (0.31–0.76) 
Adjustment for age and 
calendar year. 
Exposure characteristics 
across job categories 
Mean conc. of resp. fibres: 
0.005–0.027 f/ml. 
Median length: 3.7–7.5 µm.  
Median diameter: 0.3–0.7 
µm. 
(90) 
Cohort: 21 967 MMMF 
production workers (18 753 
males and 3 214 females) 
from 13 plants in 7 countries. 
Rock wool/slag wool cohort: 
10 115, glass wool cohort: 
8 286, continuous filament 
cohort: 3 566. 
Referents: national rates. 
1981–1983 Mortality (ICD-8) 
from circulatory 
diseases (390–
459), IHD (410–
414) and CeVD 
(430–438). 
 
Circulatory disease  
IHD 
CeVD 
 
Circulatory disease, 
exposure duration  
< 1 y 
≥ 1 y 
 
1 043 
722 
178 
 
 
 
216 
827 
SMR 
1.00 (0.94–1.07) 
1.03 (0.96–1.11) 
0.88 (0.75–1.02) 
 
 
 
1.10 and 1.13 a 
0.98  
 
 
 
 
 
 
 
a Risk estimates differ 
between publications. 
(869, 
870) 
Cohort: 11 373 male MMVF 
production workers from 13 
plants in 7 countries, who had 
worked ≥ 1 y 1933–1977. 
Referents: national rates. 
1990–1992 Mortality (ICD-
10) from 
circulatory 
diseases (I00–
I99), IHD (I20–
Circulatory disease 
All workers 
Rock/slag wool 
Glass wool 
Continuous filament 
IHD 
 
1 208 
519 
623 
66 
 
SMR 
1.03 (0.97–1.09) 
0.99 (0.91–1.08) 
1.05 (0.97–1.14) 
1.22 (0.94–1.55) 
 
7 factories produced rock 
or slag wool, 5 factories 
glass wool and 2 factories 
continuous filament.  
 
 
(822) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
I25) and CeVD 
(I60–I69). 
All workers 
Rock/slag wool 
Glass wool 
Continuous filament 
CeVD 
All workers 
Rock/slag wool 
Glass wool 
Continuous filament 
IHD, duration of 
employment 
Rock/slag wool 
1–4 y 
5–9 y 
10–19 y 
≥ 20 y 
Glass wool 
1–4 y 
5–9 y 
10–19 y 
≥ 20 y 
Continuous filament 
1–4 y 
5–9 y 
10–19 y 
≥ 20 y 
Technological phase  
at first employment 
Rock/slag wool 
813 
335 
427 
51 
 
214 
91 
112 
11 
 
 
 
152 
67 
71 
45 
 
184 
84 
99 
60 
 
12 
17 
18 
4 
 
 
 
1.03 (0.96–1.11) 
0.97 (0.87–1.08) 
1.05 (0.95–1.15) 
1.43 (1.06–1.88) 
 
1.01 (0.88–1.16) 
0.95 (0.77–1.17) 
1.05 (0.86–1.26) 
1.21 (0.60–2.16) 
 
 
 
1 
1.0 (0.7–1.3) 
0.9 (0.6–1.2) 
0.7 (0.5–1.0) 
 
1 
0.8 (0.7–1.1) 
1.0 (0.8–1.4) 
1.2 (0.8–1.7) 
 
1 
1.3 (0.6–2.9) 
2.5 (1.0–6.2) 
1.6 (0.3–8.7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P(trend): 0.07. 
 
 
 
 
P(trend): 0.5. 
 
 
 
 
P(trend): 0.1. 
 
 
 
 331 
 
Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Late 
Intermediate 
Early 
Glass wool 
Late 
Intermediate 
Early 
225 
59 
51 
 
88 
222 
117 
1 
1.0 (0.7–1.4) 
1.0 (0.7–1.5) 
 
1 
1.3 (0.9–1.9) 
1.6 (1.0–2.5) 
 
 
P(trend): 0.9. 
 
 
 
P(trend): 0.04. 
North America        
Cohort: 1 448 white males 
employed 1940–1949 in a 
fibrous glass production plant 
and with ≥ 5 y employment.  
Referents: US white male 
rates. 
Until 1972 Mortality (ICD-7) 
from diseases of 
the heart (400–
443) and vascular 
lesions affecting 
CNS (330–334). 
 
Heart disease 
Vascular CNS lesions 
 
163 
30 
SMR 
0.91 
0.91 
Adjustment for age and 
calendar year. 
Mean concentrations:  
0.3 mg/m3 (dust) 
0.08 f/ml. 
Median fibre dimensions:  
1.8 µm (diameter)  
28 µm (length). 
(72) 
Cohort: 6 536 males employed 
in fibre glass production ≥ 10 y 
any time 1968–1977.  
Referents: US white male rates. 
Until 1978 Mortality from all 
diseases of the 
circulatory system 
(ICD-8).  
Circulatory disease 
All workers 
Workers with ≥ 20 y of 
employment and ≥ 30 y 
latency  
 
199 
49 
SMR 
0.84 
0.73 
Already in 1968, 4 046 
workers were included in 
the cohort. 
(669) 
Cohort: 596 male rock and 
slag workers exposed ≥ 1 y 
1940–1948. 
Referents: US white male 
rates. 
Until 1974 Mortality from 
diseases of the 
heart (ICD-8, 
400–443). 
Heart diseases 
All workers 
Subcohort of mineral 
wool production 
workers 
 
93 
77 
SMR (90% CI) 
0.97 (0.81–1.16) 
1.03 (0.84–1.24) 
The average historical air-
borne fibre concentration 
probably did not exceed 
2.5 f/ml before 1935 and 
1.0 f/ml after 1935. 
(785) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 16 661 MMMF-
workers employed ≥ 1 y (0.5 y 
in 2 plants) 1945–1963 in 17 
US manufacturing plants. 
14 815 fibrous glass plant + 
1 846 mineral wool plant 
workers.  
Referents: US white male 
rates.  
Until 1982 Mortality (ICD-8) 
from all heart 
diseases (380–
398, 400.1, 402, 
404, 410–429), 
IHD (410–413) 
and CeVD (430–
438).  
All heart diseases 
1946–1982 
1946–1977 
1978–1982 
IHD 
1946–1982 
1946–1977 
1978–1982 
CeVD 
1946–1982 
1946–1977 
1978–1982 
 
2 008 
1 521 
487 
 
1 749 
1 347 
402 
 
326 
244 
82 
SMR 
0.98 
0.96 
1.06 
 
0.99 
0.97 
1.06 
 
1.00 
0.94 
1.27 (P < 0.05) 
Race information was 
unknown for more than 
30% of the participants. 
Whites constituted > 96% 
of those with known race 
information. 
(260) 
Cohort: same as above. Until 1982 Mortality (ICD-8) 
from all heart 
diseases (380–
398, 400.1, 402, 
404, 410–429) 
and CeVD (430–
438). 
All heart diseases  
1946–1985 
1946–1977 
1978–1982 
1983–1985 
CeVD 
1946–1985 
1946–1977 
1978–1982 
1983–1985 
 
2 343 
1 516 
495 
332 
 
368 
248 
81 
39 
SMR 
1.00 
0.95 (P < 0.05) 
1.07 
1.15 (P < 0.05) 
 
1.01 
0.95 
1.25 
1.05 
 (604) 
Cohort: 32 110 workers 
employed ≥ 1 y 1945–1978 in 
10 fibre-glass manufacturing 
plants in US (same as above 
but expanded). 
Referents: US national and 
local county rates. 
Until 1992 Mortality (ICD-8) 
from all heart 
diseases (390–
398, 400.1, 402, 
404, 410–414, 
420–429) and 
CeVD (430–438). 
All heart diseases  
National rates 
Local rates 
CeVD 
National rates 
Local rates 
 
3 518 
3 237 
 
547 
501 
SMR 
0.92 (0.88–0.95) 
0.88 (0.85–0.91) 
 
0.86 (0.79–0.94) 
0.86 (0.78–0.93) 
 (606) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 4 008 female fibre 
glass workers employed ≥ 1 y 
(0.5 y in 2 plants) 1945–1978 
in 10 US manufacturing 
plants. 
Referents: US national and 
local county rates.  
Until 1992 Mortality (ICD-8) 
from all heart 
diseases (390–
398, 400.1, 400.9, 
402, 404, 410–
414, 420–429) 
and CeVD (430–
438). 
All heart diseases 
National rates 
Local rates 
CeVD  
National rates 
Local rates 
 
323 
323 
 
82 
82 
SMR 
0.77 (0.69–0.86) 
0.73 (0.65–0.82) 
 
0.74 (0.59–0.92) 
0.78 (0.62–0.97) 
More than half of the 
women (57%) worked in 
the plants for < 5 years. 
(920) 
Cohort: 2 933 white male 
workers employed ≥ 1 y 1951–
1991 at the Anderson Plant, 
South Carolina. 
Referents: US white male 
rates. 
Until 1991 Mortality (ICD-7–
9) from all heart 
diseases, IHD and 
CeVD. 
 
All heart diseases  
IHD 
CeVD 
 
122 
96 
15 
SMR 
0.84 (0.70–1.00) 
0.83 (0.67–1.02) 
0.97 (0.54–1.60) 
Average diameter of the 
majority of the continuous 
fibre glass products:  
≥ 10–12 µm.  
Respirable glass (Beta) 
fibres were produced  
1963–1968 with an average 
diameter of 3.5 µm.  
(170) 
Cohort: 1 074 white female, 
130 non-white female and 494 
non-white male workers 
employed ≥ 1 y 1951–1991 at 
the Anderson Plant, South 
Carolina. 
Referents: US national rates. 
Until 1991 Mortality (ICD-7–
9) from all heart 
diseases, IHD and 
CeVD. 
White women 
All heart diseases  
IHD 
CeVD  
Non-white women 
All heart diseases  
IHD 
CeVD  
Non-white men 
All heart diseases  
IHD 
CeVD 
 
18 
7 
9 
 
1 
1 
2 
 
12 
9 
2 
SMR 
0.68 (0.41–1.08) 
0.39 (0.16–0.80) 
1.40 (0.64–2.65) 
 
0.57 (0.01–3.17) 
1.06 (0.03–5.92) 
3.23 (0.39–11.68) 
 
0.54 (0.28–0.95) 
0.67 (0.31–1.27) 
0.41 (0.05–1.47) 
 (994) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 942 male workers 
employed ≥ 1 y producing 
refractory ceramic fibres in 
New York and Indiana  
(446 former employees who 
terminated work before 1987 
and 496 employed 1987 or 
after). 
Referents: US national rates. 
1952–2000 Mortality from all 
heart diseases, 
IHD and CeVD 
(according to ICD 
in effect at time of 
death). 
 
Heart diseases  
IHD 
CeVD 
 
27 
23 
2 
SMR 
0.73 (0.48–1.06) 
0.85 (0.54–1.28) 
0.43 (0.05–1.54) 
In the 1950s, the maximum 
exposure estimate was 10 
f/ml for carding in textile 
operations. Subsequent 
improvements reduced 
exposure to < 10 f/ml.  
1987–1988 TWAs (f/ml) 
0.03–0.61 dry fabrication  
0.01–0.27 wet fabrication 
0.01–0.47 furnace 
operations 
0.02–0.62 maintenance.  
(552) 
Cohort: 2 557 male insulating 
glass wool plant workers 
employed ≥ 90 d 1955–1977, 
Sarnia, Ontario, Canada. 
Referents: Ontario male rates. 
Until 1984 Mortality from 
circulatory 
disease, IHD and 
CeVD (ICD-
codes not given).  
 
Circulatory disease  
IHD 
CeVD 
 
57 
38 
10 
SMR 
0.91 
0.82 
1.32 
 
(860) 
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Table A14. Man-made vitreous fibres.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of  
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: same as above. 
Referents: same as above. 
Until 1997 Mortality (ICD-9) 
from circulatory 
disease (390.0–
459.9), IHD 
(410.0–414.9) and 
CeVD (430.0–
438.9). 
 
Circulatory disease 
IHD 
CeVD  
Year of first employment 
IHD 
–1960 
1960–1970 
1970– 
CeVD 
–1960 
1960–1970 
1970– 
 
111 
72 
14 
 
 
59 
7 
6 
 
11 
2 
1 
SMR 
0.90 (0.74–1.09) 
0.81 (0.63–1.02) 
0.91 (0.50–1.52) 
 
 
0.88 
0.42 (P < 0.05) 
1.00 
 
0.92 
0.80 
0.94 
The factory closed 1991. 
Average exposure to glass 
fibres 1977–1990:  
0.03 (0.01–0.32) f/ml.  
(858) 
Cohort: 1 465 male and 
female glass filament 
producing workers employed 
≥ 1 y 1951–1986 from Guelph, 
Ontario, Canada. 
Referents: rates from Ontario. 
Until 1986 Mortality from 
circulatory 
disease. 
Circulatory disease 
Men 
Women 
 
29 
8 
SMR 
0.65 (P < 0.05) 
1.89 (P = 0.07) 
Exposure concentrations 
0.02–0.05 f/ml (TWAs)  
0.91 f/ml (highest value). 
(859) 
  
 336 
 
Table A15. Arsenic.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Nordic countries        
Case-control study 
Totally 369 deaths recorded in 
men aged 30–74 y in the parish 
around a Swedish copper 
smelter factory. 
Controls: subjects who had died 
from all remaining causes of 
death after exclusion of unclear 
diagnoses, mental deficiency, 
diabetes, all malignant disease, 
and cirrhosis of the liver. 
1960–1976 Mortality (ICD-8) 
from CVD (410–
412, 427–428) and 
CeVD (430–438). 
 
 
CVD 
Cases, 129 
Controls, 74 
CeVD 
Cases, 34  
Controls, 73 
Exposed/ 
non-exposed 
 
53/76 
18/56 
 
12/22 
18/55 
RR (90% CI) based 
on Mantel-Haenszel 
2.1 (1.2–3.5) 
 
 
1.6 (0.7–3.4) 
 
(56) 
Cohort: 3 916 male Swedish 
smelter workers employed  
≥ 3 mo 1928–1967. 
Referents: local county rates. 
Until 1981 Mortality (ICD-8) 
from IHD and 
CeVD. 
Cum arsenic 
exposure, mg/m3-y 
IHD 
< 25 
0.25– < 1 
1– < 5 
5– < 15 
15– < 50 
50– < 100 
≥ 100 
All 
CeVD 
< 25 
0.25– < 1 
1– < 5 
5– < 15 
15– < 50 
 
 
 
67 
53 
96 
71 
111 
19 
20 
437 
 
19 
19 
24 
15 
37 
 
 
SMR 
1.00 (0.78–1.27) 
1.15 (0.86–1.50) 
0.98 (0.79–1.19) 
1.02 (0.80–1.29) 
1.13 (0.93–1.36) 
1.57 (0.94–2.45) 
1.12 (0.68–1.72) 
1.07 (0.97–1.17) 
 
1.08 (0.65–1.68) 
1.61 (0.97–2.52) 
0.93 (0.60–1.38) 
0.71 (0.40–1.17) 
1.22 (0.86–1.68) 
 (471) 
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Table A15. Arsenic.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
50– < 100 
≥ 100 
All 
5 
4 
123 
1.43 (0.46–3.34) 
0.69 (0.19–1.78) 
1.06 (0.88–1.26) 
Cohort: arsenic exposed Finnish 
men who were in the same 
occupation in 1975 and 1980 in 
Finland, and who were 25–64 y 
old in 1980. 
Referents: non-exposed men. 
In total, 507 000 men in both 
groups. 
1981–1994 Mortality from 
CeVD (ICD-9, 
430–438). 
 
CeVD 
 RR 
1.04 (0.75–1.45) 
 (1031) 
North America        
Cohort: 8 047 white male 
Anaconda smelter workers in 
Montana, who had worked ≥ 1 y 
before December 1956. 
Referents: white male rates in 
Montana, US. 
1938–1963 Mortality from 
disease of the heart 
(ICD-6, 400–443). 
 
Heart disease 
 
725 
SMR 
1.18 (P < 0.01) 
 (543) 
Cohort: 1 800 men sampled 
from the cohort above. 
Referents: as above. 
1938–1978 Mortality (ICD-8) 
from IHD (410–
413) and vascular 
lesions of CNS 
(430–438). 
IHD 
Heavy exposure 
Other exposure 
Vascular CNS lesions 
Heavy exposure 
Other exposure 
IHD, exposure, µg/m3 
< 100 
100–499 
500–4 999 
 
53 
199 
 
6 
55 
 
72 
67 
88 
SMR 
1.77 (P < 0.01) 
1.37 (P < 0.01) 
 
0.87 
1.48 (P < 0.01) 
 
1.26 (P < 0.05) 
1.35 (P < 0.01) 
1.69 (P < 0.01) 
 
 
 
 
 
 
 
 
 
 
(1004) 
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Table A15. Arsenic.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
≥ 5 000 
Smokers 
< 100 
100–499 
500–4 999 
≥ 5 000 
Ceiling value  
< 100 
100–499 
500–4 999 
≥ 5 000 
Ceiling value smokers 
< 100 
100–499 
500–4 999 
≥ 5 000 
25 
 
51 
42 
63 
19 
 
48 
28 
129 
47 
 
33 
18 
88 
36 
1.48 (P < 0.05) 
 
1.31 (P < 0.05) 
1.31 
1.77 (P < 0.01) 
1.48 
 
1.08 
1.26 
1.59 (P < 0.01) 
1.71 (P < 0.01) 
 
1.09 
1.13 
1.65 (P < 0.01) 
1.82 (P < 0.01) 
 
 
 
 
 
 
The ceiling value was 
based on the highest 
exposure category in 
which a man had spent 
at least 30 d.  
Cohort: 8 014 white male 
Anaconda smelter workers in 
Montana who had worked ≥ 1 y 
1938–1956. 
1938–1990 Mortality from 
heart disease  
(ICD-8, 410–414, 
420–429). 
TWA arsenic conc., 
mg/m3, age 60 y 
0.29 (light) 
0.58 (medium) 
11.4 (heavy)  
 Excess death/1 000 
 
4.1 (-0.4–8.4) 
8.7 (1.4–16) 
18 (2.8–34) 
 
(484) 
Cohort: 2 802 white male 
smelter workers from a copper 
smelter in Tacoma, Washington, 
who had worked ≥ 1 y 1940–
1964. 
1940–1976 Mortality (ICD-8) 
from circulatory 
disease (390–458), 
CVD (410–414, 
420–429) and 
CeVD (430–438). 
Cum arsenic 
exposure, µg/m3-y 
Circulatory disease 
< 750 
750–1 999 
2 000–3 999 
4 000–7 999 
8 000–19 999 
 
 
525 
 
 
 
 
 
RR 
 
 
1.0 
0.97 (0.68–1.4) 
1.0 (0.73–1.5) 
1.2 (0.83–1.7)  
1.2 (0.81–1.7)  
Adjustment for healthy 
worker survivor effect.  
(402) 
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Table A15. Arsenic.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
≥ 20 000 
CVD 
< 750 
750–1 999 
2 000–3 999 
4 000–7 999 
8 000–19 999 
≥ 20 000 
CeVD 
< 750 
750–1 999 
2 000–3 999 
4 000–7 999 
8 000–19 999 
≥ 20 000 
20-year lag 
Circulatory disease 
< 750 
750–1 999 
2 000–3 999 
4 000–7 999 
8 000–19 999 
≥ 20 000 
CVD 
< 750 
750–1 999 
2 000–3 999 
4 000–7 999 
 
394 
 
 
 
 
 
 
91 
1.3 (0.87–1.9) 
 
1.0 
0.92 (0.60–1.4) 
1.1 (0.72–1.6) 
1.3 (0.89–2.0) 
1.5 (0.99–2.3) 
1.7 (1.1–2.6) 
 
1.0 
0.88 (0.41–1.9) 
0.84 (0.39–1.8) 
0.64 (0.28–1.4) 
0.40 (0.17–0.99) 
0.58 (0.23–1.5) 
 
 
1.0 
0.98 (0.73–1.3) 
1.2 (0.91–1.6) 
1.3 (1.0–1.8) 
1.6 (1.2–2.1) 
1.5 (1.0–2.3) 
 
1.0 
0.94 (0.66–1.3) 
1.2 (0.85–1.7) 
1.5 (1.1–2.1) 
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Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
8 000–19 999 
≥ 20 000 
1.9 (1.3–2.7) 
1.7 (1.1–2.8) 
Cohort: 2 422 male workers 
employed ≥ 3 y in smelter, mill, 
or sulphur operations 1946–
1996 in Copperhill, Tennessee. 
Referents: US national rates and 
local rates from the 3-county 
area in which Copperhill 
workers largely resided.  
External 
comparison 
1960–2000 
Internal 
comparison 
1946–2000 
Mortality (ICD-9) 
from all heart 
disease (390–398, 
402, 404, 410–429), 
IHD (410–414) and 
CeVD (430–438). 
All heart disease 
US rates 
Local rates 
IHD 
US rates 
Local rates 
CeVD 
US rates 
Local rates 
CeVD, cum arsenic 
exposure, µg/m3-y 
US rates 
Unexposed  
< 0.046 
0.046–0.413 
0.414–0.721 
≥ 0.722 
Internal rates  
Unexposed 
< 0.046 
0.046–0.413 
0.414–0.721 
≥ 0.722 
 
326 
314 
 
272 
262 
 
72 
68 
 
 
 
43 
6 
6 
7 
6 
 
47 
6 
6 
7 
6 
SMR 
0.73 (0.66–0.82) 
0.76 (0.68–0.85) 
 
0.79 (0.70–0.89) 
0.80 (0.70–0.90) 
 
0.93 (0.73–1.17) 
1.07 (0.83–1.36) 
 
 
SMR 
0.93 (0.67–1.25) 
1.02 (0.37–2.22) 
1.55 (0.57–3.37) 
4.04 (1.62–8.32) 
1.22 (0.45–2.65) 
RR 
1.00 
1.08 (0.46–2.52) 
1.46 (0.62–3.46) 
3.70 (1.65–8.30) 
1.33 (0.56–3.13) 
The authors concluded 
that possible alter-
native explanations to 
the increased risk of 
CeVD included chance 
alone and uncontrolled 
confounding or effect 
modification by co-
exposures or other 
factors correlated with 
arsenic exposure and 
unique to the 
Copperhill facility. 
(605) 
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Table A15. Arsenic.       
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Meta-analysis        
CVD: 7 studies of which 3 
based on water, 2 studies based 
on toenails, 1 based on urine 
concentrations and 1 with un-
specified matrix. 
CHD: 8 studies of which 4 
studies based on water, 1 study 
based on toenails, 2 studies 
based on urine concentrations 
and 1 study with un-specified 
matrix.  
Stroke: 4 studies of which 1 
study based on water, 1 study 
based on toenails, 1 study based 
on urine concentrations and 1 
study with un-specified matrix.  
Varying Incidence of or 
mortality from 
CVD, CHD and 
stroke. 
Top vs bottom tertile 
of different exposure 
levels 
CVD 
CHD 
Stroke 
 
 
 
3 208 
4 640 
961 
 
 
 
 
 
 
 
 
 
RR 
 
 
1.30 (1.04–1.63) 
1.23 (1.04–1.45) 
1.15 (0.92–1.43) 
 
 (172) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Nordic countries         
Cohort: 869 Swedish workers 
employed ≥ 1 y in a nickel-
cadmium battery factory 
1940–1980. 
Referents: regional rates from 
Kalmar County, Sweden. 
1951–1992 Mortality from 
IHD and CVD. 
Battery workers, males 
IHD 
CVD 
Battery workers, females 
IHD 
CVD 
 
115 
19 
 
5 
4 
SMR 
1.16 (0.96–1.40) 
0.78 (0.47–1.21) 
 
0.75 (0.24–1.76) 
1.34 (0.36–3.43) 
Smoking data were not 
used in the epidemio-
logical analyses. 
(470) 
Cohort: 599 women, 64-y old, 
in Gothenburg, Sweden, 
identified in the County 
Register and invited 2001–
2003. Stratified, random 
selection to groups with 
normal glucose tolerance, 
impaired glucose tolerance and 
diabetes, as assessed in a 
population-based screening 
examination.  
Follow-up 
examination 
after a 
median time 
of 5.4 y. 
Prevalence of large 
atherosclerotic 
plaques in the 
carotid arteries. 
Quartiles (Q) of baseline 
B-Cd  
Q1 
Q2 
Q3 
Q4 
Quartiles (Q) of baseline 
U-Cd (creatinine) 
Q1 
Q2 
Q3 
Q4 
 
 
104 
120 
108 
91 
 
 
102 
111 
101 
92 
OR 
 
1 
2.6 (1.1–6.5) 
3.9 (1.6–9.7) 
4.6 (1.7–12.9) 
P(Q4:Q1): 0.003 
 
1 
1.2 (0.6–2.5) 
1.8 (0.9–3.9) 
2.7 (1.2–6.1) 
P(Q4:Q1): 0.018 
Baseline cadmium 
0.34 µg/l (0.14–1.69)  
in blood,  
0.35 µg/g creatinine  
(0.14–1.01) in urine. 
Adjustment for pack-years 
of smoking, HbA1c, 
systolic blood pressure, 
ICAM-1, apolipoprotein 
B/A-1, statin treatment, 
BMI, high-sensitivity  
CRP and plaque status at 
baseline. 
(275) 
Cohort: same as above. Follow-up 
examination 
after a 
median time 
of 5.4 y. 
Peripheral artery 
disease measured 
as low ankle-
brachial index 
(ratio of systolic 
blood pressure in 
tibial and brachial 
arteries ≤ 0.9 in any 
artery). 
Tertiles (T) of baseline 
B-Cd, µg/l  
T1: 0.08–0.25 
T2: 0.25–0.44 
T3: 0.44–4.07 
Tertiles (T) of baseline 
U-Cd, µg/g creatinine  
T1: 0.06–0.28 
T2: 0.29–0.46 
440 OR 
 
1 
0.6 (0.2–1.6) 
2.4 (0.9–6.3) 
P(T3:T1): 0.068 
 
1 
0.8 (0.3–1.8) 
Adjustment for pack-years 
of smoking, current 
smoking, systolic blood 
pressure, HbA1c, apo-
lipoprotein B/A-1, statin 
treatment, stratification 
group at baseline (normal 
glucose tolerance, im-
paired glucose tolerance, 
(276) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
 T3: 0.46–2.06 
 
2.5 (1.1–5.8) 
P(T3:T1): 0.037 
diabetes). 
Case-control study 
30 447 men and women from 
the Malmö Diet and Cancer 
cohort with baseline 
examination 1991–1996.  
Cases: 302 subjects with 
abdominal aortic aneurysm. 
Controls: 2/case randomly 
selected from the study base. 
Until 2009 Diagnose of 
abdominal aortic 
aneurysm from the 
Swedish Inpatient 
Register and Cause 
of Death Register 
(ICD 8–10). 
Tertiles of B-Cd, µg/l
  
< 0.17 
0.17–0.31 
> 0.31 
Cases/ 
controls 
26/183 
50/179 
197/184 
RR 
 
1 
1.5 (0.8–2.8) 
2.5 (1.3–5.0) 
P(trend): 0.018 
Adjustment for sex, age, 
smoking, low level of 
education, low physical 
activity, hypertension, 
diastolic blood pressure 
and apolipoprotein. 
(277) 
Cohort: population-based 
cohort from the city of 
Malmö, Sweden (4 378 
participants aged 46–67 y) 
with baseline examination 
1992–1994.  
Until 2010 Incidence of heart 
failure (ICD-8, 
427.00, 427.10, and 
428.99; ICD-9, 
428; ICD-10, I50 
and I11) and atrial 
fibrillation (ICD-8, 
427.92; ICD-9, 
427D; ICD-10, 
I48). 
Quartiles (Q) of B-Cd  
(Q4: men 0.49–5.07 μg/l, 
women 0.49–4.83 μg/l). 
Heart failure 
Q1 
Q2 
Q3 
Q4 
Atrial fibrillation 
Q1 
Q2 
Q3 
Q4 
143 
 
 
 
22 
38 
33 
50 
 
83 
90 
122 
90 
HR 
 
 
 
1.00 
1.59 (0.92–2.72) 
1.04 (0.59–1.84) 
1.95 (1.02–3.72) 
P(trend): 0.21 
1.00 
0.98 (0.73–1.33) 
1.19 (0.89–1.59) 
1.02 (0.69–1.51) 
P(trend): 0.45 
Adjustment for age, 
systolic blood pressure, 
use of blood pressure- or 
lipid-lowering drugs, 
presence of diabetes 
mellitus, history of a 
coronary event, waist 
circumference, smoking 
status, alcohol intake, 
LDL, HDL, high-
sensitivity CRP, plasma 
creatinine, marital and 
educational status. 
(120) 
Cohort: as above, 4 819 
participants aged 45–64 y 
with baseline examination 
1991–1994, of which 1 793 
Until 2010 Incidence  
Acute coronary 
event (ICD-9, 410, 
412, 414; ICD-10, 
Quartiles of B-Cd, µg/l 
Acute coronary event 
All 
< 0.17 
 
 
 
80 
HR 
 
 
1 
All: Adjustment for sex, 
smoking, waist circum-
ference, education, 
physical activity, 
(63) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
never-smokers. I21, I22, I23, I25), 
acute MI (ICD-9, 
410; ICD-10, I21), 
major adverse 
cardiac event (acute 
coronary event, 
coronary artery 
bypass graft, 
percutaneous 
coronary inter-
vention), any stroke 
(ICD-9, 430, 431, 
434, 436; ICD-10, 
I60, I61, I63, I64), 
ischaemic stroke 
(ICD-9, 434; ICD-
10, I63)  
Mortality 
CVD (ICD-9, 390–
459; ICD-10, I00–
I99). 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Never-smokers 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Acute MI 
All 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Never-smokers 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Major adverse cardiac 
event 
All 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Never-smokers 
< 0.17 
0.17–0.259 
81 
88 
128 
 
47 
31 
26 
7 
 
 
75 
77 
79 
113 
 
44 
31 
24 
7 
 
 
 
96 
193 
122 
158 
 
57 
39 
1.0 (0.7–1.4) 
1.2 (0.8–1.6) 
1.9 (1.2–2.9) 
 
1 
0.9 (0.6–1.5) 
1.0 (0.6–1.6) 
2.3 (1.0–5.1) 
 
 
1 
1.0 (0.7–1.5) 
1.1 (0.8–1.6) 
1.8 (1.2–2.8) 
 
1 
1.0 (0.6–1.5) 
1.0 (0.6–1.6) 
2.4 (1.1–5.4) 
 
 
 
1 
1.1 (0.9–1.5) 
1.4 (1.0–1.9) 
1.9 (1.3–2.8) 
 
1 
1.0 (0.7–1.5) 
alcohol intake, serum 
triglycerides, HbA1c, 
CRP, postmenopausal 
status, hormonal 
replacement, treatment 
for hypertension, diabetes 
mellitus, lipid-lowering 
medication, diastolic 
blood pressure, LDL and 
HDL cholesterol. 
Never-smokers: 
Adjustment for sex, 
smoking, waist circum-
ference, education, 
physical activity, 
alcohol intake, serum 
triglycerides, HbA1c and 
CRP. 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
0.26–0.499 
0.50–5.1 
Any stroke 
All 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Never-smokers 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Ischaemic stroke 
All 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
Never-smokers 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
CVD, mortality 
All 
< 0.17 
0.17–0.259 
0.26–0.499 
32 
8 
 
 
76 
71 
74 
115 
 
41 
32 
31 
7 
 
 
63 
58 
59 
98 
 
32 
25 
22 
6 
 
 
45 
57 
66 
1.1 (0.7–1.7) 
2.2 (1.0–4.6) 
 
 
1 
0.8 (0.6–1.2) 
0.9 (0.7–1.4) 
2.1 (1.3–3.2) 
 
1 
1.0 (0.6–1.6) 
1.2 (0.7–2.0) 
2.2 (1.0–4.8) 
 
 
1 
0.8 (0.6–1.2) 
0.9 (0.6–1.3) 
2.1 (1.3–3.3) 
 
1 
1.0 (0.6–1.7) 
1.1 (0.6–2.0) 
2.5 (1.0–6.0) 
 
 
1 
1.2 (0.8–1.9) 
1.3 (0.9–2.1) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
0.50–5.1 
Never-smokers 
< 0.17 
0.17–0.259 
0.26–0.499 
0.50–5.1 
89 
 
22 
26 
16 
5 
1.9 (1.1–3.2) 
 
1 
1.4 (0.8–2.6) 
1.1 (0.6–2.2) 
2.6 (1.0–6.9) 
Cohort: 4 156 subjects 
without history of stroke  
from the Malmö Diet and 
Cancer cohort with baseline 
examination 1991–1994.  
2010 Incidence of 
ischaemic stroke 
(ascertained by 
linkage to the 
Swedish Hospital 
Discharge Register 
and the Stroke 
Register of Malmö).  
Quartiles (Q) of B-Cd 
Q1 
Q2 
Q3 
Q4 (men 0.47–5.07 μg/l; 
women 0.49–4.83 μg/l).  
 
47 
46 
48 
80 
HR  
1.00 
0.91 (0.60–1.37) 
0.84 (0.56–1.28) 
1.66 (1.01–2.72) 
P(trend): 0.04 
Adjustment for age, sex, 
waist circumference, 
smoking status, diabetes 
mellitus, systolic blood 
pressure, use of blood 
pressure-lowering or 
lipids-lowering drugs, 
LDL, HDL and CRP. 
The association between 
B-Cd and stroke was 
evident, independently 
of, and in synergistic 
interaction with, carotid 
plaques. 
(121) 
Cohort: Cd-exposed men who 
were in the same occupation 
in 1975 and 1980 in Finland, 
and were 25–64 y old in 1980.  
Referents: non-exposed men. 
In total, 507 000 men in both 
groups.  
1981–1994 Mortality (ICD-9) 
from CVD (390–
459) and CeVD 
(430–438). 
 
CVD 
CeVD 
 RR 
1.01 (0.93–1.10) 
1.07 (0.91–1.24) 
Working conditions were 
evaluated from a JEM. 
Adjustment for age, 
marital status, period, 
professional status, 
education, income, 
socioeconomic and job 
exposure variables.  
(1031) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Europe (non-Nordic)        
Cohorts: 480 subjects from 
high-exposure areas and 476 
subjects from low-exposure 
areas, from north-eastern 
Belgium (environmentally 
exposed), randomly recruited 
1985–1989. The last Cd-
producing plant in the high-
exposure areas closed in 
2002.  
In a second analysis, 42 
smelter workers were added. 
B-Cd until 
2003,  
24-h U-Cd 
until 1996, 
mortality 
until 2007. 
Mortality from 
CVD, cardiac 
disease and CeVD. 
Original cohorts 
 
 
B-Cd 
CVD 
Cardiac disease 
CeVD 
U-Cd 
CVD 
Cardiac disease 
CeVD 
Inclusion of 42 workers 
B-Cd 
CVD 
Cardiac disease 
CeVD 
U-Cd 
CVD 
Cardiac disease 
CeVD 
High-/ 
low-
exposure 
areas 
50/38 
33/23 
9/12 
 
50/38 
33/23 
9/12 
 
 
60/38 
41/23 
10/12 
 
60/38 
41/23 
10/12 
HRs for a doubling 
of the internal Cd 
dose at baseline. 
 
1.20 (0.90–1.60) 
1.19 (0.84–1.71) 
0.83 (0.46–1.49) 
 
1.07 (0.85–1.34) 
1.05 (0.79–1.40) 
0.70 (0.59–0.98) 
 
 
1.29 (0.99–1.67) 
1.31 (0.95–1.81) 
0.85 (0.49–1.47) 
 
1.11 (0.89–1.38) 
1.09 (0.83–1.43) 
0.61 (0.37–0.99) 
Adjustment for sex, age 
BMI, smoking status,  
γ-glutamyltransferase as 
index of alcohol intake 
and socioeconomic 
status. 
(699) 
Cohort: 347 male copper- 
cadmium alloy workers from 
2 factories in Great Britain, 
first employed 1922–1978 
and for a minimum of 1 y. 
Referents: general population 
of England and Wales. 
1946–1992 Mortality from 
circulatory disease 
(ICD-8, 398–458). 
 
Circulatory disease 
 
88 
SMR 
1.03 (0.83–1.27) 
Adjustment for age and 
calendar year. 
(896) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 1 462 males employed 
≥ 1 y 1967–1995 at a tin 
smelter complex in North 
Humberside, UK, and 
potentially exposed to a 
number of substances, 
including lead, arsenic, 
cadmium and natural-series 
radionuclides. 
Referents: national and 
regional populations.  
1982–2001 Mortality from 
circulatory disease, 
IHD, CeVD and 
hypertensive 
diseases. 
Tin smelter workers  
vs national rates 
Circulatory disease  
IHD 
CeVD 
Hypertension 
vs regional rates 
Circulatory disease  
IHD 
CeVD 
Hypertension 
 
 
175 
104 
32 
7 
 
175 
104 
32 
7 
SMR 
 
0.96 (0.82–1.11) 
0.83 (0.68–1.01) 
1.07 (0.73–1.51) 
2.37 (0.95–4.89) 
 
0.94 (0.80–1.09) 
0.77 (0.63–0.94) 
1.04 (0.71–1.47) 
3.66 (1.47–7.53) 
Adjustment for sex, age 
and calendar year. 
(94) 
Cohort: almost 7 000 male 
cadmium-exposed workers 
born before 1940 and exposed 
to cadmium for > 1 y 1942–
1970.  
Referents: population of 
England and Wales.  
1943–1984 Mortality (ICD-8) 
from CVD (430–
438) and hyper-
tensive diseases 
(400–404). 
Exposure 
CVD 
Total 
Ever high 
Ever medium 
Always low 
Hypertension 
Total 
Ever high 
Ever medium 
Always low 
 
 
178 
2 
23 
153 
 
49 
1 
8 
40 
SMR 
 
0.77 (0.66–0.89) 
0.42 (0.05–1.51) 
0.79 (0.50–1.19) 
0.78 (0.66–0.90) 
 
1.19 (0.85–1.52) 
1.24 (0.03–6.92) 
1.68 (0.72–3.31) 
1.12 (0.77–1.47) 
SMR values calculated in 
5-y age and calendar 
strata. Jobs were classified 
according to past Cd 
exposure (high, medium 
or low). Years at risk 
divided based on these 
categories into “ever 
high” (at least 1 y), “ever 
medium” (at least 1 y) and 
“always low”. 
(483) 
North America        
Cross-sectional study: 2 125 
participants ≥ 40 y of age 
from NHANES 1999–2000, 
selected to represent the US 
population.  
1999–2000  Peripheral arterial 
disease defined as 
an ankle brachial 
index < 0.9 in at 
least one leg. 
Quartiles of B-Cd, nmol/l 
≤ 3.56 
3.57–5.33 
5.34–6.23  
> 6.23 
 
 
27 
20 
32 
60 
 
OR 
1.00 
0.96 (0.41–2.25) 
1.17 (0.61–2.25) 
2.42 (1.13–5.15) 
P(trend): 0.02 
Adjustment for age, sex, 
race, education, BMI, 
alcohol intake, hyper-
tension, diabetes, hyper-
cholesterolaemia, 
glomerular filtration rate, 
(696) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
CRP, self-reported 
smoking status, serum 
cotinine and lead. 
Cross-sectional study: 790 
participants ≥ 40 y of age 
from NHANES 1999–2000. 
1999–2000 As above. 75th vs 25th percentile of 
the U-Cd distribution. 
 
49 
OR 
3.05 (0.97–9.58) 
Adjustment for age, sex, 
race, education, smoking 
status and urinary 
creatinine. 
(697) 
Cross-sectional study: 4 912 
individuals 45–79 y old in 
NHANES III (1988–1994) of 
which 2 187 (653 male and 
1 534 female) never-smokers. 
When weighted, participants 
represented 52 234 055 
Americans.  
1988–1994 MI, determined by 
ECG.  
Tertiles (T) of U-Cd, 
µg/g creat. 
All men 
T1: < 0.43 
T2: 0.43–0.87 
T3: ≥ 0.88 
All women 
T1: < 0.43 
T2: 0.43–0.87 
T3: ≥ 0.88 
Never-smokers 
T3:T1 
451 OR 
 
 
1.00 
1.09 (0.60–2.00) 
1.26 (0.71–2.26) 
 
1.00 
1.27 (0.77–2.09) 
1.80 (1.06–3.04) 
 
1.85 (1.10–3.14) 
Adjustment for the 
Framingham risk score 
(age, total cholesterol, 
smoking status (yes vs 
no), HDL cholesterol, 
systolic blood pressure, 
and treatment for hyper-
tension, pack-years of 
smoking, race-ethnicity, 
family history of heart 
attack and diabetes. 
(272) 
Cohort: 2 422 male workers 
employed ≥ 3 y in smelter, 
mill or sulphur operations 
1946–1996, Copperhill, US. 
Referents: US national and 
local county rates. 
1949–2000 Mortality (ICD-9) 
from CeVD (430–
438), all heart 
disease (390–398, 
402, 404, 410–
429), IHD (410–
414), chronic 
disease of 
endocardium and 
other myocardial 
CeVD 
National rates 
Local rates 
All heart disease 
National rates 
Local rates 
IHD 
National rates 
Local rates 
Chronic disease of 
72 
 
 
326 
 
 
272 
 
 
9 
SMR 
0.93 (0.73–1.17) 
1.07 (0.83–1.36) 
 
0.73 (0.66–0.82) 
0.76 (0.68–0.85) 
 
0.79 (0.70–0.89) 
0.80 (0.70–0.90) 
 
SMRs computed for the 
total cohort and subgroups 
defined by work area 
within the Copperhill 
facility (smelter, acid, 
mill/mine, and mixed 
areas), race, year of hire, 
duration of employment, 
and the time since first 
employment. 
(605) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
insufficiency (424, 
428), hypertension 
with heart disease 
(402, 404), all 
other heart disease 
(415–417, 420–
423, 425–427, 429) 
and hypertension 
without heart 
disease (401, 403, 
405). 
endocardium and other 
myocardial insufficiency 
National rates 
Local rates 
Hypertension with heart 
disease 
National rates 
Local rates 
All other heart disease 
National rates 
Local rates 
Hypertension without 
heart disease  
National rates 
Local rates 
 
 
 
 
6 
 
 
 
37 
 
 
2 
 
 
0.56 (0.26–1.07) 
0.58 (0.27–1.11) 
 
 
0.37 (0.13–0.80) 
0.67 (0.22–1.57) 
 
0.59 (0.41–0.81) 
0.61 (0.43–0.84) 
 
 
0.36 (0.04–1.29) 
0.49 (0.06–1.75) 
Historical exposures 
estimated for lead, SO2, 
arsenic, cadmium, dust 
and cobalt.  
Cross-sectional study: 12 049 
participants aged ≥ 30 y from 
NHANES 1999–2006 selected 
to represent the US population 
(of which all were analysed for 
B-Cd and 3 909 for U-Cd). 
1999–2006 Stroke and 
congestive heart 
failure, self-
reported. 
 
Stroke 
B-Cd (5.1 vs 3.8 nmol/l) 
U-Cd (3.7 vs 2.6 nmol/l) 
 
Congestive heart failure 
B-Cd (5.0 vs 3.8 nmol/l) 
U-Cd (4.0 vs 2.6 nmol/l)  
 
 
492 
171 
 
 
471 
135 
OR for a 50% 
increase in Cd 
1.38 (1.14–1.67) 
1.10 (1.00–1.20) 
 
 
1.48 (1.17–1.87) 
1.12 (1.04–1.21) 
Adjustment for age, sex, 
race/ethnicity, education, 
BMI, poverty income ratio, 
alcohol consumption, 
smoking status, diabetes, 
hypertension, hyper-
cholesterolaemia, chronic 
kidney disease, and CHD. 
CHD was omitted in 
congestive heart failure 
analyses.  
U-Cd analyses were also 
adjusted for creatinine. 
(741) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cross-sectional study: 15 332 
adults  20 y of age with 
determinations of Cd in blood 
(n = 10 991) and urine 
(n = 3 496) participating in 
the US NHANES 1999–2004.  
1999–2004 Systolic and 
diastolic blood 
pressure levels,  
and hypertension. 
 
Quartiles of B-Cd, nmol/l 
Systolic blood pressure 
 ≤ 1.78  
1.78–3.56  
3.56–6.23  
> 6.23 
 
90th vs 10th percentile 
 
Diastolic blood pressure  
≤ 1.78  
1.78–3.56  
3.56–6.23  
> 6.23 
 
90th vs 10th percentile 
 
Quartiles of U-Cd, nmol/l 
Systolic blood pressure 
≤ 1.51 
1.51–2.93 
2.93–5.51 
> 5.51 
 
90th vs 10th percentile 
 
Diastolic blood pressure 
≤ 1.51 
 
 
 
2 508 
3 394 
2 821 
2 268 
 
 
 
 
2 508 
3 394 
2 821 
2 268 
 
 
 
 
 
852 
895 
881 
868 
 
 
 
 
852 
Blood pressure 
change (95% CI), 
mmHg 
0.00 
0.72 (-0.11–1.57) 
1.85 (0.52–3.19) 
1.50 (-0.24–3.24) 
P(trend): 0.116 
1.36 (-0.28–3.00) 
 
 
0.00 
1.00 (0.28–1.71) 
2.01 (0.86–3.15) 
1.23 (0.10–2.35) 
P(trend): 0.006 
1.68 (0.57–2.78) 
 
 
 
0.00 
-0.89 (-2.47–0.69) 
-0.55 (-3.03–1.93) 
-2.05 (-5.11–0.99) 
P(trend): 0.251 
-1.78 (-4.76–1.19) 
 
 
0.00 
Adjustment for age, sex, 
race/ethnicity, education, 
smoking status (never, 
former, current), cotinine, 
alcohol intake, BMI, 
menopause status, anti-
hypertensive medication), 
blood lead. 
The association between 
B-Cd and blood pressure 
was stronger among 
never-smokers. 
All models for U-Cd 
were also adjusted for 
creatinine levels. 
(945) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
1.51–2.93 
2.93–5.51 
> 5.51 
 
90th vs 10th percentile 
 
Hypertension 
B-Cd, nmol/l 
≤ 1.78  
1.78–3.56  
3.56–6.23  
> 6.23 
 
90th vs 10th percentile 
 
U-Cd, nmol/l 
≤ 1.51 
1.51–2.93 
2.93–5.51 
> 5.51 
 
90th vs 10th percentile 
895 
881 
868 
 
 
 
 
 
819 
1 419 
1 452 
979 
 
 
 
 
301 
369 
430 
415 
 
 
-0.26 (-1.28–0.75) 
0.26 (-0.94–1.48) 
-0.45 (-2.34–1.44) 
P(trend): 0.565 
-0.44 (-1.94–1.05) 
 
 
OR 
1.00 
0.98 (0.80–1.19) 
1.25 (0.98–1.59) 
1.03 (0.77–1.36) 
P(trend): 0.303 
1.14 (0.89–1.45) 
 
 
1.00 
0.80 (0.54–1.21) 
1.02 (0.66–1.58) 
0.72 (0.43–1.21) 
P(trend): 0.170 
0.66 (0.37–1.17) 
Cohort: 8 989 participants 
≥ 20 y of age in the US 
NHANES 1999–2004.  
Until 2006 Mortality (ICD-10) 
from CVD (I00–
I78), heart disease 
(I00–I09, I11, I13, 
I20–I51) and IHD 
(I20–I25). 
B-Cd  
80th vs 20th percentile 
(0.80 vs 0.22 μg/l)  
CVD 
Heart disease 
IHD 
U-Cd  
 
 
 
191 
113 
88 
 
HR  
 
 
1.69 (1.03–2.77) 
1.98 (1.11–3.54) 
1.73 (0.88–3.40) 
 
Adjustment for sex, 
education, annual house-
hold income and race/ 
ethnicity, postmenopausal 
status, BMI, blood lead, 
CRP, total cholesterol, 
HDL cholesterol, 
(946) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
80th vs 20th percentile 
(0.57 vs 0.14 μg/g creat.)  
CVD 
Heart disease 
IHD 
 
 
191 
113 
88 
 
 
1.74 (1.07–2.83) 
2.53 (1.54–4.16) 
2.09 (1.06–4.13) 
cholesterol lowering 
medication, hypertension, 
diabetes, estimated 
glomerular filtration rate, 
smoking status, 
cumulative smoking dose 
and serum cotinine.  
Cohort: 3 348 American 
Indian men and women  
45–74 y of age from 13 
American Indian communities 
in Arizona, Oklahoma, and 
North and South Dakota, who 
participated in the Strong 
Heart Study in 1989–1991. 
Mortality 
until 2008 
Incidence 
from clinic 
visits 
1993–1995, 
1998–1999 
Mortality from, and 
incidence of, CVD, 
CHD, heart failure 
and stroke.  
U-Cd, µg/g creatinine 
Mortality 
CVD 
≤ 0.61 
0.62–0.92 
0.93–1.45 
> 1.45 
CHD 
≤ 0.61 
0.62–0.92 
0.93–1.45 
> 1.45 
Incidence,  
fatal and non-fatal 
CVD 
≤ 0.61 
0.62–0.92 
0.93–1.45 
> 1.45 
CHD 
≤ 0.61 
0.62–0.92 
 
 
 
90 
101 
94 
115 
 
79 
71 
78 
79 
 
 
 
249 
263 
269 
303 
 
193 
182 
HR 
 
 
1.0 
1.33 (0.99–1.79) 
1.37 (1.00–1.88) 
1.87 (1.34–2.60) 
P(trend): < 0.001 
1.0 
1.09 (0.78–1.53) 
1.32 (0.93–1.87) 
1.51 (1.04–2.20) 
P(trend): < 0.005 
 
 
1.0 
1.20 (1.00–1.44) 
1.30 (1.07–1.58) 
1.48 (1.21–1.80) 
P(trend): < 0.001 
1.0 
1.13 (0.92–1.40) 
Follow-up was 99.8% 
complete for mortality 
99.2% complete for 
morbidity events. 
Adjustment for sex, 
postmenopausal status, 
education, BMI, total 
cholesterol, estimated 
LDL cholesterol, 
hypertension, diabetes, 
estimated glomerular 
filtration rate, smoking 
status and cumulative 
dose. 
(943) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
0.93–1.45 
> 1.45 
Heart failure 
≤ 0.61 
0.62–0.92 
0.93–1.45 
> 1.45 
Stroke 
≤ 0.61 
0.62–0.92 
0.93–1.45 
> 1.45 
198 
193 
 
60 
81 
87 
100 
 
51 
51 
53 
89 
1.31 (1.05–1.63) 
1.33 (1.05–1.68) 
P(trend): 0.002 
1.0 
1.40 (0.99–1.99) 
1.52 (1.06–2.18) 
1.61 (1.10–2.36) 
P(trend): 0.01 
1.0 
1.21 (0.81–1.80) 
1.11 (0.73–1.69) 
1.87 (1.22–2.86) 
P(trend): 0.03 
Asia        
Cohort: 3 119 inhabitants 
(1 403 men, 1 716 women) of 
the Cd-polluted Kakehashi 
River basin in Japan, who 
participated in a health impact 
survey conducted by Ishikawa 
Prefecture in 1981–1982. The 
subjects amounted to 89% of 
all inhabitants ≥ 50 y old 
living in this area at that time. 
Referents: inhabitants living 
in a reference area. 
Until 1996 Mortality (ICD-9) 
from heart failure, 
CeVD and cerebral 
infarction.  
U-Cd, high a vs moderate b 
(≥ 10 vs < 10 µg/g creat.) 
Heart failure 
Men 
Women 
CeVD 
Men 
Women 
Cerebral infarction 
Men 
Women 
 
 
 
13 
36 
 
11 
30 
 
10 
19 
HR  
 
 
1.97 (1.06–3.66) 
1.59 (1.03–2.46) 
 
1.01 (0.53–1.91) 
1.22 (0.78–1.91) 
 
1.32 (0.67–2.62) 
1.18 (0.67–2.09) 
Adjustment for age 
group. 
a 11.0% of men and 
28.7% of women. 
b upper limit of referents. 
(690) 
Cohort: 3 178 inhabitants 
(1 424 men, 1 754 women) 
who participated in a health 
Until 1996 Mortality (ICD-9) 
from heart failure 
and cerebral 
U-β2 μ-globulin,  
µg/g creatinine 
Heart failure, men 
 
 
 
HR 
 
 
Adjustment for age 
group. 
(709) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
impact survey 1981–1982, 
amounting to 91% of all 
residents ≥ 50 y old, living in 
the Cd-polluted Kakehashi 
River basin in Japan. 
infarction. 
 
< 300 
300–1 000 
1 000–10 000 
≥ 10 000 
Heart failure, women 
< 300 
300–1 000 
1 000–10 000 
≥ 10 000 
Cerebral infarction, men 
< 300 
300–1 000 
1 000–10 000 
≥ 10 000 
Cerebral infarction, 
women 
< 300 
300–1 000 
1 000–10 000 
≥ 10 000 
29 
9 
14 
8 
 
16 
25 
26 
20 
 
18 
13 
22 
6 
 
 
12 
11 
21 
10 
1 
0.88 (0.41–1.89) 
1.45 (0.74–2.84) 
3.69 (1.62–8.39) 
 
1 
1.94 (1.08–3.48) 
3.05 (1.73–5.35) 
3.19 (1.19–5.52) 
 
1 
2.4 (1.15–4.98)  
4.48 (2.29–8.78)  
5.36 (2.04–8.78) 
 
 
1 
1.88 (0.82–4.29) 
3.58 (1.71–7.51) 
3.19 (1.29–7.88) 
Cross-sectional study: 5 919 
inhabitants ≥ 20 y of age 
(2 957 men, 2 962 women) 
who participated in the 
Korean NHANES 2008–
2010, selected to represent the 
adult South Korean 
population. 
 
2008–2010 Hypertension 
defined as ≥ 90 
mmHg diastolic 
or ≥ 140 mmHg 
systolic blood 
pressure, or self-
reported current 
use of an anti-
hypertensive 
Per doubling of B-Cd 
Men 
Women 
B-Cd quartiles, μg/l  
Men 
≤ 0.62 
> 0.62–0.93 
> 0.93–1.33 
> 1.33 
 OR 
1.32 (1.15–1.50) 
1.19 (1.00–1.41) 
 
 
1 
1.23 (0.91–1.67) 
1.66 (1.22–2.28) 
1.83 (1.32–2.52) 
Adjustment for sex, age, 
residence area, education 
level, smoking and 
drinking status, serum 
creatinine, haemoglobin, 
BMI and diabetic status. 
ORs for having hyper-
tension with doubling of 
the blood metal levels 
(545) 
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Table A16. Cadmium. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
medication. 
 
Women 
≤ 0.73 
> 0.73–1.11 
> 1.11–1.57 
> 1.57 
 
1 
1.34 (0.82–2.19) 
1.27 (0.81–2.01) 
1.47 (0.95–2.26) 
were calculated using 
log2-transformed blood 
Cd as an independent 
continuous variable. 
Meta-analysis         
CVD: 4 studies based on 
blood and 2 studies based on 
urine concentrations. 
CHD: 3 studies based on 
blood and 2 studies based on 
urine concentrations.  
Stroke: 2 studies based on 
blood and 1 study based on 
urine concentrations.  
Varying Incidence of, or 
mortality from, 
CVD, CHD and 
stroke. 
Top vs bottom tertile of 
blood or urine levels. 
CVD 
CHD 
Stroke 
 
 
3 756 
1 654 
601 
RR 
 
1.33 (1.09–1.64) 
1.29 (0.98–1.71) 
1.72 (1.29–2.28) 
 (172) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Nordic countries        
Total male population in the 
Swedish national census 1960. 
Cohort: 23 464 male welders 
and gas cutters. 
Referents: total male population. 
1961–1970 Mortality from 
IHD (ICD-8, 
410–414). 
IHD 252 SMR 0.99  (876)  
All gainfully employed men 
identified in the Swedish 
national censuses 1970 and 
1990, respectively. 
Cohorts: male welders and gas 
cutters. 
Referents: all gainfully 
employed men. 
1970–1995, 
1990–1995 
Mortality from 
IHD (ICD-7–8, 
410–414). 
IHD 
Census 1970 
Census 1990 
 
2 156 
102 
SMR 
1.06 (1.02–1.11) 
1.35 (1.10–1.64) 
The increased SMR in the 
census 1990 is unlikely 
explained by smoking habits. 
(882) 
Case-control study: 26 847 
Swedish men with first MI, 2 
controls/case. 
Stockholm 
County: 
1976–1984 
Other 
counties: 
1976–1981 
Incidence of first 
MI, mortality 
(ICD-8, 410)  
and hospital 
discharges 
(410.00, 410.99). 
First MI  
Male welders and 
flame cutters 
 RR 
1.1 (1.0–1.3) 
 
1.0 (0.9–1.2) 
 
Adjustment for age, county and 
calendar year.  
Adjustment for age, county and 
socioeconomic group. 
(377) 
All manual workers (984 040 
males, 741 631 females) from 
the Swedish national census in 
1980 who were alive on 1 
January 1987. 
Cohort: welders. 
Referents: manual workers 
with no exposure to particles. 
1987–2005 First-time events 
of acute MI (ICD-
9, 410; ICD-10, 
I21) and other 
IHD (ICD-9, 
411–414; ICD-10, 
I20, I22–I25). 
Males  
Acute MI 
Other IHD 
Females 
Acute MI 
Other IHD 
 
3 368 
4 499 
 
110 
162 
HR 
1.19 (1.13–1.25) 
1.18 (1.13–1.23) 
 
1.29 (1.07–1.56) 
1.14 (0.98–1.33) 
Morbidity and mortality was 
retrieved from the Hospital 
Discharge Register and the 
National Cause of Death 
Register. 
(1015) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort I: 233 male welders 
working on stainless steel ≥ 5 y 
1950–1965. 
Cohort II: 208 male railway 
track welders working ≥ 5 y 
1950–1965. 
Referents: Swedish national 
male rates. 
Until 1992 Mortality from 
IHD (ICD-9, 
410–414). 
IHD 
Cohort I 
Cohort II 
 
24 
35 
SMR 
0.92 (0.59–1.37) 
0.89 (0.62–1.24) 
Chromium exposure, µg/m3 
Cohort I: 10–750 (range)  
Cohort II: 10 (geometric mean). 
(641) 
Cross-sectional study 
Cohort: 236 men < 70 y of age 
who worked > 1 y 1960–1993 
in a welding factory. Main 
tasks were stainless steel 
welding and grinding. 
Referents: 989 men randomly 
chosen from the general 
population matched for age 
with ≥ 5 y occupational 
activity after 1960.  
1993 Morbidity of 
MI and angina 
pectoris. 
MI 
All  
≥ 10 y employment 
Angina pectoris 
All  
≥ 10 y employment 
Specific activities 
Grinding 
MI 
Angina pectoris  
Welding 
MI 
Angina pectoris 
 OR 
2.4 (1.1–4.9) 
1.3 (1.0–1.7) 
 
2.5 (1.1–5.8) 
1.1 (0.7–1.7) 
 
 
2.5 (1.1–5.9) 
3.3 (1.3–8.5) 
 
1.8 (0.7–4.4) 
1.4 (0.5–4.2) 
72% of the exposed and 74% 
of the referents answered a 
standardised questionnaire. The 
question on MI was validated 
and the sensitivities were 100% 
in the exposed group and 90% 
in the referent group. The 
corresponding specificities were 
both 90%.  
Multiple logistic regression 
(OR) adjusted for age, smoking, 
education and first degree 
relatives with CVD. 
(407) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 3 321 survivors from 
the Copenhagen Male Study 
(started in 1970) with baseline 
established 1985–1986. 
Exposed were compared with 
unexposed. 
Until 1993 Prevalence of 
MI. 
 
 
 
 
 
 
Incidence of 
IHD (ICD-8, 
410–414). 
≥ 5 y exposure 
Blood group O 
Welding 
Soldering 
Other blood group  
Welding 
Soldering 
 
≥ 5 y exposure 
Blood group O 
Welding 
Soldering 
Other blood group  
Welding 
Soldering 
  
OR 
2.1 (1.05–4.3) 
3.0 (1.6–5.8) 
 
0.8 (0.4–1.9) 
0.7 (0.3–1.7) 
 
 
OR 
1.1 (0.6–2.2) 
1.8 (1.0–3.2) 
 
1.0 (0.5–2.1) 
1.05 (0.5–2.2) 
ABO blood groups have been 
discussed as a genetic risk factor 
for IHD. 
In a further analysis, all parti-
cipants with overt CVD at 
baseline (1985–1986) were 
excluded and the cohort was 
followed until 1993. 
Calculated ORs were based on 
logistic regression analysis and 
adjustments were made for 
smoking habits, serum lipids, 
BMI, blood pressure, hyper-
tension, leisure time activities 
and alcohol habits. 
One possible explanation for the 
discrepancy between historical 
IHD and the prospective follow-
up is a larger proportion of older 
(mean age 63 y), retired and 
consequently now non-exposed 
subjects in the second analysis. 
(924) 
Cohort: 5 866 male Danish 
welders employed ≥ 1 y  
1964–1984. 
External referents: national 
male rates of CVD diagnosis 
calculated from the Danish 
National Patient Registry. 
1986–2006 Incidence of 
acute MI (ICD-8, 
410; ICD-10, 
I21), angina 
pectoris (ICD-8, 
413; ICD-10, 
I20), other acute 
Cumulative particle 
exposure, mg/m3-y  
Acute MI, all 
0–10 
10–50 
50–100 
> 100 
 
 
377 
11 
40 
80 
76 
 
SIR 
1.12 (1.01–1.24) 
1.26 (0.63–2.26) 
0.94 (0.94 a–1.28)  
1.26 (1.00–1.57) 
0.98 (0.77–1.23) 
Shipyards were excluded in 
order to exclude asbestos 
exposure.  
 
a Mismatch between SMR and 
CI. 
 
(441) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Internal referents: 3 499 
welders. 
IHD (ICD-8, 
411; ICD-10, 
I24), chronic 
IHD (ICD-8, 
412; ICD-10, 
I25), cardiac 
arrhythmias 
(ICD-8, 427; 
ICD-10, I48–49), 
cardiac arrest 
(none; ICD-10, 
I46), heart failure 
(none; ICD-10 
I50) and cerebral 
infarction (ICD-
8, 433–434; 
ICD-10, I63). 
Angina pectoris, all 
0–10 
10–50 
50–100 
> 100 
Chronic IHD, all 
0–10 
10–50 
50–100 
> 100 
Cerebral infarct., all 
0–10 
10–50 
50–100 
> 100 
Other acute IHD 
Cardiac arrhythmias 
Cardiac arrest 
Heart failure 
Internal comparison, 
cumulative particle 
exposure, mg/m3-y 
Acute MI 
0–10 
10–50 
50–100 
> 100 
Angina pectoris 
0–10 
437 
9 
65 
87 
101 
326 
5 
42 
68 
65 
169 
2 
21 
30 
46 
14 
237 
32 
157 
 
 
 
 
17 
67 
96 
80 
 
17 
1.11 (1.01–1.22) 
0.80 (0.36–1.52) 
1.13 (0.87–1.44) 
1.06 (0.85–1.31) 
1.12 (0.91–1.36) 
1.17 (1.05–1.31) 
0.68 (0.22–1.59) 
1.14 (0.82–1.55) 
1.23 (0.95–1.56) 
1.00 (0.77–1.27) 
1.24 (1.06–1.44) 
0.58 (0.07–2.10) 
1.26 (0.78–1.92) 
1.17 (0.79–1.67) 
1.43 (1.05–1.91) 
1.08 (0.59–1.80) 
1.01 (0.89–1.15) 
0.95 (0.65–1.34) 
1.05 (0.90–1.23) 
 
 
 
HRR 
1 
1.11 (0.65–1.89) 
1.43 (0.85–2.41) 
1.03 (0.61–1.74) 
 
1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HRR (hazard rate ratio) adjusted 
for calendar year, smoking, 
alcohol consumption and use of 
anti-hypertensive or “heart” 
medicine.  
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
10–50 
50–100 
> 100 
Chronic IHD  
0–10 
10–50 
50–100 
> 100 
Cerebral infarction 
0–10 
10–50 
50–100 
> 100 
80 
107 
95 
 
7 
61 
83 
60 
 
7 
32 
32 
52 
1.23 (0.73–2.08) 
1.41 (0.84–2.36) 
1.21 (0.72–2.03) 
 
1 
2.51 (1.15–5.49) 
2.79 (1.29–6.04) 
1.70 (0.78–3.72) 
 
1 
1.32 (0.58–3.01) 
1.17 (0.52–2.67) 
1.54 (0.70–3.39) 
Europe (non-Nordic)        
Cohort: 1 000 welders 
employed at a shipyard in 
England 1940–1968. 
Referents: national rates from 
England and Wales.  
Until 1982 Mortality from 
IHD (ICD-8, 
400–414). 
 
IHD 
 
66 
SMR (90% CI) 
1.30 (1.04–1.56) 
Mean iron oxide levels:  
13.6 (< 0.1–60) mg/m3  
(personal sampling). 
(705) 
Study base: proportion of 
deaths among male welders 
compared with that of other 
male workers (boilermakers, 
shipwrights, painters, electrical 
fitters and joiners) employed at 
HM Dockyard Devonport  
≥ 6 mo 1955–1974. Totally 
656 deaths, 52 among welders. 
Until 1975 Mortality (ICD-
9) from CVD, 
MI and CeVD. 
 
CVD 
MI 
CeVD 
 
25 
18 
4 
PMR 
0.90 
1.06 
0.79 
 (627) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 1 213 welders and 
1 688 turners who had worked 
≥ 6 mo 1950–1970 in the 
German metal industry. 
Referents: rates from the 
Federal Republic of Germany. 
1989–1995 Mortality from 
circulatory 
diseases (ICD-9, 
390–459). 
Circulatory disease 
Welders 
Turners 
 
Welders/turners  
Welding 
Coated electrodes 
MIG, MAG, TIG 
Mixed 
Effective welding 
period per day 
> 25% 
≤ 25% 
 
94 
196 
 
 
 
53 
11 
27 
 
 
37 
57 
SMR 
0.83 (0.67–1.02) 
0.92 (0.79–1.05) 
RR 
0.86 (0.68–1.11) 
SMR 
1.10 (0.82–1.44) 
0.71 (0.36–1.28) 
0.60 (0.40–0.87) 
 
 
0.71 (0.50–0.98) 
0.94 (0.71–1.21) 
Arc welders exposed to fumes 
containing chromium and 
nickel. 
Welding with coated electrodes 
produce much higher levels of 
fumes containing chromium and 
nickel than other techniques 
such as metal inert gas (MIG), 
metal active gas (MAG) or 
tungsten inert gas (TIG) 
welding.  
(75) 
Cohort: 2 721 male welders 
from 13 factories including  
3 shipyards. 
Referents: French national 
male rates.  
1975–1988 Mortality (ICD-8) 
from circulatory 
diseases (390–
459), IHD (410–
414) and CeVD 
(430–438).  
 
Circulatory disease 
IHD 
CeVD 
IHD 
Employment duration 
< 10 y 
10–19 y 
≥ 20 y 
Time since first 
employment 
< 10 y 
10–19 y 
≥ 20 y 
 
47 
28 
9 
 
 
0 
4 
24 
 
 
1 
4 
23 
SMR 
1.09 (0.80–1.45) 
1.51 (1.00–2.18) 
0.93 (0.42–1.76) 
 
 
– 
1.00 
1.79 (P < 0.05) 
 
 
0.55 
0.95 
1.84 (P < 0.05) 
Materials most commonly used 
were mild steel and low alloyed 
steel.  
The main welding techniques 
were manual metal arc welding 
and oxyacetylene welding to a 
lesser extent.  
(675) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 267 male electric arc 
welders and 228 male gas 
welders ever employed in a 
shipyard 1960–1981, Italy. 
Referents: Italian regional male 
rates from Genoa. 
1960–1996 Mortality from 
CVD (ICD-9, 
390–459). 
CVD 
Electric arc welders 
Gas welders 
 
40 
47 
SMR 
0.91 
1.22 
Electric arc welders were mainly 
exposed to fumes containing 
nickel and chromium.  
Gas welders used oxyacetylene 
torchers and were exposed to 
hydrocarbon vapours, during 
cutting inside oil and petroleum 
ship holds.  
(763) 
North America        
Cohort: 3 247 US male 
welders employed ≥ 1 d 1950–
1973 and who worked ≥ 3 y. 
Referents: US male rates. 
Until 1976 Mortality from 
circulatory 
diseases (ICD-7, 
400–468). 
 
Circulatory disease 
 
204 
SMR 
0.76 (P < 0.01) 
 (74) 
Cohort: 4 459 male mild steel 
welders with ≥ 2 y of welding 
heavy equipment at 3 plants in 
the Midwestern US. The plants 
started operation 1951–1957. 
Referents: US male rates. 
1988–1998 Mortality from 
IHD (ICD-9, 
410–414). 
 
IHD 
 
203 
SMR 
0.99 (0.86–1.14) 
The welders were not exposed 
to asbestos (typical of shipyard 
welders), chromium or nickel 
(present in stainless steel). 
In 1974–1987, concentrations of 
dust were 6–7 mg/m3 and iron 
oxide concentrations were 3–4 
mg/m3 (906). 
(904) 
Asia        
Cohort: 2 818 male welders 
employed before 1980 with  
≥ 6 mo employment in an iron-
steel plant, Anshan, China. 
Referents: Non-exposed blue-
collar workers from the same 
1980–1993 Mortality (ICD-9) 
from circulatory 
disease except 
CeVD (390–429, 
440–459), acute 
MI (410), IHD 
 
Circulatory disease 
except CeVD 
Acute MI 
IHD except acute MI 
CeVD 
 
20 
 
12 
3 
52 
SRR 
1.31 (1.14–1.50) 
 
2.04 (1.14–3.63) 
0.95 (0.86–1.03) 
1.28 (1.19–1.40) 
 (422) 
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Table A17. Welding fumes. 
Study group  
and design 
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
plant. 
 
except acute MI 
(411–412), CeVD 
(430–439), 
intracranial (431–
432) and cerebral 
infarction (434). 
Intracranial infarction 
Cerebral infarction 
 
31 
19 
 
1.24 (1.13–1.37) 
1.59 (1.22–2.05) 
 
Cohort: 2 826 male flame 
cutters employed from  
around 1975 in shipbreaking 
operations in Taiwan. 
Referents: Taiwanese 
population. 
1985–2008 Mortality from 
CVD (ICD-9, 
390–459), 
arteriosclerotic 
heart disease 
(410–414, 429) 
and vascular 
lesions of CNS 
(430–438). 
 
CVD 
Heart disease 
Vascular CNS 
lesions 
 
68 
27 
26 
SMR 
1.14 (0.88–1.44) 
1.63 (1.07–2.37) 
0.94 (0.61–1.37) 
Shipbreaking operations 
included exposure to asbestos, 
heavy metals and other toxic 
materials, e.g. PCBs. 
(1039) 
Pooled analysis        
Cohort: 11 092 male welders 
from 9 European countries. 
Referents: national rates. 
Varying Mortality from 
circulatory 
disease (ICD-8, 
390–458). 
 
Circulatory disease 
 
469 
SMR 
0.94 (0.86–1.03) 
Cohorts from Denmark, 
England, Finland, France, 
Germany, Italy, Norway, 
Scotland and Sweden. 
(868) 
Meta-analysis        
10 studies. Varying Morbidity and 
mortality from 
IHD. 
IHD 
All studies 
Internal referents  
External referents 
Acute MI 
Other IHD 
 RR 
1.09 (1.00–1.18) 
1.39 (0.96–2.02) 
1.08 (0.99–1.18) 
1.69 (1.18–2.42) 
1.06 (0.98–1.14) 
 
10 studies 
4 studies 
7 studies 
3 studies 
10 studies 
(655) 
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Table A18. Wood industry.  
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments  
and comments  
Ref. 
Nordic countries        
Cohort: 20 854 male Swedish workers 
exposed to wood dust out of totally 
248 087 construction workers. The 
database included records of medical 
examinations 1971–1993.  
Referents: 71 778 unexposed 
construction workers. 
1971–2001 Mortality from 
IHD (ICD-9, 410–
412; ICD-10, I21–
I25) and CeVD 
(ICD-9, 430–438; 
ICD-10, I60–I69). 
 
IHD 
CeVD 
 
786 
201 
RR 
1.12 (1.04–1.20) 
0.91 (0.79–1.04) 
Adjustment for age, 
smoking, hypertension 
and BMI.  
(967) 
Case-control study: 26 847 men and 
9 755 women (Swedish) with first 
MI, 2 controls for each case. 
Stockholm 
County:  
1976–1984 
Other 
counties: 
1976–1981 
Mortality from MI 
(ICD-8, 410) and 
hospital discharges 
(410.00, 410.99).  
Male frame and 
circular sawyers and 
planers 
Female bench 
carpenters and cabinet 
makers 
 
– 
 
– 
RR 
1.7 (1.0–3.0) 
 
2.0 (1.0–3.9) 
Adjustment for age, 
county and socio-
economic group. 
(377) 
All economically active males and 
females identified in the Finnish 
national census 1970. 
Cohort: forestry workers, log 
floaters, plywood and fibreboard 
workers and timber workers.  
Referents: all economically active 
males and females. 
1971–1991 Mortality from 
CVD, MI, other 
IHD than MI, and 
CeVD. 
CVD 
Males 
Forestry workers and 
log floaters 
Plywood and fibre-
board workers 
Timber workers 
Females 
Plywood and fibre-
board workers 
MI 
Males  
Forestry workers and 
log floaters 
Females 
 
 
4 357 
 
351 
 
1 112 
 
273 
 
 
 
2 391 
 
 
SMR 
 
1.21 (1.17–1.24) 
 
1.19 (1.07–1.32) 
 
1.07 (1.01–1.14) 
 
1.18 (1.04–1.33) 
 
 
 
1.23 (1.19–1.28) 
 
 
 (713) 
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Table A18. Wood industry.  
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments  
and comments  
Ref. 
Forestry workers and 
log floaters 
Other IHD than MI 
Males 
Plywood and fibre-
board workers 
Females 
Plywood and fibre-
board workers 
CeVD 
Males 
Forestry workers and 
log floaters 
Females 
Forestry workers and 
log floaters 
11 
 
 
 
79 
 
 
46 
 
 
 
646 
 
 
10 
2.14 (1.07–3.85) 
 
 
 
1.42 (1.13–1.78) 
 
 
1.42 (1.05–1.91) 
 
 
 
1.16 (1.08–1.26) 
 
 
2.90 (1.39–5.37) 
Cohort: male members of the Danish 
carpenters and cabinet makers’ trade 
union on 1 January 1971. 
Referents: Danish national male 
rates. 
1971–1976 Mortality from 
diseases of the 
heart (ICD-8, 
390–429). 
Heart disease 
Age 20–64 y 
 
211 
SMR 
0.81 (0.70–0.92) 
 (726) 
Europe (non-Nordic)        
Cohort: 5 108 male workers born 
< 1940 and employed < 1968 in the 
Buckinghamshire furniture industry. 
Referents: from England and Wales 
as a whole and an area correction to 
adjust for local mortality 1968–1978. 
Until 1982 Mortality from 
heart disease (ICD-
9, 400–405, 410–
414, 428–429). 
 
Heart disease 
 
499 
SMR 
0.69 (0.63–0.75) 
 (6) 
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Table A18. Wood industry.  
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments  
and comments  
Ref. 
North America        
Cohort: 10 322 US male workers in 
woodworking industries (7 157 
carpenters and joiners, 2 409 workers 
in lumber and sawmill and 735 in 
furniture cabinetry). 
Referents: 406 798 US non-wood 
workers.  
1959–1972 Mortality from 
CHD (ICD-7). 
CHD 
All woodworkers 
Carpenters and joiners 
Lumber and sawmill 
Furniture cabinetry  
 
1 008 
706 
228 
73 
SMR 
0.95 (P < 0.05) a 
0.93 (P < 0.05) 
1.00 
1.04 
 
a SMR 0.95 (P = 0.045) 
after adjustment for age 
and smoking. 
(913) 
Cohort: 8 579 US white male wood 
furniture plant workers identified 
among 36 622 first employed 1946–
1962 and members of the United 
Furniture Workers of America. 
Referents: US national rates. 
Until 1979 Mortality (ICD-8) 
from arterio-
sclerotic heart 
disease (410–413) 
and CeVD (430–
438). 
All 
Heart disease 
CeVD 
≥ 20 y since first 
exposure  
Heart disease 
CeVD 
 
519 
69 
 
 
193 
28 
SMR 
0.7 (0.7–0.8) 
0.5 (0.4–0.7) 
 
 
0.8 (0.7–1.0) 
0.6 (0.4–0.9) 
Adjustment for age, 
race, sex and calendar 
time. 
(645) 
Cohort: 10 497 US white and black 
male and female wood furniture plant 
workers. Follow-up of the study 
above (645). 
Until 1984 Mortality (ICD-8) 
from arterio-
sclerotic heart 
disease (410–413) 
and CeVD (430–
438). 
≥ 20 y since first 
exposure  
Heart disease 
CeVD 
 
 
527 
106 
SMR 
 
0.9 (0.9–1.0) 
0.9 (0.8–1.1) 
 (644) 
Study base: proportion of deaths 
among white male carpenters 
compared with that of 61 682 white 
men employed in construction 
occupations who died 1984–1986 in 
19 US states. 
1984–1986 Mortality from 
IHD (ICD-9, 410–
414). 
IHD 
Carpenters 
 
4 302 
PMR 
0.94 (0.92–0.97) 
 (784) 
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Table A18. Wood industry.  
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments  
and comments  
Ref. 
The Honolulu Heart Program Cohort 
established in 1965. All were 
residents on Oahu at the time of 
baseline (1965–1968). 
Cohort: 685 present and usual 
carpenters + 365 usual carpenters of 
Japanese ancestry, born 1900–1919. 
Referents: 6 458 male never 
carpenters of Japanese ancestry born 
1900–1919. 
Until 1986 Incidence of 
definite CHD in-
cluded non-fatal 
MI, CHD death  
and sudden death 
within 1 h. 
Thromboembolic 
or haemorrhagic 
stroke defined by a 
trained neurologist. 
Present and usual 
carpenters 
CHD 
Stroke 
Usual carpenters 
CHD 
Stroke 
Never carpenters 
CHD 
Stroke 
 Rate/1 000 
 
40.1 (P < 0.05) 
23.1 
 
55.5 
39.1 
 
62.4 
34.4 
Adjustment for age, 
lung function, BMI, 
serum cholesterol, 
systolic blood pressure, 
smoking, physical 
activity and alcohol 
consumption. 
(647) 
Pooled analysis        
Cohort: 28 704 persons combined 
from 5 studies: British furniture 
workers, members of the union 
representing furniture workers in the 
US, 2 cohorts of plywood workers 
and 1 cohort of wood model makers. 
Pooled analyses were carried out for 
all cohorts combined, the 2 furniture 
worker cohorts combined and the 2 
plywood workers cohorts combined.  
Referents: national or regional rates. 
Varying Mortality (ICD-9) 
from circulatory 
diseases (390–
459) and IHD 
(410–414). 
All wood workers  
Circulatory disease 
IHD 
Furniture workers 
Circulatory disease 
IHD 
Plywood workers 
Circulatory disease 
IHD 
 
3 699 
2 535 
 
2 355 
1 578 
 
446 
305 
SMR 
0.8 (0.7–0.8) 
0.8 (0.7–0.8) 
 
0.7 (0.7–0.8) 
0.7 (0.7–0.8) 
 
0.8 (0.8–0.9) 
0.9 (0.8–1.0) 
Included studies:  
(6, 105, 106, 644, 645, 
783, 796). 
(225) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Nordic countries        
Cohort: 18 163 men and 
2 291 women from 8 
Swedish mills employed 
1939–1999 and with > 1 y of 
employment. 
Referents: Swedish national 
rates. 
1952–2001 
(acute MI 
from 1969) 
Mortality (ICD-9) 
from diseases of the 
circulatory system, 
(390–459), IHD 
(410–414), acute MI 
(410) and CeVD 
(430–438). 
Sulphate mills, males 
Circulatory disease 
IHD 
Acute MI 
CeVD  
Sulphate mills, females 
Circulatory disease 
IHD 
Acute MI 
CeVD 
Sulphite mills, males 
Circulatory disease 
IHD 
Acute MI 
CeVD 
Sulphite mills, females 
Circulatory disease 
IHD 
Acute MI  
CeVD 
Sulphate pulping, males 
Circulatory disease 
IHD 
Acute MI 
CeVD 
Sulphite pulping, males 
Circulatory disease 
IHD 
 
1 518 
969 
580 
244 
 
84 
42 
32 
24 
 
1 387 
902 
556 
232 
 
69 
41 
24 
15 
 
319 
216 
121 
46 
 
325 
233 
SMRs 
1.11 (1.05–1.16) 
1.09 (1.02–1.16) 
1.22 (1.12–1.32) 
1.06 (0.93–1.20) 
 
0.94 (0.75–1.16) 
0.97 (0.70–1.30) 
1.25 (0.85–1.76) 
1.05 (0.67–1.56) 
 
0.95 (0.90–1.00) 
0.96 (0.89–1.02) 
1.11 (1.02–1.21) 
0.94 (0.83–1.07) 
 
0.84 (0.65–1.06) 
1.00 (0.72–1.36) 
1.07 (0.68–1.59) 
0.72 (0.40–1.19) 
 
1.12 (1.00–1.25) 
1.17 (1.02–1.34) 
1.29 (1.07–1.54) 
0.95 (0.70–1.27) 
 
0.94 (0.84–1.04) 
1.03 (0.90–1.17) 
Exposure levels as AM, 
GM (range) expressed as 
mg/m3:  
Sulphate pulping, total 
dust: 3.6, 1.5 (0.1–64). 
Sulphite pulping, SO2: 
9.5, 4.5 (< 0.01–160). 
Wood preparation, wood 
dust: 2.0, 1.1 (0.1–15). 
Paper production, paper 
dust: 0.63, 0.41 (0.07–
4.4). 
Possible confounders 
such as shift work and 
noise were not taken into 
account. 
(30) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Acute MI 
CeVD 
Wood preparation, males  
Circulatory disease 
IHD 
Acute MI  
CeVD 
Paper production, males 
Circulatory disease 
IHD 
Acute MI  
CeVD 
143 
47  
 
345 
217 
122 
49 
 
343 
225 
137 
58 
1.16 (0.98–1.37) 
0.81 (0.59–1.08) 
 
0.98 (0.88–1.09) 
0.96 (0.83–1.09) 
1.04 (0.86–1.24) 
0.82 (0.61–1.08) 
 
1.11 (0.99–1.23) 
1.12 (0.98–1.27) 
1.26 (1.06–1.49) 
1.13 (0.85–1.46) 
Study base: 4 070 men 
deceased 1950–1987 and 
≥ 20 y old at the time of 
death (of which 616 paper 
and paper mill workers) in 6 
rather rural parishes in 
southeast Sweden.  
1950–1987 Mortality (ICD-8) 
from IHD (410–414) 
and CeVD (430–
438).  
Pulp and paper mill workers 
IHD 
 
CeVD 
 
207 
 
94 
OR (90% CI) 
0.9 (0.8–1.0) a 
0.9 (0.8–1.1) b 
0.9 (0.8–1.2) a 
1.0 (0.9–1.1) b 
Causes of death excluded 
among the referents:  
a Malignant causes. 
b Malignant causes, 
diabetes mellitus, 
obstructive lung 
disorders, pulmonary 
emboli and accidents. 
A previous smoking sur-
vey indicated an equal 
prevalence of smokers 
among subjects with and 
without a history of em-
ployment in paper mills 
(959). 
(1028) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Case-control study: 26 847 
Swedish men with first MI.  
2 controls for each case.  
Stockholm 
County: 
1976–1984 
Other 
counties: 
1976–1981 
Incidence of first MI, 
mortality (ICD-8, 
410) and hospital 
discharges (410.00, 
410.99). 
First MI 
Paper and paperboard 
workers 
Paper pulp workers 
 RR 
1.6 (1.0–2.7) 
 
1.3 (1.0–1.7) 
Adjustment for age, 
county and socio-
economic group. 
(377) 
Cohort: 3 520 paper and 
pulp industry workers 
employed for at least 1 y 
1945–1961. 
Referents: Finnish national 
rates. 
 
Until 1981 Mortality (ICD-8) 
from diseases of 
circulatory system 
(390–458) and IHD 
(410–414). 
All men  
Circulatory disease 
IHD 
All women 
Circulatory disease 
IHD 
Sulphite mill, men 
Circulatory disease 
IHD 
Sulphate mill, men 
Circulatory disease 
IHD 
Paper mill, men 
Circulatory disease 
IHD 
Board mill, men 
Circulatory disease 
IHD 
Maintenance, men 
Circulatory disease 
IHD 
Power plant, men 
 
489 
332 
 
89 
35 
 
69 
50 
 
143 
96 
 
53 
34 
 
111 
81 
 
252 
170 
 
SMR 
1.21 (1.09–1.34) 
1.28 (1.14–1.44) 
 
1.05 (0.84–1.29) 
0.97 (0.68–1.35) 
 
1.14 (0.89–1.44) 
1.31 (0.97–1.73) 
 
1.40 (1.16–1.70) 
1.42 (1.15–1.74) 
 
1.32 (0.99–1.73) 
1.38 (0.95–1.93) 
 
0.98 (0.80–1.22) 
1.09 (0.87–1.36) 
 
1.12 (0.98–1.29) 
1.18 (1.01–1.38) 
 
The observed excess of 
heart disease mortality 
could not be explained 
by differing smoking 
habits (468).  
(467) 
 372 
 
Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Circulatory disease 
IHD 
93 
67 
1.45 (1.17–1.78) 
1.58 (1.22–2.00) 
Subcohorts: Finnish sulphate 
and sulphite mill workers 
from the study above (467). 
Until 1981 Mortality (ICD-8) 
from diseases of 
circulatory system 
(390–458) and IHD 
(410–414). 
Circulatory disease 
Exposure duration < 5 y  
Exposure duration ≥ 5 y 
Followed > 15 y 
IHD 
Exposure duration < 5 y  
Exposure duration ≥ 5 y 
Followed > 15 y 
 
9 
28 
22 
 
7 
18 
14 
SMR 
2.16 (0.99–4.10) 
1.36 (0.91–1.97) 
1.73 (1.09–2.62) 
 
2.54 (1.02–5.23) 
1.29 (0.77–2.05) 
1.62 (0.88–2.72) 
Exposure to hydrogen 
sulphide and organic 
sulphides. 
(469) 
All economically active 
males, 25–64 y, identified in 
the Finnish national census 
1970.  
Cohort: male pulp mill 
workers. 
Referents: all economically 
active males.  
1971–1991 Mortality from IHD 
other than MI. 
 
IHD other than MI 
 
101 
SMR 
1.34 (1.10–1.64) 
 (713) 
Cohort: 3 143 female pulp 
and paper workers employed 
at least 1 y 1920–1993. 
Referents: Norwegian 
national rates and internal 
referents. 
1951–2000 Mortality (ICD-9) 
from CVD (390–
459), IHD (410–414) 
and CeVD (430–
438). 
 
CVD 
IHD 
CeVD 
Tenure in paper department 
< 3 y 
CVD 
IHD 
CeVD 
≥ 3 y 
CVD 
 
315 
147 
95 
 
 
54 
32 
10 
 
261 
SMR 
1.17 (1.05–1.30) 
1.22 (1.03–1.43) 
1.16 (0.94–1.42) 
 
 
1.33 (1.00–1.74) 
1.73 (1.18–2.44) 
0.83 (0.40–1.52) 
 
1.14 (1.01–1.29 
The women were 
unlikely exposed to 
microorganisms as they 
were not working with 
fresh logs or wet part of 
the paper mills. 
Only a small number of 
women had been shift 
workers. 
(536) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
IHD 
CeVD 
Internal referents 
CVD 
1–2 y 
3–14 y 
≥ 15 y 
IHD 
1–2 y 
3–14 y 
≥ 15 y 
115 
85 
1.12 (0.94–1.35) 
1.22 (0.97–1.51) 
 
RR 
1.00 (0.70–1.44) 
0.96 (0.73–1.28) 
1.02 (0.74–1.39) 
 
1.56 (0.97–2.52) 
1.07 (0.70–1.63) 
1.21 (0.77–1.90) 
No information on 
smoking habits. 
Europe (non-Nordic)        
Cohort: 4 242 male and 
female paper mill workers 
employed at least 1 y 1955–
1992. 
Referents: Scottish national 
rates.  
Until 1994 Mortality (ICD-9) 
from CVD (390–
459), IHD (410–414) 
and CeVD (430–
438). 
All 
CVD 
IHD  
CeVD 
Tenure ≥ 10 y 
CVD 
IHD 
CeVD 
 
554 
351 
136 
 
381 
237 
95 
SMR 
1.00 (0.92–1.09) 
0.98 (0.88–1.09) 
1.12 (0.94–1.33) 
 
1.04 (0.94–1.15) 
1.00 (0.88–1.14) 
1.16 (0.94–1.42) 
 (184) 
 
Cohort: 5 529 male and 876 
female pulp and paper mill 
workers employed in 4 
factories.  
Referents: French national 
rates.  
1968–1992 Mortality from 
CVD. 
 
CVD 
 
168 
SMR 
0.80 (0.68–0.93) 
 (1021) 
Cohort: 2 502 male and 739 
female pulp and paper mill 
workers employed ≥ 3 mo in 
1970–1992 Mortality from CVD 
(ICD-9, 390–459).  
CVD 
All 
 
42 
SMR 
0.55 (0.39–0.74) 
 (821) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
4 factories in Catalonia 
1970–1992.  
Referents: Spanish national 
rates.  
Men 
Women 
39 
3 
0.57 (0.40–0.78) 
0.37 (0.07–1.10) 
North America        
Study base: proportion of 
deaths among 210 white male 
decedent members of the 
United Paperworkers Inter-
national Union who had 
worked ≥ 10 y compared 
with that in the US 
population.  
1970–1984 Mortality from 
arteriosclerotic heart 
disease (ICD-8, 410–
414). 
 
Heart disease 
 
71 
PMR 
1.00 (0.78–1.26) 
Adjustment for race, age 
at death and calendar 
year of death. 
(893) 
Study base: proportion of 
deaths among 2 113 decedent 
members of the US and 
Canadian Pulp, Sulfite and 
Paper Workers’ Union 
compared with the proportion 
in the US population.  
1935–1964 Mortality from 
diseases of 
circulatory system 
(ICD-8, 390–458).  
 
Circulatory disease 
Sulphite, plus others 
Sulphate, plus others 
Sulphite, not sulphate, plus 
others 
Sulphate, not sulphite, plus 
others 
Paper, plus others, neither 
sulphite nor sulphate 
 
1 110 
722 
444 
413 
 
135 
 
121 
PMR 
1.14 
1.14 (P < 0.05) 
1.21 (P < 0.05) 
1.07 (P < 0.05) 
 
1.15 
 
1.13 
 (643) 
Cohort: 3 572 white male 
pulp and paper mill workers 
employed for at least 1 y 
1945–1955. 
Referents: US national rates.  
Until 1977 Mortality (ICD-7) 
from diseases of 
circulatory system 
(400–468) and 
vascular lesions of 
 
Circulatory disease 
Vascular CNS lesions 
 
432 
72 
SMR (90% CI) 
0.81 (0.75–0.88) 
0.85 (0.69–1.03) 
 (783) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
CNS (330–334). 
Cohort: 883 white males of 
which 297 sulphite pulp mill 
and 376 paper mill workers, 
enrolled for a respiratory 
study 1961–1985, employed 
≥ 1 y in a paper company in 
Berlin, New Hampshire.  
Referents: US national rates.  
A previous cohort was 
followed until 1973 (286). 
Until 1985 Mortality (ICD-8) 
from diseases of 
circulatory system 
(390–458) and IHD 
(410–414). 
All 
Circulatory disease 
IHD 
 
Circulatory disease 
Sulphite pulp mill 
Paper mill 
 
220 
145 
 
 
73 
89 
SMR 
0.91 (0.80–1.04) 
0.89 (0.75–1.05) 
 
 
0.91 (0.72–1.15) 
1.02 (0.82–1.26) 
 (398) 
Cohort: same as above. Until 1992 Mortality from all 
heart disease (no 
ICD-code given). 
 
All heart disease 
 
199 
SMR 
0.87 (0.75–1.00) 
Over 80% of the cohort 
were cigarette smokers. 
(399) 
Cohort: 11 178 employees 
from 7 pulp and paper mills 
(9 358 males, 1 820 females) 
who worked ≥ 1 y 1975–
1992.  
Referents: US national rates. 
Until 1992 Mortality (ICD-9) 
from all heart 
disease, IHD,  
all other heart 
disease and CeVD. 
Tenure ≥ 1 y 
All heart disease 
IHD 
All other heart disease 
CeVD 
Tenure ≥ 30 y  
All heart disease 
IHD 
All other heart disease 
CeVD 
 
276 
222 
43 
32 
 
170 
139 
24 
17 
SMR 
0.75 (0.66–0.84) 
0.80 (0.70–0.91) 
0.67 (0.48–0.90) 
0.84 (0.58–1.19) 
 
0.80 (P < 0.01) 
0.87 
0.65 (P < 0.05) 
0.77  
 (1035) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 63 025 pulp and 
paper mill workers from 51 
mills employed 1970–1991 
for ≥ 10 y.  
Referents: US national and 
regional rates and also 
internal comparisons. 
Until 1991 Mortality (ICD-9) 
from diseases of 
circulatory system 
and CVD.  
 
Circulatory disease, US rates 
CVD, US rates 
CVD, white males 
US rates 
State rates 
County rates 
CVD, white males 
US rates  
Kraft (sulphate) 
Sulphite 
Other chemical pulping 
Other pulping 
Heart disease, white males 
Internal comparison 
Kraft (sulphate) 
Sulphite 
Other chemical pulping 
Other pulping 
 
3 259 
2 243 
 
1 999 
SMR 
0.75 (0.72–0.78) 
0.74 (0.71–0.77) 
 
0.75 (0.71–0.78) 
0.80 (0.76–0.83) 
0.86 (0.82–0.89) 
 
 
0.75 (0.71–0.78) 
0.78 (0.71–0.84) 
0.77 (0.72–0.83) 
0.71 (0.65–0.77) 
 
RR 
0.96 (0.84–1.10) 
1.06 (0.96–1.17) 
1.12 (1.03–1.23) 
0.91 (0.83–1.01) 
Adjustment for race and 
sex.  
 
 
 
 
 
 
 
 
(609) 
New Zealand        
Cohort: 8 456 pulp and 
paper mill workers who 
worked ≥ 1 y 1978–1990.  
Referents: New Zealand 
national rates. 
Until 1992 Mortality from 
diseases of 
circulatory system 
(ICD-9, 390–459). 
 
Circulatory disease 
 
119 
SMR 
0.78 (0.64–0.93) 
 (624) 
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Table A19. Pulp and paper industry.  
Study group and design  Time of 
follow-up 
Outcome (diagnose) Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Pooled analysis        
Cohort: 57 613 pulp and 
paper workers (51 240 men, 
6 373 women) who worked 
≥ 1 y in Brazil, Denmark, 
Finland, France, Japan, New 
Zealand, Norway, Poland, 
South Africa, Spain, Sweden 
and the US.  
Referents: national rates. 
 Mortality from 
diseases of 
circulatory system 
(ICD-9, 390–459). 
Circulatory disease 
Never exposed 
Ever exposed 
High exposed 
 
1 438 
3 660 
342 
SMR 
0.92 (0.87–0.96) 
0.94 (0.91–0.97) 
0.96 (0.86–1.07) 
SMRs by SO2 exposure. (549) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Nordic countries        
All gainfully employed identified in 
the Swedish national censuses 1970 
and 1980.  
Cohorts: textile workers  
I: 1970 (7 419 men, 9 157 women)  
II: 1970 and 1980 (1 620 men, 1 772 
women).  
Referents: all gainfully employed:  
I: 2 047 861 men, 1 260 583 women 
II: 645 393 men, 370 903 women. 
1970–1995,  
1980–1995 
Mortality from 
IHD (ICD 7–8, 
410–414).  
Cohort I 
Males  
Females 
Cohort II 
Males 
Females 
 
988 
434 
 
114 
35 
SMR 
1.15 (1.08–1.22) 
1.08 (0.98–1.18) 
 
1.34 (1.11–1.62) 
1.35 (0.94–1.88) 
No socioeconomic 
adjustment. 
(888) 
Cohort: 1 065 women exposed to 
raw cotton for ≥ 5 y and hired 
1950–1971. 
Referents: Finnish female national 
rates. 
Cross-sectional study  
Cohort: same as above (still alive 
or next of kin), questionnaire study 
regarding previous disease; 
response rate 73%.  
Referents: 398 female paper box 
assembly workers, response rate 
77%.  
1950–1985 
 
 
 
 
1985 
Mortality (ICD-8) 
from CVD, IHD 
and CeVD. 
 
 
Morbidity from 
heart diseases, 
CeVD and 
hypertension. 
 
CVD 
IHD  
CeVD 
 
 
Heart diseases 
CeVD 
Hypertension 
 
37 
16 
13 
SMR 
0.77 
0.74 
0.91 
 
OR 
1.0 
1.3 
0.8 
Mean dust levels:  
1.8–3.3 mg/m3 
(highest levels for 
carding) measured in  
5 mills in 1972. 
(509) 
All economically active males 
identified in the Finnish national 
census 1970. 
Cohort: male weaving machine 
operators. 
1971–1991 Mortality from 
CeVD. 
CeVD 
Age 25–64 y 
 
11 
SMR 
2.05 (1.02–3.70) 
No socioeconomic 
adjustment. 
(713) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Referents: all economically active 
males. 
Cohort: 353 self-employed males 
in textile industry identified in the 
Central Population Register of 
Denmark. 
Referents: all economically active 
persons 20–59 y old on 1 January 
1981, identified in the Register.  
Until 1984 Hospitalisations 
from IHD (ICD-8, 
410–414).  
 
IHD 
 
11 
SHR 
1.85 (1.03–3.35) 
SHR: standardised 
hospitalisation ratio. 
(973) 
Europe (non-Nordic)        
Registrar General reports for 
England and Wales, 1930–1932. 
Cohort: cotton weavers, spinners, 
strippers and grinders. 
Referents: all males aged 55–64 y. 
1930–1932 Mortality from 
cerebral vascular 
lesions. 
Cerebral vascular lesions 
Referents 
Social class III 
Cotton weavers  
Cotton spinners 
Strippers and grinders 
 
10 621 
 4 503 
 60 
 49 
 13 
Rate/1 000 
2.0 
2.0 
2.4 
3.4 (P = 0.02) 
6.4 (P = 0.02) 
Strippers and grinders 
were those most 
exposed to fine dust  
in the card rooms. 
Spinning rooms were 
sometimes continuous 
with card rooms. 
Weavers had little 
contact with fine 
cotton dust.  
(837) 
Cross-sectional study (first)  
Cohort: 103 male card- and blow-
room cotton workers, England. 
Referents: 93 male weavers and 
warehousemen. 
Participants were 35–65 y of age 
and had worked ≥ 10 y in the 
respective departments. 
Cross-sectional study (second)  
Not given. 
Year of 
publication 
1952. 
 
Casual blood 
pressure taken in 
the beginning of 
the examination. 
Lowest blood 
pressure taken after 
lying down in 
silence. 
 
Mean blood pressure 
First study  
Casual, systolic 
Lowest, systolic  
Casual, diastolic 
Lowest, diastolic 
 
 
Second study 
Exp/ 
refs 
 
 
 
 
 
 
 
Exp/refs (mmHg)  
 
141.1/141.5 
127.7/127.7 
87.6/84.7 a 
82.0/80.3 
 
 
 
 
 
 
 
a P = 0.04. 
 
 
 
(838) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 59 male card- and blow-
room workers.  
Referents: 50 male weavers and 
warehousemen, all aged 50–59 y. 
Hypertension 
defined as lowest 
pressures ≥ 150/90. 
Systolic 
Diastolic 
Hypertension 
 
 
15/4 b 
137.9/129.9 b 
84.9/81.6 
b P < 0.05. 
 
Study base: proportion of deaths 
among 1 429 dyers, bleachers and 
textile workers (Bradford National 
Union, membership for ≥ 1 y before 
1936) compared with the proportion 
in the general population. 
1957–1968 Mortality from 
CVD (ICD-8).  
 
CVD 
 
728 
PMR 
1.03 
The principle jobs in 
the industry were 
dyeing, finishing, 
bleaching and printing.  
(704) 
Cohort: 1 586 workers (663 men, 
923 women) seen at least once 
1963–1966 in 16 Lancashire mills; 
1 359 in mills processing cotton 
and 227 in mills processing man-
made fibres. 
Referents: national rates from 
England and Wales. 
1967–1977 
(90% of 
the group) 
1967–1979 
(10% of 
the group) 
Mortality (ICD-8) 
from IHD, CeVD 
and other cir-
culatory disease. 
Cotton mills 
Women 
IHD 
CeVD 
Other circulatory disease 
Men 
IHD 
CeVD 
Other circulatory disease 
Man-made fibre mills 
All circulatory disease 
Women 
Men 
 
 
11 
4 
7 
 
16 
8 
1 
 
 
2 
5 
SMR 
Crude (adjusted) 
0.84 (0.75) 
0.5 (0.4) 
1.4 (–) 
 
0.72 (0.63) 
1.3 (1.0) 
0.2 (–) 
 
 
0.4 (0.4) 
0.8 (0.7) 
Adjustment for region 
of the mills. 
Mean dust levels:  
1.0 mg/m3 in card-
rooms of cotton mills.  
 
(89) 
Cohorts:  
Main study group: 3 458 cotton 
workers (with at least 1 medical 
examination) enrolled in a study of 
respiratory symptoms 1968–1970. 
 
Until 1984 Mortality  
(ICD 8–9) from 
circulatory 
disease, IHD and 
CeVD. 
 
Main study group 
Circulatory disease 
IHD 
CeVD 
Circulatory disease by 
 
 
298 
174 
69 
 
SMR 
 
0.91 (0.81–1.02) 
0.90 (0.77–1.05) 
0.95 (0.74–1.20) 
 
SMR by follow-up 
< 5 y ≥ 5 y 
0.50 1.00 
0.44 (P < 0.01) 1.01 
0.75 1.00 
(414) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Second group: 340 workers with 
no medical examination data. 
Referents: national rates from 
England and Wales. 
years of cotton exposure 
Men 
< 15 y  
15–29 y 
≥ 30 y 
Women 
< 15 y 
15–29 y 
≥ 30 y 
Circulatory disease by 
byssinosis 
Men 
With byssinosis 
Without byssinosis 
Women  
With byssinosis 
Without byssinosis 
Second group  
Circulatory disease 
IHD 
 
 
23 
62 
82 
 
  3 
39 
89 
 
Smoker 
Yes/No 
44/2 
85/22 
 
21/7 
55/45 
 
36 
22 
 
 
0.96 
1.16 
0.72 (P < 0.01) 
 
0.53 
1.42 (P < 0.01) 
0.86 
 
Smoker 
Yes/No 
0.97/0.24 a 
0.97/0.75 
 
1.71 a/0.45 a 
1.44 a/0.71 a 
 
1.63 (1.14–2.26) 
1.78 (1.11–2.69) 
 
Percentage of smokers 
consuming < 15 cig/day 
in the cohort vs in the 
general population:  
males: 52% vs 35%  
females: 62% vs 62%. 
 
 
 
 
 
a P < 0.05 
 
 
 
SMR by follow-up 
< 5 y ≥ 5 y 
2.87 (P < 0.01) 1.24 
3.64 (P < 0.01) 1.17 
 
Study base: proportion of deaths 
among textile and fabric workers 
compared with the proportion 
among 3.5 million deaths in 
England and Wales.  
1979–2000 Mortality from 
IHD (ICD-9, 410–
414). 
IHD 
Males 
1979–1990 
1991–2000 
Females 
1979–1990 
1991–2000 
 
 
8 271 
2 808 
 
7 125 
3 711 
PMR 
 
1.11 (1.09–1.13) 
1.13 (1.08–1.17) 
 
1.06 (1.04–1.09) 
1.03 (0.99–1.06) 
Adjustment for age 
and social class. 
Increased risks for 
weavers, spinners and 
winders. An increased 
PMR of diabetes 
among male textile and 
fabric workers. 
(1051) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 7 545 cotton industry 
workers (2 852 men, 4 693 women) 
employed 1964–1993 and working 
≥ 10 y.  
Referents: Polish national rates. 
Until 1995 Mortality (ICD-9) 
from diseases of 
the circulatory 
system (390–459), 
hypertensive 
disease (401–405), 
IHD (410–414), 
CeVD (430–438) 
and athero-
sclerosis (440). 
Men 
Circulatory disease 
Hypertension 
IHD 
CeVD 
Atherosclerosis 
Spinning department 
Circulatory disease 
Hypertension 
IHD 
CeVD 
Atherosclerosis 
Weaving department 
Circulatory disease 
Hypertension 
IHD 
CeVD 
Atherosclerosis 
Women 
Circulatory disease 
Hypertension  
IHD 
CeVD 
Atherosclerosis 
Spinning department 
Circulatory disease 
Hypertension 
IHD 
CeVD 
 
562 
29 
156 
58 
195 
 
127 
10 
25 
15 
47 
 
142 
8 
40 
14 
56 
 
378 
24 
64 
55 
145 
 
144 
8 
26 
19 
SMR 
0.99 (0.91–1.08) 
1.35 (0.90–1.94) 
0.92 (0.78–1.08) 
0.81 (0.62–1.05) 
1.45 (1.25–1.67) 
 
1.15 (0.96–1.37) 
2.39 (1.15–4.40) 
0.76 (0.49–1.12) 
1.07 (0.60–1.76) 
1.75 (1.29–2.33) 
 
0.86 (0.72–1.01) 
1.29 (0.55–2.52) 
0.82 (0.59–1.12) 
0.68 (0.37–1.14) 
1.41 (1.07–1.83) 
 
0.84 (0.76–0.93) 
0.73 (0.47–1.09) 
0.74 (0.57–0.94) 
0.67 (0.50–0.87) 
1.17 (0.99–1.38) 
 
0.90 (0.76–1.06) 
0.70 (0.30–1.38) 
0.86 (0.56–1.26) 
0.65 (0.39–1.02) 
The authors point out 
that the determination 
of specific diseases of 
the circulatory system 
in Poland is not 
reliable. 
Cotton was the basic 
material, but during 
some periods other 
types of fibre were 
also processed: 
polyester: 1973–1993 
polyamide: 1983–1990 
rayon: 1983–1993 
acrylics: 1991–1993. 
Mean dust 
concentrations:  
1.8 (carding machine 
operators) to 11.7 
µg/m3 (cotton waste 
baling press operators); 
11.4 µg/m3 (weaving 
room operators).  
(Units probably 
mg/m3). 
(933) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Atherosclerosis 
Weaving department 
Circulatory disease 
Hypertension 
IHD 
CeVD 
Atherosclerosis 
59 
 
163 
12 
24 
24 
60 
1.29 (0.98–1.66) 
 
0.77 (0.66–0.90) 
0.75 (0.39–1.31) 
0.57 (0.37–0.85) 
0.61 (0.39–0.91) 
1.09 (0.83–1.40) 
Cohort: 2 916 male synthetic 
spinning plant workers working 
≥ 6 mo 1968–1984. 
Referents: regional rates from 
Franche-Comté, France. 
Until 1999 Mortality from 
diseases of the 
circulatory system 
(ICD-9, 390–459). 
 
Circulatory disease 
 
134 
SMR 
0.71 (0.60–0.85) 
Exposure included 
heat-transfer fluids, 
mineral fibres, textile 
lubricants, dusts and 
degradation products 
of hot polymers. 
(423) 
Cohort: 3 961 cotton mill workers 
from 4 textile industries in Vicenza, 
Italy, working some time 1946–85. 
Referents: regional rates from 
Veneto, Italy. 
1970–1994 Mortality from 
diseases of the 
circulatory system 
(ICD-9). 
 
Circulatory disease 
 
213 
SMR 
1.06 (0.93–1.22) 
 (608) 
North America        
Study base: proportion of deaths 
among 6 113 male textile workers 
compared with the proportion 
among 45 482 male deaths in 
Rhode Island, US. 
1968–1978 Mortality (ICD-8) 
from diseases of 
the circulatory 
system (390–458), 
IHD (410–414) 
and CeVD (430–
438). 
 
Circulatory disease 
IHD 
CeVD 
IHD 
Weavers 
Miscellaneous textile 
finishing operatives 
Dyeing and finishing 
 
3 726 
2 870 
499 
 
486 
164 
 
608 
PMR 
1.03 (1.01–1.05) 
1.06 (1.03–1.09) 
1.01 (0.93–1.09) 
 
1.10 (1.03–1.17) 
1.18 (1.05–1.32) 
 
1.07 (1.01–1.13) 
Stratification by 5-y 
age groups. The years 
of death strata were 
1968–1973 and 1974–
1978. Only whites and 
blacks included. 
(243) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 1 062 white men and 382 
white women employed at 2 cotton 
mills in North Carolina some time 
during 1937–1940.  
Referents: US general population. 
1940–1975 Mortality (ICD-8) 
from arterio-
sclerotic heart 
disease and other 
diseases of the 
heart. 
Employment duration 
Heart disease, males 
All jobs  
< 20 y  
20–29 y 
≥ 30 y 
Yarn processing  
< 20 y 
20–29 y 
≥ 30 y 
Other heart diseases, 
males 
All jobs  
< 20 y  
20–29 y 
≥ 30 y 
Yarn processing  
< 20 y  
20–29 y 
≥ 30 y 
Heart disease, females 
All jobs  
< 20 y  
20–29 y 
≥ 30 y 
Yarn processing 
< 20 y  
20–29 y 
≥ 30 y 
 
 
199 
64 
67 
68 
68 
32 
19 
17 
 
 
20 
11 
5 
4 
5 
3 
1 
1 
 
35 
13 
13 
9 
27 
12 
10 
5 
SMR 
 
1.03 
0.86 
1.20 
1.09 
1.37 (P < 0.01) 
1.30 
1.69 (P < 0.02) 
1.23 
 
 
2.12 (P < 0.01) 
2.70 (P < 0.01) 
1.88 
1.48 
2.15 
2.44 
1.91 
1.72 
 
1.28 
1.03 
1.52 
1.47 
1.58 (P < 0.02) 
1.29 
2.18 (P < 0.02) 
1.54 
 (633) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohorts: white male cotton textile 
workers from 3 cotton textile mills 
in Georgia, US.  
Cohort I: 5 822 subjects working 
1938–1941. 
Cohort II: 6 316 subjects working 
1948–1951.  
Referents: white male population 
from Georgia, US. 
Cohort I: 
1938–1963 
Cohort II: 
1948–1963 
Mortality (ICD-7) 
from heart disease 
(400–443), CHD 
(420) and stroke 
(330–334). 
Cohort I 
Heart disease 
CHD 
Stroke 
Cohort II 
Heart disease 
CHD 
Stroke 
 
294 
224 
64 
 
197 
165 
37 
SMR 
0.76 
0.82 
0.73 
 
0.84 
0.90 
0.79 
 (397) 
Study base: proportion of deaths 
among yarn, thread and fabric mill 
workers compared with the 
proportion among 10 million 
decedents aged 18–64 y in the 
National Occupational Mortality 
Surveillance system in 30 US 
states. 
1985–1999, 
2003–2004, 
2007 
Mortality from 
acute MI (ICD-10, 
I21). 
Yarn, thread and fabric 
mills 
White males 
White females 
Black males 
Black females  
 
 
2 420 
761 
448 
197 
PMR 
 
1.22 (1.17–1.26) 
1.38 (1.29–1.49) 
1.32 (1.20–1.44) 
1.22 (1.06–1.40) 
Adjustment for age 
and smoking. 
(786) 
Cohorts: 7 487 male and 2 724 
female workers in a synthetic 
textile plant, who had worked ≥ 1 y 
in 1947 or were newly employed 
1947–1977.  
Referents: regional rates from 
Quebec and from 2 subregions of 
the province.  
1947–1986 Mortality 
originally 
according to ICD 
5–9. Underlying 
cause of death  
re-classified 
according to a 
scheme by 
Laboratory Center 
for Disease 
Control. 
Circulatory diseases 
Males 
Females 
IHD, males 
Exposure duration 
1–4 y 
5–9 y 
10–19 y  
≥ 20 y 
IHD, females 
Exposure duration 
1–4 y 
 
834 
65 
 
 
101 
92 
117 
258 
 
 
15 
SMR 
0.75 (0.70–0.80) 
0.59 (0.46–0.76) 
 
RR 
1 
1.16 (0.87–1.55) 
1.13 (0.85–1.48) 
1.40 (1.10–1.79) 
 
RR 
1 
 
 
 
 
 
 
 
 
 
 
 
 
(344) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
5–9 y 
10–19 y 
≥ 20 y 
IHD, maintenance unit, 
males 
Exposure duration 
0 y 
> 0–4 y 
5–9 y 
10–19 y 
≥ 20 y 
IHD, janitor unit, females 
Exposure duration  
0 y 
> 0–4 y 
5–9 y 
10–19 y 
≥ 20 y 
CeVD, weaving unit, males 
Exposure duration 
0 y 
> 0–4 y 
5–9 y 
10–19 y 
≥ 20 y 
7 
6 
13 
 
 
 
411 
63 
32 
28 
34 
 
 
33 
3 
0 
3 
2 
 
 
67 
6 
4 
5 
19 
0.63 (0.25–1.56) 
0.79 (0.29–2.14) 
1.41 (0.61–3.23) 
 
 
RR 
1  
1.00 (0.75–1.30) 
1.27 (0.86–1.83) 
1.26 (0.83–1.84) 
1.65 (1.13–2.34) 
 
RR 
1  
1.53 (0.29–4.89) 
0.00 (0.00–9.57) 
3.02 (0.58–9.62) 
9.57 (1.03–37.4) 
 
RR 
1  
0.72 (0.26–1.66) 
0.88 (0.23–2.36) 
0.77 (0.24–1.88) 
2.14 (1.21–3.60) 
 
 
P(trend): 0.003.  
 
 
 
 
 
 
 
P(trend): 0.002. 
 
 
 
 
 
 
P(trend): 0.037. 
Asia        
Cohort: 267 400 female textile 
workers in Shanghai, China, active 
or retired 1989–1991. 
1989–2000 Mortality (ICD-9) 
from IHD (410–
414), ischaemic 
Endotoxin exposure 
IHD 
Exposed 
 
 
184 
HR 
 
1.00 (0.84–1.21) 
Adjustment for age and 
smoking. 
 
(324) 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cumulative exposures were 
analysed in a subcohort of 3 128 
workers. 
Exposure to endotoxins during 
cotton spinning, weaving and 
knitting. 
Exposure to particulates during 
cotton, wool, mixed fibre or 
synthetic spinning, weaving and 
knitting. 
Referents: females from all other 
textile sectors. 
stroke (434) and 
intracerebral 
haemorrhage 
(431). 
Referents 
Ischaemic stroke 
Exposed 
Referents 
Haemorrhagic stroke 
Exposed 
Referents 
Particulate exposure 
IHD 
Exposed 
Referents 
Ischaemic stroke 
Exposed 
Referents 
Haemorrhagic stroke 
Exposed 
Referents 
Subcohort 
All stroke, cum endotoxin 
exposure, EU/m3-y 
Unexposed 
> 0–2 275 
> 2 275–2 944 
> 2 944–5 168 
> 5 168 
310 
 
287 
412 
 
711 
1 104 
 
 
312 
182 
 
463 
236 
 
1 190 
625 
 
 
 
20 
10 
10 
10 
10 
 
 
1.12 (0.97–1.31) 
 
 
1.12 (1.02–1.23) 
 
 
 
0.99 (0.82–1.18) 
 
 
1.08 (0.92–1.26) 
 
 
1.12 (1.02–1.24) 
 
 
 
 
1.00 
0.71 (0.33–1.53) 
1.07 (0.49–2.32) 
0.91 (0.43–1.95) 
1.52 (0.72–3.24) 
P(trend): 0.09 
Mortality rate/100 000:  
IHD  
6.5 never-smokers  
20.6 ever-smokers  
Ischaemic stroke  
8.3 never-smokers  
15.9 ever-smokers  
Haemorrhagic stroke 
23.9 never-smokers  
92.9 ever-smokers  
 
 
 
 
 
 
 
Adjustment for age and 
smoking. 
 
 
 
 
P(trend): 0.35 for 
cumulative cotton dust 
exposure. 
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Table A20. Textile industry. 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Australia        
Cohort: 7 684 workers from the 
Textile, Clothing and Footwear 
Union.  
Referents: Australian population. 
1988–1999 Mortality from 
CVD (ICD-9, 
390–459). 
CVD 
Males 
Females 
 
14 
7 
SMR 
0.91 (0.50–1.53) 
1.21 (0.49–2.50) 
 (315) 
Meta-analysis        
Meta-analysis of 6 cohorts:  
(89, 397, 414, 509, 633). 
Varying Mortality from 
circulatory system 
diseases.  
Circulatory disease 
Males 
Females 
 
1 010 
228 
SMR 
0.85 (0.79–0.91) 
0.94 (0.81–1.06) 
 (922) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Nordic        
All economically active 
persons identified in the 
Swedish census 1960 and 
born in Sweden 1896–1940. 
Cohort: agricultural workers. 
Referents: all economically 
active persons; 1.9 million 
men and 0.7 million women. 
1961–1968  Mortality (ICD-7) 
from CHD (420), 
MI (420.1), CNS 
vascular disease 
(330–334) and 
cerebral haemorr-
hage (331).  
Males 
Self-employed 
agricultural 
CHD 
MI 
Vascular CNS lesions 
Cerebral haemorrhage 
Manual agricultural 
CHD 
MI 
Vascular CNS lesions 
Cerebral haemorrhage 
Females 
Self-employed 
agricultural 
CHD 
MI 
Vascular CNS lesions 
Cerebral haemorrhage 
Manual agricultural 
CHD 
MI 
Vascular CNS lesions 
Cerebral haemorrhage 
 
 
 
2 820 
2 319 
932 
532 
 
1 225 
1 020 
351 
170 
 
 
 
90 
68 
82 
47 
 
22 
17 
25 
15 
SMR 
 
 
0.87 (0.84–0.90) 
0.87 (0.84–0.91) 
0.96 (0.90–1.02) 
0.98 (0.90–1.07) 
 
0.90 (0.85–0.95) 
0.91 (0.86–0.97) 
0.88 (0.79–0.98) 
0.77 (0.66–0.90) 
 
 
 
0.91 (0.73–1.12) 
0.90 (0.70–1.14) 
1.07 (0.85–1.33) 
1.10 (0.81–1.46) 
 
0.75 (0.47–1.13) 
0.75 (0.44–1.20) 
1.07 (0.69–1.58) 
1.16 (0.65–1.91) 
Adjustment for age and 
urbanisation. 
Farmers and agricultural 
workers had a low 
mortality compared to 
other self-employed or 
manual workers. 
Smoking habits were 
likely to contribute to 
these differences. 
(1042) 
 390 
 
Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
All economically active 
persons identified in the 
Swedish census 1980. 
Cohort: 60 515 farmers 
(39 386 males, 21 129 
females). 
Referents: 2 843 237 
economically active persons 
(1 470 293 males, 1 372 944 
females).  
The cohort 
was linked to 
the national 
hospital care 
registry 
1978–1983. 
Morbidity (ICD of 
1965) from CVD, 
IHD, MI, hyper-
tension and CeVD. 
Males 
CVD 
IHD 
MI 
Hypertension 
CeVD 
Females 
CVD 
 
1 969 
322 
393 
93 
334 
 
732 
SMR 
0.74 (0.70–0.77) 
0.66 (0.59–0.74) 
0.64 (0.58–0.71) 
0.70 (0.57–0.86) 
1.03 (0.92–1.18) 
 
1.01 (0.90–1.13) 
 (951) 
Cohort: 1 220 male farmers 
born 1930–1949, living in 
nine rural municipalities and 
identified in the Swedish 
Farm Register in 1989. 
Urban referents: 1 087 males 
randomly sampled from the 
population of the county 
where the farmers lived. 
Mortality 
1989–2001 
Morbidity 
1990–2002 
(admissions 
to hospitals, 
Hospital 
Patient 
Registry). 
Mortality and 
morbidity from 
CVD, IHD and 
stroke according to 
ICD-9–10. ICD-10 
diagnoses were 
transformed to 
ICD-9 diagnoses. 
Mortality 
CVD 
IHD 
CeVD 
 
Morbidity 
CVD 
IHD 
CeVD 
 
26 
15 
3 
 
 
238 
104 
27 
HR 
0.60 (0.36–0.99) 
0.55 (0.29–1.04) 
P = 0.71 
 
OR 
0.72 (0.59–0.87) 
0.66 (0.50–0.86) 
0.46 (0.29–0.74) 
Farmers were defined as 
persons who owned or 
rented a farm and who 
spent at least 25 h/wk 
farming. Farm labourers 
were not included. Female 
farmers were excluded 
due to small numbers. 
The cohort was previously 
followed until 1996 (916). 
(952) 
Case-control study: 26 847 
Swedish men with first MI.  
2 controls for each case. 
Stockholm 
County: 
1976–1984 
Other 
counties: 
1976–1981 
Incidence of first 
MI, mortality (ICD-
8, 410) and hospital 
discharges (410.00, 
410.99). 
First MI 
Farm managers and 
supervisors 
Agricultural/livestock 
workers 
 RR 
1.6 (1.0–2.6) 
 
0.8 (0.7–1.0) 
Adjustment for age, 
county and socio-
economic group. 
(377) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
All males identified in the 
Swedish censuses 1960, 1970, 
1980 and 1985. 
Cohorts: males employed in 
agriculture. 
Referents: all males 1986–
1990.  
Each cohort 
was followed 
5–10 y. 
Mortality from 
CVD (ICD-8, 390–
458). 
CVD 
1961–1965 
1966–1970 
1971–1975 
1976–1980 
1981–1986 
1986–1990 
 RR 
0.97 
0.98 
1.08 
1.09 
1.11 
0.93 
Age-standardised mortality 
RR, adjusted for the 
healthy worker effect, for 
ages 45–69 y in Sweden 
1961–1990.  
(231) 
All gainfully employed males 
and females identified in the 
Swedish national census 
1970.  
Cohort: agricultural (22 663 
males, 36 080 females) and 
livestock (3 015 males, 6 242 
females) workers. 
Referents: all gainfully em-
ployed (2 047 861 males, 
1 260 583 females). 
1970–1995 Mortality from IHD 
(ICD-7–8, 410–
414). 
Males 
Agricultural work 
Livestock work 
Females 
Agricultural work 
Livestock work 
 
2 122 
353 
 
1 791 
305 
SMR 
1.00 (0.96–1.05) 
1.06 (0.95–1.18) 
 
0.98 (0.94–1.03) 
1.10 (0.98–1.23) 
Agricultural and livestock 
workers smoke less than 
the general population. 
Thus, the crude SMR may 
underestimate the risk by 
ca. 9% for men and 5% for 
women.  
(889) 
Case-control study: all patients 
30–72 y of age, residents in 
province Halland, Sweden, 
with first time acute MI,  
treated in two hospitals.  
Totally 4 737 cases (3 514 
men, 1 223 women). 
3 controls/case randomly 
selected from the register of  
the total population matched 
for sex, age and municipality.  
1980–1992 Incidence of acute 
MI (ICD 8–9). 
Males 
Self-employed farmers 
Agricultural employees 
Females 
Self-employed farmers 
Agricultural employees 
 
396 
94 
 
127 
25 
RR 
0.67 (0.59–0.75) 
0.92 (0.72–1.16) 
 
0.94 (0.75–1.17) 
1.05 (0.66–1.68) 
Fatal cases not treated 
in the hospitals were 
excluded. 
(60) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 213 self-employed 
females 20–59 y old in other 
agricultural occupations 
identified in the Central 
Population Register of 
Denmark. 
Referents: all economically 
active persons 20–59 y old on 
1 January 1981 and identified 
in the Register. 
Until 1984 Hospitalisations 
from IHD (ICD-8, 
410–414).  
 
IHD 
 
2 
SHR 
4.55 (1.14–18.2) 
SHR: standardised 
hospitalisation ratio. 
(973) 
Cohort: male farmers from 
the Finnish Farm Register 
identified in 1978. All persons 
owing a farm were included 
in the register. 
External referents: all 
economically active men in 
Finland. 
Internal referents: male 
farmers with no animals. 
1979–1983 Mortality from 
CVD (ICD-8, 390–
459).  
CVD  
External rates 
Internal rates 
Type of farm  
No animals 
Dairy farms 
Pig farms 
Poultry farms 
Other animal 
husbandry 
 
2 491 
 
 
637 
1 554 
58 
89 
153 
SMR 
0.96 (0.94–0.98) 
 
RR a RR b 
1.00 1.00 
0.86 0.89 
0.66 0.72 
0.92 0.96 
0.81 0.85 
Ever-smokers (%)  
Farmers: 68.9 
Industrial workers: 82.7 
Service sector workers: 
75.6. 
a Adjustment for age and 
location of farms.  
b Adjustment for age, 
location and size of farms.  
The authors discussed the 
problem of selection. In 
livestock production, 
farmers were probably 
more exposed to organic 
and microbial dusts, but the 
respiratory mortality of 
farmers with animals was 
not higher than among 
farmers with no animals. 
(715) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
This might be explained by 
the fact that animal farmers 
with respiratory problems 
changed their type of 
production, e.g. from dairy 
farming to grain crops. 
Cohort: female farmers and 
spouses to farmers, actively 
insured in the Farmers’ Social 
Insurance Institution identi-
fied in the Finnish Farm 
Register in 1978. 
1979–1985 Mortality from 
CVD (ICD-8, 390–
459). 
CVD, type of farm 
No animals 
Dairy farms 
Pig farms 
Poultry farms 
Other animal husbandry 
CVD, farm size, hectare 
20–  
15–19.9 
10–14.9 
5–9.9 
1–4.9 
 
104 
202 
9 
14 
21 
 
72 
122 
56 
45 
55 
RR 
1.00  
0.76 
0.59 
0.84 
0.78 
 
1.00 
1.13 
0.88 
1.16 
1.18 
Adjustment for age and 
location of farm. No 
significant differences 
observed. 
The larger area of land 
under cultivation the more 
likely a farmer was to 
own a dust respirator. 
Smoking habits could not 
explain minor differences. 
(714) 
All economically active males 
and females identified in the 
Finnish national census 1970. 
Cohort: agricultural workers 
and animal caretakers. 
Referents: all economically 
active males and females. 
1971–1991 Mortality (ICD-9) 
from CVD and MI.  
CVD, males 
25–64 y 
25–44 y 
45–64 y 
MI, males 
25–64 y 
25–44 y 
45–64 y 
MI, females a 
 
1 057 
 
 
 
534 
 
 
2 775 
 
1.19 (1.12–1.27) 
1.47 (1.29–1.67) 
1.13 (1.06–1.21) 
 
1.13 (1.04–1.23) 
1.48 (1.23–1.77) 
1.05 (0.95–1.16) 
1.07 (1.04–1.12) 
 
 
 
 
 
 
 
 
a Entrepreneurs. 
(713) 
Cohort: 2 497 male and 1 956 
female farmers born 1913–
13 y or until 
endpoint 
Mortality from 
coronary disease 
Coronary death, IHD 
Males 
 
 
RR 
0.86 (0.65–1.16) 
Adjustment for age, 
smoking, serum 
(465, 
466) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
1947 in the eastern provinces 
of Finland. The cohort was 
surveyed in 1972 and 1977. 
Referents: white collar 
workers. 
and incidence of 
non-fatal acute MI  
(ICD-8–9, 410–
411). 
Females 
First coronary event 
Males 
Females 
115 
32 
 
259 
75 
1.67 (1.03–2.75) 
 
0.87 (0.72–1.06) 
1.07 (0.81–1.42) 
cholesterol and systolic 
blood pressure.  
Cohort: 5 923 Icelandic 
farmers who were either 
registered in the Farmers’ 
Pension Fund in 1977 or 
became members before 
1984. 
Referents: Icelandic male 
rates. 
1977–1985 Mortality (ICD-7) 
from IHD (420) and 
CeVD (330–334). 
 
IHD 
CeVD 
 
106 
21 
SMR 
0.55 (0.45–0.67) 
0.67 (0.42–1.03) 
Probably male farmers but 
not clearly stated. 
(769) 
Cohorts: farm workers, 
farmers and farm managers in 
the Nordic countries 
identified around 1971. 
Referents: all economically 
active persons in the Nordic 
countries. 
1971–1980 Mortality (ICD-8) 
from diseases of the 
circulatory system 
(390–458) and 
sudden death 
(782.4, 795). 
Male farm workers 
Denmark 
Finland 
Norway 
Sweden 
Total 
Male farmers and farm 
managers 
Denmark 
Finland 
Norway 
Sweden 
Total 
Female farm managers 
and farm workers 
Denmark 
 
945 
716 
527 
1 383 
3 571 
 
 
3 991 
10 957 
3 251 
4 747 
22 946 
 
 
477 
SMR 
0.81 
1.53 
0.84 
0.83 
0.91 
 
 
0.66 
1.34 
0.76 
0.71 
0.91 
 
 
0.83 
 (711) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Finland 
Norway 
Sweden 
Total 
2 460 
771 
696 
4 404 
1.37 
0.85 
0.89 
1.08 
Europe (non-Nordic)        
Cohort: 62 960 certified 
pesticide users included in the 
Pesticide Users’ Health Study 
(PUHS) 1987–2003, Great 
Britain. 
Referents: rates from 
Scotland, England and Wales. 
1987–2005 Mortality from 
diseases of the 
circulatory system 
(ICD-9, 390–459; 
ICD-10, I00–I99), 
IHD (ICD-9, 410–
414; ICD-10, I20–
I25) and CeVD 
(ICD-9, 430–438; 
ICD-10, I60–I69). 
Males 
Circulatory disease 
IHD 
CeVD 
Females 
Circulatory disease 
IHD 
CeVD 
 
530 
335 
89 
 
4 
1 
2 
SMR 
0.58 (0.53–0.63) 
0.54 (0.48–0.60) 
0.66 (0.54–0.82) 
 
0.43 (0.16–1.14) 
0.27 (0.04–1.90) 
0.71 (0.18–2.85) 
 (316) 
Irish males (15–64 y of age) 
identified in the census 1981.  
Cohort I: farmers, relatives 
assisting and farm managers. 
Cohort II: farm labourers and 
fishermen. 
Referents: all Irish males. 
1986–1991 Mortality from 
circulatory diseases 
(ICD 8–9). 
Circulatory disease 
Cohort I  
Cohort II 
 SMR 
0.89 (P < 0.01) 
0.94 
 (720) 
Cohort: Irish farmers and 
agricultural workers. 
Referents: Irish national rates, 
using the WHO European 
standard population.  
2000–2006  Mortality from 
circulatory diseases 
(ICD-9, 390–459). 
Circulatory disease 
Farmers 
Agricultural workers  
 SMR 
2.16 (2.02–2.30) 
2.26 (1.93–2.60) 
Linear regression showed 
an upward trend 2000–
2006 for farmers, P < 0.04. 
No significant trend for 
agricultural workers. The 
inclusion of fishermen in 
(891) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
agricultural workers may 
have raised the SMR. 
Cohort: 567 157 farm owners 
and workers were invited  
and 180 060 (97 833 males, 
82 227 females) answered a 
questionnaire 2005–2007. 
Referents: French general 
population. 
Until 2009 Mortality (ICD-10) 
from diseases of  
the circulatory 
system (I00–I99), 
ischaemic cardio-
pathy (I20–I25), 
other cardiopathy 
(I30–I33, I39–I52) 
and CeVD (I60–
I69). 
Males 
Circulatory disease 
Ischaemic cardiopathy 
Other cardiopathy 
CeVD 
Females 
Circulatory disease 
Ischaemic cardiopathy 
Other cardiopathy 
CeVD 
 
1 998 
598 
528 
432 
 
1 653 
391 
507 
370 
SMR 
0.68 (0.65–0.71) 
0.65 (0.60–0.70) 
0.66 (0.60–0.72) 
0.71 (0.65–0.78) 
 
0.73 (0.70–0.77) 
0.78 (0.71–0.87) 
0.73 (0.67–0.80) 
0.67 (0.60–0.74) 
An excess of total deaths 
among non-participants 
compared with participants.  
Males: SMR 1.06 (1.04–
1.07) vs 0.68 (0.67–0.70). 
Females: SMR 1.03 (1.01–
1.04) vs 0.71 (0.69–0.73). 
(554) 
Skilled male workers, 30–59 
y old, identified in the 1982 
and 1990 censuses, based on 
three registers from the 
WHO-MONICA project in 
France (Lille, Strasbourg and 
Toulouse). 
Cohort: male farmers and 
agricultural workers. 
Referents: skilled male 
workers. 
1985–1989 Incidence (ICD-9) 
of CHD (410–414), 
sudden death (797–
799), arterial 
hypertension (401–
405), other heart 
diseases (420–429), 
CeVD (430–438), 
disease of the 
arteries, arterioles, 
and capillaries 
(440–447), shock 
(785.5), pulmonary 
embolism (415) and 
heart failure (428). 
Farmers 
Acute MI, incidence 
All coronary events, 
incidence 
mortality 
Agricultural workers 
Acute MI, incidence 
All coronary events, 
incidence 
mortality 
 OR 
0.76 (0.58–1.00) 
 
0.79 (0.64–0.97) 
1.39 (0.86–2.26) 
 
1.16 (0.72–1.89) 
 
1.43 (1.03–1.99) 
1.54 (0.73–3.26) 
ORs calculated by 
multiple logistic 
regression analysis with 
age, occupational 
categories and region as 
independent variables. 
A cross-sectional study 
showed the following 
proportion of smokers: 
farmers 38%, unskilled 
and agricultural workers 
47% and skilled workers 
47%. 
(533) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: economically active 
males in agricultural and 
related occupations 25–64 y 
at death in France and Spain.  
Referents: professional, 
technical, administrative and 
managerial workers 25–64 y 
at death in France and Spain.  
1980–1982, 
1988–1990 
Mortality (ICD-9) 
from IHD (410–
414) and CeVD 
(430–438). 
IHD, France 
Age 25–44 y 
1980–1982 
1988–1990 
Age 45–64 y 
1980–1982 
1988–1990 
IHD, Spain 
Age 25–44 y 
1980–1982 
1988–1990 
Age 45–64 y 
1980–1982 
1988–1990 
CeVD, France 
Age 25–44 y 
1980–1982 
1988–1990 
Age 45–64 y 
1980–1982 
1988–1990 
CeVD, Spain 
Age 25–44 y 
1980–1982 
1988–1990 
Age 45–64 y 
1980–1982 
1988–1990 
3 052 
 
 
 
 
 
 
853 
 
 
 
 
 
 
1 671 
 
 
 
 
 
 
468 
RR 
 
0.53 (0.41–0.70) 
1.21 (0.96–1.53) 
 
0.48 (0.45–0.51) 
1.25 (1.16–1.35) 
 
 
1.27 (0.69–2.33) 
2.10 (1.02–4.33) 
 
0.51 (0.42–0.63) 
1.25 (0.98–1.60) 
 
 
1.12 (0.84–1.48) 
1.80 (1.28–2.54) 
 
0.90 (0.82–0.99) 
1.88 (1.66–2.12) 
 
 
0.89 (0.65–1.21) 
2.99 (0.84–10.6) 
 
0.82 (0.60–1.13) 
1.68 (1.14–2.47) 
The almost consistently 
lower RRs in 1980–1982 
than in 1988–1990 
represent the shift from 
low to high disease 
occurrence in low socio-
economic groups due to 
smoking and other 
lifestyle factors.  
(577) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 23 401 male farmers 
from Asti, Alessandria and 
Cuneo, Italy, licensed during 
1970–1974 to use pesticides 
in agriculture. 
Referents: regional rates from 
Piedmont, and provincial 
rates from Asti, Alessandria 
and Cuneo. 
Until 1986 Mortality from 
CVD (ICD-8). 
CVD 
Regional rates 
Provincial rates 
1 080 SMR 
0.52 (0.49–0.56)  
0.58 (0.55–0.61)  
 (966) 
Cohorts: 1 701 male and  
426 female farmers or farm 
workers identified in the 1971 
census. Each subject was 
considered from January 1972 
or from the date of first 
arrival to the cohort. 
Referents: Italian general 
population.  
Until 1988 Mortality (ICD-8) 
from diseases of the 
circulatory system 
(390–458), hyper-
tensive disease 
(400–404) and IHD 
(410–414). 
Males 
Circulatory disease 
Hypertension  
IHD 
Females 
Circulatory disease 
 
188 
18 
50 
 
15 
SMR 
0.79 (0.69–0.92) 
1.53 (0.91–2.43) 
0.57 (0.42–0.75) 
 
0.63 (0.35–1.05) 
The cohort composition 
was mainly of a cross-
sectional design and the 
mortality of those who 
retired before 1971, or 
even during the study 
period, is missing. 
(281) 
Cohort: 1 493 male rice 
farming owners and workers 
registered in 1988 in Novara 
province, Italy. 
Referents: Italian general 
population. 
1957–1992 Mortality from MI, 
other IHD and 
stroke (ICD-codes 
not reported). 
 
MI 
Other IHD 
Stroke 
 
67 
72 
155 
SMR 
0.72 (0.56–0.92) 
0.41 (0.32–0.52) 
0.96 (0.81–1.12) 
The study has a systemic 
error by counting person-
years prior to the date of 
cohort formation. 
(325) 
North America        
Cohort: 18 811 male farm 
owners and operators members 
≥ 1 y of the New York State 
Farm Bureau 1973–1979. 
1973–1984 Mortality from 
diseases of the 
circulatory system 
(ICD-8, 390–458; 
 
Circulatory disease 
IHD 
CeVD 
 
814 
569 
102 
SMR 
0.68 (P < 0.005) 
0.65 (P < 0.005) 
0.72 (P < 0.005) 
Overall and cause-specific 
mortality rates by single 
years of age were cal-
culated for the referents. 
(901) 
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Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Referents: 747 128 males, 
identified in the US census 
1980, who resided in upstate 
New York State, excl. New 
York City.  
ICD-9, 390–459), 
IHD (ICD 8–9, 
410–414) and 
CeVD (ICD 8–9, 
430–438). 
 
 
 
 
 
 
 
 
Cross-sectional study 
Participants identified by a 
health census form mailed to 
every permanent residents in 
the Otsego County, New York 
State in 1999.  
Cohort: 1 140 male farmers. 
Referents: 10 132 male non-
farmers. 
 Prevalence of heart 
disease, hyper-
tension and diabetes. 
 
Heart disease 
Hypertension 
Diabetes 
 OR 
0.67 (0.40–1.12) 
0.83 (0.72–0.96) 
0.86 (0.70–1.05) 
Multiple logistic 
regression adjusted for 
age, smoking and BMI. 
The OR for heart disease 
was also adjusted for 
hypertension, diabetes and 
high cholesterol. 
(455) 
Cohort: 35 972 deceased 
white male farmers in 
Wisconsin, US.  
Referents: deceased white 
male non-farmers in 
Wisconsin. 
1968–1976 Mortality (ICD-8) 
from diseases of the 
circulatory system, 
all arteriosclerotic 
heart disease, and 
all vascular lesions 
of CNS. 
 
Circulatory disease 
All arteriosclerotic 
Vascular CNS lesions 
 
23 045 
15 143 
4 344 
PMR 
1.02 (P < 0.05) 
1.00 
1.05 (P < 0.05) 
Adjustment for age and 
calendar year of death. 
There was a deficit of 
smoking- and alcohol-
related diseases due to 
less prevalent use of 
tobacco and alcohol by 
farmers. 
(817) 
Study base: farmers compared 
with other occupations from 
the male population ≥ 35 y of 
age in the 6-county area 
around Grand Forks, North 
Dakota, US, approximately 
20 000 subjects. 
1957 Reported cases. 
Diagnosis made by 
review committee: 
angina pectoris, 
coronary in-
sufficiency, MI, 
sudden death, other 
All CHD 
Farmers 
Others 
MI 
Farmers 
Others 
CHD without previous 
 
101 
127 
 
42 
59 
 
Rate/1 000 
9.60 
13.64 
 
3.99 
6.34 
 
 (1058) 
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Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
 manifestations of 
CHD. 
manifestations 
Farmers 
Others 
 
70 
90 
 
6.65 
9.67 
All males aged 20–64 y from 
the Iowa censuses 1960 and 
1970.  
Cohort: male farmers (totally 
6 960 deaths).  
Referents: all males (totally 
31 310 deaths). 
1964–1970, 
1971–1978 
Mortality from 
IHD, hypertensive 
heart disease and 
CeVD.  
1964–1970 
IHD 
Hypertension 
CeVD 
1971–1978 
IHD 
Hypertension 
CeVD 
 SMR  
0.89 (P < 0.001) 
0.82 
0.89 (P < 0.05) 
 
0.93 (P < 0.001) 
0.97 
0.91 
A cross-sectional study 
was presented in the same 
paper. Current smoking 
was less common among 
farmers (19%) than 
among non-farmers (46%) 
and regular physical 
activity was twice as 
common among farmers.  
(755) 
Study base: white male 
farmers and farm managers 
compared with non-farmers, 
all 20–64 y of age in Iowa, 
US.  
1971–1978 Mortality from 
diseases of the 
circulatory system 
(ICD-8). 
Circulatory disease  
 
Farmers 
Non-farmers 
Rate/ 
100 000 
248 
322 
RR 
 
0.77 (P < 0.01) 
 (133) 
Cross-sectional study 
Subjects ≥ 65 y old from 2 
counties in Iowa were inter-
viewed in their homes. 
Cohort: 696 male and 591 
female farm workers with 
> 25 y of exposure to farm 
work. 
Referents: 146 males and 379 
females who had never 
worked on a farm. 
December 
1981–July 
1982 
Anamnestic history 
of heart attacks, 
stroke and blood 
pressure. 
 
Heart attacks 
Males 
Retired 
Working 
Females  
Retired 
Working 
Stroke  
Males 
Retired 
Working 
Exp/refs 
% 
 
23.1/16.9 
17.7/12.8 
 
7.7/8.8 
6.4/7.4 
 
 
7.9/2.8 
5.1/1.8 
 
 
 
 
Standardised to age 75 y, 
non-smoker, non-drinker, 
using individual logistic 
regression models. 
Male farm workers had 
more frequently (P < 0.05) 
a history of stroke and 
higher diastolic blood 
pressure. 
(1044) 
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Study group and design  Time of  
follow-up 
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(diagnose) 
Categories of exposure No. of 
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Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Females  
Retired 
Working 
 
5.7/7.0 
1.1/1.3 
Study base: proportion of 
deaths among 9 245 white and 
3 508 non-white male farmers 
who died in North Carolina, 
US, 1976–1978 compared 
with that among other male 
decedents in the state. 
1976–1978 Mortality from 
diseases of the 
circulatory system 
(ICD-8, 390–458). 
Circulatory disease 
Whites 
Non-whites 
 
5 606 
1 866 
PMR 
1.0 (1.0–1.1) 
1.0 (1.0–1.1) 
 (221) 
Cohort: 52 393 private 
licensed pesticide applicators 
(51 034 men, 1 359 women), 
almost entirely farmers, 
recruited 1994–1997 to the 
Agricultural Health Study in 
Iowa and North Carolina, US.  
Referents: Iowa and North 
Carolina general populations.  
Until 2000 Mortality from 
CVD (ICD-9). 
CVD 
All 
Farm growing corn 
Yes 
No 
Farm with animals 
Yes 
No 
 
537 
 
315 
222 
 
215 
322 
SMR 
0.5 (0.5–0.6) 
 
0.5 a 
0.6 a 
 
0.5 a 
0.6 a 
Adjustment for age, 
calendar year of death, 
state, race and gender. 
a 95% CI did not include 
1.0. 
(104) 
Cohort: same as above (now 
containing 52 394 subjects) 
was further followed. 
Referents: Iowa and North 
Carolina general populations. 
Until 2007 Mortality (ICD-9 or 
10) from heart 
disease (divided in 
IHD, chronic 
diseases of the 
endocardium, 
cardiomyopathy and 
conductive disorder) 
and other circulatory 
diseases (divided in 
 
Heart disease 
IHD 
Endocardial disease 
Cardiomyopathy 
Conductive disorder 
Other circulatory dis. 
CeVD 
Vessels  
 
 
1 376 
1 099 
32 
75 
61 
376 
236 
125 
 
SMR 
0.54 (0.51–0.56) 
0.52 (0.49–0.55) 
0.64 (0.44–0.90) 
0.69 (0.54–0.87) 
0.59 (0.45–0.75) 
0.51 (0.46–0.57) 
0.52 (0.45–0.59) 
0.54 (0.45–0.64) 
 
Adjusted for age, calendar 
year, state, race and 
gender. 
A comparable occupa-
tional population in Iowa 
and North Carolina would 
be a preferred reference 
group, but such a group 
did not exist. An alter-
native was to calculate the 
(977) 
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Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
CeVD and diseases 
of arteries/veins/ 
lymphatic vessels). 
 
Heart disease 
IHD 
Endocardial disease 
Cardiomyopathy 
Conductive disorders 
Other circulatory dis.  
CeVD 
Vessels 
 
1 376 
1 099 
32 
75 
61 
376 
236 
125 
rSMR 
0.99 (0.93–1.06) 
0.96 (0.90–1.03) 
1.18 (0.84–1.68) 
1.29 (1.03–1.62) 
1.09 (0.85–1.40) 
0.95 (0.86–1.06) 
0.96 (0.84–1.09) 
1.00 (0.84–1.20) 
relative SMR (rSMR) 
defined as the ratio of the 
cause-specific SMR to the 
SMR for all other causes, 
omitting the cause of 
interest (i.e. rSMRx = 
SMRx/SMRnot x). Some 
diagnoses were omitted. 
Rates of death from 
chronic lung and liver 
diseases commonly 
associated with tobacco 
and alcohol use were 
significantly lower.  
Cohort: 83 378 farmers, their 
spouses and commercial 
pesticide applicators residing 
primarily in Iowa and North 
Carolina, US, and enrolled 
1993–1997 to the Agricultural 
Health Study. Deaths were 
identified via annual linkage 
with death registries in Iowa 
and North Carolina as well as 
the National Death Index. 
Until 2009 Mortality from 
CVD (ICD-9, 400–
440; ICD-10, I10–
I70), IHD (ICD-10, 
I25) and CeVD 
(ICD-10, I60–I69). 
 
CVD, all 
Men 
Women 
CVD, all non-movers 
Men 
Women 
 
IHD 
CeVD 
 
1 055 
786 
269 
801 
592 
209 
 
213 
242 
HR 
1.31 (0.84–2.04) 
1.66 (1.00–2.78) 
0.62 (0.25–1.55) 
1.33 (0.80–2.23) 
1.87 (1.04–3.36) 
0.45 (0.16–1.29) 
 
2.68 (1.04–6.87) 
1.78 (0.72–4.42) 
HR mortality per 10-µg/m3 
increase of satellite-based 
estimates of ambient PM2.5 
in fully adjusted models. 
PM2.5 levels were assigned 
to each enrolment address, 
which was based on geo-
coding. Air levels reflected 
6-y mean (2001–2006) of 
combined daily aerosol 
optical depth retrievals. 
(999) 
Study base: proportion of 
deaths among farmers and 
farm operators compared with 
the proportion among the US 
1984–1988 Mortality (ICD-8, 
recoded from ICD-
9) from all disease 
of the circulatory 
Circulatory disease 
White males 
US referents 
Alabama referents  
 PMR 
 
0.99 
1.05 (P < 0.05) 
 (54) 
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Study group and design  Time of  
follow-up 
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cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
population in 1985 and the 
Alabama population in 1984–
1988. 
system (390–458) 
and IHD (410–
413). 
White females 
US referents 
Alabama referents 
Non-white males 
US referents 
Alabama referents 
Non-white females 
US referents 
Alabama referents 
IHD 
White males 
US referents 
Alabama referents 
White females 
US referents 
Alabama referents 
Non-white males 
US referents 
Alabama referents 
Non-white females 
US referents 
Alabama referents 
 
0.97 
0.99 
 
1.05 (P < 0.05) 
1.06 (P < 0.05) 
 
1.02 
1.03 
 
 
0.76 (P < 0.05) 
1.03 
 
0.71 
0.97 
 
0.69 (P < 0.05) 
1.09 (P < 0.05) 
 
0.53 (P < 0.05) 
0.88 
Study base: odds of mortality 
among farmers compared 
with those among non-
farmers. Data from the 
Georgia Office of Vital 
Statistics, US, 1985–1994. 
1985–1994 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
hypertensive 
diseases (401–405), 
IHD (410–414), 
other heart disease 
White male farmers 
Circulatory disease 
Hypertension 
IHD 
Other heart disease 
CeVD 
Black male farmers 
 
3 493 
78 
1 746 
923 
569 
 
OR 
1.11 (1.08–1.15) 
0.94 (0.80–1.10) 
1.06 (1.02–1.09) 
1.08 (1.02–1.13) 
1.17 (1.10–1.24) 
 
 (942) 
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Confounder adjustments 
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(415–429) and 
CeVD (430–438). 
Circulatory disease 
Hypertension 
IHD 
CeVD 
4 091 
218 
1 598 
877 
1.16 (1.11–1.21) 
0.75 (0.65–0.87 
1.21 (1.14–1.29) 
1.27 (1.18–1.38) 
Study base: proportion of 
deaths among 7 504 deceased 
farm workers and 7 404 
deceased farm owners/ 
managers obtained from 
California Department of 
Health Services’ Center 
compared with the proportion 
of deaths in California, US, 
1975.  
1978–1979 Mortality (ICD-8) 
from circulatory 
disease (390–458), 
arteriosclerotic 
heart disease (410–
413) and vascular 
CNS lesions (430–
438). 
Farm workers 
White males 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
White females 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
Non-white males 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
Non-white females 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
Farm owners/managers 
White males 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
White females 
Circulatory disease 
Heart disease 
 PMR 
 
0.87 (P < 0.01) 
0.61 (P < 0.01) 
0.82 (P < 0.01) 
 
0.94 
0.75 (P < 0.01) 
0.90 
 
0.96 
0.67 (P < 0.01) 
0.96 
 
1.02 
0.64 (P < 0.01) 
1.14 
 
 
0.95 (P < 0.01) 
0.67 (P < 0.01) 
0.85 (P < 0.01) 
 
0.88 (P < 0.01) 
0.61 (P < 0.01) 
Mexican-Americans  
(36% of the deceased 
farm workers) belonged to 
the category of whites. 
(921) 
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Confounder adjustments 
and comments  
Ref. 
Vascular CNS lesions 
Non-white males 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
Non-white females 
Circulatory disease 
Heart disease 
Vascular CNS lesions 
0.85 
 
0.99 
0.66 (P < 0.01) 
1.09 
 
1.30 (P < 0.05) 
0.75 
1.88 (P < 0.05) 
Participants, 16–64 y old,  
derived from the California 
Occupational Mortality Study 
(US). 
Cohort: white male farm 
workers and farmers. 
Referents: white male workers 
from all occupations. 
1979–1981 Mortality from 
IHD, CeVD, other 
circulatory disease 
and hypertension. 
Farm workers 
IHD 
CeVD 
Other circulatory 
Hypertension 
Farmers 
IHD 
CeVD 
Other circulatory 
Hypertension 
 
347 
87 
132 
17 
 
257 
20 
77 
9 
SMR 
1.03 (0.92–1.14) 
1.43 (1.14–1.76) 
0.93 (0.78–1.11) 
0.72 (0.42–1.16) 
 
1.24 (1.09–1.40) 
0.69 (0.42–1.06) 
1.08 (0.85–1.35) 
0.72 (0.33–1.36) 
Adjustment for age, 
smoking, alcohol and 
socioeconomic status. 
(73) 
Cohort: 1 428 white male 
farm owners and managers 
from the California 
Agricultural Statistics 
Service, randomly sampled 
and interviewed in 1993. 
Referents: white male 
population in California, US. 
1993–2004 Mortality from 
heart disease and 
CeVD. 
 
Heart disease 
CeVD 
 
81 
4 
PMR 
0.96 
0.31 (P < 0.004) 
Adjustment for age and 
year.  
The smoking rate in 1993 
was 11% which was 
approximately half the 
rate in the general 
population. 
(44) 
Cohort: 20 505 male private 
and farmer pesticide appli-
1975–1993 Mortality from 
circulatory disease, 
 
Circulatory disease 
 
686 
SMR 
0.87 (0.81–0.94) 
Adjustment for age and 
calendar year. 
(297) 
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cators licensed in Florida, US, 
1975–1993.  
Referents: male population in 
Florida.  
atherosclerotic  
heart disease with 
congestive heart 
failure and vascular 
disease in CNS. 
Atherosclerotic heart 
Vascular CNS lesions  
446 
79 
0.99 (0.90–1.09) 
0.81 (0.64–1.01) 
Study base: proportion of 
deaths among farmers 
compared with that among 
occupation-coded death 
certificates from 23 US states. 
1984–1988 Mortality from 
arteriosclerotic 
heart disease, 
vascular lesions of 
the CNS and 
hypertension. 
Farmers 
White men 
Heart disease 
Vascular CNS lesions 
Hypertension 
White women 
Heart disease 
Vascular CNS lesions 
Hypertension 
Non-white men 
Heart disease 
Vascular CNS lesions 
Hypertension 
Non-white women 
Heart disease 
Vascular CNS lesions 
Hypertension 
 
 
39 032 
9 874 
1 162 
 
718 
237 
25 
 
2 850 
1 275 
303 
 
533 
338 
80 
PMR 
 
1.02 (1.01–1.03) 
1.15 (1.13–1.17) 
0.92 (0.87–0.98) 
 
0.96 (0.89–1.04) 
0.91 (0.79–1.03) 
0.63 (0.41–0.93) 
 
1.03 (0.99–1.06) 
1.38 (1.30–1.46) 
0.90 (0.80–1.01) 
 
0.96 (0.88–1.04) 
1.38 (1.23–1.53) 
0.91 (0.72–1.13) 
Adjustment for age at 
death. 
(101) 
Cohort: 2 681 white male 
farmers sampled from the US 
population and interviewed 
within the National Health 
Interview Survey. 
Referents: 113 377 currently 
employed white men.  
1986–1990 Diseases were 
classified as CVD, 
IHD (ICD-9, 413–
414) and hyper-
tension (401–405). 
 
 
CVD 
IHD 
Hypertension 
 
 
116 
29 
84 
Prevalence risk 
ratio (PRR) 
1.3 (1.0–1.7) a 
1.3 (0.7–1.9) 
1.4 (1.0–1.7) 
Adjustment for age. 
 
a P < 0.05. 
(123) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Study base: proportion of 
deaths among farmers and 
workers in agriculture 
(age ≥ 25 y) compared with 
registered deaths in the 1986 
US National Mortality 
Followback Survey. 
1986  Mortality (ICD-9) 
from MI (410), IHD 
(414), other heart 
disease (429.2) and 
CeVD (436).  
Farmers 
MI 
IHD 
Other heart disease 
CeVD 
Workers in agriculture, 
crops 
MI 
IHD 
Other heart disease 
CeVD 
 
12 719 
8 241 
3 733 
4 946 
 
 
13 535 
10 672 
3 419 
5 087 
PMR 
1.11 
0.98 
1.25 
1.41 
 
 
1.06 
1.14 
1.04 
1.31 
Smoking is an unlikely 
factor behind increased 
risks as the PMRs for lung 
cancer were low among 
farmers and workers in 
agriculture, 0.59 and 0.61 
respectively.  
(777) 
Study base: proportion of 
deaths among farm workers 
compared with the proportion 
among occupation-coded 
death certificates from 24 US 
states. 
1984–1993 Mortality from 
diseases of the 
circulatory system, 
arteriosclerotic 
heart disease, 
hypertension and 
CeVD. 
Farm workers 
White men 
Circulatory disease 
Heart disease 
Hypertension 
CeVD 
White women 
Circulatory disease 
Heart disease 
Hypertension 
CeVD 
Non-white men 
Circulatory disease 
Heart disease 
Hypertension 
CeVD 
Non-white women 
Circulatory disease 
 
 
5 773 
3 646 
118 
808 
 
421 
233 
18 
77 
 
2 987 
1 450 
191 
620 
 
1 660 
PMR 
 
0.96 (0.94–0.99) 
0.95 (0.92–0.98) 
0.85 (0.71–1.02) 
1.05 (0.98–1.13) 
 
0.94 (0.85–1.04) 
0.96 (0.84–1.09) 
1.22 (0.72–1.93) 
0.91 (0.72–1.14) 
 
1.06 (1.02–1.09) 
1.01 (0.96–1.07) 
0.91 (0.78–1.04) 
1.24 (1.15–1.34) 
 
1.08 (1.03–1.14) 
Adjustment for age. (187) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Heart disease 
Hypertension 
CeVD 
730 
160 
411 
1.02 (0.95–1.10) 
1.24 (1.05–1.44) 
1.26 (1.14–1.39) 
Study base: proportion of 
deaths among 222 549 crop 
farmers and 44 930 livestock 
farmers compared with the 
proportion among occupation-
coded death certificates from 
26 US states.  
1984–1993 Mortality (ICD-9) 
from acute MI 
(410), CeVD (430–
438) and diseases  
of arteries, arterioles 
and capillaries (440–
448). 
Crop farmers  
White men 
Acute MI 
CeVD 
Vessels  
White women 
Acute MI 
CeVD 
Vessels 
Black men 
Acute MI 
CeVD 
Vessels 
Black women 
Acute MI 
CeVD 
Vessels 
Livestock farmers 
White men  
Acute MI 
CeVD 
Vessels 
 
 
31 596 
15 284 
4 927 
 
557 
467 
152 
 
2 650 
2 411 
421 
 
481 
661 
93 
 
 
7 209 
3 153 
1 139 
PMR 
 
1.18 (1.17–1.19) 
1.16 (1.14–1.17) 
0.97 (0.94–0.99) 
 
1.04 (0.93–1.15) 
1.01 (0.92–1.10) 
1.21 (1.03–1.42) 
 
1.22 (1.19–1.26) 
1.37 (1.33–1.42) 
1.10 (1.00–1.21) 
 
1.06 (0.97–1.16) 
1.37 (1.27–1.48) 
0.96 (0.77–1.18) 
 
 
1.20 (1.18–1.22) 
1.08 (1.05–1.12) 
1.01 (0.95–1.07) 
White male crop farmers 
15–64 y of age at death 
had a higher PMR for 
acute MI (1.23, 1.20–
1.27) than older farmers 
(1.18, 1.17–1.19). This 
was not consistent for 
livestock farmers or other 
diagnoses. 
(546) 
Cohort: 9 471 pesticide-
exposed workers (9 293 
farmers, 178 pesticide 
applicators) identified in the 
Until 1997 Mortality from 
CVD, follow-up 
performed through 
linkage with the 
 
CVD 
 
231 
RR 
1.4 (1.2–1.7) 
Adjustment for age. 
All participants were 
included at ≥ 18 y of age. 
(298) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
US National Health Interview 
Survey (NHIS) 1986–1994. 
Referents: 438 228 non-
pesticide exposed in other 
occupations from the same 
source, NHIS. 
National Death 
Index. 
No excess of respiratory 
cancers (RR 1.0, 0.8–1.4) 
indicates no bias from 
smoking habits. 
Study base: proportion of 
deaths among farmers and 
agricultural workers com-
pared with that among 550 
occupations in the National 
Occupational Mortality 
Surveillance system in 30 US 
states, based on 10 million 
deaths aged 18–64 years. 
1985–1999, 
2003–2004, 
2007 
Mortality from 
acute MI (ICD-10, 
I21). 
Acute MI 
Farmers 
White males 
Black males 
Agricultural workers 
Black females 
Hispanic males 
 
 
4 678 
506 
 
83 
117 
PMR 
 
1.49 (1.46–1.52) 
1.45 (1.32–1.58) 
 
1.35 (1.08–1.68) 
1.24 (1.03–1.50) 
Adjustment for age and 
smoking. 
(786) 
Cohort: 155 547 male farmers 
aged ≥ 35 y from Alberta, 
Saskatchewan, Manitoba, 
assembled by linking data 
from the Canadian Censuses 
of Agriculture and Population 
1971.  
Referents: male population 
from these areas.  
1971–1987 Mortality from 
circulatory disease 
(ICD-9). 
 
Circulatory disease 
 
15 219 
SMR 
0.73 (0.72–0.74) 
In a previous estimation, 
up to 10–15% of deaths 
were missed because of 
limitations in record 
linkage. 
A previous study of 
Saskatchewan farmers 
showed the same result 
(1018). 
(855) 
Australia/Asia        
Cohort: Australian male 
farmers and farm managers 
aged 25–74 y.  
Referents: general male 
1999–2002 Mortality from 
circulatory disease 
(ICD-10, I00–I99), 
IHD and other 
 
Circulatory disease 
IHD 
Other circulatory 
 
1 251 
823 
428 
SMR 
1.40 (1.23–1.59) 
1.39 (1.18–1.63) 
1.42 (1.13–1.72) 
The higher all-cause 
mortality in farmers 
supports other Australian 
data illustrating that 
(306) 
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Table A21. Agriculture. 
Study group and design  Time of  
follow-up 
Outcome 
(diagnose) 
Categories of exposure No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
population, from the 
Australian Population Census 
2001.  
circulatory disease. 
 
disease 
 
 
 
 
 
mortality rates rise as 
remoteness increases in 
rural populations. In 
another study, farming 
men and women exhibited 
an increased prevalence of 
CVD risk factors (132). 
Cohort: male agricultural 
workers in Hong Kong. 
Referents: general male 
population in Hong Kong. 
1979–1983 Mortality from 
circulatory disease 
(ICD-9, 359–390). 
 
Circulatory disease 
 
346 
SMR 
0.77 (0.69–0.85) 
 (706) 
Cohort: agricultural workers 
in Korea.  
Referents: manual and non-
manual workers in Korea.  
 
Cross-sectional: Participants 
collected from the 2005 
Korean NHANES. 
Cohort: agricultural workers.  
Referents: manual and non-
manual workers. 
 
2004–2008 
 
 
 
 
2005 
Mortality (ICD-10) 
from hypertension 
(I10–I15), IHD 
(I20–I25) and CeVD 
(I60–I69). 
Prevalence of 
hypertension, IHD 
and CeVD. 
Mortality 
Hypertension 
IHD 
CeVD 
 
Prevalence 
Hypertension  
IHD 
CeVD 
 
1 940 
6 475 
16 635 
 
 
406 
37 
56 
SMR 
0.72 (0.65–0.80) 
0.77 (0.73–0.82) 
0.89 (0.86–0.92) 
 
OR 
0.9 (0.7–1.1) 
1.3 (0.6–2.7) 
1.4 (0.7–2.9) 
The agricultural workers 
included about 4.4% 
fishery and 0.2% forestry 
workers. 
 
ORs adjusted for age, 
education, marriage, 
smoking and drinking. 
Mental health was an 
important health issue in 
agricultural workers as 
suicide was more 
common. 
(548) 
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Table A22. Dichloromethane (DCM). 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Europe        
Cohort: 1 473 male workers 
employed 1946–1988 producing 
cellulose triacetate film in 
Brantham, UK. 
Referents: national rates from 
England and Wales.  
Until 1994 Mortality (ICD-9) 
from all heart 
disease (390–398, 
402, 404, 410–429), 
IHD (410–414) and 
CeVD (430–438). 
 
All heart disease 
IHD 
CeVD 
IHD, cumulative 
exposure, ppm-y  
< 400 
400–799 
> 800 
IHD, time since first 
exposure 
< 20 y 
20–30 y 
> 30 y 
 
124 
114 
16 
 
 
47 
13 
10 
 
 
28 
47 
39 
SMR 
0.88 (0.74–1.05) 
0.92 (0.76–1.10) 
0.50 (0.29–0.82) 
 
 
0.79 
1.06 
1.22 
 
 
0.73 
1.16 
0.86 
 
 
 
 
 
 
 
 
P(trend): 0.11. 
(964) 
Follow-up of the previous 
cohort.  
Until 2006 As above.  
All heart disease 
IHD 
CeVD 
IHD, cumulative 
exposure, ppm-y 
< 400 
400–799 
> 800 
IHD, continuous 
exposure, ppm-y 
1 000 
 
178 
156 
29 
 
 
68 
15 
15 
SMR 
0.88 (0.75–1.02) 
0.88 (0.75–1.03) 
0.59 (0.39–0.84) 
 
 
0.78 (P < 0.05) 
0.93 
1.17 
 
RR 
1.47 (0.91–2.39) 
Mean exposure (8-h TWA): 
19 ppm for 9 y. 
 
 
 
 
 
 
P(trend): 0.20. 
(963) 
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Table A22. Dichloromethane (DCM). 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
North America        
Study base: all death certificates 
of Kodak Park male employees 
who died in 1956–1976.  
Cohort: all 751 males hourly 
employed in 1964 and DCM 
exposed. 
Internal referents (I): other non-
exposed males at Kodak Park. 
External referents (E): New 
York State males (exclusion of 
New York City).  
1956–1976 
 
 
 
 
Until 1976 
Mortality (ICD-8) 
from circulatory 
diseases (390–458) 
and IHD (410–
414). 
Mortality (ICD-8) 
from circulatory 
diseases (390–458), 
hypertension (400–
404), IHD (410–
414) and CeVD 
(430–439). 
 
Circulatory disease  
IHD 
 
 
Circulatory disease 
Hypertension 
IHD 
CeVD 
≥ 20 y exposure 
Circulatory disease 
Hypertension 
IHD 
CeVD 
 
200 
129 
 
 
45 
4 
33 
5 
 
24 
2 
19 
1 
PMR 
1.00 
0.95 
 
SMR (I ref; E ref) 
1.17; 0.73  
3.91a; 2.72  
1.15; 0.70 a  
1.56; 0.75  
 
0.96; 0.59 a  
2.99; 2.08  
1.03; 0.61 a  
0.46; 0.22  
Air concentrations (ppm)  
of DCM 1959–1976 as 
mean (range); no. of 
samples:  
1959: 79.4 (9–350); 188 
1966: 118.8 (100–150); 4 
1973: 90.5 (41–188); 28  
1975: 40.3 (0–250); 57. 
 
a P < 0.05.  
(309) 
Cohort: 1 013 male workers 
employed in the Roll Coating 
Division, Kodak for ≥ 1 y 1964–
1970 (expansion of previous 
cohort). 
Internal referents (I): 40 000 
non-exposed males at Kodak. 
External referents (E): New 
York State males (exclusion of 
New York City).  
Until 1984 Mortality from 
circulatory diseases, 
IHD and CeVD. 
ICD-8 until 1978 
and ICD-9 from 
1979.  
 
Circulatory disease  
IHD 
CeVD 
IHD, cumulative 
exposure, ppm-y 
< 350 
350–749 
≥ 750 
 
90 
69 
8 
 
 
19 
22 
28 
SMR (I ref; E ref) 
0.83; 0.68  
0.90; 0.70  
0.65; 0.53  
 
 
1.23; 0.95  
0.79; 0.61 
0.84; 0.66 
Mean exposure 26 ppm. (393) 
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Table A22. Dichloromethane (DCM). 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 1 013 male workers 
(same as above) employed in 
the Roll Coating Division, 
Kodak for ≥ 1 y 1964–1970. 
Internal referents (I): non-
exposed males at Kodak. 
External referents (E): New 
York State males (exclusion of 
New York City). 
Until 1994 As above.  
Circulatory disease 
IHD 
CeVD 
IHD, cumulative 
exposure, ppm-y 
< 400 
400–799 
800–1 199 
≥ 1 200 
 
171 
122 
19 
 
 
34 
38 
33 
17 
SMR (I ref; E ref) 
0.95; 0.84 
1.00; 0.85 
0.90; 0.87 
 
RR (I ref; E ref) 
1.19; 1.17 
0.84; 0.83 
1.18; 1.03 
0.85; 0.85 
 
 
 
 
Mean exposure: 26 ppm 
for 24 y. 
 
 
 
(394) 
Cohort: 1 311 male workers 
(1 070 in the Roll Coating 
Division and 241 in the Dope 
and Distilling Departments) 
employed at Kodak Rochester 
for ≥ 1 y 1946–1970. This and 
the previous cohort overlapped. 
Of 1 617 unique employees, 707 
(44%) were members of both 
cohorts.  
Internal referents (I): Expected 
numbers based on intracohort 
distribution of person-years.  
External referents (E): New 
York State males residing 
outside New York City  
1945–1990. 
Until 1994 As above.  
Circulatory disease 
IHD 
CeVD 
IHD, cumulative 
exposure, ppm-y 
< 150 
150–349 
350–799 
≥ 800 
 
166 
117 
20 
 
 
34 
22 
33 
28 
SMR (vs E ref) 
0.86 (0.74–1.01) 
0.86 (0.71–1.03) 
1.06 (0.65–1.63) 
 
RR (I ref; E ref) 
1.12; 0.91 
0.92; 0.76 
1.03; 0.90 
0.91; 0.83 
 
 
 
 
Mean exposure: 39 ppm 
for 17 y. 
 
 
 
(394) 
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Table A22. Dichloromethane (DCM). 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 3 211 white workers 
(2 187 men, 1 024 women) at the 
Amcelle textile manufacturing 
plant in Cumberland, Maryland, 
US, who worked ≥ 3 mo  
1970–1981 when the plant 
closed.  
Referents: regional rates from 
Allegany County. 
Until 1989 Mortality from IHD 
(ICD-9, 410–414). 
Exposure 
Men 
High 
Low 
None 
Women 
High 
Low 
None 
High exposed men,  
by exposure duration  
< 10 y 
10–19 y 
20 y– 
 
 
98 
96 
41 
 
0 
32 
2 
 
 
33 
45 
20 
SMR 
 
0.92 (0.75–1.12) 
0.96 (0.78–1.17) 
0.99 (0.71–1.34) 
 
– 
0.70 (0.48–0.99) 
0.41 (0.05–1.49) 
 
 
1.30 (0.89–1.82) 
0.84 (0.61–1.13) 
0.72 (0.44–1.11) 
Exposure categories 
High: 350–700 ppm 
Low: 50–100 ppm. 
 
(336) 
Cohort: 1 271 workers (white 
and non-white men and women) 
in the preparation or extrusion 
areas of a textile manufacturing 
plant in Rock Hill, South 
Carolina who worked ≥ 3 mo 
1954–1977. 
Internal referents (I): 948 
workers from a referent plant. 
External referents (E): US 
national rates. 
Until 1977 Mortality from 
diseases of the 
circulatory system 
and IHD. 
Circulatory disease 
White men 
White women 
Non-white men 
IHD 
White men 
White women 
Non-white men 
 
11 
3 
4 
 
10 
2 
2 
SMR (E); HR (I) 
0.79 (E); 1.9 (I)  
0.81 (E) 
1.82 (E) 
 
0.95 (E); 2.6 (I) 
1.25 (E) 
1.82 (E) 
 (728) 
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Table A22. Dichloromethane (DCM). 
Study group and design  Time of 
follow-up 
Outcome 
(diagnose) 
Categories of 
exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments 
and comments  
Ref. 
Cohort: 1 271 workers (same as 
above). 
Referents: local rates from York 
County, US. 
Until 1990 Mortality from IHD 
and CeVD. 
 
IHD 
CeVD 
 
43 
7 
SMR 
0.90 (0.65–1.21) 
0.54 (0.22–1.11) 
By including only active 
workers, the SMR for IHD 
decreased to 0.67. A 
previous follow-up until 
1986 gave similar results 
(530). 
(531) 
Pooled analysis        
Cohorts: 6 964 photographic 
film base workers, ref. (394, 
964) and textile fibre workers, 
ref. (336, 531). 
Varying Mortality from IHD 
(ICD-9, 410–414). 
IHD 
All workers 
Only active workers 
 
500 
66 
SMR 
0.89 (0.81–0.97) 
0.76 (0.59–0.97) 
 (394) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Nordic countries        
Cohort: 1 909 male 
chlorophenoxy herbi-
cide applicators  
1955–1971. 
Referents: Finnish male 
population. 
1972–1989 Mortality from 
IHD, other heart 
disease and hyper-
tension, and CeVD. 
 
IHD 
Other heart disease 
and hypertension 
CeVD 
 
148 
20 
 
26 
SMR 
0.94 (0.80–1.10) 
1.03 (0.63–1.59) 
 
0.73 (0.48–1.04) 
4/5 preparations of 2,4,5-trichloro-
phenoxyacetic acids used in 
Finland during the 1960s 
contained 0.1–0.95 mg/kg TCDD; 
in 1 preparation the TCDD content 
was below the detection limit.  
Neither sentinel tumours nor 
overall cancer were increased. 
(50) 
Europe (non-Nordic)        
Cohort: 1 189 male 
chemical workers 
producing phenoxy 
herbicides in Hamburg, 
employed ≥ 3 mo  
1952–1984.  
Referents: 2 528 gas 
workers from the same 
German region with 
comparable socio-
economic status.  
1952–1992 Mortality (ICD-9) 
from CVD (390–
459) and IHD 
(410–414). 
TCDD,  
ng/kg blood fat  
CVD  
0–2.8 
2.81–14.4 
14.5–49.2 
49.3–156.7 
156.8–344.6 
344.7–3 890.2 
IHD 
0–2.8 
2.81–14.4 
14.5–49.2 
49.3–156.7 
156.8–344.6 
344.7–3 890.2 
 
 
157 
 
 
 
 
 
 
76 
RR 
 
 
1.22 (0.81–1.83) 
0.88 (0.54–1.44) 
1.35 (0.91–2.01) 
1.64 (1.12–2.39) 
1.53 (0.95–2.44) 
1.96 (1.15–3.34) 
 
1.43 (0.83–2.44) 
0.81 (0.41–1.61) 
1.18 (0.65–2.16) 
0.90 (0.47–1.75) 
1.61 (0.85–3.04) 
2.48 (1.32–4.66) 
RR = 1 refers to a TCDD level 
below the median among the 
referents. 
 
 
 
 
 
P(trend): 0.01. 
 
 
 
 
 
 
P(trend): < 0.01.  
(299) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 1 191 male and 
398 female chemical 
workers in Hamburg 
employed ≥ 3 mo 
1952–1984 producing 
phenoxy herbicides. 
The same cohort as 
(299). 
Referents: regional 
rates from Hamburg, 
Germany.  
1952–2007 Mortality (ICD-9) 
from circulatory 
disease (390–459) 
and CeVD (430–
438). 
Men 
Circulatory disease 
CeVD 
Women 
Circulatory disease 
CeVD 
Circulatory disease, 
cumulative TCDD 
exposure, ppt (sic) 
Men 
> 0– < 13.1 
13.1– < 77.4 
77.4– < 334.5 
≥ 334.5 
Women 
0 
> 0–19.5 
> 19.5–78.3 
> 78.3 
 
251 
54 
 
58 
11 
 
 
 
 
55 
63 
70 
63 
 
10 
11 
18 
19 
SMR 
1.16 (1.02–1.31) 
1.57 (1.19–2.05) 
 
0.74 (0.56–0.94) 
0.64 (0.32–1.15) 
 
 
 
 
1.14 (0.86–1.49) 
1.20 (0.92–1.53) 
1.20 (0.94–1.52) 
1.08 (0.83–1.39) 
 
0.65 (0.35–1.20) 
0.79 (0.39–1.41) 
0.78 (0.46–1.23) 
0.73 (0.44–1.15) 
The plant closed in June 1984. 
Median estimated cumulative job 
exposure to TCDD:  
77.4 (0–16 514) ppt (men)  
19.5 (0–15 195) ppt (women). 
The concentrations were based on 
blood fat.  
(602) 
Cohort: 243 male 
workers engaged in 
clean up, repair and 
demolition after an 
accident.  
Referents: male rates 
from the former West 
Germany. 
1953–1992 Mortality (ICD-9) 
from circulatory 
disease and IHD. 
 
Circulatory disease 
TCDD, µg/kg bw 
< 0.1 
0.1–0.99 
≥ 1 
 
IHD 
TCDD, µg/kg bw  
< 0.1 
 
37 
 
13 
11 
13 
 
16 
 
7 
SMR 
0.8 (0.6–1.2) 
 
0.8 (0.4–1.4) 
1.0 (0.5–1.7) 
0.8 (0.4–1.3) 
 
0.7 (0.4–1.1) 
 
0.9 (0.3–1.8) 
In 1953, an uncontrolled 
decomposition reaction occurred 
in the trichlorophenol production 
unit in Ludwigshafen, Germany. 
(729) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
0.1–0.99 
≥ 1 
4 
5 
0.7 (0.2–1.7) 
0.6 (0.2–1.3) 
Cohort: 562 workers 
(549 males, 13 females) 
classified as exposed  
to phenoxy herbicides 
or chlorophenols  
1955–1985. 
External referents: 
gender-specific Dutch 
national rates. 
Internal referents: 567 
non-exposed workers 
(482 males, 85 females). 
1955–1991 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
IHD (410–414), 
and CeVD (430–
438). 
All males 
Circulatory disease  
IHD 
CeVD 
140 males exposed  
at accident 
Circulatory disease 
IHD 
501 medium or high 
exposed vs 530 
low/non-exposed, 
TCDD exposure 
Circulatory disease 
Medium 
High 
IHD 
Medium 
High 
CeVD 
Medium 
High 
 
45 
33 
9 
 
 
15 
14 
SMR 
1.0 (0.8–1.4) 
1.2 (0.8–1.6) 
1.4 (0.6–2.6) 
 
 
1.1 (0.6–1.7) 
1.5 (0.8–2.5) 
 
 
 
 
RR a 
1.5 (0.8–2.8) 
1.5 (0.8–2.9) 
 
1.5 (0.7–3.6) 
2.3 (1.0–5.0) 
 
2.0 (0.5–8.2) 
0.8 (0.2–4.1) 
Production of chlorophenoxy 
herbicides started in 1950 and 
ended in 1969. In 1963, an un-
controlled reaction occurred in the 
autoclave where 2,4,5-trichloro-
phenol was synthesised. An 
explosion followed and TCDD 
was released. The last TCDD 
contaminated process ended in 
1976. 
 
 
a Adjustment for age, calendar 
period and time since first 
exposure. 
Medium: TCDDmax 7.7–124.1 
ppt, lipid adjusted. 
High: TCDDmax 124.2–7 308 ppt, 
lipid adjusted. 
(420) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 1 020 male 
workers from factory A 
(same factory as above) 
employed 1965–1986.  
Referents: non-exposed 
male workers from 
factories A and B, 
including all 1 036 
workers of the latter. 
1955–2006 Mortality (ICD-10) 
from circulatory 
disease (I00–I99), 
IHD (I20–I25) and 
CeVD (I60–I67). 
 
Circulatory disease 
IHD 
CeVD 
IHD, TCDD, based 
on occupational 
history, ppt 
≤ 0.4 
0.4–1.9 
1.9–9.9 
≥ 9.9 
IHD, TCDD, based 
on a priori assumed 
exposure status, ppt 
≤ 0.4 
0.4–1.9 
1.9–9.9 
≥ 9.9 
 
182 
93 
39 
 
 
 
35 
16 
14 
28 
 
 
 
33 
21 
20 
19 
HR 
1.07 (0.98–1.16) 
1.19 (1.08–1.32) 
0.98 (0.83–1.16) 
 
 
 
1.0 
1.17 (0.65–2.09) 
1.00 (0.54–1.85) 
2.60 (1.57–4.31) 
 
 
 
1.0 
1.02 (0.60–1.76) 
1.25 (0.72–2.18) 
2.78 (1.57–4.91) 
Exposure assessment was based 
on a predictive model for TCDD 
plasma levels at the time of 
assumed last exposure.  
Half-time estimate: 7.1 y. 
(112) 
North America        
Cross-sectional study 
Cohort: 281 workers 
from 2 US factories 
producing trichloro-
phenol or derivatives 
employed > 15 y earlier. 
Referents: 260 subjects 
with no self-reported 
occupational exposure  
to TCDD.  
1987 Reported MI, 
angina pectoris, 
arrhythmia and 
hypertension. 
Serum TCDD,  
pg/g lipid 
MI 
< 238 
≥ 238 
Angina pectoris 
< 238 
≥ 238 
Arrhythmia 
< 238 
 
 
 
20 
9 
 
15 
6 
 
25 
OR 
 
 
1.28 (0.67–2.45) 
1.91 (0.84–4.38) 
 
0.84 (0.43–1.67) 
1.10 (0.43–2.83 
 
0.89 (0.51–1.53) 
Matching for age, race and 
gender. 
(138) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
≥ 238 
Hypertension 
< 238 
≥ 238 
8 
 
93 
34 
0.91 (0.40–2.07) 
 
1.14 (0.79–1.66) 
1.46 (0.84–2.52) 
Cohort: 5 132 chemical 
workers from 12 US 
plants producing 
TCDD-contaminated 
products 1942–1984,  
of which 608 with 
chloracne and 3 538 
with cumulative 
exposure estimates. 
Referents: US national 
population. 
Until 1993 Mortality (ICD-9) 
from IHD (410–
414) and CeVD 
(430–438). 
Total cohort 
IHD 
CeVD 
Workers with 
chloracne 
IHD 
IHD by cumulative 
exposure score 
0– < 19 
19–139 
139– < 581 
581– < 1 650 
1 650– < 5 740 
5 740– < 20 200 
≥ 20 200 
 
456 
69 
 
 
92 
SMR 
1.09 (1.00–1.20) 
0.96 (0.74–1.21) 
 
 
1.17 (0.94–1.44) 
 
RR 
1.00 
1.23 (0.75–2.00) 
1.34 (0.83–2.18) 
1.30 (0.79–2.13) 
1.39 (0.86–2.24) 
1.57 (0.96–2.56) 
1.75 (1.07–2.87) 
P(trend): 0.05 
Exposure score based on the 
following:  
1) the concentration of TCDD 
(mg/g) in process materials.  
2) the fraction of the day the 
worker worked on the specific 
process.  
3) a qualitative contact level 
(0.01–1.5) based on estimates  
of the amount of TCDD 
contamination reaching exposed 
skin areas or the potential for 
inhalation of TCDD-contaminated 
dust. 
The trend for IHD was 
strengthened with the use of the 
logarithm of cumulative exposure. 
(909) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Cohort: 1 262 male US 
veterans of Operation 
Ranch Hand exposed to 
herbicides 1962–1971 
in Vietnam, of which 
587 enlisted ground 
crew. 
Referents: 19 078 male 
US veterans who flew 
or serviced other 
aircrafts in Southeast 
Asia, of which 10 724 
enlisted ground crew.  
Until 1999 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
atherosclerotic heart 
disease (410– 412, 
414.0, 414.8, 414.9, 
428.4, 440.9, 444), 
CeVD (430, 431, 
432.9, 434.0, 434.9, 
436, 442.8, 437.9) 
and hypertensive 
disease (401.9, 
402.9, 437.2, 441.0, 
441.1, 441.2, 441.3, 
441.5). 
All cohort 
Circulatory disease 
Enlisted ground 
crew veterans 
Circulatory disease 
Heart disease 
CeVD 
Hypertension 
2 452 veterans with 
dioxin assay results 
Circulatory disease 
1 436 referents 
442 background 
287 low 
287 high 
Exp/refs 
 66/745 
 
 
 40/393 
 28/281 
 5/34 
 2/15 
 
 
 
 31 
 8 
 12 
 9 
RR 
1.3 (1.0–1.6) 
 
 
1.7 (1.2–2.4) 
1.7 (1.1–2.5) 
2.3 (0.9–6.0) 
2.5 (0.6–10.8) 
 
 
 
1.0 
0.8 (0.4–1.8) a 
1.8 (0.9–3.5) a 
1.5 (0.7–3.3) a 
P(trend): 0.07 
a Adjustment for military 
occupation, birth year, smoking 
and family history of heart disease. 
 
 
 
 
Dioxin exposure categories 
Background: Ranch Hand veterans 
≤ 10 ppt. Among veterans with 
exposure > 10 ppt the level at the 
end of service in Vietnam was 
estimated with a 1st order kinetics 
model (half-time 7.6 y). 
Low: initial level ≤ 117.6 ppt. 
High: initial level > 117.6 ppt. 
(489) 
Cross-sectional study 
1 469 male US veterans 
from Army Chemical 
Corps with minimum 18 
mo service 1965–1973 
in Vietnam. Agent 
Orange was sprayed 
1965–1970. 
Cohort: 907 herbicide 
sprayers.  
Referents: 562 non-
sprayers.  
2013 Self-reported 
physician-
diagnosed 
hypertension. 
Hypertension 
Herbicide sprayers 
Non-sprayers 
 
740 (81.6%) 
406 (72.2%)  
OR 
1.77 (1.35–2.30) 
Blood samples of TCDD  
1999–2000. 
Serum TCDD concentrations 
mean (range), lipid corrected:  
361 sprayers  
3.5 (0.5–30.6) ppt 
192 non-sprayers  
2.5 (0.7–17.7) ppt 
P = 0.0001. 
(207) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Asia        
Cohort: 180 639 
Korean Vietnam 
veterans who served in 
Vietnam 1964–1973. 
1992–2005 Mortality (ICD-10) 
from circulatory 
disease (I00–I99), 
hypertension (I10–
I13), IHD (I20–I25), 
angina pectoris 
(I20), acute MI 
(I21), chronic IHD 
(I25), CeVD (I60–
I69), intracerebral 
haemorrhage (I61–
I62), cerebral 
infarction (I63) and 
aortic aneurysm 
(I71). 
Circulatory disease 
Continuous exp. 
High vs low exp. 
Hypertension 
Continuous exp. 
High vs low exp. 
IHD 
Continuous exp. 
High vs low exp. 
Angina pectoris  
Continuous exp. 
High vs low exp. 
Acute MI  
Continuous exp. 
High vs low exp. 
Chronic IHD 
Continuous exp. 
High vs low exp. 
CeVD  
Continuous exp. 
High vs low exp. 
Intracerebral 
haemorrhage  
Continuous exp. 
High vs low exp. 
Cerebral infarction 
Continuous exp. 
High vs low exp. 
 
3 180 
1 716/1 464 
 
192 
110/82 
 
843 
437/406 
 
60 
43/17 
 
699 
352/347 
 
82 
41/41 
 
1 618 
879/739 
 
 
758 
407/351 
 
309 
167/142 
HR 
1.02 (1.00–1.04) 
1.04 (0.97–1.12) 
 
1.06 (0.99–1.14) 
1.18 (0.88–1.58) 
 
0.99 (0.96–1.03) 
0.99 (0.86–1.14) 
 
1.22 (1.05–1.41) 
2.34 (1.32–4.15) 
 
0.98 (0.95–1.02) 
0.93 (0.80–1.09) 
 
0.97 (0.88–1.08) 
0.92 (0.59–1.44) 
 
1.01 (0.99–1.04) 
1.01 (0.92–1.12) 
 
 
1.03 (0.99–1.07) 
1.05 (0.90–1.22) 
 
0.99 (0.94–1.05) 
0.96 (0.76–1.20) 
An Agent Orange exposure index 
was based on a geographical 
information system model. 
Exposure was presented as a 
continuous variable and as a 
comparison between high- and 
low-exposure groups.  
(1045) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
Aortic aneurysm 
Continuous exp. 
High vs low exp. 
 
29 
17/12 
 
1.05 (0.88–1.26) 
1.26 (0.59–2.66) 
Pooled studies        
IARC multicentre 
cohort: 21 863 
phenoxyacid herbicide 
and chlorophenol 
production workers and 
sprayers from 36 
cohorts in 12 countries 
(of which 13 831 
exposed, 7 553 non-
exposed and 479 with 
unknown exposure). 
External referents: 
national rates from the 
respective countries. 
Internal referents: 
7 553 non-exposed 
workers. 
1939–1992 Mortality (ICD-9) 
from circulatory 
disease (390–459), 
IHD (410–414), 
CeVD (430–438) 
and other diseases 
of the heart (415–
429). 
Circulatory disease  
Males 
Females 
IHD 
Males 
Females 
CeVD 
Males 
Females 
Other heart disease 
Males 
Females 
Workers exposed to 
TCDD/HCD 
Circulatory disease 
IHD 
CeVD 
Other heart disease 
Internal referents, 
exposure duration  
Circulatory disease 
< 1 y 
1–4 y 
5–9 y 
10–19 y 
 
1 738 
48 
 
1 179 
24 
 
254 
9 
 
166 
6 
 
 
1 170 
789 
162 
138 
 
 
1 151/582 
248 
370 
220 
233 
SMR 
0.91 (0.87–0.95) 
1.00 (0.73–1.32) 
 
0.92 (0.87–0.98) 
1.07 (0.68–1.59) 
 
0.86 (0.76–0.97) 
0.73 (0.33–1.38) 
 
1.11 (0.95–1.29) 
0.92 (0.34–2.00) 
 
SMR 
0.94 (0.88–0.99) 
0.97 (0.90–1.04) 
0.84 (0.71–0.98) 
1.20 (1.01–1.42) 
 
RR 
1.51 (1.17–1.96) 
1.00 
1.16 (0.98–1.38) 
1.32 (1.08–1.60) 
1.28 (1.05–1.55) 
HCD: higher chlorinated dioxins. (1005) 
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Table A23. Dioxins and dioxin-like compounds. 
Study group  
and design  
Time of  
follow-up 
Outcome 
(diagnose) 
Categories  
of exposure 
No. of 
cases 
Risk estimates 
(95% CI) 
Confounder adjustments and 
comments 
Ref. 
≥ 20 y 
 
 
IHD 
< 1 y 
1–4 y 
5–9 y 
10–19 y 
≥ 20 y 
 
 
CeVD 
< 1 y 
1–4 y 
5–9 y 
10–19 y 
≥ 20 y 
80 
 
 
775/391 
187 
236 
135 
158 
59 
 
 
161/95 
31 
54 
38 
34 
4 
0.96 (0.73–1.27) 
P(trend): 0.19 
 
1.67 (1.23–2.26) 
1.00 
1.05 (0.86–1.29) 
1.17 (0.92–1.48) 
1.21 (0.96–1.53) 
0.98 (0.70–1.36) 
P(trend): 0.29 
 
1.54 (0.83–2.88) 
1.00 
1.13 (0.70–1.82) 
1.39 (0.83–2.32) 
1.22 (0.72–2.08) 
0.30 (0.10–0.91) 
P(trend): 0.51 
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Appendix B. Previous NEG criteria documents 
NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Acetonitrile 1989:22, 1989:37* 
Acid aerosols, inorganic 1992:33, 1993:1* 
Acrylonitrile 1985:4 
Allyl alcohol 1986:8 
Aluminium and aluminium compounds 1992:45, 1993:1*, 2011;45(7)*D 
Ammonia 1986:31, 2005:13* 
Antimony 1998:11* 
Arsenic, inorganic 1981:22, 1991:9, 1991:50* 
Arsine 1986:41 
Asbestos 1982:29 
Benomyl 1984:28 
Benzene 1981:11 
1,2,3-Benzotriazole 2000:24*D 
Boric acid, Borax 1980:13 
1,3-Butadiene 1994:36*, 1994:42 
1-Butanol 1980:20 
γ-Butyrolactone 2004:7*D 
Cadmium 1981:29, 1992:26, 1993:1* 
7/8 Carbon chain aliphatic monoketones 1990:2*D 
Carbon monoxide 1980:8, 2012;46(7)* 
Carbon nanotubes 2013;47(5)* 
Ceramic Fibres, Refractory 1996:30*, 1998:20 
Chloramines, Inorganic 2019;53(2) 
Chlorine, Chlorine dioxide 1980:6 
Chloromequat chloride 1984:36 
4-Chloro-2-methylphenoxy acetic acid 1981:14 
Chlorophenols 1984:46 
Chlorotrimethylsilane 2002:2 
Chromium 1979:33 
Cobalt 1982:16, 1994:39*, 1994:42 
Copper 1980:21 
Creosote 1988:13, 1988:33* 
Cyanoacrylates 1995:25*, 1995:27 
Cyclic acid anhydrides 2004:15*D 
Cyclohexanone, Cyclopentanone 1985:42 
n-Decane 1987:25, 1987:40* 
Deodorized kerosene 1985:24 
Diacetone alcohol 1989:4, 1989:37* 
Dichlorobenzenes 1998:4*, 1998:20 
Diesel engine exhaust 2016;49(6)*D 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Diesel exhaust 1993:34, 1993:35* 
Diethylamine 1994:23*, 1994:42 
2-Diethylaminoethanol 1994:25*N 
Diethylenetriamine 1994:23*, 1994:42 
Diisocyanates 1979:34, 1985:19 
Dimethylamine 1994:23*, 1994:42 
Dimethyldithiocarbamates 1990:26, 1991:2* 
Dimethylethylamine 1991:26, 1991:50* 
Dimethylformamide 1983:28 
Dimethylsulfoxide 1991:37, 1991:50* 
Dioxane 1982:6 
Endotoxins 2011;45(4)*D 
Enzymes, industrial 1994:28*, 1994:42 
Epichlorohydrin 1981:10 
Ethyl acetate 1990:35* 
Ethylbenzene 1986:19 
Ethylenediamine 1994:23*, 1994:42 
Ethylenebisdithiocarbamates and Ethylenethiourea 1993:24, 1993:35* 
Ethylene glycol 1980:14 
Ethylene glycol monoalkyl ethers 1985:34 
Ethylene oxide 1982:7 
Ethyl ether 1992:30* N 
2-Ethylhexanoic acid 1994:31*, 1994:42 
Flour dust 1996:27*, 1998:20 
Formaldehyde 1978:21, 1982:27, 2003:11*D 
Fungal spores 2006:21* 
Furfuryl alcohol 1984:24 
Gasoline 1984:7 
Glutaraldehyde 1997:20*D, 1998:20 
Glyoxal 1995:2*, 1995:27 
Halothane 1984:17 
n-Hexane 1980:19, 1986:20 
Hydrazine, Hydrazine salts 1985:6 
Hydrogen fluoride 1983:7 
Hydrogen sulphide 1982:31, 2001:14*D 
Hydroquinone 1989:15, 1989:37* 
Industrial enzymes 1994:28* 
Isoflurane, sevoflurane and desflurane 2009;43(9)* 
Isophorone 1991:14, 1991:50* 
Isopropanol 1980:18 
Lead, inorganic 1979:24, 1992:43, 1993:1* 
Limonene 1993:14, 1993:35* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Lithium and lithium compounds 2002:16* 
Manganese 1982:10 
Mercury, inorganic 1985:20 
Methacrylates 1983:21 
Methanol 1984:41 
Methyl bromide 1987:18, 1987:40* 
Methyl chloride 1992:27*D 
Methyl chloroform 1981:12 
Methylcyclopentadienyl manganese tricarbonyl 1982:10 
Methylene chloride 1979:15, 1987:29, 1987:40* 
Methyl ethyl ketone 1983:25 
Methyl formate 1989:29, 1989:37* 
Methyl isobutyl ketone 1988:20, 1988:33* 
Methyl methacrylate 1991:36*D 
N-Methyl-2-pyrrolidone  1994:40*, 1994:42 
Methyl-tert-butyl ether 1994:22*D 
Microbial volatile organic compounds (MVOCs) 2006:13* 
Microorganisms 1991:44, 1991:50* 
Mineral fibers 1981:26 
Nickel 1981:28, 1995:26*, 1995:27 
Nitrilotriacetic acid 1989:16, 1989:37* 
Nitroalkanes 1988:29, 1988:33* 
Nitrogen oxides 1983:28 
N-Nitroso compounds 1990:33, 1991:2* 
Nitrous oxide 1982:20 
Occupational exposure to chemicals and hearing impairment 2010;44(4)* 
Occupational skin exposure to chemicals 2018;52(3)* 
Oil mist 1985:13 
Organic acid anhydrides 1990:48, 1991:2* 
Ozone 1986:28 
Paper dust 1989:30, 1989:37* 
Penicillins 2004:6* 
Permethrin 1982:22 
Petrol 1984:7 
Phenol 1984:33 
Phosphate triesters with flame retardant properties 2010;44(6)* 
Phthalate esters 1982:12 
Platinum 1997:14*D, 1998:20 
Polychlorinated biphenyls (PCBs) 2012;46(1)* 
Polyethylene,  1998:12* 
Polypropylene, Thermal degradation products in the 
processing of plastics 
1998:12* 
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NEG documents published in the scientific serial Arbete och Hälsa (Work and Health). 
Substance/Agent Arbete och Hälsa issue 
Polystyrene, Thermal degradation products in the processing 
of plastics 
1998:12* 
Polyvinylchloride, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polytetrafluoroethylene, Thermal degradation products in 
the processing of plastics 
1998:12* 
Propene 1995:7*, 1995:27 
Propylene glycol 1983:27 
Propylene glycol ethers and their acetates 1990:32*N  
Propylene oxide 1985:23 
Refined petroleum solvents 1982:21 
Refractory Ceramic Fibres 1996:30* 
Selenium 1992:35, 1993:1* 
Silica, crystalline 1993:2, 1993:35* 
Silicon carbide 2018;52(1)*  
Styrene 1979:14, 1990:49*, 1991:2 
Sulphur dioxide 1984:18 
Sulphuric, hydrochloric, nitric and phosphoric acids 2009;43(7)* 
Synthetic pyretroids 1982:22 
Tetrachloroethane 1996:28*D 
Tetrachloroethylene 1979:25, 2003:14*D 
Thermal degradation products of plastics 1998:12* 
Thiurams 1990:26, 1991:2* 
Tin and inorganic tin compounds 2002:10*D 
Toluene 1979:5, 1989:3, 1989:37*, 2000:19* 
1,1,1-Trichloroethane 1981:12 
Trichloroethylene 1979:13, 1991:43, 1991:50* 
Triglycidyl isocyanurate 2001:18* 
n-Undecane 1987:25, 1987:40* 
Vanadium 1982:18 
Vinyl acetate 1988:26, 1988:33* 
Vinyl chloride 1986:17 
Welding gases and fumes 1990:28, 1991:2* 
White spirit 1986:1 
Wood dust 1987:36 
Xylene 1979:35 
Zinc 1981:13 
 * : in English, remaining documents are in a Scandinavian language.  
D: collaboration with the Dutch Expert Committee on Occupational Safety (DECOS).  
N: collaboration with the US National Institute for Occupational Safety and Health (NIOSH).  
To order further copies in this series, please contact: 
Arbete och Hälsa, Box 414, SE-405 30 Göteborg, Sweden  
E-mail: arbeteochhalsa@amm.gu.se. Phone: +46 31 786 62 61 
All NEG documents are free to download at: www.nordicexpertgroup.org. 
